TempI

Aus coViki

(Unterschied zwischen Versionen)

Wechseln zu: Navigation, Suche

Aktuelle Version vom 12. November 2021, 12:53 Uhr

C7723464 2020. Contributory role of SARS-CoV-2 genomic variations and life expectancy in COVID-19 transmission and low fatality rate in Africa.
C7709652 2020. COVID-19 natural herd immunity and risk of neuropsychiatric disorders.
C7709602 ?. Syndrome inflammatoire avec atteinte multisystémique post-infection par le SARS-CoV-2 chez l?enfant : quand l?envisager et comment le prendre en charge ?
C7685301 ?. Role of gut-lung microbiome crosstalk in COVID-19.
C7670013 2020. SARS-CoV-2 und das Kawasaki-Syndrom.
33333024 ?. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.
C7688432 ?. A Dermatologic Perspective on Multisystem Inflammatory Syndrome in Children.
C7604155 ?. Dermatologic manifestations of COVID-19-associated multisystem inflammatory syndrome in children.
33312565 2020. Rapid detection of SARS?CoV?2?specific memory T?cell immunity in recovered COVID?19 cases.
C7665476 ?. Conservation analysis of SARS-CoV-2 spike suggests complicated viral adaptation history from bat to human.
33312178 2020. MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity.
C7720652 ?. Phylogenomics and phylodynamics of SARS-CoV-2 genomes retrieved from India.
C7692877 ?. Phylogenetic and whole genome analysis of first seven SARS-CoV-2 isolates in Bangladesh.
33319124 2021. Mutational insights into the envelope protein of SARS-CoV-2.
C7604183 2020. SÍNDROME HEMOFAGOCÍTICA EM CORONAVÍRUS 19: EXPERIÊNCIA DE UM CENTRO DE CURITIBA-PR.
C7604150 2020. IMUNOPATOLOGIA DA INFECÇÃO POR SARS-COV-2 EM PACIENTES ONCO-HEMATOLÓGICOS.
C7604096 2020. RELATO DE CASO: SINDROME HIPERINFLAMATÓRIA MULTISSISTÊMICA COVID 19 EM PACIENTE PORTADORA DE SÍNDROME MIELODISPLÁSICA- CITOPENIA REFRATÁRIA E ESPECTRO AUTISTA.
C7604066 2020. COVID-19 E SÍNDROME INFLAMATÓRIA MULTISSISTÊMICA SEMELHANTE À DOENÇA DE KAWASAKI: REVISÃO SISTEMÁTICA.
C7604036 2020. SÍNDROME INFLAMATÓRIA MULTISSISTÊMICA PEDIÁTRICA KAWASAKI-LIKE ASSOCIADA A COVID-19.
C7604054 2020. SÍNDROME HEMOFAGOCÍTICA EM PACIENTE COM LMA RECIDIVADA E COVID-19: RELATO DE CASO.
C7604043 2020. AVALIAÇÃO DAS SUBPOPULAÇÕES LINFOCITÁRIAS T B E NK EM PACIENTES COM COVID-19 GRAVE ATENDIDOS EM UM HOSPITAL UNIVERSITÁRIO.
33326767 2020. SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors.
33310664 2021. Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients.
33319167 ?. Structural characterization of Nonstructural protein 1 from SARS-CoV-2.
33319166 2021. Transcriptional response modules characterize IL-1? and IL-6 activity in COVID-19.
C7698825 ?. Development of Herd Immunity to COVID-19 in Louisiana nursing homes.
33328133 ?. Kawasaki disease and COVID-19; a pretext for a hot topic.
C7711743 ?. Potential implications of SARS-CoV-2 oral infection in the host microbiota.
33316043 ?. A phylodynamic workflow to rapidly gain insights into the dispersal history and dynamics of SARS-CoV-2 lineages.
C7677618 ?. Physiochemical Characterization and Domain Annotation of ORF1ab Polyprotein of Novel Corona Virus 19.
C7677617 ?. Comparing Proteomics of NCoV 19 and MERS Corona Virus.
C7677611 ?. Genomics and Evolution of Novel Corona Virus 2019.
C7677609 ?. Evolutionary and Structural Studies of NCoV and SARS CoV-Spike proteins and their association with ACE2 Receptor.
C7717355 ?. Cytokine and Chemokine Levels in COVID-19 Convalescent Plasma.
C7717363 ?. High Prevalence of SARS-CoV-2 Genetic Variation and D614G Mutation in Pediatric Patients with COVID-19.
33333460 2021. Increased Intracranial Pressure in the Setting of Multisystem Inflammatory Syndrome in Children Associated With COVID-19.
C7717369 ?. Significant reduction of humoral response to SARS-CoV-2 4 months after the diagnosis of COVID-19.
C7607336 2020. O03?A case of hyperinflammatory COVID-19 that responded to tocilizumab therapy.
C7607334 2020. EP10?Hyperinflammatory syndrome in a patient with rheumatoid arthritis and COVID-19.
C7607308 2020. O01?Adult onset PIMS-TS with secondary haemophagocytic lymphistiocytosis: into the eye of the cytokine storm.
33309104 ?. Using Genetics To Dissect SARS-CoV-2 Infection.
C7665770 ?. Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation.

32921750 2020. Iron overload and Hepcidin overexpression could play a key role in COVID infection, and may explain vulnerability in elderly, diabetics, and obese patients.
33219817 2020. Individuals With Less Severe Manifestations of SARS-CoV-2 Infection May Not Develop Long-Lasting Humoral Immunity.
33303190 2020. The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.
33299872 2020. Phylogenomics Analysis of SARS-CoV2 Genomes Reveals Distinct Selection Pressure on Different Viral Strains.
33299503 2020. An Immunoinformatics Study to Predict Epitopes in the Envelope Protein of SARS-CoV-2.
33299631 2020. Varying Presentations of Multisystem Inflammatory Syndrome Temporarily Associated with COVID-19.
33274096 2020. Multisystem Inflammatory Syndrome in Children in a 15-Year-Old Male with a Retropharyngeal Phlegmon.
33298836 2020. RNA 2'-O-methylation modification and its implication in COVID-19 immunity.
33298900 2020. Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro.
33301717 2020. FRETing over SARS-CoV-2: Conformational Dynamics of the Spike Glycoprotein.
33306985 2020. D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.
33112651 2020. Addition of Corticosteroids to Immunoglobulins Is Associated With Recovery of Cardiac Function in Multi-Inflammatory Syndrome in Children.
33257339 2020. Le syndrome inflammatoire multisystemique de l'enfant ayant un lien temporel avec la COVID-19 : multiples visages, multiples appellations.
33304243 2020. Neuropathobiology of COVID-19: The Role for Glia.
33281831 2020. The Role of Structure in the Biology of Interferon Signaling.
33089820 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) - Recent Updates.
33302033 2020. The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease.
33299610 2020. SARS-CoV-2, Early Entry Events.
33303307 2020. Could changes in the airborne pollutant particulate matter acting as a viral vector have exerted selective pressure to cause COVID-19 evolution?
33173546 2020. Hyperinflammation bei SARS-CoV-2-Infektion.
32503876 2020. T cell engagement of cross-presenting microglia protects the brain from a nasal virus infection.

33253656 2020. One year update on the COVID-19 pandemic: Where are we now?
33230418 2020. Characteristics and considerations in the medical treatment of COVID-19 in children.
33169815 2020. Basics of mechanical ventilation for non-anaesthetists. Part 1: Theoretical aspects.
33279488 2020. The Utility of CHA(2)DS(2)-VASc Scores as a Risk Assessment Tool in Low-Risk In-Hospital Patients With Coronavirus Disease 2019 Infection.
33197639 2020. Our insight about Mukhtar et al.'s outcome of non-invasive ventilation in COVID-19 critically ill patients.
33242934 2020. Clinical outcomes of high-flow nasal cannula in COVID-19 associated postextubation respiratory failure. A single-centre case series.
33245382 2020. Empfehlungen fur die Behandlung von kritisch kranken Patienten mit COVID-19 : Version 3 S1-Leitlinie.
33241252 2020. Knowledge and Confidence Level Among Emergency Healthcare Workers in Airway Management and Resuscitation of Suspected COVID-19 Patients: A Cross Sectional Study in Malaysia.
33264802 2020. Ambulatory Clinician's Guide to Inpatient Service: An Innovative Rapid Onboarding Strategy for the COVID-19 Pandemic.
33272716 2020. Surgical strategy and optimal timing of tracheostomy in patients with COVID-19: Early experiences in Japan.
33294449 2020. Differences in Clinical Features and Laboratory Results between Adults and Children with SARS-CoV-2 Infection.
33256643 2020. A nomogramic model based on clinical and laboratory parameters at admission for predicting the survival of COVID-19 patients.
33287804 2020. Development of a data-driven COVID-19 prognostication tool to inform triage and step-down care for hospitalised patients in Hong Kong: a population-based cohort study.
33272250 2020. Comparative analysis of COVID-19 guidelines from six countries: a qualitative study on the US, China, South Korea, the UK, Brazil, and Haiti.
33293361 2020. Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA.
33223045 2020. Haemodynamic impact of positive end-expiratory pressure in SARS-CoV-2 acute respiratory distress syndrome: oxygenation versus oxygen delivery.
33254199 2020. Hemodynamic and mechanical ventilation approach in patients with COVID-19.
33263635 2020. Update on the diagnosis and management of COVID-19 in pediatric patients.
33287864 2020. Electrical impedance tomography to titrate positive end-expiratory pressure in COVID-19 acute respiratory distress syndrome.
33283196 2020. A Novel Low-Cost Ventilator for Use in a Worldwide Pandemic: The Portsmouth Ventilator.
33278017 2020. Inpatient Hyperglycemia Management and COVID-19.
33273040 2020. Post-exertion oxygen saturation as a prognostic factor for adverse outcome in patients attending the emergency department with suspected COVID-19: a substudy of the PRIEST observational cohort study.
33282444 2020. Development and Validation of a Prognostic Risk Score System for COVID-19 Inpatients: A Multi-Center Retrospective Study in China.
33257913 2020. Veno-venous extracorporeal membrane oxygenation in coronavirus disease 2019: a case series.
33257912 2020. Continuous positive airway pressure-treated patients' behaviours during the COVID-19 crisis.
33293151 2020. Home-based COVID 19 management: A consensus document from Italian general medical practitioners and hospital consultants in the Lombardy region (Italy).
33275268 2020. Extracorporeal membrane oxygenation (ECMO) in patients with COVID-19: a rapid systematic review of case studies.
33230401 2020. Inclusive Biomedical Innovation during the COVID-19 Pandemic.
33271960 2020. What Can COVID-19 Teach Us about Using AI in Pandemics?
33281326 2020. Modified Negative Airflow Aerosol Prevention Box for COVID-19 Patients.
33281316 2020. Noninvasive Oxygen Strategies to Manage Confirmed COVID-19 Patients in Indian Intensive Care Units: A Survey.
33281314 2020. Awake Prone Positioning in COVID-19 Patients.
33281309 2020. Role of Noninvasive Oxygen Therapy Strategies in COVID-19 Patients: Where are We Going?
33281307 2020. Conscious Proning or Mixed Positioning for Improving Oxygenation-COVID-19 Brings Many Changes!
33289013 2020. Outlier-SMOTE: A refined oversampling technique for improved detection of COVID-19.
33287859 2020. Criteria for referral of pediatric SARS-CoV-2 infection: a real-life experience in the pandemic era.
33277163 2020. Performing Ultrasound-Guided Percutaneous Tracheostomy in COVID-19 Patients.
33185672 2020. Ensemble learning for poor prognosis predictions: a case study on SARS-CoV2.
33288431 2020. Con: Venoarterial ECMO Should Not Be Considered in Patients With COVID-19.
33288430 2020. Pro: Venoarterial ECMO Should Be Considered in Patients With COVID-19.
33262038 2020. Acute Respiratory Distress Syndrome Treated With Awake Extracorporeal Membrane Oxygenation in a Patient With COVID-19 Pneumonia.
33282650 2020. Pulmonary Embolism in COVID-19 Pneumonia: An Overlapping Diagnosis or a Misdiagnosis?
33274414 2020. Derivation of a Clinical Risk Score to Predict 14-Day Occurrence of Hypoxia, ICU Admission, and Death Among Patients with Coronavirus Disease 2019.
33268203 2020. A chronicle of SARS-CoV-2: Seasonality, environmental fate, transport, inactivation, and antiviral drug resistance.
33284779 2020. Artificial Intelligence in the Fight against COVID-19: A Scoping Review.
33273946 2020. Current status of COVID-19 pandemic; characteristics, diagnosis, prevention, and treatment.
33282011 2020. How chemical engineers can contribute to fight the COVID-19.
33256918 2020. SARS-CoV-2 risk misclassification explains poor COVID-19 management.
33276832 2020. Noninvasive Positive Pressure Ventilation in Patients With COVID-19.
33254558 2020. Role of graphene in biosensor and protective textile against viruses.
33254485 2020. The "COVID-19 Score" can predict the need for tracheal intubation in critically ill COVID-19 patients - A hypothesis.
33295326 2020. Silent or 'Happy' Hypoxemia: An Urgent Dilemma for COVID-19 Patient Care.
33285690 2020. Successful treatment of a critically ill patient with acute respiratory distress syndrome from COVID-19 using mechanical ventilation strategy with low levels of positive end-expiratory pressure: A CARE-compliant case report.
33282284 2020. COVID-19: general overview, pharmacological options and ventilatory support strategies.
33283160 2020. "Neurological manifestations of COVID-19" - guideline of the German society of neurology.
33274248 2020. The BAS(2)IC Score: A Useful Tool to Identify Patients at High Risk of Early Progression to Severe Coronavirus Disease 2019.
33294107 2020. Preventing Acute Respiratory Distress Syndrome (ARDS) and to avoiding intubation in patients with COVID-19: an experience from a reanimation service in Morocco.
33263088 2020. Chest Tube Drainage in the Age of COVID-19.
33296409 2020. COVID-MATCH65-A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2.
33296405 2020. COVID-19 mortality risk assessment: An international multi-center study.
33296357 2020. Development and external validation of a prognostic tool for COVID-19 critical disease.
33259540 2020. Core warming of coronavirus disease 2019 (COVID-19) patients undergoing mechanical ventilation-A protocol for a randomized controlled pilot study.
33262075 2020. Effects of prone and lateral position in non-intubated patients with 2019 Novel Coronavirus (COVID-19) pneumonia.
33272911 2020. Wearing of medical mask over the high-flow nasal cannula for safer oxygen therapy in the COVID-19 era.
33294226 2020. From Radiological Manifestations to Pulmonary Pathogenesis of COVID-19: A Bench to Bedside Review.
33288840 2020. Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19.
33260852 2020. ResUHUrge: A Low Cost and Fully Functional Ventilator Indicated for Application in COVID-19 Patients.
33262803 2020. Prone-Position Ventilation in a Pregnant Woman with Severe COVID-19 Infection Associated with Acute Respiratory Distress Syndrome.
33262795 2020. NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals.
33249683 2020. Derivation with Internal Validation of a Multivariable Predictive Model to Predict COVID-19 Test Results in Emergency Department Patients.
33296169 2020. Recent Insights into Emerging Coronavirus: SARS-CoV-2.
33247469 2020. Coronaviruses in Children: A Review of Potential Mechanisms of Childhood Protection.
33205450 2020. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19.
33284040 2020. Novel Tracheostomy and Percutaneous Endoscopic Gastrostomy Technique for COVID-19 Patients in a Nonnegative Pressure Environment.
33283190 2020. Awake proning of a 2-year-old extubated child with severe COVID-19 pneumonitis.
33274761 2020. Are tracheal intubation and extubation aerosol-generating procedures?
33288635 2020. Evidence-Based Guidelines Should Be Used to Inform COVID-19 Management.
33262177 2020. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections.
33277976 2020. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 2.
33256990 2020. Controversies in airway management of COVID-19 patients: updated information and international expert consensus recommendations.
33255120 2020. Positive End-Expiratory Pressure in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: Higher May Be Too High.
33278112 2020. Epidemiologic trends and characteristics of SARS-CoV-2 infections among children in the United States.
33231148 2020. Respiratory Therapeutic Strategies in Children and Adolescents with COVID-19: a Critical Review.
33183207 2020. COVID-19 and Comorbidities: is Inflammation the Underlying Condition in Children? A narrative Review.
33238869 2020. Therapeutic management of COVID-19 patients: Clinical manifestation and limitations.
33280586 2020. COVID-19 Impacts, Diagnosis and Possible Therapeutic Techniques: A Comprehensive Review.
33273392 2021. Reply to: video laryngoscopy during airway management in COVID-19 patients.
33273391 2021. Video laryngoscopy during airway management in COVID-19 patients: practical relevance of a recent EJA Christmas issue article.
33257600 2020. What is the Determinant of 2019 Novel Coronavirus Prognosis in Children?
33257599 2020. Duration of Viral Clearance in Children With SARS-CoV-2 Infection in Rajasthan, India.
33278855 2020. COVID-19; current situation and recommended interventions.
33291198 2020. A Patient with COVID-19 Treated with ECMO for 26 Days.
33257957 2020. COVID 19: Trends, Disparities, and Consequences for Older Adults.
33285451 2020. Novel expandable architected breathing tube for improving airway securement in emergency care.
33289142 2020. Development and Validation of a Nomogram Using on Admission Routine Laboratory Parameters to Predict In-hospital Survival of Patients With COVID-19.
33259470 2020. Implementing Prone Positioning for COVID-19 Patients Outside the Intensive Care Unit.
33280024 2020. Paediatric COVID-19: Milder Presentation-A Silver Lining in Dark Cloud.
33295047 2020. Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group.
33295002 2020. Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group.
33288946 2020. COVID-19: what health experts could and could not predict.
33280533 2020. Adequate anticoagulation and ECMO therapy in COVID-19 patients with severe pulmonary embolism.
33226885 2020. An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
33264801 2020. Score to Assess the Risk of Pneumonia in Coronavirus Disease-19.

33205948 2020. Detection, Mapping, and Proteotyping of SARS-CoV-2 Coronavirus with High Resolution Mass Spectrometry.
33186121 2020. Comparative analysis of SARS-CoV-2 and its receptor ACE2 with evolutionarily related coronaviruses.
33231569 2020. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.
33203793 2020. Cell differentiation and aging accompanied by depletion of the ACE2 protein.
33237794 2020. Immunoglobulin Deficiency as an Indicator of Disease Severity in Patients with COVID-19.
33082620 2020. Insights into the Immunopathophysiology of Severe COVID-19 in Metabolic Disorders.
33183023 2020. Morphological changes of lymphocytes in peripheral blood smears of patients with COVID-19.
33240994 2020. Dynamic changes of T-lymphocyte subsets and the correlations with 89 patients with coronavirus disease 2019 (COVID-19).
33145296 2020. Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study.
33231054 2020. Recomendaciones para el manejo inicial del sindrome inflamatorio multisistemico relacionado temporalmente con COVID-19, en ninos y adolescentes.
33201341 2020. ceRNA analysis of SARS-CoV-2.
33190827 2020. T cell immunity to SARS-CoV-2 following natural infection and vaccination.
33220925 2020. T-cell dysregulation in COVID-19.
33187644 2020. Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.
33234239 2020. Host-directed editing of the SARS-CoV-2 genome.
33199022 2020. The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.
33220921 2020. Functional importance of the D614G mutation in the SARS-CoV-2 spike protein.
33027600 2020. A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis.
33189832 2020. The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response.
33066821 2020. COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein.
33224987 2020. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation.
33225414 2020. (1)H,(13)C and (15)N chemical shift assignments of the SUD domains of SARS-CoV-2 non-structural protein 3c: "the N-terminal domain-SUD-N".
33219414 2020. (1)H, (13)C, and (15)N backbone and side chain chemical shift assignments of the SARS-CoV-2 non-structural protein 7.
33191083 2020. Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.
33253634 2020. A Multiscale Coarse-grained Model of the SARS-CoV-2 Virion.
33189680 2020. The Flexibility of ACE2 in the Context of SARS-CoV-2 Infection.
33152090 2020. COVID-19-induced atypical pulmonary lymphocytes.
33119481 2020. Kawasaki-like disease and acute myocarditis in the SARS-CoV-2 pandemic - reports of three adolescents.
33097885 2020. Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2.
33188677 2020. Numbers and phenotype of non-classical CD14dimCD16+ monocytes are predictors of adverse clinical outcome in patients with coronary artery disease and severe SARS-CoV-2 infection.
33207184 2020. Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.
33232691 2020. Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis.
33245857 2020. Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies.
33242391 2020. Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles.
33207245 2020. SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in beta Cells.
33207244 2020. Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19.
33220791 2020. The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein.
33232663 2020. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men.
33196989 2020. Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention.
33238570 2020. The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes.
33217417 2020. Lower respiratory tract myeloid cells harbor SARS-CoV-2 and display an inflammatory phenotype.
33203513 2020. An enlightening role for cytokine storm in coronavirus infection.
33253854 2020. Peripheral immunological features of COVID-19 patients in Taizhou, China: A retrospective study.
33189887 2020. Major reduction of NKT cells in patients with severe COVID-19 pneumonia.
32496544 2020. Evaluating Immune Dysregulation in Patients With COVID-19 Requires a More Accurate Definition of the CD45RA+ T-cell Phenotype.
33217259 2020. Case Report: Pediatric Patient with COVID-19 and Multisystem Inflammatory Syndrome in Children.
33209300 2020. Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19.
33162723 2020. Stability Analysis in COVID-19 Within-Host Model with Immune Response.
33221119 2020. Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism.
33200028 2020. Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization.
33217169 2020. A Prototype QSP Model of the Immune Response to SARS-CoV-2 for Community Development.
33240687 2020. Multisystem Inflammatory Syndrome in Children, the Real Disease of COVID-19 in Pediatrics - A Multicenter Case Series From Al-Ahsa, Saudi Arabia.
33214962 2020. Kawasaki Disease-Like Features in 10 Pediatric COVID-19 Cases: A Retrospective Study.
33194461 2020. A Rare Presentation of Multi-System Inflammatory Disease in Children Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
33242255 2020. An integrative analysis identifying transcriptional features and key genes involved in COVID-19.
33253796 2020. The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2.
33220345 2020. Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19.
33207533 2020. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.
33237152 2020. Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses.
33239605 2020. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.
33203641 2020. COVID-19 cytokine storm: what is in a name?
33232209 2020. Megakaryocytes: Masters of Innate Immunity?
33199021 2020. Evolution patterns of SARS-CoV-2: Snapshot on its genome variants.
33249673 2020. Specialized proresolving mediators in infection and lung injury.
33244583 2020. Novel SARS-CoV-2 encoded small RNAs in the passage to humans.
33205194 2020. The SARS-CoV-2 receptor, Angiotensin converting enzyme 2 (ACE2) is required for human endometrial stromal cell decidualization.
33248129 2020. From Examining the Relationship between (Corona)Viral Adhesins and Galectins to Glyco-Perspectives.
33243116 2020. Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?
33186231 2021. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
33186230 2021. Molecular epidemiology in the HIV and SARS-CoV-2 pandemics.
33200826 2020. SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs.
33202024 2020. Metabolic Syndrome and COVID-19: Endocrine-Immune Vascular Interactions Shape the Clinical Course.
33251605 2020. Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients.
33182073 2020. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.
33246355 2020. A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression.
33234246 2020. TAM receptors: A phosphatidylserine receptor family and its implications in viral infections.
33111578 2020. Pathogenesis guided therapeutic management of COVID-19: an immunological perspective.
33155525 2020. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
33191813 2020. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
33215821 2020. COVID-19: where have the lymphocytes gone?
33254234 2020. Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control.
33247640 2020. Post COVID Inflammation Syndrome: Different Manifestations Caused by the Virus.
33249452 2020. New Horizons: Does Mineralocorticoid Receptor activation by cortisol cause ATP release and COVID-19 complications?
33184940 2020. Clinical significance of the serum IgM and IgG to SARS-CoV-2 in coronavirus disease-2019.
33208459 2020. Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.
33208457 2020. SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.
33249471 2020. Serum protein profiling reveals a specific upregulation of the immunomodulatory protein progranulin in COVID-19.
33206973 2020. Monocyte CD169 expression as a biomarker in the early diagnosis of COVID-19.
33197260 2020. Early plasma IL-37 responses accompanied with low inflammatory cytokines correlate with benign clinical outcomes during SARS-CoV-2 infection.
33211354 2020. Atypical monocytes in COVID-19: Lighting the fire of cytokine storm?
33252101 2020. Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review.
33188394 2020. SARS-CoV-2 triggering severe ARDS and secondary HLH in a 3-year-old child with Down syndrome.
33234675 2020. Structure of nonstructural protein 1 from SARS-CoV-2.
33237291 2020. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
33211045 2020. A digital protein microarray for COVID-19 cytokine storm monitoring.
33220726 2020. Kinetics and seroprevalence of SARS-CoV-2 antibodies in children.
33245861 2020. Herd immunity for COVID-19.
33185926 2020. SARS-CoV-2-mediated immune system activation and potential application in immunotherapy.
33242097 2020. Multisystem Inflammatory Syndrome in Children during the COVID-19 Pandemic: A Case Report on Managing the Hyperinflammation.
33188728 2020. Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.
33244183 2020. Deciphering the ins and outs of SARS-CoV-2-specific T cells.
33208929 2020. Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19.
33184509 2020. Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells.
33244168 2020. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.
33199863 2020. Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals.
33253058 2020. A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions.
33236427 2020. Immunological basis of virus-host interaction in COVID-19.
33222290 2020. Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS-C.
33249696 2020. Kawasaki disease mimickers.
33184170 2020. MIS-C and Cardiac Conduction Abnormalities.
33239446 2020. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion.
33203681 2020. Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.

33048448 2020. Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome.
33246770 2020. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.
33199178 2020. A clinical trial of IL-15 and IL-21 combination therapy for COVID-19 is warranted.
33186810 2020. A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways.
33231169 2020. COVID-19 research risks ignoring important host genes due to pre-established research patterns.
33205709 2020. Loss of orf3b in the circulating SARS-CoV-2 strains.
33179566 2020. Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target.
33131453 2020. Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal.
33118859 2020. A SARS-CoV-2 variant with the 12-bp deletion at E gene.
33245471 2020. Expression and co-expression analyses of TMPRSS2, a key element in COVID-19.
33250893 2020. Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.
33042918 2020. Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome.
33251267 2020. A Mini-Review on Cell Cycle Regulation of Coronavirus Infection.
33224264 2020. Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection.
33244382 2020. Significant changes of CD4, FOXP3, CD25, and IL6 expression level in Iranian COVID-19 patients.
33244381 2020. Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine.
33244380 2020. Introducing APOA1 as a key protein in COVID-19 infection: a bioinformatics approach.
33242394 2020. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity.
33232865 2020. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
33239109 2020. Increased circulating level of interleukin-6 and CD8(+) T cell exhaustion are associated with progression of COVID-19.
33249264 2020. Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2.
33206207 2020. Histamine receptors and COVID-19.
33072849 2020. Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes.
33221169 2020. The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
33227512 2020. Low dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19.
33202218 2020. Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis.
33207699 2020. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
33043312 2020. Synthea Novel coronavirus (COVID-19) model and synthetic data set.
33251489 2020. SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain.
33236586 2020. Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives.
33236584 2020. The Hyper-Inflammatory Response in Adults with Severe COVID-19 Pneumonia Differs from the Cytokine Storm of Hemophagocytic Syndrome.
33221383 2020. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.
33229438 2020. The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles.
33214224 2020. SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles.
33243941 2020. Characteristics of viral specimens collected from asymptomatic and fatal cases of COVID-19.
33245474 2020. N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects.
33216734 2020. Does common cold coronavirus infection protect against severe SARS-CoV2 disease?
33233425 2020. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors.
33231615 2021. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
33242672 2020. Cytokine storm of a different flavor: the different cytokine signature of SARS-CoV2 the cause of COVID-19 from the original SARS outbreak.
33238745 2020. A 23-Year-Old Man With Multisystem Inflammatory Syndrome After Mild COVID-19.
33245961 2020. Structural insights into SARS-CoV-2 proteins.
33250660 2020. Thermal and hydrodynamic properties of coronavirus at various temperature and pressure via molecular dynamics approach.
33252688 2020. Race/Ethnicity Among Children With COVID-19-Associated Multisystem Inflammatory Syndrome.
33220289 2020. High GRP78 levels in Covid-19 infection: A case-control study.
33246692 2020. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival.
33231720 2020. Lungenveranderungen bei COVID-19 - Storung des pulmonalen Surfactants? : Eine nicht ganz weit hergeholte Hypothese.
33242646 2020. Structural and functional insights into non-structural proteins of coronaviruses.
33237893 2020. Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020.
33248025 2020. Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions.
33242581 2020. The phylogenetic relationship within SARS-CoV-2s: an expanding basal clade.
33200082 2020. Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection.
33239366 2020. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.
33247152 2020. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
33247108 2020. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.
33243994 2020. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.
33239633 2020. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2.
33208793 2020. SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography.
33208736 2020. Architecture of a SARS-CoV-2 mini replication and transcription complex.
33208735 2020. Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site.
33203890 2020. Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses.
33203833 2020. Immune suppression in the early stage of COVID-19 disease.
33160723 2020. Sustancia P, citocinas proinflamatorias, receptor de potencial transitorio vaniloide tipo 1 y COVID-19: una hipotesis de trabajo.
33230417 2020. SARS-COV2 and P. falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt.
33244341 2020. An elevated 8-isoprostaglandin F2 alpha (8-iso-PGF2alpha) in COVID-19 subjects co-infected with malaria.
33198594 2020. Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study.
33131800 2020. Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes.
33202215 2020. Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension.
33206635 2020. Stability of SARS-CoV-2 phylogenies.
33253226 2020. SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia.
33232382 2020. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
33211781 2020. Antibody profiling and prevalence in US patients during the SARS-CoV2 pandemic.
33201914 2020. Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam.
33035234 2020. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.
33237441 2020. Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody.
33219837 2020. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
33239683 2020. Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19.
33199778 2020. Similarities and differences between the 'cytokine storms' in acute dengue and COVID-19.
33060566 2020. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
33203855 2020. A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins.
33251482 2020. Acute Kidney Injury in Multisystem Inflammatory Syndrome in Children (MIS-C): a Case Report.
33235185 2020. Influence of social isolation caused by coronavirus disease 2019 (COVID-19) on the psychological characteristics of hospitalized schizophrenia patients: a case-control study.
33221483 2020. The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury.
33214057 2020. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.
33207583 2020. Antibody Responses to SARS-CoV-2 Antigens in Humans and Animals.
33198287 2020. SARS-CoV-2 Proteins Induce IFNG in Th1 Lymphocytes Generated from CD4+ Cells from Healthy, Unexposed Polish Donors.
33232769 2020. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.
33210477 2020. Evolutionary study of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emerging coronavirus: Phylogenetic analysis and literature review.
33225958 2020. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.
33235813 2020. Temporal signal and the phylodynamic threshold of SARS-CoV-2.
33227343 2020. Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a.
33114742 2020. Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization.
33207802 2020. Recombination and Positive Selection Differentially Shaped the Diversity of Betacoronavirus Subgenera.
33184176 2020. The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses.
33184173 2020. Analysis of genomic distributions of SARS-CoV-2 reveals a dominant strain type with strong allelic associations.
33231324 2020. Prefusion spike protein stabilization through computational mutagenesis.
33174706 2020. Les strategies subversives utilisees par SARS-CoV-2 pour supprimer les defenses de l'hote.
33174705 2020. Covid-19: que sait-on de la reponse immune humorale au virus SARS-CoV-2 ?
33205496 2020. Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment.
33197261 2020. Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist.
33205718 2020. Multisystem inflammatory syndrome in adult COVID-19 patients.
33208380 2020. The known unknowns of T cell immunity to COVID-19.
33184193 2020. Enhancing host cell infection by SARS-CoV-2.
33184236 2020. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.
33207070 2020. Global SNP analysis of 11,183 SARS-CoV-2 strains reveals high genetic diversity.
33215583 2020. [Multisystem inflammatory syndrome in children after SARS-CoV-2 infection].
33202195 2020. Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19.
33198855 2020. [Analysis of pathogenesis, syndrome differentiation and treatment of asymptomatic infectors of coronavirus disease 2019 based on the theory of "pathogen hiding in the pleurodiaphragmatic interspace"].

33042442 2020. Transcription factor-mediated signaling pathways' contribution to the pathology of acute lung injury and acute respiratory distress syndrome.
33034338 2020. Computer-aided prediction and design of IL-6 inducing peptides: IL-6 plays a crucial role in COVID-19.
33126244 2020. Compositional diversity and evolutionary pattern of coronavirus accessory proteins.
33110251 2020. SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response.
33060840 2020. Unique immunological profile in patients with COVID-19.
33139905 2020. Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods.
33037400 2020. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract.
33139926 2020. The SARS-CoV-2 spike protein: balancing stability and infectivity.
33077165 2020. Editorial overview: Membrane traffic in the time of COVID-19.
33071044 2020. Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19.
33029657 2020. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study.
33023827 2020. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis.
33158808 2020. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology.
33038769 2020. The role for the metagenome in the pathogenesis of COVID-19.
33050983 2020. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection.
33083436 2020. Does inflammation help during COVID-19?
33107217 2020. Delayed acute myocarditis and COVID-19-related multisystem inflammatory syndrome.
33162632 2020. Are dopamine and serotonin involved in COVID-19 pathophysiology?
33149541 2020. New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release.
33171276 2020. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.
33118022 2020. Molecular diversity of coronavirus host cell entry receptors.
33038530 2020. The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19.
33194826 2020. miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 via Targeting SARS-CoV-2 RNA.
33123498 2020. Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities.
33072624 2020. The Possible Dual Role of the ACE2 Receptor in Asthma and Coronavirus (SARS-CoV2) Infection.
33178720 2020. Frequencies of CD33+CD11b+HLA-DR-CD14-CD66b+ and CD33+CD11b+HLA-DR-CD14+CD66b- Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19.
33178021 2020. Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease.
32974267 2020. An Overview of the Temporal Shedding of SARS-CoV-2 RNA in Clinical Specimens.
33085541 2020. Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs.
33163695 2020. Genomic exploration light on multiple origin with potential parsimony-informative sites of the severe acute respiratory syndrome coronavirus 2 in Bangladesh.
33173592 2020. A Hydrophobic-Interaction-Based Mechanism Triggers Docking between the SARS-CoV-2 Spike and Angiotensin-Converting Enzyme 2.
33135055 2020. Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.
33139855 2020. The pivotal role of the angiotensin-II-NF-kappaB axis in the development of COVID-19 pathophysiology.
33163360 2020. A fatal course of multiple inflammatory syndrome in children coinfection with dengue. A case report from Indonesia.
33040752 2020. Whither immunity? The search for effective, durable immunity to coronavirus disease 2019 (COVID-19).
33039603 2020. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex.
33035643 2020. Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics.
32937193 2020. Quasi-species nature and differential gene expression of severe acute respiratory syndrome coronavirus 2 and phylogenetic analysis of a novel Iranian strain.
33079210 2020. Inflammasome formation in the lungs of patients with fatal COVID-19.
33029758 2020. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications.
33159646 2020. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
33131215 2020. What is the long-term clinical significance of anti-SARS-CoV-2-specific IgG?
33039966 2020. Continuous tracking of COVID-19 patients' immune status.
33039965 2020. Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study.
33068863 2020. Nucleic acid and antibody assay results in Chinese patients with coronavirus disease 2019 (COVID-19).
33068865 2020. Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics.
33058970 2020. Papain-like cysteine proteinase zone (PCP-zone) and PCP structural catalytic core (PCP-SCC) of enzymes with cysteine proteinase fold.
33061814 2020. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
33076729 2020. Immune system changes during COVID-19 recovery play key role in determining disease severity.
33115680 2020. Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia.
33075532 2020. Higher binding affinity of Furin to SARS-CoV-2 spike (S) protein D614G could be associated with higher SARS-CoV-2 infectivity.
33176202 2020. High prevalence of pre-existing serological cross-reactivity against SARS-CoV-2 in sub-Sahara Africa.
33160066 2020. Viral Kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period.
33057783 2020. Paediatric Inflammatory Multisystem Syndrome Temporally-Associated with SARS-CoV-2 Infection: An Overview.
33099545 2020. Understanding Severe Acute Respiratory Syndrome Coronavirus 2 Replication to Design Efficient Drug Combination Therapies.
33043283 2020. SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum.
33134888 2020. SARS-CoV-2 Targets by the pscRNA Profiling of ACE2, TMPRSS2 and Furin Proteases.
33122196 2020. High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity.
33060199 2020. Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography.
33051211 2020. Coronavirus infection and PARP expression dysregulate the NAD Metabolome: an actionable component of innate immunity.
33154165 2020. Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment.
33161818 2020. The Circadian Clock and Viral Infections.
33145472 2020. SARS-CoV-2 (COVID-19) and the Endocrine System.
32910820 2020. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies.
33128369 2020. Analysis of humoral immune responses in SARS-CoV-2 infected patients.
33122141 2020. Dynamics of Blood Viral Load Is Strongly Associated with Clinical Outcomes in Coronavirus Disease 2019 (COVID-19) Patients: A Prospective Cohort Study.
33099199 2021. Exploring the intrinsic dynamics of SARS-CoV-2, SARS-CoV and MERS-CoV spike glycoprotein through normal mode analysis using anisotropic network model.
33135884 2020. Structure of the SARS-CoV-2 Nsp1/5'-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence.
33103907 2020. Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients.
33103435 2020. Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks.
32946692 2020. Structural Insights into the Binding Modes of Viral RNA-Dependent RNA Polymerases Using a Function-Site Interaction Fingerprint Method for RNA Virus Drug Discovery.
33169633 2020. Angiotensin II, III, and IV may be important in the progression of COVID-19.
33035201 2020. Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors.
33129392 2020. Host or pathogen-related factors in COVID-19 severity? - Authors' reply.
33129391 2020. Host or pathogen-related factors in COVID-19 severity?
33129826 2020. Immunity after COVID-19: Protection or sensitization?
33049594 2020. Viral replication of SARS-CoV-2 could be self-limitative - The role of the renin-angiotensin system on COVID-19 pathophysiology.
33112981 2020. Interdisziplinares COVID-Board bei SARS-CoV-2-getriggerter hyperferritinamischer Inflammation.
33083157 2020. Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load.
32983652 2020. Potential role of cellular miRNAs in coronavirus-host interplay.
33065209 2020. The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection.
33137344 2020. Human coronavirus spike protein-host receptor recognition.
33106987 2020. Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review.
33098476 2020. An Overview of the Crystallized Structures of the SARS-CoV-2.
33181413 2020. High-density lipoprotein cholesterol as a factor affecting virus clearance in covid-19 patients.
33058760 2020. The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET.
33189428 2020. Duration of anti-SARS-CoV-2 antibodies much shorter in India.
33164796 2020. Identification of a dominant CD8(+) CTL epitope in the SARS-associated coronavirus 2 spike protein.
33050053 2020. Evolutionary Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reveals Genomic Divergence with Implications for Universal Vaccine Efficacy.
33036202 2020. Host Receptors of Influenza Viruses and Coronaviruses-Molecular Mechanisms of Recognition.
33041736 2020. Glicosilacion, sitios de union de ligandos y variaciones antigenicas entre la glicoproteina de membrana del COVID-19 y los coronavirus asociados.
33121513 2020. Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2.
33059711 2020. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
33164536 2020. Is mitochondrial bioenergetics and coenzyme Q10 the target of a virus causing COVID-19?
33108121 2020. Lecons biochimiques et statistiques de l'evolution du virus SARS-CoV-2 : nouveaux chemins pour combattre les virus.
33064620 2020. The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization.
33166547 2020. A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex.
33176080 2020. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
33077916 2020. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor.
33077915 2020. Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option.
33169014 2020. Proinflammatory IgG Fc structures in patients with severe COVID-19.
33139917 2020. Overlapping B cell pathways in severe COVID-19 and lupus.
33028979 2020. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.
32855347 2020. Atrioventricular Block in Children With Multisystem Inflammatory Syndrome.
33115920 2020. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.
33093098 2020. The engines of SARS-CoV-2 spread.
33060197 2020. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.
33159009 2020. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
33082295 2020. Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
33082294 2020. Neuropilin-1 is a host factor for SARS-CoV-2 infection.
33082293 2020. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
33147933 2020. [Progress in research on cytokine storm].

33140034 2020. Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein.
33166035 2020. The role of senescent T cells in immunopathology.
33041634 2020. Characterization of SARS-CoV-2 Dynamics in the Host.
33178900 2020. SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes.
33072893 2020. Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2.
33039147 2020. High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2.
33097184 2020. Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
33069360 2020. Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies.
33138856 2020. Serological determinants of COVID-19.
33153065 2020. Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients.
33120236 2020. Innate and adaptive immune responses against coronavirus.
33102591 2020. Sequence Analysis and Structure Prediction of SARS-CoV-2 Accessory Proteins 9b and ORF14: Evolutionary Analysis Indicates Close Relatedness to Bat Coronavirus.
33143053 2020. miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19.
33159807 2020. (1)H, (13)C, and (15)N backbone chemical shift assignments of coronavirus-2 non-structural protein Nsp10.
33142431 2020. A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules.
33035469 2020. COVID-19 in children: a case report of Multisystem Inflammatory Syndrome (MIS-C) in Sao Paulo, Brazil.
33038939 2020. Cytokine Storms in Cancer and COVID-19.
33101705 2020. The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing.
33031765 2020. Mining the Antibody Repertoire for Solutions to SARS-CoV-2.
33096026 2020. Large-Scale Multi-omic Analysis of COVID-19 Severity.
33138195 2020. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
33086697 2020. Effects of Coronavirus Persistence on the Genome Structure and Subsequent Gene Expression, Pathogenicity and Adaptation Capability.
33171736 2020. Cell Biology of Viral Infections.
33087172 2020. The epigenetic implication in coronavirus infection and therapy.
33069853 2020. Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children.
33147319 2020. Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons.
33123353 2020. Complement and protection from tissue injury in COVID-19.
33049415 2020. Cardiovascular magnetic resonance imaging in children with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 and heart dysfunction.
33144203 2020. Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain.
33055229 2020. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.
33072323 2020. Kinetics and isotype assessment of antibodies targeting the spike protein receptor-binding domain of severe acute respiratory syndrome-coronavirus-2 in COVID-19 patients as a function of age, biological sex and disease severity.
33135345 2020. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19.
32965311 2020. Hemophagocytic syndrome: a potential COVID-19 complication.
33066459 2020. Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS).
33147321 2020. An unconventional view of COVID-19 T cell immunity.
32999425 2020. Response to "the role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection".
33031080 2020. Could "trained immunity" be induced by live attenuated vaccines protect against COVID-19? Review of available evidence.
33140086 2020. Longitudinal analysis of serology and neutralizing antibody levels in COVID19 convalescents.
33116747 2020. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
33046418 2020. Antibody response to SARS-CoV-2 in people living with HIV.
33082599 2020. Chloroquine and hydroxychloroquine inhibitors for COVID-19 sialic acid cellular receptor: Structure, hirshfeld atomic charge analysis and solvent effect.
33157499 2020. Detailed immune monitoring of a pregnant woman with critical Covid-19.
33130538 2020. Can immunity during pregnancy influence SARS-CoV-2 infection? - A systematic review.
33158944 2020. The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
33144321 2020. Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
33170317 2020. ACE2: The Major Cell Entry Receptor for SARS-CoV-2.
33163958 2020. Comparative analysis of nanomechanical features of coronavirus spike proteins and correlation with lethality and infection rate.
33127861 2020. Pervasive RNA Secondary Structure in the Genomes of SARS-CoV-2 and Other Coronaviruses.
33067385 2020. Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.
33067384 2020. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
33184103 2020. Defensive Properties of Mucin Glycoproteins during Respiratory Infections-Relevance for SARS-CoV-2.
33146390 2020. Characterizing transcriptional regulatory sequences in coronaviruses and their role in recombination.
33047062 2020. Designing of cytotoxic and helper T cell epitope map provides insights into the highly contagious nature of the pandemic novel coronavirus SARS-CoV-2.
33163105 2020. Analyses genomiques et phylodynamiques du Sars-CoV-2.
33113222 2020. T cell immunobiology and cytokine storm of COVID-19.
33187979 2020. Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm.
33106497 2020. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
33082451 2020. Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses.
33077873 2020. Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients.
33077837 2020. Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method.
33067518 2020. Quantifying the adhesive strength between the SARS-CoV-2 S-proteins and human receptor and its effect in therapeutics.
33184506 2020. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19).
33177594 2020. SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells.
33173052 2020. Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.
33037188 2020. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
33037187 2020. Inhibition of translation and immune responses by the virulence factor Nsp1 of SARS-CoV-2.
33127889 2020. SARS-CoV-2 spike protein: flexibility as a new target for fighting infection.
33127886 2020. SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic.
33043252 2020. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children with COVID-19.
33106783 2020. Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: a New Challenge amid the Pandemic.
33195997 2020. Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19.
33041212 2020. Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions.
33153908 2020. Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.
33132005 2020. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis.
33190685 2020. The Mystery of MIS-C Post-SARS-CoV-2 Infection.
33077340 2020. Sex-biased Immune Responses Following SARS-CoV-2 Infection.
33051104 2020. A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes.
33029383 2020. Intra-genome variability in the dinucleotide composition of SARS-CoV-2.
33050511 2020. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.
33182268 2020. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
33147840 2020. First Phylogenetic Analysis of Malian SARS-CoV-2 Sequences Provides Molecular Insights into the Genomic Diversity of the Sahel Region.
33187074 2020. Spike Glycoprotein-Mediated Entry of SARS Coronaviruses.
33067221 2020. Defining the Cytokine Storm Syndrome of COVID-19: Role of the Clinical Laboratory.
33023959 2020. Response to 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID19): a multicentre cohort by Mastrolia et al.
33086866 2020. ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart.
33181224 2020. Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.
33105999 2020. Computer simulations of the interaction between SARS-CoV-2 spike glycoprotein and different surfaces.
33139323 2020. Covid-19: T cell response lasts for at least six months after infection, study shows.
33084150 2020. Why Does the Novel Coronavirus Spike Protein Interact so Strongly with the Human ACE2? A Thermodynamic Answer.
33174669 2020. Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain / ACE2 Complex.
33081670 2020. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
33164997 2020. Inflammatory endotypes of CRSwNP and responses to COVID-19.
33165008 2020. The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2.
33145867 2020. Immunology of COVID-19.
33174592 2020. Composition of the immunoglobulin G glycome associates with the severity of COVID-19.
33155530 2020. SARS-CoV-2 mutations and where to find them: an in silico perspective of structural changes and antigenicity of the spike protein.
33162259 2020. Multisystem Inflammatory Syndrome in Children.
33086932 2020. The bumpy road to achieve herd immunity in COVID-19.
33148714 2020. SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.
33083826 2020. Associations between genetically predicted protein levels and COVID-19 severity.
33038254 2020. Complement activation in the disease course of COVID-19 and its effects on clinical outcomes.
33135795 2020. Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.
33180935 2020. Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19.
33175159 2020. Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in an 8-week old infant.
33075008 2020. Private Tour Guide to Pediatric Coronavirus Disease of 2019 and Multisystem Inflammatory Syndrome in Children in 10 Minutes: What Thoracic Radiologists Need to Know.
33141192 2020. Newly Discovered Cellular Pathway Blocks Ebola, COVID-19 Viruses.
33074293 2020. Herd Immunity and Implications for SARS-CoV-2 Control.
33106674 2020. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.
33177698 2020. Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers.
33106671 2020. Spike mutation D614G alters SARS-CoV-2 fitness.
33139913 2020. Interferon deficiency can lead to severe COVID.
33084624 2020. Immune Responses During Human Coronavirus Infection: Suggestions for Future Studies.

33108239 2020. Can secondary lymphoid organs exert a favorable effect on the mild course of COVID-19 in children?
33090696 2020. Sex differences in antiviral immunity in SARS-CoV-2 infection: Mitochondria and mitomiR come into view.
33065551 2020. CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients.
33049711 2020. Using the common cold virus as a naturally occurring vaccine to prevent COVID-19: Lessons from Edward Jenner.
33040337 2020. Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections.
33131972 2020. Multisystem inflammatory syndrome in children associated with novel coronavirus SARS-CoV-2: Presentations to a pediatric emergency department in Michigan.
33151090 2020. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of COVID-19 patients.
33146564 2020. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19.
33174447 2020. In well-differentiated primary human bronchial epithelial cells, TGF-beta1 and TGF-beta2 induce expression of furin.
33132066 2020. Documento espanol de consenso sobre diagnostico, estabilizacion y tratamiento del sindrome inflamatorio multisistemico pediatrico vinculado a SARS-CoV-2 (SIM-PedS).
33134148 2020. Clinical Management of Il-6 Driven Cytokine Storm Related to COVID-19 in a Patient with Recent Spinal Cord Stimulator Implants: A Case Report.
33161155 2020. Potential Association of Mast Cells with COVID-19.
33025199 2020. Identification of novel mutations in SARS-COV-2 isolates from Turkey.
33130000 2020. SARS-CoV-2, the autoimmune virus.
33153403 2020. Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?
33152343 2020. Detection of Viral Infections by Innate Immunity.
33161004 2020. Special section involvement of lipids in the occurrence of COVID-19.
33159981 2020. Bis(monoacylglycero)phosphate, an important actor in the host endocytic machinery hijacked by SARS-CoV-2 and related viruses.
33115667 2020. Membrane heist: Coronavirus host membrane remodeling during replication.
33075136 2020. Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19.
33146371 2020. ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV.
33090599 2020. Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown.
33088822 2020. SARS-CoV-2 Bound Human Serum Albumin and Systemic Septic Shock.
33072741 2020. How to Understand "Herd Immunity" in COVID-19 Pandemic.
33042994 2020. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
33195336 2020. Centrality of G6PD in COVID-19: The Biochemical Rationale and Clinical Implications.
33195331 2020. The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences.
33195321 2020. Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients.
33042039 2020. Flexible, Functional, and Familiar: Characteristics of SARS-CoV-2 Spike Protein Evolution.
33195436 2020. ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives.
33195427 2020. Investigation of the Effect of Temperature on the Structure of SARS-CoV-2 Spike Protein by Molecular Dynamics Simulations.
33195415 2020. Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis.
33195414 2020. Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues.
33195401 2020. SARS-CoV-2 Virion Stabilization by Zn Binding.
33195400 2020. COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response.
33173781 2020. Computational Study of the Ion and Water Permeation and Transport Mechanisms of the SARS-CoV-2 Pentameric E Protein Channel.
33134318 2020. ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection?
33088807 2020. Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer.
33034002 2020. Cardiac Affection in a Young Girl with Post Covid-19 Kawasaki Like Syndrome.
33090321 2020. A Pediatric COVID19 Case with Suspected Acute Abdomen, Hyperferritinemic Sepsis and Developing MIS-C and Pancreatitis.
33078283 2020. Neurological Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS).
33149633 2020. Exploring Diversity of COVID19 Based on Substitution Distance.
33036230 2020. Crystal Structure of Non-Structural Protein 10 from Severe Acute Respiratory Syndrome Coronavirus-2.
33063791 2020. Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures.
33063790 2020. Room-temperature X-ray crystallography reveals the oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL M(pro): insights into enzyme mechanism and drug design.
33145962 2020. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
33119547 2020. Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection.
33104057 2020. Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity?
33116752 2020. Cytokine Response in SARS-CoV-2 Infection in the Elderly.
33054818 2020. Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.
33112147 2020. Critical Sequence Hotspots for Binding of Novel Coronavirus to Angiotensin Converter Enzyme as Evaluated by Molecular Simulations.
33085491 2020. Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus-2 and the Receptor of Human Angiotensin-Converting Enzyme 2. Effects of Possible Ligands.
33134610 2020. In the Age of COVID: Genomic Changes Over the Lifespan Help Explain Severe SARS-CoV-2 Disease.
33073064 2020. Cardiorenal Tissues Express SARS-CoV-2 Entry Genes and Basigin (BSG/CD147) Increases With Age in Endothelial Cells.
32984657 2020. Multiorgan Damage in Patients With COVID-19: Is the TGF-beta/BMP Pathway the Missing Link?
32950081 2020. A history of herd immunity.
33072868 2020. Cross-reactions between rheumatoid factor and IgM SARS-CoV-2.
33103107 2020. Protein-driven mechanism of multiorgan damage in COVID-19.
33110678 2020. Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor.
33061829 2020. Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.
33028028 2020. Positive Anti-SSA/Ro Antibody in a Woman with SARS-CoV-2 Infection Using Immunophenotyping: A Case Report.
33196005 2020. COVID-19: An Archetype Innate Immunity Reaction and Modes of Treatment.
33196004 2020. Kawasaki Disease and COVID-19.
33157216 2020. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection.
33049387 2020. Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants.
33093050 2020. Coding-Complete Genome Sequences of 23 SARS-CoV-2 Samples from the Philippines.
33066057 2020. Kinetics of Nucleo- and Spike Protein-Specific Immunoglobulin G and of Virus-Neutralizing Antibodies after SARS-CoV-2 Infection.
33147871 2020. New Insights in Laboratory Testing for COVID-19 Patients: Looking for the Role and Predictive Value of Human epididymis secretory protein 4 (HE4) and the Innate Immunity of the Oral Cavity and Respiratory Tract.
33077685 2020. Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins.
33040198 2020. SARS-CoV-2 has the advantage of competing the iMet-tRNAs with human hosts to allow efficient translation.
33167852 2020. SARS-CoV-2 and interferon blockade.
33053318 2020. The Road Less Traveled: SARS-CoV-2 and Cell-Mediated Immunity.
33186542 2020. COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a(+).
33038327 2020. Tackling COVID19 by Exploiting Pre-existing Cross-Reacting Spike-Specific Immunity.
33033248 2020. Two distinct immunopathological profiles in autopsy lungs of COVID-19.
33028810 2020. Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease.
33116139 2020. ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs.
33110068 2020. Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation.
33046696 2020. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.
33139888 2020. Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models.
33051610 2020. IL-18-dependent MAIT cell activation in COVID-19.
33073555 2020. SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications.
33154981 2020. The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET.
33036180 2020. Tissue Proteases and Immune Responses: Influencing Factors of COVID-19 Severity and Mortality.
33114356 2020. New Insights on the Mobility of Viral and Host Non-Coding RNAs Reveal Extracellular Vesicles as Intriguing Candidate Antiviral Targets.
33099164 2020. Atypical lymphocytes in bronchoalveolar lavage fluid from patients with COVID-19 ARDS.
33194341 2020. Excessive G-U transversions in novel allele variants in SARS-CoV-2 genomes.
33088633 2020. Positive selection within the genomes of SARS-CoV-2 and other Coronaviruses independent of impact on protein function.
32898168 2020. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.
33170902 2020. Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations.
33091042 2020. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
33085715 2020. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
33079950 2020. Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients.
33034798 2020. Whole genome sequencing and phylogenetic classification of Tunisian SARS-CoV-2 strains from patients of the Military Hospital in Tunis.
33166565 2021. Deletion in the C-terminal region of the envelope glycoprotein in some of the Indian SARS-CoV-2 genome.
33069815 2020. The role of dysregulated immune responses in COVID-19 pathogenesis.
33180463 2020. COVID-19 in the Developing World: Is the Immune Response to alpha-Gal an Overlooked Factor Mitigating the Severity of Infection?
33073197 2020. Can SARS-CoV-2 Accumulate Mutations in the S-Protein to Increase Pathogenicity?
33112638 2020. Literature review on Virus and Host Response Proteins in COVID-19: Pathobiology, Management, Diagnosis and Treatment.
33112637 2020. Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV2.
33128792 2020. Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
33105230 2020. Characteristics of Pediatric Inflammatory Multisystem Syndrome Associated with COVID-19.
33064955 2020. Will Research on COVID-19 Stimulate the Identification of Immunological Mechanisms Underlying Some Protective Effects?
33140827 2020. ACE2 and gut amino acid transport.
33044282 2020. Acute Kidney Injury in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic: Experience From PICUs Across United Kingdom.
33176273 2020. Detection of viruses by inflammasomes.
33023438 2020. miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis.
33084029 2020. Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset.
33080068 2020. Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.
33073359 2020. Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients.
33152254 2020. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.
33113212 2020. COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints.

33096082 2020. Structure-Altering Mutations of the SARS-CoV-2 Frameshifting RNA Element.
33100352 2020. Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm.
33171100 2020. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
33157038 2020. beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway.
33147445 2020. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.
33147444 2020. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
33096020 2020. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19.
33080218 2020. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
33037393 2020. An aberrant STAT pathway is central to COVID-19.
33110074 2020. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.
33072409 2020. The role of death domain proteins in host response upon SARS-CoV-2 infection: modulation of programmed cell death and translational applications.
33024578 2020. Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2.
33158455 2020. Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care.
33138839 2020. CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS.
33131507 2020. The double edged interferon riddle in COVID-19 pathogenesis.
33063036 2020. Delayed Development of Coronary Artery Dilitation in Suspected Severe Acute Respiratory Syndrome Coronavirus 2 Multisystem Inflammatory Syndrome: More Research Needed.
33145128 2020. A Case of Multisystem Inflammatory Syndrome in Children Mimicking Acute Appendicitis in a COVID-19 Pandemic Area.
33133836 2020. Atypical Case of COVID-19 Associated Kawasaki Disease in an Eight-Year-Old Pakistani Boy.
33110725 2020. Multisystem Inflammatory Syndrome in Children Temporally Related to COVID-19: A Case Report From Saudi Arabia.
33112236 2020. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
33103998 2020. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
33164753 2020. Single-cell multiomic profiling of human lungs reveals cell-type-specific and age-dynamic control of SARS-CoV2 host genes.
33164751 2020. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities.
33051876 2020. Syncytia formation by SARS-CoV-2-infected cells.
33078545 2020. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia.
33112036 2020. SARS-CoV-2 evades immune detection in alveolar macrophages.
33058753 2020. Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
33083367 2020. Kawasaki-like Syndrome as an Emerging Complication of SARS-CoV-2 Infection in Young Adults.
33058143 2020. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.
33038418 2020. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review.
33086029 2020. Renin-angiotensin system at the interface of COVID-19 infection.
33193414 2020. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
33193390 2020. SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19.
33193384 2020. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
33193377 2020. I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People.
33193337 2020. COVID-19 as an Immune Complex Hypersensitivity in Antigen Excess Conditions: Theoretical Pathogenetic Process and Suggestions for Potential Therapeutic Interventions.
33193331 2020. A 21st Century Evil: Immunopathology and New Therapies of COVID-19.
33178221 2020. T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis.
33178220 2020. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
33178207 2020. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients.
33178193 2020. Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?
33163005 2020. The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation.
33154753 2020. Elevated Exhaustion Levels of NK and CD8(+) T Cells as Indicators for Progression and Prognosis of COVID-19 Disease.
33154751 2020. Coronavirus Proteins as Ion Channels: Current and Potential Research.
33149733 2020. The Inflammasome in Times of COVID-19.
33133104 2020. Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients.
33133098 2020. Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases.
33133083 2020. Immune Correlates of COVID-19 Control.
33123167 2020. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
33123154 2020. Increased Plasma Heparanase Activity in COVID-19 Patients.
33123152 2020. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
33123149 2020. A "Window of Therapeutic Opportunity" for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019.
33117408 2020. The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19.
33117402 2020. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
33117392 2020. Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.
33117379 2020. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19.
33117378 2020. The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens.
33101320 2020. Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
33101306 2020. Covid-19: Perspectives on Innate Immune Evasion.
33072103 2020. Immunopathogenesis of COVID-19: Summary and Possible Interventions.
33072099 2020. Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology.
33072097 2020. COVID-19: In the Eye of the Cytokine Storm.
33042116 2020. COVID-19: Infection or Autoimmunity.
33098549 2020. Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges.
33086021 2020. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus.
33125064 2020. A path towards SARS-CoV-2 attenuation: metabolic pressure on CTP synthesis rules the virus evolution.
33069829 2020. Clustering and classification of virus sequence through music communication protocol and wavelet transform.
33161087 2020. Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirus.
33124193 2020. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.
33163249 2020. The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene.
33129373 2020. Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.
33128877 2020. Unbiased Screens Show CD8(+) T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein.
33128875 2020. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19.
33130519 2020. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies.
33168413 2020. Associations of medications used during hospitalization and immunological changes in patients with COVID-19 during 3-month follow-up.
33035675 2020. First COVID-19 Case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.
33031941 2020. Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh.
32920092 2020. Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19.
32896310 2020. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection.
33075409 2020. COVID-19-associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome-the superantigen hypothesis.
33064671 2020. SARS-CoV-2 specific antibody rearrangements in pre-pandemic immune repertoires of risk cohorts and COVID-19 patients.
33055417 2020. What are protective antibody responses to pandemic SARS-CoV-2?
33064340 2020. Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects.
33058235 2020. Background immunity: How important is it for SARS-CoV-2?
33090512 2020. Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
33090493 2020. Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19.
33049069 2020. Analysis of SARS-CoV-2 mutations in Mexico, Belize, and isolated regions of Guatemala and its implication in the diagnosis.
33075298 2020. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes.
33073244 2020. Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?
33051609 2020. Intestinal attenuation of COVID-19 inflammation.
33068416 2020. Structural analysis of SARS-CoV-2 genome and predictions of the human interactome.
33097660 2020. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
33082228 2020. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
33037310 2020. The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV.
33033346 2020. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism.
33033344 2020. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
33122706 2020. Kinetics of SARS-CoV-2 positivity of infected and recovered patients from a single center.
33106569 2020. The global population of SARS-CoV-2 is composed of six major subtypes.
33060796 2020. Rapid genomic characterization of SARS-CoV-2 viruses from clinical specimens using nanopore sequencing.
33149224 2020. Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins.
33148089 2020. Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature.
33107601 2020. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
33095454 2020. Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.
33085084 2020. SARS-CoV-2-specific virulence factors in COVID-19.
33087872 2020. The false promise of herd immunity for COVID-19.
33181794 2020. Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2: A Case Series Quantitative Systematic Review.
33055501 2020. COVID-19 and Multisystem Inflammatory Syndrome in Latin American Children: A Multinational Study.
33181783 2020. Fatal SARS-CoV-2 Inflammatory Syndrome and Myocarditis in an Adolescent: A Case Report.
33177233 2020. In fatal COVID-19, the immune response can control the virus but kill the patient.
33033173 2020. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
33033172 2020. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.
33148390 2020. [Progress on role of cytokine storm in exacerbation of coronavirus disease 2019 (COVID-19): Review].

33029570 2020. Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions.
33047493 2020. T cell and antibody responses to SARS-CoV-2: Experience from a French transplantation and hemodialysis center during the COVID-19 pandemic.
33064451 2020. Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry.
33087299 2020. Understanding the role of neutrophils in acute respiratory distress syndrome.
33036956 2020. Machine learning techniques for sequence-based prediction of viral-host interactions between SARS-CoV-2 and human proteins.
33118327 2020. Biophysical analysis of SARS-CoV-2 transmission and theranostic development via N protein computational characterization.
33167900 2020. Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study.
33167916 2020. Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran.
33142819 2020. COVID-19 and Parkinson's Disease: Shared Inflammatory Pathways Under Oxidative Stress.
33062362 2020. Discovering Associations: Kawasaki Disease and COVID-19.
33092458 2020. Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment.
33115882 2020. The beneficial and pathogenic roles of complement in COVID-19.
33111059 2020. Histopathologic Findings of Coronavirus in Lung: A Mini-Review.
33091758 2020. The role of androgens in COVID-19.
33100263 2020. ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection.
33033152 2020. Cellular Senescence: Friend or Foe to Respiratory Viral Infections?
33060154 2020. mTORC1 Hyperactivation in LAM Leads to ACE2 Upregulation in Type II Pneumocytes: Implications for COVID-19.
33155247 2020. COVID-19 - gastrointestinal and gut microbiota-related aspects.
33193227 2020. Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals.
33193156 2020. G-Quadruplexes Are Present in Human Coronaviruses Including SARS-CoV-2.
33193132 2020. Positive Selection of ORF1ab, ORF3a, and ORF8 Genes Drives the Early Evolutionary Trends of SARS-CoV-2 During the 2020 COVID-19 Pandemic.
33178176 2020. Differential Expression of Viral Transcripts From Single-Cell RNA Sequencing of Moderate and Severe COVID-19 Patients and Its Implications for Case Severity.
33133055 2020. SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs.
33101264 2020. Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2.
33101244 2020. Rapid Genomic Characterization of SARS-CoV-2 by Direct Amplicon-Based Sequencing Through Comparison of MinION and Illumina iSeq100(TM) System.
33072032 2020. Small Non-coding RNAs: Do They Encode Answers for Controlling SARS-CoV-2 in the Future?
33072018 2020. Translation-Associated Mutational U-Pressure in the First ORF of SARS-CoV-2 and Other Coronaviruses.
33071996 2020. Proteomics Insights Into the Molecular Basis of SARS-CoV-2 Infection: What We Can Learn From the Human Olfactory Axis.
33072695 2020. The CHIR Score for Evaluating the Hyperimmune Response in COVID-19: A Preliminary Concept.
33075345 2020. The SARS-CoV-2 attachment receptor ACE2 is decreased in Crohn's disease and regulated by microbial and inflammatory signaling.
33143811 2020. Clinical characteristics and persistence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in 4,607 French healthcare workers: Comparison with European countries.
33092731 2020. Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children: A Call to Action.
33108354 2020. Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum.
33085654 2020. Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity.
33143379 2020. The Role of Molecular Chaperones in Virus Infection and Implications for Understanding and Treating COVID-19.
33126723 2020. Similar Clinical Course and Significance of Circulating Innate and Adaptive Immune Cell Counts in STEMI and COVID-19.
33105634 2020. Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID-19 Prevalence, Preliminary Results of a Nationwide Register.
33161369 2020. Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect.
33110452 2020. Case report: a fatal combination of hemophagocytic lymphohistiocytosis with extensive pulmonary microvascular damage in COVID-19 pneumonia.
33169560 2020. Multisystem Inflammatory Syndrome in Children Related to COVID-19: the First Case in Korea.
33038012 2020. Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.
33065115 2020. Discriminating Multisystem Inflammatory Syndrome in Children Requiring Treatment from Common Febrile Conditions in Outpatient Settings.
33186512 2020. Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study.
33043289 2020. Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein.
32988176 2020. The first case of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS) in Poland, complicated by giant coronary artery aneurysms.
33160625 2020. CD64, CD11a and CD18 leukocytes expression in children with SARS-CoV-2 multisystem inflammatory syndrome versus children with Kawasaki disease: Similar but not the same.
33107277 2020. An unusual inflammatory disease linked to SARS coronavirus-2 in children: are we prepared enough?
33107273 2020. Covid-19 and kawasaki disease: is there a need for revising treatment guidelines?
33031361 2020. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020.
33177214 2020. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
33036934 2020. Multisystem inflammatory syndrome in SARS-CoV-2 infection mimicking acute appendicitis in children.
33170884 2020. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
33152019 2020. Variant analysis of 1,040 SARS-CoV-2 genomes.
33112891 2020. Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2.
33181855 2020. Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult.
33186686 2020. Protective immunity against COVID-19: Unravelling the evidences for humoral vs. cellular components.
33086860 2020. COVID-19 and Endocan Levels.
33115730 2020. Covid-19: Antibody prevalence in England fell from 6.0% to 4.4% over three months, study finds.
33166189 2020. Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe.
33166178 2020. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children.
33105391 2020. Eosinophilic esophagitis: is the Th2 inflammation protective against the severe form of COVID-19?
33124149 2020. The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection.
33098359 2020. Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients.
33077007 2020. Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature.
33151142 2020. Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression.
33137315 2020. Coronavirus disease 2019, multisystem inflammatory syndrome in children, apolipoprotein E4, and race.
33093376 2020. COVID-19-associated Multisystem Inflammatory Syndrome in Children Presenting as Acute Pancreatitis.
33174576 2020. Context contribution to the intermolecular recognition of human ACE2-derived peptides by SARS-CoV-2 spike protein: implications for improving the peptide affinity but not altering the peptide specificity by optimizing indirect readout.
33070335 2020. The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's Disease.
33167030 2020. Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy.
33166999 2020. Genome-wide mapping of SARS-CoV-2 RNA structures identifies therapeutically-relevant elements.
33147113 2020. Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons.
33181057 2020. Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-gamma as a Novel Antiviral Approach Against COVID-19.

32918894 2020. Stability of severe acute respiratory syndrome coronavirus 2 RNA in placenta and fetal cells.
32866527 2020. Confirmatory evidence of the visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy.
32858014 2020. Comparative nanostructure consideration on novel coronavirus and possibility of transplacental transmission.
32853537 2020. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia.
33020692 2020. In-host Mathematical Modelling of COVID-19 in Humans.
32904415 2020. A data-driven understanding of COVID-19 dynamics using sequential genetic algorithm based probabilistic cellular automata.
32901204 2020. Analyzing COVID-19 virus based on enhanced fragmented biological Local Aligner using improved Ions Motion Optimization algorithm.
32943188 2020. RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19.
32981683 2020. Machine learning methods accurately predict host specificity of coronaviruses based on spike sequences alone.
32931703 2020. Sequence Characterization and Molecular Modeling of Clinically Relevant Variants of the SARS-CoV-2 Main Protease.
32976572 2020. COVID-19 Knowledge Graph: a computable, multi-modal, cause-and-effect knowledge model of COVID-19 pathophysiology.
32994678 2020. Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin.
32994673 2020. CoViD-19 Susceptibility.
32923488 2020. Adaptive Evolution of Feline Coronavirus Genes Based on Selection Analysis.
32933047 2020. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
32895643 2020. Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020.
33008363 2020. Real-time audio and visual display of the Coronavirus genome.
32993540 2020. A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report.
32892755 2020. Obesity, COVID-19 and innate immunometabolism.
32975865 2020. Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases.
32978971 2020. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
32864374 2020. Coronavirus epitope prediction from highly conserved region of spike protein.
32920210 2020. On the genetics and immunopathogenesis of COVID-19.
32866645 2020. Interferon gamma, TGF-beta1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients.
32898238 2020. Sustained responses of neutralizing antibodies against MERS-CoV in recovered patients and their therapeutic applicability.
32997739 2020. Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies.
32130405 2020. 2019 Novel Coronavirus Is Undergoing Active Recombination.
32797228 2020. Potential antigenic cross-reactivity between SARS-CoV-2 and Dengue viruses.
32898715 2020. The kinetics of viral load and antibodiesto SARS-CoV-2.
33005417 2020. Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32989903 2020. COVID-19 and immunological dysregulation: can autoantibodies be useful?
32983400 2020. Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity.
32983399 2020. An immersive journey to the molecular structure of SARS-CoV-2: Virtual reality in COVID-19.
32894160 2020. Assessment of pulmonary surfactant in COVID-19 patients.
32988728 2020. Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
33017040 2020. Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.
32979342 2020. Compartmental immunophenotyping in COVID-19 ARDS: a case series.
32895779 2020. Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets.
32944935 2020. Single-cell RNA sequencing analysis of SARS-CoV-2 entry receptors in human organoids.
32897993 2020. Challenges in Diagnosing Multisystem Inflammatory Syndrome Related to SARS-CoV-2 in a Child With Severe Neurocognitive Impairment and Social Isolation.
32814701 2020. The Urgency of Conducting Serological Studies for COVID-19.
32788194 2020. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
33024281 2020. Cross-reactive memory T cells and herd immunity to SARS-CoV-2.
32943538 2020. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.
32989130 2020. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
32963094 2020. Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.
32964627 2020. Immune response following infection with SARS-CoV-2 and other coronaviruses: A rapid review.
32946131 2020. Investigation of immune cells on elimination of pulmonary-Infected COVID-19 and important role of innate immunity, phagocytes.
32928234 2020. Characterization of codon usage pattern in SARS-CoV-2.
33011520 2020. Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.
32979477 2020. Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world.
32918944 2020. SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.
33003587 2020. Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins.
32992592 2020. Host Immune Response Driving SARS-CoV-2 Evolution.
32971895 2020. Identification of a Membrane Binding Peptide in the Envelope Protein of MHV Coronavirus.
32967229 2020. Immune Checkpoints in Viral Infections.
32961897 2020. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.
32937868 2020. Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic.
32929876 2020. The Longitudinal Immune Response to Coronavirus Disease 2019: Ch<iframe src="http://www.kidney.de/amapp.php?a=g the Cytokine Storm.
32964796 2020. Coronavirus interactions with the cellular autophagy machinery.
32975439 2020. Cardiac Findings in Pediatric Patients With Multisystem Inflammatory Syndrome in Children Associated With COVID-19.
32912123 2020. Emerging Novel Coronavirus is a Global Threat: Insight in the Biology of COVID-19 and its Hijacking Process of Hosts' Cell.
33019935 2020. COVID-19: a Great Mime or a Trigger Event of Autoimmune Manifestations?
33016156 2020. Hypothesis: The electrical properties of coronavirus.
32914439 2020. Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design.
32972235 2020. Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients.
32990479 2020. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
32986664 2020. COVID-19: Significance of antibodies.
32981399 2020. COVID-19 Infection: Concise Review Based on the Immunological Perspective.
33010854 2020. COVID-19-Related Multisystem Inflammatory Syndrome in Children Affects Left Ventricular Function and Global Strain Compared with Kawasaki Disease.
33023287 2020. COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome?
32945158 2020. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
33016027 2020. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
32948117 2020. Household pets and SARS-CoV2 transmissibility in the light of the ACE2 intrinsic disorder status.
32901940 2020. ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19.
32926425 2020. Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls.
33022076 2020. Immunobiology and immunotherapy of COVID-19: A clinically updated overview.
32962383 2020. Mathematical modeling and cellular automata simulation of infectious disease dynamics: Applications to the understanding of herd immunity.
32910875 2020. Is 'inflammaging' fuelling severe COVID-19 disease?
32817223 2020. Cryo-electron Microscopy Structure of the Swine Acute Diarrhea Syndrome Coronavirus Spike Glycoprotein Provides Insights into Evolution of Unique Coronavirus Spike Proteins.
32880615 2020. Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions.
32840583 2020. Difficult to Determine Herd Immunity Threshold for COVID-19.
32808969 2020. Neutralizing Antibodies Against SARS-CoV-2-Important Questions, Unclear Answers.
32795406 2020. Pseudotumor cerebri syndrome associated with MIS-C: a case report.
32960167 2020. Immunite adaptative contre le virus SARS-CoV-2.
32905684 2020. Trained Innate Immunity, Epigenetics, and Covid-19.
32966713 2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.
32966712 2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
32966711 2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
32966710 2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
32999467 2020. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
32788748 2020. Single-cell landscape of immunological responses in patients with COVID-19.
32855555 2020. The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge.
32895541 2020. T cells in COVID-19 - united in diversity.
32887977 2020. Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.
32929268 2020. Seasonal coronavirus protective immunity is short-lasting.
32382153 2020. Protecting the population with immune individuals.
32812012 2020. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.
32908214 2020. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.
32690955 2020. Inhibition of the integrated stress response by viral proteins that block p-eIF2-eIF2B association.
32788708 2020. The type I interferon response in COVID-19: implications for treatment.
32908316 2020. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.
32906143 2020. The coding capacity of SARS-CoV-2.
32942285 2020. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion.
32901123 2020. The coronavirus is mutating - does it matter?
32895961 2020. Neuropathological findings in two patients with fatal COVID-19.
32935873 2020. Invited Review: The spectrum of neuropathology in COVID-19.
32981462 2020. The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia.
32925824 2020. Bronchopulmonary MDR protein expression may protect against COVID-19 infection.
32932334 2020. Multisystem Inflammatory Syndrome Associated With COVID-19 With Neurologic Manifestations in a Child: A Brief Report.
33021596 2020. Serum Responses of Children With Kawasaki Disease Against Severe Acute Respiratory Syndrome Coronavirus 2 Proteins.
32994342 2020. Coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and optimal virion avidity.

32997488 2020. Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor.
32946224 2020. Structural, Biophysical, and Biochemical Elucidation of the SARS-CoV-2 Nonstructural Protein 3 Macro Domain.
32934769 2020. Striking Similarities between CDRs in Some mAbs That Neutralize COVID-19.
33006576 2020. Room-temperature neutron and X-ray data collection of 3CL M(pro) from SARS-CoV-2.
33020343 2020. The Management of Cytokine Storm in COVID-19.
32895623 2020. Crystal structure of SARS-CoV-2 papain-like protease.
32962761 2020. Severe COVID-19: what have we learned with the immunopathogenesis?
32991323 2020. SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime.
33006233 2020. COVID-19 is an emergent disease of aging.
32955770 2020. Cellular senescence as a potential mediator of COVID-19 severity in the elderly.
32956495 2020. Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19.
32965717 2020. SARS-CoV-2 infection in India bucks the trend: Trained innate immunity?
32978876 2020. Transmission-dynamics models for the SARS Coronavirus-2.
32838273 2020. Detection of severe acute respiratory syndrome coronavirus 2 in placentas with pathology and vertical transmission.
32996784 2020. Sex steroids skew ACE2 expression in human airway: a contributing factor to sex differences in COVID-19?
32851969 2020. Identification of Exertional Hypoxia and Its Implications in SARS-CoV-2 Pneumonia.
32925314 2020. Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.
32925313 2020. Human Leukocyte Antigen-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection.
32968798 2020. Unveiling COVID-19-associated organ-specific cell types and cell-specific pathway cascade.
32914167 2020. Comparative host-pathogen protein-protein interaction analysis of recent coronavirus outbreaks and important host targets identification.
32966582 2020. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
32966547 2020. Hypertension and SARS-CoV-2 infection: is inflammation the missing link?
32966765 2020. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.
32841599 2020. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.
32946786 2020. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
32810439 2020. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
32810438 2020. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
32783916 2020. Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex.
33010815 2020. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
32991844 2020. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
32991843 2020. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).
32970989 2020. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
32991842 2020. Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
32979941 2020. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
32979319 2020. Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study.
32976799 2020. COVID-19 Makes B Cells Forget, but T Cells Remember.
32877699 2020. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.
33020722 2020. Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2.
32983570 2020. Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019.
32953130 2020. SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2.
32941787 2020. Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2.
32841605 2020. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor.
32877692 2020. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis.
32810597 2020. Identification of Transcription Factors Regulating SARS-CoV-2 Entry Genes in the Intestine.
32917983 2020. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
32895485 2020. Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients.
32879471 2020. Expansion of atypical memory B cells is a prominent feature of COVID-19.
32963357 2020. Serum inflammatory factors are positively correlated with the production of specific antibodies in coronavirus disease 2019 patients.
32966801 2020. Activation of the SARS-CoV-2 Receptor Ace2 through JAK/STAT-Dependent Enhancers during Pregnancy.
32946807 2020. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors.
32941788 2020. SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant.
32979938 2020. Evasion of Type I Interferon by SARS-CoV-2.
32904468 2020. Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients.
32839763 2020. SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential.
33015650 2020. Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike.
32835306 2020. Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
32838342 2020. Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19.
32861744 2020. The multifaceted role of plasminogen in inflammation.
32916095 2020. Estimating the Binding of Sars-CoV-2 Peptides to HLA Class I in Human Subpopulations Using Artificial Neural Networks.
32911691 2020. Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection.
33003471 2020. Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils' but Impaired Monocytes' and Dendritic Cells' Responsiveness.
32859121 2020. SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway.
32854433 2020. Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects.
32847031 2020. A New ERAP2/Iso3 Isoform Expression Is Triggered by Different Microbial Stimuli in Human Cells. Could It Play a Role in the Modulation of SARS-CoV-2 Infection?
32750325 2020. Chemical kinetics of the development of coronaviral infection in the human body: Critical conditions, toxicity mechanisms, "thermoheliox", and "thermovaccination".
32971122 2020. Deciphering the SSR incidences across viral members of Coronaviridae family.
32986926 2020. Binding of SARS-CoV-2 to cell receptors: a tale of molecular evolution.
32910974 2020. COVID-19 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units.
32931823 2020. Etoposide as Salvage Therapy for Cytokine Storm Due to COVID-19.
32221133 2020. Detection of serum immunoglobulin M and immunoglobulin G antibodies in 2019 novel coronavirus infected patients from different stages.
32938299 2020. Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19.
32897389 2020. Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease.
32901577 2020. Ribonucleocapsid assembly/packaging signals in the genomes of the coronaviruses SARS-CoV and SARS-CoV-2: detection, comparison and implications for therapeutic targeting.
33000143 2020. Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection.
32941618 2020. A Granulocytic Signature Identifies COVID-19 and Its Severity.
32986250 2020. A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB101 with COVID-19 fatality in Mexican population: An ecological approach.
32975856 2020. Evolution of SARS-CoV-2 genome from December 2019 to late March 2020: Emerged haplotypes and informative Tag nucleotide variations.
32970329 2020. Genomic and proteomic mutation landscapes of SARS-CoV-2.
32966656 2020. Biochemical rationale for hypoalbuminemia in COVID-19 patients.
32966646 2020. Phylogenetic analysis of SARS-CoV-2 in the first few months since its emergence.
32966614 2020. Clinical value anti-SARS-COV-2 serum IgA titration in patients with COVID-19.
33006900 2020. Molecular Simulations and Network Modeling Reveal an Allosteric Signaling in the SARS-CoV-2 Spike Proteins.
32786692 2020. Studying the Effects of ACE2 Mutations on the Stability, Dynamics, and Dissociation Process of SARS-CoV-2 S1/hACE2 Complexes.
32786691 2020. Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level.
32937590 2020. Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia.
32963239 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
32985562 2020. Immune dysfunction following COVID-19, especially in severe patients.
32929138 2020. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.
33020502 2020. SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals.
32979900 2020. The assessment of the serum levels of TWEAK and prostaglandin F2? in COVID - 19.
32921745 2020. Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.
32921728 2020. The "perfect" storm: Current evidence on pediatric inflammatory multisystem disease during SARS-CoV-2 pandemic.
32921739 2020. Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma.
32914749 2020. Revisiting Clinical Autopsies: Lessons to be Taken from the COVID-19 Pandemic.
32985209 2020. Genomic characterization and phylogenetic evolution of the SARS-CoV-2.
33010181 2020. Maximizing the value of human biospecimens: Lessons from coronavirus and the Seattle flu study.
32997945 2020. Biological Mechanisms of COVID-19 ARDS.
32997512 2020. Positive Bubble Study in Severe COVID-19 Indicates the Development of Anatomical Intra-pulmonary Shunts in Response to Microvascular Occlusion.
32997507 2020. Reply to: Positive Bubble Study in Severe COVID-19 Indicates the Development of Anatomical Intra-pulmonary Shunts in Response to Microvascular Occlusion.
32826529 2020. Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues.
32996443 2020. Is Higher Viral Load in SARS-CoV-2 Associated with Death?
32897891 2020. Severe hyperphosphatasemia and severe acute respiratory syndrome coronavirus 2 infection in children.
33006605 2020. Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity.
32941261 2020. Myocarditis in Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019.
33020822 2020. Upper respiratory tract levels of SARS-CoV-2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical COVID-19.
32902889 2020. The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.
32897566 2020. Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19.
32897544 2020. Immune response against SARS-CoV-2 in pediatric patients including young infants.
32910461 2020. The dynamics of immune response in COVID-19 patients with different illness severity.
32910458 2020. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
33009829 2020. The antibody response to the glycan alpha-Gal correlates with COVID-19 disease symptoms.
32940328 2020. Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19.

32894217 2020. Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset.
32930052 2020. SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease.
33008679 2020. inverted question markInfeccion por SARS-CoV-2 como desencadenante de un sindrome inflamatorio sistemico?
32904601 2020. Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications.
32959075 2020. Paediatric multisystem inflammatory syndrome associated with COVID-19: filling the gap between myocarditis and Kawasaki?
32949577 2020. Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients.
32974353 2020. SARS-CoV-2 Codon Usage Bias Downregulates Host Expressed Genes With Similar Codon Usage.
32850499 2020. Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2.
33013929 2020. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
32983176 2020. What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses.
32983174 2020. Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.
32983172 2020. Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in".
32983157 2020. The Metabolic Changes and Immune Profiles in Patients With COVID-19.
32983152 2020. The Immune Response and Immunopathology of COVID-19.
32983141 2020. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.
32983106 2020. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease.
32973803 2020. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
32922406 2020. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
33013759 2020. Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature.
32973730 2020. The Strengths of Scanning Electron Microscopy in Deciphering SARS-CoV-2 Infectious Cycle.
32974389 2020. SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle.
33013423 2020. Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis.
32982760 2020. Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2.
32922297 2020. COVID-19 Usurps Host Regulatory Networks.
32943587 2020. Impact of Circulating SARS-CoV-2 Mutant G614 on the COVID-19 Pandemic.
32895641 2020. Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis.
33015593 2020. Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity.
33015591 2020. PPARgamma Cistrome Repression during Activation of Lung Monocyte-Macrophages in Severe COVID-19.
32989429 2020. SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients.
32939273 2020. Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes.
32916324 2020. IFN-gamma receptor 2 deficiency initial mimicry of multisystem inflammatory syndrome in children (MIS-C).
32990278 2020. Antibody responses in COVID-19 patients.
32975374 2020. Naturally activated adaptive immunity in COVID-19 patients.
32949179 2020. STAT3 isoforms differentially affect ACE2 expression: A potential target for COVID-19 therapy.
32924263 2020. Identification of Hub genes associated with infection of three lung cell lines by SARS-CoV-2 with integrated bioinformatics analysis.
32966269 2020. Healthy donor T-cell responses to common cold coronaviruses and SARS-CoV-2.
33021506 2020. COVID-19 and myeloid cells: complex interplay correlates with lung severity.
32976117 2020. Are T cells helpful for COVID-19: the relationship between response and risk.
32957548 2020. Complex Immunometabolic Profiling Reveals the Activation of Cellular Immunity and Biliary Lesions in Patients with Severe COVID-19.
32989935 2020. COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis.
32929291 2021. Structural dynamics of COVID-19 main protease.
32930936 2020. Infectivity of SARS-CoV-2: there Is Something More than D614G?
32885971 2020. The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations May Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein.
32847856 2020. SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.
33015645 2020. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.
33015644 2020. Defining the scourge of COVID-19 hyperinflammatory syndrome.
32978313 2020. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
32978311 2020. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
32948688 2020. Impaired Cytotoxic CD8(+) T Cell Response in Elderly COVID-19 Patients.
32913009 2020. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
32899009 2020. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.
32997001 2020. Genomic and phylogenetic characterisation of an imported case of SARS-CoV-2 in Amazonas State, Brazil.
32916246 2020. Immune response in COVID-19: What do we currently know?
32911086 2020. Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses.
32891874 2020. Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis.
32972948 2020. Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020.
32972934 2020. Coding-Complete Genome Sequences of Three SARS-CoV-2 Strains from Bangladesh.
33019592 2020. Gut Microbiota Dysbiosis-Immune Hyperresponse-Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches.
32895815 2020. COVID-19-Spatfolge bei Kindern: Multisystemische Entzundung : Coronavirus-Pandemie.
32790663 2020. COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020.
32888056 2020. GC usage of SARS-CoV-2 genes might adapt to the environment of human lung expressed genes.
32993497 2020. The role of host defences in Covid 19 and treatments thereof.
32945643 2020. SeXX and COVID-19: tussle between the two.
32938700 2020. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
32871063 2020. Humoral Immune Response to SARS-CoV-2 in Iceland.
32948854 2020. Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19.
32943637 2020. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.
32943630 2020. SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.
32917884 2020. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.
32908300 2020. COVID-19 herd immunity: where are we?
33009506 2020. Fatty monocytes in COVID-19.
32895513 2020. Coordinated and sustained immune memory responses after mild COVID-19.
32895512 2020. SARS-CoV-2 ORF9c: a mysterious membrane-anchored protein that regulates immune evasion?
32895511 2020. Does a host restriction factor facilitate entry of SARS-CoV-2?
32995660 2020. Single cell sequencing unraveling genetic basis of shared immunologic switch between Severe COVID19 and Obesity.
32984641 2020. Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity.
32939324 2020. Immune responses during COVID-19 infection.
32961074 2020. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines.
32898469 2020. SARS-CoV-2 envelope protein topology in eukaryotic membranes.
32999893 2020. Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19.
32989419 2020. The Antibody Response to SARS-CoV-2 Infection.
32792288 2020. Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19.
32891582 2020. Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation.
32901164 2020. Apparent scaling of virus surface roughness-An example from the pandemic SARS-nCoV.
32911234 2020. A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection.
32997660 2020. IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis.
32941419 2020. Genetic grouping of SARS-CoV-2 coronavirus sequences using informative subtype markers for pandemic spread visualization.
33006981 2020. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic.
32976531 2020. The changes of the peripheral CD4+ lymphocytes and inflammatory cytokines in Patients with COVID-19.
32970753 2020. A web visualization tool using T cell subsets as the predictor to evaluate COVID-19 patient's severity.
32936826 2020. Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey.
32903266 2020. Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma.
32913364 2020. A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients.
32894404 2020. The impact of aging and COVID-19 on our immune system: a high-resolution map from single cell analysis.
32965372 2020. Kawasaki and COVID-19 disease in children: a systematic review.
32936318 2020. Kawasaki-like disease in children with COVID-19.
32895366 2020. Storm of soluble immune checkpoints associated with disease severity of COVID-19.
32929061 2020. Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients.
33024093 2020. SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunity.
33024073 2020. Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling.
32984664 2020. Identification of Geographic Specific SARS-Cov-2 Mutations by Random Forest Classification and Variable Selection Methods.
32920296 2020. Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease.
32815359 2020. Rettelse: Multiorgan inflammatorisk syndrom assosiert med sars-CoV-2 hos et barn.
32904637 2020. The role of carbon monoxide and heme oxygenase-1 in COVID-19.
32954666 2020. Comprehensive annotations of the mutational spectra of SARS-CoV-2 spike protein: a fast and accurate pipeline.
32953471 2020. Proprotein convertase furin in SARS-CoV-2 and non-small cell lung cancer.
32923679 2020. C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis.
33024515 2020. Immunological aspects of COVID-19: What do we know?
32917722 2020. Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.
32922564 2020. Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets.
32796063 2020. Neuronal Ablation of Alpha/Beta Interferon (IFN-alpha/beta) Signaling Exacerbates Central Nervous System Viral Dissemination and Impairs IFN-gamma Responsiveness in Microglia/Macrophages.
32938761 2020. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.

32934770 2020. Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity.
32952147 2020. Atypical Chest Computed Tomography Finding of Predominant Interstitial Thickening in a Patient with Coronavirus Disease 2019 (COVID-19) Pneumonia.
32919977 2020. Immunopathology of Hyperinflammation in COVID-19.
32876012 2020. Case Report: Adrenal Pathology Findings in Severe COVID-19: An Autopsy Study.
32950319 2020. Bell's palsy in a pediatric patient with hyper IgM syndrome and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32992681 2020. Identification of Novel Hypothalamic MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating ACE2 and TMPRSS2 Expression: An In Silico Analysis.
32954242 2020. Host tolerance contributes to persistent viral shedding in COVID-19.
32923992 2020. Multisystem inflammatory syndrome in children: A systematic review.
32984786 2020. The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study.
33001029 2020. Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic.
32983015 2020. Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses.
32984206 2020. Pediatric Inflammatory Multisystem Syndrome: Statement by the Pediatric Section of the European Society for Emergency Medicine and European Academy of Pediatrics.
32974046 2020. Toll-like receptors and COVID-19: a two-faced story with an exciting ending.
33005212 2020. In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome.
33015411 2020. Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics.
32954047 2020. Genetic characterization of structural and open reading Fram-8 proteins of SARS-CoV-2 isolates from different countries.
33007398 2020. Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection.
32966857 2020. Mutations on COVID-19 diagnostic targets.
32927009 2020. Molecular phylogeny and missense mutations of envelope proteins across coronaviruses.
32920121 2020. SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design.
33017875 2020. Confidence intervals for the COVID-19 neutralizing antibody retention rate in the Korean population.
33017874 2020. Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA.
32902818 2020. A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin.
32983837 2020. Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays.
32984566 2020. Selective pressure on SARS-CoV-2 protein coding genes and glycosylation site prediction.
32904785 2020. Integrate structural analysis, isoform diversity, and interferon-inductive propensity of ACE2 to predict SARS-CoV2 susceptibility in vertebrates.
32984567 2020. A SARS-CoV-2 host infection model network based on genomic human Transcription Factors (TFs) depletion.
32904861 2020. Antibody response to SARS-Co-V-2, diagnostic and therapeutic implications.
32950268 2020. Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China.
32953455 2020. A challenging case of multisystem inflammatory syndrome in children related to coronavirus Disease-19 hospitalized under adult medical service.
33007369 2020. "Cytokine storm", not only in COVID-19 patients. Mini-review.
33007368 2020. How NETosis could drive "Post-COVID-19 syndrome" among survivors.
32989677 2020. Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2.
32930973 2020. Multisystem Inflammatory Syndrome in Children Associated with COVID 19 Treated with Oral Steroid.
32950697 2020. Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America.
33014208 2020. How COVID-19 induces cytokine storm with high mortality.
33002623 2020. Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation.
32920233 2020. Antibody-dependent enhancement of coronavirus.
32920235 2020. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome.
32945352 2020. Transcriptomic analysis of COVID19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection.
32993015 2020. Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans.
32933166 2020. Host Synthesized Carbohydrate Antigens on Viral Glycoproteins as "Achilles' Heel" of Viruses Contributing to Anti-Viral Immune Protection.
32917729 2020. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients.
32997749 2020. Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in a patient receiving Infliximab therapy for Inflammatory Bowel Disease.
33011038 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) in an Adolescent that Developed Coronary Aneurysms: A Case Report and Review of the Literature.
32954708 2020. Analysis of Host Cell Receptor GRP78 for Potential Natural Reservoirs of SARS-CoV-2.
32970885 2020. Comment on 'Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19': involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19.
32956726 2020. Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection.
32920062 2020. A possible role for GRP78 in cross vaccination against COVID-19.
32853600 2020. Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by RT-PCR.
32853599 2020. COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity.
32853597 2020. SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on.
32910175 2020. SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
32919931 2020. Syndrome resembling Kawasaki disease in COVID-19 asymptomatic children.
32982366 2020. Role of IFN and Complements System: Innate Immunity in SARS-CoV-2.
32991738 2020. Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia.
32979386 2020. Use of tocilizumab in multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2.
32946801 2020. Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view.
32945863 2020. Pediatric Inflammatory Multisystem Syndrome: Time to Collaborate.
32951037 2020. Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients.
32919067 2020. A graph-based approach identifies dynamic H-bond communication networks in spike protein S of SARS-CoV-2.
32967693 2020. A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual.
32938769 2020. The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.
32937615 2020. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
32972123 2020. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19.
32956615 2020. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process.
32835654 2020. Multisystem inflammatory syndrome in children in South Africa.
32979317 2020. The complexities of SARS-CoV-2 serology.
32987502 2020. The within-host viral kinetics of SARS-CoV-2.
32944295 2020. Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein.
2972994 1988. Sequence specificity of streptozotocin-induced mutations.
32958678 2020. Low genetic diversity may be an Achilles heel of SARS-CoV-2.
32956843 2021. Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes.
32965173 2020. Secondary structure of the SARS-CoV-2 5'-UTR.
32991014 2020. The cytokine storm-An appropriate, over-reactive response to SARS-CoV-2 or the wrong immune pathway?
33024223 2020. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
33024213 2020. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
32963115 2020. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection.
32972818 2020. COVID-19 and Metabolic Syndrome: NF-kappaB Activation. Crossroads.
32921279 2020. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.
32921711 2020. An Outbreak of Kawasaki-like Disease in children during SARS-CoV- 2 Epidemic: No Surprise?
32969849 2020. Atypical Endovascular Cells in SARS-CoV-2 Pneumonia.
32915505 2020. Structural Characterization of N-Linked Glycans in the Receptor Binding Domain of the SARS-CoV-2 Spike Protein and their Interactions with Human Lectins.
32907802 2020. Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al.
32907800 2020. Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al.
32978236 2020. Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al.
32958511 2020. Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case-control study'.
32958508 2020. Correspondence to 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort'.
32933921 2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): what does the future hold?
32943427 2020. Covid-19: Do many people have pre-existing immunity?
32920919 2020. Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection?
32902374 2020. Analysis of partial sequences of the RNA-dependent RNA polymerase gene as a tool for genus and subgenus classification of coronaviruses.
32902372 2020. Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus.
32985922 2020. Early Identification of IgA Anti-SARSCoV-2 in Milk of Mother With COVID-19 Infection.
32826281 2020. Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy.
32978281 2020. Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.
32958687 2020. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
32930458 2020. Regulatory CD4(+) and CD8(+) T cells are negatively correlated with CD4(+) /CD8(+) T cell ratios in patients acutely infected with SARS-CoV-2.
32930456 2020. Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.
32918747 2020. Ultrastructure of cell trafficking pathways and coronavirus: how to recognise the wolf amongst the sheep.
32969960 2020. Features of Intestinal Disease Associated with COVID-Related Multisystem Inflammatory Syndrome in Children.
32924059 2020. The Natural History of SARS-Cov-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): A Systematic Review.
31743644 2019. Membrane Cholesterol Modulates Oligomeric Status and Peptide-Membrane Interaction of Severe Acute Respiratory Syndrome Coronavirus Fusion Peptide.
32989174 2020. MAIT cell activation and dynamics associated with COVID-19 disease severity.
32943497 2020. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19.
32994211 2020. High-resolution structures of the SARS-CoV-2 2'-O-methyltransferase reveal strategies for structure-based inhibitor design.
32958614 2020. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients.
32994364 2020. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity.
32958581 2020. Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years.
32972996 2020. Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
32972995 2020. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
32958580 2020. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein.

32881367 2020. Global Initiative Seeks to Crack the COVID-19 Genetic Code.
32912866 2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): the Evelina Experience.
32933913 2020. Paediatric case of prolonged COVID-19 manifesting as PMIS-TS and atypical Kawasaki.
32943758 2020. Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy.
32966752 2020. Cardiometabolic Traits, Sepsis, and Severe COVID-19: A Mendelian Randomization Investigation.
32935083 2020. Management of Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Survey from the International Kawasaki Disease Registry.
32967859 2020. The pulmonary pathology of COVID-19.
32948868 2020. SARS-CoV-2 spreads to lymph nodes and strongly expands CD4+ TEMRA cells in a patient with mild COVID-19.
32927483 2020. Kinetics of SARS-CoV-2 Antibody Avidity Maturation and Association with Disease Severity.
32907819 2020. Pediatric inflammatory multisystem syndrome temporally associated with COVID-19: a spectrum of diseases with many names.
33020707 2020. Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2'-O-Methyltransferase.
32977223 2020. Immunological features of coronavirus disease 2019 in patients with cancer.
33022277 2020. ACE2-containing extracellular vesicles and exomeres bind the SARS-CoV-2 spike protein.
33025514 2020. Low-Dose Dexamethasone Following IVIG in Pediatric Inflammatory Multisystem Syndrome in Temporal Association with COVID-19 (PIMS-TC).
32986832 2020. Biased mutation and selection in RNA viruses.
32941612 2020. Potential pathogenicity determinants identified from structural proteomics of SARS-CoV and SARS-CoV-2.
33000221 2020. Neuropilin1 as a new potential SARSCoV2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID19.
32995557 2020. Integrated genomic view of SARS-CoV-2 in India.
32976188 2020. High level of defensin alpha 5 in intestine may explain the low incidence of diarrhoea in COVID-19 patients.
32910469 2020. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.
32935333 2020. T-cell responses and therapies against SARS-CoV-2 infection.
33001920 2020. Light and corona: guided-wave readout for coronavirus spike protein-host-receptor binding.
33009246 2020. SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia.
32979740 2020. Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients.
32897642 2020. The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic.
33003176 2020. Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019 in a Children's Hospital in New York City: Patient Characteristics and an Institutional Protocol for Evaluation, Management, and Follow-Up.
32970023 2020. Distinguishing Multisystem Inflammatory Syndrome in Children From Kawasaki Disease and Benign Inflammatory Illnesses in the SARS-CoV-2 Pandemic.
32925543 2020. Acute Appendicitis in Multisystem Inflammatory Syndrome in Children With COVID-19.
32947601 2020. Multisystem Inflammatory Syndrome (MIS-C) Surveillance and COVID-19 in Latin America.
32925547 2020. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection.
32898090 2020. MIS-C After ARDS Associated With SARS-CoV-2.
32907921 2020. SARS-CoV-2 Polymorphisms and Multisystem Inflammatory Syndrome in Children.
32973121 2020. Multisystem Inflammatory Syndrome in Children and SARS-CoV-2 Serology.

32776378 2020. Beyond serosurveys: Human biology and the measurement of SARS-Cov-2 antibodies.
32459509 2020. Breaking Circular Thinking about the Value of Oxygenation.
32459507 2020. Reply to Modesto-Alapont et al.: Breaking Circular Thinking about the Value of Oxygenation.
32860089 2020. High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a Th2 response due to severe COVID-19.
32745829 2020. Orientation of immobilized antigens on common surfaces by a simple computational model: Exposition of SARS-CoV-2 Spike protein RBD epitopes.
32721790 2020. Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics.
32818817 2020. Host-membrane interacting interface of the SARS coronavirus envelope protein: Immense functional potential of C-terminal domain.
32866437 2020. Immune response in SARS-CoV-2 infection: the role of interferons type I and type III.
32889638 2020. Coronaviruses and stress: from cellular to global.
32777699 2020. SARS-CoV-2 IgG antibody responses in New York City.
32799894 2020. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge.
32752129 2020. Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension.
32784826 2020. Preliminary Post-Mortem COVID-19 Evidence of Endothelial Injury and Factor VIII Hyperexpression.
32844713 2020. Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population.
32882706 2020. COVID-19 is, in the end, an endothelial disease.
32882708 2020. How does COVID-19 kill at home and what should we do about it?
32887992 2020. Multisystem inflammatory syndrome in an adult with SARS-CoV-2 infection.
32859681 2020. Endothelial to mesenchymal transition (EndMT): a precursor to post-SARS-CoV-2 infection (COVID-19) interstitial pulmonary fibrosis and vascular obliteration?
32763951 2020. A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions.
32881045 2020. COVID-19 related lung pathology: old patterns in new clothing?
32888767 2020. Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2-An in silico glance.
32773417 2020. Quasispecies analysis of the SARS-CoV-2 from representative clinical samples: A preliminary analysis.
32837525 2020. Role of Damage-Associated Molecular Patterns in Light of Modern Environmental Research: A Tautological Approach.
32767018 2020. Complete post-mortem data in a fatal case of COVID-19: clinical, radiological and pathological correlations.
32851474 2020. Postmortem examination of three SARS-CoV-2-positive autopsies including histopathologic and immunohistochemical analysis.
32861838 2020. Peripheral blood CD4+ cell counts but not CD3+ and CD8+ cell counts are reduced in SARS-CoV-2 infection.
32853638 2020. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1.
32864865 2020. The phenotypic changes of gammadelta T cells in COVID-19 patients.
32786709 2020. Computational Prediction of Mutational Effects on SARS-CoV-2 Binding by Relative Free Energy Calculations.
32827284 2020. Unraveling the Immune Response in Severe COVID-19.
32829467 2020. Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
32870815 2020. Immune pathogenesis of COVID-19-related Multisystem Inflammatory Syndrome in Children (MIS-C).
32730233 2020. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.
32730226 2020. Is multisystem inflammatory syndrome in children on the Kawasaki syndrome spectrum?
32764200 2020. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.
32759504 2020. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.
32841212 2020. Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals.
32833687 2020. SARS-CoV-2 specific T-cell responses and correlations with COVID-19 patient predisposition.
32784290 2020. COVID-19 severity associates with pulmonary redistribution of CD1c+ DC and inflammatory transitional and nonclassical monocytes.
32531971 2020. Evaluation of Innate Immune Mediators Related to Respiratory Viruses in the Lung of Stable COPD Patients.
32826322 2020. Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate.
32763812 2020. The D614G substitution in the S gene and clinical information for patients with COVID-19 detected in Hong Kong.
32818852 2020. SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies.
32850082 2020. COVID-19 infection and its deadly cytokine storm in a young obese adult.
32779780 2020. Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2.
32773261 2020. SARS-CoV 2 and the pathobiology of the respiratory control mechanisms in the brainstem.
32887634 2020. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.
32243948 2020. Respiratory mucus and persistence of virus on surfaces.
32727811 2020. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
32726448 2020. Interferon-Induced Transmembrane Protein 3 Related to Coronavirus Disease 2019.
32726417 2020. Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
31621854 2020. Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.
32726446 2020. Plasmodium falciparum infection may protect a population from SARS-CoV-2 infection.
32745172 2020. Transient lymphopenia and interstitial pneumonia with endotheliitis in SARS-CoV-2-infected macaques.
32812049 2020. Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19.
32785649 2020. COVID 19 Vaccines: Should we fear ADE?
32738141 2020. Immunoserologic detection and diagnostic relevance of cross-reactive auto-antibodies in COVID-19 patients.
31610541 2020. Innate Immune Evasion by Human Respiratory RNA Viruses.
32736274 2020. Structural stability of the SARS-CoV-2 main protease: Can metal ions affect function?
32794348 2020. Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID-19.
32779742 2020. A child with a severe multisystem inflammatory syndrome following an asymptomatic COVID-19 infection: A novel management for a new disease?
32761905 2020. Comment on Hu et al: The cytokine storm and COVID-19.
32779784 2020. Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America.
32717049 2020. Cytoskeleton-a crucial key in host cell for coronavirus infection.
32771409 2020. Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus.
32818486 2020. Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes.
32870373 2020. Why do SARS-CoV-2 NSPs rush to the ER?
32826022 2020. Kawasaki-like disease among Italian children in the COVID-19 era.
32768467 2020. Longitudinal Echocardiographic Assessment of Coronary Arteries and Left Ventricular Function following Multisystem Inflammatory Syndrome in Children.
32768466 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: A Systematic Review.
32756980 2020. Incomplete Kawasaki Disease as Presentation of COVID-19 Infection in an Infant: A Case Report.
32828177 2020. SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome.
32791052 2020. Multisystem inflammatory syndrome associated with COVID-19 in children in Pakistan.
32791050 2020. Coronial autopsies identify the indirect effects of COVID-19.
32813814 2020. Low risk of serological cross-reactivity between dengue and COVID-19.
32872641 2020. Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization.
32835005 2020. Methods for making multiple alignment of genomic sequences for severe acute respiratory syndrome coronavirus 2.
32839745 2020. miRNA target prediction might explain the reduced transmission of SARS-CoV-2 in Jordan, Middle East.
32847471 2020. Vascular underpinning of COVID-19.
32750256 2020. Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester.
32756606 2020. Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain.
32726325 2020. Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2.
32787702 2020. Anterior Pulmonary Ventilation Abnormalities in COVID-19.
32810737 2020. The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients.
32738789 2020. Nox2 activation in Covid-19.
32853309 2020. Sindrome inflamatorio multisistemico asociado a COVID-19 en ninos y adolescentes: un llamado al diagnostico.
32845568 2020. Interleukin-6 in Covid-19: A systematic review and meta-analysis.
32844538 2020. Alpha-1-antitrypsin: A possible host protective factor against Covid-19.
32883951 2020. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm.
32883949 2020. Profiling and characterization of SARS-CoV-2 mutants' infectivity and antigenicity.
32879307 2020. Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
32815352 2020. Multiorgan inflammatorisk syndrom assosiert med sars-CoV-2 hos et barn.
32854725 2020. Characterization of accessory genes in coronavirus genomes.
32755175 2020. CT Manifestations of Coronavirus Disease (COVID-19) Pneumonia and Influenza Virus Pneumonia: A Comparative Study.
32720486 2020. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications.
32872802 2020. Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2.
32755395 2020. MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension.
32787714 2020. The Striking Similarities of Multisystem Inflammatory Syndrome in Children and a Myocarditis-like Syndrome in Adults: Overlapping Manifestations of COVID-19.
32885825 2020. Specialized pro-resolving mediator network: an update on production and actions.
32723457 2020. Silent Hypoxia in COVID-19: What is Old is New Again!
32826724 2020. Multisystem Inflammatory Syndrome Associated With Coronavirus Disease in Children: A Multi-centered Study in Belem, Para, Brazil.
32677813 2020. Cytokine Profile in an Adolescent With Pediatric Multisystem Inflammatory Syndrome Temporally Related to COVID-19.
32639461 2020. Pediatric Inflammatory Multisystem Syndrome With Central Nervous System Involvement and Hypocomplementemia Following SARS-COV-2 Infection.
32833376 2020. Mutation dans la proteine Spike de SARS-CoV-2.
32615049 2020. The emerging role and significance of circular RNAs in viral infections and antiviral immune responses: possible implication as theranostic agents.
32788292 2020. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.
32753553 2020. Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.
32763915 2020. A molecular pore spans the double membrane of the coronavirus replication organelle.
32675355 2020. The pandemic virus is slowly mutating. But does it matter?
32753554 2020. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.
32855215 2020. MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.
32817270 2020. In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges.

32840109 2020. iPSCs-Derived Platform: A Feasible Tool for Probing the Neurotropism of SARS-CoV-2.
32765942 2020. Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients.
32765940 2020. Decreased Naive T-cell Production Leading to Cytokine Storm as Cause of Increased COVID-19 Severity with Comorbidities.
32790652 2020. Three Cases of Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Due to SARS-CoV-2.
32876680 2020. Forty Postmortem Examinations in COVID-19 Patients.
32776556 2020. Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients.
32811513 2020. The current landscape of coronavirus-host protein-protein interactions.
32864628 2020. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study.
32864626 2020. Delving beneath the surface of hyperinflammation in COVID-19.
32838362 2020. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.
32778426 2020. Reacciones cruzadas entre factor reumatoide e IgM SARS-CoV-2.
32838292 2020. Viral sepsis is a complication in patients with Novel Corona Virus Disease (COVID-19).
32759017 2020. The importance of cell-mediated immunity in COVID-19 - An opinion.
32758906 2020. Are night shift workers at an increased risk for COVID-19?
32795830 2020. Autoimmunity to ACE2 as a possible cause of tissue inflammation in Covid-19.
32721809 2020. Kawasaki-like disease in children with COVID-19: A hypothesis.
32795834 2020. IL-17A and TNF-alpha as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19.
32724296 2020. Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment.
32769902 2020. Macrophage activation syndrome as an unusual presentation of paucisymptomatic severe acute respiratory syndrome coronavirus 2 infection: A case report.
32808941 2020. Hypermetabolism in critically ill patients with COVID-19 and the effects of hypothermia: A case series.
31883098 2020. Histopathologic Evaluation and Scoring of Viral Lung Infection.
31883097 2020. Evaluation of Activation and Inflammatory Activity of Myeloid Cells During Pathogenic Human Coronavirus Infection.
32732237 2020. Genome Sequences of SARS-CoV-2 Strains Detected in Hong Kong.
32732236 2020. Reports of Coding-Complete Genome Sequences of Five 2019 Novel Coronavirus (SARS-CoV-2) Strains Isolated in Bangladesh.
32732235 2020. SARS-CoV-2 Genome Sequence from Morocco, Obtained Using Ion AmpliSeq Technology.
32763945 2020. Genome Sequences of Six SARS-CoV-2 Strains Isolated in Morocco, Obtained Using Oxford Nanopore MinION Technology.
32855259 2020. Four SARS-CoV-2 Genome Sequences from Late April in Stockholm, Sweden, Reveal a Rare Mutation in the Spike Protein.
32791568 2020. Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection.
32858978 2020. Compartmentalized Replication of SARS-Cov-2 in Upper vs. Lower Respiratory Tract Assessed by Whole Genome Quasispecies Analysis.
32879413 2020. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City.
32741970 2020. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers.
32792598 2020. Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data.
32802902 2020. Genome-wide computational prediction of miRNAs in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) revealed target genes involved in pulmonary vasculature and antiviral innate immunity.
32788344 2020. Serum protein profiling reveals a landscape of inflammation and immune signaling in early-stage COVID-19 infection.
32744436 2020. Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.
32817460 2020. Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS.
32873611 2020. Low Baseline Pulmonary Levels of Cytotoxic Lymphocytes as a Predisposing Risk Factor for Severe COVID-19.
32733001 2020. Activation and evasion of type I interferon responses by SARS-CoV-2.
32764693 2020. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells.
32764665 2020. Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm.
32737462 2020. IgGs drive COVID-19 myeloid hyperinflammation.
32732951 2020. NK cells in COVID-19: protectors or opponents?
32728222 2020. T cell responses in patients with COVID-19.
32728221 2020. Tissue damage from neutrophil-induced oxidative stress in COVID-19.
32873888 2020. Long-lasting SARS-CoV-2-specific T cell memories.
32873886 2020. Immune correlates of SARS-CoV-2 protection.
32839569 2020. Not just antibodies: B cells and T cells mediate immunity to COVID-19.
32826976 2020. CD8(+) T cells remember same bits of SARS-CoV-2.
32826975 2020. Attacking the defence: SARS-CoV-2 can infect immune cells.
32826974 2020. Altered immune cell differentiation in the lungs of patients with critical COVID-19.
32807862 2020. Shared CD8(+) T cell receptors for SARS-CoV-2.
32807861 2020. Spatial resolution of SARS-CoV-2 lung infection.
32782358 2020. The role of IgG Fc receptors in antibody-dependent enhancement.
32782355 2020. Getting to the (germinal) centre of SARS-CoV-2.
32782353 2020. Antibody response to SARS-CoV-2 - sustained after all?
32835124 2020. A multicenter consensus: A role of furin in the endothelial tropism in obese patients with COVID-19 infection.
32855992 2020. A Case of Steroid-Responsive, COVID-19 Immune Reconstitution Inflammatory Syndrome Following the Use of Granulocyte Colony-Stimulating Factor.
32879797 2020. Mutation density changes in SARS-CoV-2 are related to the pandemic stage but to a lesser extent in the dominant strain with mutations in spike and RdRp.
32742818 2020. RdRp mutations are associated with SARS-CoV-2 genome evolution.
32742815 2020. Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2.
32722596 2020. Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?
32721181 2020. Immunometabolic Status of COVID-19 Cancer Patients.
32881907 2020. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.
32857808 2020. SNPs or RNA modifications? Concerns on mutation-based evolutionary studies of SARS-CoV-2.
32726355 2020. Interplay between SARS-CoV-2 and the type I interferon response.
32845937 2020. Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020.
32822426 2020. COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2.
32797103 2020. Footprint of the host restriction factors APOBEC3 on the genome of human viruses.
32785209 2020. Molecular epidemiology of SARS CoV-2: a review of current data on genetic variability of the virus.
32844302 2020. The Interplay Between Coagulation and Inflammation Pathways in COVID-19-Associated Respiratory Failure: A Narrative Review.
32727465 2020. Association between cytokine profiles and lung injury in COVID-19 pneumonia.
32723327 2020. The pathophysiology of 'happy' hypoxemia in COVID-19.
32880863 2020. Structure of SARS-CoV-2 main protease in the apo state.
32161317 2020. A high ATP concentration enhances the cooperative translocation of the SARS coronavirus helicase nsP13 in the unwinding of duplex RNA.
32848162 2020. Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms.
32843695 2020. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome.
32820179 2020. Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide.
32814791 2020. Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity.
32680882 2020. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
32669297 2020. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
32694201 2020. Distinct conformational states of SARS-CoV-2 spike protein.
32703906 2020. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.
32661059 2020. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
32661058 2020. Structural basis of a shared antibody response to SARS-CoV-2.
32728018 2020. Crystal structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral drug design.
32712629 2020. COVID-19: immunopathogenesis and Immunotherapeutics.
32868756 2020. Immune characteristics of severe and critical COVID-19 patients.
32843617 2020. Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2.
32796814 2020. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.
32879905 2020. Reduction of ADAMTS13 Levels Predicts Mortality in SARS-CoV-2 Patients.
32684101 2020. Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study.
32424954 2020. The hypothetical role of phosphatidic acid in subverting ER membranes during SARS-CoV infection.
32701194 2020. Emergence of European and North American mutant variants of SARS-CoV-2 in South-East Asia.
32863136 2020. Does Cross-neutralization of SARS-CoV-2 Only Relate to High Pathogenic Coronaviruses?
32863134 2020. Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis.
32863133 2020. Effect of Low-Pathogenic Human Coronavirus-Specific Antibodies on SARS-CoV-2.
32863132 2020. Is Immunological Memory a Burden in Times of COVID-19?
32720214 2020. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
32705575 2020. Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity.
32822061 2020. Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection.
31505321 2019. Coronavirus genomic RNA packaging.
32717345 2020. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
32730781 2020. Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.
32771430 2020. Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
32825063 2020. The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV.
32824272 2020. A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture.
32787398 2020. Coronavirus-19 and malaria: The great mimics.
32734595 2020. Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding.
32881583 2020. The Respiratory Drive: An Overlooked Tile of COVID-19 Pathophysiology.
32833500 2020. Injury to the Endothelial Glycocalyx in Critically Ill COVID-19 Patients.
32822239 2020. Bubble Trouble in COVID-19.
32813543 2020. On Happy Hypoxia and on Sadly Ignored "Acute Vascular Distress Syndrome" in COVID-19 Patients.

32761524 2020. Is hypoxemia explained by intracardiac or intrapulmonary shunt in COVID-19-related acute respiratory distress syndrome?
32805179 2020. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
32805177 2020. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
32854247 2020. The Importance of Redox Status in the Frame of Lifestyle Approaches and the Genetics of the Lung Innate Immune Molecules, SP-A1 and SP-A2, on Differential Outcomes of COVID-19 Infection.
32735900 2020. Topoisomerase III-beta is required for efficient replication of positive-sense RNA viruses.
31705922 2020. Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy in the central nervous system of live mice.
31634494 2020. Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication.
32749662 2020. SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study.
32761270 2020. Detection of SARS-CoV-2 by RNAscope((R)) in situ hybridization and immunohistochemistry techniques.
32737584 2020. A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2.
32719955 2020. The antiviral protein viperin interacts with the viral N protein to inhibit proliferation of porcine epidemic diarrhea virus.
32884212 2020. Comments on "An insertion unique to SARS-CoV-2 exhibits super antigenic character strengthened by recent mutations" by Cheng MH et al.2020.
32831521 2020. Putative Natural History of CoViD-19.
32754004 2020. Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.
32728349 2020. Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients.
32882823 2020. Computational and Transcriptome Analyses Revealed Preferential Induction of Chemotaxis and Lipid Synthesis by SARS-CoV-2.
32861070 2020. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.
32803496 2020. (1)H, (13)C, and (15)N backbone chemical shift assignments of the apo and the ADP-ribose bound forms of the macrodomain of SARS-CoV-2 non-structural protein 3b.
32770392 2020. (1)H, (13)C, and (15)N backbone chemical shift assignments of the nucleic acid-binding domain of SARS-CoV-2 non-structural protein 3e.
32825713 2020. Caveolae and Lipid Rafts in Endothelium: Valuable Organelles for Multiple Functions.
32752270 2020. Viral Ubiquitin and Ubiquitin-Like Deconjugases-Swiss Army Knives for Infection.
32829962 2020. The looming storm: Blood and cytokines in COVID-19.
32803145 2020. Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19.
32750108 2020. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
32707576 2020. Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?
32733733 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus (SARS-CoV-2) Infection.
32723436 2020. COVID-19: disCOVering the role of complement system.
32820801 2020. Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission.
32749472 2020. Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies.
32883529 2020. Coronavirus 2019, Microthromboses, and Platelet Activating Factor.
32742654 2020. Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection.
32771962 2020. An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2.
32859264 2020. Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies.
32854750 2020. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
32742881 2020. Pediatric Case of Severe COVID-19 With Shock and Multisystem Inflammation.
32775080 2020. COVID-19 as a Possible Cause of Functional Exhaustion of CD4 and CD8 T-cells and Persistent Cause of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
32864262 2020. A Review of Postmortem Findings in Patients With COVID-19.
32884871 2020. COVID-19 and Hyperinflammatory Syndrome in Children: Kawasaki Disease with Macrophage Activation Syndrome in Disguise?
32852642 2020. Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses.
32767259 2020. Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients.
32838054 2021. Subcellular hot spots of GPCR signaling promote vascular inflammation.
32784125 2020. Natural killer cell responses to emerging viruses of zoonotic origin.
32866898 2020. ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis.
32873506 2020. Cytokine storm with rapidly elevated interleukin-6 indicates sudden death in patients with critical COVID-19.
32864402 2020. Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections.
32861199 2020. Monocyte activation in systemic Covid-19 infection: Assay and rationale.
32818801 2020. SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta.
32815517 2020. 3D virtual pathohistology of lung tissue from Covid-19 patients based on phase contrast X-ray tomography.
32752979 2020. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients.
32691695 2020. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.
32880939 2020. Telomere length, epidemiology and pathogenesis of severe COVID-19.
32869220 2020. COVID-19 and the Antiviral Effect of Saliva.
32816244 2020. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis.
32803422 2020. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach.
32718910 2020. Extensive coronary artery thrombosis complicating COVID-19 infection and haemophagocytic lymphohistiocytosis.
32733388 2020. Working Hypothesis for Glucose Metabolism and SARS-CoV-2 Replication: Interplay Between the Hexosamine Pathway and Interferon RF5 Triggering Hyperinflammation. Role of BCG Vaccine?
32849840 2020. Genetic Analysis of the Coronavirus SARS-CoV-2 Host Protease TMPRSS2 in Different Populations.
32765596 2020. Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein.
32765592 2020. Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.
32849666 2020. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
32849654 2020. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
32849650 2020. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies.
32849648 2020. Mucosal-Associated Invariant T Cells as a Possible Target to Suppress Secondary Infections at COVID-19.
32886791 2020. Site-specific characterisation of SARS-CoV-2 spike glycoprotein receptor binding domain.
32883919 2020. Recent developments in COVID-19 therapeutics & current evidence for COVID-19-associated multisystem inflammatory syndrome.
32859866 2020. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients.
32890939 2020. COVID-19: Brief check through the pathologist's eye (autopsy archive).
32888706 2020. SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings.
32826334 2020. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.
32826331 2020. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
32890979 2020. Quantitative phylogenomic evidence reveals a spatially structured SARS-CoV-2 diversity.
32759262 2020. Response to: 'Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future' by Wang et al.
32759260 2020. Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future.
32866279 2020. Haemoglobin oxygen affinity in patients with severe COVID-19 infection: Still unclear.
32826650 2020. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
32833696 2020. Does Severe Acute Respiratory Syndrome Coronavirus 2 Cause Sepsis?
32749095 2020. MAIT Cells in COVID-19: Heroes, Villains, or Both?
32749094 2020. Novel Coronavirus SARS-CoV-2 Target and Disable Natural Killer Cells: Core Immune Effectors for Fighting the Disease.
32881654 2020. Renin-angiotensin system (RAS) and immune system profile in specific subgroups with COVID-19.
32633334 2020. The hemagglutinin-esterase gene in human coronaviruses SARS-CoV-2, HKU1 and OC43.
32750889 2020. AGTR2, one possible novel key gene for the entry of SARS-CoV-2 into human cells.
32864784 2020. Angiotensin-Converting Enzyme as a new immunologic target for the new SARS-CoV-2.
32762417 2020. Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study.
32752936 2020. Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19.
32746720 2020. Deciphering the protein motion of S1 subunit in SARS-CoV-2 spike glycoprotein through integrated computational methods.
32851910 2020. Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding.
32773643 2020. Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32860278 2020. Associations between serum amyloid A, interleukin-6, and COVID-19: A cross-sectional study.
32769685 2020. Immunity, inflammation and the vasculature in the COVID-19 era.
32887754 2020. Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.
32878912 2020. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
32744884 2020. Letter to the Editor: COVID-19, Mitochondria, and Interferon.
32721252 2020. Eosinophil-Derived Neurotoxin and Respiratory Tract Infection and Inflammation: Implications for COVID-19 Management.
32729633 2020. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?
32881026 2020. Fox3(+) CD25(+) CD4(+) T regulatory cells (Tregs) may transform the n-CoV's final destiny to CNS!
32880990 2020. Coronavirus Disease 2019 (COVID-19) is Associated with Low Circulating Plasma Levels of Angiotensin 1 and Angiotensin 1,7.
32726803 2020. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
32726801 2020. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
32726800 2020. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
32805734 2020. Structures and distributions of SARS-CoV-2 spike proteins on intact virions.
32807916 2020. COVID-19 poses a riddle for the immune system.
32826642 2020. A Novel Pediatric Multisystem Inflammatory Syndrome During the COVID-19 Pandemic.
32879033 2020. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
32843441 2020. COVID-19 Inflammatory Syndrome With Clinical Features Resembling Kawasaki Disease.
32812956 2020. Dynamical properties of enzyme-substrate complexes disclose substrate specificity of the SARS-CoV-2 main protease as characterized by the electron density descriptors.
32756685 2020. Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding.
32734714 2020. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
32875598 2020. Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms.
32826343 2020. Natural killer cell immunotypes related to COVID-19 disease severity.
31538715 2020. Updated phylogenetic analysis of the spike gene and identification of a novel recombinant porcine epidemic diarrhoea virus strain in Taiwan.
32492472 2020. How ISG15 combats viral infection.
32838495 2020. [Recognition of critical coronavirus disease 2019: from the injury of alveolar epithelial cells to vascular endothelial cells].

32738055 2020. Discrepancy between Sp O2 and Sa O2 in patients with COVID-19.
32776522 2020. An analysis of SARS-CoV-2 cell entry genes identifies the intestine and colorectal cancer as susceptible tissues.
32885345 2020. The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach.
32835036 2020. Quantitative proteomic dataset from oro- and naso-pharyngeal swabs used for COVID-19 diagnosis: Detection of viral proteins and host's biological processes altered by the infection.
32775582 2020. Dataset for homologous proteins in Drosophila melanogaster for SARS-CoV-2/human interactome.
32885781 2020. Pediatric Multisystemic Inflammatory Syndrome Associated With SARS-CoV-2 Infection.
32865490 2020. The Pathology of Severe COVID-19-Related Lung Damage.
32745993 2020. Vascular occlusion by neutrophil extracellular traps in COVID-19.
32736307 2020. The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19).
32857691 2020. Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020.
32730568 2020. Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes.
32860146 2020. Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy.
32883678 2020. Confronting the controversy: Interleukin-6 and the COVID-19 cytokine storm syndrome.
32747391 2020. Pathogenesis of COVID-19-induced ARDS: implications for an ageing population.
32849623 2020. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
32793244 2020. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
32793223 2020. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System.
32754163 2020. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.
32754162 2020. The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions.
32754159 2020. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
32733487 2020. Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements.
32719688 2020. Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19.
32719687 2020. Cell-Mediated Immune Responses to COVID-19 Infection.
32719686 2020. Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology.
32849425 2020. Coronavirus Interplay With Lipid Rafts and Autophagy Unveils Promising Therapeutic Targets.
32793182 2020. Geographic and Genomic Distribution of SARS-CoV-2 Mutations.
32719673 2020. In-Depth Bioinformatic Analyses of Nidovirales Including Human SARS-CoV-2, SARS-CoV, MERS-CoV Viruses Suggest Important Roles of Non-canonical Nucleic Acid Structures in Their Lifecycles.
32793108 2020. The Consequences of Coronavirus-Induced Cytokine Storm Are Associated With Neurological Diseases, Which May Be Preventable.
32850560 2020. Quantitative Assessment of Parenchymal Involvement Using 3D Lung Model in Adolescent With Covid-19 Interstitial Pneumonia.
32719757 2020. SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association.
32754041 2020. Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy.
32848893 2020. The Enigma of Endothelium in COVID-19.
32754056 2020. SARS-CoV-2 Molecular Network Structure.
32850603 2020. Improving Non-specific Immunity to Coronavirus Disease (COVID-19) by the Novelty, Diversity, and Quantity of Antigen.
32719819 2020. Analysis of ACE2 Gene-Encoded Proteins Across Mammalian Species.
32805314 2020. Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19).
32835214 2020. Time-series analyses of directional sequence changes in SARS-CoV-2 genomes and an efficient search method for candidates for advantageous mutations for growth in human cells.
32708319 2020. Computational Analysis of the Global Effects of Ly6E in the Immune Response to Coronavirus Infection Using Gene Networks.
32867305 2020. COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells.
32858958 2020. Prediction and Analysis of SARS-CoV-2-Targeting MicroRNA in Human Lung Epithelium.
32723359 2020. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.
32822756 2020. Missense mutations in SARS-CoV2 genomes from Indian patients.
32739507 2020. From Mutation Signature to Molecular Mechanism in the RNA World: A Case of SARS-CoV-2.
32844125 2020. Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies.
32844126 2020. Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue.
32835122 2020. Molecular biology of coronaviruses: current knowledge.
32835135 2020. Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications.
32750378 2020. A review of the main histopathological findings in coronavirus disease 2019.
32783921 2020. Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.
32783920 2020. Distinct Early Serological Signatures Track with SARS-CoV-2 Survival.
32791036 2020. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
32863636 2020. Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.
32746940 2020. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
32801801 2020. Effect of SARS-CoV-2 Infection on the Microbial Composition of Upper Airway.
32801787 2020. Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy.
32765013 2020. Molecular Basis for Pathogenicity of Human Coronaviruses.
32771700 2020. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.
32853823 2020. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2.
32737833 2020. Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases.
32834892 2020. Macrophage activation syndrome and COVID-19.
32834891 2020. Genome evolution of SARS-CoV-2 and its virological characteristics.
32767095 2020. Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality.
32844604 2020. Human post-infection serological response to the spike and nucleocapsid proteins of SARS-CoV-2.
32790065 2020. A COVID-19 human viral challenge model. Learning from experience.
32838020 2020. SARS-CoV-2-human protein-protein interaction network.
32792851 2020. Immune Response and COVID-19: A mirror image of Sepsis.
32721529 2020. Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak.
32771639 2020. Clinical immunity in discharged medical patients with COVID-19.
32771640 2020. Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
32768699 2020. What can we learn from a COVID-19 lung biopsy?
32758688 2020. The characteristics and predictive role of lymphocyte subsets in COVID-19 patients.
32866640 2020. Comprehensive evolution and molecular characteristics of a large number of SARS-CoV-2 genomes reveal its epidemic trends.
32861823 2020. Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic.
32841689 2020. A genetic barcode of SARS-CoV-2 for monitoring global distribution of different clades during the COVID-19 pandemic.
32841688 2020. First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: Factors predicting fibrotic evolution.
32812365 2020. Interest of the cellular population data analysis as an aid in the early diagnosis of SARS-CoV-2 infection.
32883007 2020. Natural Killer Cell Dysfunction and Its Role in COVID-19.
32630064 2020. Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections.
32867123 2020. Using All-Atom Potentials to Refine RNA Structure Predictions of SARS-CoV-2 Stem Loops.
32767455 2020. Pediatric multisystem inflammatory syndrome temporally associated with SARS-COV-2: Oral manifestations and implications.
32779341 2020. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
32770345 2020. Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters.
32844260 2020. Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters. Author's reply.
32861856 2020. Age-Related Differences in Immunological Responses to SARS-CoV-2.
32742475 2020. Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer.
32835160 2020. The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection.
32867328 2020. Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors.
32873700 2020. Gene of the month: TMPRSS2 (transmembrane serine protease 2).
32722979 2020. Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019.
32884216 2020. Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.
32880929 2020. Molecular dynamics study with mutation shows that N-terminal domain (NTD) structural re-orientation in NPC1 is required for proper alignment of cholesterol transport.
32735721 2020. Update on the COVID-19-associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2.
32762140 2020. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases.
32762081 2020. Is the COVID-19 thrombotic catastrophe complement-connected?
32860073 2020. Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity.
32770582 2020. Elucidating the microscopic and computational techniques to study the structure and pathology of SARS-CoVs.
32841626 2020. Sublingual microcirculation in patients with SARS-CoV-2 undergoing veno-venous extracorporeal membrane oxygenation.
32755094 2020. Coronavirus disease 2019 (COVID-19) in critically ill patients: can we re-program the immune system? A primer for intensivists.
32843733 2020. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19.
32817413 2020. Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiency.
32794245 2020. A Japanese case of COVID-19: An autopsy report.
32863022 2020. Histopathology of cutaneous COVID-19 lesion: possible SARS-CoV-2 cytopathogenic effect.
32809036 2020. Postmortale Bildgebung der Lunge bei COVID-19-Todesfallen.
32889497 2020. Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective.
32845122 2020. Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis.
32778542 2020. High oligoclonality of immunoglobulins in SARS-CoV2 positive patients.
30943371 2019. SARS coronavirus protein nsp1 disrupts localization of Nup93 from the nuclear pore complex.
32854812 2020. Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran.
32776691 2020. The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.
32723800 2020. Fatal pulmonary fibrosis: a post-COVID-19 autopsy case.
32817204 2020. Histopathological observations in COVID-19: a systematic review.
32734876 2020. [Findings in post-mortem CT and autopsy in a 53-year-old-man with COVID-19].

32833435 2020. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
32806067 2020. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
32821883 2020. SARS-CoV-2 Receptor ACE2 Is Enriched in a Subpopulation of Mouse Tongue Epithelial Cells in Nongustatory Papillae but Not in Taste Buds or Embryonic Oral Epithelium.
32799392 2020. Kawasaki disease or Kawasaki-like disease: influence of SARS-CoV-2 infections in Japan.
32725143 2020. Phosphate metabolism and Respiratory Alkalosis: a forgotten lesson in COVID-19.
32754908 2020. Delayed virus-specific antibody responses associate with COVID-19 mortality.
32851645 2020. Angiotensin-converting enzyme II expression and its implication in the association between COVID-19 and allergic rhinitis.
32743884 2020. Blood Myeloperoxidase-DNA, a biomarker of early response to SARS-CoV-2 infection?
32808976 2020. Humoral Immune Response to SARS-CoV-2.
32755307 2020. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.
32878480 2020. Elevated FiO2 increases SARS-CoV-2 co-receptor expression in respiratory tract epithelium.
32755325 2020. The potential role of the carotid body in COVID-19.
31942559 2019. The characteristics of hDPP4 transgenic mice subjected to aerosol MERS coronavirus infection via an animal nose-only exposure device.
32825305 2020. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Exhibits High Predicted Binding Affinity to ACE2 from Lagomorphs (Rabbits and Pikas).
32588590 2020. Coronaviruses fusion with the membrane and entry to the host cell.
32831935 2020. COVID-19: Lessons in laboratory medicine, pathology, and autopsy.
32821902 2020. The Spectrum of Histopathologic Findings in Lungs of Patients with Fatal COVID-19 Infection.
32829876 2020. Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3.
31594639 2019. An in vivo cell-based assay for investigating the specific interaction between the SARS-CoV N-protein and its viral RNA packaging sequence.
32854762 2020. The receptor binding domain of SARS-CoV-2 spike protein is the result of an ancestral recombination between the bat-CoV RaTG13 and the pangolin-CoV MP789.
32828489 2020. Epigenetic susceptibility to severe respiratory viral infections: pathogenic and therapeutic implications: a narrative review.
32805061 2020. COVID-19 and haemoglobin oxygen affinity: some clarity?
32743639 2020. Application of Bayesian phylogenetic inference modelling for evolutionary genetic analysis and dynamic changes in 2019-nCoV.
32742035 2020. Variant analysis of SARS-CoV-2 genomes.
32856707 2020. Viral dynamics and immune correlates of COVID-19 disease severity.
32844958 2020. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.
32837710 2020. Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein.
32765822 2020. Genus-specific pattern of intrinsically disordered central regions in the nucleocapsid protein of coronaviruses.
32787909 2020. Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients.
32778136 2020. A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection.
32880654 2020. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
32880957 2020. Variation and multilevel selection of SARS-CoV-2.
32890763 2020. Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene.
32889094 2020. Inferring the genetic variability in Indian SARS-CoV-2 genomes using consensus of multiple sequence alignment techniques.
32890666 2020. Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 in the United States.
32725137 2020. Role of the early secretory pathway in SARS-CoV-2 infection.
32759312 2020. Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population.
32759311 2020. Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2).
32848014 2020. Histopathological features of multiorgan percutaneous tissue core biopsy in patients with COVID-19.
32761894 2020. COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.
32678431 2020. Neutrophils and COVID-19: Nots, NETs, and knots.
32754556 2020. Is there antibody-dependent enhancement in SARS Coronavirus 2?
32787459 2020. Epstein-Barr Virus Versus Novel Coronavirus-Induced Hemophagocytic Lymphohistocytosis: The Uncharted Waters.
32790406 2020. Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?
32787330 2020. Dynamic Asymmetry Exposes 2019-nCoV Prefusion Spike.
32787225 2020. Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence.
32867854 2020. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
32746922 2020. A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases.
31776274 2020. Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle.
31911390 2020. Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design.
32796155 2020. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
32838080 2020. SARS-CoV-2 Virions or Ubiquitous Cell Structures? Actual Dilemma in COVID-19 Era.
32822564 2020. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.
32818434 2020. COVID-19 and multisystem inflammatory syndrome in children and adolescents.
32844161 2020. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study.
32739876 2020. Autopsies of COVID-19 deceased? Absolutely!
32823907 2020. Molecular Epidemiology Analysis of SARS-CoV-2 Strains Circulating in Romania during the First Months of the Pandemic.
32735885 2020. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
32735883 2020. Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13.
32768580 2020. Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2.
32871183 2020. Immunocytometric analysis of COVID patients: A contribution to personalized therapy?
32835700 2020. Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies.
32822087 2020. Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson's Disease.
32878932 2020. A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture.
32878931 2020. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.
32461278 2020. Respiratory Syncytial Virus-Induced Oxidative Stress Leads to an Increase in Labile Zinc Pools in Lung Epithelial Cells.
32874019 2020. Coronavirus herd immunity optimizer (CHIO).
32825438 2020. SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence.
32785274 2020. Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies.
32780783 2020. Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2.
32780218 2020. A human circulating immune cell landscape in aging and COVID-19.
32822073 2020. Comparing the binding properties of peptides mimicking the Envelope protein of SARS-CoV and SARS-CoV-2 to the PDZ domain of the tight junction-associated PALS1 protein.
32777054 2020. Vascular inflammation and endothelial injury in SARS-CoV-2 infection: The overlooked regulatory cascades implicated by the ACE2 gene cluster.
32876096 2021. CLINICAL-EPIDEMIOLOGICAL RELATION BETWEEN SARS-COV-2 AND KAWASAKI DISEASE: AN INTEGRATIVE LITERATURE.
32876282 2020. MULTISYSTEM INFLAMMATORY SYNDROME IN A CHILD ASSOCIATED WITH CORONAVIRUS DISEASE 19 IN THE BRAZILIAN AMAZON: FATAL OUTCOME IN AN INFANT.
32611651 2020. Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic.
32699064 2020. Viral subversion of nonsense-mediated mRNA decay.
32747912 2020. Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection.
32838198 2020. Lung Barrier Function in COVID-19?
32642005 2020. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
32839288 2020. Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: preliminary experience from a series of 10 Spanish patients.
32851697 2020. Single-cell RNA expression profiling of ACE2 and TMPRSS2 in the human trophectoderm and placenta.
32798244 2020. Anatomical and timely assessment of protein expression of angiotensin-converting enzyme 2, SARS-CoV-2 specific receptor, in fetal and placental tissues: new insight for perinatal counseling.
32551795 2020. Coronaviruses.
32732586 2020. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID 19): What we know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects.
32366572 2020. The Biology of Pulmonary Coronavirus Infection Underscores Host-Directed Therapies as an Option.
32826274 2020. Response to: 'Exaggerated neutrophil extracellular trap formation in Kawasaki disease: a key phenomenon behind the outbreak in western countries?' by Yamashita et al.
32529459 2020. Genome-wide analysis of long noncoding RNA profiles in Vero cells infected with porcine epidemic diarrhea virus.
32730589 2020. Persistent minimal sequences of SARS-CoV-2.
32818261 2020. Structural basis of SARS-CoV-2 spike protein induced by ACE2.
32805023 2020. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
32877502 2020. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition.
32737031 2020. Cellular immune responses to covid-19.
32871617 2020. The implications of COVID-19 infection on the endothelium: A metabolic vascular perspective.
32628899 2020. Coronaviruses and Integrin alphavbeta3: Does Thyroid Hormone Modify the Relationship?
32749914 2020. Resolution of coronavirus disease 2019 (COVID-19).
32878546 2020. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.
32845733 2020. Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.
32841579 2020. Cytokines and COVID-19: friends or foes?
32753027 2020. Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein.
32738851 2020. Can a Healthy Lung Keep the COVID-19 Away?
32889794 2020. SARS-CoV-2 infection, oxidative stress and male reproductive hormones: can testicular-adrenal crosstalk be ruled-out?
32013309 2020. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.
32744052 2020. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
32828084 2020. Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states.
32886755 2020. Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.
32841329 2020. Underlying Vulnerabilities to the Cytokine Storm and Adverse COVID-19 Outcomes in the Aging Immune System.
32731783 2020. Novel coronavirus infection and Kawasaki disease.
32846427 2020. Sex differences in immune responses that underlie COVID-19 disease outcomes.
32776761 2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): providing resuscitative care.
32882717 2020. Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis.
32882716 2020. Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19).

32766671 2020. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19.
32735892 2020. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection.
32838215 2020. An Impaired Natriuretic Peptide Hormone System May Play a Role in COVID-19 Severity in Vulnerable Populations.
32779891 2020. Sympathetic activation: a potential link between comorbidities and COVID-19.
32790936 2020. Nicotine and the nicotinic cholinergic system in COVID-19.
32738184 2020. Tumor markers as an entry for SARS-CoV-2 infection?
32760733 2020. Multisystem Inflammatory Syndrome With Complete Kawasaki Disease Features Associated With SARS-CoV-2 Infection in a Young Adult. A Case Report.
32866507 2020. Fever and diarrhea as the only symptoms of Multisystem Inflammatory Syndrome in Children (MIS-C).
32769230 2020. Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children.
32441271 2020. Novel Coronavirus Mimicking Kawasaki Disease in an Infant.
32788432 2020. Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India.
32738607 2020. The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.
32812719 2020. The Hyper-Inflammatory Response in Adults with Severe COVID-19 Pneumonia Differs from the Cytokine Storm of Hemophagocytic Syndrome.
32763970 2020. Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection.
32713862 2020. RNAi suppressor: The hidden weapon of SARS-CoV.
32840072 2020. [The mechanism and treatment strategies of SARS-CoV-2 mediated inflammatory response].
32859733 2020. Functional respiratory imaging identifies redistribution of pulmonary blood flow in patients with COVID-19.
32852402 2020. Histopatological Findings in the Explant Lungs of a Patient With COVID-19 Treated With Bilateral Orthotopic Lung Transplant.
32762171 2020. [Comparative analysis of structural characteristics and epitopes in S proteins between SARS-CoV-2 and SARS-CoV].
32762165 2020. [Replication and transmission mechanisms of highly pathogenic human coronavirus].

32725143 2020. Phosphate metabolism and Respiratory Alkalosis: a forgotten lesson in COVID-19.
32726150 2020. Cardiac Endotheliitis and Multisystem Inflammatory Syndrome After COVID-19.
32735900 2020. Topoisomerase III-beta is required for efficient replication of positive-sense RNA viruses.
32737584 2020. A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2.
32754004 2020. Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.
32728349 2020. Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients.
32745829 2020. Orientation of immobilized antigens on common surfaces by a simple computational model: Exposition of SARS-CoV-2 Spike protein RBD epitopes.
32721790 2020. Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics.
32743639 2020. Application of Bayesian phylogenetic inference modelling for evolutionary genetic analysis and dynamic changes in 2019-nCoV.
32707576 2020. Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?
32728199 2020. SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70.
32725381 2020. Interaction of HSPA5 (Grp78, BIP) with negatively charged phospholipid membranes via oligomerization involving the N-terminal end domain.
32722449 2020. A Message from the Human Placenta: Structural and Immunomodulatory Defense against SARS-CoV-2.
32770235 2020. Cerebrospinal fluid features in SARS-CoV-2 RT-PCR positive patients.
32745196 2020. Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection.
32742654 2020. Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection.
32771962 2020. An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2.
32742881 2020. Pediatric Case of Severe COVID-19 With Shock and Multisystem Inflammation.
32775080 2020. COVID-19 as a Possible Cause of Functional Exhaustion of CD4 and CD8 T-cells and Persistent Cause of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
32767259 2020. Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients.
32745993 2020. Vascular occlusion by neutrophil extracellular traps in COVID-19.
32749957 2020. SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease.
32752979 2020. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients.
32691695 2020. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.
32730568 2020. Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes.
32735892 2020. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection.
32738184 2020. Tumor markers as an entry for SARS-CoV-2 infection?
32741461 2020. Endometrial susceptibility to SARS CoV-2: explained by gene expression across the menstrual cycle?
32765596 2020. Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein.
32765592 2020. Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.
32754162 2020. The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions.
32754159 2020. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
32733448 2020. Role of Autophagy in Lung Inflammation.
32719688 2020. Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19.
32719687 2020. Cell-Mediated Immune Responses to COVID-19 Infection.
32719686 2020. Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology.
32723359 2020. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.
32739507 2020. From Mutation Signature to Molecular Mechanism in the RNA World: A Case of SARS-CoV-2.
32737833 2020. Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases.
32720978 2020. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.
32721529 2020. Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak.
32738607 2020. The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.
32730233 2020. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.
32730226 2020. Is multisystem inflammatory syndrome in children on the Kawasaki syndrome spectrum?
32739486 2020. Characterising differential antibody response is integral to future SARS-CoV-2 serostudies.
32726448 2020. IFITM3 related to COVID-19.
32726417 2020. Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections.
32738141 2020. Immunoserologic detection and diagnostic relevance of cross-reactive auto-antibodies in COVID-19 patients.
32735721 2020. Update on the COVID-19-associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2.
32735785 2020. Lung fibrosis: an undervalued finding in COVID-19 pathological series.
32739471 2020. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach.
32735885 2020. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
32735883 2020. Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13.
32732237 2020. Genome Sequences of SARS-CoV-2 Strains Detected in Hong Kong.
32732236 2020. Reports of Coding-Complete Genome Sequences of Five 2019 Novel Coronavirus (SARS-CoV-2) Strains Isolated in Bangladesh.
32732235 2020. SARS-CoV-2 Genome Sequence from Morocco, Obtained Using Ion AmpliSeq Technology.
32744436 2020. Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.
32733001 2020. Activation and evasion of type I interferon responses by SARS-CoV-2.
32737462 2020. IgGs drive COVID-19 myeloid hyperinflammation.
32732951 2020. NK cells in COVID-19: protectors or opponents?
32728222 2020. T cell responses in patients with COVID-19.
32728221 2020. Tissue damage from neutrophil-induced oxidative stress in COVID-19.
32724189 2020. Rising to the challenge of COVID-19.
32722596 2020. Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?
32721181 2020. Immunometabolic Status of COVID-19 Cancer Patients.
32780783 2020. Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2.
32726325 2020. Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2.
32726355 2020. Interplay between SARS-CoV-2 and the type I interferon response.
32738789 2020. Nox2 activation in Covid-19.
32727465 2020. Association between cytokine profiles and lung injury in COVID-19 pneumonia.
32723327 2020. The pathophysiology of 'happy' hypoxemia in COVID-19.
32703906 2020. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.
32661059 2020. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
32728018 2020. Crystal structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral drug design.
32712629 2020. COVID-19: immunopathogenesis and Immunotherapeutics.
32720214 2020. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
32705575 2020. Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity.
32717345 2020. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
32730781 2020. Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.
32730780 2020. 100 days of solitude: The spring of COVID-19 through the eyes of 15 young virologists of the INITIATE program.
32732586 2020. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID 19): What we know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects.
32734595 2020. Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding.
32726474 2020. SARS-CoV-2 receptor ACE2 protein expression in serum is significantly associated with age.
32675499 2020. Tracheobronchial Slough, a Potential Pathology in Endotracheal Tube Obstruction in Patients With Coronavirus Disease 2019 (COVID-19) in the Intensive Care Setting.
32730589 2020. Persistent minimal sequences of SARS-CoV-2.
32737031 2020. Cellular immune responses to covid-19.
32735457 2020. The vascular nature of COVID-19.
32697499 2020. Dealing With the CARDS of COVID-19.
32749095 2020. MAIT Cells in COVID-19: Heroes, Villains, or Both?
32749094 2020. Novel Coronavirus SARS-CoV-2 Target and Disable Natural Killer Cells: Core Immune Effectors for Fighting the Disease.
32628899 2020. Coronaviruses and Integrin alphavbeta3: Does Thyroid Hormone Modify the Relationship?
32654788 2020. Histological characterization of placenta in COVID19 pregnant women.
32773420 2020. Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells.
32727719 2020. Postmortem Kidney Pathology Findings in Patients with COVID-19.
32723800 2020. Fatal pulmonary fibrosis: a post-COVID-19 autopsy case.
32744884 2020. COVID-19, Mitochondria, and Interferon.
32721252 2020. Eosinophil-Derived Neurotoxin and Respiratory Tract Infection and Inflammation: Implications for COVID 19 Management.
32731783 2020. Novel coronavirus infection and Kawasaki disease.
32770807 2020. Kawasaki disease fact check: Myths, misconceptions and mysteries.
32740530 2020. COVID-19-Associated Multisystem Inflammatory Syndrome in Children Presenting as Acute Pancreatitis.
32739908 2020. COVID-19, neutrophil extracellular traps and vascular complications in obstetric practice.
32726507 2020. Hypoxia - an overlooked trigger for thrombosis in COVID-19 and other critically ill patients.
32730555 2020. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases.
32725017 2020. Quantitative determination of mechanical stability in the novel coronavirus spike protein.
32724171 2020. Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic.
32737467 2020. A thermostable, closed SARS-CoV-2 spike protein trimer.
32726803 2020. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
32726801 2020. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
32677813 2020. Cytokine Profile in an Adolescent With Pediatric Multisystem Inflammatory Syndrome Temporally Related to COVID-19.
32639461 2020. Pediatric Inflammatory Multisystem Syndrome With Central Nervous System Involvement and Hypocomplementemia Following SARS-COV-2 Infection.
32734714 2020. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
32753554 2020. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.

32747721 2020. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.
32773102 2020. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.
32773100 2020. NK cells: A double edge sword against SARS-CoV-2.
32706115 2020. Relative lymphocytosis in COVID-19 - a ray of hope.
32754908 2020. Delayed virus-specific antibody responses associate with COVID-19 mortality.
32755307 2020. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.
32755325 2020. The potential role of the Carotid Body in COVID-19.
32761524 2020. Is hypoxemia explained by intracardiac or intrapulmonary shunt in COVID-19-related acute respiratory distress syndrome?
32759839 2020. Is the Host Viral Response and the Immunogenicity of Vaccines Altered in Pregnancy?
32749662 2020. SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study.
32762083 2020. Neuropathologic features of four autopsied COVID-19 patients.
32778874 2020. Pathogenetic profiling of COVID-19 and SARS-like viruses.
32742035 2020. Variant analysis of SARS-CoV-2 genomes.
32733733 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus (SARS-CoV-2) Infection.
32730807 2020. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.
32759967 2020. Dysregulated adaptive immune response contributes to severe COVID-19.
32753756 2020. SARS-CoV-2 infects human neural progenitor cells and brain organoids.
32754823 2020. Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19.
32611087 2020. Topological analysis of SARS CoV-2 main protease.
32690231 2020. The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy.
32753517 2020. Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: The role of GM-CSF.
32758273 2020. Management of epigenomic networks entailed in coronavirus infections and COVID-19.
32749472 2020. Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies.
32765822 2020. Genus-specific pattern of intrinsically disordered central regions in the nucleocapsid protein of coronaviruses.
32775582 2020. Dataset for homologous proteins in Drosophila melanogaster for SARS-CoV-2/human interactome.
32752129 2020. Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension.
32766671 2020. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19.
32779891 2020. Sympathetic activation: a potential link between comorbidities and COVID-19.
32760733 2020. Multisystem Inflammatory Syndrome With Complete Kawasaki Disease Features Associated With SARS-CoV-2 Infection in a Young Adult. A Case Report.
32719673 2020. In-Depth Bioinformatic Analyses of Nidovirales Including Human SARS-CoV-2, SARS-CoV, MERS-CoV Viruses Suggest Important Roles of Non-canonical Nucleic Acid Structures in Their Lifecycles.
32719672 2020. Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy.
32719757 2020. SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association.
32765270 2020. The Folate Concentration and/or Folic Acid Metabolites in Plasma as Factor for COVID-19 Infection.
32754041 2020. Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy.
32754056 2020. SARS-CoV-2 Molecular Network Structure.
32754569 2020. Clinical Characteristics and Eosinophils in Young SARS-CoV-2-Positive Chinese Travelers Returning to Shanghai.
32769230 2020. Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children.
32746940 2020. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
32765013 2020. Molecular Basis for Pathogenicity of Human Coronaviruses.
32771700 2020. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.
32767095 2020. Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality.
32760213 2020. Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients.
32771640 2020. Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
32768699 2020. What can we learn from a COVID-19 lung biopsy?
32763446 2020. Patterns of viral clearance in the natural course of asymptomatic COVID-19: Comparison with symptomatic non-severe COVID-19.
32767018 2020. Complete post-mortem data in a fatal case of COVID-19: clinical, radiological and pathological correlations.
32767455 2020. Pediatric multisystem inflammatory syndrome temporally associated with SARS-COV-2: Oral manifestations and implications.
32779341 2020. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
32770345 2020. Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters.
32756323 2020. Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic.
32759312 2020. Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population.
32763812 2020. The D614G substitution in the S gene and clinical information for patients with COVID-19 detected in Hong Kong.
32777762 2020. Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19.
32779780 2020. Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2.
32678431 2020. Neutrophils and COVID-19: Nots, NETs, and knots.
32779742 2020. A child with a severe multisystem inflammatory syndrome following an asymptomatic COVID-19 infection: A novel management for a new disease?
32761905 2020. Comment on Hu et al: The cytokine storm and COVID-19.
32779784 2020. Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America.
32776556 2020. Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 Patients.
32762140 2020. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases.
32756980 2020. Incomplete Kawasaki Disease as Presentation of COVID-19 Infection in an Infant: A Case Report.
32733785 2020. Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2.
32768580 2020. Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2.
32724296 2020. Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment.
32755094 2020. Coronavirus disease 2019 (COVID-19) in critically ill patients: can we re-program the immune system? A primer for intensivists.
32778817 2020. A paradox of social distancing for SARS-CoV-2: loneliness and heightened immunological risk.
32764693 2020. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells.
32764665 2020. Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm.
32780218 2020. A human circulating immune cell landscape in aging and COVID-19.
32743565 2020. Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators.
32611651 2020. Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic.
32680882 2020. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
32669297 2020. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
32661058 2020. Structural basis of a shared antibody response to SARS-CoV-2.
32771430 2020. Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
32722574 2020. In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection.
32732269 2020. COVID-19 and Involvement of the Corpus Callosum: Potential Effect of the Cytokine Storm?
32755212 2020. Imaging Findings in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19
32755507 2020. Rewiring the Immune Response in COVID-19.
32778542 2020. High oligoclonality of immunoglobulins in SARS-CoV2 positive patients.
32720486 2020. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications.
32779445 2020. Profiling of Initial Available SARS-CoV-2 Sequences from Iranian Related COVID-19 Patients.
32772742 2020. Non-chemical signatures of biological materials: Radio signals from Covid19?
32750889 2020. AGTR2, one possible novel key gene for the entry of SARS-CoV-2 into human cells.
32773417 2020. Quasispecies analysis of the SARS-CoV-2 from representative clinical samples: A preliminary analysis.
32753027 2020. Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein.
32776691 2020. The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.
32744052 2020. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
32773643 2020. Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32723457 2020. Silent Hypoxia in COVID-19: What is Old is New Again!
32723446 2020. A Case of 45-Year Man Who Succumbed to Coronavirus Disease 2019 (COVID-19).
32769685 2020. Immunity, inflammation and the vasculature in the COVID-19 era.
32729633 2020. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?
32780968 2020. Four months into the COVID-19 pandemic, Sweden's prized herd immunity is nowhere in sight.
32631657 2020. Molecular chronicles of cytokine burst in patients with coronavirus disease 2019 (COVID-19) with cardiovascular diseases.
32778886 2020. Multi-System Inflammatory Syndrome in a Child Mimicking Kawasaki Disease.
32780125 2020. Regulatory T Cells Tested in Patients With COVID-19 ARDS.
32758881 2020. SARS-CoV-2 and the sympathetic immune response: Dampening inflammation with antihypertensive drugs (Clonidine and Propranolol).
32762609 2020. A Novel Hypothesis for Original Antigenic Sin in the Severe Disease of SARS-CoV-2 Infection.
32747830 2020. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection.
32753755 2020. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation.
32776761 2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): providing resuscitative care.
32756685 2020. Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding.
32748124 2020. Endo-Lysosomal Cation Channels and Infectious Diseases.
32732280 2020. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.
32631885 2020. Rewilding immunology.
32694201 2020. Distinct conformational states of SARS-CoV-2 spike protein.
32675364 2020. Aging immunity may exacerbate COVID-19.
32675355 2020. The pandemic virus is slowly mutating. But does it matter?
32762171 2020. [Comparative analysis of structural characteristics and epitopes in S proteins between SARS-CoV-2 and SARS-CoV].
32762165 2020. [Replication and transmission mechanisms of highly pathogenic human coronavirus].

32765942 2020. Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients.
32765940 2020. Decreased Naive T-cell Production Leading to Cytokine Storm as Cause of Increased COVID-19 Severity with Comorbidities.
32656827 2020. Letter: ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID-19.
32750108 2020. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
32763951 2020. A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions.
32750378 2020. A review of the main histopathological findings in the Coronavirus Disease 2019 (COVID-19).
32681497 2020. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
32713862 2020. RNAi suppressor: The hidden weapon of SARS-CoV.
32742475 2020. Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer.
32761894 2020. COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.
32773261 2020. SARS-CoV 2 and the pathobiology of the respiratory control mechanisms in the brainstem.
32727811 2020. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
32736274 2020. Structural stability of the SARS-CoV-2 main protease: Can metal ions affect function?
32768467 2020. Longitudinal Echocardiographic Assessment of Coronary Arteries and Left Ventricular Function Following Multisystem Inflammatory Syndrome in Children (MIS-C).
32768466 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: A Systematic Review.
32746922 2020. A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases.
32759577 2020. Role of cytotoxic T lymphocytes and interferon-gamma in coronavirus infection: lessons from murine coronavirus infections in mice.
32778426 2020. Reacciones cruzadas entre factor reumatoide e IgM SARS-CoV-2.
32759016 2020. Estrogen shields women from COVID-19 complications by reducing ER stress.
32758906 2020. Are night shift workers at an increased risk for COVID-19?
32759006 2020. Low Incidence and Mortality from SARS-CoV-2 in Southern Europe. Proposal of a hypothesis for Arthropod borne Herd immunity.
32759008 2020. Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19.
32759007 2020. Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease.
32758903 2020. Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections.
32758901 2020. Acute respiratory distress syndrome from Covid-19: A perfect storm from free radicals? Proposal for a new treatment.
32721809 2020. Kawasaki-like disease in children with COVID-19: A hypothesis.
32721808 2020. Prior infection with intestinal coronaviruses moderates symptom severity and mortality in patients with COVID-19: A hypothesis and preliminary evidence.
32769902 2020. Macrophage activation syndrome as an unusual presentation of paucisymptomatic severe acute respiratory syndrome coronavirus 2 infection: A case report.
32741970 2020. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers.
32723797 2020. Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Reveals Mosaic Pattern of Phylogeographical Distribution.
32750256 2020. Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester.
32742818 2020. RdRp mutations are associated with SARS-CoV-2 genome evolution.
32742815 2020. Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2.
32684101 2020. Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study.
32769398 2020. Shedding Light on COVID-19: ADAM17 the Missing Link?
32759264 2020. Correspondence on: 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al.
32759261 2020. Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al' by Pino et al.
32633334 2020. The hemagglutinin-esterase gene in human coronaviruses SARS-CoV-2, HKU1 and OC43.
32746720 2020. Deciphering the protein motion of S1 subunit in SARS-CoV-2 spike glycoprotein through integrated computational methods.
32725137 2020. Role of the early secretory pathway in SARS-CoV-2 infection.

012

head
32669777 2020. Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge von Willebrand Factor (eULVWF) Decorated-Platelet Strings.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
32671009 2020. Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 Through Suppression of Antiviral Peptide LL37.
C7255426 ?. Overcoming nonstructural protein 15-nidoviral uridylate-specific endoribonuclease (nsp15/NendoU) activity of SARS-CoV-2.
32658591 ?. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.
C7236793 ?. Prediction and analysis of key protein structures of 2019-nCoV.
C7341045 2020. Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2.
C7323676 ?. Coronavirus disease 2019 (COVID-19): cytokine storms hyper-inflammatory phenotypes and acute respiratory distress syndrome.
C7264919 ?. Amino acid variation analysis of surface spike glycoprotein at 614 in SARS-CoV-2 strains.
32668194 ?. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
32659347 2020. Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.
C7308782 2020. Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells.
32683296 2020. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.
32669955 2020. A comprehensive investigation of the mRNA and protein level of ACE2 the putative receptor of SARS-CoV-2 in human tissues and blood cells.
C7274027 ?. The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development.
32659712 2020. First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences.
32707511 2020. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.
32674001 2020. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis a case series.
32661206 2020. Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human.
C7358169 ?. Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
C7332243 ?. Activation of cytotoxic T cell population and inversion of CD4:CD8 ratio as manifestations of cellular immune response in SARS-COV-2 infection.
C7323226 ?. Cancer Prevales on Covid?19: To Maintain a High Quality Standard Concerning Diagnosis and Oncological Care Even During a Pandemic.
C7351386 ?. Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions.
C7311326 2020. Coronavirus disease 2019?related Kawasaki-like disease in an adult: A case report.
C7314447 ?. Dynamic Regulation of SARS-CoV-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium.
C7296312 ?. Children at risk: multisystem inflammatory syndrome and COVID-19.
C7316659 ?. Localization of Cell Receptor-Related Genes of SARS-CoV-2 in the Kidney through Single-Cell Transcriptome Analysis.
C7275990 ?. COVID-19?Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis.
32659211 2020. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.
C7292579 2020. Genotyping SARS-CoV-2 through an interactive web application.
C7266609 2020. An integrated national scale SARS-CoV-2 genomic surveillance network.
C7351415 ?. Severe refractory Kawasaki disease in seven infants in the COVID-19 era.
C7259908 2020. Coronavirus is the trigger but the immune response is deadly.
C7234786 2020. Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases.
32680625 2020. Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection.
C7256601 ?. In Reply?The ?Perfect Cytokine Storm? of COVID-19.
C7256539 2020. Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19).
C7256537 ?. THE ?PERFECT CYTOKINE STORM? OF COVID-19.
32721799 2020. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression.
32679425 2020. The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.
32679426 2020. The «moonlighting protein» able to explain the Th1 immune lockdown in severe COVID-19?.
32673940 2020. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.
32679424 2020. Natural protection of ocular surface from viral infections ? A hypothesis.
32688183 2020. Corrigendum to ?COVID-19-related Complications and Decompression Illness Share Main Features. Could the SARS-CoV2-related complications rely on blood foaming?? [Med Hypothesis 144 (2020) 109918].
C7326438 2020. Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities.
C7322475 2020. COVID-19: NAD+ deficiency may predispose the aged obese and type2 diabetics to mortality through its effect on SIRT1 activity.
C7313490 2020. Understanding Covid and the associated post-infectious hyper-inflammatory state (PIMS-TS) in children.
C7313483 2020. Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions.
32670517 2020. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.
32670592 2020. Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress and antioxidant capabilities.
C7334952 2020. Pathologic features of COVID-19: A concise review.
32703502 2020. Autopsy of patients with COVID-19: A balance of fear and curiosity.
C7346848 2020. Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.
C7328593 2020. Behavioral immune system linked to responses to the threat of COVID-19.
C7329651 ?. Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: Retrospective diagnosis of a puzzling presentation. A case report.
C7244417 ?. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach.
32713710 ?. Neuropsychiatric Symptoms in an Adolescent Boy With Multisystem Inflammatory Syndrome in Children.
C7335763 ?. Histopathologische Befunde bei therapierter und nichttherapierter SARS-CoV-2-Infektion ? Bericht über 3 Autopsien.
C7335629 ?. Der erste COVID-19-Hotspot in einer Hamburger Senioreneinrichtung: Präventionskonzept Letalität und Obduktionsbefunde.
C7247437 ?. Evidence for systematic autopsies in COVID-19 positive deceased: Case report of the first German investigated COVID-19 death.
C7311357 2020. Expression profiling meta-analysis of ACE2 and TMPRSS2 the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells and identification of putative modulators.
32702724 ?. Age-dependent assessment of genes involved in cellular senescence telomere and mitochondrial pathways in human lung tissue of smokers COPD and IPF: Associations with SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 axis .
32702726 ?. SARS-CoV2 drives JAK1/2-dependent local and systemic complement hyper-activation .
32702716 ?. Can Hyperperfusion of Nonaerated Lung Explain COVID-19 Hypoxia? .
32702718 ?. E-cigarette-Induced Pulmonary Inflammation and Dysregulated Repair are Mediated by nAChR ?7 Receptor: Role of nAChR ?7 in ACE2 Covid-19 receptor regulation.
32702714 ?. Interactome of SARS-CoV-2 / nCoV19 modulated host proteins with computationally predicted PPIs.
32702737 ?. B cell clonal expansion and convergent antibody responses to SARS-CoV-2.
32702728 ?. A potential role for AHR in SARS-CoV-2 pathology.
C7347481 2020. Hemophagocytic syndrome and COVID-19.
C7328624 2020. Sars-CoV-2 et Kawasaki rapprochement ? risque.
C7297549 ?. Kawasaki Disease and Invasive Pneumococcal Infection.
32680648 ?. Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak. head
C7340772 ?. Prototype of a Smart Microfluidic Platform for the Evaluation of SARS-Cov-2 Pathogenesis Along with Estimation of the Effectiveness of Potential Drug Candidates and Antigen?Antibody Interactions in Convalescent Plasma Therapy.
C7358563 2020. Unleashing the mysterious link between COVID-19 and a famous childhood vasculitis: Kawasaki disease.
C7320653 ?. Fractal signature of coronaviruses related to severe acute respiratory syndrome.
C7318729 2020. Gemeinschaftlich in Krisenzeiten: NMR-Strukturbiologie gegen COVID-19.
C7297671 2020. Covid-19: An urgent need for a psychoneuroendocrine perspective.
C7344205 2020. Crystal Structure of the Main Protease of Human Coronavirus NL63.
C7225694 2020. COVID-19 y estudios microbiológicos post mortem.
C7211634 2020. Autopsias en casos sospechosos de SARS-CoV-2.
C7211618 2020. Gestión de los cadáveres durante la pandemia por COVID-19 en España.
C7334659 2020. Devilishly radical NETwork in COVID-19: Oxidative stress neutrophil extracellular traps (NETs) and T cell suppression.
C7292949 2020. NK cells: A double edge sword against SARS-CoV-2.
C7315969 ?. COVID-19 and preeclampsia with severe features at 34-weeks gestation.
32668317 ?. COVID-19?Related Collapsing Glomerulopathy in a Kidney Transplant Recipient.
32659225 ?. The role of a cytokine storm in severe COVID-19 disease in pregnancy.
32659620 2020. Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx.
C7314264 ?. Human neutralizing antibodies to SARS-CoV-2: views and perspectives from Professor Linqi Zhang at Tsinghua University.
32718664 ?. Afectación endotelial por COVID-19 en criobiopsia pulmonar.
32682575 ?. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
C7323440 ?. Children s (and autoimmune patients) morbidity (and mortality) from Covid?19 is similar to the general population: immunologic rationale.
C7305885 2020. SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine.
32703419 2020. Proteasome activator PA28?-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.
C7356136 2020. Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.
32601146 2020. Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme.
32665075 ?. Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19.
C7308744 2020. Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk.
32673567 ?. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
32697970 ?. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.
32697968 ?. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
C7091918 ?. COVID-19 infection: the perspectives on immune responses.
32735849 ?. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2.
32668215 2020. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.
C7276302 2020. Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients.
32673562 2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.
32673668 2020. Insights into pediatric multi-system inflammatory syndrome and COVID-19.
32673711 2020. mTORC inhibitor Sirolimus deprograms monocytes in ?cytokine storm? in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis- like syndrome.
32659373 2020. Long-term infection of SARS-CoV-2 changed the body s immune status.
C7245680 ?. Hyperinflammation with COVID-19: The key to patient deterioration????.
C7354860 2020. Citrullinated histone H3 a marker of extracellular trap formation is increased in blood of stable asthma patients.
32696004 2020. Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors.
32711241 2020. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.
C7287426 ?. On the evolutionary epidemiology of SARS-CoV-2.
C7328575 ?. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization.
C7354376 ?. Monitoring antibody response following SARS-CoV-2 infection: Diagnostic efficiency of four automated immunoassays.
32711184 2020. The importance of cycle threshold values in interpreting molecular tests for SARS-CoV-2.
C7335417 ?. Assessment of samples pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia.
32673978 2020. How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory.
32731192 2020. COVID-19: Understanding the science of antibody testing and lessons from the HIV epidemic.
C7316051 2020. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series.
C7305505 2020. Tocilizumab for treatment of patients with severe COVID?19: A retrospective cohort study.
C7245291 ?. EL CUIDADO HUMANIZADO EN LA MUERTE POR COVID-19: A PROPÓSITO DE UN CASO.
C7357538 ?. Particulate matter (PM10) enhances RNA virus infection through modulation of innate immune responses?.
C7358302 ?. A Study on Herd Immunity of COVID-19 in South Korea: Using a Stochastic Economic-Epidemiological Model.
32665942 2020. Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia.
C7267447 2020. An address to the European immunology community concerning the Coronavirus pandemic.
C7318732 2020. Can India develop herd immunity against COVID-19?
C7262083 ?. SARS?CoV?2 an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability.
C7337683 ?. Lions Tigers and Kittens too: ACE2 and susceptibility to CoVID-19.
C7337764 ?. COVID-19 and Evolutionary Medicine.
C7324322 2020. Endometrial susceptibility to SARS CoV-2: explained by gene expression across the menstrual cycle?

32656452 2020. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
32631771 2020. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult.
32598981 2020. Infections and Collapsing Glomerulopathy.
32564928 2020. Host immune responses to influenza infection and vaccines: Lessons learned for all viral pandemic challenges.
32653819 2020. The autopsy at the time of SARS-CoV-2: Protocol and lessons.
32571869 2020. Kawasaki disease or Kawasaki syndrome?
32489438 2020. Spectrum of histopathological findings in coronavirus disease-19, Middle East respiratory syndrome and severe acute respiratory syndrome.
32565134 2020. The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.
32533513 2020. Cytosolic DNA sensing through cGAS and STING is inactivated by gene mutations in pangolins.
32405132 2020. Targeting the Linear Ubiquitin Assembly Complex to Modulate the Host Response and Improve Influenza A Virus Induced Lung Injury.
32653765 2020. Immunosenescence exacerbates the COVID-19.
32611485 2020. Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism.
32651741 2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
32559654 2020. Hypoxia induced up-regulation of tissue factor is mediated through extracellular RNA activated Toll-like receptor 3-activated protein 1 signalling.
32646445 2020. Isolation and characterization of WUPyV in polarized human airway epithelial cells.
32618551 2020. Covid-19 and Kawasaki syndrome.
32645325 2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
32645326 2020. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.
32649876 2020. Human Virus Transcriptional Regulators.
32623480 2020. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
32623546 2020. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.
32632255 2020. Pulmonary alveolar regeneration in adult COVID-19 patients.
32612199 2020. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.
32622823 2020. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.
32622819 2020. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.
32118646 2020. Voice from China: nomenclature of the novel coronavirus and related diseases.
32118645 2020. Single-cell RNA sequencing data suggest a role for angiotensin-converting enzyme 2 in kidney impairment in patients infected with 2019-novel coronavirus.
32653658 2020. Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery.
32533338 2020. A 9-year-old girl with Kawasaki disease and pulmonary nodules.
32418043 2020. Experience with Cidofovir as an adjunctive therapy in a patient of adenovirus-induced macrophage activation syndrome in systemic arthritis.
32513224 2020. Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study.
32541570 2020. Bronchiolitis and Potential Pathophysiological Implications in Coronavirus Disease 2019 ARDS Patients With Near-Normal Respiratory Compliance.
32642354 2020. Do COVID-19 and SARS Gene Complexities and Variations Help Overcome the Knowledge Gap?
32428465 2020. Pandemics and the great evolutionary mismatch.
32563779 2020. Protective and pathogenic roles for mast cells during viral infections.
32484440 2020. Shear stress activates ADAM10 sheddase to regulate Notch1 via the Piezo1 force sensor in endothelial cells.
32617121 2020. Myocardial and Microvascular Injury Due to Coronavirus Disease 2019.
24935083 2015. Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party.
23452147 2013. Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins.
32641214 2020. SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle.
32637365 2020. Participation of the IL-10RB Related Cytokines, IL-22 and IFN-lambda in Defense of the Airway Mucosal Barrier.
32655580 2020. Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation?
32655579 2020. Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis.
32612617 2020. The COVID-19 Cytokine Storm; What We Know So Far.
32582219 2020. IL-22 Plays a Critical Role in Maintaining Epithelial Integrity During Pulmonary Infection.
32574256 2020. Pangolins Lack IFIH1/MDA5, a Cytoplasmic RNA Sensor That Initiates Innate Immune Defense Upon Coronavirus Infection.
32626680 2020. Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients With COVID-19 Pneumonia: A Retrospective Case-Control Study.
32392463 2020. Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection.
32294404 2020. Something Else to Stress about: Perinatal Stress Attenuates CD8(+) T Cell Activity in Adults.
32500198 2020. Corona deaths in Hamburg, Germany.
32626922 2020. A dissection of SARSCoV2 with clinical implications (Review).
32466119 2020. Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.
32365944 2020. SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.
32340172 2020. Glycyrrhizin Inhibits PEDV Infection and Proinflammatory Cytokine Secretion via the HMGB1/TLR4-MAPK p38 Pathway.
32488343 2020. Coronavirus disease 2019 as a particular sepsis: a 2-week follow-up of standard immunological parameters in critically ill patients.
32385629 2020. From the quarantine diary of an emergency physician: the coronavirus and the dysautonomic storm.
17340620 2007. Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung.
28063205 2017. Pathogenetic determinants in Kawasaki disease: the haematological point of view.
30146782 2019. Modulation of the immune response by Middle East respiratory syndrome coronavirus.
32648027 2020. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
32623351 2020. Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates.
16752365 2006. Coronavirus phylogeny based on 2D graphical representation of DNA sequence.
32006540 2020. Genetic diversity and potential recombination between ferret coronaviruses from European and American lineages.
32142930 2020. Insights into the cross-species evolution of 2019 novel coronavirus.
26287378 2016. Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis.
24760654 2014. Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease.
32585239 2020. Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features.
32441751 2020. Pediatric Coronavirus Disease-2019-Associated Multisystem Inflammatory Syndrome.
32582339 2020. Variation of 2019 novel coronavirus complete genomes recorded in the 1(st) month of outbreak: Implication for mutation.
32188728 2020. Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.
26269185 2015. Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination.
24478444 2014. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.
16940539 2006. Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein.
32432657 2020. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults.
32437764 2020. Visualization of putative coronavirus in kidney.
32505464 2020. Am I a coronavirus?
32653518 2020. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.
32498008 2020. Is the gingival sulcus a potential niche for SARS-Corona virus-2?
32652428 2020. Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role?
32634734 2020. Hypoxemia in COVID-19 patients: An hypothesis.
32653475 2020. Does the hygiene hypothesis apply to COVID-19 susceptibility?
32656314 2020. COVID-19-A theory of autoimmunity to ACE-2.
25077179 2014. Kawasaki disease patients homozygous for the rs12252-C variant of interferon-induced transmembrane protein-3 are significantly more likely to develop coronary artery lesions.
32598829 2020. Childhood Multisystem Inflammatory Syndrome - A New Challenge in the Pandemic.
32461612 2020. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation.
32555182 2020. Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins provide insights into coronavirus evolution.
32651568 2020. T cell renaissance in COVID-19.
32591759 2020. Caught by NETs.
32591758 2020. Transient IgA, steady IgG?
32533112 2020. Neutralizing antibodies in convalescent patients.
32533130 2020. Epigenetic and epitranscriptomic regulation of viral replication.
32561857 2020. Coronavirus replication factories.
32287794 2020. Wuhan-like virus discovered seven years ago.
31863580 2020. A nucleobase-binding pocket in a viral RNA-dependent RNA polymerase contributes to elongation complex stability.
30070073 2018. Is an infectious trigger always required for primary hemophagocytic lymphohistiocytosis? Lessons from in utero and neonatal disease.
28950425 2018. Pulmonary presentation of Kawasaki disease-A diagnostic challenge.
22022266 2011. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
32620366 2020. COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor.
32611518 2020. COVID-19: Role of neutrophil extracellular traps in acute lung injury.
32650970 2020. Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain.
32650969 2020. The first COVID-19 autopsy in Spain performed during the early stages of the pandemic.
32434680 2020. AID in Antibody Diversification: There and Back Again.
32651761 2020. Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review.
28738245 2017. Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication.
18045721 2008. SARS coronavirus accessory proteins.
32456011 2020. The Role of Extracellular Vesicles as Allies of HIV, HCV and SARS Viruses.
32331321 2020. Broadly Neutralizing Bovine Antibodies: Highly Effective New Tools against Evasive Pathogens?

32656452 2020. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
32712145 2020. Multisystem inflammatory syndrome with particular cutaneous lesions related to COVID 19 in a young adult.
32659225 2020. The role of a cytokine storm in severe COVID-19 disease in pregnancy.
32701539 2020. HLA-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection.
32659620 2020. Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx.
32653819 2020. The autopsy at the time of SARS-CoV-2: Protocol and lessons.
32676824 2020. Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study.
32708525 2020. From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry.
32669265 2020. Discovery of M Protease inhibitors encoded by SARS-CoV-2.
32708430 2020. Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm.
32653765 2020. Immunosenescence exacerbates the COVID-19.
32651741 2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
32717432 2020. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.
32685484 2020. Identification of COVID-19 Infection-Related Human Genes Based on a Random Walk Model in a Virus-Human Protein Interaction Network.
32664932 2020. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
32664879 2020. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.
32665075 2020. Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19.
32708264 2020. Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19.
32645325 2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
32697970 2020. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.
32697968 2020. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
32673567 2020. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
32690996 2020. COVID-19 infection: mitohormetic concept of immune response.
32697943 2020. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis.
32612152 2020. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.
32623480 2020. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
32712910 2020. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.
32623546 2020. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.
32668215 2020. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.
32632255 2020. Pulmonary alveolar regeneration in adult COVID-19 patients.
32612199 2020. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.
32673562 2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.
32619549 2020. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.
32660065 2020. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.
32635598 2020. Canonical and Noncanonical Autophagy as Potential Targets for COVID-19.
32707842 2020. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes.
32622823 2020. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.
32707182 2020. Novel Temperature Trajectory Subphenotypes in COVID-19.
32622819 2020. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.
32630212 2020. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.
32700055 2020. The extended autonomic system, dyshomeostasis, and COVID-19.
32671502 2020. Is 'happy hypoxia' in COVID-19 a disorder of autonomic interoception? A hypothesis.
32661775 2020. Testing cardiovascular autonomic function in the COVID-19 era: lessons from Bologna's Autonomic Unit.
32673668 2020. Insights into pediatric multi-system inflammatory syndrome and COVID-19.
32683814 2020. Can we get a clue for the etiology of Kawasaki disease in the COVID-19 pandemic?
32664709 2020. Immunopathogenesis of COVID-19 and early immunomodulators.
32712394 2020. Letter to the Editor: Lessons from COVID-19, ACE2 and intestinal inflammation - could a virus trigger chronic intestinal inflammation?
32659373 2020. Long-term infection of SARS-CoV-2 changed the body's immune status.
32653662 2020. Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.
32653658 2020. Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery.
32717416 2020. Evolution of viral quasispecies during SARS-CoV-2 infection.
32711057 2020. Viable SARS-CoV-2 in various specimens from COVID-19 patients.
32688067 2020. Body temperature and host species preferences of SARS-CoV-2.
32658736 2020. Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans.
32709253 2020. Response to "Body temperature correlates with mortality in COVID-19 patients".
32698857 2020. Could the severity of COVID-19 be increased by low gastric acidity?
32690058 2020. Detection of IgG antibody during the follow-up in patients with COVID-19 infection.
32711241 2020. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.
32685628 2020. Haematological and immunological data of Chinese children infected with coronavirus disease 2019.
32707212 2020. Lymphocyte subsets with the lowest decline at baselineand the slow lowest rise during recovery in COVID-19 critical illnesspatients with diabetes mellitus.
32665025 2020. The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2.
32699547 2020. Kawasaki disease in siblings and a review of drug treatment.
32711256 2020. Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis.
32711254 2020. Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity.
32707445 2020. Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections.
32717182 2020. Lessons for COVID-19 Immunity from Other Coronavirus Infections.
32712315 2020. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.
32707288 2020. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
32668462 2020. COVID-19: An Immunopathologic Assault.
32709193 2020. Lung Injury in COVID-19-An Emerging Hypothesis.
32673476 2020. Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism.
32672403 2020. microRNAs as new possible actors in gender disparities of Covid-19 pandemic.
32662161 2020. Covid-19, ACE2, and the kidney.
32681166 2020. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.
32666092 2020. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
32662111 2020. COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes.
32706609 2020. Inducible Epithelial Resistance Against Coronavirus Pneumonia in Mice.
32663409 2020. Single-cell RNA Expression Profiling of ACE2, The Receptor of SARS-CoV-2.
32662396 2020. Temporal Change of SARS-CoV-2 in Clinical Specimens of COVID-19 Pneumonia Patients.
32705809 2020. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 1.
32716641 2020. Coronavirus Optimization Algorithm: A Bioinspired Metaheuristic Based on the COVID-19 Propagation Model.
32686774 2020. Multiple sclerosis and COVID-19.
32654296 2020. A Tale of (Glycogen Synthase Kinase) Three: Lithium, The Kidney and Coronavirus Disease 19.
32679621 2020. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients.
32678953 2020. Clinical characteristics, management and outcome of Covid-19-associated immune thrombocytopenia. A French multicenter series.
32678950 2020. Single-cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID-19 patients.
32663362 2020. ACE2, the Receptor that Enables the Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators.
32654514 2020. Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-mediated Effects on Potassium Channel Expression.
32689809 2020. Unexpected Features of Cardiac Pathology in COVID-19 Infection.
32706417 2020. Characteristics and roles of SARS-CoV-2 specific antibodies in patients with different severities of COVID-19.
32717055 2020. Diagnosing SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium.
32710613 2020. Multi-Inflammatory Syndrome in Children related to SARS-CoV-2 in Spain.
32672790 2020. Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients.
32667973 2020. SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters.
32663256 2020. Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity.
32694169 2020. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?
32713339 2020. Viral Evolution will Automatically Resolve COVID-19 Pandemic.
32660402 2020. NPC1 as a Modulator of Disease Severity and Viral Entry of Sars-CoV-2.
32657802 2020. Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: menage a trois.
32675718 2020. Reflections on rheumatological aspects of COVID-19.
32654350 2020. Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection.
32662099 2020. Therapeutic dilemma in the repression of severe acute respiratory syndrome coronavirus-2 proteome.
32657473 2020. TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2.
32652001 2020. Endocrine significance of SARS-CoV-2's reliance on ACE2.
32686577 2020. Epigenetic mechanisms regulating COVID-19 infection.
32710612 2020. Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2.
32643968 2020. Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress.
32706090 2020. CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients.
32692465 2020. COVID-19, Cilia, and Smell.
32692408 2020. Third Trimester Placentas of SARS-CoV-2-Positive Women: Histomorphology, including Viral Immunohistochemistry and in Situ Hybridization.
32678695 2020. Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development.
32689852 2020. Immune Responses to the Novel Coronavirus-2: Friend or Foe?

32662421 2020. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?
32665942 2020. Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia.
32675207 2020. Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects.
32675206 2020. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue.
32703822 2020. Abnormal carbon monoxide diffusion capacity in COVID-19 patients at time of hospital discharge.
32714336 2020. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.
32676080 2020. "Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-gamma, IL-17A, and a Janus Kinase Inhibitor.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
32695025 2020. Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host.
32676039 2020. COVID-19 Sepsis and Microcirculation Dysfunction.
32658591 2020. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.
32682765 2020. Lipotoxicity and cytokine storm in severe acute pancreatitis and COVID-19.
32668194 2020. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
32659267 2020. Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response.
32683337 2020. Pediatric Inflammatory Multisystem Syndrome Temporally Associated With COVID-19.
32683336 2020. Hyperinflammatory Syndrome in Children Associated with COVID-19: Need for Awareness.
32659347 2020. Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.
32708334 2020. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.
32668803 2020. COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.
32664543 2020. Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation.
32681297 2020. Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?
32666177 2020. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply.
32695405 2020. COVID-19 and cryo-EM.
32675285 2020. Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease.
32701511 2020. Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children.
32708872 2020. Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients.
32674356 2020. Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells.
32690544 2020. Genetic variations in the human severe acute respiratory syndrome coronavirus receptor ACE2 and serine protease TMPRSS2.
32707511 2020. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.
32674001 2020. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.
32652214 2020. Factors affecting stability and infectivity of SARS-CoV-2.
32699345 2020. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.
32675312 2020. ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19.
32652168 2020. Oscillation of SARS CoV-2 RNA load in a cohort of children and adolescents with neuro-psychiatric disorders resident in a nursing home of Lombardy Region (Italy).
32718895 2020. Immune response in COVID-19: A review.
32707537 2020. Hazards of the cytokine storm and cytokine-targeted therapy in COVID-19 patients: A Review.
32627759 2020. An Overview of the Genetic Variations of the SARS-CoV-2 Genomes Isolated in Southeast Asian Countries.
32710986 2020. Mutations Strengthened SARS-CoV-2 Infectivity.
32717229 2020. Epidemiological trends in Kawasaki disease during COVID-19 in Singapore.
32661139 2020. Broad and differential animal ACE2 receptor usage by SARS-CoV-2.
32706339 2020. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
32687484 2020. Severe immunosuppression and not a cytokine storm characterize COVID-19 infections.
32659211 2020. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.
32682491 2020. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.
32653054 2020. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.
32653518 2020. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.
32693241 2020. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.
32687918 2020. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
32703818 2020. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.
32694143 2020. Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2.
32679426 2020. The <> able to explain the Th1 immune lockdown in severe COVID-19.
32679424 2020. Natural protection of ocular surface from viral infections - A hypothesis.
32673940 2020. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.
32683222 2020. The immunomodulatory effects of exercise against COVID-19.
32679425 2020. The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.
32664116 2020. Late histological findings in symptomatic COVID-19 patients: A case report.
32670525 2020. Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure.
32670517 2020. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.
32653475 2020. Does the hygiene hypothesis apply to COVID-19 susceptibility?
32710269 2020. Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2.
32709887 2020. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.
32709886 2020. Structural basis of RNA cap modification by SARS-CoV-2.
32708840 2020. Genetic Diversity Among SARS-CoV2 Strains in South America may Impact Performance of Molecular Detection.
32672799 2020. Eosinopenia and COVID-19.
32680910 2020. Kidney Biopsy Findings in Patients with COVID-19.
32675304 2020. Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19.
32669323 2020. Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.
32660970 2020. COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.
32651224 2020. Caution in Identifying Coronaviruses by Electron Microscopy.
32700513 2020. Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?
32660959 2020. Is FURIN gene expression in salivary glands related to SARS-CoV-2 infectivity through saliva?
32667280 2020. A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a.
32699160 2020. COVID-19: Complement, Coagulation, and Collateral Damage.
32696489 2020. Cytokine storm syndrome in coronavirus disease 2019: A narrative review.
32716059 2020. Response to Comment on "Genetic Variants and Source of Introduction of SARS-CoV-2 in South America".
32710647 2020. Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen.
32706425 2020. The dynamic changes of serum IgM and IgG against SARS-CoV-2 in patients with COVID-19.
32706420 2020. Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay.
32706410 2020. SARS-CoV-2 Causes Kawasaki like Disease in children; Cases reported in Pakistan.
32706407 2020. SARS-Cov-2 infection causes pulmonary shunt by vasodilatation.
32681651 2020. COVID-19: What type of cytokine storm are we dealing with?
32699095 2020. Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes.
32679087 2020. COVID-19: from rapid genome sequencing to fast decisions.
32654359 2020. Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations.
32687176 2020. Evidence for strong mutation bias towards, and selection against, U content in SARS-CoV-2: implications for vaccine design.
32706959 2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.
32706954 2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.
32678534 2020. Pulmonary Vascular Pathology in Covid-19. Reply.
32678533 2020. Pulmonary Vascular Pathology in Covid-19.
32678532 2020. Pulmonary Vascular Pathology in Covid-19.
32678531 2020. Pulmonary Vascular Pathology in Covid-19.
32719485 2020. Sampling the host response to SARS-CoV-2 in hospitals under siege.
32661393 2020. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.
32704094 2020. LY6E impairs coronavirus fusion and confers immune control of viral disease.
32669681 2020. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.
32717743 2020. Longitudinal analyses reveal immunological misfiring in severe COVID-19.
32668444 2020. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
32659783 2020. A perspective on potential antibody-dependent enhancement of SARS-CoV-2.
32661414 2020. A race to determine what drives COVID-19 severity.
32684080 2020. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
32659199 2020. COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?
32654247 2020. Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein.
32672025 2020. Immunite cellulaire contre SARS-CoV-2 : substrat de l'immunite croisee entre coronavirus saisonniers et SARS-CoV-2 ?
32686248 2020. Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body.
32671966 2020. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.
32656939 2020. Lessons from dermatology about inflammatory responses in Covid-19.
32668509 2020. Variabilidad genetica y epigenetica, y la pandemia de Covid-19.
32697854 2020. Interferon: the invisible link between COVID-19 and BCGitis female protection?
32697367 2020. inverted question markAre Superantigens the Cause of Cytokine Storm and viral sepsis in Severe COVID-19? Observations and hypothesis.
32680954 2020. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.
32669287 2020. Comprehensive mapping of immune perturbations associated with severe COVID-19.
32651212 2020. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.

32679910 2020. SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders.
32678072 2020. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020.
32694615 2020. Comments to: A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression.
32715628 2020. Can ACE2 expression explain SARS-CoV-2 infection of the respiratory epithelia in COVID-19?
32715618 2020. The protein expression profile of ACE2 in human tissues.
32669467 2020. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
32694127 2020. COVID-19 and the Gut Microbiome: More than a Gut Feeling.
32681106 2020. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.
32665645 2020. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.
32686754 2020. Antibody responses to SARS-CoV-2 short-lived.
32686753 2020. Virus dissociated from inflammation in fatal COVID-19.
32651570 2020. CRISPRing for host genes regulating SARS-CoV-2.
32651569 2020. SARS-CoV-2 on the neural battleground.
32651568 2020. T cell renaissance in COVID-19.
32690876 2020. Can COVID-19 strike twice?
32699357 2020. COVID-19 management in light of the circadian clock.
32668692 2020. Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA.
32691391 2020. Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology.
32665786 2020. Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.
32685291 2020. Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure.
32659343 2020. Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.
32671793 2020. Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients.
32651900 2020. SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology.
32611518 2020. COVID-19: Role of neutrophil extracellular traps in acute lung injury.
32704472 2020. Hemophagocytic syndrome and COVID-19.
32664949 2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
32704018 2020. Human SARS-CoV-2 has evolved to reduce CG dinucleotide in its open reading frames.
32691370 2020. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45(-) Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.
32702413 2020. Multisystem Inflammatory Syndrome in Children: Is There a Linkage to Kawasaki Disease?
32653566 2020. Understanding The Complex Relationship Between Androgens and SARS-CoV2.
32679691 2020. Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes.
32666230 2020. Germany's first COVID-19 deceased: a 59-year-old man presenting with diffuse alveolar damage due to SARS-CoV-2 infection.
32699972 2020. Mild Cytokine Elevation, Moderate CD4(+) T Cell Response and Abundant Antibody Production in Children with COVID-19.
32687861 2020. Phylogenetic and phylodynamic analyses of SARS-CoV-2.
32674515 2020. Validation of Variant Assembly Using HAPHPIPE with Next-Generation Sequence Data from Viruses.
32614178 2020. Pulmonary Edema in COVID19-A Neural Hypothesis.
32638079 2020. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19.
32628642 2020. Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China.
32650004 2020. Eicosanoids: the Overlooked Storm in COVID-19?
32628931 2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.
32639866 2020. DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY.
32622243 2020. Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective.
32611313 2020. Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.
32629042 2020. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters.
32646930 2020. Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1.
32645391 2020. Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU.
32646523 2020. Adrenomedullin in COVID-19 induced endotheliitis.
32643351 2020. Successful sequencing of the first SARS-CoV-2 genomes from Croatian patients.
32640417 2020. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.
32610564 2020. COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood Biomarkers.
32646736 2020. Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms.
32650275 2020. Reappearance of effector T cells is associated with recovery from COVID-19.
32629393 2020. Illuminating COVID-19 lung disease through autopsy studies.
32632419 2020. Eosinopenia and COVID-19 patients: So specific ?
32633718 2020. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
32614767 2020. Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda.
32618497 2020. High neutralizing antibody titer in intensive care unit patients with COVID-19.
32620946 2020. Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology.
32615182 2020. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
32634438 2020. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus.
32631841 2020. JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk.
32631838 2020. Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19.
32631836 2020. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?
32646049 2020. Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts.
32646047 2020. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
32645523 2020. Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses.
32640274 2020. SARS-CoV2 envelope protein: Non-synonymous mutations and its consequences.
32641873 2020. Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review.
32621172 2020. Multisystem Inflammatory Syndrome in Children in COVID-19 Pandemic.
32615316 2020. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.
32622082 2020. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.
32638151 2020. A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms.
32634585 2020. Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19.
32613447 2020. SARS-CoV-2-related deaths in routine forensic autopsy practice: histopathological patterns.
32630032 2020. Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity.
32629995 2020. Putative Roles for Peptidylarginine Deiminases in COVID-19.
32645951 2020. Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting.
32640747 2020. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.
32621017 2020. SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models.
32642784 2020. Serum antibody response in critically ill patients with COVID-19.
32624257 2020. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
32615258 2020. Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak.
32639084 2020. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.
32634129 2020. Kinetics of viral load and antibody response in relation to COVID-19 severity.
32610587 2020. Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis.
32635302 2020. Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm.
32645361 2020. Inflammasome Activation and Pyroptosis in Lymphopenic COVID-19 Liver Patients.
32615199 2020. SARS-CoV-2 detection, viral load and infectivity over the course of an infection.
32622905 2020. Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient.
32614392 2020. Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study.
32647285 2020. Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents.
32645344 2020. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination.
32645661 2020. Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer?
32645660 2020. Is macrophages heterogeneity important in determining COVID-19 lethality?
32650197 2020. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.
32645659 2020. Epithelial cilia is the first line of defence against Coronavirus; addressing the observed age-gradient in the COVID-19 infection.
32646911 2020. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Early Manifestations of COVID-19 in Israel.
32646908 2020. Coding-Complete Genome Sequence of SARS-CoV-2 Isolate from Bangladesh by Sanger Sequencing.
32641700 2020. Immunological and inflammatory profiles in mild and severe cases of COVID-19.
32641705 2020. Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production.
32648040 2020. Unlocking the lockdown of science and demystifying COVID-19: how autopsies contribute to our understanding of a deadly pandemic.
32642842 2020. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.
32627524 2020. Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms.
32650002 2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.
32631071 2020. COVID-ARDS Clarified: A Vascular Endotype?
32649217 2020. RV Infections in Asthmatics Increase ACE2 Expression and Cytokine Pathways Implicated in COVID-19.
32608999 2020. COVID-19 Severity Correlates with Weaker T Cell Immunity, Hypercytokinemia and Lung Epithelium Injury.
32628534 2020. Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study.
32633104 2020. Covid-19 related IgA vasculitis.
32636189 2020. Covid-19: Herd immunity is "unethical and unachievable," say experts after report of 5% seroprevalence in Spain.
32643798 2020. Tackling COVID-19 infection through complement-targeted immunotherapy.
32640169 2020. Potential impact of SARS-CoV-2 infection on the thymus.
32641195 2020. Reply to the letter concerning Kawasaki Disease and Covid-19.
32638018 2020. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
32636454 2020. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.
32639942 2020. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.
32639941 2020. The early antibody response to SARS-Cov-2 infection.
32638022 2020. Direct evidence of active SARS-CoV-2 replication in the intestine.
32645713 2020. Microbiota and Covid-19. Which came first, the chicken or the egg?
32645228 2020. Angiotensin II Receptors - Impact for COVID-19 Severity.
32631463 2020. COVID-19: Yin and Yang and Herd Immunity.
32645207 2020. Basic Immunology may lead to translational therapeutic rationale:: SARS-CoV-2 and Rheumatic Diseases.
32635753 2020. Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32614086 2020. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies.
32629518 2020. Inflammatory Cell Infiltration of Adrenals in COVID-19.
32643416 2020. SARS-CoV-2 Receptor ACE2 is upregulated in Colonic Organoids from Hypertensive Rats.
32615317 2020. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.
32624498 2020. COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby.
32643586 2020. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity.
32639183 2020. The Inter-alpha-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.
32640487 2020. BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.
32644266 2020. Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.
32644223 2020. Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.
32639581 2020. Changes in RT-PCR test results and symptoms during the menstrual cycle of female individuals infected with SARS-CoV-2: Report of two cases.
32633840 2020. The variability of the serological response to SARS corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).
32633815 2020. An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues.
32642770 2020. Proteome-wide Data Analysis Reveals Tissue-specific Network Associated with SARS-CoV-2 Infection.
32640066 2020. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran.
32641486 2020. Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
32622377 2020. Kawasaki disease in the COVID-19 era: a distinct clinical phenotype?
32611256 2020. Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection.
32640127 2020. Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19.
32641847 2020. A COVID-19 model.
32647358 2020. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.
32647346 2020. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.
32616673 2020. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.
32638509 2020. The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.

32611670 2020. Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in synovial tissues.
32627126 2020. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
32641482 2020. LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
32622376 2020. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
32619412 2020. Endothelial cells orchestrate COVID-19 coagulopathy.
32619411 2020. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
32616514 2020. Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework.
32629204 2020. A hypothesis on the role of the human immune system in covid-19.
32622045 2020. Integrated Approaches to Reveal Mechanisms by which RNA Viruses Reprogram the Cellular Environment.
32616647 2020. Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Morocco.
32616644 2020. Genome Sequencing of a Severe Acute Respiratory Syndrome Coronavirus 2 Isolate Obtained from a South African Patient with Coronavirus Disease 2019.
32620916 2020. Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection.
32632085 2020. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.
32612128 2020. High-altitude populations need special considerations for COVID-19.
32636479 2020. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.
32636475 2020. SARS-CoV-2-specific T cells without antibodies.
32629960 2020. Evidence for SARS-CoV-2 Infection of Animal Hosts.
32640525 2020. Molecular Aspects of COVID-19 Differential Pathogenesis.
32627515 2020. Dysregulation of the immune system as a driver of the critical course of the novel coronavirus disease 2019.
32638966 2020. Immunological aspects of coronavirus disease during pregnancy: an integrative review.
32621057 2020. The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2.
32616709 2020. Mapping the T cell response to COVID-19.
32619819 2020. S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study.
32615987 2020. Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis.

C7568207 ?. Síndrome inflamatorio multisistémico en niños con COVID-19: una visión desde la reumatología.
C7561343 ?. Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes?.
C7544460 2020. Caractériser la réponse immunitaire au cours de la pneumopathie grave.
C7577707 ?. Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.
C7548726 2020. PROTECTIVE FACTORS AGAINST THE COVID-19 STORM.
C7548724 2020. COVID-19 AND A HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME IN THE ABSENCE OF ARDS.
C7548599 2020. CALM BEFORE THE STORM: COVID-19 AND CYTOKINE STORM SYNDROME.
C7548549 2020. SECONDARY HLH PRESENTING AS ARDS.

33330852 2021. Unfolded protein response in the COVID-19 context.
33123500 2020. Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection.
33095394 2020. Multisystem Inflammatory Syndrome in Children: A Mimicker of Severe Dengue.
33228920 2020. Herd immunity confusion.
33031752 2020. MIS-C: post-infectious syndrome or persistent infection?

33484168 2021. Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19.
33399182 2021. Herd Immunity to COVID-19.
33469560 2021. Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS).
33521168 2020. Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications.
33406838 2021. N- and O-Glycosylation of the SARS-CoV-2 Spike Protein.
33458987 2021. Sindrome inflamatorio multisistemico en ninos, relacionado con COVID-19: actualizacion a proposito de la presentacion de 2 pacientes criticos.
33458972 2021. Tormenta de citoquinas y tormenta de informacion asociadas a COVID-19: consideraciones sobre el sindrome inflamatorio multisistemico en ninos.
33398692 2021. Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective.
33483791 2021. A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics.
33464421 2021. Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: an endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations.
33462671 2021. The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.
33521335 2021. The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus - evolved or yet to evolve.
33506114 2021. Mutational sensitivity of D614G in spike protein of SARS-CoV-2 in Jordan.
33515911 2021. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.
33413979 2021. A nidovirus perspective on SARS-CoV-2.
33450483 2021. The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy.
33484784 2021. Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2.
33445785 2021. The Long-Term Evolutionary History of Gradual Reduction of CpG Dinucleotides in the SARS-CoV-2 Lineage.
33486617 2021. NMR assignments of the macro domain from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
33484403 2021. (1)H, (13)C and (15)N chemical shift assignment of the stem-loop 5a from the 5'-UTR of SARS-CoV-2.
33475934 2021. (1)H, (13)C and (15)N backbone chemical shift assignments of SARS-CoV-2 nsp3a.
33423172 2021. (1)H,(13)C and (15)N chemical shift assignments of the SUD domains of SARS-CoV-2 non-structural protein 3c: "The SUD-M and SUD-C domains".
33392924 2021. Backbone chemical shift assignments for the SARS-CoV-2 non-structural protein Nsp9: intermediate (ms - mus) dynamics in the C-terminal helix at the dimer interface.
33389548 2021. (1)H, (15)N and (13)C resonance assignments of the N-terminal domain of the nucleocapsid protein from the endemic human coronavirus HKU1.
33504682 2021. Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection.
33484712 2021. Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 S-protein.
33460600 2021. Improving SARS-CoV-2 structures: Peer review by early coordinate release.
33401144 2021. Entropy-driven electrochemiluminescence ultra-sensitive detection strategy of NF-kappaB p50 as the regulator of cytokine storm.
33407800 2021. Identification and characterization of a silent mutation in RNA binding domain of N protein coding gene from SARS-CoV-2.
33419930 2021. What are SARS-CoV-2 genomes from the WHO Africa region member states telling us?
33479725 2021. An integrated approach to determine the abundance, mutation rate and phylogeny of the SARS-CoV-2 genome.
33491070 2021. Noncoding RNAs: modulators and modulatable players during infection-induced stress response.
33405097 2021. SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation.
33448856 2021. Dynamic Network Modeling of Allosteric Interactions and Communication Pathways in the SARS-CoV-2 Spike Trimer Mutants: Differential Modulation of Conformational Landscapes and Signal Transmission via Cascades of Regulatory Switches.
33426894 2021. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.
33426872 2021. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.
33400372 2021. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.
33485447 2021. Neuropathology associated with SARS-CoV-2 infection - Authors' reply.
33485446 2021. Neuropathology associated with SARS-CoV-2 infection.
33485445 2021. Neuropathology associated with SARS-CoV-2 infection.
33485444 2021. Neuropathology associated with SARS-CoV-2 infection.
33453781 2021. Using EM data to understand COVID-19 pathophysiology - Authors' reply.
33453779 2021. Using EM data to understand COVID-19 pathophysiology.
33450180 2021. First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020.
33417829 2021. New variant of SARS-CoV-2 in UK causes surge of COVID-19.
33392518 2021. SARS-CoV-2 serological cross-reactivity with autoantibodies - Authors' reply.
33392517 2021. SARS-CoV-2 serological cross-reactivity with autoantibodies.
33454368 2021. Monocytes and macrophages in COVID-19: Friends and foes.
33453245 2021. The proteomic characteristics of airway mucus from critical ill COVID-19 patients.
33508291 2021. SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis.
33468702 2021. SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia.
33468697 2021. Atypical Divergence of SARS-CoV-2 Orf8 from Orf7a within the Coronavirus Lineage Suggests Potential Stealthy Viral Strategies in Immune Evasion.
33468695 2021. SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike.
33436436 2021. Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity?
33511329 2020. Adhesive contact between cylindrical (Ebola) and spherical (SARS-CoV-2) viral particles and a cell membrane.
33412501 2021. Polycations and polyanions in SARS-CoV-2 infection.
33505220 2021. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.
33414350 2021. Genomic Sequences and Analysis of Five SARS-CoV-2 Variants Obtained from Patients in Lambayeque, Peru.
33414330 2021. Mutation Profile of SARS-CoV-2 Genome Sequences Originating from Eight Israeli Patient Isolates.
33414329 2021. Genome Sequences of Two GH Clade SARS-CoV-2 Strains Isolated from Patients with COVID-19 in South Korea.
33509997 2021. Genome Sequence of a SARS-CoV-2 VUI 202012/01 Strain Identified from a Patient Returning from London, England, to the Apulia Region of Italy.
33509993 2021. Genome Sequences of 10 SARS-CoV-2 Viral Strains Obtained by Nanopore Sequencing of Nasopharyngeal Swabs in Malta.
33509990 2021. Genome Sequencing of a Novel Coronavirus SARS-CoV-2 Isolate from Iraq.
33479004 2021. Expression of Concern for Sah et al., "Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal".
33401565 2021. SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients.
33445583 2021. Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers.
33476315 2021. Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.
33386849 2021. Population dynamics and structural effects at short and long range support the hypothesis of the selective advantage of the G614 SARS-Cov2 spike variant.
33417854 2021. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2.
33444546 2021. Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms.
33474931 2021. Topography, Spike Dynamics, and Nanomechanics of Individual Native SARS-CoV-2 Virions.
33420022 2021. Host and viral determinants for efficient SARS-CoV-2 infection of the human lung.
33397909 2021. Neutralizing antibody titres in SARS-CoV-2 infections.
33397903 2021. Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray.
33504779 2021. Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics.
33483492 2021. SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques.
33479198 2021. The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein.
33431842 2021. Stabilizing the closed SARS-CoV-2 spike trimer.
33402727 2021. Endemic SARS-CoV-2 will maintain post-pandemic immunity.
33442033 2021. What have we learnt so far from COVID-19?
33432128 2021. Super(antigen) target for SARS-CoV-2.
33425367 2021. A single nucleotide distinguishes the SARS-CoV-2 in the Wuhan outbreak in December 2019 from that in Beijing-Xinfadi in June 2020, China.
33398006 2021. SARS-CoV-2 structural features may explain limited neutralizing-antibody responses.
33381273 2020. SARS-CoV-2 and Other Respiratory Viruses: What Does Oxidative Stress Have to Do with It?
33391390 2021. SARS-CoV-2 paediatric inflammatory syndrome.
33479801 2021. Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.
33437273 2021. Real-Time Polymerase chain reaction trends in COVID-19 patients.
33401530 2021. SARS-CoV-2-Cholesterol Interaction: A Lot of Food for Thought.
33428826 2021. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis.
33433671 2021. Extracardiac imaging findings in COVID-19-associated multisystem inflammatory syndrome in children.
33404786 2021. Chest radiograph features of multisystem inflammatory syndrome in children (MIS-C) compared to pediatric COVID-19.
33505806 2021. Identification and molecular characterization of mutations in nucleocapsid phosphoprotein of SARS-CoV-2.
33391880 2020. Full-length genome characterization and phylogenetic analysis of SARS-CoV-2 virus strains from Yogyakarta and Central Java, Indonesia.
33384909 2020. Mutational spectra of SARS-CoV-2 isolated from animals.
33382773 2020. Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis.
33382764 2020. Antibody response to SARS-CoV-2 infection in humans: A systematic review.
33382687 2020. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
33507952 2021. Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium.
33493182 2021. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion.
33476327 2021. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.
33465137 2021. The coronavirus proofreading exoribonuclease mediates extensive viral recombination.
33411764 2021. Novel modulators of p53-signaling encoded by unknown genes of emerging viruses.
33395426 2021. The role of Neuropilin-1 in COVID-19.
33399747 2020. Sindrome inflamatorio multisistemico asociado con SARS-CoV-2 en pediatria.
33399746 2020. Sindrome inflamatorio multisistemico temporal asociado con SARS-CoV-2 pediatrico: inverted question markComo nos enfrentamos a un enemigo impredecible?
33411967 2021. Association of endopeptidases, involved in SARS-CoV-2 infection, with microbial aggravation in sputum of severe asthma.
33414185 2021. Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'.
33414184 2021. Response to: 'Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm by Tampe et al.
33446481 2021. Covid-19: Past infection provides 83% protection for five months but may not stop transmission, study finds.
33380408 2020. Covid-19: Antibodies protect against reinfection for at least six months, study finds.
33464010 2021. COVID-19-Related Potential Multisystem Inflammatory Syndrome in Childhood in a Neonate Presenting as Persistent Pulmonary Hypertension of the Newborn.
33414238 2021. Inflammatory Bowel Disease Presenting With Concurrent COVID-19 Multisystem Inflammatory Syndrome.

33505752 2021. COVID-19-Associated Multisystem Inflammatory Syndrome Complicated with Giant Coronary Artery Aneurysm.
33382968 2021. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.
33412089 2021. COVID-19-neutralizing antibodies predict disease severity and survival.
33497610 2021. Adaptive immunity to SARS-CoV-2 and COVID-19.
33516131 2021. Lysosomal ion channels involved in cellular entry and uncoating of enveloped viruses: Implications for therapeutic strategies against SARS-CoV-2.
33441142 2021. On the role of bacterial metalloproteases in COVID-19 associated cytokine storm.
33500559 2021. Antibodies, epicenter of SARS-CoV-2 immunology.
33510134 2021. N(6)-methyladenosine regulates RNA abundance of SARS-CoV-2.
33479219 2021. SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation into stress granules through its N-terminal intrinsically disordered region.
33388094 2021. Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19.
33483707 2021. Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients.
33473190 2021. Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response.
33420358 2021. Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months.
33420356 2021. The interplay between dendritic cells and CD8 T lymphocytes is a crucial component of SARS-CoV-2 immunity.
33408342 2021. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity.
33449149 2021. Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release.
33503420 2021. The immunodominant and neutralization linear epitopes for SARS-CoV-2.
33440148 2021. MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.
33417835 2021. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction.
33485405 2021. Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD.
33500101 2020. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.
33495758 2021. Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses.
33495757 2021. Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19.
33495756 2021. Use of machine learning to identify a T cell response to SARS-CoV-2.
33420426 2021. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.
33450186 2021. ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response.
33518776 2020. Computed optical spectra of SARS-CoV-2 proteins.
33445833 2021. Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019.
33417689 2021. Lack of SARS-CoV2 neutralization by antibodies to seasonal coronaviruses: making sense of the COVID-19 pandemic.
33400782 2021. The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers.
33395482 2021. SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses.
33388756 2021. Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany.
33501951 2021. Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
33501950 2021. Occurrence and Timing of Subsequent Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-transcription Polymerase Chain Reaction Positivity Among Initially Negative Patients.
33386403 2021. SARS-CoV-2 immunity and reinfection.
33479086 2021. Lessons of the month: A misunderstood teenager with paediatric inflammatory multisystem syndrome - temporarily associated with SARS-CoV-2 admitted under adult medicine.
33524589 2021. A global analysis of replacement of genetic variants of SARS-CoV-2 in association with containment capacity and changes in disease severity.
33482352 2021. Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study.
33465499 2021. SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient.
33450388 2021. Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays.
33484220 2021. Development of a SARS-CoV-2 rapid antibody detection kit and study on dynamic changes in antibodies in infected patients.
33389315 2021. Haemophagocytic syndrome and COVID-19.
33520118 2021. Meta-analysis of transcriptome datasets: An alternative method to study IL-6 regulation in coronavirus disease 2019.
33506994 2021. Different hair loss patterns in two pediatric patients with COVID-19-associated multisystem inflammatory syndrome in children.
33522642 2021. Syncytia formation by SARS-CoV-2-infected cells.
33522893 2021. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
33401657 2021. The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection.
33497356 2021. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.
33492309 2021. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.
33427749 2021. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.
33467466 2021. When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It.
33399879 2021. Production of ORF8 protein from SARS-CoV-2 using an inducible virus-mediated expression system in suspension-cultured tobacco BY-2 cells.
33465066 2021. Modeling the structure of the frameshift-stimulatory pseudoknot in SARS-CoV-2 reveals multiple possible conformers.
33411735 2021. COVID-19, leprosy, and neutrophils.
33513195 2021. High SARS-CoV-2 load in the nasopharynx of patients with a mild form of COVID-19 is associated with clinical deterioration regardless of the hydroxychloroquine administration.
33507994 2021. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration.
33497392 2021. Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains.
33493185 2021. T cell response to SARS-CoV-2 infection in humans: A systematic review.
33479167 2021. Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.
33446512 2021. Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset.
33406522 2021. Genetic Variation and Evolution of the 2019 Novel Coronavirus.
33460776 2021. Can efficient stimulation of myogenic microcirculatory oscillations by transient ischemia predict low incidence of COVID-19 infection?
33472605 2021. Plasma microbial cell-free DNA load is associated with mortality in patients with COVID-19.
33495715 2021. SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production.
33495714 2021. Binding of the SARS-CoV-2 Spike Protein to Glycans.
33420163 2021. Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples.
33510359 2021. Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors.
33510353 2021. Network theoretic analysis of JAK/STAT pathway and extrapolation to drugs and viruses including COVID-19.
33510275 2021. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
33504824 2021. Altered high-density lipoprotein composition and functions during severe COVID-19.
33500507 2021. CD8(+) T cells predicted the conversion of common covid-19 to severe.
33479465 2021. SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness.
33432067 2021. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.
33514692 2021. Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA.
33514685 2021. Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection.
33462185 2021. Not only ACE2-the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19.
33431822 2021. Connections between biomechanics and higher infectivity: a tale of the D614G mutation in the SARS-CoV-2 spike protein.
33381288 2020. Sleep and COVID-19: considerations about immunity, pathophysiology, and treatment.
33437929 2021. Childhood Multisystem Inflammatory Syndrome: An Emerging Disease with Prominent Cardiovascular Involvement-A Scoping Review.
33432304 2021. Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection: a Systematic Review with Meta-analysis.
33426471 2021. Is Eye Immune-Privileged to COVID-19 Infection?
33403490 2021. Does the Global Outbreak of COVID-19 or Other Viral Diseases Threaten the Stem Cell Reservoir Inside the Body?
33500718 2021. Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19.
33391477 2021. Immunopathogenesis and treatment of cytokine storm in COVID-19.
33457321 2020. Can we Turn off the "Covid-Biting-Tail" Inflammation?
33455862 2021. Altered Cholesterol and Lipid Synthesis Mediates Hyperinflammation in COVID-19.
33451855 2021. Dysregulation of Cell Signaling by SARS-CoV-2.
33467724 2021. Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome.
33440622 2021. SARS-CoV-2 Epitope Mapping on Microarrays Highlights Strong Immune-Response to N Protein Region.
33413449 2021. Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling.
33450669 2021. Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan.
33387787 2021. Programmed -1 Ribosomal Frameshifting in coronaviruses: A therapeutic target.
33500788 2021. Synonymous mutations and the molecular evolution of SARS-CoV-2 origins.
33500787 2021. Possible host-adaptation of SARS-CoV-2 due to improved ACE2 receptor binding in mink.
33476695 2021. The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses.
33418027 2021. Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19).
33499234 2021. Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy.
33498225 2021. Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein.
33477951 2021. Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) Patients.
33477885 2021. Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia.
33467206 2021. MicroRNAs for Virus Pathogenicity and Host Responses, Identified in SARS-CoV-2 Genomes, May Play Roles in Viral-Host Co-Evolution in Putative Zoonotic Host Species.
33440724 2021. The Fatty Acid Lipid Metabolism Nexus in COVID-19.
33396605 2020. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-beta Production.
33419245 2020. Can Coronaviruses Steal Genes from the Host as Evidenced in Western European Hedgehogs by EriCoV Genetic Characterization?
33392306 2020. Virus load and virus shedding of SARS-CoV-2 and their impact on patient outcomes.
33410308 2021. Pitfalls of barcodes in the study of worldwide SARS-CoV-2 variation and phylodynamics.
33389884 2020. Immune Computation and COVID-19 Mortality: A Rationale for IVIg.
33494667 2021. Role of Poly(ADP-ribose) polymerase (PARP1) in viral infection and its implication in SARS-CoV-2 pathogenesis.
33394725 2021. Editorial: Do not lose focus on myeloid biology in the era of COVID-19.
33434935 2021. Macrophage Activation and Cytokine Release Syndrome in COVID-19: Current Updates and Analysis of Repurposed and Investigational Anti-Cytokine Drugs.
33479166 2021. Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.
33472860 2021. Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit.

33432808 2021. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.
33458462 2021. Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis.
33489438 2020. An unorthodox pathophysiology of severe cases of COVID-19 the weak heme hypothesis.
33434105 2021. SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport.
33434104 2021. Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality.
33416946 2021. Are all cytokine storms the same?
33407957 2021. Junctional tachycardia due to multisystem inflammatory syndrome in children with SARS-CoV-2 infection in a 12-year-old female.
33516277 2021. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.
33521695 2021. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.
33387094 2021. Kawasaki disease and influenza-new lessons from old associations.
33428101 2021. Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic.
33411143 2021. COVID-19, rheumatic diseases and immune dysregulation-a perspective.
33456620 2021. Principal Component Analysis Applications in COVID-19 Genome Sequence Studies.
33514825 2021. SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus.
33383528 2021. Identification and computational analysis of mutations in SARS-CoV-2.
33456724 2021. Unraveling the molecular basis of host cell receptor usage in SARS-CoV-2 and other human pathogenic beta-CoVs.
33425248 2021. Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes.
33391633 2021. Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?
33397460 2021. Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome.
33403180 2020. Adult Inflammatory Multi-System Syndrome Mimicking Kawasaki Disease in a Patient With COVID-19.
33425537 2020. A Case of Multisystem Inflammatory Syndrome Post-COVID-19 Infection in an Adult.
33457109 2021. Decoding Covid-19 with the SARS-CoV-2 Genome.
33508651 2021. ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?
33487779 2020. Genomic Study of COVID-19 Corona Virus Excludes Its Origin from Recombination or Characterized Biological Sources and Suggests a Role for HERVS in Its Wide Range Symptoms.
33522107 2021. Sustained cellular immunity in adults recovered from mild COVID-19.
33496367 2021. A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID-19.
33422265 2021. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation.
33436069 2021. Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus.
33388575 2021. Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities.
33520333 2020. Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity.
33427152 2021. SARS-CoV-2 viral RNA load dynamics in the nasopharynx of infected children.
33517929 2021. Diversity of SARS-CoV-2 isolates driven by pressure and health index.
33462598 2021. COVID 19: in the eye of the cytokine storm.
33404891 2021. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
33421274 2021. Circulating cardiovascular microRNAs in critically ill COVID-19 patients.
33452570 2021. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
33419887 2021. Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia.
33506945 2021. High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19.
33478625 2021. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020.
33495994 2021. Is lymphopenia different between SARS and COVID-19 patients?
33503469 2021. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between alpha7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins.
33510633 2020. Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases.
33520952 2020. Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19.
33521069 2020. Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19.
33505977 2020. Identifying Transcriptomic Signatures and Rules for SARS-CoV-2 Infection.
33392109 2020. Is the "Common Cold" Our Greatest Ally in the Battle Against SARS-CoV-2?
33511102 2020. Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences.
33469527 2020. Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations.
33381492 2020. Host DDX Helicases as Possible SARS-CoV-2 Proviral Factors: A Structural Overview of Their Hijacking Through Multiple Viral Proteins.
33488517 2020. The Adrenal Cortex, an Underestimated Site of SARS-CoV-2 Infection.
33519902 2020. Detecting the Multiomics Signatures of Factor-Specific Inflammatory Effects on Airway Smooth Muscles.
33505425 2020. Deciphering the Subtype Differentiation History of SARS-CoV-2 Based on a New Breadth-First Searching Optimized Alignment Method Over a Global Data Set of 24,768 Sequences.
33424918 2020. A Comprehensive Analysis of cis-Acting RNA Elements in the SARS-CoV-2 Genome by a Bioinformatics Approach.
33519814 2020. Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury.
33519802 2020. Does Angiotensin II Peak in Response to SARS-CoV-2?
33424856 2020. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.
33391280 2020. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.
33384691 2020. Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures.
33392257 2020. Surveying the Side-Chain Network Approach to Protein Structure and Dynamics: The SARS-CoV-2 Spike Protein as an Illustrative Case.
33469522 2020. Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland.
33425823 2020. Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment.
33381049 2020. A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface.
33510644 2020. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
33414726 2020. Physiology of Midkine and Its Potential Pathophysiological Role in COVID-19.
33392612 2020. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Codon Usage and Replicative Fitness.
33403225 2020. SARS-CoV-2: A Trigger for Kawasaki Disease or a New Syndrome?
33431578 2021. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
33495741 2021. Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa.
33437888 2021. Clinically distinct COVID-19 cases share notably similar immune response progression: A follow-up analysis.
33524881 2021. What do we know about the antibody responses to SARS-CoV-2?
33427136 2021. The 501.V2 and B.1.1.7 variants of coronavirus disease 2019 (COVID-19): A new time-bomb in the making?
33521603 2021. A high-throughput liquid bead array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity.
33521593 2021. The presentation of SARS-CoV-2 peptides by the common HLA-A( )02:01 molecule.
33480287 2021. Clocks, Viruses, and Immunity: Lessons for the COVID-19 Pandemic.
33506741 2021. Structural similarity-based prediction of host factors associated with SARS-CoV-2 infection and pathogenesis.
33513242 2021. Robust neutralizing antibodies to SARS-CoV-2 develop and persist in subjects with diabetes and COVID-19 pneumonia.
33524125 2021. Post Convalescent SARS-CoV-2 IgG and Neutralizing Antibodies Are Elevated in Individuals with Poor Metabolic Health.
33464307 2021. Mapping and role of T cell response in SARS-CoV-2-infected mice.
33431260 2021. Reply to letter to the editor: Kawasaki disease and COVID-19: A pretext for a hot topic.
33464637 2021. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.
33512021 2021. Evolutionary analysis of SARS-CoV-2 spike protein for its different clades.
33506970 2021. Will the emergent SARS-CoV2 B.1.1.7 lineage affect molecular diagnosis of COVID-19?
33506952 2021. Role of Toll-like receptors in the pathogenesis of COVID-19.
33506951 2021. Emergence of SARS-CoV-2 Variant: A wake-up call for Pakistan's overburdened healthcare system.
33506950 2021. Clinical significance of cellular immunity function and inflammatory factors assays in alveolar lavage fluid for severe COVID-19 pneumonia.
33506962 2021. A parsimonious approach for recognizing SARS-CoV-2 and host interactions.
33433004 2021. Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure.
33427302 2021. Antibody response to SARS-CoV-2 in infected patients with different clinical outcome.
33493263 2021. Kidney injury molecule-1 is a potential receptor for SARS-CoV-2.
33453103 2021. Kidney injury molecule-1: a novel entry factor for SARS-CoV-2.
33518219 2020. Compelling evidence of a novel multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection.
33458751 2021. 16 Weeks Later: Expanding the Risk Period for MIS-C.
33500262 2021. Covid-19: New UK variant may be linked to increased death rate, early data indicate.
33380449 2021. Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection.
33504377 2021. Coronary aneurysms, myocardial dysfunction, and shock in a COVID-19 child, role of ECMO, immunomodulation, and cardiac CT.
33382348 2021. MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?
33510385 2021. The m(6)A methylome of SARS-CoV-2 in host cells.
33394568 2021. Illuminating the immunopathology of SARS-CoV-2.
33504318 2021. An Alternative "Trojan Horse" Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology.
33499661 2021. RNA editors: key regulators of viral response in cancer patients.
33467896 2021. Inter-proteomic posttranslational modifications of the SARS-CoV-2 and the host proteins A new frontier.
33435808 2021. Immune memory: an evolutionary perspective.
33417561 2021. Detection of Phenotype-related Mutations of COVID-19 via the Whole Genomic Data.
33444511 2021. Immune response to COVID-19 infection: a double-edged sword.
33443384 2021. What Is a Cytokine Storm and Should It Matter to Me?
33412850 2021. Computational Insight Into the Mechanism of SARS-CoV-2 Membrane Fusion.
33427605 2021. A genetic element in the SARS-CoV-2 genome is shared with multiple insect species.
33506974 2021. Multiplexed analysis of circulating IgA antibodies for SARS-CoV-2 and common respiratory pathogens in COVID-19 patients.
33458832 2021. World-wide tracking of major SARS-CoV-2 genome haplotypes in sequences of June 1 to November 15, 2020 and discovery of rapid expansion of a new haplotype.
33386744 2021. The dilemma of herd immunity for COVID-19.
33404091 2021. In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humans.
33510530 2021. Kawasaki Disease like Multisystem Inflammatory Syndrome in a Toddler during SARS-CoV-2 Pandemic in Nepal.

33399535 2021. Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection.
33393462 2021. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site.
33443016 2021. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2.
33496249 2021. Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020.
33496647 2021. Long-Term Humoral Immune Response in Persons with Asymptomatic or Mild SARS-CoV-2 Infection, Vietnam.
33407005 2021. Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.
33399033 2021. Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France.
33399028 2021. The interplay between emerging human coronavirus infections and autophagy.
33422505 2021. Exposure to particulate matter upregulates ACE2 and TMPRSS2 expression in the murine lung.
33478621 2021. Updated rapid risk assessment from ECDC on the risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA - first update.
33413740 2021. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.
33400927 2021. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?
33504359 2021. Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients.
33444084 2021. Potential role of glycoprotein 340 in milder SARS-CoV-2 infection in children.
33382362 2021. Changes of peripheral lymphocyte subset in patients with SARS-CoV-2 infection during the whole course of disease.
33500774 2020. Reproducibly sampling SARS-CoV-2 genomes across time, geography, and viral diversity.
33456761 2020. SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets.
33391730 2020. 'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients.
33467912 2021. The potential association between PARP14 and SARS-CoV-2 infection (COVID-19).
33484691 2021. Reply: Dysbiosis in SARS-CoV-2 infected patients.
33387514 2020. Dysbiosis in SARS-CoV-2 infected patients.
33398248 2021. Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways.
33521382 2021. Genome-wide in silico identification and characterization of Simple Sequence Repeats in diverse completed SARS-CoV-2 genomes.
33490718 2021. Mutational analysis of SARS-CoV-2 ORF8 during six months of COVID-19 pandemic.
33521384 2020. Genetic variations among SARS-CoV-2 strains isolated in China.
33503821 2021. Epigenetic Evolution of ACE2 and IL-6 Genes: Non-Canonical Interferon-Stimulated Genes Correlate to COVID-19 Susceptibility in Vertebrates.
33396837 2020. Strong Correlation between the Case Fatality Rate of COVID-19 and the rs6598045 Single Nucleotide Polymorphism (SNP) of the Interferon-Induced Transmembrane Protein 3 (IFITM3) Gene at the Population-Level.
33521209 2020. Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies.
33395363 2021. Epigenetic mechanisms influencing COVID-19.
33512495 2021. Rapid Spread of Mutant Alleles in Worldwide SARS-CoV-2 Strains Revealed by Genome-Wide Single Nucleotide Polymorphism and Variation Analysis.
33383142 2021. Comprehensive analysis of TCR repertoire in COVID-19 using single cell sequencing.
33412761 2020. Updated confidence intervals for the COVID-19 antibody retention rate in the Korean population.
33412760 2020. Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19.
33390179 2021. Alu retrotransposons and COVID-19 susceptibility and morbidity.
33406391 2021. T Cell Memory: Understanding COVID-19.
33382973 2021. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.
33513337 2021. B cell memory: understanding COVID-19.
33428993 2021. Did we forget the diffuse chemosensory system when studying COVID-19?
33421440 2021. Immune reactivity during COVID-19: Implications for treatment.
33400966 2021. Are the emerging SARS-COV-2 mutations friend or foe?
33384516 2020. Multisystem Inflammatory Syndrome in Children: Clinical Features and Management-Intensive Care Experience from a Pediatric Public Hospital in Western India.
33384501 2020. Multisystem Inflammatory Syndrome of Children Related to SARS-CoV-2: A Novel Experience in Children with a Novel Virus.
33446986 2020. COVID-19-associated Severe Multisystem Inflammatory Syndrome in Children with Encephalopathy and Neuropathy in an Adolescent Girl with the Successful Outcome: An Unusual Presentation.
33403611 2021. COVID-19 in a Young Infant - A Fatal Multisystem Inflammatory Disorder.
33508515 2021. Association of clade-G SARS-CoV-2 viruses and age with increased mortality rates across 57 countries and India.
33513449 2021. Different SARS-CoV-2 haplotypes associate with geographic origin and case fatality rates of COVID-19 patients.
33516969 2021. Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2.
33476804 2021. Clade GR and clade GH isolates of SARS-CoV-2 in Asia show highest amount of SNPs.
33387262 2021. Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strain.
33385239 2021. Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge.
33521758 2020. From Animal to Human: Interspecies Analysis Provides a Novel Way of Ascertaining and Fighting COVID-19.
33498051 2021. Dynamic Changes of Lymphocyte Subsets in the Course of COVID-19.
33486489 2021. SARS-CoV-2-Associated T-Cell Responses in the Presence of Humoral Immunodeficiency.
33440306 2021. An overview of Betacoronaviruses-associated severe respiratory syndromes, focusing on sex-type-specific immune responses.
33401205 2021. The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients.
33385714 2021. Genome-wide analysis of Indian SARS-CoV-2 genomes to identify T-cell and B-cell epitopes from conserved regions based on immunogenicity and antigenicity.
33450373 2021. Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2.
33430309 2021. Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.
33430234 2021. Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions.
33498725 2021. A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections.
33498183 2021. Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
33396557 2020. Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus.
33396899 2020. Role of Host-Mediated Post-Translational Modifications (PTMs) in RNA Virus Pathogenesis.
33433784 2021. A Novel Protein Mapping Method for Predicting the Protein Interactions in COVID-19 Disease by Deep Learning.
33386601 2021. Two different patterns of lymphocyte alterations in critically ill COVID-19 patients.
33454715 2021. Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets.
33463113 2020. Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.
33463127 2020. COVID-19 Associated Multisystem Inflammatory Syndrome: A Systematic Review and Meta-analysis.
33437935 2021. Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections.
33421631 2021. Type 2 Asthma Inflammation and COVID-19: A Double Edged Sword.
33388272 2020. Dynamics of severe acute respiratory syndrome coronavirus 2 genome variants in the feces during convalescence.
33493496 2021. Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico.
33472093 2021. Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.
33406394 2021. Insight into the reason of prolonged viral RNA shedding in patients with COVID-19 infection.
33383088 2021. Emergence of a new SARS-CoV-2 variant in the UK.
33487533 2021. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.
33411935 2021. Early differences in cytokine production distinguish severity of COVID-19.
33502532 2021. Role of cell adhesion molecules for disease development of patients with and without COVID-19 in the emergency department.
33493287 2021. Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis.
33476387 2021. Immune profiling reveals early disease trajectories associated with COVID-19 mortality: a sub-study from the ACTT-1 trial.
33433587 2021. Nature and dimensions of the systemic hyper-inflammation and its attenuation by convalescent plasma in severe COVID-19.
33524124 2021. Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19.
33524110 2021. Increased PD-L1 expression may be associated with the cytokine storm and CD8 + T-cell exhaustion in severe COVID-19.
33519225 2021. Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms.
33432259 2021. Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species.
33429476 2021. The Importance of Early Recognition, Timely Management, and the Role of Healthcare Providers in Multisystem Inflammatory Syndrome in Children.
33506254 2021. Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis.
33513240 2021. Unusual Clinical Manifestations and Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C) in a Tertiary Care Hospital of North India.
33518372 2021. Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient.
33521734 2021. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.
33521726 2020. Immunogenomic phases of COVID-19 and appropriate clinical management.
33521749 2021. Cell-Free DNA Tissues-of-Origin by Methylation Profiling Reveals Significant Cell, Tissue and Organ-Specific injury related to COVID-19 Severity.
33521750 2020. Vaccination Is the Only Acceptable Path to Herd Immunity.
33521315 2021. CD64, CD11a and CD18 leukocytes expression in children with SARS-CoV-2 multisystem inflammatory syndrome versus children with Kawasaki disease: Similar but not the same.
33427554 2021. The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases.
33514928 2021. Addendum: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.
33423311 2021. Human SARS CoV-2 spike protein mutations.
33415739 2021. Unsupervised cluster analysis of SARS-CoV-2 genomes reflects its geographic progression and identifies distinct genetic subgroups of SARS-CoV-2 virus.
33380494 2021. Coronavirus Receptors as Immune Modulators.
33514628 2021. SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells.
33523115 2021. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
33404586 2021. Genetic Variants of SARS-CoV-2-What Do They Mean?
33393161 2021. Recent advancements in glycoproteomic studies: Glycopeptide enrichment and derivatization, characterization of glycosylation in SARS CoV2, and interacting glycoproteins.
33432184 2021. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection.
33442016 2021. Immune determinants of COVID-19 disease presentation and severity.
33402708 2021. Cold sensitivity of the SARS-CoV-2 spike ectodomain.
33494095 2021. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.
33461210 2021. Evolution of antibody immunity to SARS-CoV-2.
33479534 2021. Fast-spreading COVID variant can elude immune responses.
33473223 2021. Lessons from the host defences of bats, a unique viral reservoir.
33469239 2021. The world needs a single naming system for coronavirus variants.
33429418 2021. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.

33515497 2021. Durability of SARS-CoV-2 IgG Antibody Among Residents in a Long-Term Care Community.
33400131 2021. European context of the diversity and phylogenetic position of SARS-CoV-2 sequences from Polish COVID-19 patients.
33401171 2021. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.
33476648 2021. SARS-CoV-2 infects cells following viral entry via clathrin-mediated endocytosis.
33434581 2020. The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles.
33475020 2021. Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study.
33459964 2021. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
33394320 2021. Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France.
33387156 2021. SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.
33402024 2021. Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease.
33383190 2021. Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2.
33508323 2021. Latent periodicity-2 in coronavirus SARS-CoV-2 genome: Evolutionary implications.
33413461 2021. Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients.
33413422 2021. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
33380328 2020. Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants.
33513380 2021. Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.
33448184 2021. ADP-ribosylhydrolases: from DNA damage repair to COVID-19.
33497357 2021. Distinct antibody repertoires against endemic human coronaviruses in children and adults.
33476301 2021. Effective virus-neutralizing activities in antisera from the first wave of survivors of severe COVID-19.
33497425 2021. Isolating SARS-CoV-2 Strains From Countries in the Same Meridian: Genome Evolutionary Analysis.
33496683 2020. The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India.
33518995 2021. Threats from new variants.
33519006 2021. The coronavirus could end up mild like a common cold.
33519005 2021. The global threat of the coronavirus variants.
33519003 2021. What are the new coronavirus variants?
33521378 2021. Hypoxia-inducible factor (HIF): The link between obesity and COVID-19.
33512464 2021. How can we interpret SARS-CoV-2 antibody test results?
33469663 2021. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
33493353 2021. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: A French study and literature review.
33519278 2021. Genome composition and genetic characterization of SARS-CoV-2.
33519271 2021. Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19.
33482019 2021. An increase in CD62L(dim) neutrophils precedes the development of pulmonary embolisms in COVID-19 patients.
33523532 2021. Early humoral defence: Contributing to confining COVID-19 to conducting airways?
33521857 2021. Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19.
33443036 2020. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.
33436498 2021. Cytoplasmic short linear motifs in ACE2 and integrin beta3 link SARS-CoV-2 host cell receptors to mediators of endocytosis and autophagy.
33436497 2021. Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications.
33408181 2021. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
33436525 2021. Immunological characteristics govern the transition of COVID-19 to endemicity.
33419936 2021. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK.
33421326 2021. First genome sequencing of SARS-CoV-2 recovered from an infected cat and its owner in Latin America.
33506644 2021. Genotype-phenotype correlation identified a novel SARS-CoV-2 variant possibly linked to severe disease.
33501730 2021. A deletion in SARS-CoV-2 ORF7 identified in COVID-19 outbreak in Uruguay.
33452828 2021. Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors.
33524849 2021. Coronavirus infection induces progressive restructuring of the endoplasmic reticulum involving the formation and degradation of double membrane vesicles.
33494661 2021. COVID-19 evolution during the pandemic - Implications of new SARS-CoV-2 variants on disease control and public health policies.
33469204 2021. Rogue antibodies could be driving severe COVID-19.
33478949 2021. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8(+) T cells.
33510015 2021. Insights from SARS-CoV-2 sequences.
33446556 2021. Learning the language of viral evolution and escape.
33446540 2021. Herd immunity by infection is not an option.
33484868 2021. Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19.
33443366 2021. Severe COVID-19: Immunosuppression or Hyperinflammation?
33481684 2021. Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.
33423443 2021. [Immunological research of COVID-19 and emerging infectious diseases].
33685917 2021. The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13.
33727331 2021. Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.
33649194 2021. Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.
33637603 2021. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.

33784032 2021. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Rapid Living Review
33745765 2021. Hemophagocytic Lymphohistiocytosis in the Emergency Department: Recognizing and Evaluating a Hidden Threat.
33656515 2021. Immunodominant antibody germlines in COVID-19.
33646265 2021. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
33739364 2021. Lasting memories of SARS-CoV-2 infection.
33533916 2021. SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.
33533915 2021. Persistent cellular immunity to SARS-CoV-2 infection.
33707363 2021. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
33721886 2021. Adaptive metabolic and inflammatory responses identified using accelerated aging metrics are linked to adverse outcomes in severe SARS-CoV-2 infection.
33528568 2021. The Nexus between Telomere Length and Lymphocyte Count in Seniors hospitalized with Covid-19.
33766545 2021. SARS-CoV-2 mutational variants may represent a new challenge to society, but not to the virucidal armamentarium.
33644235 2021. Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population.
33707314 2021. Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic.
33581239 2021. Single nucleotide polymorphisms in key aging pathways, and phenotypic markers of frailty are associated with increased odds of hospital admission with COVID-19.
33548358 2021. Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK.
33545166 2021. Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study.
33766552 2021. Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan.
33531292 2021. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19.
33718952 2021. Durability of Viral Neutralization in Asymptomatic Coronavirus Disease 2019 for at Least 60 Days.
33675366 2021. The Association Between Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Post-COVID-19 Syndrome in Healthcare Workers.
33580264 2021. Uncovering Ways That Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Lineages May Increase Transmissibility.
33580259 2021. S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction.
33556959 2021. Circulating CD4 T Cells Elicited by Endemic Coronaviruses Display Vast Disparities in Abundance and Functional Potential Linked to Antigen Specificity and Age.
33693749 2021. Sex differences in the evolution of neutralizing antibodies to SARS-CoV-2.
33686421 2021. Longitudinal assessment of anti-SARS-CoV-2 immune responses for six months based on the clinical severity of COVID-19.
33649773 2021. Persistent SARS-CoV-2 RNA Shedding without Evidence of Infectiousness: A Cohort Study of Individuals with COVID-19.
33743370 2021. Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health.
33732005 2021. Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers.
33531826 2021. Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality.
33630386 2021. Remembering Metchnikoff in the time of COVID-19.
33638484 2021. New SARS-CoV-2 variant of concern imported from the United Kingdom to Vietnam, December 2020.
33620098 2021. Antibody response patterns in COVID-19 patients with different levels of disease severity in Japan.
33590900 2021. Anti-spike S1 receptor-binding domain antibodies against SARS-CoV-2 persist several months after infection regardless of disease severity.
33570181 2021. Importation of SARS-CoV-2 Variant B.1.1.7 in Pakistan.
33638460 2021. Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.
33624270 2021. A comprehensive review of SARS-CoV-2 genetic mutations and lessons from animal coronavirus recombination in one health perspective.
33623737 2020. Artificial Intelligence in COVID-19 Ultrastructure.
33744314 2021. SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca(2).
33556408 2021. The Mechanism of SARS-CoV-2 Nucleocapsid Protein Recognition by the Human 14-3-3 Proteins.
33630074 2021. Short sequence motif dynamics in the SARS-CoV-2 genome suggest a role for cytosine deamination in CpG reduction.
33740562 2021. Which species does the virus like most: Binding modes study between SARS-CoV-2 S protein and ACE2 receptor.
33588349 2021. Epitope mimicry analysis of SARS-COV-2 surface proteins and human lung proteins.
33624189 2021. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): Role of (18)F-FDG PET/CT to assess myocardial involvement.
33550983 2021. COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
33640331 2021. Intracranial Hypertension in Multisystem Inflammatory Syndrome in Children.
33713130 2021. Multisystem Inflammatory Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 in Children: A Case Series From Mayotte Island.
33626315 2021. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes.
33613009 2021. Aggregation hot spots in the SARS-CoV-2 proteome may constitute potential therapeutic targets for the suppression of the viral replication and multiplication.
33724837 2021. Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses.
33666082 2021. Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis.
33555895 2021. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
33582489 2021. Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery.
33662570 2021. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
33532723 2021. Characteristics of COVID-19 infection and antibody formation in patients known at a tertiary immunology department.
33693926 2021. SARS-CoV-2 Variant of Concern 202 012/01 (B.1.1.7) in a traveller from the UK to China.
33693754 2021. First Report of SARS-CoV-2 B.1.1.251 lineage in Brazil.
33563656 2021. The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.
33644276 2021. Two adult cases of multisystem inflammatory syndrome associated with SARS-CoV-2.
33681536 2021. What Are the Clinical Implications of the SARS-CoV-2 Variants: 5 Things Every Cardiologist Should Know.
33782672 2021. Regression of Coronary Aneurysms With Intravenous Immunoglobulins and Steroids for COVID-19 Adult Multisystem Inflammatory Syndrome.
33649746 2021. Reversible Coronary Artery Aneurysm With Delayed Anti-inflammatory Therapy in Multisystem Inflammatory Syndrome in Children.
33625463 2021. Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection.
33749770 2021. Association of Age With SARS-CoV-2 Antibody Response.
33674591 2021. Deciphering the state of immune silence in fatal COVID-19 patients.
33785765 2021. SARS-CoV-2 in severe COVID-19 induces a TGF-beta-dominated chronic immune response that does not target itself.
33782395 2021. The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA.
33771993 2021. N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection.
33767183 2021. SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition.
33753738 2021. SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19.
33741972 2021. Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection.
33723254 2021. SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication.
33712622 2021. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.
33712587 2021. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions.
33707453 2021. Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution.
33563974 2021. Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection.
33558507 2021. Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers.
33558493 2021. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.
33547281 2021. Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2.
33619281 2021. Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients.
33608522 2021. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.
33597532 2021. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery.
33597531 2021. Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children.
33589636 2021. Discrete SARS-CoV-2 antibody titers track with functional humoral stability.
33574281 2021. A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry.
33542501 2021. SARS-CoV-2 variant evades antibodies whilst maintaining fitness.
33542500 2021. Do rogue antibodies make the difference between mild versus severe COVID-19?
33726806 2021. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
33627147 2021. Distinguishing active pediatric COVID-19 pneumonia from MIS-C.
33665043 2021. Low compositions of human toll-like receptor 7/8-stimulating RNA motifs in the MERS-CoV, SARS-CoV and SARS-CoV-2 genomes imply a substantial ability to evade human innate immunity.
33614298 2021. Is there a link between pre-existing antibodies acquired due to childhood vaccinations or past infections and COVID-19? A case control study.
33721239 2021. COVID-19 and the ethnicity link - is there a photochemical link?
33687143 2021. Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19?
33625796 2021. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.
33780434 2021. Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium.
33760807 2021. SARS-CoV-2 variants reveal features critical for replication in primary human cells.
33750978 2021. A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
33730024 2021. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
33711012 2021. Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen.
33730053 2021. SARS-CoV-2 viral dynamics in non-human primates.
33534793 2021. ViralLink: An integrated workflow to investigate the effect of SARS-CoV-2 on intracellular signalling and regulatory pathways.
33793546 2021. Computational epitope map of SARS-CoV-2 spike protein.
33770098 2021. Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel.
33755704 2021. Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan.
33750984 2021. Antibody kinetics and clinical course of COVID-19 a prospective observational study.
33730017 2021. Structural analysis of viral ExoN domains reveals polyphyletic hijacking events.
33725024 2021. Variability in digestive and respiratory tract Ace2 expression is associated with the microbiome.
33662015 2021. Genomic characterization and evolution of SARS-CoV-2 of a Canadian population.
33661923 2021. Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.
33685917 2021. The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13.
33727331 2021. Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.
33649194 2021. Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.
33637603 2021. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.

33619452 2021. Rare mutations in the accessory proteins ORF6, ORF7b, and ORF10 of the SARS-CoV-2 genomes.
33662365 2021. The serum metabolome of COVID-19 patients is distinctive and predictive.
33631142 2021. Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study.
33548252 2021. COVID-19 letter to the editor: Epicardial fat inflammation as possible enhancer in COVID-19?
33750009 2021. COVID-19: emergence and mutational diversification of SARS-CoV-2.
33727169 2021. Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus.
33691172 2021. Contribution of STAT3 to the pathogenesis of COVID-19.
33609650 2021. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
33588026 2021. Variant analysis of SARS-CoV-2 genomes in the Middle East.
33548481 2021. Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients.
33664151 2021. Identification of a SARS-CoV-2 Lineage B1.1.7 Virus in New York following Return Travel from the United Kingdom.
33766902 2021. Genome Sequences of Three SARS-CoV-2 P.1 Strains Identified from Patients Returning from Brazil to Italy.
33766897 2021. Near-Complete Genome Sequence of a SARS-CoV-2 VOC 202012/01 Strain in Peru.
33737349 2021. First Report of a SARS-CoV-2 Genome Sequence with a Spike His69-Val70 Deletion and an Asn439Lys Mutation in Morocco.
33707329 2021. Coding-Complete Genome Sequences and Mutation Profiles of Nine SARS-CoV-2 Strains Detected from COVID-19 Patients in Bangladesh.
33707325 2021. Coding-Complete Genome Sequence and Phylogenetic Relatedness of a SARS-CoV-2 Strain Detected in March 2020 in Cameroon.
33632859 2021. In-Frame 12-Nucleotide Deletion within Open Reading Frame 3a in a SARS-CoV-2 Strain Isolated from a Patient Hospitalized with COVID-19.
33632858 2021. Genome Sequence of a SARS-CoV-2 Strain from Bangladesh That Is Nearly Identical to United Kingdom SARS-CoV-2 Variant B.1.1.7.
33574104 2021. Coding-Complete Genome Sequences of NITMA1086 and NITMA1139, Two SARS-CoV-2 Isolates from Belagavi District, Karnataka State, India, Harboring the D614G Mutation.
33562210 2021. Silence of the Lambs: The Immunological and Molecular Mechanisms of COVID-19 in Children in Comparison with Adults.
33652815 2021. SARS-CoV-2 Nonstructural Proteins 1 and 13 Suppress Caspase-1 and the NLRP3 Inflammasome Activation.
33671631 2021. Genomic Epidemiology of SARS-CoV-2 in Madrid, Spain, during the First Wave of the Pandemic: Fast Spread and Early Dominance by D614G Variants.
33540596 2021. Dynamics of a Dual SARS-CoV-2 Lineage Co-Infection on a Prolonged Viral Shedding COVID-19 Case: Insights into Clinical Severity and Disease Duration.
33609027 2021. Whole-genome Sequencing of SARS-CoV-2: Using Phylogeny and Structural Modeling to Contextualize Local Viral Evolution.
33709674 2021. Can natural immunity partially replace vaccine against SARS-COV2 infection? A small single center study.
33705368 2021. Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021.
33705367 2021. First Identified Cases of SARS-CoV-2 Variant P.1 in the United States - Minnesota, January 2021.
33630825 2021. First Identified Cases of SARS-CoV-2 Variant B.1.1.7 in Minnesota - December 2020-January 2021.
33630820 2021. Detection of B.1.351 SARS-CoV-2 Variant Strain - Zambia, December 2020.
33605421 2021. Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2.
33555346 2021. The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2.
33674876 2021. Identifying primate ACE2 variants that confer resistance to SARS-CoV-2.
33713597 2021. The SARS-CoV-2 subgenome landscape and its novel regulatory features.
33564990 2021. Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis.
33745077 2021. Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs.
33740184 2021. Possible role of purinergic signaling in COVID-19.
33781838 2021. Emerging importance of ACE2 in external stratified epithelial tissues.
33743061 2021. Host-dependent molecular factors mediating SARS-CoV-2 infection to gain clinical insights for developing effective targeted therapy.
33590968 2021. SARS-CoV-2 infection remodels the host protein thermal stability landscape.
33578036 2021. Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.
33686311 2021. PIMS - eine neue padiatrische Herausforderung: 9-Jahre alter Knabe mit SARS-CoV-2 assoziiertem hyperinflammatorischem Schocksyndrom.
33816662 2021. Severe Acute Respiratory Syndrome Coronavirus 2, Olfactory Mucosa, and the Entrance in the Central Nervous System: Expanding the Evidence?
33619443 2021. Supervised machine learning approach to molecular dynamics forecast of SARS-CoV-2 spike glycoproteins at varying temperatures.
33789940 2021. Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.
33692194 2021. Original Antigenic Sin: the Downside of Immunological Memory and Implications for COVID-19.
33627511 2021. Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients.
33597174 2021. Why Are Viruses Spiked?
33568452 2021. Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup.
33622851 2021. Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2.
33608656 2021. COVID-19-from mucosal immunology to IBD patients.
33526920 2021. Myeloid-derived suppressor cells in the era of incre<iframe src="http://www.kidney.de/amapp.php?a=g myeloid cell diversity.
33723416 2021. The first 12 months of COVID-19: a timeline of immunological insights.
33753932 2021. Transmissibility and transmission of respiratory viruses.
33758362 2021. Soluble ACE2 in SARS-CoV-2 infection.
33762726 2021. Neuroimmune interactions and COVID-19 in lung transplant recipients.
33762725 2021. Reply to: Neuroimmune interactions and COVID-19 in lung transplant recipients.
33547426 2021. Immune cartography of macrophage activation syndrome in the COVID-19 era.
33609131 2021. The humoral immune response to SARS-CoV-2 mounts and is durable in symptomatic haemodialysis patients.
33720379 2021. Persistence of antibody response to SARS-CoV-2 in a cohort of haemodialysis patients with COVID-19.
33680474 2021. Severe acute respiratory syndrome coronavirus 2 may exploit human transcription factors involved in retinoic acid and interferon-mediated response: a hypothesis supported by an in silico analysis.
33540664 2021. miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells.
33670580 2021. MicroRNAs and Long Non-Coding RNAs as Potential Candidates to Target Specific Motifs of SARS-CoV-2.
33545540 2021. SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link?
33569904 2021. Amino acid sensing pathway: A major check point in the pathogenesis of obesity and COVID-19.
33543899 2021. Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)-Related Morbidity.
33542096 2021. Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy.
33768966 2021. Implications of the Emerging SARS-CoV-2 Variant: Caution is the Key.
33778091 2021. Cutaneous Findings in SARS-CoV-2-Associated Multisystem Inflammatory Disease in Children.
33778090 2021. Dysregulated Host Response in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Critical Illness.
33614814 2021. SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response.
33604403 2021. Prevalence and Longevity of SARS-CoV-2 Antibodies Among Health Care Workers.
33527081 2020. Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding Profile From Different Body Sites, and Antibody Response Kinetics.
33659153 2021. Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020.
33738456 2021. The role of pseudotype neutralization assays in understanding SARS CoV-2.
33585820 2021. Mucosal immune responses in COVID19 - a living review.
33575657 2021. T cell phenotypes in COVID-19 - a living review.
33815663 2021. HIF-1, the Warburg Effect, and Macrophage/Microglia Polarization Potential Role in COVID-19 Pathogenesis.
33691013 2021. Protein sequence models for prediction and comparative analysis of the SARS-CoV-2 -human interactome.
33631039 2021. Postoperative inflammation to "hyper"-inflammation: cryptic COVID-19 connections!
33654512 2020. In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data.
33706759 2021. Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19.
33572190 2021. Molecular Epidemiology Surveillance of SARS-CoV-2: Mutations and Genetic Diversity One Year after Emerging.
33561763 2021. Fibroblast function in COVID-19.
33676105 2021. Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: Case report and review of the literature.
33817672 2021. Network-based virus-host interaction prediction with application to SARS-CoV-2.
33661546 2021. SARS-CoV-2-related multisystem inflammatory syndrome in an immunocompromised child with leukemia.
33547936 2021. Coronary Artery Dilation in an Asymptomatic Pediatric Patient with COVID19 Antibodies.
33551363 2021. Critical illness-associated brain microhemorrhages in a child with multisystem inflammatory syndrome secondary to coronavirus disease 2019.
33595703 2021. Imaging in support of the clinical diagnoses of COVID-19 and multisystem inflammatory syndrome in children.
33534852 2021. Uncovering potential host proteins and pathways that may interact with eukaryotic short linear motifs in viral proteins of MERS, SARS and SARS2 coronaviruses that infect humans.
33529260 2021. Clinical and whole genome characterization of SARS-CoV-2 in India.
33428634 2021. Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.
33780519 2021. Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19.
33760889 2021. Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry.
33635931 2021. Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication.
33635919 2021. Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
33600486 2021. Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes.
33596266 2021. SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development.
33556147 2021. Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins.
33579792 2021. The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2.
33571544 2021. Dissecting lipid metabolism alterations in SARS-CoV-2.
33584087 2021. Cardiac Manifestations, Treatment Characteristics, and Outcomes of Paediatric Inflammatory Multisystem Syndrome Temporally Associated with Severe Acute Respiratory Syndrome Coronavirus-2: systematic review of case reports and case series.
33592322 2021. Role of arachidonic cascade in COVID-19 infection: A review.
33629236 2021. A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2.
33625752 2021. Crystallographic molecular replacement using an in silico-generated search model of SARS-CoV-2 ORF8.
33594727 2021. Nonstructural protein 7 and 8 complexes of SARS-CoV-2.
33778663 2021. A Novel Large-Vessel Arteritis in SARS-CoV-2-Related Multisystem Inflammatory Syndrome in Children (MIS-C).
33778614 2020. Thoracic Imaging Findings of Multisystem Inflammatory Syndrome in Children Associated with COVID-19: What Radiologists Need to Know Now.
33785227 2021. Revision de los hallazgos clinicos y radiologicos del nuevo sindrome inflamatorio multisistemico pediatrico vinculado a la COVID-19.
33662873 2021. The age-dependent decline of the extracellular thiol-disulfide balance and its role in SARS-CoV-2 infection.
33719897 2021. Post COVID 19 multisystem inflammatory syndrome in an older adult.

33749660 2021. Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore-Washington metropolitan area.
33621211 2021. Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2.
33651717 2021. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury.
33720905 2021. A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2.
33575504 2021. Valuable Insights into the Immune Responses against Coronavirus Disease 2019.
33575497 2021. The Neutralizing Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 and the Cytokine/Chemokine Release in Patients with Different Levels of Coronavirus Diseases 2019 Severity: Cytokine Storm Still Persists Despite Viral Disappearance in Critical Patients.
33711083 2020. A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study.
33790073 2021. Assessment of Galectin-1, Galectin-3, and PGE2 Levels in Patients with COVID-19.
33642431 2021. Early anti-SARS-CoV-2 immunoglobulin G response may be associated with disease severity in patients with COVID-19.
33774082 2021. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection.
33743869 2021. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
33743854 2021. Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2.
33705696 2021. (18)F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine.
33581803 2021. SARS-CoV-2 variants and ending the COVID-19 pandemic.
33549181 2021. Understanding variants of SARS-CoV-2.
33765408 2021. Rapid identification and tracking of SARS-CoV-2 variants of concern.
33711293 2021. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study.
33675696 2021. Multisystem inflammatory syndrome in a neonate, temporally associated with prenatal exposure to SARS-CoV-2: a case report.
33581054 2021. Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people.
33571446 2021. CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants.
33723535 2021. Surveillance of SARS-CoV-2 in Zimbabwe shows dominance of variants of concern.
33778792 2021. Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study.
33655232 2021. Neutrophils as a pallbearer for SARS-CoV-2 disease burden - Authors' reply.
33655231 2021. Neutrophils as a pallbearer for SARS-CoV-2 disease burden.
33655230 2021. COVID-19 cytokine storm syndrome: a threshold concept.
33754142 2021. Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
33562321 2021. Population Genomics Insights into the First Wave of COVID-19.
33609539 2021. A double edged-sword - The Complement System during SARS-CoV-2 infection.
33727249 2021. Phylo-geo-network and haplogroup analysis of 611 novel coronavirus (SARS-CoV-2) genomes from India.
33574037 2021. SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters.
33679227 2021. Post-COVID-19 Outbreak of Severe Kawasaki-like Multisystem Inflammatory Syndrome in Children.
33680867 2021. COVID-19 Outbreak in Malaysia: Decoding D614G Mutation of SARS-CoV-2 Virus Isolated from an Asymptomatic Case in Pahang.
33715846 2021. The Yin and Yang of SARS-CoV-2 Mutation and Evolution.
33727353 2021. Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication.
33727347 2021. Mechanism of Viral Glycoprotein Targeting by Membrane-Associated RING-CH Proteins.
33589885 2021. Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.
33554155 2021. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes.
33649749 2021. Deadly COVID-19 among the elderly: Innate immune memory helping those most in need.
33681755 2021. The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant.
33657459 2021. COVID-19: A methyl-group assault?
33761694 2021. Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach.
33607766 2021. Novel signaling pathways regulate SARS-CoV and SARS-CoV-2 infectious disease.
33747404 2021. First Tunisian Cluster Admissions of Critically Ill Patients with Multisystem Inflammatory Syndrome in Children (MIS-C).
33747397 2021. Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options.
33630927 2021. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
33606828 2021. SARS-CoV-2 genetic diversity in Venezuela: Predominance of D614G variants and analysis of one outbreak.
33606823 2021. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.
33596252 2021. The analysis on the human protein domain targets and host-like interacting motifs for the MERS-CoV and SARS-CoV/CoV-2 infers the molecular mimicry of coronavirus.
33592054 2021. Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation.
33571241 2021. In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses.
33544733 2021. Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan.
33680800 2021. Cytokine profiles in severe SARS-CoV-2 infection requiring extracorporeal membrane oxygenation support.
33728718 2021. Gateway to the lungs: Viral entry receptors and susceptibility to COVID-19.
33707796 2021. A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children - literature review based on two case reports.
33759933 2021. Children's Multisystem inflammatory syndrome with myopathy.
33742229 2021. Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent.
33790049 2021. COVID-19-induced hyperinflammation, immunosuppression, recovery and survival: how causal inference may help draw robust conclusions.
33552515 2021. Reviewing immunopathology characteristics of SARS-CoV-2 for cancer entwisted with SARS-CoV-2.
33613046 2021. Durability of the humoral immune response in recovered COVID-19 patients.
33679194 2021. Molecular adaptive evolution of SARS-COV-2 spike protein in Saudi Arabia.
33674317 2021. Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution.
33658206 2021. Hallmarks of Alpha- and Betacoronavirus non-structural protein 7+8 complexes.
33579701 2021. Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile.
33547084 2021. Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression.
33536218 2021. A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood.
33585048 2021. Evolutionary analysis and lineage designation of SARS-CoV-2 genomes.
33587268 2021. Making sense of spike D614G in SARS-CoV-2 transmission.
33564978 2021. Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19.
33637768 2021. A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection.
33782449 2021. DNA methylation architecture of the ACE2 gene in nasal cells of children.
33767306 2021. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2.
33762651 2021. Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients.
33758205 2021. Emergence of novel SARS-CoV-2 variants in the Netherlands.
33737694 2021. Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients.
33737684 2021. Proteomic blood profiling in mild, severe and critical COVID-19 patients.
33727674 2021. Genomic investigation of the coronavirus disease-2019 outbreak in the Republic of Korea.
33723294 2021. SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals.
33692390 2021. Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities.
33649400 2021. Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient.
33542420 2021. Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans.
33536486 2021. Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19.
33637823 2021. Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses.
33637820 2021. Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19.
33633229 2021. Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population.
33633155 2021. Immunoinformatic based identification of cytotoxic T lymphocyte epitopes from the Indian isolate of SARS-CoV-2.
33633121 2021. Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients.
33623101 2021. Clinical correlates of anti-SARS-CoV-2 antibody profiles in Spanish COVID-19 patients from a high incidence region.
33619331 2021. Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2.
33531605 2021. Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan.
33608566 2021. Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community.
33608565 2021. Flexibility and mobility of SARS-CoV-2-related protein structures.
33602998 2021. Molecular features similarities between SARS-CoV-2, SARS, MERS and key human genes could favour the viral infections and trigger collateral effects.
33568776 2021. Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes.
33568759 2021. Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus).
33568715 2021. Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature.
33568700 2021. Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures.
33536258 2021. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.
33593674 2021. Mutaciones, variantes y cepas de SARS-CoV-2.
33686064 2021. The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity.
33677468 2021. Dynamic blood single-cell immune responses in patients with COVID-19.
33790222 2021. Longitudinal dynamics of antibody responses in recovered COVID-19 patients.
33774649 2021. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development.
33758169 2021. The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2.
33654054 2021. 'nAb' the self-reactive activity in the COVID-19 combat.
33723219 2021. Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins.
33707416 2021. SARS-CoV-2 non-structural protein 13 (nsp13) hijacks host deubiquitinase USP13 and counteracts host antiviral immune response.
33649313 2021. TMPRSS2 activity may mediate sex differences in COVID-19 severity.
33649300 2021. COVID-19: cross-immunity of viral epitopes may influence severity of infection and immune response.
33649299 2021. Mutation D614G increases SARS-CoV-2 transmission.
33649290 2021. D614G and SARS-CoV-2 replication fitness.
33637679 2021. SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies.
33786417 2021. Potential New Treatments for Kawasaki Disease, Its Variations, and Multisystem Inflammatory Syndrome.

33791293 2021. Coronavirus-Induced Host Cubic Membranes and Lipid-Related Antiviral Therapies: A Focus on Bioactive Plasmalogens.
33644077 2021. Mechanistic and Therapeutic Implications of Extracellular Vesicles as a Potential Link Between Covid-19 and Cardiovascular Disease Manifestations.
33816325 2021. Severe Acute Respiratory Syndrome Coronavirus 2 Viral RNA Load Status and Antibody Distribution Among Patients and Asymptomatic Carriers in Central China.
33791232 2021. Perspectives and Challenges in the Fight Against COVID-19: The Role of Genetic Variability.
33791231 2021. SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?
33777844 2021. Next-Generation Sequencing Reveals the Progression of COVID-19.
33732659 2021. Exogenous Coronavirus Interacts With Endogenous Retrotransposon in Human Cells.
33718270 2021. T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression.
33659220 2021. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?
33585285 2020. Unraveling the Interconnection Patterns Across Lung Microbiome, Respiratory Diseases, and COVID-19.
33815467 2021. Initial Insights Into the Genetic Epidemiology of SARS-CoV-2 Isolates From Kerala Suggest Local Spread From Limited Introductions.
33815459 2021. Genomic Variations in SARS-CoV-2 Genomes From Gujarat: Underlying Role of Variants in Disease Epidemiology.
33796130 2021. Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection.
33767730 2021. Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients.
33719350 2021. A Negative Feedback Model to Explain Regulation of SARS-CoV-2 Replication and Transcription.
33679887 2021. SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene.
33659022 2021. SARS CoV-2 Spike Protein in silico Interaction With ACE2 Receptors From Wild and Domestic Species.
33613621 2020. SARS-CoV-2 Genomes From Oklahoma, United States.
33815415 2021. Immunity to SARS-CoV-2: Lessons Learned.
33796097 2021. Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.
33790892 2021. Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China.
33777054 2021. T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19.
33777047 2021. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody.
33777028 2021. Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.
33777012 2021. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
33763088 2021. Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.
33763085 2021. Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C).
33763078 2021. The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients.
33746948 2021. Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19.
33732254 2021. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
33732251 2021. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
33717195 2021. COVID-19 Impairs Immune Response to Candida albicans.
33717193 2021. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies.
33717168 2021. Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19.
33717140 2021. Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.
33717074 2021. In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection.
33692788 2021. Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.
33692785 2021. Glycocalyx as Possible Limiting Factor in COVID-19.
33679778 2021. Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19.
33603759 2021. Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients.
33597956 2021. Cytokine Storm as a Cellular Response to dsDNA Breaks: A New Proposal.
33613518 2020. Virus Infections and Host Metabolism-Can We Manage the Interactions?
33603755 2020. Legend of the Sentinels: Development of Lung Resident Memory T Cells and Their Roles in Diseases.
33584731 2020. Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses.
33584719 2020. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.
33584709 2020. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
33584679 2020. COVID-19: Imbalanced Immune Responses and Potential Immunotherapies.
33584675 2020. Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?
33552069 2020. Delving Into the Origin of Destructive Inflammation in COVID-19: A Betrayal of Natural Host Defense Peptides?
33552062 2020. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.
33542724 2020. SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties.
33816516 2021. Detecting SARS-CoV-2 in the Breath of COVID-19 Patients.
33777970 2021. Insights on the Structural Variations of the Furin-Like Cleavage Site Found Among the December 2019-July 2020 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection.
33768104 2021. Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India.
33585509 2020. Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study.
33585507 2020. Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients.
33585502 2020. Structural Comparison of the SARS CoV 2 Spike Protein Relative to Other Human-Infecting Coronaviruses.
33807556 2021. Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level.
33809954 2021. Why Does SARS-CoV-2 Infection Induce Autoantibody Production?
33767074 2021. Association Between Treatments and Short-Term Biochemical Improvements and Clinical Outcomes in Post-Severe Acute Respiratory Syndrome Coronavirus-2 Inflammatory Syndrome.
33822809 2021. Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
33811184 2021. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes.
33804408 2021. C1q Complement/Tumor Necrosis Factor-Associated Proteins in Cardiovascular Disease and COVID-19.
33633944 2021. Multisystem inflammatory syndrome in children during the coronavirus disease 2019 (COVID-19) pandemic: a systematic review of published case studies.
33684592 2021. COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?
33582244 2021. Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies.
33727176 2021. Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India.
33548551 2021. Evolution of SARS-CoV-2: A prediction on the lineages and vaccine effectiveness.
33622601 2021. Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation.
33597826 2021. Current mutatome of SARS-CoV-2 in Turkey reveals mutations of interest.
33640145 2021. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
33744048 2021. Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers.
33572702 2021. Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review.
33661489 2021. Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months.
33560482 2021. Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study.
33582454 2021. Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2.
33774551 2021. The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein.
33774510 2021. Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution.
33711560 2021. SARS_CoV2 RBD gene transcription cannot be driven by CMV promoter.
33706207 2021. Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India.
33545556 2021. Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution.
33757410 2021. Immune dysregulation and system pathology in COVID-19.
33738124 2021. SARS-CoV-2 genomic analyses in cancer patients reveal elevated intrahost genetic diversity.
33692906 2021. Unification and extensive diversification of M/Orf3-related ion channel proteins in coronaviruses and other nidoviruses.
33753180 2021. Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay.
33737154 2021. Global and local mutations in Bangladeshi SARS-CoV-2 genomes.
33781798 2021. Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism.
33631222 2021. Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil.
33626380 2021. The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta.
33723515 2021. Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus.
33530371 2021. Viral Evasion of RIG-I-Like Receptor-Mediated Immunity through Dysregulation of Ubiquitination and ISGylation.
33557213 2021. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
33546489 2021. Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients.
33671076 2021. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.
33652634 2021. The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses.
33669141 2021. Liquid Biomolecular Condensates and Viral Lifecycles: Review and Perspectives.
33673067 2021. Titers of Neutralizing Antibodies against SARS-CoV-2 Are Independent of Symptoms of Non-Severe COVID-19 in Young Adults.
33670182 2021. VOC 202012/01 Variant Is Effectively Neutralized by Antibodies Produced by Patients Infected before Its Diffusion in Italy.
33728295 2021. Regulation of the expression of proinflammatory cytokines induced by SARS-CoV-2.
33728294 2021. Review of the risk factors for SARS-CoV-2 transmission.
33608839 2021. Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis.
33738989 2021. Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2.
33537743 2021. SARS-CoV-2 RT-PCR profile in 298 Indian COVID-19 patients: a retrospective observational study.
33724541 2021. SARS-CoV-2-specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi-System Syndrome.
33651762 2021. Distinguishing Features of Patients Evaluated for Multisystem Inflammatory Syndrome in Children.
33635161 2021. Familial hemophagocytic lymphohistiocytosis induced by SARS-CoV-2.
33591080 2021. Severe Foodborne Bacterial Infections Mimicking Multisystem Inflammatory Syndrome in Children Associated With COVID-19.
33565816 2021. Abnormal Nailfold Capillaroscopy in a Patient With Multisystem Inflammatory Syndrome in Children.
33710982 2021. Mistaken MIS-C: A Case Series of Bacterial Enteritis Mimicking MIS-C.
33813796 2021. Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors.
33786919 2021. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V.
33811468 2021. Resourcing, annotating, and analysing synthetic peptides of SARS-CoV-2 for immunopeptidomics and other immunological studies.

33582906 2021. Differences in Immune Responses between Children and Adults with COVID-19.
33582904 2021. Characteristics of Viral Shedding in Respiratory Samples and Specific Antibodies Production in 564 COVID-19 Patients.
33582903 2021. Infection-associated Hemophagocytic Syndrome in Critically Ill Patients with COVID-19.
33688459 2021. Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients.
33608189 2021. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors.
33573850 2021. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved.
33563543 2021. Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity.
33547747 2021. Monocyte CD169 expression in COVID-19 patients upon intensive care unit admission.
33621488 2021. Autophagosome maturation stymied by SARS-CoV-2.
33595856 2021. Genetic variation analyses indicate conserved SARS-CoV-2-host interaction and varied genetic adaptation in immune response factors in modern human evolution.
33668325 2021. Involvement of Oxidative Stress and the Innate Immune System in SARS-CoV-2 Infection.
33689070 2021. Novel Negative Sense Genes in the RNA Genome of Coronaviruses.
33706390 2021. Erste Falle des Multisystem Inflammatory Syndrome nach SARS-CoV-2-Infektion bei jungen Erwachsenen in Deutschland.
33765855 2021. Post-COVID-19 Kawasaki-Like Syndrome.
33530741 2021. Local Nasal Response Against COVID-19: Debate Regarding the Absence of Nasal Inflammatory Symptoms.
33571742 2021. COVID-19 and developmental origins of health and disease.
33691247 2021. Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution.
33662833 2021. Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARSCoV-2 infection.
33530000 2021. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses.
33754139 2021. COVID-19 and the new variant strain in England - What are the implications for those from ethnic minority groups?
33589882 2021. Antibody titers against SARS-CoV-2 decline, but do not disappear for several months.
33533060 2021. Isoelectric point determination by imaged CIEF of commercially available SARS-CoV-2 proteins and the hACE2 receptor.
33752797 2021. Rare variants increase the risk of severe COVID-19.
33650490 2021. Genomic epidemiology of COVID-19 in care homes in the east of England.
33724185 2021. Seroconversion stages COVID19 into distinct pathophysiological states.
33554856 2021. SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.
33570490 2021. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
33544398 2021. Epithelial response to IFN-gamma promotes SARS-CoV-2 infection.
33769253 2021. Detecting Rapid Spread of SARS-CoV-2 Variants, France, January 26-February 16, 2021.
33760727 2021. Risk for International Importations of Variant SARS-CoV-2 Originating in the United Kingdom.
33760725 2021. Multisystem Inflammatory Syndrome in Children, Chile, May-August 2020.
33647228 2021. Novel Mutation of SARS-CoV-2, Vietnam, July 2020.
33784237 2021. Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada.
33734962 2021. Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK.
33600302 2021. Difficulties in Differentiating Coronaviruses from Subcellular Structures in Human Tissues by Electron Microscopy.
33567247 2021. Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan.
33567246 2021. Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy.
33539720 2021. Surveillance of COVID-19-Associated Multisystem Inflammatory Syndrome in Children, South Korea.
33739917 2021. Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy.
33734013 2021. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.
33525998 2021. Isolation of SARS-CoV-2 strains carrying a nucleotide mutation, leading to a stop codon in the ORF 6 protein.
33554871 2021. The Impact of COVID-19 Viral Infection on the Hypothalamic-Pituitary-Adrenal Axis.
33685741 2021. First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant.
33566596 2021. Optical Tracking of the Interfacial Dynamics of Single SARS-CoV-2 Pseudoviruses.
33685230 2021. An immune epigenetic insight to COVID-19 infection.
33663644 2021. Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.
33795929 2021. The Functional Classification of ORF8 in SARS-CoV-2 Replication, Immune Evasion, and Viral Pathogenesis Inferred through Phylogenetic Profiling.
33738101 2021. Let fever do its job: The meaning of fever in the pandemic era.
33732461 2021. Between a hygiene rock and a hygienic hard place: Avoiding SARS-CoV-2 while needing environmental exposures for immunity.
33564281 2021. Unraveled roles of hyaluronan in severe COVID-19.
33790994 2021. Severe acute respiratory syndrome coronavirus 2 ORF3a induces the expression of ACE2 in oral and pulmonary epithelial cells and the food supplement Vita Deyun((R)) diminishes this effect.
33718934 2021. Membrane remodeling by SARS-CoV-2 - double-enveloped viral replication.
33815307 2021. Genomic Feature Analysis of Betacoronavirus Provides Insights Into SARS and COVID-19 Pandemics.
33746914 2021. Global Geographic and Temporal Analysis of SARS-CoV-2 Haplotypes Normalized by COVID-19 Cases During the Pandemic.
33643275 2021. Low Levels of Natural Anti-alpha-N-Acetylgalactosamine (Tn) Antibodies Are Associated With COVID-19.
33679622 2020. Evolutionary Dynamics and Dissemination Pattern of the SARS-CoV-2 Lineage B.1.1.33 During the Early Pandemic Phase in Brazil.
33816549 2021. Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression.
33693030 2021. Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection.
33585567 2020. SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells.
33585558 2020. Characteristics of COVID-19 Patients Based on the Results of Nucleic Acid and Specific Antibodies and the Clinical Relevance of Antibody Levels.
33585554 2020. SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.
33537341 2020. Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line.
33551947 2020. The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains.
33816399 2021. Kawasaki Disease Shock Syndrome in Japan and Comparison With Multisystem Inflammatory Syndrome in Children in European countries.
33816398 2021. Characteristics of Children With Kawasaki Disease-Like Signs in COVID-19 Pandemic: A Systematic Review.
33537269 2020. Prevalence and Clinical Characteristics of SARS-CoV-2 Confirmed and Negative Kawasaki Disease Patients During the Pandemic in Spain.
33537261 2020. Cross-Immunization Against Respiratory Coronaviruses May Protect Children From SARS-CoV2: More Than a Simple Hypothesis?
33716737 2021. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19.
33633566 2020. Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches.
33613280 2020. Chemokine Regulation During Epidemic Coronavirus Infection.
33584267 2020. Nasal Delivery of Hesperidin/Chitosan Nanoparticles Suppresses Cytokine Storm Syndrome in a Mouse Model of Acute Lung Injury.
33755725 2021. Longitudinal Analysis of Human Memory T-Cell Response according to the Severity of Illness up to 8 Months after SARS-CoV-2 Infection.
33754149 2021. Human rhinovirus infection blocks SARS-CoV-2 replication within the respiratory epithelium: implications for COVID-19 epidemiology.
33822106 2021. Inflammatory profiles and clinical features of COVID-19 survivors three months after discharge in Wuhan, China.
33822097 2021. Differential T cell reactivity to endemic coronaviruses and SARS-CoV-2 in community and health care workers.
33822045 2021. IgG immune complexes may contribute to neutrophil activation in the course of severe COVID-19.
33813307 2021. A SARS-CoV-2 -human metalloproteome interaction map.
33725751 2021. Circular RNA-MicroRNA-MRNA interaction predictions in SARS-CoV-2 infection.
33721918 2021. Novel perspectives for SARS-CoV-2 genome browsing.
33726544 2021. COVID-19 hospitalization rates rise exponentially with age, inversely proportional to thymic T-cell production.
33593209 2021. Infection, inflammation and intervention: mechanistic modelling of epithelial cells in COVID-19.
33794925 2021. Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.
33763697 2021. Epidemiological, clinical and genomic snapshot of the first 100 B.1.1.7 SARS-CoV-2 cases in Madrid.
33787904 2021. Multisystem Inflammatory Syndrome in a Child with Scrub Typhus and Macrophage Activation Syndrome.
33608407 2021. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
33822073 2021. COVID-19 Pandemic Sets New Clues on the Transmission Pathways in Kawasaki Disease.
33822065 2021. Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan.
33822777 2021. Natural mucosal barriers and COVID-19 in children.
33812491 2021. Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
33799853 2021. Role of Mitochondria in Viral Infections.
33821250 2021. Alterations in T and B cell function persist in convalescent COVID-19 patients.
33558375 2021. T Cell Phenotyping in Individuals Hospitalized with COVID-19.
33535236 2021. Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
33759207 2021. Monoclonal antibodies capable of binding SARS-CoV-2 spike protein receptor-binding motif specifically prevent GM-CSF induction.
33617048 2021. B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19.
33617030 2021. Flow cytometric evaluation of the neutrophil compartment in COVID-19 at hospital presentation: A normal response to an abnormal situation.
33725410 2021. Similarities and perspectives on the two C's-Cancer and COVID-19.
33789998 2021. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.
33627397 2021. Potential differences in cleavage of the S protein and type-1 interferon together control human coronavirus infection, propagation, and neuropathology within the central nervous system.
33625505 2021. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
33595644 2021. SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.
33571363 2021. SARS-CoV-2 Viral Variants-Tackling a Moving Target.
33571356 2021. Emergence of a Novel SARS-CoV-2 Variant in Southern California.
33630068 2021. Otolaryngologic Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With COVID-19.
33821923 2021. Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic.
33753011 2021. Extracellular vesicles: Their emerging roles in the pathogenesis of respiratory diseases.
33689249 2021. Covid-19 et memoire immunologique : des donnees suggerent une protection durable et efficace.
33538145 2021. Covid 19 : caracteristiques et duree des reponses anticorps et leurs liens a la gravite de la maladie.
33724631 2021. Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.
33724604 2021. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.
33793006 2021. Features of HLA class I expression and its clinical relevance in SARS-CoV-2: What do we know so far?
33530819 2021. Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points.

33712145 2021. Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus.
33705542 2021. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.
33817452 2021. Echocardiographic clues in diagnosis of Takayasu arteritis in a child with SARS-CoV-2 related Multisystem Inflammatory Syndrome.
33532103 2021. COVID-19-Related Giant Coronary Aneurysms in an Infant with Multisystem Inflammatory Disorder in Children: The First Case Report from the United Arab Emirates and the Arab Region.
33815857 2021. A 6-Year-Old Boy with COVID-19-Positive Pleural Effusion and Kawasaki-Like Features.
33621484 2021. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.
33571429 2021. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
33794143 2021. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
33743211 2021. Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions.
33735608 2021. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.
33730597 2021. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.
33713620 2021. Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system.
33743212 2021. COVID-19 and the human innate immune system.
33713619 2021. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.
33657410 2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
33636127 2021. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.
33631096 2021. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.
33664221 2021. Actively or passively deacidified lysosomes push beta-coronavirus egress.
33712574 2021. Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis.
33649297 2021. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes.
33758165 2021. SARS-CoV-2 cell tropism and multiorgan infection.
33705702 2021. The great escape? SARS-CoV-2 variants evading neutralizing responses.
33548198 2021. Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response.
33789086 2021. The variant gambit: COVID-19's next move.
33742186 2021. Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm.
33637960 2021. Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients.
33637958 2021. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
33580167 2021. Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques.
33715015 2021. High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients.
33789116 2021. Cell-type-specific immune dysregulation in severely ill COVID-19 patients.
33735881 2021. SARS-CoV-2 Lineages and Sub-Lineages Circulating Worldwide: A Dynamic Overview.
33609517 2021. Immunological Subpopulations Within Critically Ill COVID-19 Patients.
33405941 2021. Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells.
33649742 2021. Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children Using Strain Analysis.
33720347 2021. Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results.
33639119 2021. Lipid metabolism changes in patients with severe COVID-19.
33741357 2021. Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.
33534923 2021. Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.
33677852 2021. Is multisystem inflammatory syndrome related with coronavirus disease 2019, Kawasaki disease, and angiotensin-converting enzyme 2 in children?
33565127 2021. Role of the SphK-S1P-S1PRs pathway in invasion of the nervous system by SARS-CoV-2 infection.
33774179 2021. Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19.
33662591 2021. Can we define CD3(+)CD56(+) cells as NKT cells with impunity?
33639276 2021. The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection.
33610741 2021. Coronavirus-induced autoimmunity.
33601017 2021. Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort.
33693643 2021. Estimated half-life of SARS-CoV-2 anti-spike antibodies more than double the half-life of anti-nucleocapsid antibodies in healthcare workers.
33675655 2021. Emergence of a Severe Acute Respiratory Syndrome Coronavirus 2 virus variant with novel genomic architecture in Hong Kong.
33730754 2021. Antibody Dynamics, Seroreversion, and Persistence After SARS-CoV-2: Another Answer.
33624751 2021. Persistence of antibodies to SARS-CoV-2 in relation to symptoms in a nationwide prospective study.
33596592 2021. Plasma metabolomic profiling of patients recovered from COVID-19 with pulmonary sequelae 3 months after discharge.
33794345 2021. Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations.
33631334 2021. Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19.
33716189 2021. Acute liver and cardiac failure in multisystem inflammatory syndrome in adults after COVID-19.
33576926 2021. Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean.
33747512 2021. Adaptive immunity to human coronaviruses is widespread but low in magnitude.
33747511 2021. Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand.
33747508 2021. RGD-binding integrins and TGF-beta in SARS-CoV-2 infections - novel targets to treat COVID-19 patients?
33728049 2021. Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity - a cohort study.
33628442 2021. Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant.
33614032 2021. High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responses.
33552508 2021. Pattern of circulating SARS-CoV-2-specific antibody-secreting and memory B-cell generation in patients with acute COVID-19.
33784011 2021. Distinct kinetics of immunoglobulin isotypes reveal early diagnosis and disease severity of COVID-19: A 6-month follow-up.
33634992 2021. SARS-CoV-2-related IFITM3 in immune dysfunction and tumor microenvironment: An integrative analysis in pan-cancers.
33667185 2021. What's important to know about the new COVID-19 variants?
33593727 2021. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?
33674719 2021. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection.
33589648 2021. Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants.
33580175 2021. Immunoreactive peptide maps of SARS-CoV-2.
33647832 2021. UMAP-assisted K-means clustering of large-scale SARS-CoV-2 mutation datasets.
33815686 2021. Neuropilins: C-end rule peptides and their association with nociception and COVID-19.
33777333 2021. Specific epitopes form extensive hydrogen-bonding networks to ensure efficient antibody binding of SARS-CoV-2: Implications for advanced antibody design.
33758649 2021. Structural determinants driving the binding process between PDZ domain of wild type human PALS1 protein and SLiM sequences of SARS-CoV E proteins.
33623641 2021. Ultra-large-scale ab initio quantum chemical computation of bio-molecular systems: The case of spike protein of SARS-CoV-2 virus.
33558827 2021. Chemokines and chemokine receptors during COVID-19 infection.
33761985 2021. Lung compartmentalization of inflammatory biomarkers in COVID-19-related ARDS.
33557911 2021. Carboxypeptidase B blocks ex vivo activation of the anaphylatoxin-neutrophil extracellular trap axis in neutrophils from COVID-19 patients.
33557908 2021. SARS-CoV-2 pneumonia-receptor binding and lung immunopathology: a narrative review.
33786445 2021. Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients.
33728228 2021. Stay-At-Home Orders Are Associated With Emergence of Novel SARS-CoV-2 Variants.
33552760 2021. Do COVID-19 Antibodies Provide Long-Term Protection?
33659125 2021. Severe SARS-CoV-2 Infection: A Multisystem Inflammatory Syndrome in Moroccan Children.
33744623 2021. Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays.
33818474 2021. Phylogenetic classification of the whole-genome sequences of SARS-CoV-2 from India & evolutionary trends.
33819603 2021. Comment to the manuscript by William P. Hausdorff and Jorge Flores: Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19, IJID 103 (2021) 37-41.
33800954 2021. Interactions of SARS-CoV-2 with the Blood-Brain Barrier.
33807854 2021. Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries.
33807682 2021. CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands.
33806254 2021. Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection.
33804769 2021. Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-beta in Triggering Inflammatory Signals in Cells of Distant Organ.
33803997 2021. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis.
33783202 2021. 3D Heteronuclear Magnetization Transfers for the Establishment of Secondary Structures in SARS-CoV-2-Derived RNAs.
33794092 2021. Protein Footprinting, Conformational Dynamics, and Core Interface-Adjacent Neutralization "Hotspots" in the SARS-CoV-2 Spike Protein Receptor Binding Domain/Human ACE2 Interaction.
33822964 2021. Longitudinal Assessment of SARS-CoV-2 Anti-Nucleocapsid and anti-Spike-1-RBD Antibody Testing Following PCR-Detected SARS-CoV-2 Infection.
33822063 2021. Serology testing demonstrates that antibodies to SARS-CoV-2 S1-RBD correlate with neutralization of virus infection of Vero E6 cells.
33774672 2021. SARS-CoV-2 spike protein binding selectively accelerates substrate-specific catalytic activity of ACE2.
33797336 2021. In silico characterization of mutations circulating in SARS-CoV-2 structural proteins.
33689337 2021. Structure, Dynamics, Receptor Binding, and Antibody Binding of the Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein in a Viral Membrane.
33602698 2021. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
33797663 2021. Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics.
33820739 2021. Genomic surveillance of Nevada patients revealed prevalence of unique SARS-CoV-2 variants bearing mutations in the RdRp gene.
33560990 2021. In silico prediction of new mutations that can improve the binding abilities between 2019-nCoV coronavirus and human ACE2.
33533266 2021. Age-associated Ligand-receptor Interactions Imputed from Nasopharyngeal Transcriptomes of COVID-19 Patients.
33742451 2021. Emerging roles of extracellular vesicles in COVID-19, a double-edged sword?
33550678 2021. Comparison of baseline laboratory findings of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis and multisystem inflammatory syndrome in children.
33657316 2021. Heterogeneity of Glycan Processing on Trimeric SARS-CoV-2 Spike Protein Revealed by Charge Detection Mass Spectrometry.
33543668 2021. Chronobiology in response to COVID-19.
33755190 2021. Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data.
33751699 2021. Variable routes to genomic and host adaptation among coronaviruses.
33587028 2021. A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India.
33782089 2021. Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.
33689357 2021. Theoretical Analysis Reveals the Cost and Benefit of Proofreading in Coronavirus Genome Replication.
33709461 2021. The envelope protein of SARS-CoV-2 increases intra-Golgi pH and forms a cation channel that is regulated by pH.

33582450 2021. Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity.
33786172 2021. Low type I interferon response in COVID-19 patients: Interferon response may be a potential treatment for COVID-19.
33542929 2021. Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients.
33770349 2021. (1)H, (13)C, and (15)N backbone chemical-shift assignments of SARS-CoV-2 non-structural protein 1 (leader protein).
33755914 2021. Backbone chemical shift spectral assignments of SARS coronavirus-2 non-structural protein nsp9.
33730325 2021. (1)H, (13)C and (15)N Backbone chemical shift assignments of the n-terminal and central intrinsically disordered domains of SARS-CoV-2 nucleoprotein.
33730680 2021. A theoretical study on the effects of interdomain flexibility on drug encounter rate for coronavirus nucleocapsid-type proteins.
33705760 2021. Exploring dynamics and network analysis of spike glycoprotein of SARS-COV-2.
33675757 2021. Binding mode of SARS-CoV-2 fusion peptide to human cellular membrane.
33794152 2021. Multivalent binding of the partially disordered SARS-CoV-2 nucleocapsid phosphoprotein dimer to RNA.
33794150 2021. SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential.
33631204 2021. Ca(2+)-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide.
33609494 2021. A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors.
33607086 2021. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.
33581060 2021. Graph, pseudoknot, and SARS-CoV-2 genomic RNA: A biophysical synthesis.
33577762 2021. New and notable: A multiscale coarse-grained model of the SARS-CoV-2 virion.
33577761 2021. Bow to the enemy: How flexibility of host protein receptors can favor SARS-CoV-2.
33558859 2021. Genetic diversity and genomic epidemiology of SARS-CoV-2 in Morocco.
33635316 2021. Lipidomic alteration of plasma in cured COVID-19 patients using ultra high-performance liquid chromatography with high-resolution mass spectrometry.
33625490 2021. The SARS-CoV-2 induced targeted amino acid profiling in patients at hospitalized and convalescent stage.
33613787 2021. On the Verge of Life: Distribution of Nucleotide Sequences in Viral RNAs.
33612988 2021. Den molekularen Wirtszellveranderungen durch SARS-CoV-2 auf der Spur.
33656534 2021. The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A.
33602138 2021. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets.
33596826 2021. The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19.
33557779 2021. Differences of blood cells, lymphocyte subsets and cytokines in COVID-19 patients with different clinical stages: a network meta-analysis.
33757449 2021. Human cell-dependent, directional, time-dependent changes in the mono- and oligonucleotide compositions of SARS-CoV-2 genomes.
33618668 2021. Identification and functional analysis of the SARS-COV-2 nucleocapsid protein.
33627333 2021. Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells.
33768168 2021. Early recognition of PIMS-TS: a single centre retrospective review.
33714258 2021. Insight into the emerging role of SARS-CoV-2 nonstructural and accessory proteins in modulation of multiple mechanisms of host innate defense.
33577445 2021. Phylogenetic pattern of SARS-CoV-2 from COVID-19 patients from Bosnia and Herzegovina: lessons learned to optimize future molecular and epidemiological approaches.
33598939 2021. Unusual morphological abnormality of neutrophils in a patient with SARS-CoV-2 infection.
33817671 2021. Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer's disease.
33729297 2021. Potential link between SARS-CoV-2 and Kawasaki disease: importance of dentists for the diagnosis.
33757279 2021. Identification and characterization of circRNAs encoded by MERS-CoV, SARS-CoV-1 and SARS-CoV-2.
33725111 2021. Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.
33675361 2021. The miRNA: a small but powerful RNA for COVID-19.
33634309 2021. A model for pH coupling of the SARS-CoV-2 spike protein open/closed equilibrium.
33620066 2021. Lysosome activation in peripheral blood mononuclear cells and prognostic significance of circulating LC3B in COVID-19.
33611368 2021. Comparison of the binding characteristics of SARS-CoV and SARS-CoV-2 RBDs to ACE2 at different temperatures by MD simulations.
33611340 2021. Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients.
33587745 2021. Roles of host small RNAs in the evolution and host tropism of coronaviruses.
33580783 2021. Functional alterations caused by mutations reflect evolutionary trends of SARS-CoV-2.
33569598 2021. Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment.
33539530 2021. Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases.
33822878 2021. Choice of assemblers has a critical impact on de novo assembly of SARS-CoV-2 genome and characterizing variants.
33753947 2021. COVID-19 chez l'enfant : syndrome inflammatoire multi-systemique lie a SARS-CoV-2 mimant un syndrome de Kawasaki.
33476581 2021. Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients.
33636047 2021. An integrated genetic-epigenetic analysis shed light on the mechanisms linking coronavirus disease 2019 (COVID-19) and cancer.
33809063 2021. Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients.
33761319 2021. Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients.
33713594 2021. The effect of spike mutations on SARS-CoV-2 neutralization.
33596407 2021. Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2.
33730580 2021. Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies.
33691089 2021. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.
33567255 2021. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
33794145 2021. Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class.
33649748 2021. Total predicted MHC-I epitope load is inversely associated with population mortality from SARS-CoV-2.
33564749 2021. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.
33748788 2021. Long-term persistence of RBD(+) memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection.
33742149 2021. SARS-CoV-2 spike protein interacts with and activates TLR41.
33737693 2021. Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2.
33557205 2021. A Transcription Regulatory Sequence in the 5' Untranslated Region of SARS-CoV-2 Is Vital for Virus Replication with an Altered Evolutionary Pattern against Human Inhibitory MicroRNAs.
33652973 2021. Assembly and Cellular Exit of Coronaviruses: Hijacking an Unconventional Secretory Pathway from the Pre-Golgi Intermediate Compartment via the Golgi Ribbon to the Extracellular Space.
33540583 2021. Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression.
33784827 2021. SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2.
33772260 2021. Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands.
33819577 2021. Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients.
33772259 2021. Phylogenetic analyses of SARS-CoV-2 B.1.1.7 lineage suggest a single origin followed by multiple exportation events versus convergent evolution.
33813122 2021. SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.
33813138 2021. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.
33821784 2021. Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan.
33755980 2021. Gene expression analysis identifies genes associated with SARS-COV-2 receptors, ACE2 and TMPRSS2, in normal human lung tissues.
33769912 2021. Analysis of the SARS-CoV-2-host protein interaction network reveals new biology and drug candidates: focus on the spike surface glycoprotein and RNA polymerase.
33779460 2021. SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics.
33809949 2021. A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection.
33789966 2021. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19.
33798758 2021. Molecular epidemiology analysis of early variants of SARS-CoV-2 reveals the potential impact of mutations P504L and Y541C (NSP13) in the clinical COVID-19 outcomes.
33545393 2021. Probing SARS-CoV-2 sequence diversity of Pakistani isolates.
33812037 2021. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
33805139 2021. Diagnostic Value of IgM and IgG Detection in COVID-19 Diagnosis by the Mobile Laboratory B-LiFE: A Massive Testing Strategy in the Piedmont Region.
33750071 2021. Cytokine Release Syndrome Biology and Management.
33683950 2021. Letter by Loomba et al Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".
33683948 2021. Letter by Navarro Castellanos and Dahdah Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".
33683946 2021. Letter by Cardenas Suri and Jimomila Bening Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".
33683944 2021. Letter by Ren et al Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".
33554562 2021. Laboratory findings in a child with SARS-CoV-2 (COVID-19) multisystem inflammatory syndrome.
33675194 2021. Protease-antiprotease imbalance in patients with severe COVID-19.
33578505 2021. Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination.
33641271 2021. Prospective serological evaluation of anti SARS-CoV-2 IgG and anti S1-RBD antibodies in a community outbreak.
33554588 2021. Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients.
33554502 2020. Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study.
33554554 2020. Cytokine "storm", cytokine "breeze", or both in COVID-19?
33682482 2021. Cytokine Storm Unmasks Immunodeficiency in a Child With Severe COVID-19.
33533405 2021. ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders.
33762895 2020. Revealing the mechanism of SARS-CoV-2 spike protein binding with ACE2.
33769770 2021. Potential Endotype Transition for Coronavirus Disease 2019-Related Sepsis With Longitudinal Transcriptome Profiling.
33530913 2021. Cluster analysis of coronavirus sequences using computational sequence descriptors: With applications to SARS, MERS and SARS-CoV-2 (CoVID-19).
33645482 2021. Predicted SARS-CoV-2 miRNAs associated with epigenetic viral pathogenesis and the detection of new possible drugs for Covid-19.
33687893 2021. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability utilizing Natural Agents.
33820514 2021. The Main Receptors Involved with COVID-19: a Systematic Review and Meta-analysis.
33749559 2021. RNA sensors as a mechanism of innate immune evasion among SARS-CoV2, HIV and Nipah viruses.
33687087 2021. Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio-renal damage in COVID-19 infection.
33788271 2021. Antigen-dependent multistep differentiation of T follicular helper cells and its role in SARS-CoV-2 infection and vaccination.
33788264 2021. Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients.
33784417 2021. Upregulation of CCR4 in activated CD8(+) T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection.
33768543 2021. Enrichment of CCR6(+) CD8(+) T cells and CCL20 in the lungs of mechanically ventilated patients with COVID-19.
33749902 2021. Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages.
33756061 2021. Non-optimal codon usage preferences of coronaviruses determine their promiscuity for infecting multiple hosts.
33705595 2021. New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2.
33728680 2021. Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations.

33552834 2021. Structural analysis of COVID-19 spike protein in recognizing the ACE2 receptor of different mammalian species and its susceptibility to viral infection.
33547873 2021. Rapid Implementation of a Multidisciplinary COVID-19 Cytokine Storm Syndrome Task Force.
33733740 2021. Computational Mutagenesis at the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Binding Interface: Comparison with Experimental Evidence.
33778306 2021. Proteomics Analysis of Serum from COVID-19 Patients.
33748632 2021. Neutrophil Elastase and Proteinase 3 Cleavage Sites Are Adjacent to the Polybasic Sequence within the Proteolytic Sensitive Activation Loop of the SARS-CoV-2 Spike Protein.
33748571 2021. SARS-CoV-2 Genome from the Khyber Pakhtunkhwa Province of Pakistan.
33615190 2021. SARS-CoV-2, Hypoxia, and Calcium Signaling: The Consequences and Therapeutic Options.
33615177 2021. Innate Immunity Plays a Key Role in Controlling Viral Load in COVID-19: Mechanistic Insights from a Whole-Body Infection Dynamics Model.
33525242 2020. COVID-19 and NF-kB: The Hepcidin paradox and the Iron Storm - Reply.
33525240 2020. Hepcidin is a friend rather than a foe in COVID19-induced complications.
33525252 2020. The role of angiotensin-converting enzyme 2 in COVID-19 induced lung injury.
33610693 2021. Adaptive immune responses to SARS-CoV-2.
33795524 2021. Aging and monocyte immunometabolism in COVID-19.
33780352 2021. Differentially expressed immune response genes in COVID-19 patients based on disease severity.
33744846 2021. TMBIM6, a potential virus target protein identified by integrated multiomics data analysis in SARS-CoV-2-infected host cells.
33714947 2021. Age cohorts stratified according to age-distributions of COVID-19 morbidity statistics identify uniquely age-dependent CD3(+)CD8(+) T-cell lymphocytopenia in COVID-19 patients without comorbidities on admission.
33647885 2021. The networks of m(6)A-SARS-CoV-2 related genes and immune infiltration patterns in idiopathic pulmonary fibrosis.
33640878 2021. Elevated frequencies of CD14(+)HLA-DR(lo/neg) MDSCs in COVID-19 patients.
33532126 2021. Prediction of SARS-CoV Interaction with Host Proteins during Lung Aging Reveals a Potential Role for TRIB3 in COVID-19.
33532121 2021. Coronavirus Disease (COVID-19): A Perspective from Immunosenescence.
33815889 2021. An Account of Immune Senescence in the Clinical Pathophysiology of COVID-19 Infection in Aging.
33722434 2021. COVID-19 disease and the hyper-inflammatory response: Are we accusing the wrong suspect?
33600784 2021. DNA and RNA Oxidative Damage and Mortality of Patients With COVID-19.
33781387 2021. Fever: Could A Cardinal Sign of COVID-19 Infection Reduce Mortality?
33741335 2021. Sequence Analysis of 20,453 Severe Acute Respiratory Syndrome Coronavirus 2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern.
33689516 2021. Molecular mechanisms of Na,K-ATPase dysregulation driving alveolar epithelial barrier failure in severe COVID-19.
33645217 2021. Detection of SARS-CoV-2 DNA Targets Using Femtoliter Optofluidic Waveguides.
33648648 2021. The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes.
33532706 2020. Sensitivity of SARS-CoV-2 to different temperatures.
33721518 2021. What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1).
33721517 2021. Antibody Response After SARS-CoV-2 Infection and Implications for Immunity : A Rapid Living Review.
33721515 2021. Summary for Patients: What is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1).
33781803 2021. Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection.
33727312 2021. Post-COVID-19 paediatric inflammatory multisystem syndrome: association of ethnicity, key worker and socioeconomic status with risk and severity.
33677719 2021. The Potential of Developing Pan-Coronaviral Antibodies to Spike Peptides in Convalescent COVID-19 Patients.
33526352 2021. Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01.
33778918 2021. Research progress on coronavirus S proteins and their receptors.
33761008 2021. Diverse SARS-CoV-2 variants preceded the initial COVID-19 outbreak in Croatia.
33610750 2021. Molecular mimicry between SARS-CoV-2 and human proteins.
33550350 2020. [Homologous modeling and binding ability analysis of Spike protein after point mutation of severe acute respiratory syndrome coronavirus 2 to receptor proteins and potential antiviral drugs].
33614383 2021. Imaging of SARS-CoV-2 infected Vero E6 cells by helium ion microscopy.
33564691 2021. Mutational hotspots and conserved domains of SARS-CoV-2 genome in African population.
33527091 2021. Variations in Orf3a protein of SARS-CoV-2 alter its structure and function.
33813274 2021. Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation.
33789211 2021. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration.
33578295 2021. Age-dependent effects of the recombinant spike protein/SARS-CoV-2 on the M-CSF- and IL-34-differentiated macrophages in vitro.
33545635 2021. RNA sequence and ligand binding alter conformational profile of SARS-CoV-2 stem loop II motif.
33685621 2021. Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.
33602511 2021. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
33581843 2021. Pathogenesis of COVID-19 and the quality control of nucleic acid detection.
33676232 2021. SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.
33569952 2021. Enhanced Cholesterol-Dependent Hemifusion by Internal Fusion Peptide 1 of SARS Coronavirus-2 Compared to Its N-Terminal Counterpart.
33705292 2020. COVID-19 and Oxidative Stress.
33621516 2021. Transport mechanisms of SARS-CoV-E viroporin in calcium solutions: Lipid-dependent Anomalous Mole Fraction Effect and regulation of pore conductance.
33771486 2021. The SARS-CoV-2 envelope (E) protein has evolved towards membrane topology robustness.
33639198 2021. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators.
33743803 2021. Indels in SARS-CoV-2 occur at template-switching hotspots.
33786001 2021. Metagenomics Approaches to Investigate the Gut Microbiome of COVID-19 Patients.
33560365 2021. Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviour.
33618659 2021. Effects of Cell Proteostasis Network on the Survival of SARS-CoV-2.
33808658 2021. Exaptation of Retroviral Syncytin for Development of Syncytialized Placenta, Its Limited Homology to the SARS-CoV-2 Spike Protein and Arguments against Disturbing Narrative in the Context of COVID-19 Vaccination.
33572760 2021. Mucociliary Respiratory Epithelium Integrity in Molecular Defense and Susceptibility to Pulmonary Viral Infections.
33771243 2020. Predictive Analysis of Susceptibility of Different Species to SARS-CoV-2 based on ACE2 Receptors.
33799060 2021. Presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during CoViD-19 infection.
33762287 2021. SARS-CoV-2 infection triggering recurrence of Kawasaki disease in a 10-year-old child.
33798491 2021. Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant.
33795851 2021. ACE2 expression is regulated by AhR in SARS-CoV-2-infected macaques.
33801464 2021. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
33808998 2021. Thymic Aging May Be Associated with COVID-19 Pathophysiology in the Elderly.
33735872 2021. Analysis of Three Mutations in Italian Strains of SARS-CoV-2: Implications for Pathogenesis.
33785044 2021. Hypothetical COVID-19 protection mechanism: hints from centenarians.
33566457 2021. Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19.
33728103 2021. Single Cell Transcriptomic Re-analysis of Immune Cells in Bronchoalveolar Lavage Fluids Reveals the Correlation of B Cell Characteristics and Disease Severity of Patients with SARS-CoV-2 Infection.
33728102 2021. Transmission Characteristics of SARS-CoV-2 That Hinder Effective Control.
33728101 2021. Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target.
33728096 2021. SARS-CoV-2 Infection of Airway Epithelial Cells.
33728095 2021. SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals.
33728094 2021. Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis.
33577760 2021. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.
33567252 2021. COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses.
33765436 2021. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19.
33765435 2021. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses.
33706067 2021. Why blood group A individuals are at risk whereas blood group O individuals are protected from SARS-CoV-2 (COVID-19) infection: A hypothesis regarding how the virus invades the human body via ABO(H) blood group-determining carbohydrates.
33533428 2020. Prediction of Single Point Mutations in Human Coronavirus and Their Effects on Binding to 9-O-Acetylated Sialic Acid and Hidroxychloroquine.
33757413 2021. Moderate forms of COVID-19 among healthcare workers in a Belgian hospital and their immune response.
33656719 2021. The Novel Coronavirus and Inflammation.
33656718 2021. The Immune Response and Effectiveness of COVID-19 Therapies.
33656713 2021. Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.
33544010 2021. Short Communication:Evidence of Novel SARS-CoV-2 Variants Circulation in Romania.
33764510 2021. Detection of SARS-CoV-2-specific memory B cells to delineate long-term COVID-19 immunity.
33757142 2021. Presumptive Neonatal Multisystem Inflammatory Syndrome in Children Associated with Coronavirus Disease 2019.
33740387 2021. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.
33797351 2021. The Role of Obesity in the Immunopathogenesis of COVID-19 Respiratory Disease and Critical Illness.
33725469 2021. Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and Hemoadsorption.
33798018 2021. Within-city Variation in Reactive Oxygen Species from Fine Particle Air Pollution and COVID-19.
33756051 2021. SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients.
33754452 2021. Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in a solid organ transplant recipient.
33792109 2021. Reduced frequency of T helper 17 and T helper 1 cells and their association with critical coronavirus disease 2019.
33651785 2021. [Guia para referencia cardiologica de pacientes con sindrome inflamatorio multisistemico pediatrico y enfermedad por Kawasaki asociados al SARS-CoV-2].
33785527 2021. Implications of a highly transmissible variant of SARS-CoV-2 for children.
33586369 2021. Prophylactic anticoagulation therapy: comment on the article by Henderson et al.
33586355 2021. Reply.
33648933 2021. Acute covid-19 and multisystem inflammatory syndrome in children.
33547053 2021. Covid-19: The E484K mutation and the risks it poses.
33619064 2021. What makes new variants of SARS-CoV-2 concerning is not where they come from, but the mutations they contain.
33579721 2021. Covid-19: Is Manaus the final nail in the coffin for natural herd immunity?
33719038 2021. Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
33745461 2021. COVID-19-associated multisystem inflammatory syndrome in children presenting uniquely with sinus node dysfunction in the setting of shock.
33818861 2021. The role of autophagy in controlling SARS-CoV-2 infection: An overview on virophagy-mediated molecular drug targets.
33592540 2021. Myeloid-derived suppressor cells (MDSC): When good intentions go awry.
33740320 2021. Annulate lamellae and intracellular pathogens.
33792447 2021. The circadian clock gene Bmal1: Role in COVID-19 and periodontitis.

33649539 2021. Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants.
33634060 2020. Immunopathological Changes in SARS-CoV-2 Critical and Non-critical Pneumonia Patients: A Systematic Review to Determine the Cause of Co-infection.
33762432 2021. COVID-19 transmission following outpatient endoscopy during pandemic acceleration phase involving SARS-CoV-2 VOC 202012/01 variant in UK.
33718878 2021. Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawai'i Reveals the Worldwide Emerging P681H Mutation.
33778179 2021. Mutational analysis of structural proteins of SARS-CoV-2.
33758785 2021. Pan-India novel coronavirus SARS-CoV-2 genomics and global diversity analysis in spike protein.
33688586 2021. In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors.
33644468 2021. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages.
33553784 2021. The molecular assessment of SARS-CoV-2 Nucleocapsid Phosphoprotein variants among Indian isolates.
33726831 2021. Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids.
33752217 2020. Variants in ACE2 and TMPRSS2 Genes Are Not Major Determinants of COVID-19 Severity in UK Biobank Subjects.
33531264 2021. Dynamic changes in monocytes subsets in COVID-19 patients.
33581170 2021. Influence of aging on T cell response and renin-angiotensin system imbalance during SARS-CoV-2 infection.
33559128 2021. Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID-19.
33728277 2021. Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches.
33716413 2021. Clinical Characteristics of Paediatric Hyperinflammatory Syndrome in the Era of Corona Virus Disease 2019 (COVID-19).
33647334 2021. Persistence of SARS-CoV-2 antibodies beyond 6 months in health care workers in Mumbai.
33625669 2021. Multisystem Inflammatory Syndrome in Children Temporarily Associated with SARS-CoV-2.
33745112 2021. Fresh Per Rectal Bleeding in Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS).
33632963 2021. Inclusion of Multisystem Inflammatory Syndrome in Children and Adolescents Temporally Related to COVID -19 in the Differential Diagnosis of Kawasaki Disease: Authors' Reply.
33632962 2021. Inclusion of Multisystem Inflammatory Syndrome in Children and Adolescents Temporally Related to COVID -19 in the Differential Diagnosis of Kawasaki Disease.
33684020 2021. Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies.
33421654 2021. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.
33607284 2021. Variants in ACE2; potential influences on virus infection and COVID-19 severity.
33556558 2021. SARS-CoV-2 mutation 614G creates an elastase cleavage site enhancing its spread in high AAT-deficient regions.
33677109 2021. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
33667722 2021. Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations.
33689159 2021. SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19.
33620427 2021. Humoral immunological kinetics of severe acute respiratory syndrome coronavirus 2 infection and diagnostic performance of serological assays for coronavirus disease 2019: an analysis of global reports.
33618296 2021. Immune response of frontline medical workers providing medical support for Wuhan COVID-19 patients, China.
33765612 2021. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19.
33765611 2021. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19.
33756225 2021. Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues.
33667553 2021. The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play.
33390836 2021. SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations.
33390833 2021. A Multiple-Hit Hypothesis Involving Reactive Oxygen Species and Myeloperoxidase Explains Clinical Deterioration and Fatality in COVID-19.
33390830 2021. ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19.
33778151 2021. Cardiac abnormalities due to multisystem inflammatory syndrome temporally associated with Covid-19 among children: A systematic review and meta-analysis.
33672177 2021. Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing.
33535692 2021. IgM and IgG Profiles Reveal Peculiar Features of Humoral Immunity Response to SARS-CoV-2 Infection.
33785459 2021. Emergence and outcomes of the SARS-CoV-2 'Marseille-4' variant.
33781906 2021. Circulating activated neutrophils in COVID-19: An independent predictor for mechanical ventilation and death.
33737135 2021. COVID-19: Is herd immunity the only option for fragile Yemen?
33713819 2021. The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS-CoV-2.
33737129 2021. Genomic surveillance of SARS-CoV-2 in the Republic of Congo.
33684558 2021. Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs.
33618008 2021. Characterizing SARS-CoV-2 genome diversity circulating in South American countries: Signatures of potentially emergent lineages?
33582372 2021. Multisystem inflammatory syndrome (MIS-C) in an adolescent Nigerian girl with COVID-19: A call for vigilance in Africa.
33582369 2021. Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay.
33578018 2021. The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients.
33526974 2021. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection induces dysregulation of immunity: in silico gene expression analysis.
33649798 2021. COVID19 and SARSCoV2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease.
33572938 2021. Expression of the SARS-CoV-2 Receptor ACE2 and Proinflammatory Cytokines Induced by the Periodontopathic Bacterium Fusobacterium nucleatum in Human Respiratory Epithelial Cells.
33567739 2021. ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?
33567580 2021. In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface.
33567524 2021. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease.
33562472 2021. Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology.
33668756 2021. Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.
33671651 2021. sFasL-The Key to a Riddle: Immune Responses in Aging Lung and Disease.
33672738 2021. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
33727631 2021. Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics.
33752089 2021. Multisystem inflammatory syndrome in children (MIS-C) and retropharyngeal edema: A case series.
33539677 2021. Autoantibodies in severe COVID-19-related acute respiratory distress syndrome: Just innocent bystanders?
33616462 2021. Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality.
33759006 2021. Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
33534080 2021. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience: reply.
33787518 2021. Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19.
33787515 2021. The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19.
33787510 2021. The role and delicate balance of Host Immunity in Coronavirus Disease-19.
33615195 2021. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14(+) monocytes.
33585805 2021. Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without.
33558857 2021. Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19.
33532709 2021. Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity.
33748697 2021. Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19.
33723527 2021. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway.
33718825 2021. SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway.
33557873 2021. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics.
33708401 2021. Crystallographic models of SARS-CoV-2 3CL(pro): in-depth assessment of structure quality and validation.
33551030 2021. Mortality-related immune features and COVID-19.
33551029 2021. Reply to "Mortality-related immune features and COVID-19".
33677002 2021. A response to "Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children.
33632409 2021. Oral manifestations of COVID-2019-related multisystem inflammatory syndrome in children: a review of 47 pediatric patients.
33540371 2021. Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status.
33716040 2021. The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization.
33564646 2021. How Our Neanderthal Genes Affect the COVID-19 Mortality: Iran and Mongolia, Two Countries with the Same SARS-CoV-2 Mutation Cluster but Different Mortality Rates.
33583326 2021. Structural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex.
33737495 2021. SARS-CoV-2 genomics: An Indian perspective on sequencing viral variants.
33709963 2021. Pattern of genomic variation in SARS-CoV-2 (COVID-19) suggests restricted nonrandom changes: Analysis using Shewhart control charts.
33759345 2021. Risk stratification by long non-coding RNAs profiling in COVID-19 patients.
33734600 2021. Back to basics in COVID-19: Antigens and antibodies-Completing the puzzle.
33660945 2021. Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease.
33609069 2021. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
33624300 2021. Akt-independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS-CoV2 infection.
33713408 2021. The association of TSH and thyroid hormones with lymphopenia in bacterial sepsis and COVID-19.
33725211 2021. Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses.
33705359 2021. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children.
33529167 2021. The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.
33635833 2021. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
33571162 2021. Durable SARS-CoV-2 B cell immunity after mild or severe disease.
33561010 2021. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.
33669527 2021. Immunological Characteristics of Non-Intensive Care Hospitalized COVID-19 Patients: A Preliminary Report.
33671159 2021. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
33722841 2021. Secondary haemophagocytic lymphohistiocytosis in COVID-19: correlation of the autopsy findings of bone marrow haemophagocytosis with HScore.
33636554 2021. Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection.
33803400 2021. Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications.
33802569 2021. mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection.
33805458 2021. Transcriptional and Non-Transcriptional Activation, Posttranslational Modifications, and Antiviral Functions of Interferon Regulatory Factor 3 and Viral Antagonism by the SARS-Coronavirus.
33739895 2021. Serological Evaluation of Human Antibodies of the Immunoglobulin Class A and G Against SARS-CoV-2 in Serum Collected in Newfoundland and Labrador.
33656935 2021. Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients.
33625297 2021. T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications.
33605822 2021. The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses.

33648924 2020. Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome
33734352 2021. Major left ventricular thrombi in an adolescent with COVID-19-associated inflammatory syndrome.
33609352 2021. Inflammatory syndrome in children associated with COVID-19 complicated by acute myocardial infarction.
33599835 2021. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review.
33791862 2021. Pediatric multisystem SARS COV2 with versus without cardiac involvement: a multicenter study from Latin America.
33540040 2021. Importance of glutamine 189 flexibility in SARS-CoV-2 main protease: Lesson learned from in silico virtual screening of ChEMBL database and molecular dynamics.
33602859 2021. Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients.
33577008 2021. COVID-19 pandemic and vaccination build herd immunity.
33629341 2021. Differential expression and immune correlation analysis of COVID-19 receptor ACE2 and TMPRSS2 genes in all normal and tumor tissues.
33629340 2021. Evaluation of molecular interaction, physicochemical parameters and conserved pattern of SARS-CoV-2 Spike RBD and hACE2: in silico and molecular dynamics approach.
33716535 2021. Does NF-kappaB Signaling Pathway Play a Crucial Role in Pneumonia Induced by SARS-COV-2 Virus Causing COVID-19?
33769251 2021. Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially incre<iframe src="http://www.kidney.de/amapp.php?a=g hospitalisation rate, February 2021, Rio Grande do Sul, Southern Brazil.
33739254 2021. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February.
33706862 2021. Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021.
33643982 2020. Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?
33766711 2021. SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin.
33549714 2021. Mutational analysis and assessment of its impact on proteins of SARS-CoV-2 genomes from India.
33778182 2021. Comparative analysis of mutational hotspots in the spike protein of SARS-CoV-2 isolates from different geographic origins.
33723522 2021. ACE2: At the crossroad of COVID-19 and lung cancer.
33681535 2021. Analysis and comparison of genetic variants and mutations of the novel coronavirus SARS-CoV-2.
33615042 2021. A comparative genomics-based study of positive strand RNA viruses emphasizing on SARS-CoV-2 utilizing dinucleotide signature, codon usage and codon context analyses.
33615041 2021. SARS-CoV-2 spillover transmission due to recombination event.
33623833 2021. Characterizing genomic variants and mutations in SARS-CoV-2 proteins from Indian isolates.
33572725 2021. Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis.
33729332 2021. MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19.
33570080 2021. Challenges in estimating virus divergence times in short epidemic timescales with special reference to the evolution of SARS-CoV-2 pandemic.
33788636 2021. A study on non-synonymous mutational patterns in structural proteins of SARS-CoV-2.
33563320 2021. CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes.
33618765 2021. Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients.
33722935 2021. Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data.
33602693 2021. SARS-CoV-2 genomic diversity and the implications for qRT-PCR diagnostics and transmission.
33581339 2021. Compositional Variability and Mutation Spectra of Monophyletic SARS-CoV-2 Clades.
33704069 2020. The Global Landscape of SARS-CoV-2 Genomes, Variants, and Haplotypes in 2019nCoVR.
33786200 2021. Global Evidence of Temperature Acclimation of COVID-19 D614G Linage.
33748343 2021. Diversity of Cardiac and Gastrointestinal Presentations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series.
33614843 2021. The "Golden Hours" Algorithm For the Management of the Multisystem Inflammatory Syndrome in Children (MIS-C).
33811541 2021. An update: the emerging evidence of complement involvement in COVID-19.
33795347 2021. Coding-Complete Genome Sequence of a SARS-CoV-2 Strain Isolated in Gilgit, Pakistan.
33795344 2021. Genome Sequence of a SARS-CoV-2 Strain from a COVID-19 Clinical Sample from the Khagrachari District of Bangladesh.
33800807 2021. Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 Infection.
33792241 2021. Diabetes and susceptibility to COVID-19: may miR-146a make the difference between life and death?
33761203 2021. New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.
33822491 2021. Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.
33795692 2021. Systems serology detects functionally distinct coronavirus antibody features in children and elderly.
33545711 2021. SARS-CoV-2 evolution during treatment of chronic infection.
33801496 2021. miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery.
33693814 2021. De novo 3D models of SARS-CoV-2 RNA elements from consensus experimental secondary structures.
33653907 2021. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19.
33692097 2021. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.
33622975 2021. Prolonged evolution of the human B cell response to SARS-CoV-2 infection.
33622974 2021. Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients.
33795722 2021. Analysis of SARS-CoV-2 genomic epidemiology reveals disease transmission coupled to variant emergence and allelic variation.
33723016 2021. T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals.
33658326 2021. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.
33727252 2021. Structural impact on SARS-CoV-2 spike protein by D614G substitution.
33688063 2021. SARS-CoV-2 within-host diversity and transmission.
33810465 2021. Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope.
33810456 2021. B-Cell Memory Responses to Variant Viral Antigens.
33810401 2021. Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure.
33810391 2021. An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity.
33806155 2021. Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells.
33804667 2021. Endogenously Produced SARS-CoV-2 Specific IgG Antibodies May Have a Limited Impact on Clearing Nasal Shedding of Virus during Primary Infection in Humans.
33801257 2021. The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense.
33808906 2021. Profiles of Peripheral Immune Cells of Uncomplicated COVID-19 Cases with Distinct Viral RNA Shedding Periods.
33804556 2021. SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations.
33704945 2021. Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.
33596363 2021. Audio Interview: Viral Variants and Covid-19.
33686287 2021. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2.
33674800 2021. Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
33531712 2021. Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.
33723418 2021. Lessons learned: new insights on the role of cytokines in COVID-19.
33723453 2021. Tracking the emergence of new SARS-CoV-2 variants in South Africa.
33654293 2021. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.
33589825 2021. Humoral signatures of protective and pathological SARS-CoV-2 infection in children.
33531709 2021. Sixteen novel lineages of SARS-CoV-2 in South Africa.
33649495 2021. Assessing the human immune response to SARS-CoV-2 variants.
33633408 2021. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity.
33727702 2021. ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity.
33767447 2021. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.
33723411 2021. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.
33684923 2021. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
33737753 2021. Five reasons why COVID herd immunity is probably impossible.
33452513 2021. 'A bloody mess': Confusion reigns over naming of new COVID variants.
33452508 2021. Alarming COVID variants show vital role of genomic surveillance.
33547435 2021. Coronapod: Variants - what you need to know.
33547438 2021. Daily briefing: Call for fully open sharing of coronavirus genome.
33580217 2021. How 'killer' T cells could boost COVID immunity in face of new variants.
33558748 2021. Signs of self-sustained inflammatory circuits in severe COVID pneumonia.
33690265 2021. Detection of a SARS-CoV-2 variant of concern in South Africa.
33636719 2021. SARS-CoV-2 spike D614G change enhances replication and transmission.
33686269 2020. Daily briefing: A protein on the surface of the coronavirus might explain why it is so contagious.
33684269 2020. The Present State of Understanding of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection - A Comprehensive Review of the Current Literature.
33783027 2021. Coronavirus infection: An immunologists' perspective.
33664060 2021. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8(+) T cell responses.
33766871 2021. The emerging plasticity of SARS-CoV-2.
33737481 2021. Appropriate names for COVID-19 variants.
33737468 2021. Studies chase clues to immune syndrome in kids.
33707254 2021. Immunity to SARS-CoV-2 variants of concern.
33446545 2021. Bioactive lipids in antiviral immunity.
33542114 2021. Two new vaccines deliver good and bad news for the pandemic.
33632832 2021. SARS-CoV-2 dependence on host pathways.
33534399 2021. Immunopathological Roles of Neutrophils in Virus Infection and COVID-19.
34094684 2021. Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail.
33877321 2021. A Cytokine/Bradykinin Storm Comparison: What Is the Relationship Between Hypertension and COVID-19?
34052147 2021. Severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children mimicking Kawasaki disease.
34033995 2021. Sindrome inflamatorio multisistemico vinculado a SARS-CoV-2 en adolescente.
34016042 2021. Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil.
34074255 2021. Molecular epidemiology of SARS-CoV-2 isolated from COVID-19 family clusters.
33892639 2021. Online biophysical predictions for SARS-CoV-2 proteins.
34074244 2021. The Great Gut Mimicker: A case report of MIS-C and appendicitis clinical presentation overlap in a teenage patient.
34001211 2021. Shortcomings of SARS-CoV-2 genomic metadata.
33846193 2021. COVID-19-associated inflammatory syndrome in an adult woman with unexplained multiple organ failure: staying vigilant for COVID-19 complications as the pandemic surges.
33952579 2021. COVID-19 rise in Bangladesh correlates with incre<iframe src="http://www.kidney.de/amapp.php?a=g detection of B.1.351 variant.
33892096 2021. Electron microscopy identification of SARS-COV-2: what is the evidence?
33865959 2021. Electron microscopic identification of SARS-CoV-2.
33965336 2021. Role of striated muscles in the pathogenesis of COVID-19.
34075603 2021. Genetic and epigenetic control of ACE2 expression and its possible role in COVID-19.
34096226 2021. Is There any Alternative Receptor for SARS-CoV-2?
33980782 2021. Multisystem Inflammatory Syndrome in Children- A New Syndrome Complicated With Acute Heart Failure Following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
33980688 2021. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
33969287 2021. Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection.
33845428 2021. Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or "just" a marker of bacterial coinfection?
33900174 2021. Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.
33928885 2021. SARS-CoV-2 mutations: the biological trackway towards viral fitness.
34084779 2021. ERS International Congress 2020: highlights from the Clinical Techniques, Imaging and Endoscopy assembly.
33332751 2021. Myocarditis and coronary aneurysms in a child with acute respiratory syndrome coronavirus 2.
34055690 2021. Case Report: Neonatal Multi-System Inflammatory Syndrome Associated With SARS-CoV-2 Exposure in Two Cases From Saudi Arabia.
33919536 2021. Successful Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 (PIMS-TS) with Split Doses of Immunoglobulin G and Estimation of PIMS-TS Incidence in a County District in Southern Germany.
33898797 2021. Identification of PBMC-based molecular signature associational with COVID-19 disease severity.
33898857 2021. Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing.
34075889 2021. Mechanism of inflammasome activation by SARS coronavirus 3a protein: abridged secondary publication.
33962680 2021. An application of slow feature analysis to the genetic sequences of coronaviruses and influenza viruses.
33576949 2021. The Multisystem Inflammatory Syndrome of Childhood (MIS-C).
33864452 2021. Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2: A Retrospective Cohort Study From Argentina.
33876782 2021. Clinical Profile and Short-Term Outcome of Children With SARS-CoV-2 Related Multisystem Inflammatory Syndrome (MIS-C) Treated With Pulse Methylprednisolone.
34086418 2021. Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.
34104087 2021. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons in vitro and in vivo.
34066920 2021. IgM and IgG Immunoreactivity of SARS-CoV-2 Recombinant M Protein.
34039006 2021. Conformational Ensembles of Noncoding Elements in the SARS-CoV-2 Genome from Molecular Dynamics Simulations.
34086443 2021. A Trimeric Hydrophobic Zipper Mediates the Intramembrane Assembly of SARS-CoV-2 Spike.
33367709 2021. SARS-CoV-2 Serologic Immune Response in Exogenously Immunosuppressed Patients.
33913101 2021. Expression map of entry receptors and infectivity factors for pan-coronaviruses in preimplantation and implantation stage human embryos.
33965698 2021. Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19.
33880178 2021. What could be the potential reasons for relatively low coronavirus disease 2019 (COVID-19) fatality rates in Africa? The case for Ethiopia.
34080738 2021. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.
34048113 2021. What drives transmission of severe acute respiratory syndrome coronavirus 2?
34057753 2021. Severe COVID-19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin.
34057760 2021. Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats.
33866607 2021. The good, the bad and the ugly: G-CSF, ageing and neutrophils-Implications for severe COVID-19.
33847393 2021. As a matter of fat: Leptin, monocyte hyperactivation, and COVID-19: A commentary to "Leptin correlates with monocytes activation and severe condition in COVID-19 patients".
33909917 2021. Emergence of immunosuppressive LOX-1+ PMN-MDSC in septic shock and severe COVID-19 patients with acute respiratory distress syndrome.
33847407 2021. TRB sequences targeting ORF1a/b are associated with disease severity in hospitalized COVID-19 patients.
33908113 2021. Cardiac injury and vasoplegia in critically ill children due to multisystem inflammatory syndrome in children associated with COVID-19.
33358846 2021. Electrocardiographic Changes in Children with Multisystem Inflammation Associated with COVID-19: Associated with Coronavirus Disease 2019.
33979162 2021. Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor.
33900080 2021. Tuning Proton Transfer Thermodynamics in SARS-CoV-2 Main Protease: Implications for Catalysis and Inhibitor Design.
33999630 2021. Mechanism of Ligand Recognition by Human ACE2 Receptor.
33306377 2021. Candidate Binding Sites for Allosteric Inhibition of the SARS-CoV-2 Main Protease from the Analysis of Large-Scale Molecular Dynamics Simulations.
33881894 2021. Intermolecular Interaction Analyses on SARS-CoV-2 Spike Protein Receptor Binding Domain and Human Angiotensin-Converting Enzyme 2 Receptor-Blocking Antibody/Peptide Using Fragment Molecular Orbital Calculation.
33856796 2021. Identification and Characterization of Species-Specific Severe Acute Respiratory Syndrome Coronavirus 2 Physicochemical Properties.
34080435 2021. Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage.
33949663 2021. Gut microbiome and resistome changes during the first wave of the COVID-19 pandemic in comparison with pre-pandemic travel-related changes.
33949647 2021. SARS-CoV-2 Genomic Surveillance in Northeast Brazil: Timing of Emergence of the Brazilian Variant of Concern P1.
33980601 2021. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
33853975 2021. Identification of B.1.346 Lineage of SARS-CoV-2 in Japan: Genomic Evidence of Re-entry of Clade 20C.
33361386 2021. Biological Significance of Anti-SARS-CoV-2 Antibodies: Lessons Learned From Progressive Multifocal Leukoencephalopathy.
34021058 2021. Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2.
33850037 2021. Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2.
33854695 2021. Predicting Severity and Intrahospital Mortality in COVID-19: The Place and Role of Oxidative Stress.
33995781 2021. A case of multisystem inflammatory syndrome in an African adolescent male: case report.
33917609 2021. Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
33946190 2021. Seasonal Stability of SARS-CoV-2 in Biological Fluids.
33923138 2021. Microscopic Observation of SARS-Like Particles in RT-qPCR SARS-CoV-2 Positive Sewage Samples.
33922476 2021. Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection.
33920011 2021. Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children?
33955167 2021. How we approach thrombosis risk in children with COVID-19 infection and MIS-C.
32706422 2021. Peripheral blood smears of children with multisystem inflammatory syndrome demonstrate prominence of early myeloid forms with morphologic evidence of toxic change.
34076713 2021. Multisystem Inflammatory Syndrome Associated with COVID-19 Anti-thrombosis Guideline of Care for Children by Action.
33333460 2021. Increased Intracranial Pressure in the Setting of Multisystem Inflammatory Syndrome in Children, Associated With COVID-19.
33904952 2021. Imaging findings of multisystem inflammatory syndrome in children associated with COVID-19.
33855870 2021. Can cilia provide an entry gateway for SARS-CoV-2 to human ciliated cells?
34038453 2021. Increased elastase sensitivity and decreased intramolecular interactions in the more transmissible 501Y.V1 and 501Y.V2 SARS-CoV-2 variants' spike protein-an in silico analysis.
34038423 2021. SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans.
34033650 2021. SARS-CoV-2: Possible recombination and emergence of potentially more virulent strains.
33914789 2021. Analysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq.
33909660 2021. Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein.
33857216 2021. I-FABP is decreased in COVID-19 patients, independently of the prognosis.
33826681 2021. Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts.
33972411 2021. COVID-19 induces lower levels of IL-8, IL-10, and MCP-1 than other acute CRS-inducing diseases.
33972410 2021. 2'-O methylation of RNA cap in SARS-CoV-2 captured by serial crystallography.
33958444 2021. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.
34108245 2021. HIF-1alpha is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes.
34001664 2021. Detection of differentially abundant cell subpopulations in scRNA-seq data.
33874647 2021. Children with Kawasaki disease or Kawasaki-like syndrome (MIS-C/PIMS) at the time of COVID-19: are they all the same? Case series and literature review.
33350025 2021. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
34111408 2021. Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies.
34096649 2021. Virus-triggered secondary hemophagocytic lymphohistiocytosis.
33915561 2021. INSTRUCTIONS: A Case of Multisystem Inflammatory Syndrome in Children Following SARS-CoV-2 Infection in a Rural Emergency Department.
34031864 2021. Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond.
33973178 2021. COVID-19 and Cell Stress.
33973177 2021. Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV.
33892139 2021. Double stranded RNA drives anti-viral innate immune responses, sickness behavior and cognitive dysfunction dependent on dsRNA length, IFNAR1 expression and age.
33838447 2021. Comments on the ambiguity of selected surface markers, signaling pathways and omics profiles hampering the identification of myeloid-derived suppressor cells.
33853355 2021. An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts.
33797464 2021. Addressing long-acting reversible contraception access, bias, and coercion: supporting adolescent and young adult reproductive autonomy.
34024159 2021. SARS-CoV-2 variants: A double-edged sword?
33960608 2021. Glucose-regulated protein (GRP78) is an important cell surface receptor for viral invasion, cancers, and neurological disorders.
34049971 2021. Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19.
33885337 2021. Linkage of Lambda Interferons in Protection Against Severe COVID-19.
33704847 2021. ACUTE EPIDIDYMITIS ASSOCIATED WITH MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN.
34011547 2021. Unique Mutations in the Murine Hepatitis Virus Macrodomain Differentially Attenuate Virus Replication, Indicating Multiple Roles for the Macrodomain in Coronavirus Replication.
34044706 2021. Immune Responses in Patients with COVID-19: An Overview.
33892833 2021. A comparative study of immunoglobulin only and immunoglobulin with methylprednisolone for treating children with Multisystem Inflammatory Syndrome.
34034587 2021. Extracorporeal membrane oxygenation for multisystem inflammatory syndrome in children.

33936927 2021. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2.
33190340 2021. Multisystem inflammatory syndrome in children rose and fell with the first wave of the COVID-19 pandemic in France.
33915560 2021. A Case of Multisystem Inflammatory Syndrome in Children Following SARS-CoV-2 Infection in a Rural Emergency Department.
34028045 2021. Long-term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS-CoV-2 infection.
33884644 2021. Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19.
34082189 2021. Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: A meta-analysis.
34092033 2021. T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19.
33835707 2021. Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients.
33830438 2021. Intramuscular deposit of calcium is a potential reason for hypocalcaemia in COVID-19.
33987131 2021. COVID-19-related Multisystem Inflammatory Syndrome in a Young Adult.
34084077 2021. SARS-Cov2 S Protein Features Potential Estrogen Binding Site.
33842877 2021. Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data.
34055851 2021. Gut Microbiota May Not Be Fully Restored in Recovered COVID-19 Patients After 3-Month Recovery.
33937152 2021. Case Report: MIS-C Temporarily Associated With COVID-19 Complicated by Reye's Syndrome.
33937149 2021. Effects of Coronavirus Disease 2019 (COVID-19) on Peripheral Blood Lymphocytes and Their Subsets in Children: Imbalanced CD4(+)/CD8(+) T Cell Ratio and Disease Severity.
33898353 2021. Case Report: Inflammation and Endothelial Injury Profiling of COVID-19 Pediatric Multisystem Inflammatory Syndrome (MIS-C).
33995033 2021. SARS-CoV-2 Switches 'on' MAPK and NFkappaB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression.
33960807 2021. Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes.
33847161 2021. Herd immunity: could it bring the COVID-19 pandemic to an end?
34035830 2021. SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses.
34095559 2021. Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19.
34075347 2021. SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of the immune cells.
33883951 2021. Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis.
33307805 2021. Immunity to glycan alpha-Gal and possibilities for the control of COVID-19.
34045815 2021. Multiple Peaked Cytokine Storm: Is Multiple Exposures to the COVID-19 Virus a Possible Cause?
33937889 2021. ROS-Driven selection pressure on COVID-19 patients with cardiovascular comorbidities.
33310028 2021. Dynamic anti-spike protein antibody profiles in COVID-19 patients.
34069441 2021. Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.
33946935 2021. Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils.
33925779 2021. PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection-"Rheumatic Fever" of the 21st Century?
33835207 2021. Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients.
33928414 2021. COVID-19-associated autoimmunity as a feature of acute respiratory failure.
33937724 2021. Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses.
33898942 2021. Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2.
34095780 2021. Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain.
33997662 2021. Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids.
33969281 2021. Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patients.
33319167 2021. Structural characterization of nonstructural protein 1 from SARS-CoV-2.
33319166 2021. Transcriptional response modules characterize IL-1beta and IL-6 activity in COVID-19.
33957250 2021. Echocardiographic Indicators Associated with Adverse Clinical Course and Cardiac Sequelae in Multisystem Inflammatory Syndrome in Children with Coronavirus Disease 2019.
34052944 2021. Multisystem inflammatory syndrome in children during the coronavirus disease pandemic of 2019: a review of clinical features and acute phase management.
33893156 2021. Kinetics of SARS-CoV-2 antibody responses pre-COVID-19 and post-COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study.
34007808 2021. Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease.
33838966 2021. Multisystem Inflammatory Syndrome in an Adult.
34041138 2021. Critical interpretative synthesis of herd immunity for COVID-19 pandemic.
34041049 2021. Association of coronavirus pathogencity with the level of antioxidants and immune system.
33930487 2021. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.
33956645 2021. Whole Genome Sequencing and Phylogenetic Analysis of SARSCoV2 strains in Turkey.
33870434 2021. SARS-CoV-2 Total and Subgenomic RNA Viral Load in Hospitalized Patients.
34023234 2021. Immunological map in COVID-19.
33880442 2021. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms.
34059065 2021. Exosomes contribution in COVID-19 patients' treatment.
34090468 2021. SARS-CoV-2 complete genome sequencing from the Italian Campania region using a highly automated next generation sequencing system.
34032853 2021. Association of Circulating Sex Hormones With Inflammation and Disease Severity in Patients With COVID-19.
34009354 2021. The Multisystem Inflammatory Syndrome in Adults With SARS-CoV-2 Infection-Another Piece of an Expanding Puzzle.
34009351 2021. Characteristics Associated With Multisystem Inflammatory Syndrome Among Adults With SARS-CoV-2 Infection.
33907361 2021. Differences in Interactions Within Viral Replication Complexes of SARS-CoV-2 (COVID-19) and SARS-CoV Coronaviruses Control RNA Replication Ability.
33844997 2021. COVID-19 severity and obesity: are MAIT cells a factor?
33882487 2021. Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations.
34069835 2021. Evaluation of SARS-CoV-2 Spike S1 Protein Response on PI3K-Mediated IL-8 Release.
33974614 2021. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology.
34070998 2021. Presence of SARS-CoV-2 and Its Entry Factors in Oral Tissues and Cells: A Systematic Review.
34075268 2021. Papel del sistema inmune en la infeccion por el SARS-CoV-2: inmunopatologia de la COVID-19.
33364597 2021. Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis.
33305919 2021. Insights on Kawasaki disease and multisystem inflammatory syndrome: relationship with COVID-19 infection.
33890746 2021. SARS-CoV-2 associated multisystem inflammatory syndrome in children (MIS-C). A single center's experience.
33939073 2021. miR-200c-3p upregulation and ACE2 downregulation via bacterial LPS and LTA as interesting aspects for COVID-19 treatment and immunity.
34001144 2021. The intersection of COVID-19 and cancer: signaling pathways and treatment implications.
33930332 2021. Functional landscape of SARS-CoV-2 cellular restriction.
33989516 2021. The SARS-CoV-2 RNA interactome.
34089862 2021. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research.
34098591 2021. An Impaired Inflammatory and Innate Immune Response in COVID-19.
34059562 2021. Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis.
34031419 2021. Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection.
34095334 2021. High Prevalence of SARS-CoV-2 Genetic Variation and D614G Mutation in Pediatric Patients With COVID-19.
34006982 2021. Systemic inflammatory syndrome in COVID-19-SISCoV study: systematic review and meta-analysis.
33903171 2021. Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike.
33883267 2021. Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex.
33864498 2021. The importance of heart and brain imaging in children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C).
33910269 2021. Evaluation of oxidative stress markers in hospitalized patients with moderate and severe COVID-19.
33853928 2021. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8(+) T cell activation in COVID-19 patients.
33963249 2021. Angiotensin converting enzyme 2 is a novel target of the gamma-secretase complex.
33958627 2021. Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress.
34031464 2021. Estimates of gene ensemble noise highlight critical pathways and predict disease severity in H1N1, COVID-19 and mortality in sepsis patients.
34021237 2021. SARS-CoV-2 and other human coronavirus show genome patterns previously associated to reduced viral recognition and altered immune response.
34021205 2021. Flow cytometry detection of sustained humoral immune response (IgG + IgA) against native spike glycoprotein in asymptomatic/mild SARS-CoV-2 infection.
34017039 2021. Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection.
34108608 2021. A single transcript for the prognosis of disease severity in COVID-19 patients.
34108510 2021. Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors.
33911163 2021. Unraveling the stability landscape of mutations in the SARS-CoV-2 receptor-binding domain.
33911109 2021. Coiled-coil heterodimers with increased stability for cellular regulation and sensing SARS-CoV-2 spike protein-mediated cell fusion.
33903660 2021. Analysis of IgM, IgA, and IgG isotype antibodies Directed against SARS-CoV-2 spike glycoprotein and ORF8 in the course of COVID-19.
34002169 2021. Sample processing and single cell RNA-sequencing of peripheral blood immune cells from COVID-19 patients.
33979601 2021. Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2.
33979600 2021. SARS-CoV-2 targets glial cells in human cortical organoids.
33932324 2021. Conformational flexibility and structural variability of SARS-CoV2 S protein.
33896688 2021. Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses.
33843171 2021. Impact of COVID-19 on serum melatonin levels and sleep parameters in children
33358968 2021. A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications.
34064525 2021. Identification of the SHREK Family of Proteins as Broad-Spectrum Host Antiviral Factors.
34072720 2021. Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections.
34072569 2021. Characterization of a Novel SARS-CoV-2 Genetic Variant with Distinct Spike Protein Mutations.
33973189 2021. Autoimmune Processes Involved in Organ System Failure Following Infection with SARS-CoV-2.
33827042 2021. The first SARS-CoV-2 genetic variants of concern (VOC) in Poland: The concept of a comprehensive approach to monitoring and surveillance of emerging variants.
33980331 2021. Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: Possible favorable mechanisms of interaction.
33872261 2021. CE: Multisystem Inflammatory Syndrome in Children: A Review.
33970826 2021. Genetic Variants of SARS-CoV-2: What Do We Know So Far?
33950792 2021. Molecular Interactions of SARS-CoV-2 in Lung Tissue of Patients with Chronic Obstructive Pulmonary Disease.
33349108 2021. Search for SARS-CoV-2 RNA in platelets from COVID-19 patients.
34035118 2021. SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.
34035116 2021. Polyclonal expansion of TCR Vbeta 21.3(+) CD4(+) and CD8(+) T cells is a hallmark of Multisystem Inflammatory Syndrome in Children.
34088747 2021. Anti-body antibodies in COVID-19.

33887214 2021. Coronavirus Activates an Altruistic Stem Cell-Mediated Defense Mechanism that Reactivates Dormant Tuberculosis: Implications in Coronavirus Disease 2019 Pandemic.
33844596 2021. Unraveling the thread of uncontrolled immune response in COVID-19 and STEMI: an emerging need for knowledge sharing.
33978488 2021. The oxygen dissociation curve of blood in COVID-19.
33895472 2021. SARS-CoV-2 variants of concern: the knowns and unknowns.
34033926 2021. Preliminary data on severe SARS-CoV-2 infection caused by the 501Y.V2 variant.
33871970 2021. Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells.
33991784 2021. Diffuse interstitial pneumonia-like/macrophage activation syndrome-like changes in patients with COVID-19 correlate with length of illness.
33987283 2021. How will emerging SARS-CoV-2 variants impact herd immunity?
34066389 2021. Comparison of Immunological Profiles of SARS-CoV-2 Variants in the COVID-19 Pandemic Trends: An Immunoinformatics Approach.
33950288 2021. The interplay between the immune system and SARS-CoV-2 in COVID-19 patients.
33880885 2021. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.
34043002 2021. Identification of evolutionarily stable functional and immunogenic sites across the SARS-CoV-2 proteome and greater coronavirus family.
33895804 2021. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C.
33986186 2021. Leukoerythroblastosis with dyserythropoiesis in an adolescent with SARS-CoV-2-associated macrophage activation syndrome.
33832550 2021. MUC1-C influences cell survival in lung adenocarcinoma Calu-3 cells after SARS-CoV-2 infection.
33941085 2021. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.
33985433 2021. IPD 2.0: To derive insights from an evolving SARS-CoV-2 genome.
34044758 2021. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
33858331 2021. Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy.
34011641 2021. Complicated case of COVID-19 disease with overlapping features of thrombotic thrombocytopenic purpura and haemophagocytic lymphohistiocytosis.
33980565 2021. Rare presentation of multisystem inflammatory syndrome in an adult associated with SARS-CoV-2 infection: unilateral neck swelling.
33975844 2021. Sinus bradycardia in a toddler with multisystem inflammatory syndrome in children (MIS-C) related to COVID-19.
33888480 2021. Pneumatosis intestinalis and intestinal perforation in a case of multisystem inflammatory syndrome in children.
33883119 2021. Adult multisystem inflammatory syndrome in a patient who recovered from COVID-19 postvaccination.
33858888 2021. Post-infectious inflammatory syndrome associated with SARS-CoV-2 in a paediatric patient with Down syndrome.
33849879 2021. COVID-19 multisystemic inflammatory syndrome in adults: a not to be missed diagnosis.
33884312 2021. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan.
34031875 2021. COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations.
33993471 2021. Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19: response.
33956332 2021. Functional and tissue enrichment analyses suggest that SARS-CoV-2 infection affects host metabolism and catabolism mediated by interference on host proteins.
33907801 2021. Analyzing master regulators and scRNA-seq of COVID-19 patients reveals an underlying anti-SARS-CoV-2 mechanism of ZNF proteins.
33885735 2021. New framework for recombination and adaptive evolution analysis with application to the novel coronavirus SARS-CoV-2.
33885726 2021. Comparative phylogenetic analysis of SARS-CoV-2 spike protein-possibility effect on virus spillover.
33837760 2021. Letter to the Editor: Significant mutation enrichment in inverted repeat sites of new SARS-CoV-2 strains.
33956950 2021. The peripheral and core regions of virus-host network of COVID-19.
34015809 2021. Global characterization of B cell receptor repertoire in COVID-19 patients by single-cell V(D)J sequencing.
34013346 2021. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.
33993223 2021. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders.
33377145 2021. Evolutionary and codon usage preference insights into spike glycoprotein of SARS-CoV-2.
33341900 2021. SARS-CoV-2 hot-spot mutations are significantly enriched within inverted repeats and CpG island loci.
33341869 2021. Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19.
33333559 2021. Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 disease.
34097003 2021. Detecting SARS-CoV-2 and its variant strains with a full genome tiling array.
34076249 2021. Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions.
34037874 2021. Compartmental Model Suggests Importance of Innate Immune Response to COVID-19 Infection in Rhesus Macaques.
33907373 2021. Identification of selected genes associated with the SARS-CoV-2: a therapeutic approach and disease severity.
34090979 2021. Kawasaki Disease Shock Syndrome versus classical Kawasaki Disease, a Meta-analysis and comparison with SARS-CoV-2 Multisystem Inflammatory Syndrome.
34082849 2021. Left ventricular thrombus in multisystem inflammatory syndrome in children associated with COVID-19.
33962629 2021. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
34010620 2021. High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies.
33852911 2021. Antibody evasion by the P.1 strain of SARS-CoV-2.
33891875 2021. Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.
33861950 2021. Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.
33831372 2021. SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms.
33991511 2021. Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs.
33991510 2021. Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19.
33974846 2021. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities.
33961823 2021. METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.
33961822 2021. Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection.
33932326 2021. Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2.
33897278 2021. The dual role of the immune system in the course of COVID-19. The fatal impact of the aging immune system.
33967407 2021. A fractional-order differential equation model of COVID-19 infection of epithelial cells.
33965937 2021. Viral Replication and Antibody Kinetics in the Recognition of Asymptomatic COVID-19 Patients.
33316234 2021. Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients.
34082475 2021. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.
34086878 2021. Emergence of the E484K Mutation in SARS-CoV-2 Lineage B.1.1.345 in Upstate New York.
33991677 2021. Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage.
34015530 2021. Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19.
33984489 2021. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
34035555 2021. Severe Acute Respiratory Syndrome Coronavirus 2: The Emergence of Important Genetic Variants and Testing Options for Clinical Laboratories.
34087062 2021. Insights into the potential role of alpha1-antitrypsin in COVID-19 patients: Mechanisms, current update, and future perspectives.
34092778 2021. Is the Intestine a Portal of Entry for the Serious COVID-19 Complications of Endotoxemia and Thrombosis?
33934534 2021. Autoantibodies in moderate and critical cases of COVID-19.
33932091 2021. Antinuclear antibodies in COVID 19.
34002013 2021. Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis.
34083759 2021. SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus.
34090748 2021. kinetics of anti-SARS-CoV-2 antibodies over time. Results of 10 month follow up in over 300 seropositive Health Care Workers.
34058787 2021. The role of lactate in sepsis and COVID-19: Perspective from contracting skeletal muscle metabolism.
33997890 2021. Variable post-translational modifications of SARS-CoV-2 nucleocapsid protein.
34091116 2021. Different T cell related immunological profiles in COVID-19 patients compared to healthy controls.
34043356 2021. Insight into the LFA-1/SARS-CoV-2 Orf7a Complex by Protein-Protein Docking, Molecular Dynamics, and MM-GBSA Calculations.
33855951 2021. SARS-CoV-2 one year on: evidence for ongoing viral adaptation.
33932299 2021. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.
33958327 2021. Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation.
33074884 2021. Multisystem Inflammatory Syndrome in Children Mimicking Surgical Pathologies: What Surgeons Need to Know about MIS-C.
33985343 2021. COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment.
33326597 2021. Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID-19.
33993500 2021. Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19.
34011563 2021. Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer.
34013681 2021. Is COVID-19 a hyperferritinemic syndrome in children?
33853368 2021. Multiple Emergency Department Presentations of COVID-19-Related Multisystem Inflammatory Syndrome in Children.
33980050 2021. Massive Pulmonary Embolism in an Adolescent With Multisystem Inflammatory Syndrome Due to COVID-19.
34001691 2021. Comparison of Circulating Immune Cells Profiles and Kinetics Between Coronavirus Disease 2019 and Bacterial Sepsis.
34049308 2021. Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock.
34052825 2021. The multisystem inflammatory syndrome in children and its association to SARS-CoV-2.
33899752 2021. Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection.
33909065 2021. The Role of Cell Surface Sialic Acids for SARS-CoV-2 Infection.
33833065 2021. Six-month follow-up of gut microbiota richness in patients with COVID-19.
33843609 2021. Paediatric multisystem inflammatory syndrome and COVID-19: another novel syndrome?
33971803 2021. Impacts of reference selection on the assembly of suspicious coronavirus genome.
34060425 2021. Computational analysis of protein stability and allosteric interaction networks in distinct conformational forms of the SARS-CoV-2 spike D614G mutant: reconciling functional mechanisms through allosteric model of spike regulation.
33883466 2021. Pandemic analysis of infection and death correlated with genomic open reading frame 10 mutation in severe acute respiratory syndrome coronavirus 2 victims.
33952596 2021. A SARS-CoV-2 Variant with L452R and E484Q Neutralization Resistance Mutations.
33952598 2021. Genomic Elucidation of a COVID-19 Resurgence and Local Transmission of SARS-CoV-2 in Guangzhou, China.
33843774 2021. Role of Biological Agents in the Treatment of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children.
33956593 2021. Differential role of sphingomyelin in influenza virus, rhinovirus and SARS-CoV-2 infection of Calu-3 cells.
33331657 2021. Apoptosis-induced T-cell lymphopenia is related to COVID-19 severity.
33331649 2021. Dysregulation of the mevalonate pathway during SARS-CoV-2 infection: An in silico study.
33300133 2021. Understanding the pathophysiological changes via untargeted metabolomics in COVID-19 patients.
33934126 2021. Neurological Manifestations of COVID-19 Associated Multi-system Inflammatory Syndrome in Children: A Systematic Review and Meta-analysis.
34001792 2021. Multisystem Inflammatory Syndrome in a Pediatric Patient With Sickle Cell Disease and COVID-19: A Case Report.

33971704 2021. Hyperinflammatory syndrome in children during the coronavirus disease 2019 pandemic in sub-Himalayan region.
33338007 2021. Could the incre<iframe src="http://www.kidney.de/amapp.php?a=g concerns regarding the post-COVID-19 symptoms cause Kawasaki disease to be under-diagnosed?
34083758 2021. Single-nucleotide conservation state annotation of the SARS-CoV-2 genome.
33879833 2021. Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals.
34004573 2021. Image processing unravels the evolutionary pattern of SARS-CoV-2 against SARS and MERS through position-based pattern recognition.
33841749 2021. Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process.
33343834 2021. Temperature dependence of the SARS-CoV-2 affinity to human ACE2 determines COVID-19 progression and clinical outcome.
33847825 2021. The Involvement of MicroRNAs in SARS-CoV-2 Infection Comorbid with HIV-Associated Preeclampsia.
33840589 2021. Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity.
33360025 2021. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.
33348065 2021. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
34074585 2021. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
33342718 2021. Macrophage-derived cytokines in pneumonia: Linking cellular immunology and genetics.
34062530 2021. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.
34058541 2021. Assay dependence of long-term kinetics of SARS-CoV-2 antibodies.
33993054 2021. An epigenetic signature to fight COVID-19.
33993052 2021. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
33979758 2021. Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers.
33915337 2021. Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series.
34098342 2021. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.
33876849 2021. The SARS-unique domain (SUD) of SARS-CoV and SARS-CoV-2 interacts with human Paip1 to enhance viral RNA translation.
33961735 2021. Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2.
33931941 2021. SARS-CoV-2 worldwide replication drives rapid rise and selection of mutations across the viral genome: a time-course study - potential challenge for vaccines and therapies.
33326687 2021. The riddle of the Sphinx: why sphingosine-1-phosphate may help define molecular mechanisms underlying risk stratification for serious COVID-19 infections.
33900195 2021. Novel SARS-CoV-2 Variant Derived from Clade 19B, France.
33900193 2021. Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China.
33350923 2021. Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection.
33883059 2021. Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June-October 2020.
34016252 2021. Persistence of SARS-CoV-2-Specific IgG in Children 6 Months After Infection, Australia.
34099945 2021. Primeras importaciones de las variantes SARS-CoV-2 P.1 y P.2 de Brasil a Madrid y transmision comunitaria.
34026297 2021. Temporal Profiles of Antibody Responses, Cytokines, and Survival of COVID-19 Patients: A Retrospective Cohort in Wuhan, China.
33876664 2021. Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection.
33341878 2021. Delayed diffuse inflammatory myocardial damage in a child with a history of systemic inflammatory syndrome related to COVID-19.
34103090 2021. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.
34023936 2021. Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adults.
34047274 2021. SARS-CoV-2 variant B.1.1.7 susceptibility and infectiousness of children and adults deduced from investigations of childcare centre outbreaks, Germany, 2021.
33960291 2021. Case series of four re-infections with a SARS-CoV-2 B.1.351 variant, Luxembourg, February 2021.
33890568 2021. Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021.
33890566 2021. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021.
33860748 2021. Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France.
33903146 2021. Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19.
33960272 2021. COVID-19 and the neonatal microbiome: will the pandemic cost infants their microbes?
33320447 2021. Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2.
33996172 2021. Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation.
33867206 2021. Fatalities of COVID-19 are rather attributable to multisystem inflammatory syndrome than infectious meningitis or sepsis.
33913889 2021. COVID-19 related multi-inflammatory syndrome presenting with uveitis - A case report.
33915216 2021. One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages.
33905892 2021. SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation.
33905891 2021. Spike protein mutational landscape in India during the complete lockdown phase: Could Muller's ratchet be a future game-changer for COVID-19?
33848683 2021. Systematizing the genomic order and relatedness in the open reading frames (ORFs) of the coronaviruses.
34044140 2021. Multisystem inflammatory syndrome in adults: A rare sequela of SARS-CoV-2 infection.
33989776 2021. Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil.
33939840 2021. Geriatric antibody response to COVID-19.
34031932 2021. Autoantibodies in Covid-19 - a model for viral induced autoimmunity.
33926500 2021. SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism.
34089757 2021. Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks.
34036353 2021. Type I, II, and III interferon signatures correspond to COVID-19 disease severity.
34031695 2021. Virological and serological characterization of critically ill patients with COVID-19 in the UK: Interactions of viral load, antibody status and B.1.1.7 variant infection.
34086960 2021. Marked increase in avidity of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) antibodies 7-8 months after infection is not diminished in old age.
34050501 2021. The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections.
34028559 2021. Macrophage Activation Syndrome in a Child with Juvenile Idiopathic Arthritis Secondary to SARS-CoV-2.
34028528 2021. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series Experience in a Tertiary Care Hospital of Southern Turkey.
34027897 2021. The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age.
33986193 2021. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.
34081630 2021. Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern.
33830084 2021. A mechanism for matrikine regulation in acute inflammatory lung injury.
34090610 2021. COVID-19 reinfections in The Gambia by phylogenetically distinct SARS-CoV-2 variants-first two confirmed events in west Africa.
33857407 2021. Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes.
33857406 2021. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.
33341124 2021. Persistence of IgG response to SARS-CoV-2.
34022142 2021. SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity.
33846703 2021. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation.
33857454 2021. Monitoring differences between the SARS-CoV-2 B.1.1.7 variant and other lineages.
33857453 2021. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
34027512 2021. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland, 2020.
33870259 2021. Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the United Kingdom and Ireland: What is new?
33892550 2021. Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2.
34060079 2021. Surveillance for SARS-CoV-2 variants of concern in the Australian context.
34031561 2021. SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome.
34028990 2021. Epicardial fat inflammation response to COVID-19 therapies.
33945220 2021. The association between obesity and peak antibody titer response in COVID-19 infection.
34103408 2021. Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro.
33846272 2021. Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues.
34029205 2021. Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome.
34006597 2021. Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2.
33361116 2021. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.
34016740 2021. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants.
34012360 2021. Forecasting the Effects of the New SARS-CoV-2 Variant in Europe.
33846275 2021. Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19.
33912658 2021. Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection.
33912411 2021. Reactivity of human antisera to codon optimized SARS-CoV2 viral proteins expressed in Escherichia coli.
34075354 2021. A matter of perspective-Cutting-edge technology-driven urine proteome in COVID-19.
33845201 2021. COVID-19 and hypertension: Is there a role for dsRNA and activation of Toll-like receptor 3?
33788823 2021. Sixth nerve palsy in pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection.
33872443 2021. Multisystem inflammatory syndrome in children (MIS-C) and the prothrombotic state: Coagulation profiles and rotational thromboelastometry in a MIS-C cohort.
33711292 2021. Addressing fundamental questions on MIS-C.
34043958 2021. 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study.
33905406 2021. Sindrome inflamatorio multisistemico por COVID-19 en ninos: reporte de diez casos en un hospital peruano.
33904379 2021. A case of multisystem inflammatory syndrome in children in a Japanese boy: with discussion of cytokine profile.
33972732 2021. Monocyte and dendritic cell defects in COVID-19.
33972731 2021. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity.
33875881 2021. Immunity after SARS-CoV-2 infections.
34040225 2021. Cellular disturbances in COVID-19.
33976430 2021. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.
33963333 2021. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.
33986507 2021. India's neighbours race to sequence genomes as COVID surges.
33976409 2021. Coronavirus variants are spreading in India - what scientists know so far.
33856952 2021. Bilateral Acute Anterior Uveitis and Corneal Punctate Epitheliopathy in Children Diagnosed with Multisystem Inflammatory Syndrome Secondary to COVID-19.
33926942 2021. How SARS-CoV-2 first adapted in humans.

33937731 2021. An autopsy study of the spectrum of severe COVID-19 in children: From SARS to different phenotypes of MIS-C.
33886935 2021. Infection of red blood cells by SARS-CoV-2: new evidence.
33904403 2021. Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses.
33835028 2021. Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation.
33890572 2021. SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation.
34049471 2021. Intra-species sialic acid polymorphism in humans: a common niche for influenza and coronavirus pandemics?
34019466 2021. Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR.
34013835 2021. Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate.
33944697 2021. Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients.
33896413 2021. Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications.
33870851 2021. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.
33830901 2021. Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort.
33372854 2021. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.
33327866 2021. Structure of the multiple functional domains from coronavirus nonstructural protein 3.
33848711 2021. High levels of TNFalpha in patients with COVID-19 refractory to tocilizumab.
33882374 2021. Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients.
34053848 2021. SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors.
33878423 2021. Aging correlates with lower threshold cycle values for RdRP/RdRP+S genes during molecular detection of SARS-CoV-2.
33953325 2021. Innate immune sensing of coronavirus and viral evasion strategies.
33828231 2021. From bedside to bench: regulation of host factors in SARS-CoV-2 infection.
33368679 2021. Spatial and temporal roles of SARS-CoV PL(pro) -A snapshot.
34023458 2021. SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis.
34026780 2021. Implications of the Novel Mutations in the SARS-CoV-2 Genome for Transmission, Disease Severity, and the Vaccine Development.
33928117 2021. Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production.
33912590 2021. Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19.
33898518 2021. An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome-Coronavirus.
33900399 2021. Genomic Epidemiology of SARS-CoV-2 Infection During the Initial Pandemic Wave and Association With Disease Severity.
33835177 2021. Genome Analysis for Sequence Variants in SARS-CoV-2 Among Asymptomatic Individuals in a Long-term Care Facility.
33887319 2021. SARS-CoV-2-reactive cellular and humoral immunity in hemodialysis population.
33964249 2021. Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19-recovered patients who received a kidney transplant.
33972935 2021. Waning antibodies to SARS-CoV-2 - Don't panic.
34007047 2021. Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients.
33358483 2021. Evaluation of variant frequency in SARS-CoV-2 infection-related genes utilizing lung cancer genomic database.
33947753 2021. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
33975939 2021. The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia.
33906918 2021. Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment.
33879594 2021. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
34075014 2021. Editorial: COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C).
34007243 2021. Correlation of Low Levels of alpha-1 Antitrypsin and Elevation of Neutrophil to Lymphocyte Ratio with Higher Mortality in Severe COVID-19 Patients.
33953641 2021. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.
33833618 2021. Whole-Transcriptome RNA Sequencing Reveals Significant Differentially Expressed mRNAs, miRNAs, and lncRNAs and Related Regulating Biological Pathways in the Peripheral Blood of COVID-19 Patients.
33993637 2021. SARS-CoV-2 RNA screening in routine pathology specimens.
33373693 2021. Spike glycoproteins: Their significance for corona viruses and receptor binding activities for pathogenesis and viral survival.
34058304 2021. Identification of E484K and other novel SARS-COV-2 variants from the Kingdom of Bahrain.
33958417 2021. Detection and Genome Sequencing of SARS-CoV-2 Variants Belonging to the B.1.1.7 Lineage in the Philippines.
34042476 2021. Genome Sequences of SARS-CoV-2 P.1 (Variant of Concern) and P.2 (Variant of Interest) Identified in Uruguay.
34065789 2021. Molecular Analysis of SARS-CoV-2 Circulating in Bangladesh during 2020 Revealed Lineage Diversity and Potential Mutations.
33925854 2021. Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern.
33881152 2021. Post-COVID Multisystem Inflammatory Syndrome in the Deployed Environment.
33871249 2021. Increased risk for severe outcome in teenagers with multisystem inflammatory syndrome temporally associated with Covid-19 mimicking Kawasaki disease: is there an age-related Achilles heel?
33988184 2021. Identification of and Surveillance for the SARS-CoV-2 Variants B.1.427 and B.1.429 - Colorado, January-March 2021.
33983915 2021. Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021.
33940513 2021. Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection.
33358567 2021. Biological functions of MAIT cells in tissues.
34075562 2021. The Effect of COVID-19 on NF-kappaB and Neurological Manifestations of Disease.
33946306 2021. D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency, Geographical Distribution, and Structural Effect.
34035552 2021. Kawasaki-Syndrom bei einem 9-jahrigen Jungen infolge von COVID-19.
34047654 2021. Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients.
33958704 2021. Adipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution.
33725430 2021. Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England.
33883721 2021. Blast from the past for coronavirus immunity.
33859371 2021. Uncovering SARS-CoV-2 kidney tropism.
33349661 2021. MIS-C: early lessons from immune profiling.
33840875 2021. How much worse can variants get?
33831567 2021. Implications of SARS-Cov-2 infection on eNOS and iNOS activity: Consequences for the respiratory and vascular systems.
33956156 2021. Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity.
33842903 2021. Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19.
34043740 2021. TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2.
34015061 2021. DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist.
34097716 2021. Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan.
34097709 2021. Signal-regulatory protein alpha is an anti-viral entry factor targeting viruses using endocytic pathways.
34061905 2021. Extensive C->U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA.
33901246 2021. Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread.
33886690 2021. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
33861802 2021. Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity.
33831133 2021. High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19.
33831132 2021. A human coronavirus evolves antigenically to escape antibody immunity.
33827988 2021. ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection.
33850412 2021. Management of COVID-19-associated multisystem inflammatory syndrome in children: A comprehensive literature review.
33929695 2021. Convergent evolution of SARS-CoV-2 in human and animals.
33933612 2021. Reconstitution and functional characterization of SARS-CoV-2 proofreading complex.
34018094 2021. Update and Supplementary Articles Proteins of SARS CoV-2, Which Causes COVID-19, and the Interacting Proteins.
33890205 2021. In Silico Study of Mutational Stability of SARS-CoV-2 Proteins.
33867315 2021. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
34021763 2021. A scientific basis for anxiety about the emergence of resistant strains of covid-19.
33907354 2021. Fallbericht: Tod eines 2-jahrigen Madchens bei postmortaler Diagnose einer seltenen, Kawasaki-Syndrom-typischen Koronararterienvaskulitis.
34020311 2021. Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19.
34051791 2021. Dysregulation of COVID-19 related gene expression in the COPD lung.
33935561 2021. Humoral immune responses in hospitalized COVID-19 patients.
33867805 2021. Prolonged humoral and cellular immunity in COVID-19-recovered patients.
33850424 2021. Virus-receptor interactions of SARS-CoV-2 spikereceptor-binding domain and human neuropilin-1 b1 domain.
33967583 2021. Antibody profile in symptomatic/asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected Saudi persons.
33966045 2021. SARS-CoV-2 promote autophagy to suppress type I interferon response.
34006847 2021. Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study.
34001855 2021. Cellular tropism and antigenicity of mink-derived SARS-CoV-2 variants.
33870746 2021. Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry.
33994605 2021. Mass spectrometry analytical responses to the SARS-CoV2 coronavirus in review.
34013222 2021. A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C).
33937741 2021. Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein.
33918599 2021. The Spike Glycoprotein of SARS-CoV-2 Binds to beta1 Integrins Expressed on the Surface of Lung Epithelial Cells.
33918060 2021. Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2.
33917138 2021. The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus.
33946311 2021. Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis.
33946747 2021. Emergence and Spread of SARS-CoV-2 Lineages B.1.1.7 and P.1 in Italy.
34079122 2021. Daily briefing: Coronavirus variants given Greek names.
34075234 2021. Coronavirus variants get Greek names - but will scientists use them?
34031583 2021. What scientists know about new, fast-spreading coronavirus variants.
34098568 2021. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.
33871226 2021. Point-of-Care Ultrasound Findings in Multisystem Inflammatory Syndrome in Children: A Cross-Sectional Study.
33949910 2021. Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) - a case series.
33941741 2021. Acral Gangrene: Ugly Cousin of "COVID Toes" in Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2?
33234669 2021. Multisystem Inflammatory Syndrome in Children: An International Survey.

34090218 2021. COVID-19 patients' sera induce epithelial mesenchymal transition in cancer cells.
34023769 2021. The emerging role of cellular senescence in complications of COVID-19.
34071688 2021. SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer.
33893398 2021. The basis of a more contagious 501Y.V1 variant of SARS-CoV-2.
33977496 2021. SARS-CoV-2 in patients with cancer: possible role of mimicry of human molecules by viral proteins and the resulting anti-cancer immunity.
33949207 2021. Role of the Immune Microenvironment in SARS-CoV-2 Infection.
33840257 2021. Surviving the Rookie Virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): The Immunopathology of a SARS-CoV2 Infection.
34062964 2021. The Systemic Immune Response in COVID-19 Is Associated with a Shift to Formyl-Peptide Unresponsive Eosinophils.
34071149 2021. Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.
33972046 2021. A dermatologic perspective on multisystem inflammatory syndrome in children.
33865990 2021. A novel application of delayed-type hipersensitivity reaction to measure cellular immune response in SARS-CoV-2 exposed individuals.
33895357 2021. SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts.
33887436 2021. Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application.
33301883 2021. Kawasaki or Kawasaki-like disease? A debate on COVID-19 infection in children.
33333256 2021. Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned.
34044153 2021. SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay.
33975009 2021. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
34044152 2021. Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France.
34015535 2021. Novel SARS-CoV-2 variants: the pandemics within the pandemic.
33956250 2021. Clinical features and outcome of MIS-C patients: an experience from Central Anatolia.
33439384 2021. Pediatric inflammatory multisystem syndrome (PIMS) presenting with retropharyngeal phlegmon mimicking Kawasaki disease.
34089099 2021. Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children.
33763799 2021. Clinical and laboratory findings of multisystem inflammatory syndrome in children (MIS-C) below age 1.
33981434 2021. The up-to-date pathophysiology of Kawasaki disease.
33976879 2021. Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals.
33968405 2021. Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019.
34047474 2021. Preliminary analyses of scRNA sequencing and immunohistochemistry of children's lung tissues indicate the expression of SARS-CoV-2 entry-related genes may not be the key reason for the milder syndromes of COVID-19 in children.
33936565 2021. Targeting protein-protein interaction interfaces in COVID-19 drug discovery.
33907612 2021. Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis.
33850607 2021. Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification.
33841750 2021. Temperature effect on the SARS-CoV-2: A molecular dynamics study of the spike homotrimeric glycoprotein.
33845874 2021. Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome.
33824793 2021. Carotid Artery Dissection and Hemorrhagic Stroke in the Setting of Multisystem Inflammatory Syndrome in Children.
33877539 2021. Genomic Evolution and Variation of SARS-CoV-2 in the Early Phase of COVID-19 Pandemic in Guangdong Province, China.
33945951 2021. Structure and function of SARS-CoV-2 polymerase.
33898662 2021. Statistics and Patterns of Occurrence of Simple Tandem Repeats in SARS-CoV-1 and SARS-CoV-2 Genomic Data.
33838172 2021. Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via alpha7-nicotinic acetylcholine receptors?
34023458 2021. SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis.
33991578 2021. Gut Microbiome Composition Is Associated with COVID-19 Disease Severity.
33969236 2021. Analysis of single nucleotide polymorphisms between 2019-nCoV genomes and its impact on codon usage.
33875973 2021. Whole genome comparison of Pakistani Corona virus with Chinese and US Strains along with its predictive severity of COVID-19.
34072181 2021. Mutational Asymmetries in the SARS-CoV-2 Genome May Lead to Increased Hydrophobicity of Virus Proteins.
33916492 2021. Genotyping of the Major SARS-CoV-2 Clade by Short-Amplicon High-Resolution Melting (SA-HRM) Analysis.
33923155 2021. Investigating Cellular Trajectories in the Severity of COVID-19 and Their Transcriptional Programs Using Machine Learning Approaches.
33983397 2021. Rapid detection of inter-clade recombination in SARS-CoV-2 with Bolotie.
33836368 2021. Identification of COVID-19 subtypes based on immunogenomic profiling.
33310664 2021. Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients.
33932694 2021. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
33895478 2021. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC.
33907518 2021. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.
33907514 2021. The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment.
33907511 2021. The Genetic Variant of SARS-CoV-2: would It Matter for Controlling the Devastating Pandemic?
33867845 2021. SARS-CoV-2-induced Overexpression of miR-4485 Suppresses Osteogenic Differentiation and Impairs Fracture Healing.
34089348 2021. Dying of VOC-202012/01 - multimodal investigations in a death case of the SARS-CoV-2 variant.
33970428 2021. Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital.
34050887 2021. The role of unconventional T cells in COVID-19.
33904682 2021. Production of SARS-CoV-2 Antibodies and Emergence of the Clinical Symptoms of COVID-19.
33899351 2021. The First Fatal Post-COVID-19 Adult Patient with Multi-System Inflammatory Syndrome in Israel.
33894209 2021. Distinct cytokine profiles associated with COVID-19 severity and mortality.
33309039 2021. Marked changes in innate immunity associated with a mild course of COVID-19 in identical twins with athymia and absent circulating T cells.
33971585 2021. An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
33937119 2021. How Antivirals Might be Linked to the Emergence of New Variants of SARS-CoV-2.
33963094 2021. SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response.
33969357 2021. Structural Consequences of Variation in SARS-CoV-2 B.1.1.7.
33969601 2021. Interplay between SARS-CoV-2 and human long non-coding RNAs.
33939913 2021. Elucidation of Cryptic and Allosteric Pockets within the SARS-CoV-2 Main Protease.
33851338 2021. Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain.
33983545 2021. Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency.
33950324 2021. Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia.
33864183 2021. Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection-Implications for Therapeutic Monitoring and Therapeutic Targets.
34032635 2021. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier.
34058261 2021. Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020-21.
33992685 2021. Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK.
33932451 2021. The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
33932450 2021. Duration of culturable SARS-CoV-2 within different specimens among mild and severe COVID-19 patients: A longitudinal study.
34052240 2021. One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG.
34060263 2021. Antibody Responses One Year after Mild SARS-CoV-2 Infection.
34035676 2021. The Trilogy of SARS-CoV-2 in Pediatrics (Part 2): Multisystem Inflammatory Syndrome in Children.
33846690 2021. Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era.
34026490 2021. COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) presenting as appendicitis with shock.
33336251 2021. Multisystem Inflammatory Syndrome in Children in February 2020 and Implications of Genomic Sequencing for SARS-CoV-2.
33211859 2021. Short-Term Outcomes After Multisystem Inflammatory Syndrome in Children Treatment.
34086459 2021. Machine Learning Reveals the Critical Interactions for SARS-CoV-2 Spike Protein Binding to ACE2.
33873242 2021. SARS-CoV-2: pushing the E(nvelope).
34089533 2021. The role of the SARS-CoV-2 envelope protein as a pH-dependent cation channel.
33889450 2021. Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
33965601 2021. SARS-CoV-2, hemoglobin and protoporphyrin IX: Interactions and perspectives.
33904656 2021. Reduced adiponectin levels in patients with COVID-19 acute respiratory failure: A case-control study.
33992044 2021. Pediatric Inflammatory Multisystem Syndrome (PIMS) - Potential role for cytokines such Is IL-6.
33999778 2021. Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19.
33961632 2021. Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.
33914735 2021. Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
33901166 2021. The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
34081747 2021. Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform.
33984048 2021. SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS.
33979391 2021. Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein.
33930996 2021. Distance matrices for nitrogenous bases and amino acids of SARS-CoV-2 via structural metric.
33934592 2021. SARS-CoV-2 infection versus the body immune defenses: the role of immune responses and mechanism of action of dexamethasone.
34034620 2021. A 'deep dive' into the SARS-Cov-2 polymerase assembly: identifying novel allosteric sites and analyzing the hydrogen bond networks and correlated dynamics.
34029506 2021. Binding mode characterization of 13b in the monomeric and dimeric states of SARS-CoV-2 main protease using molecular dynamics simulations.
33834772 2021. Insights into SARS-CoV-2's Mutations for Evading Human Antibodies: Sacrifice and Survival.
33830171 2021. S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021.
33835019 2021. Implication de la cascade du complement dans les formes severes de COVID-19.
33856143 2021. A clinical variant of coronavirus disease 2019 with diarrhoea as the initial symptom compared with other variants.
33951359 2021. Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control.
34040250 2021. Had COVID? You'll probably make antibodies for a lifetime.
34050346 2021. Daily briefing: What we know about fast-spreading coronavirus variants.
33990783 2021. Coronapod: The variant blamed for India's catastrophic second wave.
33986504 2021. How a worrisome coronavirus variant spread unnoticed.
33979833 2021. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis.
34030176 2021. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.
34010947 2021. Diverse functional autoantibodies in patients with COVID-19.

33348007 2021. The role of renin-angiotensin system activated phagocytes in the SARS-CoV-2 coronavirus infection.
33999400 2021. Hyperinflammation hos vuxna med covid-19 - ovanligt men allvarligt.
33969329 2021. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics.
33880456 2021. Mounting evidence of impaired viral control in severe COVID-19.
34000237 2021. A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19.
33965003 2021. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity.
34095856 2021. Defining COVID-19-associated hyperinflammatory syndrome in specific populations.
33299142 2021. SARS-CoV-2 antibody responses in patients with acute leukaemia.
33921938 2021. Temporal Dominance of B.1.1.7 over B.1.354 SARS-CoV-2 Variant: A Hypothesis Based on Areas of Variant Co-Circulation.
34087834 2021. Multi-system inflammatory syndrome in children during the coronavirus disease 2019 in Saudi Arabia: Clinical perspective from a case series.
34099172 2021. SARS-CoV-2 3a expression, purification, and reconstitution into lipid nanodiscs.
34042471 2021. Genome Sequencing Identified a SARS-CoV-2 Lineage B.1.1.7 Strain with a High Number of Mutations from Dhaka, Bangladesh.
34016683 2021. Complete Genome Sequence of a SARS-CoV-2 Strain Sampled in Morocco in May 2020, Obtained Using Sanger Sequencing.
33888505 2021. Report of SARS-CoV-2 B1.1.7 Lineage in Morocco.
33858933 2021. Genome Sequences of Three SARS-CoV-2 ORF7a Deletion Variants Obtained from Patients in Hong Kong.
33858931 2021. Genome Sequences of Five SARS-CoV-2 Variants from Mumbai, India, Obtained by Nanopore Sequencing.
34103074 2021. SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment.
33853691 2021. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity.
33904651 2021. Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut.
33852796 2021. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
33897804 2021. Inherited and acquired corona of coronavirus in the host: Inspiration from the biomolecular corona of nanoparticles.
34046592 2021. A map of the SARS-CoV-2 RNA structurome.
34098792 2021. Multisystem Inflammatory Syndrome in Children and COVID-19 Infections.
34035301 2021. Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.
34021148 2021. Peripheral and lung resident memory T cell responses against SARS-CoV-2.
34021143 2021. Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes.
34011939 2021. Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection.
33990585 2021. Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions.
33986286 2021. Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein.
33976165 2021. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.
33976134 2021. SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes.
33972535 2021. Identification and characterization of a SARS-CoV-2 specific CD8(+) T cell response with immunodominant features.
34103506 2021. Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1.
34103499 2021. A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses.
34078893 2021. A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2'-O methylation of its first nucleotide.
33824342 2021. T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.
33879890 2021. Single-cell multi-omics analysis of the immune response in COVID-19.
33349665 2021. The SARS-CoV-2 RNA-protein interactome in infected human cells.
33854230 2021. Seeing SARS-CoV-2 variants through the eyes of T cells.
33990788 2021. Single-cell atlases dissect tissue destruction by SARS-CoV-2.
33927374 2021. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.
33910211 2021. Evolution of SARS-CoV-2: Review of Mutations, Role of the Host Immune System.
33936746 2021. Extensive genetic diversity with novel mutations in spike glycoprotein of severe acute respiratory syndrome coronavirus 2, Bangladesh in late 2020.
33846689 2021. First detection of SARS-CoV-2 variant B.1.1.7 in Senegal.
34026228 2021. Evaluation of oxidative stress level: total antioxidant capacity, total oxidant status and glutathione activity in patients with COVID-19.
33969248 2021. The Intersection of COVID-19 and Autoimmunity: What is Our Current Understanding?
34072434 2021. S-Acylation of Proteins of Coronavirus and Influenza Virus: Conservation of Acylation Sites in Animal Viruses and DHHC Acyltransferases in Their Animal Reservoirs.
34064143 2021. The Emerging Concern and Interest SARS-CoV-2 Variants.
34067881 2021. Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old Man.
33868814 2021. Multi-schema computational prediction of the comprehensive SARS-CoV-2 vs. human interactome.
34021074 2021. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Iota.
34088793 2021. Altered amino acid profile in patients with SARS-CoV-2 infection.
34083352 2021. The total number and mass of SARS-CoV-2 virions.
34045361 2021. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein.
34031243 2021. Transfer transcriptomic signatures for infectious diseases.
33361333 2021. Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein.
33361332 2021. DeepTracer for fast de novo cryo-EM protein structure modeling and special studies on CoV-related complexes.
34055582 2021. SARS-CoV-2 infection with lytic and non-lytic immune responses: A fractional order optimal control theoretical study.
34076402 2021. New variants of SARS-CoV-2.
33888467 2021. SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity.
33863729 2021. The SARS-CoV-2 Spike variant D614G favors an open conformational state.
33853786 2021. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking.
34095639 2021. Serologic response to SARS-CoV-2 in an African population.
34047913 2021. NPC1-regulated dynamic of clathrin-coated pits is essential for viral entry.
34086155 2021. Distinct durability of IgM/IgG antibody responses in COVID-19 patients with differing severity.
33945070 2021. Longitudinal virological changes and underlying pathogenesis in hospitalized COVID-19 patients in Guangzhou, China.
33827897 2021. SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation.
34045585 2021. Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis.
34045524 2021. Dynamic changes in gene-to-gene regulatory networks in response to SARS-CoV-2 infection.
34099808 2021. SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions.
34088957 2021. Atomic force microscopy analysis of native infectious and inactivated SARS-CoV-2 virions.
33875719 2021. Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology.
33850271 2021. Pattern of inflammatory immune response determines the clinical course and outcome of COVID-19: unbiased clustering analysis.
33846375 2021. A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood.
33979301 2021. High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages.
33853970 2021. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.
34001847 2021. Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq.
33980808 2021. The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry.
33972497 2021. Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection.
34083512 2021. Sera proteomic features of active and recovered COVID-19 patients: potential diagnostic and prognostic biomarkers.
33837186 2021. Landscapes of SARS-CoV-2-reactive CD8(+) T cells: heterogeneity of host immune responses against SARS-CoV-2.
33895775 2021. Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain.
33895773 2021. RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-kappaB hyper-activation and inflammation.
33863870 2021. COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas.
33309104 2021. Using Genetics To Dissect SARS-CoV-2 Infection.
34088317 2021. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
33931090 2021. The basic reproductive number and particle-to-plaque ratio: comparison of these two parameters of viral infectivity.
33910569 2021. Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes.
33900543 2021. Genetic Mutation of SARS-CoV-2 during Consecutive Passages in Permissive Cells.
33851337 2021. Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing.
34034617 2021. Time-dependent viral interference between influenza virus and coronavirus in the infection of differentiated porcine airway epithelial cells.
34030593 2021. Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis.
33961897 2021. Epitope mapping of severe acute respiratory syndrome-related coronavirus nucleocapsid protein with a rabbit monoclonal antibody.
33940003 2021. Pathogenic perspective of missense mutations of ORF3a protein of SARS-CoV-2.
34071984 2021. The Spike of Concern-The Novel Variants of SARS-CoV-2.
34073577 2021. Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays.
34073177 2021. Epidemic Spread of SARS-CoV-2 Lineage B.1.1.7 in Brazil.
34067349 2021. Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19.
34070055 2021. Prediction and Evolution of the Molecular Fitness of SARS-CoV-2 Variants: Introducing SpikePro.
34067890 2021. Structural Analysis of the Novel Variants of SARS-CoV-2 and Forecasting in North America.
34067878 2021. Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2.
34067745 2021. An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India.
34066091 2021. Cascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein Interactions.
34064904 2021. Mutation in a SARS-CoV-2 Haplotype from Sub-Antarctic Chile Reveals New Insights into the Spike's Dynamics.
34068703 2021. Virological Correlates of IgM-IgG Patterns of Response to SARS-CoV-2 Infection According to Targeted Antigens.
33925492 2021. The Significance of Phenotyping and Quantification of Plasma Extracellular Vesicles Levels Using High-Sensitivity Flow Cytometry during COVID-19 Treatment.
33922936 2021. Within-Host and Between-Host Evolution in SARS-CoV-2-New Variant's Source.
33923338 2021. From Multiplex Serology to Serolomics-A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome.
33919314 2021. A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.
33918371 2021. FIB-SEM as a Volume Electron Microscopy Approach to Study Cellular Architectures in SARS-CoV-2 and Other Viral Infections: A Practical Primer for a Virologist.
33921873 2021. Arthropod Ectoparasites Have Potential to Bind SARS-CoV-2 via ACE.
33923828 2021. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.

33867312 2021. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients.
33857905 2021. High dimensional cytokine panels reveal common SARS-CoV-2-related inflammation patterns across different latitudes.
33840632 2021. Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study.
34056568 2021. A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States.
33922613 2021. Semicovariance Coefficient Analysis of Spike Proteins from SARS-CoV-2 and Other Coronaviruses for Viral Evolution and Characteristics Associated with Fatality.
33824882 2021. Viral reverse engineering using Artificial Intelligence and big data COVID-19 infection with Long Short-term Memory (LSTM).
34013161 2021. Coronary artery ectasia in a child after arterial switch operation for transposition of the great arteries and suspected multisystem inflammatory syndrome in children associated with COVID-19: a case report.
34017166 2021. Analysis of Emerging Variants in Structured Regions of the SARS-CoV-2 Genome.
34040499 2021. Potential role of Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in SARS-CoV-2 infection: First insights.
33883984 2021. Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis.
33325750 2021. Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana.
33849359 2021. The importance of genomic analysis in cracking the coronavirus pandemic.
33929923 2021. Can proteomics-based approaches further help COVID-19 prevention and therapy?
34026045 2021. Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold coronaviruses.
33996638 2021. The Unfolded Protein Response and Autophagy on the Crossroads of Coronaviruses Infections.
33889552 2021. IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection.
33968142 2021. Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study.
33828579 2021. Epigenetic Lens to Visualize the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in COVID-19 Pandemic.
34093595 2021. Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay.
34084167 2021. SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1.
34079547 2021. Quantification of Cytokine Storms During Virus Infections.
34054876 2021. Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course.
34054828 2021. The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?
34054820 2021. Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis.
34054808 2021. Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.
34054793 2021. Identify. Quantify. Predict. Why Immunologists Should Widely Use Molecular Imaging for Coronavirus Disease 2019.
34046036 2021. Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis.
34040616 2021. The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome.
34025675 2021. Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health.
33995382 2021. SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs.
33995366 2021. A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain.
33995364 2021. Cellular Immune Response to COVID-19 and Potential Immune Modulators.
33995351 2021. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
33995341 2021. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
33981314 2021. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
33968063 2021. Enhancing the Prefusion Conformational Stability of SARS-CoV-2 Spike Protein Through Structure-Guided Design.
33959123 2021. Circulating Adaptive Immune Cells Expressing the Gut Homing Marker alpha4beta7 Integrin Are Decreased in COVID-19.
33936086 2021. SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia.
33936072 2021. Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019.
33936053 2021. Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19.
33936045 2021. Antibody Responses in COVID-19: A Review.
33936026 2021. Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus.
33927728 2021. Interplay of Opposing Effects of the WNT/beta-Catenin Pathway and PPARgamma and Implications for SARS-CoV2 Treatment.
33912161 2021. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19.
33868301 2021. Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19.
33868293 2021. MicroLet-7b Regulates Neutrophil Function and Dampens Neutrophilic Inflammation by Suppressing the Canonical TLR4/NF-kappaB Pathway.
33854501 2021. Integrin Activation Enables Sensitive Detection of Functional CD4(+) and CD8(+) T Cells: Application to Characterize SARS-CoV-2 Immunity.
33841442 2021. Understanding of COVID-19 Pathology: Much More Attention to Plasma Proteins.
33841438 2021. Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-gamma Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome.
33841435 2021. Neutrophils in COVID-19.
33833755 2021. SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients.
33889583 2021. First Report on the Latvian SARS-CoV-2 Isolate Genetic Diversity.
34093495 2021. Genomic Epidemiology of SARS-CoV-2 From Mainland China With Newly Obtained Genomes From Henan Province.
34093454 2021. Antigenic Evolution on a Global Scale Reveals the Potential Natural Selection of Severe Acute Respiratory Syndrome-Coronavirus 2 by Pre-existing Cross-Reactive T-Cell Immunity.
34025615 2021. Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors.
33935986 2021. Interrogating the Impact of Intestinal Parasite-Microbiome on Pathogenesis of COVID-19 in Sub-Saharan Africa.
33889134 2021. Base Composition and Host Adaptation of the SARS-CoV-2: Insight From the Codon Usage Perspective.
33996911 2021. Computational Identification of a Putative Allosteric Binding Pocket in TMPRSS2.
34045976 2021. Alteration in the Lipid Profile and the Desaturases Activity in Patients With Severe Pneumonia by SARS-CoV-2.
33912067 2021. The Affinity of Hemoglobin for Oxygen Is Not Altered During COVID-19.
33825125 2021. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity.
33840038 2021. The first familial cluster of the B.1.1.7 variant of SARS-CoV-2 in the northeast of Italy.
33346851 2021. Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia.
34086061 2021. The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications.
33864915 2021. Is it all MIS-C? Unusual findings in a series of nine German patients with multi-system inflammatory syndrome in children after SARS-CoV-2 infection.
34058196 2021. Role of host factors in SARS-CoV-2 entry.
34029587 2021. Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication.
33965375 2021. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection.
33844652 2021. SARS-CoV-2 as a superantigen in multisystem inflammatory syndrome in children.
33830946 2021. Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses.
34003804 2021. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19.
33626241 2021. COVID-19 and human papillomavirus: Paradoxical immunity.
34023553 2021. Viral load dynamics in intubated patients with COVID-19 admitted to the intensive care unit.
33861846 2021. Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection.
33904890 2021. SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
33890986 2021. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.
33963016 2021. Immune profiling of COVID-19: preliminary findings and implications for the pandemic.
33889008 2021. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications.
33859488 2021. Decreased T Cell Levels in Critically Ill Coronavirus Patients: Single-Center, Prospective and Observational Study.
33833547 2021. Interferon-lambda3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 Pathogenesis.
33833543 2021. Association of Early Inflammation with Age and Asymptomatic Disease in COVID-19.
33915711 2021. Previous Humoral Immunity to the Endemic Seasonal Alphacoronaviruses NL63 and 229E Is Associated with Worse Clinical Outcome in COVID-19 and Suggests Original Antigenic Sin.
33984360 2021. Beclin-1, an autophagy-related protein, is associated with the disease severity of COVID-19.
34007097 2021. Discrete and continuum models of COVID-19 virus, formal solutions, stability and comparison with real data.
33849978 2021. Interferon-Independent Restriction of RNA Virus Entry and Replication by a Class of Damage-Associated Molecular Patterns.
33849972 2021. SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98.
33870241 2021. Mucosal-associated invariant T cell responses differ by sex in COVID-19.
33873150 2021. The role of carbohydrate antigen 125 in COVID-19.
33308936 2021. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory.
34059225 2021. Living evidence for SARS-CoV-2.
34111831 2021. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19).
34109258 2021. Use of Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry Analysis of Serum Peptidome to Classify and Predict Coronavirus Disease 2019 Severity.
33872279 2021. Multisystem Inflammatory Syndrome in Infants <12 months of Age, United States, May 2020-January 2021.
34009707 2021. Multisystem inflammatory syndrome associated with SARS-CoV-2 in a Japanese girl.
33934422 2021. Predictable fold switching by the SARS-CoV-2 protein ORF9b.
33983654 2021. Comparative protein structure network analysis on 3CL(pro) from SARS-CoV-1 and SARS-CoV-2.
33864655 2021. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor.
33860983 2021. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
33945677 2021. Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression.
33987944 2021. Proteomic and metabolomic investigation of serum lactate dehydrogenase elevation in COVID-19 patients.
33947773 2021. Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes.
34028939 2021. Development and longevity of antibodies against SARS-CoV-2 in kidney transplant recipients after symptomatic COVID-19.
33845483 2021. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
33915569 2021. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.
33915568 2021. A molecular single-cell lung atlas of lethal COVID-19.
33864048 2021. Daily briefing: Video guide to the science of coronavirus variants.
33854226 2021. Coronavirus variants: what viral mutants mean for the pandemic.
34097663 2021. Rationale of Therapeutic Plasma Exchange as Rescue Immunomodulatory Treatment for MIS-C With Multiorgan Failure.
34016834 2021. Coronavirus Disease 2019-associated Cytotoxic Lesions of the Corpus Callosum Diagnosis As a Result of Hallucination in a Child With Multisystem Inflammatory Syndrome in Children.
33298763 2021. Abdominal Imaging Findings in Critically Ill Children With Multisystem Inflammatory Syndrome Associated With COVID-19.
34032527 2021. The understanding of the immunopathology in COVID-19 infection.
33986163 2021. Do coronavirus genes slip into human chromosomes?

34009775 2020. Scientific Brief: SARS-CoV-2 Transmission
34009774 2020. Science Brief: Emerging SARS-CoV-2 Variants
34056088 2021. Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike.
33988161 2021. Pediatric inflammatory multisystem disease in children with COVID-19.
33988157 2021. Pediatric inflammatory multisystem disease in children with COVID-19 - Reply.
33971111 2021. SARS-CoV-2 Infection Is Associated with Reduced Kruppel-like Factor 2 in Human Lung Autopsy.
33841649 2021. Correlation of the ratio of IgM/IgG concentration to days after symptom onset (IgM/T or IgG/T) with disease severity and outcome in non-critical COVID-19 patients.
33345622 2021. Increased expression of hypoxia-induced factor 1alpha mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients.
33327744 2021. Journey to a Receptor for Advanced Glycation End Products Connection in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: With Stops Along the Way in the Lung, Heart, Blood Vessels, and Adipose Tissue.
33872769 2021. Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent.
33864942 2021. Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?
33899609 2021. COVID-19: captures iron and generates reactive oxygen species to damage the human immune system.
33894532 2021. Relevance of carotid bodies in COVID-19: A hypothetical viewpoint.
34013072 2021. Sequence and structural analysis of COVID-19 E and M proteins with MERS virus E and M proteins-A comparative study.
33894414 2021. In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5.
34000512 2021. SARS-Cov-2 spike protein fragment 674-685 protects mitochondria from rele<iframe src="http://www.kidney.de/amapp.php?a=g cytochrome c in response to apoptogenic influence.
34062392 2021. Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant.
34049205 2021. Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective.
33360543 2021. Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex.
33367597 2021. Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies.
33900725 2021. Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations.
33838638 2021. Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection.
33838626 2021. Recombinant SARS-CoV-2 S Protein Binds to Glycans of the Lactosamine Family in vitro.
33338598 2021. Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study.
33932525 2021. Genome sequencing of SARS-CoV-2 in a cohort of Egyptian patients revealed mutation hotspots that are related to clinical outcomes.
33984400 2021. Molecular simulation studies of the interactions between the human/pangolin/cat/bat ACE2 and the receptor binding domain of the SARS-CoV-2 spike protein.
34092964 2021. D614G substitution at the hinge region enhances the stability of trimeric SARS-CoV-2 spike protein.
33600624 2021. Intracellular host cell membrane remodelling induced by SARS-CoV-2 infection in vitro.
33986591 2021. Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target.
34072585 2021. Immune Responses to SARS-CoV2 Mirror Societal Responses to COVID-19: Identifying Factors Underlying a Successful Viral Response.
34064163 2021. Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility.
34046413 2021. Potential Role of the Galectin-9/TIM-3 Axis in the Disparate Progression of SARS-CoV-2 in a Married Couple: A Case Report.
33915502 2021. Novel and emerging mutations of SARS-CoV-2: Biomedical implications.
34066729 2021. Mutations in the B.1.1.7 SARS-CoV-2 Spike Protein Reduce Receptor-Binding Affinity and Induce a Flexible Link to the Fusion Peptide.
33920487 2021. Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective.
33928512 2021. (1)H, (13)C, (15)N and (31)P chemical shift assignment for stem-loop 4 from the 5'-UTR of SARS-CoV-2.
33914244 2021. The (1)H, (15)N, and (13)C resonance assignments of the N-terminal domain of the nucleocapsid protein from the Middle East respiratory syndrome coronavirus.
33660218 2021. The highly flexible disordered regions of the SARS-CoV-2 nucleocapsid N protein within the 1-248 residue construct: sequence-specific resonance assignments through NMR.
33875625 2021. Multifactorial Traits of SARS-CoV-2 Cell Entry Related to Diverse Host Proteases and Proteins.
33925394 2021. Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach.
33340543 2021. Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase.
34087218 2021. Neuropilin-1 assists SARS-CoV-2 infection by stimulating the separation of Spike protein S1 and S2.
34087216 2021. Physical phenotype of blood cells is altered in COVID-19.
34087207 2021. Enhanced sampling protocol to elucidate fusion peptide opening of SARS-CoV-2 spike protein.
33984310 2021. Computational optimization of the SARS-CoV-2 receptor-binding-motif affinity for human ACE2.
33359834 2021. The Molecular Mechanism of Domain Swapping of the C-Terminal Domain of the SARS-Coronavirus Main Protease.
34095806 2021. Virology features of a family cluster of SARS-CoV-2 infections in Shanghai, China.
33350432 2021. Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19.
33305306 2021. Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potential.
34047452 2021. SARS-CoV-2 first contact: Spike-ACE2 interactions in COVID-19.
33895815 2021. Mutation Rates and Selection on Synonymous Mutations in SARS-CoV-2.
34001247 2021. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
33883027 2021. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.
33879239 2021. IFN-gamma and TNF-alpha drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation.
33875001 2021. Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispecies.
34019999 2021. Comparative analysis of human coronaviruses focusing on nucleotide variability and synonymous codon usage patterns.
33839270 2021. ACoRE: Accurate SARS-CoV-2 genome reconstruction for the characterization of intra-host and inter-host viral diversity in clinical samples and for the evaluation of re-infections.
33951417 2021. CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.
33945786 2021. CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses.
33891889 2021. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children.
34051148 2021. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.
34048708 2021. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2.
34022127 2021. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.
33915108 2021. Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections.
33338412 2021. PD-1-Expressing SARS-CoV-2-Specific CD8(+) T Cells Are Not Exhausted, but Functional in Patients with COVID-19.
33357409 2021. The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells.
34022670 2021. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.
33928531 2021. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).
33921604 2021. Absence of "Cytokine Storm" in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.
34050885 2021. Dynamic Antibody Responses in Patients with Different Severity of COVID-19: A Retrospective Study.
34044192 2021. E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil.
34004362 2021. Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis.
34004360 2021. Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2.
33951560 2021. Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients.
33932696 2021. A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19).
33347989 2021. Different mutations in SARS-CoV-2 associate with severe and mild outcome.
33359807 2021. SARS-Cov-2 ORF3a: Mutability and function.
33932604 2021. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection.
33901653 2021. Antibody and viral RNA kinetics in SARS-CoV2 infected patients admitted to a Romanian University Hospital of Infectious Diseases.
33932603 2021. Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors.
34073283 2021. Induction of the Proinflammatory Chemokine Interleukin-8 Is Regulated by Integrated Stress Response and AP-1 Family Proteins Activated during Coronavirus Infection.
34067272 2021. Altered Local Interactions and Long-Range Communications in UK Variant (B.1.1.7) Spike Glycoprotein.
33989635 2021. Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template.
33965637 2021. A scheme for inferring viral-host associations based on codon usage patterns identifies the most affected signaling pathways during COVID-19.
34106885 2021. Kawasaki like illness due to COVID-19: a review of the literature.
33367897 2021. Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2.
33961690 2021. Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
33895266 2021. N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 M(pro) Dimer.
34023401 2021. Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants.
33992693 2021. Structural Modeling of the SARS-CoV-2 Spike/Human ACE2 Complex Interface can Identify High-Affinity Variants Associated with Increased Transmissibility.
33310017 2021. The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition.
33340519 2021. Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition.
33677567 2021. Entry, egress and vertical transmission of SARS-CoV-2.
33760045 2021. Membraneless organelles restructured and built by pandemic viruses: HIV-1 and SARS-CoV-2.
33377937 2020. SARS-CoV-2 infection and the antiviral innate immune response.
33377928 2020. The development of neutralizing antibodies against SARS-CoV-2 and their common features.
33326034 2020. A promiscuous interaction of SARS-CoV-2 with bacterial products.
33993372 2021. The Evolution of Severe Acute Respiratory Syndrome Coronavirus-2 during Pandemic and Adaptation to the Host.
34023935 2021. Glycosylation is a key in SARS-CoV-2 infection.
34089819 2021. Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19.
33921718 2021. The Challenging Diagnosis of Pediatric Multisystem Inflammatory Syndrome Associated with Sars-Cov-2 Infection-Two Case Reports and Literature Review.
33825700 2021. Structural biology of coronavirus ion channels.
34086538 2021. The Central Role of PAI-1 in COVID-19: Thrombosis and beyond.
34003736 2021. ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial PAI-1.
34033529 2021. Importance of Lung Epithelial Injury in COVID-19-associated Acute Respiratory Distress Syndrome: Value of Plasma Soluble Receptor for Advanced Glycation End-Products.
33974890 2021. Gene selection using hybrid dragonfly black hole algorithm: A case study on RNA-seq COVID-19 data.
34088699 2021. Covid-19: Delta variant is now UK's most dominant strain and spreading through schools.
33942835 2021. Influence of charge configuration on substrate binding to SARS-CoV-2 main protease.
34037640 2021. Immune evasion of SARS-CoV-2 variants of concern is driven by low affinity to neutralizing antibodies.
34019602 2021. ACE2 glycans preferentially interact with SARS-CoV-2 over SARS-CoV.
33902795 2021. Experimental Identification of Immuno- dominant B-cell Epitopes from SARS-CoV-2.
34074849 2021. Cytokine levels and pathological characteristics of a patient with severe coronavirus disease 2019: a case report.

33992073 2021. Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population.
33991487 2021. Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.
34015271 2021. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.
33974910 2021. Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.
33333024 2021. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.
33930298 2021. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
33930293 2021. SARS-CoV-2 RNA: Exclusive friends and common foes.
33831378 2021. The origins of viral infection sleuth.
33743891 2021. Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.
33879858 2021. SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination.
33981020 2021. Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes.
34035220 2021. Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery.
34006825 2021. Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells.
33947832 2021. The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes.
34035218 2021. SARS-CoV-2 nucleocapsid protein impairs stress granule formation to promote viral replication.
33850112 2021. Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages.
33984277 2021. An NTD supersite of attack.
33887205 2021. Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.
33984285 2021. Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans.
34022154 2021. Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19.
33357464 2021. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
33905951 2021. Functional responsiveness of memory T cells from COVID-19 patients.
33359760 2021. Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients.
33972738 2021. IL-33 in COVID-19: friend or foe?
34059791 2021. Cross-reactive antibody immunity against SARS-CoV-2 in children and adults.
33318627 2021. Severe COVID-19 patients exhibit an ILC2 NKG2D(+) population in their impaired ILC compartment.
34004174 2021. Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells.
34043946 2021. SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression.
33357411 2021. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.
33857422 2021. SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization.
34027499 2021. SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition.
33969320 2021. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions.
33899033 2021. Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
33899032 2021. Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome.
34075365 2021. Broad auto-reactive IgM responses are common in critically ill patients, including those with COVID-19.
34056628 2021. Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions.
34056627 2021. Landscape of epitopes targeted by T cells in 852 individuals recovered from COVID-19: Meta-analysis, immunoprevalence, and web platform.
33997824 2021. Decay of Fc-dependent antibody functions after mild to moderate COVID-19.
33977279 2021. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.
33969322 2021. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset.
33842902 2021. Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.
33842901 2021. Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19.
34067965 2021. Impaired Glucose-Insulin Metabolism in Multisystem Inflammatory Syndrome Related to SARS-CoV-2 in Children.
33826953 2021. Clinical relevance of serum alpha-l-fucosidase activity in the SARS-CoV-2 infection.
33906227 2021. SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection.
33905478 2021. Disease severity and durability of the SARS-CoV-2 antibody response: A view through the lens of the second year of the pandemic.
33851216 2021. Sera neutralizing activities against SARS-CoV-2 and multiple variants six month after hospitalization for COVID-19.
33872970 2021. A unique view of SARS-CoV-2 through the lens of ORF8 protein.
34022485 2021. Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD.
34020131 2021. Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach.
34020127 2021. Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity.
33827651 2021. Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment.
33874973 2021. Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study.
34089541 2021. Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2 in humans and mice.
33913206 2021. Potential 3-chymotrypsin-like cysteine protease cleavage sites in the coronavirus polyproteins pp1a and pp1ab and their possible relevance to COVID-19 vaccine and drug development.
34033145 2021. High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients.
33864728 2021. Host PDZ-containing proteins targeted by SARS-CoV-2.
33991349 2021. A weak COPI binding motif in the cytoplasmic tail of SARS-CoV-2 spike glycoprotein is necessary for its cleavage, glycosylation, and localization.
33961290 2021. Serum levels of the IgA isotype switch factor TGF-beta1 are elevated in patients with COVID-19.
34086357 2021. SARS-CoV-2-specific CD8(+) T-cell responses and TCR signatures in the context of a prominent HLA-A24:02 allomorph.
34053124 2021. Monocytes and macrophages in severe COVID-19 - friend, foe or both?
34028807 2021. COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts.
33864388 2021. A concomitant diagnosis of COVID-19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report.
34078711 2021. Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation.
34042186 2021. Genome-wide analysis of SARS-CoV-2 strains circulating in Vietnam: Understanding the nature of the epidemic and role of the D614G mutation.
34009691 2021. Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leukocytes sequencing data set of patients with COVID-19.
34002405 2021. Emergence of the SARS-CoV-2 B.1.1.7 variant observed at the Poitiers University Hospital.
33990970 2021. Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case report.
33990965 2021. Multisystemic inflammatory syndrome in a young adult after SARS-CoV-2 infection: Case report.
33969513 2021. Coronavirus disease 2019 (COVID-19): A systematic review of 133 Children that presented with Kawasaki-like multisystem inflammatory syndrome.
33969504 2021. SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients.
33963559 2021. Cytokine storm in severe COVID-19 pneumonia.
33951211 2021. Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K.
33945634 2021. Determinants of IgG antibodies kinetics after severe and critical COVID-19.
33934387 2021. Betacoronaviruses genome analysis reveals evolution toward specific codons usage: Implications for SARS-CoV-2 mitigation strategies.
33913550 2021. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
33913546 2021. Comparable endemic coronavirus nucleoprotein-specific antibodies in mild and severe Covid-19 patients.
33913544 2021. Characterization of T lymphocytes in severe COVID-19 patients.
33913542 2021. Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach.
34061395 2021. Relative expression of proinflammatory molecules in COVID-19 patients who manifested disease severities.
34061367 2021. Longitudinal detection of SARS-CoV-2-specific antibody responses with different serological methods.
33837972 2021. Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target.
33830520 2021. SARS-CoV-2 show no infectivity at later stages in a prolonged COVID-19 patient despite positivity in RNA testing.
33818797 2021. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.
33811680 2021. Downregulation of type III interferons in patients with severe COVID-19.
33782995 2021. Transmissibility and viral replication of SARS-COV-2 in immunocompromised patients.
33755226 2021. Cross-immunity and trained immunity in explaining variable COVID-19 mortality-Guidance for future pandemics.
33739452 2021. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
33713457 2021. Development of neutralizing antibody responses against SARS-CoV-2 in COVID-19 patients.
33704818 2021. Immunoinformatic analysis of structural and epitope variations in the spike and Orf8 proteins of SARS-CoV-2/B.1.1.7.
33893169 2021. Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.
33848432 2021. IL-6 Induction and Signaling: Horizons of COVID-19-Related Pathogenesis.
33872068 2021. COVID-19: A Mitochondrial Perspective.
34081326 2021. Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells.
33955468 2021. Molecular diversity of coronavirus host cell entry receptors.
33951416 2021. Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection.
34035081 2021. Navigating in Deep Waters: How Tissue Damage and Inflammation Shape Effector and Memory CD8(+) T Cell Responses.
34042182 2021. Unknown/enigmatic functions of extracellular ASC.
34049969 2021. Metabolic Defects of Peripheral T Cells in COVID-19 Patients.
33941660 2021. Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis.
33941657 2021. Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients.
33846224 2021. Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
33980582 2021. Identification of T Cell Epitopes in the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2 in Rhesus Macaques.
33972373 2021. Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination.
33952616 2021. Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain.
33911008 2021. Genome-Wide B Cell, CD4(+), and CD8(+) T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines.
33298615 2021. A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4(+) and CD8(+) T Cells in COVID-19 Patients.
33605463 2021. Toward an understanding of regulatory T cells in COVID-19: A systematic review.
33368386 2021. Dynamic tracking of variant frequencies depicts the evolution of mutation sites amongst SARS-CoV-2 genomes from India.
33347622 2021. Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.
33999091 2021. Key residues of the receptor binding domain in the spike protein of SARS-CoV-2 mediating the interactions with ACE2: a molecular dynamics study.
33953384 2021. Delayed production of neutralizing antibodies correlates with fatal COVID-19.

34017137 2021. CD8(+) T cells contribute to survival in patients with COVID-19 and hematologic cancer.
34045737 2021. SARS-CoV-2 variants of concern are emerging in India.
34035535 2021. COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence.
34002089 2021. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
33907312 2021. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.
33328624 2021. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice.
34116467 2021. Multisystem inflammatory syndrome in children with COVID-19.
34154831 2021. The comparison of oxidative markers between Covid-19 patients and healthy subjects.
34134920 2021. Vasoactive Peptides: Their Role in COVID-19 Pathogenesis and Potential Use as Biomarkers and Therapeutic Targets.
34118455 2021. Autoimmunity and COVID-19 - The microbiotal connection.
34116356 2021. Analysis of the molecular mechanism of SARS-CoV-2 antibodies.
34121839 2021. Bioinformatics Analysis Unveils Certain Mutations Implicated in Spike Structure Damage and Ligand-Binding Site of Severe Acute Respiratory Syndrome Coronavirus 2.
34153851 2021. Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options.
34144455 2021. Identification of oligopeptides from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non structural protein 8 (NSP8) and their similarities with type 1 angiotensin II receptor key sites.
34103044 2021. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar.
34155633 2021. Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations'.
34160596 2021. LSTM-PHV: prediction of human-virus protein-protein interactions by LSTM with word2vec.
34134808 2021. Cardiac manifestations and short-term outcomes of multisystem inflammatory syndrome in Middle Eastern children during the COVID-19 pandemic: a case series.
34166652 2021. TRP channels in COVID-19 disease: Potential targets for prevention and treatment.
34127868 2021. Dynamic properties of SARS-CoV and SARS-CoV-2 RNA-dependent RNA polymerases studied by molecular dynamics simulations.
34163622 2021. A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design.
34168762 2021. High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.
34123218 2020. Unveiling the molecular mechanism of SARS-CoV-2 main protease inhibition from 137 crystal structures using algebraic topology and deep learning.
34132013 2021. alphaV beta6 Integrin: An Intriguing Target for COVID-19 and Related Diseases.
34160124 2021. Preliminary Structural Data Revealed That the SARS-CoV-2 B.1.617 Variant's RBD Binds to ACE2 Receptor Stronger Than the Wild Type to Enhance the Infectivity.
34155573 2021. Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease.
34127355 2021. Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19.
34183243 2021. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.
34125495 2021. Impact of age and gender on lymphocyte subset counts in patients with COVID-19.
34183244 2021. Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.
34164811 2021. IFN-gamma(+) cell response and IFN-gamma release concordance after in vitro SARS-CoV-2 stimulation.
34114541 2021. The SARS-CoV-2 B.1.351 lineage (VOC beta) is outgrowing the B.1.1.7 lineage (VOC alpha) in some French regions in April 2021.
34149696 2021. SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage.
34127926 2021. Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity.
34122423 2021. Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.
34122416 2021. Potent and Persistent Antibody Response in COVID-19 Recovered Patients.
34122407 2021. Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection.
34113347 2021. A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19.
34108966 2021. Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19.
34178896 2021. Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?
34178893 2021. Pediatric Multisystem Inflammatory Syndrome in Children as a Challenging Problem for Pediatric Surgeons in the COVID 19 Pandemic-A Case Report.
34178891 2021. Efficacy of CytoSorb in a Pediatric Case of Severe Multisystem Infammatory Syndrome (MIS-C): A Clinical Case Report.
34178882 2021. Multisystem Inflammatory Syndrome in Children (MIS-C)-A Case Series in December 2020 in Vienna, Austria.
34150685 2021. Multisystemic Inflammatory Syndrome and Thrombotic Microangiopathy as Complications of COVID-19 in a Child: A Case Report.
34123977 2021. Pediatric Obesity-A Potential Risk Factor for Systemic Inflammatory Syndrome Associated to COVID-19, a Case Report.
34123970 2021. Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland.
34109148 2021. Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19.
34183466 2021. Clinical Spectrum of Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection.
34116286 2021. Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity.
34121407 2021. Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics.
34182794 2021. Mapping the Nonstructural Transmembrane Proteins of Severe Acute Respiratory Syndrome Coronavirus 2.
34128580 2021. Case reports of annular erythema: A diagnostic clue of multisystem inflammatory syndrome in children related to coronavirus disease 2019?
34161567 2021. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
34186336 2021. Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis.
34118414 2021. 7-Ketocholesterol: Effects on viral infections and hypothetical contribution in COVID-19.
34185704 2021. IL-13 is a driver of COVID-19 severity.
34166229 2021. Autoantibodies stabilize neutrophil extracellular traps in COVID-19.
34143754 2021. Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses.
34154708 2021. COVID-19 and the multisystem inflammatory syndrome in children: how vulnerable are the kidneys?
34139198 2021. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.
34171234 2021. SARS-CoV-2 variants and considerations of inferring causality on disease severity.
34171232 2021. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
34171231 2021. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
34139598 2021. Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19?
34173452 2020. Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.
34121378 2021. A case of B.1.1.7 SARS-CoV-2 UK strain with an atypical radiological presentation.
34128696 2021. Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021.
34119708 2021. Is haem the real target of COVID-19?
34177077 2021. Synchronized attachment and the Darwinian evolution of coronaviruses CoV-1 and CoV-2.
34143766 2021. The landscape of antibody binding in SARS-CoV-2 infection.
34185681 2021. AI-based spectroscopic monitoring of real-time interactions between SARS-CoV-2 and human ACE2.
34140350 2021. Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
34121829 2021. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; revisiting the Western New York approach as the pandemic evolves.
34184718 2021. Linfohistiocitosis hemofagocitica secundaria y sindrome de liberacion de citoquinas en COVID-19, inverted question markentidades iguales o diferentes?
34127534 2021. Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein.
34117209 2021. Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity.
34179694 2021. SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report.
34124695 2021. Protein purification and crystallization of HLA-A 02:01 in complex with SARS-CoV-2 peptides.
34181186 2021. Role of Glycoprotein Hemagglutinin-Esterase in COVID-19 Pathophysiology?
34155611 2021. Stress Decreases Host Viral Resistance and Increases Covid Susceptibility in Embryonic Stem Cells.
34151035 2021. Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19.
34114198 2021. Complexities in viral replication strategies as a potential explanation for prevalence of asymptomatic carriers in Covid-19 infections: analytical observation on SARS-Cov2 genome characteristics.
34158856 2021. TRPV2-spike protein interaction mediates the entry of SARS-CoV-2 into macrophages in febrile conditions.
34104908 2021. Multisystemic inflammatory syndrome in children associated with COVID-19: a single center experience in Turkey.
34160770 2021. Clinical characteristics of Kawasaki disease and concurrent pathogens during isolation in COVID-19 pandemic.
34164955 2021. Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.
34115386 2021. Kawasaki-like multisystem inflammatory syndrome associated with COVID-19 in an adult: a case report.
34143202 2021. Understanding structural malleability of the SARS-CoV-2 proteins and relation to the comorbidities.
34121111 2021. Co-mutation modules capture the evolution and transmission patterns of SARS-CoV-2.
34107645 2021. Profiling Inflammatory Cytokines in a Cohort Study of Egyptian Patients with COVID-19 Infection.
34116534 2021. Letter to the Editor: Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
34165401 2021. Interfering Reactive Cysteine Proteome in Covid-19 Disease.
34161984 2021. The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19.
34160586 2021. The immunopathobiology of SARS-CoV-2 infection.
34085882 2021. Potential role of free-radical processes in biomolecules damage during COVID-19 and ways of their regulation.
34105843 2021. Multisystem inflammatory syndrome in children (MISC): A systematic review.
34100279 2021. Be aware of SARS-CoV-2 spike protein: There is more than meets the eye.
34133162 2021. Interactive Interface for Graph-Based Analyses of Dynamic H-Bond Networks: Application to Spike Protein S.
34138559 2021. Dynamic Profiling of Binding and Allosteric Propensities of the SARS-CoV-2 Spike Protein with Different Classes of Antibodies: Mutational and Perturbation-Based Scanning Reveals the Allosteric Duality of Functionally Adaptable Hotspots.
34145203 2021. No Increase in Kawasaki Disease-Like Illnesses During the COVID-19 Pandemic Compared With 4 Previous Years: A Retrospective Analysis.
34176363 2021. The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.
34166506 2021. Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection.
34161170 2021. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.
34181987 2021. Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.
34133374 2021. Multisystem Inflammatory Syndrome in Children During Induction Chemotherapy in a Newly Diagnosed Pediatric Acute Myeloid Leukemia and Concurrent COVID-19.
34173667 2021. Retropharyngeal Edema and Neck Pain in Multisystem Inflammatory Syndrome in Children (MIS-c).
34110264 2021. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
34105996 2021. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
34132373 2021. SARSCoV2 spike proteininduced host inflammatory response signature in human corneal epithelial cells.
34107199 2021. Identifying and Tracking SARS-CoV-2 Variants - A Challenge and an Opportunity.
34108657 2021. Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19.
34108656 2021. Immune memory in individuals with COVID-19.
34183855 2021. A STING in the tail for SARS-CoV-2.
34155406 2021. SARS-CoV-2-specific hotspots in virus-host interaction networks.
34103714 2021. SARS-CoV-2 takes its Toll.
34183391 2021. IgA potentiates NETosis in response to viral infection.
34148697 2020. Sindrome inflamatorio multisistemico de tipo Kawasaki asociado a COVID-19 en un adulto.
34088785 2021. Immune responses to SARS-CoV-2 in the lung.

34179666 2021. Landscape-Based Mutational Sensitivity Cartography and Network Community Analysis of the SARS-CoV-2 Spike Protein Structures: Quantifying Functional Effects of the Circulating D614G Variant.
34179644 2021. Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein.
34115965 2021. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals.
34125890 2021. Possible Pleiotropic Effect Of Sry Gene May Increase Male Susceptibility To Covid-19.
34185889 2021. An epigenome-wide DNA methylation study of patients with COVID-19.
34101005 2021. Antibody response in COVID-19 patients with and without re-positive RT-PCR results during the convalescent phase.
34116667 2021. A blood RNA transcriptome signature for COVID-19.
34130987 2021. Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis.
34102147 2021. New Brazilian variant of the SARS-CoV-2 (P1/Gamma) of COVID-19 in Alagoas state.
34184738 2021. DeepIPs: comprehensive assessment and computational identification of phosphorylation sites of SARS-CoV-2 infection using a deep learning-based approach.
34111889 2021. Single-cell multi-omics sequencing: application trends, COVID-19, data analysis issues and prospects.
34143953 2021. Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.
34139176 2021. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.
34171305 2021. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.
34162440 2021. Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion.
34103487 2021. Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19.
34127650 2021. Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2.
34174992 2021. Antibody and B cell responses to SARS-CoV-2 infection and vaccination.
34171266 2021. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.
34108680 2021. Mucins produced by type II pneumocyte: culprits in SARS-CoV-2 pathogenesis.
34099890 2021. Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection.
34117354 2021. Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain.
34112887 2021. I(nsp1)ecting SARS-CoV-2-ribosome interactions.
34171504 2021. A computational analysis of molecular evolution for virulence genes of zoonotic novel coronavirus (COVID-19).
34166886 2021. Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak.
34157472 2021. Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection.
34184973 2021. Emergence of the novel SARS-CoV-2 lineage VUI-NP13L and massive spread of P.2 in South Brazil.
34125658 2021. Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations.
34150352 2021. Identification of Monocytes Associated with Severe COVID-19 in the PBMCs of Severely Infected patients Through Single-Cell Transcriptome Sequencing.
34179146 2021. SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity.
34124207 2021. The Notch Pathway: A Link Between COVID-19 Pathophysiology and Its Cardiovascular Complications.
34163530 2021. Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation.
34122515 2021. Transcriptional Start Site Coverage Analysis in Plasma Cell-Free DNA Reveals Disease Severity and Tissue Specificity of COVID-19 Patients.
34122498 2021. A Computational Framework for Pattern Detection on Unaligned Sequences: An Application on SARS-CoV-2 Data.
34177962 2021. Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease.
34177923 2021. SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNgamma-Induced Antiviral Gene Expression in Human Lung Epithelial Cells.
34177897 2021. Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics.
34163491 2021. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
34163490 2021. PD-L1 Dysregulation in COVID-19 Patients.
34149717 2021. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets.
34146758 2021. Analysis of endogenous oxidative damage markers and association with pulmonary involvement severity in patients with SARS-CoV-2 pneumonia.
34110618 2021. Dynamic Changes in the Immune Response Correlate with Disease Severity and Outcomes During Infection with SARS-CoV-2.
34163183 2021. Effect of Genomic and Amino Acid Sequence Mutation on Virulence and Therapeutic Target of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS COV-2).
34147651 2021. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
34146731 2021. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic.
34147667 2021. Detection of SARS-CoV-2 variants requires urgent global coordination.
34067854 2021. Viral Interactions with Adaptor-Protein Complexes: A Ubiquitous Trait among Viral Species.
34179732 2021. Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution.
34111453 2021. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.
34112485 2021. Reply to "Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium".
34112484 2021. Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium.
34112483 2021. Reply to "Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?"
34112482 2021. Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?
34181169 2021. SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19.
34137173 2021. Single-cell RNA sequencing identify SDCBP in ACE2-positive bronchial epithelial cells negatively correlates with COVID-19 severity.
34156227 2021. Anchor-Locker Binding Mechanism of the Coronavirus Spike Protein to Human ACE2: Insights from Computational Analysis.
34160366 2021. Zonulin as a biomarker and potential therapeutic target in multisystem inflammatory syndrome in children.
34153860 2021. Lack of active SARS-CoV-2 virus in a subset of PCR-positive COVID-19 congregate care patients.
34157514 2021. SARS-CoV-2 spike protein removes lipids from model membranes and interferes with the capacity of high density lipoprotein to exchange lipids.
34107824 2021. Of mitochondrion and COVID-19.
34146596 2021. The incubation period of the SARS-CoV-2 B1.1.7 variant is shorter than that of other strains.
34176716 2021. Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort.
34175236 2021. New COVID-19 variant (B.1.1.7): Forecasting the occasion of virus and the related meteorological factors.
34168484 2021. Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.
34163208 2021. Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.
34184438 2021. The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.
34138483 2021. Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers.
34138461 2021. Medium-term serostatus in Spanish case series recovered from SARS-CoV-2 infection.
34125455 2021. Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge.
34101203 2021. Prevalence of IgG antibodies induced by the SARS-COV-2 virus in asymptomatic adults in Nuevo Leon, Mexico.
34170519 2021. Over 1-year duration and age difference of SARS-CoV-2 antibodies in convalescent COVID-19 patients.
34174328 2021. A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.
34116123 2021. Can We AlphaFold Our Way Out of the Next Pandemic?
34161778 2021. The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.
34153515 2021. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Genome Sequencing from Post-Mortem Formalin-Fixed, Paraffin-Embedded Lung Tissues.
34121768 2021. Comparative analysis of non structural protein 1 of SARS-CoV2 with SARS-CoV1 and MERS-CoV: An in silico study.
34163172 2021. Structural Zero Data of COVID-19 Discovers Exodus Probabilities.
34180678 2021. Genetic Variability of the SARS-CoV-2 Pocketome.
34124702 2021. SARS-CoV-2 emerging variants in Africa: view from Gabon.
34118186 2021. Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19.
34124694 2021. Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study.
34163002 2021. An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner.
34168074 2021. Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.
34182784 2021. Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.
34182775 2021. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
34111060 2021. Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020-May 2021.
34118193 2021. Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection.
34146663 2021. In-silico analysis of Covid-19 genome sequences of Indian origin: Impact of mutations in identification of SARS-Co-V2.
34133855 2021. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
34133854 2021. Treatment of Multisystem Inflammatory Syndrome in Children.
34168138 2021. The architecture of the SARS-CoV-2 RNA genome inside virion.
34155209 2021. Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain.
34145263 2021. Immunological imprinting of the antibody response in COVID-19 patients.
34140485 2021. Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2.
34162970 2021. Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies.
34162945 2021. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.
34131210 2021. Attractive and repulsive residue fragments at the interface of SARS-CoV-2 and hACE2.
34117310 2021. The major genetic risk factor for severe COVID-19 does not show any association among South Asian populations.
34131072 2021. Mn(2+) coordinates Cap-0-RNA to align substrates for efficient 2'-O-methyl transfer by SARS-CoV-2 nsp16.
34106169 2021. inverted question markQue sabemos de la enfermedad de Kawasaki y COVID 19?
34181887 2021. Nuclear factor-kappa B and its role in inflammatory lung disease.
34144638 2021. Does COVID-19 alter the oxyhemoglobin dissociation curve? - An observational cohort study using a mixed-effect modelling.
34116589 2021. Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients.
34145459 2021. Large-Scale Identification of T-Cell Epitopes Derived From Severe Acute Respiratory Syndrome Coronavirus 2 for the Development of Peptide Vaccines Against Coronavirus Disease 2019.
34158670 2021. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19.
34108654 2021. SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse.
34158638 2021. Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs.
34108727 2021. How a rampant coronavirus variant blunts our immune defences.
34108702 2021. Embrace the WHO's new naming system for coronavirus variants.
34158664 2021. Delta coronavirus variant: scientists brace for impact.
34127832 2021. A long-term perspective on immunity to COVID.
34060442 2021. [Prediction of the epitopes of SARS-CoV-2 by immunoinformatics].

34146538 2021. Peptides of H. sapiens and P. falciparum that are predicted to bind strongly to HLA-A24:02 and homologous to a SARS-CoV-2 peptide.
34143752 2021. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.
34138748 2021. Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India.
34161644 2021. Exploring the Druggability of Conserved RNA Regulatory Elements in the SARS-CoV-2 Genome.
34149107 2021. Innentitelbild: Synthetic Homogeneous Glycoforms of the SARS-CoV-2 Spike Receptor-Binding Domain Reveals Different Binding Profiles of Monoclonal Antibodies (Angew. Chem. 23/2021).
34154787 2021. Eosinophils in antiviral immunity and (perhaps) a benefit of having asthma during the SARS-CoV2 pandemic.
34113953 2022. Antibody persistency and trend post-SARS-CoV-2 infection at eight months.
34174806 2021. Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.
34181320 2021. Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study.
34127503 2021. Can PIMS-TS lead to a facial nerve palsy?
34173107 2021. Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.
34117968 2021. Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders.
34166618 2021. Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.
34166617 2021. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
34146478 2021. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4(+) T cell help.
34151306 2021. Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity.
34124701 2021. Young infants exhibit robust functional antibody responses and restrained IFN-gamma production to SARS-CoV-2.
34112954 2021. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target.
34146659 2021. TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2.
34139154 2021. A time-resolved proteomic and prognostic map of COVID-19.
34166080 2021. Macrophages: Potential Therapeutic Target of Myocardial Injury in COVID-19.
34105720 2021. Increased household secondary attacks rates with Variant of Concern SARS-CoV-2 index cases.
34155047 2021. Multisystem inflammatory syndrome in an adult after SARS-CoV-2 infection.
34122620 2021. Correlation Analysis between the Viral Load and the Progression of COVID-19.
34109017 2021. The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival.
34104356 2021. Dissecting nucleotide selectivity in viral RNA polymerases.
34120861 2021. SARS-CoV-2 and Multisystem Inflammatory Syndrome In Children (MIS-C).
34186492 2021. NK cells on the ViP stage of COVID-19.
34158771 2021. Functional and Structural Characterization of SARS-Cov-2 Spike Protein: An In Silico Study.
34185144 2021. Epidemiological analysis in support of hypothesis that D614G virus mutation is a major contributing factor to chemosensory dysfunction in COVID-19 patients.
34149667 2021. SARS-CoV-2-Host Chimeric RNA-Sequencing Reads Do Not Necessarily Arise From Virus Integration Into the Host DNA.
34179075 2021. Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer.
34150848 2021. Sex-Related Overactivation of NLRP3 Inflammasome Increases Lethality of the Male COVID-19 Patients.
34109214 2021. Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study.
34136461 2021. Proliferation of SARS-CoV-2 B.1.1.7 Variant in Pakistan-A Short Surveillance Account.
34123997 2021. SARS-CoV-2 B.1.1.7 UK Variant of Concern Lineage-Related Perceptions, COVID-19 Vaccine Acceptance and Travel Worry Among Healthcare Workers.
34175388 2021. Variants in AGTR2 gene in Maya people with COVID-19.
34131597 2021. A bioinformatics approach for identifying potential molecular mechanisms and key genes involved in COVID-19 associated cardiac remodeling.
34131596 2021. SARS-CoV-2 mutations altering regulatory properties: Deciphering host's and virus's perspectives.
34152577 2021. Comparative study of predicted miRNA between Indonesia and China (Wuhan) SARS-CoV-2: a bioinformatics analysis.
34140652 2021. Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia.
34159627 2021. Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain.
34183789 2021. An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.
34179538 2021. Computational search of hybrid human/SARS-CoV-2 dsRNA reveals unique viral sequences that diverge from those of other coronavirus strains.
34142358 2021. The role of estradiol in the immune response against COVID-19.
34116863 2021. Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms.
34166623 2021. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.
34145089 2021. Electron microscopy imaging of SARS-CoV-2 at different temperatures.
34137349 2021. SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
34163216 2021. KDELC1 and TRMT1 Serve as Prognosis-Related SARS-CoV-2 Proteins Binding Human mRNAs and Promising Biomarkers in Clear Cell Renal Cell Carcinoma.
34128960 2021. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.
34128959 2021. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.
34140221 2021. Immune response to COVID-19 in older adults.
34150910 2021. Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia.
34130119 2021. The immunological response among COVID-19 patients with acute respiratory distress syndrome.
34118739 2021. SARS-CoV-2 and Plasmodium falciparum are probably adopting Analogous strategy to invade erythrocytes.
34159904 2021. B cells and COVID-19: Lessons from agammaglobulinemia patients and the study of functional B cell polymorphisms.
34185327 2021. Unrecognized introduction of SARS-CoV-2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent.
34110159 2021. Structural and Dynamical Differences in the Spike Protein RBD in the SARS-CoV-2 Variants B.1.1.7 and B.1.351.
34110168 2021. Conformational Dynamics in the Interaction of SARS-CoV-2 Papain-like Protease with Human Interferon-Stimulated Gene 15 Protein.
34161095 2021. Allosteric Cross-Talk among Spike's Receptor-Binding Domain Mutations of the SARS-CoV-2 South African Variant Triggers an Effective Hijacking of Human Cell Receptor.
34155521 2021. An early assessment of a case fatality risk associated with P.1 SARS-CoV-2 lineage in Brazil: an ecological study.
34170328 2021. Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.
34106002 2021. Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells.
34160250 2021. SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells.
34133899 2021. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
34133897 2021. SARS-CoV-2 NSP12 Protein Is Not an Interferon-beta Antagonist.
34166701 2021. Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.
34110391 2021. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2.
34143756 2021. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes.
34149046 2021. Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2.
34149939 2021. Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report.
34153417 2021. Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo.
34119626 2021. Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions.
34132615 2021. Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results.
34132580 2021. Structural Basis and Function of the N Terminus of SARS-CoV-2 Nonstructural Protein 1.
34069681 2021. Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance.
34163035 2021. Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.
34126625 2021. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.
34151992 2021. Kinetics of Anti-SARS-CoV-2 IgG among healthcare workers in a General Hospital.
34185793 2021. Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.
34166398 2021. SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.
34161373 2021. The human microbiome and COVID-19: A systematic review.
34161337 2021. SARS-CoV-2 uses major endothelial integrin alphavbeta3 to cause vascular dysregulation in-vitro during COVID-19.
34115768 2021. Longitudinal changes in IgG levels among COVID-19 recovered patients: A prospective cohort study.
34106957 2021. SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1.
34101725 2021. Potential G-quadruplexes and i-Motifs in the SARS-CoV-2.
34181691 2021. The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.
34146958 2021. SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione.
34186259 2021. Cellular senescence is a potential severity factor for COVID-19: Suitable targets required to eliminate cellular senescence.
34159291 2021. A Kawasaki-like illness in an adult with recent SARS-CoV-2 infection.
34134991 2021. Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity.
34170629 2021. The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh.
34157565 2021. Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia.
34141447 2021. Structural phylogenetic analysis reveals lineage-specific RNA repetitive structural motifs in all coronaviruses and associated variations in SARS-CoV-2.
34118359 2021. Positive selection as a key player for SARS-CoV-2 pathogenicity: Insights into ORF1ab, S and E genes.
34073934 2021. Identification of Novel Candidate CD8(+) T Cell Epitopes of the SARS-CoV2 with Homology to Other Seasonal Coronaviruses.
34130462 2021. Relational interaction between T-lymphocytes and SARS-CoV-2: A review.
34076457 2021. Radiologic Manifestations of Multisystem Inflammatory Syndrome in Children.
34076453 2021. Reply to "Radiologic Manifestations of Multisystem Inflammatory Syndrome in Children".
34159794 2021. Endothelial metabolism in pulmonary vascular homeostasis and acute respiratory distress syndrome.
34183280 2021. Apendicitis aguda en ninos con sindrome inflamatorio multisistemico pediatrico asociado a SARS-CoV-2 (SIM-PedS). Una complicacion a considerar.
34132382 2021. The kidnapping of mitochondrial function associated with the SARS-CoV-2 infection.
34160551 2021. Local memory CD4 T cell niches in respiratory viral infection.
34117201 2021. Ocular Manifestations of Multisystem Inflammatory Syndrome in Children with COVID-19.
34117202 2021. Intrafamilial Spread and Altered Symptomatology of SARS-CoV-2, During Predominant Circulation of Lineage B.1.1.7 Variant in Israel.
34158313 2021. Duration of Effective Antibody Levels After COVID-19.
34158312 2021. Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers.
34078749 2021. iciHHV-6 in a Patient With Multisystem Inflammatory Syndrome in Children.
34137759 2021. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2 vs. SARS-CoV and RaTG13.
34132301 2021. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.
34077977 2021. Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients.

34129731 2021. Multisystem inflammatory syndrome in children occurred in one of four thousand children with severe acute respiratory syndrome coronavirus 2.
34094637 2021. Cellular Tropism of SARS-CoV-2 across Human Tissues and Age-related Expression of ACE2 and TMPRSS2 in Immune-inflammatory Stromal Cells.
34303698 2021. Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome Sequences.
34231390 2021. Erythrocytes identify complement activation in patients with COVID-19.
34235568 2021. Glycosylation of SARS-CoV-2: structural and functional insights.
34389878 2021. The challenge of structural heterogeneity in the native mass spectrometry studies of the SARS-CoV-2 spike protein interactions with its host cell-surface receptor.
34356359 2021. Time Course of Redox Biomarkers in COVID-19 Pneumonia: Relation with Inflammatory, Multiorgan Impairment Biomarkers and CT Findings.
34450201 2021. Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target.
34261445 2021. Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.
34210694 2021. Giant coronary artery aneurysm as a feature of coronavirus-related inflammatory syndrome.
34192188 2021. Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee.
34188776 2021. Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants.
34310359 2021. Learning about Kawasaki disease from COVID-19 and the Multisystem Inflammatory Syndrome in Children.
34320263 2021. Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic.
34212320 2021. Increased Levels of serum Pentraxin 3 in Critical Coronavirus Disease-2019 Patients.
34289974 2021. Metabolomic analyses reveals new stage-specific features of the COVID-19.
34142653 2021. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021.
34136131 2021. Interactive SARS-CoV-2 mutation timemaps.
34186206 2021. Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection.
34307358 2021. Potential Impact of Diabetes and Obesity on Alveolar Type 2 (AT2)-Lipofibroblast (LIF) Interactions After COVID-19 Infection.
34268136 2021. The Gut Microbiota of Critically Ill Patients With COVID-19.
34249864 2021. Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.
34220703 2021. Covid-19 and Growth Hormone/Insulin-Like Growth Factor 1: Study in Critically and Non-Critically Ill Patients.
34194420 2021. sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.
34307408 2021. Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
34307393 2021. Elevation of Serum Cytokine Profiles and Liver Metabolomic Normalization in Early Convalescence of COVID-19 Patients.
34262921 2021. Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.
34277453 2021. Comparison of COVID-19 and Lung Cancer via Reactive Oxygen Species Signaling.
34261300 2021. Comparative study: nonsynonymous and synonymous substitution of SARS-CoV-2, SARS-CoV, and MERS-CoV genome.
34261299 2021. A protein interactions map of multiple organ systems associated with COVID-19 disease.
34132630 2021. Effect of COVID-19 precautions on the gut microbiota and nosocomial infections.
34100340 2021. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
34217989 2021. COVID-19 variants in India: Potential role in second wave and impact on vaccination.
34302327 2021. Comparison of Clinical Features and Outcome of Dengue Fever and Multisystem Inflammatory Syndrome in Children Associated With COVID-19 (MIS-C).
34293483 2021. SARS-CoV-2 as a betacoronavirus comprises five structural proteins?
34271187 2021. Genetic and evolutionary analysis of SARS-CoV-2 circulating in the region surrounding Islamabad, Pakistan.
34252616 2021. New infections by SARS-CoV-2 variants of concern after natural infections and post-vaccination in Rio de Janeiro, Brazil.
34316588 2021. Bangladesh reported delta variant of coronavirus among its citizen: Actionable items to tackle the potential massive third wave.
34160788 2021. Detection of SARS-CoV-2 variants in India from UK returnees.
34174700 2021. Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.
34286447 2021. COVID 19 disease independently predicted endothelial dysfunction measured by flow-mediated dilatation.
34107136 2021. Algorithm for the diagnosis and management of the multisystem inflammatory syndrome in children associated with COVID-19.
34107113 2021. Changes of serum IL-10, IL-1beta, IL-6, MCP-1, TNF-alpha, IP-10 and IL-4 in COVID-19 patients.
34209719 2021. New Onset of Hepatic Steatosis Post-Severe Multisystem Inflammatory Syndrome in Children (MIS-C): A Case Report.
34299089 2021. Role of Extracellular Vimentin in Cancer-Cell Functionality and Its Influence on Cell Monolayer Permeability Changes Induced by SARS-CoV-2 Receptor Binding Domain.
34299045 2021. Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion.
34281186 2021. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.
34281182 2021. Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies.
34290504 2021. Glycan Nanostructures of Human Coronaviruses.
34283611 2021. To Knot or Not to Knot: Multiple Conformations of the SARS-CoV-2 Frameshifting RNA Element.
34270232 2021. Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket.
34328324 2021. Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Top-Down Mass Spectrometry.
34177193 2021. Exploring AyuGenomics approach for understanding COVID-19 predisposition and progression.
34157282 2021. Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion.
34116654 2021. C-type lectins and extracellular vesicles in virus-induced NETosis.
34319802 2021. Assessment of SARS-CoV-2 Genome Sequencing: Quality Criteria and Low-Frequency Variants.
34232708 2021. Indeterminate QuantiFERON Gold Plus Results Reveal Deficient Interferon Gamma Responses in Severely Ill COVID-19 Patients.
34315010 2021. Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection.
34298379 2021. Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2.
34312809 2021. Non-thyroidal illness syndrome and SARS-CoV-2-associated multisystem inflammatory syndrome in children.
34185312 2021. Long-term monitoring of the development and extinction of IgA and IgG responses to SARS-CoV-2 infection.
34273397 2021. Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies.
34289053 2021. The virological impacts of SARS-CoV-2 D614G mutation.
34242876 2021. Energetic and structural basis for the differences in infectivity between the wild-type and mutant spike proteins of SARS-CoV-2 in the Mexican population.
34255304 2021. SARS-CoV-2 Infection and Racial Disparities in Children: Protective Mechanisms and Severe Complications Related to MIS-C.
34192291 2021. Phlegmonous Ileocolitis as a Presentation of Post SARS-CoV-2 (COVID-19) Multisystem Inflammatory Syndrome in Children.
34248243 2021. Delta to dominate world.
34222663 2021. T cell epitopes of SARS-CoV-2 spike protein and conserved surface protein of Plasmodium malariae share sequence homology.
34265172 2021. Oxidant and antioxidant balance in patients with COVID-19.
34252080 2021. Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.
34237054 2021. The interplay of SARS-CoV-2 evolution and constraints imposed by the structure and functionality of its proteins.
34228725 2021. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.
34280196 2021. Short Report: Early genomic detection of SARS-CoV-2 P.1 variant in Northeast Brazil.
34237072 2021. Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis.
34324605 2021. Modeling neutral viral mutations in the spread of SARS-CoV-2 epidemics.
34259777 2021. Comments on "Kawasaki and COVID-19 disease in children: a systematic review".
34140530 2021. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.
34189404 2021. SARS-CoV2 Related Multi System Inflammatory Syndrome in a Child with Chronic Kidney Disease: Case Report.
34254052 2021. "Authors' Reply: Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection".
34250445 2021. Comment on: Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection.
34308376 2021. SARS-CoV-2 spike linear epitope scanning via a peptide microarray through sera profiling.
34221480 2021. SARS-CoV-2-related Multisystem Inflammatory Syndrome in Children: A case series.
34177422 2021. Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism.
34280534 2021. First detection of SARS-CoV-2 A.23.1 sub-lineage in migrants arriving to Italy via the Mediterranean Sea and public health implications.
34187722 2021. Cell entry by SARS-CoV-2.
34229912 2021. Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses: (Trends in Microbiology, 29, 648-662, 2021).
34151202 2021. Identification of Novel MicroRNAs Targeting SARS-CoV-2 through the Regulation of TMPRSS2/PI3K/AKT/PTEN Alignment in Lung Cancer: An in Silico Analysis.
34152944 2021. Different long-term avidity maturation for IgG anti-spike and anti-nucleocapsid SARS-CoV-2 in hospitalized COVID-19 patients.
34279825 2021. Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement.
34284575 2021. Comprehensive O-Glycosylation Analysis of the SARS-CoV-2 Spike Protein with Biomimetic Trp-Arg Materials.
34261329 2021. Inflammasome Activation in Children With Kawasaki Disease and Multisystem Inflammatory Syndrome.
34124300 2021. Computational Analysis and Phylogenetic Clustering of SARS-CoV-2 Genomes.
34154997 2021. Covid-19: Cases of delta variant rise by 79%, but rate of growth slows.
34224431 2021. Protein S: function, regulation, and clinical perspectives.
34227577 2021. Cholesterol 25-hydroxylase expression following immune activation in response to SARS-CoV-2 infection.
34261116 2021. Clinical features of multisystem inflammatory syndrome in children.
34232536 2021. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
34328182 2021. Roles of steroid receptors in the lung and COVID-19.
34136915 2021. Regression of coronary arteries aneurysms 6 months after multisystem inflammatory syndrome in children (MIS-C).
34237522 2021. Dysphonia and dysphagia consequences of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS).
34241335 2021. The role of the envelope protein in the stability of a coronavirus model membrane against an ethanolic disinfectant.
34263708 2021. Human microRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2.
34250968 2021. Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.
34227711 2021. Multisystem inflammatory syndrome in children: A single-center experience.
34219413 2021. EVALI versus MIS-C, one more overlapping diagnosis to consider.
34293253 2021. Cytokine storm syndrome in a young patient with cystic fibrosis.
34260328 2021. Platelet-leukocyte interactions in the pathogenesis of viral infections.
34168071 2021. Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.
34168070 2021. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.
34172701 2021. Potential severe pediatric SARS-CoV-2-induced multisystem inflammatory syndrome resembles dengue infection.
34101517 2021. An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay.
34304428 2021. [Expressions of MPV, P-LCR and NLR in patients with novel coronavirus disease 2019].

34452902 2021. Letter to the Editor: Morphoproteomics Confirms the Expression of Fatty Acid Synthase (FAS) in Reactive Alveolar Pneumocytes in a COVID-19 Victim: Biological and Therapeutic Implications.
34437814 2021. COVID-19: Inflammatory Profile.
34293954 2021. Re: "COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment" by Cumpstey et al.
34269622 2021. Response to Verd and Verd Re: "COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment".
34348482 2021. The MAVS Immune Recognition Pathway in Viral Infection and Sepsis.
34213801 2021. Does chronic inflammation cause acute inflammation to spiral into hyper-inflammation in a manner modulated by diet and the gut microbiome, in severe Covid-19?
34406356 2021. coronaSPAdes: from biosynthetic gene clusters to RNA viral assemblies.
34231935 2021. Identification of HLA-A2 restricted CD8(+) T cell epitopes in SARS-CoV-2 structural proteins.
34232823 2021. The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung.

34431626 2021. Performance of Cytokine Storm Syndrome Scoring Systems in Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children.
34235261 2021. Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.
34341769 2021. CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2.
34328734 2021. The SARS-CoV-2 Programmed -1 Ribosomal Frameshifting Element Crystal Structure Solved to 2.09 A Using Chaperone-Assisted RNA Crystallography.
34437808 2021. Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease.
34319698 2021. Reproducible Breath Metabolite Changes in Children with SARS-CoV-2 Infection.
34337269 2021. Conformational Variability Correlation Prediction of Transmissibility and Neutralization Escape Ability for Multiple Mutation SARS-CoV-2 Strains using SSSCPreds.
34430559 2021. Analysis of the dynamic relationship between immune profiles and the clinical features of patients with COVID-19.
34410443 2021. Identification and characterization of mutations in the SARS-CoV-2 RNA-dependent RNA polymerase as a promising antiviral therapeutic target.
34258664 2021. Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.
34322866 2021. First direct human-to-cat transmission of the SARS-CoV-2 B.1.1.7 variant.
34281462 2021. Manipulation of autophagy by SARS-CoV-2 proteins.
34303694 2021. Differential mutation profile of SARS-CoV-2 proteins across deceased and asymptomatic patients.
34284028 2021. Computational analysis of TMPRSS2 expression in normal and SARS-CoV-2-infected human tissues.
34276947 2021. Determination of intermediate state structures in the opening pathway of SARS-CoV-2 spike using cryo-electron microscopy.
34265150 2021. Hidden in Plain Sight: Natural Products of Commensal Microbiota as an Environmental Selection Pressure for the Rise of New Variants of SARS-CoV-2.
34245743 2021. IL-33 Depletion in COVID-19 Lungs.
34208141 2021. The Role of Therapeutic Plasma Exchange (TPE) in Multisystem Inflammatory Syndrome in Children (MIS-C).
34327082 2021. Late-Onset COVID-19-Related Multi-System Inflammatory Syndrome in a Middle-Aged Man.
34306850 2021. The Perfect Cytokine Storm: Utilization of Lung Ultrasound During Urgent Surgery in an Infant With Multisystem Inflammatory Syndrome in Children and Hemophagocytic Lymphohistiocytosis.
34311326 2021. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
34222846 2021. Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study.
34325753 2021. Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany in 2020: insights into the cause of the second wave.
34212240 2021. Investigation of endothelial dysfunction and arterial stiffness in multisystem inflammatory syndrome in children.
34303662 2021. SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing DUSP1 expression and activating p38 MAPK pathway.
34267671 2021. How and to What Extent Immunological Responses to SARS-CoV-2 Shape Pulmonary Function in COVID-19 Patients.
34304938 2021. Soluble HLA-G is upregulated in serum of patients with severe COVID-19.
34209788 2021. Does the SARS-CoV-2 Spike Protein Receptor Binding Domain Interact Effectively with the DPP4 (CD26) Receptor? A Molecular Docking Study.
34201415 2021. Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms.
34205487 2021. Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives.
34215960 2021. Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).
34225441 2021. ORF8 382 Mutation: A Possible Viral Prognostic Biomarker for the Severity of the COVID-19.
34308298 2021. Multi-omics analysis of respiratory specimen characterizes baseline molecular determinants associated with SARS-CoV-2 outcome.
34308276 2021. Sensor array and gas chromatographic detection of the blood serum volatolomic signature of COVID-19.
34329427 2021. SARS-CoV-2 Antibodies and Associated Factors at Different Hospitalization Time Points in 192 COVID-19 Cases.
34209269 2021. Ocular and Systemic Manifestations in Paediatric Multisystem Inflammatory Syndrome Associated with COVID-19.
34196431 2021. SARS-CoV-2 virulence evolution: Avirulence theory, immunity and trade-offs.
34329486 2021. A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine.
34314050 2021. SARS-CoV-2 R.1 lineage variants that prevailed in Tokyo in March 2021.
34314049 2021. Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy.
34314048 2021. Sequencing on an imported case in China of COVID-19 Delta variant emerging from India in a cargo ship in Zhoushan, China.
34292617 2021. Evolution trace of SARS-CoV-2 from January 19 to March 12, 2020, in the United States.
34260088 2021. SARS-CoV-2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate?
34255352 2021. The variants question: What is the problem?
34245452 2021. Updated SARS-CoV-2 single nucleotide variants and mortality association.
34241897 2021. Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 (beta) variant (20H/501Y.V2) in Brazil.
34193667 2021. Less frequent sequence mismatches in variants of concern (VOCs) of SARS-CoV-2 in the real-time RT-PCR assays developed by the National Institute of Infectious Diseases, Japan.
34273381 2021. Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients.
34197767 2021. The SARS-CoV-2 B.1.1.7 variant and increased clinical severity-the jury is out.
34278372 2021. Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.
34278371 2021. Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany.
34292071 2021. Genomic Surveillance of SARS-CoV-2 Viruses Collected during the Ending Phase of the First Wave of the COVID-19 Pandemic in Bangladesh.
34264104 2021. Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.
34264100 2021. Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.
34197207 2021. New SARS-CoV-2 Variant from Jordan.
34287058 2021. Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks.
34200249 2021. Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study.
34203277 2021. Multisystem Inflammatory Syndrome in an Adult (MIS-A) Successfully Treated with Anakinra and Glucocorticoids.
34203929 2021. Dose-Related Aberrant Inhibition of Intracellular Perforin Expression by S1 Subunit of Spike Glycoprotein That Contains Receptor-Binding Domain from SARS-CoV-2.
34193870 2021. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.
34234119 2021. The molecular basis for SARS-CoV-2 binding to dog ACE2.
34230476 2021. Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan.
34226537 2021. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.
34326343 2021. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.
34326336 2021. Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection.
34321474 2021. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.
34315903 2021. Integrative genomic analyses identify susceptibility genes underlying COVID-19 hospitalization.
34315893 2021. Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets.
34315889 2021. The trans-omics landscape of COVID-19.
34199224 2021. Is SARS-CoV-2 Neutralized More Effectively by IgM and IgA than IgG Having the Same Fab Region?
34297786 2021. SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts.
34214116 2021. Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.
34320031 2021. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.
34280244 2021. Early antibody responses associated with survival in COVID19 patients.
34270631 2021. SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence.
34270613 2021. Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection.
34260666 2021. COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.
34259880 2021. Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection.
34315815 2021. SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block.
34248311 2021. Genetic Control of Human Infection with SARS-CoV-2.
34188167 2021. Activation of NF-kappaB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2.
34238985 2021. In vitro Interleukin-7 treatment partially rescues MAIT cell dysfunction caused by SARS-CoV-2 infection.
34234167 2021. Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.
34226622 2021. Understanding protection from SARS-CoV-2 using metabolomics.
34312429 2021. S494 O-glycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study.
34217923 2021. Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability.
34325286 2021. SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung.
34265628 2021. Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.
34320912 2021. COVID-19 adaptive evolution during the pandemic - Implications of new SARS-CoV-2 variants on public health policies.
34251989 2021. The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences.
34251592 2021. Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.
34314772 2021. Structural modelling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity.
34329696 2021. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
34207696 2021. HERC5 and the ISGylation Pathway: Critical Modulators of the Antiviral Immune Response.
34207490 2021. A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic.
34200386 2021. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
34205098 2021. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
34209881 2021. Modular Evolution of Coronavirus Genomes.
34199077 2021. From Recoding to Peptides for MHC Class I Immune Display: Enriching Viral Expression, Virus Vulnerability and Virus Evasion.
34206990 2021. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.
34202160 2021. Modulation of Viral Programmed Ribosomal Frameshifting and Stop Codon Readthrough by the Host Restriction Factor Shiftless.
34202098 2021. How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?
34200602 2021. The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation.
34452902 2021. Letter to the Editor: Morphoproteomics Confirms the Expression of Fatty Acid Synthase (FAS) in Reactive Alveolar Pneumocytes in a COVID-19 Victim: Biological and Therapeutic Implications.
34437814 2021. COVID-19: Inflammatory Profile.
34293954 2021. Re: "COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment" by Cumpstey et al.
34269622 2021. Response to Verd and Verd Re: "COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment".
34348482 2021. The MAVS Immune Recognition Pathway in Viral Infection and Sepsis.
34213801 2021. Does chronic inflammation cause acute inflammation to spiral into hyper-inflammation in a manner modulated by diet and the gut microbiome, in severe Covid-19?
34406356 2021. coronaSPAdes: from biosynthetic gene clusters to RNA viral assemblies.
34231935 2021. Identification of HLA-A2 restricted CD8(+) T cell epitopes in SARS-CoV-2 structural proteins.
34232823 2021. The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung.

34214538 2021. Biophysical properties of the isolated spike protein binding helix of human ACE2.
34214535 2021. Role of spatial patterning of N-protein interactions in SARS-CoV-2 genome packaging.
34197807 2021. Regulation of epithelial sodium channel activity by SARS-CoV-1 and SARS-CoV-2 proteins.
34197802 2021. Dynamics of the SARS-CoV-2 nucleoprotein N-terminal domain triggers RNA duplex destabilization.
34197805 2021. Transient and stabilized complexes of Nsp7, Nsp8, and Nsp12 in SARS-CoV-2 replication.
34313294 2021. A lipidomic view of SARS-CoV-2.
34225645 2021. Immune cell profiling and antibody responses in patients with COVID-19.
34225644 2021. Sex-based clinical and immunological differences in COVID-19.
34260684 2021. Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.
34257504 2021. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system.
34306789 2021. COVID-19 Infection in Spinal Muscular Atrophy Associated with Multisystem Inflammatory Syndrome.
34242577 2021. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
34289344 2021. A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation.
34294141 2021. Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication.
34246414 2021. SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET.
34238338 2021. Single-cell analysis reveals cell communication triggered by macrophages associated with the reduction and exhaustion of CD8(+) T cells in COVID-19.
34301919 2021. RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.
34226505 2021. H-Ras gene takes part to the host immune response to COVID-19.
34315869 2021. ScRNA-seq revealed the kinetic of nasopharyngeal immune responses in asymptomatic COVID-19 carriers.
34265243 2021. An aberrant inflammatory response in severe COVID-19.
34265239 2021. Virus hunters: Discovering the evolutionary origins of SARS-CoV-2.
34242582 2021. HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.
34237248 2021. SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19.
34216827 2021. Gut ACE2 Expression, Tryptophan Deficiency, and Inflammatory Responses The Potential Connection That Should Not Be Ignored During SARS-CoV-2 Infection.
34321622 2021. Increase in serum levels of phosphatidylserine-specific phospholipase A1 in COVID-19 patients.
34290398 2021. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection.
34223911 2021. Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.
34270919 2021. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination.
34260965 2021. Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.
34242574 2021. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins.
34272947 2021. An Update on SARS-CoV-2 Diversity in the United States National Capital Region: Evolution of Novel and Variants of Concern.
34221376 2021. Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders.
34221375 2021. Genes, COVID-19 and phenotype.
34253247 2021. Emerging SARS-CoV-2 variants of concern and potential intervention approaches.
34328076 2021. An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021.
34328074 2021. Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021.
34269174 2021. Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021.
34240695 2021. Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021.
34290742 2021. Identification of Causal Genes of COVID-19 Using the SMR Method.
34211506 2021. COVID-19 and SARS-CoV-2 Variants: Current Challenges and Health Concern.
34326844 2021. Impaired Priming of SARS-CoV-2-Specific Naive CD8(+) T Cells in Older Subjects.
34326843 2021. The Many Faces of JAKs and STATs Within the COVID-19 Storm.
34322127 2021. A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.
34322120 2021. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
34305949 2021. SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns.
34305903 2021. ROS/RNS Balancing, Aerobic Fermentation Regulation and Cell Cycle Control - a Complex Early Trait ('CoV-MAC-TED') for Combating SARS-CoV-2-Induced Cell Reprogramming.
34305895 2021. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.
34305894 2021. The Spike of SARS-CoV-2: Uniqueness and Applications.
34305888 2021. Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1.
34290717 2021. Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins.
34276680 2021. AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19.
34276672 2021. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.
34267764 2021. Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.
34262555 2021. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.
34249006 2021. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
34248984 2021. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
34248968 2021. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
34248962 2021. Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.
34248940 2021. Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.
34234779 2021. Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?
34220870 2021. Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset.
34220859 2021. Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19.
34220846 2021. A Comparative Analysis of Coronavirus Nucleocapsid (N) Proteins Reveals the SADS-CoV N Protein Antagonizes IFN-beta Production by Inducing Ubiquitination of RIG-I.
34220844 2021. The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom.
34211469 2021. Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses.
34194438 2021. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
34194429 2021. Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.
34239886 2021. SARS-CoV-2 Viral Shedding and Transmission Dynamics: Implications of WHO COVID-19 Discharge Guidelines.
34239884 2021. Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease.
34222275 2021. Persisting Antibody Response to SARS-CoV-2 in a Local Austrian Population.
34229864 2021. Humoral immune mechanisms involved in protective and pathological immunity during COVID-19.
34273395 2021. Distinctive pseudopalisaded histiocytic hyperplasia characterizes the transition of exudative to proliferative phase of diffuse alveolar damage in patients dying of COVID-19.
34230877 2021. Red face may be a specific sign of SARS-CoV-2 alpha variant.
34231951 2021. A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia.
34246326 2021. Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants.
34228987 2021. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.
34292476 2021. Humoral immune durability of IgG for anti-SARS-CoV-2 in the normal pregnant women in Wuhan, China.
34202646 2021. Virus-Negative Necrotizing Coronary Vasculitis with Aneurysm Formation in Human SARS-CoV-2 Infection.
34267528 2021. Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan.
34271202 2021. Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case.
34273512 2021. Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19.
34260956 2021. High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!
34209845 2021. Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators.
34193364 2021. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.
34285538 2021. Prevalence and Characteristics of Rheumatoid-Associated Autoantibodies in Patients with COVID-19.
34319496 2021. The potential role of neopterin in Covid-19: a new perspective.
34242919 2021. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
34254040 2021. Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 Isolates.
34224908 2021. SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?
34199852 2021. Long-Term Persistence of Anti-SARS-CoV-2 Antibodies in a Pediatric Population.
34201967 2021. Study of the Plasma and Buffy Coat in Patients with SARS-CoV-2 Infection-A Preliminary Report.
34288921 2021. Molecular epidemiology of SARS-CoV-2 in Cyprus.
34211037 2021. The RNA sensor MDA5 detects SARS-CoV-2 infection.
34210996 2021. Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant.
34230210 2021. Kynurenic acid may underlie sex-specific immune responses to COVID-19.
34201088 2021. A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel.
34199761 2021. The Many Faces of Innate Immunity in SARS-CoV-2 Infection.
34202276 2021. Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination.
34199357 2021. Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination.
34276267 2021. Variantes de SARS-CoV-2, una historia todavia inacabada.
34275492 2021. SARS-CoV-2: preliminary study of infected human nasopharyngeal tissue by high resolution microscopy.
34201767 2021. SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies.
34206453 2021. Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
34205489 2021. Broad Impact of Exchange Protein Directly Activated by cAMP 2 (EPAC2) on Respiratory Viral Infections.
34198530 2021. Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments.
34199223 2021. Functions of Coronavirus Accessory Proteins: Overview of the State of the Art.
34204754 2021. Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.
34204732 2021. Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera.
34208191 2021. Full-Length Computational Model of the SARS-CoV-2 Spike Protein and Its Implications for a Viral Membrane Fusion Mechanism.
34340962 2021. Covid-19: Delta infections threaten herd immunity vaccine strategy.
34413059 2021. Covid-19: How many variants are there, and what do we know about them?
34413020 2021. Covid-19: Fully vaccinated people can carry as much delta virus as unvaccinated people, data indicate.

34246957 2021. Syncope and silent hypoxemia in COVID-19: Implications for the autonomic field.
34224022 2021. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.
34246830 2021. Analysis of SARS-CoV-2 nucleocapsid phosphoprotein N variations in the binding site to human 14-3-3 proteins.
34213308 2021. Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation.
34274319 2021. Membranotropic and biological activities of the membrane fusion peptides from SARS-CoV spike glycoprotein: The importance of the complete internal fusion peptide domain.
34237472 2021. In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies.
34220199 2021. Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins.
34234394 2021. Differential binding of SARS-CoV-2 Spike protein variants to its cognate receptor hACE2 using molecular modeling based binding analysis.
34198622 2021. SARS-CoV-2 Variants in Lebanon: Evolution and Current Situation.
34193390 2021. Role of SARS-CoV-2 and ACE2 variations in COVID-19.
34271250 2021. Emerging mutation in SARS-CoV-2 spike: Widening distribution over time in different geographic areas.
34307679 2021. Identifying COVID-19-Specific Transcriptomic Biomarkers with Machine Learning Methods.
34258267 2021. Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.
34202515 2021. Oxidative Stress and Inflammation in SARS-CoV-2- and Chlamydia pneumoniae-Associated Cardiovascular Diseases.
34207362 2021. Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19.
34204735 2021. Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19-The Role of RAGE-RAS Crosstalk.
34237251 2021. Computational methods to predict the mutational landscape of the spike protein.
34219983 2021. Atlas der SARS-CoV-2-RNA-Protein-Interaktionen in infizierten Zellen.
34210280 2021. Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients.
34189273 2021. Mass spectrometric based detection of protein nucleotidylation in the RNA polymerase of SARS-CoV-2.
34320442 2021. Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach.
34246161 2021. High-throughput analysis of the interactions between viral proteins and host cell RNAs.
34234921 2021. Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.
34306570 2021. Exploiting the molecular basis of age and gender differences in outcomes of SARS-CoV-2 infections.
34217135 2021. Natural killer cells and unconventional T cells in COVID-19.
34272088 2021. Alterations of Lipid Profile in COVID-19: A Narrative Review.
34305860 2021. Host- and Species-Dependent Quasispecies Divergence of Severe Acute Respiratory Syndrome Coronavirus-2 in Non-human Primate Models.
34267735 2021. Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2.
34234758 2021. A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3' Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity.
34220784 2021. The First Molecular Characterization of Serbian SARS-CoV-2 Isolates From a Unique Early Second Wave in Europe.
34322518 2021. Mathematical Model of SARS-Cov-2 Propagation Versus ACE2 Fits COVID-19 Lethality Across Age and Sex and Predicts That of SARS.
34274478 2021. No association between the SARS-CoV-2 variants and mortality rates in the Eastern Mediterranean Region.
34202172 2021. Uncovering Signals from the Coronavirus Genome.
34222571 2021. Identification of Cross-Reactive CD8(+) T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant Variants.
34228320 2021. Relative synonymous codon usage of ORF1ab in SARS-CoV-2 and SARS-CoV.
34210356 2021. CLIMB-COVID: continuous integration supporting decentralised sequencing for SARS-CoV-2 genomic surveillance.
34281603 2021. Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19.
34296023 2021. Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis.
34207510 2021. Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms.
34200325 2021. Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors.
34198800 2021. In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3'-UTR.
34207476 2021. Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2.
34204305 2021. The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA.
34206057 2021. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses.
34205975 2021. Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications.
34299201 2021. Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes).
34299124 2021. Extension of Collagen Deposition in COVID-19 Post Mortem Lung Samples and Computed Tomography Analysis Findings.
34299101 2021. COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases.
34273582 2021. SARS-CoV-2 Infection in the Immunodeficient Host: Necessary and Dispensable Immune Pathways.
34273581 2021. Association of Varying Clinical Manifestations and Positive Anti-SARS-CoV-2 IgG Antibodies: A Cross-Sectional Observational Study.
34303083 2021. Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study.
34223909 2021. Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro.
34282461 2021. Kinetics of the SARS-CoV-2 antibody response and serological estimation of time since infection.
34268819 2021. Self-infection with speech aerosol may contribute to COVID-19 severity.
34255499 2021. Binding of SARS-CoV-2 Fusion Peptide to Host Endosome and Plasma Membrane.
34328740 2021. Role of ATP in the RNA Translocation Mechanism of SARS-CoV-2 NSP13 Helicase.
34196568 2021. Interfacial Water Many-Body Effects Drive Structural Dynamics and Allosteric Interactions in SARS-CoV-2 Main Protease Dimerization Interface.
34196550 2021. Regulation Mechanism for the Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II.
34236232 2021. Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh.
34236224 2021. Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.
34312385 2021. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'.
34272374 2021. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance.
34207055 2021. microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection-A Commentary.
34294722 2021. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.
34232992 2021. SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.
34192263 2020. A 3.4-A cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles.
34290329 2021. Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays.
34290262 2021. Lipid bilayer degradation induced by SARS-CoV-2 spike protein as revealed by neutron reflectometry.
34215811 2021. Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients.
34267263 2021. A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.
34253751 2021. Deep learning identifies antigenic determinants of severe SARS-CoV-2 infection within T-cell repertoires.
34222416 2021. Dynamics of host immune responses to SARS-CoV-2.
34370288 2021. Emerging Role for Ferroptosis in Infectious Diseases.
34453338 2021. In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion.
34344757 2021. Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19?
34365984 2021. Preoperative monocytosis is predictable at diagnosis for RT-PCR negative COVID-19 paediatric cardiac surgery patients.
34348808 2021. Cardiac echocardiogram findings of severe acute respiratory syndrome coronavirus-2-associated multi-system inflammatory syndrome in children.
34190246 2021. Effective ACE2 peptide-nanoparticle conjugation and its binding with the SARS-Cov-2 RBD quantified by dynamic light scattering.
34218284 2021. Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.
34309648 2021. Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination.
34302458 2021. Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis.
34231319 2021. One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19.
34213568 2021. Development of IgG, IgM, and IgA autoantibodies against angiotensin converting enzyme 2 in patients with COVID-19.
34188005 2021. The interaction of the severe acute respiratory syndrome coronavirus 2 spike protein with drug-inhibited angiotensin converting enzyme 2 studied by molecular dynamics simulation.
34312258 2021. The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated.
34301847 2021. SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
34329672 2021. SARS-CoV-2 viral dynamics in infections with Alpha and Beta variants of concern in the French community.
34192326 2021. Comment on: Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.
34192319 2021. Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.
34280026 2021. Quantitative Insight into Immunopathology of SARS-CoV-2 Infection.
34251833 2021. Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.
34289271 2021. ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply.
34289270 2021. ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.
34254633 2021. Interaction of serum proteins with SARS-CoV-2 RBD.
34316026 2021. Broadly neutralizing anti-coronavirus antibodies.
34261126 2021. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.
34237774 2021. Mapping the human genetic architecture of COVID-19.
34321649 2021. Daily briefing: How SARS-CoV-2 infects cells.
34290423 2021. How the Delta variant achieves its ultrafast spread.
34272531 2021. Daily briefing: 'Super-antibodies' fight many coronavirus variants.
34262194 2021. This 'super antibody' for COVID fights off multiple coronaviruses.
34321669 2021. How the coronavirus infects cells - and why Delta is so dangerous.
34239118 2021. The quest to find genes that drive severe COVID.
34237773 2021. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.
34275790 2021. Profiling of inflammatory biomarkers in mild to critically ill severe acute respiratory syndrome corona virus-19 (SARS Covid-19) patients from Karachi, Pakistan.
34210785 2021. CD8(+) T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients.
34233952 2021. Increasing threats from SARS-CoV-2 variants: Time to establish global surveillance.
34315827 2021. Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme.
34210893 2021. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.
34301854 2021. Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence.
34210892 2021. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.
34269109 2021. Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment.

34284918 2021. Imaging of Multisystem Inflammatory Disease in Children (MIS-C) Associated With COVID-19.
34431501 2021. COVID-19 and ROS Storm: What is the Forecast for Hypertension.
34273437 2021. Outcomes From Infections With Variant Strains of SARS-CoV-2 Among Patients Receiving Maintenance Hemodialysis.
34328495 2021. Neutralizing antibody responses against SARS-CoV-2 spike receptor-binding domain 13 months after the recovery from the disease.
34342755 2021. Novel phenotypes of coronavirus disease: a temperature-based trajectory model.
34461036 2021. Annals Graphic Medicine - Wanted: All COVID-19 Variants.
34374354 2022. Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay.
34286216 2021. Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection.
34199430 2021. Immune Response to SARS-CoV-2 in an Asymptomatic Pediatric Allergic Cohort.
34309328 2021. Consenso sobre el tratamiento del sindrome inflamatorio multisistemico asociado a COVID-19.
34419338 2021. OBESITY AND SEVERE COVID-19 IN THE YOUNG: IS DOWNREGULATION OF miR-126 A PIECE OF THE SARS-COV2 PATHOGENICITY PUZZLE?
34235495 2021. Asymmetric dynamics of dimeric SARS-CoV-2 and SARS-CoV main proteases in an apo form: Molecular dynamics study on fluctuations of active site, catalytic dyad, and hydration water.
34326117 2021. Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V).
34301692 2021. Kawasaki-like multisystem inflammatory syndrome associated with SARS-CoV-2 infection in an adult.
34312842 2021. Haemophagocytosis and atypical vacuolated lymphocytes in bone marrow and blood films after SARS-CoV-2 vaccination.
34247384 2021. Immature platelets in COVID-19 infection.
34230917 2021. Impact of SARS-CoV-2 variants on the total CD4(+) and CD8(+) T cell reactivity in infected or vaccinated individuals.
34201214 2021. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
34200500 2021. How SARS-CoV-2 and Other Viruses Build an Invasion Route to Hijack the Host Nucleocytoplasmic Trafficking System.
34200372 2021. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.
34201847 2021. Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19.
34202997 2021. From RNA World to SARS-CoV-2: The Edited Story of RNA Viral Evolution.
34205262 2021. The Role of Th17 Response in COVID-19.
34200572 2021. Identification of Lung and Blood Microbiota Implicated in COVID-19 Prognosis.
34272033 2021. A dermatologic perspective on multisystem inflammatory syndrome in children.
34272031 2021. Dermatologic manifestations of COVID-19-associated multisystem inflammatory syndrome in children.
34303849 2021. Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach.
34245905 2021. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance.
34256141 2021. The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses.
34277221 2021. A Case of COVID-19 Mimicking Acute Appendicitis in Multi-System Inflammatory Syndrome.
34306899 2021. Cardiogenic Shock Due to Multisystem Inflammatory Syndrome in a Young Adult Female.
34314723 2021. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic.
34226898 2021. Green bodies: Inclusions in a critically ill COVID-19 patient.
34323691 2021. Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains.
34296442 2021. SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage.
34260159 2021. Individual COVID-19 disease trajectories revealed by plasma proteomics.
34232570 2021. High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.
34314668 2021. Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19.
34296992 2021. SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA.
34324704 2021. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1.
34318976 2021. COVID-19 severity, miR-21 targets, and common human genetic variation. Letter regarding the article 'Circulating cardiovascular microRNAs in critically ill COVID-19 patients'.
34256840 2021. The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization.
34228902 2021. Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2.
34216102 2021. The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes.
34307198 2021. SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro.
34282405 2021. Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells.
34192318 2021. Are sialic acids involved in COVID-19 pathogenesis?
34259195 2021. A focus on the spread of the delta variant of SARS-CoV-2 in India.
34220204 2021. Multisystem Inflammatory Syndrome in Children and Adolescents (MIS-C) under the Setting of COVID-19: A Review of Clinical Presentation, Workup and Management.
34191907 2021. Multisystem Inflammatory Syndrome in an Adult With COVID-19.
34213733 2021. IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.
34324165 2021. Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
34233864 2021. MCP-1: Function, regulation, and involvement in disease.
34284045 2021. SARS-CoV-2-infected primary human airway epithelia illustrate mucus hypersecretion.
34224783 2021. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C).
34309742 2021. Neutralizing Anti-interferon-gamma Autoantibodies: an Ameliorating Factor in COVID-19 Infection?
34273064 2021. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study.
34196300 2021. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes.
34202613 2021. The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review.
34205655 2021. Carboxyhemoglobinemia in Critically Ill Coronavirus Disease 2019 Patients.
34203844 2021. SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence.
34188786 2021. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies.
34216637 2021. A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.
34329674 2021. Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 - April 2021.
34324939 2021. Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays.
34320390 2021. Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected.
34237342 2021. Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated health care worker in Italy.
34274361 2021. Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?
34241906 2021. Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins.
34232521 2021. N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.
34228322 2021. Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients.
34193239 2021. COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively.
34274504 2021. Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2-Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology.
34283810 2021. CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2-infected patients.
34291736 2021. L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus.
34251356 2021. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.
34265359 2021. Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2.
34197809 2021. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
34198454 2021. Track the dynamical features for mutant variants of COVID-19 in the UK.
34311587 2021. B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies.
34311586 2021. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
34311574 2021. Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect In Vivo in a Mouse Model in a Neutralization-Dependent Manner.
34281387 2021. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.
34225491 2021. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.
34225487 2021. Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.
34291385 2021. Computational predictions for protein sequences of COVID-19 virus via machine learning algorithms.
34199617 2021. The Emergence of SARS-CoV-2 Variant(s) and Its Impact on the Prevalence of COVID-19 Cases in the Nabatieh Region, Lebanon.
34199203 2021. Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19.
34254825 2021. RNA-Protein Interaction Analysis of SARS-CoV-2 5' and 3' Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection.
34221400 2021. Differential alterations in peripheral lymphocyte subsets in COVID-19 patients: upregulation of double-positive and double-negative T cells.
34289274 2021. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
34233096 2021. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
34218651 2021. Review of the early reports of the epidemiological characteristics of the B.1.1.7 variant of SARS-CoV-2 and its spread worldwide.
34270608 2021. Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.
34270576 2021. Is increased mortality by multiple exposures to COVID-19 an overseen factor when aiming for herd immunity?
34242356 2021. Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.
34279520 2021. SARS-CoV-2 Variants in Rhode Island.
34246424 2021. Clinical and radiological findings for the new multisystem inflammatory syndrome in children associated with COVID-19.
34231777 2021. SARS-CoV-2 nucleic acid shedding is variable for every person.
34273991 2021. Estimating COVID-19 cases infected with the variant alpha (VOC 202012/01): an analysis of screening data in Tokyo, January-March 2021.
34211709 2021. The emerging SARS-CoV-2 variants of concern.
34405795 2021. Inpatient Occupational Therapy Management for a Pediatric Patient With COVID-19 and Multisystem Inflammatory Syndrome in Children: A Case Report.
34212497 2021. Humoral response to SARS-CoV-2 is well preserved and symptom dependent in kidney transplant recipients.
34382433 2021. Multi-System Inflammatory Syndrome Presenting as Non-Specific Colitis: A Medical Diagnosis with a Surgical Presentation.
34193457 2021. How long does covid-19 immunity last?
34254909 2021. COVID-19 candidate genes and pathways potentially share the association with lung cancer.
34298578 2021. Determination of Factors to Distinguish MIS-C from Acute Appendicitis in Children with Acute Abdominal Pain.
34227076 2021. Evolving biothreat of variant SARS-CoV-2 - molecular properties, virulence and epidemiology.
34286505 2021. Immunohistochemical findings in the lungs of COVID-19 subjects: evidence of surfactant dysregulation.
34297037 2021. Epigenetic and transcriptional control of interferon-beta.
34217595 2021. The 'cytokine storm': molecular mechanisms and therapeutic prospects.
34297627 2021. Pathogenesis of Coronaviruses Through Human Monocytes and Tissue Macrophages.

34285445 2020. COULD COVID-19 BE A HEMOGLOBINOPATHY?
34347313 2021. Virus antibodies after SARS-CoV-2 infection.
34331326 2021. Multi-inflammatory syndrome and Kawasaki disease in children during the COVID-19 pandemic: A nationwide register-based study and time series analysis.
34265136 2021. SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.
34228876 2021. Relation between ORF8a and the mitochondrial protein TOM70 in SARS-CoV-2 infection.
34430865 2021. Lymphopenia and IgG2 subclass deficiency in patients with severe COVID-19 pneumonia.
34334284 2021. Emergency department levels of NT-proBNP and inotropic/vasoactive support in multi-inflammatory syndrome in children (MIS-C).
34358389 2021. Decline in Sars-CoV-2 antibodies over 6-month follow-up in obstetrical healthcare workers.
34407240 2021. Molecular mimicry between SARS-CoV-2 and the female reproductive system.
34230709 2021. Magnetization Transfer to Enhance NOE Cross-Peaks among Labile Protons: Applications to Imino-Imino Sequential Walks in SARS-CoV-2-Derived RNAs.
34352377 2021. Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies.
34244164 2021. Differentiating multisystem inflammatory syndrome in children: a single-centre retrospective cohort study.
34313714 2021. Plasma Levels of Glycohydrolase Activities in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients.
34219981 2021. SARS-CoV-2 Nsp1: Ein kleines Protein blockiert die Immunantwort.
34315173 2021. Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets.
34258762 2021. Analysis of T-cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain-like lesions during the COVID-19 pandemic.
34278987 2021. Kawasaki disease shock syndrome in the COVID-19 pandemic.
34261560 2021. Cardiac implications of multisystem inflammatory syndrome associated with COVID-19 in children under the age of 5 years.
34237283 2021. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects.
34297909 2021. Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome.
34250512 2021. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.
34293929 2021. SARS-CoV-2 Initiates Programmed Cell Death in Platelets.
34238021 2021. Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19.
34208057 2021. Case Series of Multisystem Inflammatory Syndrome (MIS-C) in Children during the SARS-CoV-2 Pandemic in Latvia.
34257967 2021. SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.
34281966 2021. Achieving and sustaining herd immunity to SARS-CoV-2.
34253551 2021. Alpha, Beta, Delta, Gamma: What's important to know about SARS-CoV-2 variants of concern?
34250324 2021. Silent hypoxia in COVID-19: a gut microbiota connection.
34264880 2021. Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate.
34189489 2021. SARS-CoV-2 NSP1 C-terminal (residues 131-180) is an intrinsically disordered region in isolation.
34216296 2021. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.
34242899 2021. Between immunomodulation and immunotolerance: The role of IFNgamma in SARS-CoV-2 disease.
34441178 2021. Entropy and Fractal Dimension Study of the TDP-43 Protein Low Complexity Domain Sequence in ALS Disease Severity and SARS-CoV-2 Gene Sequences in Virulence Variability.
34383213 2021. Deciphering epigenetic(s) role in modulating susceptibility to and severity of COVID-19 infection and/or outcome: a systematic rapid review.
34375814 2021. Modeling the population effects of escape mutations in SARS-CoV-2 to guide vaccination strategies.
34412446 2021. Herd immunity: challenges and the way forward in Korea.
34255566 2021. Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C).
34253862 2021. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms.
34324734 2021. Dimethyl sulfoxide reduces the stability but enhances catalytic activity of the main SARS-CoV-2 protease 3CLpro.
34222140 2021. Similarities and Differences Between COVID-19-Related Multisystem Inflammatory Syndrome in Children and Kawasaki Disease.
34194534 2021. V483A: an emerging mutation hotspot of SARS-CoV-2.
34219999 2021. Notable and Emerging Variants of SARS-CoV-2 Virus: A Quick Glance.
34269987 2021. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 Infection.
34286362 2021. SARS-CoV-2 and pathological matrix remodeling mediators.
34241783 2021. SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism.
34264010 2021. Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.
34307830 2021. In-Silico analysis reveals lower transcription efficiency of C241T variant of SARS-CoV-2 with host replication factors MADP1 and hnRNP-1.
34289645 2021. Letter to editor: Alimentary system is directly attacked by SARS-COV-2 and further prevents immune dysregulation caused by COVID-19.
34195921 2021. High anti-SARS-CoV-2 antibody seroprevalence in healthcare workers in an Irish university teaching hospital.
34237902 2021. Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2.
34237894 2021. Reply to Hayashi and Konishi: Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between virus and ACE2.
34237302 2021. Recombinant SARS-CoV-2 envelope protein traffics to the trans-Golgi network following amphipol-mediated delivery into human cells.
34270181 2021. What is Currently Known About the SARS-CoV2 Variants of Concern.
34238684 2021. Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19.
34252180 2021. Surviving older patients show preserved cellular and humoral immunological memory several months after SARS-CoV-2 infection.
34273592 2021. Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility.
34327751 2021. Cardiac Magnetic Resonance Follow-Up of Children After Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 With Initial Cardiac Involvement.
34288064 2021. A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients.
34248441 2021. Multisystem Inflammatory Syndrome in Children.
34203982 2021. Severe COVID-19 in Hospitalized Carriers of Single CFTR Pathogenic Variants.
34225749 2021. HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease.
34260266 2021. SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway.
34228642 2021. Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents.
34265238 2021. Lifting of COVID-19 restrictions in the UK and the Delta variant.
34204549 2021. The Role of Coronavirus RNA-Processing Enzymes in Innate Immune Evasion.
34239770 2021. Multisystem Inflammatory Syndrome in Adults (MIS-A) Associated with SARS-CoV-2 Infection in a Young Adult Case from Turkey.
34208136 2021. NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases.
34264910 2021. SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility - Oklahoma, April-May 2021.
34280038 2021. Traces of SARS-CoV-2 RNA in Peripheral Blood Cells of Patients with COVID-19.
34322566 2021. Systemic Inflammation and Microbial Translocation Are Characteristic Features of SARS-CoV-2-Related Multisystem Inflammatory Syndrome in Children.
34322559 2021. CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants.
34295945 2021. Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection.
34295944 2021. SARS-CoV-2 Subgenomic RNA Kinetics in Longitudinal Clinical Samples.
34306718 2021. Orchiepididymitis in the context of multisystem inflammatory syndrome in a child with Covid-19 from Syria: a very rare presentation for SARS-Cov-19 in children.
34192268 2020. Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.
34192267 2020. Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.
34187503 2021. Intravenous administration of anakinra in children with macrophage activation syndrome.
34315200 2021. Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review.
34228753 2021. Characterization of low-density granulocytes in COVID-19.
34292871 2021. Ongoing global and regional adaptive evolution of SARS-CoV-2.
34231823 2021. Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.
34191369 2021. Persistence of humoral response upon SARS-CoV-2 infection.
34260780 2021. A systematic meta-analysis of immune signatures in patients with COVID-19.
34305429 2021. Relevance between COVID-19 and host genetics of immune response.
34234112 2021. The signal pathways and treatment of cytokine storm in COVID-19.
34234102 2021. SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.
34315848 2021. Assessment of infectivity and the impact on neutralizing activity of immune sera of the COVID-19 variant, CAL.20C.
34315847 2021. N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding.
34253708 2021. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction.
34315677 2021. Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors.
34230895 2021. Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing.
34274029 2021. Reverse Transcription Polymerase Chain Reaction Pattern of SARS-CoV-2 Beta Variant.
34383706 2021. Alpha variant (B.1.1.7) of SARS-CoV-2 increases fatality-rate for patients under age of 70 years and hospitalization risk overall.
34432905 2021. Incidence rate of MIS-C in paediatrics: A good reason to vaccinate children against SARS-CoV-2.
34279831 2021. Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known?
34418362 2021. The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives.
34413034 2021. Sudden cardiac death in a young boy with multisystemic inflammatory syndrome in children (MISC).
34213849 2021. Structure-function relations of the SARS-CoV-2 spike protein and impact of mutations in the variants of concern.
34213846 2021. Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.
34213845 2021. COVID-19: individual and herd immunity.
34265244 2021. The devil in the details: Herd immunity and pandemic response.
34251316 2021. SARS-CoV-2 infection may not be a prerequisite for developing multisystem inflammatory syndrome in children.
34259663 2021. Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis.
34269657 2021. The role of PCSK9 in infectious diseases.
34189878 2021. COVID 19 in India: Waves, Variants of Concern, Airborne Transmission.
34233453 2021. Viral shedding in symptomatic patients with mild COVID-19: an experience with nebulized nasal treatment.
34229570 2021. Comparative analysis of SARS-CoV-2 envelope viroporin mutations from COVID-19 deceased and surviving patients revealed implications on its ion-channel activities and correlation with patient mortality.
34323931 2021. Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19.
34287999 2021. Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG-I-like receptors.
34266903 2021. Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.
34225390 2021. Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1.
34190914 2021. Sindrome inflamatorio multisistemico pediatrico asociado a COVID-19: reporte preliminar de un hospital del Peru.

34425281 2021. Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion.
34336288 2021. Coronavirus Disease 2019-Related Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis.
34351418 2021. Host ADP-ribosylation and the SARS-CoV-2 macrodomain.
34461258 2021. SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling.
34364043 2021. Interleukin-17A (IL-17A): A silent amplifier of COVID-19.
34356872 2021. Different Within-Host Viral Evolution Dynamics in Severely Immunosuppressed Cases with Persistent SARS-CoV-2.
34440241 2021. Structural Dissection of Viral Spike-Protein Binding of SARS-CoV-2 and SARS-CoV-1 to the Human Angiotensin-Converting Enzyme 2 (ACE2) as Cellular Receptor.
34453696 2021. (1)H, (13)C and (15)N assignment of stem-loop SL1 from the 5'-UTR of SARS-CoV-2.
34439792 2021. Relevance of BET Family Proteins in SARS-CoV-2 Infection.
34439910 2021. Molecular Dynamics Simulation Study of the Interaction between Human Angiotensin Converting Enzyme 2 and Spike Protein Receptor Binding Domain of the SARS-CoV-2 B.1.617 Variant.
34439887 2021. HMGB1-TIM3-HO1: A New Pathway of Inflammation in Skin of SARS-CoV-2 Patients? A Retrospective Pilot Study.
34439868 2021. Cytokine Storms in the Course of COVID-19 and Haemophagocytic Lymphohistiocytosis in Pregnant and Postpartum Women.
34349042 2021. Green-blue intracytoplasmic inclusions in the bone marrow in severe COVID-19.
34388982 2021. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
34373240 2021. Severe acute inflammatory myositis and rhabdomyolysis in paediatric SARS-CoV-2-associated MIS-C (multisystem inflammatory syndrome in children).
34380685 2021. Transient acetylcholine receptor-related myasthenia gravis, post multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19 infection.
34351888 2021. Lactante criticamente enfermo con sindrome inflamatorio multisistemico relacionado con COVID-19.
34392826 2021. Sustained seroprevalence of SARS-CoV-2 antibodies one year after infection: one of the first COVID-19 cluster cases in Bosnia and Herzegovina.
34428473 2021. The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines.
34382087 2021. Data-driven identification of SARS-CoV-2 subpopulations using PhenoGraph and binary-coded genomic data.
34421386 2021. Epidemiologic and clinical characteristics of multisystem inflammatory syndrome in adults: a rapid review.
34385216 2021. Le syndrome inflammatoire multisystemique post-COVID-19 chez les enfants.
34385205 2021. Post-COVID-19 multisystem inflammatory syndrome in children.
34367385 2021. The Relationship between Pre-Pandemic Interferon Gamma Release Assay Test Results and COVID-19 Infection: Potential Prognostic Value of Indeterminate IFN-gamma Release Assay Results.
34386717 2021. Salivary markers and coronavirus disease 2019: insights from cross-talk between the oral microbiome and pulmonary and systemic low-grade inflammation and implications for vascular complications.
34352228 2021. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
34332650 2021. Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike.
34351662 2021. Role of hemagglutinin-esterase protein in SARS-CoV-2 infection?
34389814 2021. SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse.
34385425 2021. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
34429403 2021. Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells.
34400613 2021. Molecular determinants for regulation of G3BP1/2 phase separation by the SARS-CoV-2 nucleocapsid protein.
34426672 2021. Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.
34413488 2021. Activation or exhaustion of CD8(+) T cells in patients with COVID-19.
34433083 2021. The nucleotide addition cycle of the SARS-CoV-2 polymerase.
34416153 2021. One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening.
34380018 2021. No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing.
34358460 2021. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
34341488 2021. O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an "O-Follow-N" rule.
34438017 2021. A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder.
34359986 2021. Role of Multifunctional Cytoskeletal Filaments in Coronaviridae Infections: Therapeutic Opportunities for COVID-19 in a Nutshell.
34359983 2021. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.
34359957 2021. MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women.
34359932 2021. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.
34359931 2021. Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells.
34440791 2021. The Molecular Interplay between Human Coronaviruses and Autophagy.
34440767 2021. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection.
34440765 2021. Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses.
34440903 2021. Implications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections.
34440879 2021. Expansion of Myeloid Derived Suppressor Cells Contributes to Platelet Activation by L-Arginine Deprivation during SARS-CoV-2 Infection.
34440816 2021. Secretory Vesicles Are the Principal Means of SARS-CoV-2 Egress.
34356552 2021. Neonatal Multisystem Inflammatory Syndrome (MIS-N) Associated with Prenatal Maternal SARS-CoV-2: A Case Series.
34438603 2021. MIS-C-Implications for the Pediatric Surgeon: An Algorithm for Differential Diagnostic Considerations.
34353002 2021. Clinical spectrum and short-term outcomes of multisystem inflammatory syndrome in children in a south Indian hospital.
34343708 2021. Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection.
34458720 2021. Multisystem inflammatory syndrome in adults following COVID-19 infection: A case report presenting with colitis.
34391929 2021. Mucosal immunity to SARS-CoV-2: a clinically relevant key to deciphering natural and vaccine-induced defences.
34455390 2021. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
34419923 2021. Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19.
34392145 2021. High throughput diagnostics and dynamic risk assessment of SARS-CoV-2 variants of concern.
34401689 2021. Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England.
34350827 2021. Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy.
34435953 2021. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
34424199 2021. Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia.
34414888 2021. SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19.
34414884 2021. N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2.
34402426 2021. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
34387545 2021. Patterns of within-host genetic diversity in SARS-CoV-2.
34375000 2021. Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites.
34352197 2021. SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy.
34437831 2021. Real-Time Genomic Surveillance for SARS-CoV-2 Variants of Concern, Uruguay.
34388358 2021. Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021.
34402744 2021. Host-dependent editing of SARS-CoV-2 in COVID-19 patients.
34396940 2021. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.
34400021 2021. Aparicion de novo de la mutacion E484K en una variante del linaje B.1.1.7 de SARS-CoV-2.
34365657 2021. Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice.
34339064 2021. S100A8 may govern hyper-inflammation in severe COVID-19.
34398806 2021. Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2.
34355822 2021. Walking down the memory lane with SARS-CoV-2 B cells.
34382228 2021. Sensitive detection of anti-spike antibodies enables improved understanding of SARS-CoV-2 pathogenesis.
34446125 2021. Early detection of the SARS-CoV-2 P.1 variant in Rio Grande do Sul, Brazil: a case report.
34414454 2021. MicroRNA283p inhibits angiotensinconverting enzyme 2 ectodomain shedding in 293T cells treated with the spike protein of severe acute respiratory syndrome coronavirus 2 by targeting A disintegrin and metalloproteinase 17.
34346720 2021. Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients.
34379531 2021. Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants.
34379530 2021. The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery.
34428777 2021. Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York.
34332518 2021. Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows.
34414796 2021. Henoch-Schonlein Purpura in a COVID-19-Positive Child With Abdominal Pain and PIMS-TS.
34417262 2021. LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes.
34424997 2021. SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector function.
34355378 2021. Alterations in lymphocyte subsets and monocytes in patients diagnosed with SARS-CoV-2 pneumonia: a mini review of the literature.
34341181 2021. Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection.
34338591 2021. Evolving ribonucleocapsid assembly/packaging signals in the genomes of the human and animal coronaviruses: targeting, transmission and evolution.
34371513 2021. Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection and Escherichia coli Sepsis: The Role of Procalcitonin for Differential Diagnosis.
34346865 2021. Memoire immunitaire contre le SARS-CoV-2 - Des anticorps contre l'infection initiale et des lymphocytes B a memoire contre les infections futures.
34346864 2021. Par ici la sortie ! Le SARS-CoV-2 utilise les lysosomes pour sortir de la cellule infectee.
34347959 2021. SARS-CoV-2 Variants in Patients with Immunosuppression.
34407350 2021. Audio Interview: Aspects of Covid-19 Immunity.
34376850 2021. The lag in SARS-CoV-2 genome submissions to GISAID.
34408314 2021. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children.
34413500 2021. A glycan gate controls opening of the SARS-CoV-2 spike protein.
34363044 2021. Coronavirus footprints.
34426697 2021. Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genome.
34385690 2021. Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function.
34373640 2021. Remember Beta? New data reveal variant's deadly powers.
34413530 2021. Delta's rise is fuelled by rampant spread from people who feel fine.
34413527 2021. COVID vaccines protect against Delta, but their effectiveness wanes.
34417582 2021. The mutation that helps Delta spread like wildfire.
34385613 2021. How do vaccinated people spread Delta? What the science says.
34354278 2021. Delta threatens rural regions that dodged earlier COVID waves.
34363057 2020. Daily briefing: The wildly complicated immune response to COVID-19.
34346604 2021. Covid-19-geassocieerde 'multisystem inflammatory syndrome'.

34423834 2021. Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta).
34389636 2021. Secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality.
34384361 2021. Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants.
34391590 2021. Conversations With the Editors: The Emergence of Variants Amid Population-Wide SARS-CoV-2 Vaccination Efforts: How Much Should We Worry?
34429968 2021. Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients.
34336207 2021. Decline in neutralising antibody responses, but sustained T-cell immunity, in COVID-19 patients at 7 months post-infection.
34345007 2021. Identification, mapping and relative quantitation of SARS-CoV-2 Spike glycopeptides by Mass-Retention Time Fingerprinting.
34429502 2021. The structure of a dimeric form of SARS-CoV-2 polymerase.
34346317 2021. Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach.
34336146 2021. Binding affinity and mechanisms of SARS-CoV-2 variants.
34336145 2021. Immune evasion of SARS-CoV-2 from interferon antiviral system.
34395179 2021. SARS-CoV spike proteins can compete for electrolytes in physiological fluids according to structure-based quantum-chemical calculations.
34336449 2021. Roles and Interplay of SARS-CoV-2 Serology With Clinical Stages of Disease in COVID-19.
34336414 2021. Acute Appendicitis Associated With Multisystem Inflammatory Syndrome in Children.
34422477 2021. Case Series of Clinical Findings of Multi-System Inflammatory Syndrome in Children in Contrast to Kawasaki Disease.
34454352 2021. Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?
34383898 2021. Comparison of cardiac computed tomography findings of Kawasaki disease and post-COVID-19 coronary aneurysms.
34333764 2021. Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing.
34425479 2021. Acute encephalitis in pediatric multisystem inflammatory syndrome associated with COVID-19.
34447577 2021. Variants in SARS-CoV-2 associated with mild or severe outcome.
34453107 2021. Mutational spectrum of SARS-CoV-2 during the global pandemic.
34409597 2021. Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination.
34409594 2021. Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production.
34375459 2021. A glycosaminoglycan microarray identifies the binding of SARS-CoV-2 spike protein to chondroitin sulfate E.
34422917 2021. Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19.
34386533 2021. IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial.
34414185 2021. N439K Variant in Spike Protein Alter the Infection Efficiency and Antigenicity of SARS-CoV-2 Based on Molecular Dynamics Simulation.
34386498 2021. ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 Replication.
34434902 2021. A Computational Approach to Evaluate the Combined Effect of SARS-CoV-2 RBD Mutations and ACE2 Receptor Genetic Variants on Infectivity: The COVID-19 Host-Pathogen Nexus.
34368076 2021. Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein.
34394197 2021. poreCov-An Easy to Use, Fast, and Robust Workflow for SARS-CoV-2 Genome Reconstruction via Nanopore Sequencing.
34447386 2021. Update Advances on C-Reactive Protein in COVID-19 and Other Viral Infections.
34447375 2021. SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage.
34421894 2021. Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19.
34408749 2021. Long Noncoding RNAs as Emerging Regulators of COVID-19.
34394120 2021. Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients.
34394108 2021. Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses.
34394094 2021. Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19.
34394090 2021. CD169 Defines Activated CD14(+) Monocytes With Enhanced CD8(+) T Cell Activation Capacity.
34386006 2021. Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography.
34367190 2021. Monocytes and Macrophages in COVID-19.
34367154 2021. Gene Expression Meta-Analysis Reveals Interferon-Induced Genes Associated With SARS Infection in Lungs.
34354712 2021. Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study.
34341659 2021. Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells.
34335624 2021. Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19.
34335605 2021. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals.
34335604 2021. The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion?
34335596 2021. Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention.
34458281 2021. Gut Microbiota Dysbiosis Is a Crucial Player for the Poor Outcomes for COVID-19 in Elderly, Diabetic and Hypertensive Patients.
34434945 2021. Role of Th22 Cells in Human Viral Diseases.
34414199 2021. Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide.
34336891 2021. Antibodies Can Last for More Than 1 Year After SARS-CoV-2 Infection: A Follow-Up Study From Survivors of COVID-19.
34394051 2021. Genomic Surveillance and Phylodynamic Analyses Reveal the Emergence of Novel Mutations and Co-mutation Patterns Within SARS-CoV-2 Variants Prevalent in India.
34394024 2021. Profiling of Oral Microbiota and Cytokines in COVID-19 Patients.
34367091 2021. Hypoxia: The "Invisible Pusher" of Gut Microbiota.
34335535 2021. Mutations in SARS-CoV-2 ORF8 Altered the Bonding Network With Interferon Regulatory Factor 3 to Evade Host Immune System.
34335530 2021. Comprehensive Deep Mutational Scanning Reveals the Immune-Escaping Hotspots of SARS-CoV-2 Receptor-Binding Domain Targeting Neutralizing Antibodies.
34335504 2021. Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes?
34386518 2021. Non-RBM Mutations Impaired SARS-CoV-2 Spike Protein Regulated to the ACE2 Receptor Based on Molecular Dynamic Simulation.
34355020 2021. A Validated Mathematical Model of the Cytokine Release Syndrome in Severe COVID-19.
34354952 2021. Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma.
34434905 2021. Acute Kidney Injury in Pediatric Acute SARS-CoV-2 Infection and Multisystem Inflammatory Syndrome in Children (MIS-C): Is There a Difference?
34422717 2021. Case Report: Mitral Valve Involvement and First-Degree Atrial-Ventricular Block in Two Patients With Multisystem Inflammatory Syndrome in Children.
34368030 2021. Case Report: Changes in Cytokine Kinetics During the Course of Disease in a Japanese Patient With Multisystem Inflammatory Syndrome in Children.
34421600 2021. NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments.
34335279 2021. The Role of High-Density Lipoprotein in COVID-19.
34413782 2021. Rarely Recognized Antibody Diversification in Covid-19 Evolution to Counteract Advanced SARS-CoV-2 Evasion Strategies, and Implications for Prophylactic Treatment.
34366882 2021. The Role of Innate Immunity and Bioactive Lipid Mediators in COVID-19 and Influenza.
34427676 2021. Potential Effect of Previous Human Coronavirus NL63 Infection on the Rate of Infection and the Clinical Course of Coronavirus Disease 2019.
34427670 2021. Critically ill COVID-19 patients exhibit hyperactive cytokine responses associated with effector exhausted senescent T cells in acute infection.
34427652 2021. SARS-CoV-2 infectivity correlates with high viral loads and detection of viral antigen and is terminated by seroconversion.
34423821 2021. Joint Estimation Of Generation Time And Incubation Period For Coronavirus Disease (Covid-19).
34409999 2021. SARS-CoV-2 variant Delta infects all 6 siblings but spares Comirnaty (BNT162b2, BioNTech/Pfizer)-vaccinated parents.
34343373 2021. Multisystem inflammatory syndrome in children during severe acute respiratory syndrome coronavirus-2 pandemic in Turkey: A single-centre experience.
34388280 2021. Neonatal Multisystem Inflammatory Syndrome secondary to SARS-CoV-2 infection.
34409452 2021. Cluster characterization of SARS-CoV-2 in military personnel deployed to Egypt and subsequent introduction of B.1.1.7 and C.36 lineages to Colombia.
34452991 2021. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1.
34433692 2021. Profound Treg perturbations correlate with COVID-19 severity.
34369011 2021. A distinct ssDNA/RNA binding interface in the Nsp9 protein from SARS-CoV-2.
34375467 2021. Molecular dynamics analysis of a flexible loop at the binding interface of the SARS-CoV-2 spike protein receptor-binding domain.
34376481 2021. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
34404118 2021. Natural infection of Delta mutant of SARS-CoV-2 in Asiatic lions of India.
34348612 2021. Role of potential COVID-19 immune system associated genes and the potential pathways linkage with type-2 diabetes.
34397331 2021. Low pH and temperature of airway surface liquid are key determinants that potentiate SARS-CoV-2 infectivity.
34417260 2021. SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis.
34389625 2021. Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8(+) T Cells during Convalescence.
34348975 2021. Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.
34452933 2021. Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.
34374752 2021. Distinct Mitochondria-Mediated T-Cell Apoptosis Responses in Children and Adults With Coronavirus Disease 2019.
34340303 2021. Why All the Fury over Furin?
34375002 2021. Viral proteins recognized by different TLRs.
34449894 2021. SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers.
34450642 2021. Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera.
34459420 2021. Multisystem inflammatory syndrome with persistent neutropenia in neonate exposed to SARS-CoV-2 virus: A case report and review of literature.
34417772 2021. Bilateral Optic Disc Edema in Multisystem Inflammatory Syndrome in Children Associated With COVID-19.
34339544 2021. Comparison of clinical and laboratory profile of survivors and non-survivors of SARS-CoV-2-related multisystem inflammatory syndrome of childhood in India: An observational study.
34414434 2021. Updated Management Protocol for Multisystem Inflammatory Syndrome in Children (MIS-C).
34392371 2021. Mucocutaneous Findings of Multisystem Inflammatory Syndrome in Children: A Single-Center Experience.
34406361 2021. Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
34383043 2021. Potential Implications of SARS-CoV-2 Delta Variant Surges for Rural Areas and Hospitals.
34387645 2021. Variants of SARS-CoV-2.
34459875 2021. One-Year Outcomes of Critical Care Patients Post-COVID-19 Multisystem Inflammatory Syndrome in Children.
34341310 2021. Prevalence of COVID-19 genomic variation in Africa: a living systematic review protocol.
34331778 2021. Recurrent assessment of lymphocyte subsets in 32 patients with multisystem inflammatory syndrome in children (MIS-C).
34385349 2021. Deaths in Children and Adolescents Associated With COVID-19 and MIS-C in the United States.
34376480 2021. Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study.
34413221 2021. Do chronic infections breed dangerous new variants?
34413215 2021. Israel's grim warning: Delta can overwhelm shots.
34362872 2021. Phylogenomic analysis of SARS-CoV-2 from third wave clusters in Malaysia reveals dominant local lineage B.1.524 and persistent spike mutation A701V.
34363852 2021. Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021.
34355546 2021. NLRP3 inflammasome activation and oxidative stress status in the mild and moderate SARS-CoV-2 infected patients: impact of melatonin as a medicinal supplement.
34428364 2021. Cytokine storm syndrome in SARS-CoV-2: a review.

34362671 2021. ORF8a as a viroporin in SARS-CoV-2 infection?
34425451 2021. SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: reports in two cities in the United States.
34410992 2021. Nine Cases of SARS-CoV-2-PCR-positive Samples Showed No Increase of Antibodies Against SARS-CoV-2.
34406867 2021. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage.

TempI

Aktuelle Version vom 12. November 2021, 12:53 Uhr

Meine Werkzeuge

Namensräume

Varianten

Ansichten

Aktionen

Suche

Navigation

Werkzeuge

@@ Zeile 1: / Zeile 1: @@
+{{tp|p=C7723464|t=2020. Contributory role of SARS-CoV-2 genomic variations and life expectancy in COVID-19 transmission and low fatality rate in Africa.|pdf=|usr=023}}
+{{tp|p=C7709652|t=2020. COVID-19 natural herd immunity and risk of neuropsychiatric disorders.|pdf=|usr=023}}
+{{tp|p=C7709602|t=?. Syndrome inflammatoire avec atteinte multisystémique post-infection par le SARS-CoV-2 chez l?enfant : quand l?envisager et comment le prendre en charge ?|pdf=|usr=023}}
+{{tp|p=C7685301|t=?. Role of gut-lung microbiome crosstalk in COVID-19.|pdf=|usr=023}}
+{{tp|p=C7670013|t=2020. SARS-CoV-2 und das Kawasaki-Syndrom.|pdf=|usr=023}}
+{{tp|p=33333024|t=?. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.|pdf=|usr=023}}
+{{tp|p=C7688432|t=?. A Dermatologic Perspective on Multisystem Inflammatory Syndrome in Children.|pdf=|usr=023}}
+{{tp|p=C7604155|t=?. Dermatologic manifestations of COVID-19-associated multisystem inflammatory syndrome in children.|pdf=|usr=023}}
+{{tp|p=33312565|t=2020. Rapid detection of SARS?CoV?2?specific memory T?cell immunity in recovered COVID?19 cases.|pdf=|usr=023}}
+{{tp|p=C7665476|t=?. Conservation analysis of SARS-CoV-2 spike suggests complicated viral adaptation history from bat to human.|pdf=|usr=023}}
+{{tp|p=33312178|t=2020. MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity.|pdf=|usr=023}}
+{{tp|p=C7720652|t=?. Phylogenomics and phylodynamics of SARS-CoV-2 genomes retrieved from India.|pdf=|usr=023}}
+{{tp|p=C7692877|t=?. Phylogenetic and whole genome analysis of first seven SARS-CoV-2 isolates in Bangladesh.|pdf=|usr=023}}
+{{tp|p=33319124|t=2021. Mutational insights into the envelope protein of SARS-CoV-2.|pdf=|usr=023}}
+{{tp|p=C7604183|t=2020. SÍNDROME HEMOFAGOCÍTICA EM CORONAVÍRUS 19: EXPERIÊNCIA DE UM CENTRO DE CURITIBA-PR.|pdf=|usr=023}}
+{{tp|p=C7604150|t=2020. IMUNOPATOLOGIA DA INFECÇÃO POR SARS-COV-2 EM PACIENTES ONCO-HEMATOLÓGICOS.|pdf=|usr=023}}
+{{tp|p=C7604096|t=2020. RELATO DE CASO: SINDROME HIPERINFLAMATÓRIA MULTISSISTÊMICA COVID 19 EM PACIENTE PORTADORA DE SÍNDROME MIELODISPLÁSICA- CITOPENIA REFRATÁRIA E ESPECTRO AUTISTA.|pdf=|usr=023}}
+{{tp|p=C7604066|t=2020. COVID-19 E SÍNDROME INFLAMATÓRIA MULTISSISTÊMICA SEMELHANTE À DOENÇA DE KAWASAKI: REVISÃO SISTEMÁTICA.|pdf=|usr=023}}
+{{tp|p=C7604036|t=2020. SÍNDROME INFLAMATÓRIA MULTISSISTÊMICA PEDIÁTRICA KAWASAKI-LIKE ASSOCIADA A COVID-19.|pdf=|usr=023}}
+{{tp|p=C7604054|t=2020. SÍNDROME HEMOFAGOCÍTICA EM PACIENTE COM LMA RECIDIVADA E COVID-19: RELATO DE CASO.|pdf=|usr=023}}
+{{tp|p=C7604043|t=2020. AVALIAÇÃO DAS SUBPOPULAÇÕES LINFOCITÁRIAS T B E NK EM PACIENTES COM COVID-19 GRAVE ATENDIDOS EM UM HOSPITAL UNIVERSITÁRIO.|pdf=|usr=023}}
+{{tp|p=33326767|t=2020. SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors.|pdf=|usr=023}}
+{{tp|p=33310664|t=2021. Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients.|pdf=|usr=023}}
+{{tp|p=33319167|t=?. Structural characterization of Nonstructural protein 1 from SARS-CoV-2.|pdf=|usr=023}}
+{{tp|p=33319166|t=2021. Transcriptional response modules characterize IL-1? and IL-6 activity in COVID-19.|pdf=|usr=023}}
+{{tp|p=C7698825|t=?. Development of Herd Immunity to COVID-19 in Louisiana nursing homes.|pdf=|usr=023}}
+{{tp|p=33328133|t=?. Kawasaki disease and COVID-19; a pretext for a hot topic.|pdf=|usr=023}}
+{{tp|p=C7711743|t=?. Potential implications of SARS-CoV-2 oral infection in the host microbiota.|pdf=|usr=023}}
+{{tp|p=33316043|t=?. A phylodynamic workflow to rapidly gain insights into the dispersal history and dynamics of SARS-CoV-2 lineages.|pdf=|usr=023}}
+{{tp|p=C7677618|t=?. Physiochemical Characterization and Domain Annotation of ORF1ab Polyprotein of Novel Corona Virus 19.|pdf=|usr=023}}
+{{tp|p=C7677617|t=?. Comparing Proteomics of NCoV 19 and MERS Corona Virus.|pdf=|usr=023}}
+{{tp|p=C7677611|t=?. Genomics and Evolution of Novel Corona Virus 2019.|pdf=|usr=023}}
+{{tp|p=C7677609|t=?. Evolutionary and Structural Studies of NCoV and SARS CoV-Spike proteins and their association with ACE2 Receptor.|pdf=|usr=023}}
+{{tp|p=C7717355|t=?. Cytokine and Chemokine Levels in COVID-19 Convalescent Plasma.|pdf=|usr=023}}
+{{tp|p=C7717363|t=?. High Prevalence of SARS-CoV-2 Genetic Variation and D614G Mutation in Pediatric Patients with COVID-19.|pdf=|usr=023}}
+{{tp|p=33333460|t=2021. Increased Intracranial Pressure in the Setting of Multisystem Inflammatory Syndrome in Children Associated With COVID-19.|pdf=|usr=023}}
+{{tp|p=C7717369|t=?. Significant reduction of humoral response to SARS-CoV-2 4 months after the diagnosis of COVID-19.|pdf=|usr=023}}
+{{tp|p=C7607336|t=2020. O03?A case of hyperinflammatory COVID-19 that responded to tocilizumab therapy.|pdf=|usr=023}}
+{{tp|p=C7607334|t=2020. EP10?Hyperinflammatory syndrome in a patient with rheumatoid arthritis and COVID-19.|pdf=|usr=023}}
+{{tp|p=C7607308|t=2020. O01?Adult onset PIMS-TS with secondary haemophagocytic lymphistiocytosis: into the eye of the cytokine storm.|pdf=|usr=023}}
+{{tp|p=33309104|t=?. Using Genetics To Dissect SARS-CoV-2 Infection.|pdf=|usr=023}}
+{{tp|p=C7665770|t=?. Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation.|pdf=|usr=023}}
+{{tp|p=32921750|t=2020. Iron overload and Hepcidin overexpression could play a key role in COVID infection, and may explain vulnerability in elderly, diabetics, and obese patients.|pdf=|usr=023}}
+{{tp|p=33219817|t=2020. Individuals With Less Severe Manifestations of SARS-CoV-2 Infection May Not Develop Long-Lasting Humoral Immunity.|pdf=|usr=023}}
+{{tp|p=33303190|t=2020. The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.|pdf=|usr=023}}
+{{tp|p=33299872|t=2020. Phylogenomics Analysis of SARS-CoV2 Genomes Reveals Distinct Selection Pressure on Different Viral Strains.|pdf=|usr=023}}
+{{tp|p=33299503|t=2020. An Immunoinformatics Study to Predict Epitopes in the Envelope Protein of SARS-CoV-2.|pdf=|usr=023}}
+{{tp|p=33299631|t=2020. Varying Presentations of Multisystem Inflammatory Syndrome Temporarily Associated with COVID-19.|pdf=|usr=023}}
+{{tp|p=33274096|t=2020. Multisystem Inflammatory Syndrome in Children in a 15-Year-Old Male with a Retropharyngeal Phlegmon.|pdf=|usr=023}}
+{{tp|p=33298836|t=2020. RNA 2'-O-methylation modification and its implication in COVID-19 immunity.|pdf=|usr=023}}
+{{tp|p=33298900|t=2020. Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro.|pdf=|usr=023}}
+{{tp|p=33301717|t=2020. FRETing over SARS-CoV-2: Conformational Dynamics of the Spike Glycoprotein.|pdf=|usr=023}}
+{{tp|p=33306985|t=2020. D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.|pdf=|usr=023}}
+{{tp|p=33112651|t=2020. Addition of Corticosteroids to Immunoglobulins Is Associated With Recovery of Cardiac Function in Multi-Inflammatory Syndrome in Children.|pdf=|usr=023}}
+{{tp|p=33257339|t=2020. Le syndrome inflammatoire multisystemique de l'enfant ayant un lien temporel avec la COVID-19 : multiples visages, multiples appellations.|pdf=|usr=023}}
+{{tp|p=33304243|t=2020. Neuropathobiology of COVID-19: The Role for Glia.|pdf=|usr=023}}
+{{tp|p=33281831|t=2020. The Role of Structure in the Biology of Interferon Signaling.|pdf=|usr=023}}
+{{tp|p=33089820|t=2020. Multisystem Inflammatory Syndrome in Children (MIS-C) - Recent Updates.|pdf=|usr=023}}
+{{tp|p=33302033|t=2020. The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease.|pdf=|usr=023}}
+{{tp|p=33299610|t=2020. SARS-CoV-2, Early Entry Events.|pdf=|usr=023}}
+{{tp|p=33303307|t=2020. Could changes in the airborne pollutant particulate matter acting as a viral vector have exerted selective pressure to cause COVID-19 evolution?|pdf=|usr=023}}
+{{tp|p=33173546|t=2020. Hyperinflammation bei SARS-CoV-2-Infektion.|pdf=|usr=023}}
+{{tp|p=32503876|t=2020. T cell engagement of cross-presenting microglia protects the brain from a nasal virus infection.|pdf=|usr=023}}
+{{tp|p=33253656|t=2020. One year update on the COVID-19 pandemic: Where are we now?|pdf=|usr=022}}
+{{tp|p=33230418|t=2020. Characteristics and considerations in the medical treatment of COVID-19 in children.|pdf=|usr=022}}
+{{tp|p=33169815|t=2020. Basics of mechanical ventilation for non-anaesthetists. Part 1: Theoretical aspects.|pdf=|usr=022}}
+{{tp|p=33279488|t=2020. The Utility of CHA(2)DS(2)-VASc Scores as a Risk Assessment Tool in Low-Risk In-Hospital Patients With Coronavirus Disease 2019 Infection.|pdf=|usr=022}}
+{{tp|p=33197639|t=2020. Our insight about Mukhtar et al.'s outcome of non-invasive ventilation in COVID-19 critically ill patients.|pdf=|usr=022}}
+{{tp|p=33242934|t=2020. Clinical outcomes of high-flow nasal cannula in COVID-19 associated postextubation respiratory failure. A single-centre case series.|pdf=|usr=022}}
+{{tp|p=33245382|t=2020. Empfehlungen fur die Behandlung von kritisch kranken Patienten mit COVID-19 : Version 3 S1-Leitlinie.|pdf=|usr=022}}
+{{tp|p=33241252|t=2020. Knowledge and Confidence Level Among Emergency Healthcare Workers in Airway Management and Resuscitation of Suspected COVID-19 Patients: A Cross Sectional Study in Malaysia.|pdf=|usr=022}}
+{{tp|p=33264802|t=2020. Ambulatory Clinician's Guide to Inpatient Service: An Innovative Rapid Onboarding Strategy for the COVID-19 Pandemic.|pdf=|usr=022}}
+{{tp|p=33272716|t=2020. Surgical strategy and optimal timing of tracheostomy in patients with COVID-19: Early experiences in Japan.|pdf=|usr=022}}
+{{tp|p=33294449|t=2020. Differences in Clinical Features and Laboratory Results between Adults and Children with SARS-CoV-2 Infection.|pdf=|usr=022}}
+{{tp|p=33256643|t=2020. A nomogramic model based on clinical and laboratory parameters at admission for predicting the survival of COVID-19 patients.|pdf=|usr=022}}
+{{tp|p=33287804|t=2020. Development of a data-driven COVID-19 prognostication tool to inform triage and step-down care for hospitalised patients in Hong Kong: a population-based cohort study.|pdf=|usr=022}}
+{{tp|p=33272250|t=2020. Comparative analysis of COVID-19 guidelines from six countries: a qualitative study on the US, China, South Korea, the UK, Brazil, and Haiti.|pdf=|usr=022}}
+{{tp|p=33293361|t=2020. Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA.|pdf=|usr=022}}
+{{tp|p=33223045|t=2020. Haemodynamic impact of positive end-expiratory pressure in SARS-CoV-2 acute respiratory distress syndrome: oxygenation versus oxygen delivery.|pdf=|usr=022}}
+{{tp|p=33254199|t=2020. Hemodynamic and mechanical ventilation approach in patients with COVID-19.|pdf=|usr=022}}
+{{tp|p=33263635|t=2020. Update on the diagnosis and management of COVID-19 in pediatric patients.|pdf=|usr=022}}
+{{tp|p=33287864|t=2020. Electrical impedance tomography to titrate positive end-expiratory pressure in COVID-19 acute respiratory distress syndrome.|pdf=|usr=022}}
+{{tp|p=33283196|t=2020. A Novel Low-Cost Ventilator for Use in a Worldwide Pandemic: The Portsmouth Ventilator.|pdf=|usr=022}}
+{{tp|p=33278017|t=2020. Inpatient Hyperglycemia Management and COVID-19.|pdf=|usr=022}}
+{{tp|p=33273040|t=2020. Post-exertion oxygen saturation as a prognostic factor for adverse outcome in patients attending the emergency department with suspected COVID-19: a substudy of the PRIEST observational cohort study.|pdf=|usr=022}}
+{{tp|p=33282444|t=2020. Development and Validation of a Prognostic Risk Score System for COVID-19 Inpatients: A Multi-Center Retrospective Study in China.|pdf=|usr=022}}
+{{tp|p=33257913|t=2020. Veno-venous extracorporeal membrane oxygenation in coronavirus disease 2019: a case series.|pdf=|usr=022}}
+{{tp|p=33257912|t=2020. Continuous positive airway pressure-treated patients' behaviours during the COVID-19 crisis.|pdf=|usr=022}}
+{{tp|p=33293151|t=2020. Home-based COVID 19 management: A consensus document from Italian general medical practitioners and hospital consultants in the Lombardy region (Italy).|pdf=|usr=022}}
+{{tp|p=33275268|t=2020. Extracorporeal membrane oxygenation (ECMO) in patients with COVID-19: a rapid systematic review of case studies.|pdf=|usr=022}}
+{{tp|p=33230401|t=2020. Inclusive Biomedical Innovation during the COVID-19 Pandemic.|pdf=|usr=022}}
+{{tp|p=33271960|t=2020. What Can COVID-19 Teach Us about Using AI in Pandemics?|pdf=|usr=022}}
+{{tp|p=33281326|t=2020. Modified Negative Airflow Aerosol Prevention Box for COVID-19 Patients.|pdf=|usr=022}}
+{{tp|p=33281316|t=2020. Noninvasive Oxygen Strategies to Manage Confirmed COVID-19 Patients in Indian Intensive Care Units: A Survey.|pdf=|usr=022}}
+{{tp|p=33281314|t=2020. Awake Prone Positioning in COVID-19 Patients.|pdf=|usr=022}}
+{{tp|p=33281309|t=2020. Role of Noninvasive Oxygen Therapy Strategies in COVID-19 Patients: Where are We Going?|pdf=|usr=022}}
+{{tp|p=33281307|t=2020. Conscious Proning or Mixed Positioning for Improving Oxygenation-COVID-19 Brings Many Changes!|pdf=|usr=022}}
+{{tp|p=33289013|t=2020. Outlier-SMOTE: A refined oversampling technique for improved detection of COVID-19.|pdf=|usr=022}}
+{{tp|p=33287859|t=2020. Criteria for referral of pediatric SARS-CoV-2 infection: a real-life experience in the pandemic era.|pdf=|usr=022}}
+{{tp|p=33277163|t=2020. Performing Ultrasound-Guided Percutaneous Tracheostomy in COVID-19 Patients.|pdf=|usr=022}}
+{{tp|p=33185672|t=2020. Ensemble learning for poor prognosis predictions: a case study on SARS-CoV2.|pdf=|usr=022}}
+{{tp|p=33288431|t=2020. Con: Venoarterial ECMO Should Not Be Considered in Patients With COVID-19.|pdf=|usr=022}}
+{{tp|p=33288430|t=2020. Pro: Venoarterial ECMO Should Be Considered in Patients With COVID-19.|pdf=|usr=022}}
+{{tp|p=33262038|t=2020. Acute Respiratory Distress Syndrome Treated With Awake Extracorporeal Membrane Oxygenation in a Patient With COVID-19 Pneumonia.|pdf=|usr=022}}
+{{tp|p=33282650|t=2020. Pulmonary Embolism in COVID-19 Pneumonia: An Overlapping Diagnosis or a Misdiagnosis?|pdf=|usr=022}}
+{{tp|p=33274414|t=2020. Derivation of a Clinical Risk Score to Predict 14-Day Occurrence of Hypoxia, ICU Admission, and Death Among Patients with Coronavirus Disease 2019.|pdf=|usr=022}}
+{{tp|p=33268203|t=2020. A chronicle of SARS-CoV-2: Seasonality, environmental fate, transport, inactivation, and antiviral drug resistance.|pdf=|usr=022}}
+{{tp|p=33284779|t=2020. Artificial Intelligence in the Fight against COVID-19: A Scoping Review.|pdf=|usr=022}}
+{{tp|p=33273946|t=2020. Current status of COVID-19 pandemic; characteristics, diagnosis, prevention, and treatment.|pdf=|usr=022}}
+{{tp|p=33282011|t=2020. How chemical engineers can contribute to fight the COVID-19.|pdf=|usr=022}}
+{{tp|p=33256918|t=2020. SARS-CoV-2 risk misclassification explains poor COVID-19 management.|pdf=|usr=022}}
+{{tp|p=33276832|t=2020. Noninvasive Positive Pressure Ventilation in Patients With COVID-19.|pdf=|usr=022}}
+{{tp|p=33254558|t=2020. Role of graphene in biosensor and protective textile against viruses.|pdf=|usr=022}}
+{{tp|p=33254485|t=2020. The "COVID-19 Score" can predict the need for tracheal intubation in critically ill COVID-19 patients - A hypothesis.|pdf=|usr=022}}
+{{tp|p=33295326|t=2020. Silent or 'Happy' Hypoxemia: An Urgent Dilemma for COVID-19 Patient Care.|pdf=|usr=022}}
+{{tp|p=33285690|t=2020. Successful treatment of a critically ill patient with acute respiratory distress syndrome from COVID-19 using mechanical ventilation strategy with low levels of positive end-expiratory pressure: A CARE-compliant case report.|pdf=|usr=022}}
+{{tp|p=33282284|t=2020. COVID-19: general overview, pharmacological options and ventilatory support strategies.|pdf=|usr=022}}
+{{tp|p=33283160|t=2020. "Neurological manifestations of COVID-19" - guideline of the German society of neurology.|pdf=|usr=022}}
+{{tp|p=33274248|t=2020. The BAS(2)IC Score: A Useful Tool to Identify Patients at High Risk of Early Progression to Severe Coronavirus Disease 2019.|pdf=|usr=022}}
+{{tp|p=33294107|t=2020. Preventing Acute Respiratory Distress Syndrome (ARDS) and to avoiding intubation in patients with COVID-19: an experience from a reanimation service in Morocco.|pdf=|usr=022}}
+{{tp|p=33263088|t=2020. Chest Tube Drainage in the Age of COVID-19.|pdf=|usr=022}}
+{{tp|p=33296409|t=2020. COVID-MATCH65-A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2.|pdf=|usr=022}}
+{{tp|p=33296405|t=2020. COVID-19 mortality risk assessment: An international multi-center study.|pdf=|usr=022}}
+{{tp|p=33296357|t=2020. Development and external validation of a prognostic tool for COVID-19 critical disease.|pdf=|usr=022}}
+{{tp|p=33259540|t=2020. Core warming of coronavirus disease 2019 (COVID-19) patients undergoing mechanical ventilation-A protocol for a randomized controlled pilot study.|pdf=|usr=022}}
+{{tp|p=33262075|t=2020. Effects of prone and lateral position in non-intubated patients with 2019 Novel Coronavirus (COVID-19) pneumonia.|pdf=|usr=022}}
+{{tp|p=33272911|t=2020. Wearing of medical mask over the high-flow nasal cannula for safer oxygen therapy in the COVID-19 era.|pdf=|usr=022}}
+{{tp|p=33294226|t=2020. From Radiological Manifestations to Pulmonary Pathogenesis of COVID-19: A Bench to Bedside Review.|pdf=|usr=022}}
+{{tp|p=33288840|t=2020. Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19.|pdf=|usr=022}}
+{{tp|p=33260852|t=2020. ResUHUrge: A Low Cost and Fully Functional Ventilator Indicated for Application in COVID-19 Patients.|pdf=|usr=022}}
+{{tp|p=33262803|t=2020. Prone-Position Ventilation in a Pregnant Woman with Severe COVID-19 Infection Associated with Acute Respiratory Distress Syndrome.|pdf=|usr=022}}
+{{tp|p=33262795|t=2020. NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals.|pdf=|usr=022}}
+{{tp|p=33249683|t=2020. Derivation with Internal Validation of a Multivariable Predictive Model to Predict COVID-19 Test Results in Emergency Department Patients.|pdf=|usr=022}}
+{{tp|p=33296169|t=2020. Recent Insights into Emerging Coronavirus: SARS-CoV-2.|pdf=|usr=022}}
+{{tp|p=33247469|t=2020. Coronaviruses in Children: A Review of Potential Mechanisms of Childhood Protection.|pdf=|usr=022}}
+{{tp|p=33205450|t=2020. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19.|pdf=|usr=022}}
+{{tp|p=33284040|t=2020. Novel Tracheostomy and Percutaneous Endoscopic Gastrostomy Technique for COVID-19 Patients in a Nonnegative Pressure Environment.|pdf=|usr=022}}
+{{tp|p=33283190|t=2020. Awake proning of a 2-year-old extubated child with severe COVID-19 pneumonitis.|pdf=|usr=022}}
+{{tp|p=33274761|t=2020. Are tracheal intubation and extubation aerosol-generating procedures?|pdf=|usr=022}}
+{{tp|p=33288635|t=2020. Evidence-Based Guidelines Should Be Used to Inform COVID-19 Management.|pdf=|usr=022}}
+{{tp|p=33262177|t=2020. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections.|pdf=|usr=022}}
+{{tp|p=33277976|t=2020. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 2.|pdf=|usr=022}}
+{{tp|p=33256990|t=2020. Controversies in airway management of COVID-19 patients: updated information and international expert consensus recommendations.|pdf=|usr=022}}
+{{tp|p=33255120|t=2020. Positive End-Expiratory Pressure in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: Higher May Be Too High.|pdf=|usr=022}}
+{{tp|p=33278112|t=2020. Epidemiologic trends and characteristics of SARS-CoV-2 infections among children in the United States.|pdf=|usr=022}}
+{{tp|p=33231148|t=2020. Respiratory Therapeutic Strategies in Children and Adolescents with COVID-19: a Critical Review.|pdf=|usr=022}}
+{{tp|p=33183207|t=2020. COVID-19 and Comorbidities: is Inflammation the Underlying Condition in Children? A narrative Review.|pdf=|usr=022}}
+{{tp|p=33238869|t=2020. Therapeutic management of COVID-19 patients: Clinical manifestation and limitations.|pdf=|usr=022}}
+{{tp|p=33280586|t=2020. COVID-19 Impacts, Diagnosis and Possible Therapeutic Techniques: A Comprehensive Review.|pdf=|usr=022}}
+{{tp|p=33273392|t=2021. Reply to: video laryngoscopy during airway management in COVID-19 patients.|pdf=|usr=022}}
+{{tp|p=33273391|t=2021. Video laryngoscopy during airway management in COVID-19 patients: practical relevance of a recent EJA Christmas issue article.|pdf=|usr=022}}
+{{tp|p=33257600|t=2020. What is the Determinant of 2019 Novel Coronavirus Prognosis in Children?|pdf=|usr=022}}
+{{tp|p=33257599|t=2020. Duration of Viral Clearance in Children With SARS-CoV-2 Infection in Rajasthan, India.|pdf=|usr=022}}
+{{tp|p=33278855|t=2020. COVID-19; current situation and recommended interventions.|pdf=|usr=022}}
+{{tp|p=33291198|t=2020. A Patient with COVID-19 Treated with ECMO for 26 Days.|pdf=|usr=022}}
+{{tp|p=33257957|t=2020. COVID 19: Trends, Disparities, and Consequences for Older Adults.|pdf=|usr=022}}
+{{tp|p=33285451|t=2020. Novel expandable architected breathing tube for improving airway securement in emergency care.|pdf=|usr=022}}
+{{tp|p=33289142|t=2020. Development and Validation of a Nomogram Using on Admission Routine Laboratory Parameters to Predict In-hospital Survival of Patients With COVID-19.|pdf=|usr=022}}
+{{tp|p=33259470|t=2020. Implementing Prone Positioning for COVID-19 Patients Outside the Intensive Care Unit.|pdf=|usr=022}}
+{{tp|p=33280024|t=2020. Paediatric COVID-19: Milder Presentation-A Silver Lining in Dark Cloud.|pdf=|usr=022}}
+{{tp|p=33295047|t=2020. Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group.|pdf=|usr=022}}
+{{tp|p=33295002|t=2020. Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group.|pdf=|usr=022}}
+{{tp|p=33288946|t=2020. COVID-19: what health experts could and could not predict.|pdf=|usr=022}}
+{{tp|p=33280533|t=2020. Adequate anticoagulation and ECMO therapy in COVID-19 patients with severe pulmonary embolism.|pdf=|usr=022}}
+{{tp|p=33226885|t=2020. An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.|pdf=|usr=022}}
+{{tp|p=33264801|t=2020. Score to Assess the Risk of Pneumonia in Coronavirus Disease-19.|pdf=|usr=022}}
+{{tp|p=33205948|t=2020. Detection, Mapping, and Proteotyping of SARS-CoV-2 Coronavirus with High Resolution Mass Spectrometry.|pdf=|usr=021}}
+{{tp|p=33186121|t=2020. Comparative analysis of SARS-CoV-2 and its receptor ACE2 with evolutionarily related coronaviruses.|pdf=|usr=021}}
+{{tp|p=33231569|t=2020. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.|pdf=|usr=021}}
+{{tp|p=33203793|t=2020. Cell differentiation and aging accompanied by depletion of the ACE2 protein.|pdf=|usr=021}}
+{{tp|p=33237794|t=2020. Immunoglobulin Deficiency as an Indicator of Disease Severity in Patients with COVID-19.|pdf=|usr=021}}
+{{tp|p=33082620|t=2020. Insights into the Immunopathophysiology of Severe COVID-19 in Metabolic Disorders.|pdf=|usr=021}}
+{{tp|p=33183023|t=2020. Morphological changes of lymphocytes in peripheral blood smears of patients with COVID-19.|pdf=|usr=021}}
+{{tp|p=33240994|t=2020. Dynamic changes of T-lymphocyte subsets and the correlations with 89 patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=021}}
+{{tp|p=33145296|t=2020. Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study.|pdf=|usr=021}}
+{{tp|p=33231054|t=2020. Recomendaciones para el manejo inicial del sindrome inflamatorio multisistemico relacionado temporalmente con COVID-19, en ninos y adolescentes.|pdf=|usr=021}}
+{{tp|p=33201341|t=2020. ceRNA analysis of SARS-CoV-2.|pdf=|usr=021}}
+{{tp|p=33190827|t=2020. T cell immunity to SARS-CoV-2 following natural infection and vaccination.|pdf=|usr=021}}
+{{tp|p=33220925|t=2020. T-cell dysregulation in COVID-19.|pdf=|usr=021}}
+{{tp|p=33187644|t=2020. Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.|pdf=|usr=021}}
+{{tp|p=33234239|t=2020. Host-directed editing of the SARS-CoV-2 genome.|pdf=|usr=021}}
+{{tp|p=33199022|t=2020. The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.|pdf=|usr=021}}
+{{tp|p=33220921|t=2020. Functional importance of the D614G mutation in the SARS-CoV-2 spike protein.|pdf=|usr=021}}
+{{tp|p=33027600|t=2020. A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis.|pdf=|usr=021}}
+{{tp|p=33189832|t=2020. The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response.|pdf=|usr=021}}
+{{tp|p=33066821|t=2020. COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein.|pdf=|usr=021}}
+{{tp|p=33224987|t=2020. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation.|pdf=|usr=021}}
+{{tp|p=33225414|t=2020. (1)H,(13)C and (15)N chemical shift assignments of the SUD domains of SARS-CoV-2 non-structural protein 3c: "the N-terminal domain-SUD-N".|pdf=|usr=021}}
+{{tp|p=33219414|t=2020. (1)H, (13)C, and (15)N backbone and side chain chemical shift assignments of the SARS-CoV-2 non-structural protein 7.|pdf=|usr=021}}
+{{tp|p=33191083|t=2020. Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.|pdf=|usr=021}}
+{{tp|p=33253634|t=2020. A Multiscale Coarse-grained Model of the SARS-CoV-2 Virion.|pdf=|usr=021}}
+{{tp|p=33189680|t=2020. The Flexibility of ACE2 in the Context of SARS-CoV-2 Infection.|pdf=|usr=021}}
+{{tp|p=33152090|t=2020. COVID-19-induced atypical pulmonary lymphocytes.|pdf=|usr=021}}
+{{tp|p=33119481|t=2020. Kawasaki-like disease and acute myocarditis in the SARS-CoV-2 pandemic - reports of three adolescents.|pdf=|usr=021}}
+{{tp|p=33097885|t=2020. Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2.|pdf=|usr=021}}
+{{tp|p=33188677|t=2020. Numbers and phenotype of non-classical CD14dimCD16+ monocytes are predictors of adverse clinical outcome in patients with coronary artery disease and severe SARS-CoV-2 infection.|pdf=|usr=021}}
+{{tp|p=33207184|t=2020. Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.|pdf=|usr=021}}
+{{tp|p=33232691|t=2020. Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis.|pdf=|usr=021}}
+{{tp|p=33245857|t=2020. Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies.|pdf=|usr=021}}
+{{tp|p=33242391|t=2020. Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles.|pdf=|usr=021}}
+{{tp|p=33207245|t=2020. SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in beta Cells.|pdf=|usr=021}}
+{{tp|p=33207244|t=2020. Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19.|pdf=|usr=021}}
+{{tp|p=33220791|t=2020. The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein.|pdf=|usr=021}}
+{{tp|p=33232663|t=2020. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men.|pdf=|usr=021}}
+{{tp|p=33196989|t=2020. Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention.|pdf=|usr=021}}
+{{tp|p=33238570|t=2020. The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes.|pdf=|usr=021}}
+{{tp|p=33217417|t=2020. Lower respiratory tract myeloid cells harbor SARS-CoV-2 and display an inflammatory phenotype.|pdf=|usr=021}}
+{{tp|p=33203513|t=2020. An enlightening role for cytokine storm in coronavirus infection.|pdf=|usr=021}}
+{{tp|p=33253854|t=2020. Peripheral immunological features of COVID-19 patients in Taizhou, China: A retrospective study.|pdf=|usr=021}}
+{{tp|p=33189887|t=2020. Major reduction of NKT cells in patients with severe COVID-19 pneumonia.|pdf=|usr=021}}
+{{tp|p=32496544|t=2020. Evaluating Immune Dysregulation in Patients With COVID-19 Requires a More Accurate Definition of the CD45RA+ T-cell Phenotype.|pdf=|usr=021}}
+{{tp|p=33217259|t=2020. Case Report: Pediatric Patient with COVID-19 and Multisystem Inflammatory Syndrome in Children.|pdf=|usr=021}}
+{{tp|p=33209300|t=2020. Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19.|pdf=|usr=021}}
+{{tp|p=33162723|t=2020. Stability Analysis in COVID-19 Within-Host Model with Immune Response.|pdf=|usr=021}}
+{{tp|p=33221119|t=2020. Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism.|pdf=|usr=021}}
+{{tp|p=33200028|t=2020. Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization.|pdf=|usr=021}}
+{{tp|p=33217169|t=2020. A Prototype QSP Model of the Immune Response to SARS-CoV-2 for Community Development.|pdf=|usr=021}}
+{{tp|p=33240687|t=2020. Multisystem Inflammatory Syndrome in Children, the Real Disease of COVID-19 in Pediatrics - A Multicenter Case Series From Al-Ahsa, Saudi Arabia.|pdf=|usr=021}}
+{{tp|p=33214962|t=2020. Kawasaki Disease-Like Features in 10 Pediatric COVID-19 Cases: A Retrospective Study.|pdf=|usr=021}}
+{{tp|p=33194461|t=2020. A Rare Presentation of Multi-System Inflammatory Disease in Children Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).|pdf=|usr=021}}
+{{tp|p=33242255|t=2020. An integrative analysis identifying transcriptional features and key genes involved in COVID-19.|pdf=|usr=021}}
+{{tp|p=33253796|t=2020. The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2.|pdf=|usr=021}}
+{{tp|p=33220345|t=2020. Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19.|pdf=|usr=021}}
+{{tp|p=33207533|t=2020. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.|pdf=|usr=021}}
+{{tp|p=33237152|t=2020. Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses.|pdf=|usr=021}}
+{{tp|p=33239605|t=2020. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.|pdf=|usr=021}}
+{{tp|p=33203641|t=2020. COVID-19 cytokine storm: what is in a name?|pdf=|usr=021}}
+{{tp|p=33232209|t=2020. Megakaryocytes: Masters of Innate Immunity?|pdf=|usr=021}}
+{{tp|p=33199021|t=2020. Evolution patterns of SARS-CoV-2: Snapshot on its genome variants.|pdf=|usr=021}}
+{{tp|p=33249673|t=2020. Specialized proresolving mediators in infection and lung injury.|pdf=|usr=021}}
+{{tp|p=33244583|t=2020. Novel SARS-CoV-2 encoded small RNAs in the passage to humans.|pdf=|usr=021}}
+{{tp|p=33205194|t=2020. The SARS-CoV-2 receptor, Angiotensin converting enzyme 2 (ACE2) is required for human endometrial stromal cell decidualization.|pdf=|usr=021}}
+{{tp|p=33248129|t=2020. From Examining the Relationship between (Corona)Viral Adhesins and Galectins to Glyco-Perspectives.|pdf=|usr=021}}
+{{tp|p=33243116|t=2020. Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?|pdf=|usr=021}}
+{{tp|p=33186231|t=2021. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.|pdf=|usr=021}}
+{{tp|p=33186230|t=2021. Molecular epidemiology in the HIV and SARS-CoV-2 pandemics.|pdf=|usr=021}}
+{{tp|p=33200826|t=2020. SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs.|pdf=|usr=021}}
+{{tp|p=33202024|t=2020. Metabolic Syndrome and COVID-19: Endocrine-Immune Vascular Interactions Shape the Clinical Course.|pdf=|usr=021}}
+{{tp|p=33251605|t=2020. Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients.|pdf=|usr=021}}
+{{tp|p=33182073|t=2020. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.|pdf=|usr=021}}
+{{tp|p=33246355|t=2020. A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression.|pdf=|usr=021}}
+{{tp|p=33234246|t=2020. TAM receptors: A phosphatidylserine receptor family and its implications in viral infections.|pdf=|usr=021}}
+{{tp|p=33111578|t=2020. Pathogenesis guided therapeutic management of COVID-19: an immunological perspective.|pdf=|usr=021}}
+{{tp|p=33155525|t=2020. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?|pdf=|usr=021}}
+{{tp|p=33191813|t=2020. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.|pdf=|usr=021}}
+{{tp|p=33215821|t=2020. COVID-19: where have the lymphocytes gone?|pdf=|usr=021}}
+{{tp|p=33254234|t=2020. Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control.|pdf=|usr=021}}
+{{tp|p=33247640|t=2020. Post COVID Inflammation Syndrome: Different Manifestations Caused by the Virus.|pdf=|usr=021}}
+{{tp|p=33249452|t=2020. New Horizons: Does Mineralocorticoid Receptor activation by cortisol cause ATP release and COVID-19 complications?|pdf=|usr=021}}
+{{tp|p=33184940|t=2020. Clinical significance of the serum IgM and IgG to SARS-CoV-2 in coronavirus disease-2019.|pdf=|usr=021}}
+{{tp|p=33208459|t=2020. Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.|pdf=|usr=021}}
+{{tp|p=33208457|t=2020. SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.|pdf=|usr=021}}
+{{tp|p=33249471|t=2020. Serum protein profiling reveals a specific upregulation of the immunomodulatory protein progranulin in COVID-19.|pdf=|usr=021}}
+{{tp|p=33206973|t=2020. Monocyte CD169 expression as a biomarker in the early diagnosis of COVID-19.|pdf=|usr=021}}
+{{tp|p=33197260|t=2020. Early plasma IL-37 responses accompanied with low inflammatory cytokines correlate with benign clinical outcomes during SARS-CoV-2 infection.|pdf=|usr=021}}
+{{tp|p=33211354|t=2020. Atypical monocytes in COVID-19: Lighting the fire of cytokine storm?|pdf=|usr=021}}
+{{tp|p=33252101|t=2020. Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review.|pdf=|usr=021}}
+{{tp|p=33188394|t=2020. SARS-CoV-2 triggering severe ARDS and secondary HLH in a 3-year-old child with Down syndrome.|pdf=|usr=021}}
+{{tp|p=33234675|t=2020. Structure of nonstructural protein 1 from SARS-CoV-2.|pdf=|usr=021}}
+{{tp|p=33237291|t=2020. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.|pdf=|usr=021}}
+{{tp|p=33211045|t=2020. A digital protein microarray for COVID-19 cytokine storm monitoring.|pdf=|usr=021}}
+{{tp|p=33220726|t=2020. Kinetics and seroprevalence of SARS-CoV-2 antibodies in children.|pdf=|usr=021}}
+{{tp|p=33245861|t=2020. Herd immunity for COVID-19.|pdf=|usr=021}}
+{{tp|p=33185926|t=2020. SARS-CoV-2-mediated immune system activation and potential application in immunotherapy.|pdf=|usr=021}}
+{{tp|p=33242097|t=2020. Multisystem Inflammatory Syndrome in Children during the COVID-19 Pandemic: A Case Report on Managing the Hyperinflammation.|pdf=|usr=021}}
+{{tp|p=33188728|t=2020. Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.|pdf=|usr=021}}
+{{tp|p=33244183|t=2020. Deciphering the ins and outs of SARS-CoV-2-specific T cells.|pdf=|usr=021}}
+{{tp|p=33208929|t=2020. Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19.|pdf=|usr=021}}
+{{tp|p=33184509|t=2020. Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells.|pdf=|usr=021}}
+{{tp|p=33244168|t=2020. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.|pdf=|usr=021}}
+{{tp|p=33199863|t=2020. Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals.|pdf=|usr=021}}
+{{tp|p=33253058|t=2020. A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions.|pdf=|usr=021}}
+{{tp|p=33236427|t=2020. Immunological basis of virus-host interaction in COVID-19.|pdf=|usr=021}}
+{{tp|p=33222290|t=2020. Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS-C.|pdf=|usr=021}}
+{{tp|p=33249696|t=2020. Kawasaki disease mimickers.|pdf=|usr=021}}
+{{tp|p=33184170|t=2020. MIS-C and Cardiac Conduction Abnormalities.|pdf=|usr=021}}
+{{tp|p=33239446|t=2020. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion.|pdf=|usr=021}}
+{{tp|p=33203681|t=2020. Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.|pdf=|usr=021}}
+{{tp|p=33048448|t=2020. Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome.|pdf=|usr=021}}
+{{tp|p=33246770|t=2020. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.|pdf=|usr=021}}
+{{tp|p=33199178|t=2020. A clinical trial of IL-15 and IL-21 combination therapy for COVID-19 is warranted.|pdf=|usr=021}}
+{{tp|p=33186810|t=2020. A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways.|pdf=|usr=021}}
+{{tp|p=33231169|t=2020. COVID-19 research risks ignoring important host genes due to pre-established research patterns.|pdf=|usr=021}}
+{{tp|p=33205709|t=2020. Loss of orf3b in the circulating SARS-CoV-2 strains.|pdf=|usr=021}}
+{{tp|p=33179566|t=2020. Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target.|pdf=|usr=021}}
+{{tp|p=33131453|t=2020. Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal.|pdf=|usr=021}}
+{{tp|p=33118859|t=2020. A SARS-CoV-2 variant with the 12-bp deletion at E gene.|pdf=|usr=021}}
+{{tp|p=33245471|t=2020. Expression and co-expression analyses of TMPRSS2, a key element in COVID-19.|pdf=|usr=021}}
+{{tp|p=33250893|t=2020. Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.|pdf=|usr=021}}
+{{tp|p=33042918|t=2020. Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome.|pdf=|usr=021}}
+{{tp|p=33251267|t=2020. A Mini-Review on Cell Cycle Regulation of Coronavirus Infection.|pdf=|usr=021}}
+{{tp|p=33224264|t=2020. Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection.|pdf=|usr=021}}
+{{tp|p=33244382|t=2020. Significant changes of CD4, FOXP3, CD25, and IL6 expression level in Iranian COVID-19 patients.|pdf=|usr=021}}
+{{tp|p=33244381|t=2020. Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine.|pdf=|usr=021}}
+{{tp|p=33244380|t=2020. Introducing APOA1 as a key protein in COVID-19 infection: a bioinformatics approach.|pdf=|usr=021}}
+{{tp|p=33242394|t=2020. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity.|pdf=|usr=021}}
+{{tp|p=33232865|t=2020. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.|pdf=|usr=021}}
+{{tp|p=33239109|t=2020. Increased circulating level of interleukin-6 and CD8(+) T cell exhaustion are associated with progression of COVID-19.|pdf=|usr=021}}
+{{tp|p=33249264|t=2020. Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2.|pdf=|usr=021}}
+{{tp|p=33206207|t=2020. Histamine receptors and COVID-19.|pdf=|usr=021}}
+{{tp|p=33072849|t=2020. Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes.|pdf=|usr=021}}
+{{tp|p=33221169|t=2020. The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.|pdf=|usr=021}}
+{{tp|p=33227512|t=2020. Low dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19.|pdf=|usr=021}}
+{{tp|p=33202218|t=2020. Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis.|pdf=|usr=021}}
+{{tp|p=33207699|t=2020. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.|pdf=|usr=021}}
+{{tp|p=33043312|t=2020. Synthea Novel coronavirus (COVID-19) model and synthetic data set.|pdf=|usr=021}}
+{{tp|p=33251489|t=2020. SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain.|pdf=|usr=021}}
+{{tp|p=33236586|t=2020. Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives.|pdf=|usr=021}}
+{{tp|p=33236584|t=2020. The Hyper-Inflammatory Response in Adults with Severe COVID-19 Pneumonia Differs from the Cytokine Storm of Hemophagocytic Syndrome.|pdf=|usr=021}}
+{{tp|p=33221383|t=2020. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.|pdf=|usr=021}}
+{{tp|p=33229438|t=2020. The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles.|pdf=|usr=021}}
+{{tp|p=33214224|t=2020. SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles.|pdf=|usr=021}}
+{{tp|p=33243941|t=2020. Characteristics of viral specimens collected from asymptomatic and fatal cases of COVID-19.|pdf=|usr=021}}
+{{tp|p=33245474|t=2020. N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects.|pdf=|usr=021}}
+{{tp|p=33216734|t=2020. Does common cold coronavirus infection protect against severe SARS-CoV2 disease?|pdf=|usr=021}}
+{{tp|p=33233425|t=2020. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors.|pdf=|usr=021}}
+{{tp|p=33231615|t=2021. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.|pdf=|usr=021}}
+{{tp|p=33242672|t=2020. Cytokine storm of a different flavor: the different cytokine signature of SARS-CoV2 the cause of COVID-19 from the original SARS outbreak.|pdf=|usr=021}}
+{{tp|p=33238745|t=2020. A 23-Year-Old Man With Multisystem Inflammatory Syndrome After Mild COVID-19.|pdf=|usr=021}}
+{{tp|p=33245961|t=2020. Structural insights into SARS-CoV-2 proteins.|pdf=|usr=021}}
+{{tp|p=33250660|t=2020. Thermal and hydrodynamic properties of coronavirus at various temperature and pressure via molecular dynamics approach.|pdf=|usr=021}}
+{{tp|p=33252688|t=2020. Race/Ethnicity Among Children With COVID-19-Associated Multisystem Inflammatory Syndrome.|pdf=|usr=021}}
+{{tp|p=33220289|t=2020. High GRP78 levels in Covid-19 infection: A case-control study.|pdf=|usr=021}}
+{{tp|p=33246692|t=2020. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival.|pdf=|usr=021}}
+{{tp|p=33231720|t=2020. Lungenveranderungen bei COVID-19 - Storung des pulmonalen Surfactants? : Eine nicht ganz weit hergeholte Hypothese.|pdf=|usr=021}}
+{{tp|p=33242646|t=2020. Structural and functional insights into non-structural proteins of coronaviruses.|pdf=|usr=021}}
+{{tp|p=33237893|t=2020. Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020.|pdf=|usr=021}}
+{{tp|p=33248025|t=2020. Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions.|pdf=|usr=021}}
+{{tp|p=33242581|t=2020. The phylogenetic relationship within SARS-CoV-2s: an expanding basal clade.|pdf=|usr=021}}
+{{tp|p=33200082|t=2020. Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection.|pdf=|usr=021}}
+{{tp|p=33239366|t=2020. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.|pdf=|usr=021}}
+{{tp|p=33247152|t=2020. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.|pdf=|usr=021}}
+{{tp|p=33247108|t=2020. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.|pdf=|usr=021}}
+{{tp|p=33243994|t=2020. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.|pdf=|usr=021}}
+{{tp|p=33239633|t=2020. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2.|pdf=|usr=021}}
+{{tp|p=33208793|t=2020. SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography.|pdf=|usr=021}}
+{{tp|p=33208736|t=2020. Architecture of a SARS-CoV-2 mini replication and transcription complex.|pdf=|usr=021}}
+{{tp|p=33208735|t=2020. Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site.|pdf=|usr=021}}
+{{tp|p=33203890|t=2020. Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses.|pdf=|usr=021}}
+{{tp|p=33203833|t=2020. Immune suppression in the early stage of COVID-19 disease.|pdf=|usr=021}}
+{{tp|p=33160723|t=2020. Sustancia P, citocinas proinflamatorias, receptor de potencial transitorio vaniloide tipo 1 y COVID-19: una hipotesis de trabajo.|pdf=|usr=021}}
+{{tp|p=33230417|t=2020. SARS-COV2 and P. falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt.|pdf=|usr=021}}
+{{tp|p=33244341|t=2020. An elevated 8-isoprostaglandin F2 alpha (8-iso-PGF2alpha) in COVID-19 subjects co-infected with malaria.|pdf=|usr=021}}
+{{tp|p=33198594|t=2020. Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study.|pdf=|usr=021}}
+{{tp|p=33131800|t=2020. Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes.|pdf=|usr=021}}
+{{tp|p=33202215|t=2020. Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension.|pdf=|usr=021}}
+{{tp|p=33206635|t=2020. Stability of SARS-CoV-2 phylogenies.|pdf=|usr=021}}
+{{tp|p=33253226|t=2020. SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia.|pdf=|usr=021}}
+{{tp|p=33232382|t=2020. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.|pdf=|usr=021}}
+{{tp|p=33211781|t=2020. Antibody profiling and prevalence in US patients during the SARS-CoV2 pandemic.|pdf=|usr=021}}
+{{tp|p=33201914|t=2020. Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam.|pdf=|usr=021}}
+{{tp|p=33035234|t=2020. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.|pdf=|usr=021}}
+{{tp|p=33237441|t=2020. Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody.|pdf=|usr=021}}
+{{tp|p=33219837|t=2020. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.|pdf=|usr=021}}
+{{tp|p=33239683|t=2020. Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19.|pdf=|usr=021}}
+{{tp|p=33199778|t=2020. Similarities and differences between the 'cytokine storms' in acute dengue and COVID-19.|pdf=|usr=021}}
+{{tp|p=33060566|t=2020. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.|pdf=|usr=021}}
+{{tp|p=33203855|t=2020. A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins.|pdf=|usr=021}}
+{{tp|p=33251482|t=2020. Acute Kidney Injury in Multisystem Inflammatory Syndrome in Children (MIS-C): a Case Report.|pdf=|usr=021}}
+{{tp|p=33235185|t=2020. Influence of social isolation caused by coronavirus disease 2019 (COVID-19) on the psychological characteristics of hospitalized schizophrenia patients: a case-control study.|pdf=|usr=021}}
+{{tp|p=33221483|t=2020. The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury.|pdf=|usr=021}}
+{{tp|p=33214057|t=2020. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.|pdf=|usr=021}}
+{{tp|p=33207583|t=2020. Antibody Responses to SARS-CoV-2 Antigens in Humans and Animals.|pdf=|usr=021}}
+{{tp|p=33198287|t=2020. SARS-CoV-2 Proteins Induce IFNG in Th1 Lymphocytes Generated from CD4+ Cells from Healthy, Unexposed Polish Donors.|pdf=|usr=021}}
+{{tp|p=33232769|t=2020. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.|pdf=|usr=021}}
+{{tp|p=33210477|t=2020. Evolutionary study of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emerging coronavirus: Phylogenetic analysis and literature review.|pdf=|usr=021}}
+{{tp|p=33225958|t=2020. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.|pdf=|usr=021}}
+{{tp|p=33235813|t=2020. Temporal signal and the phylodynamic threshold of SARS-CoV-2.|pdf=|usr=021}}
+{{tp|p=33227343|t=2020. Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a.|pdf=|usr=021}}
+{{tp|p=33114742|t=2020. Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization.|pdf=|usr=021}}
+{{tp|p=33207802|t=2020. Recombination and Positive Selection Differentially Shaped the Diversity of Betacoronavirus Subgenera.|pdf=|usr=021}}
+{{tp|p=33184176|t=2020. The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses.|pdf=|usr=021}}
+{{tp|p=33184173|t=2020. Analysis of genomic distributions of SARS-CoV-2 reveals a dominant strain type with strong allelic associations.|pdf=|usr=021}}
+{{tp|p=33231324|t=2020. Prefusion spike protein stabilization through computational mutagenesis.|pdf=|usr=021}}
+{{tp|p=33174706|t=2020. Les strategies subversives utilisees par SARS-CoV-2 pour supprimer les defenses de l'hote.|pdf=|usr=021}}
+{{tp|p=33174705|t=2020. Covid-19: que sait-on de la reponse immune humorale au virus SARS-CoV-2 ?|pdf=|usr=021}}
+{{tp|p=33205496|t=2020. Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment.|pdf=|usr=021}}
+{{tp|p=33197261|t=2020. Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist.|pdf=|usr=021}}
+{{tp|p=33205718|t=2020. Multisystem inflammatory syndrome in adult COVID-19 patients.|pdf=|usr=021}}
+{{tp|p=33208380|t=2020. The known unknowns of T cell immunity to COVID-19.|pdf=|usr=021}}
+{{tp|p=33184193|t=2020. Enhancing host cell infection by SARS-CoV-2.|pdf=|usr=021}}
+{{tp|p=33184236|t=2020. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.|pdf=|usr=021}}
+{{tp|p=33207070|t=2020. Global SNP analysis of 11,183 SARS-CoV-2 strains reveals high genetic diversity.|pdf=|usr=021}}
+{{tp|p=33215583|t=2020. [Multisystem inflammatory syndrome in children after SARS-CoV-2 infection].|pdf=|usr=021}}
+{{tp|p=33202195|t=2020. Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19.|pdf=|usr=021}}
+{{tp|p=33198855|t=2020. [Analysis of pathogenesis, syndrome differentiation and treatment of asymptomatic infectors of coronavirus disease 2019 based on the theory of "pathogen hiding in the pleurodiaphragmatic interspace"].|pdf=|usr=021}}
 {{tp|p=33042442|t=2020. Transcription factor-mediated signaling pathways' contribution to the pathology of acute lung injury and acute respiratory distress syndrome.|pdf=|usr=020}}
@@ Zeile 585: / Zeile 978: @@
 {{tp|p=32961897|t=2020. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.|pdf=|usr=019}}
 {{tp|p=32937868|t=2020. Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic.|pdf=|usr=019}}
-{{tp|p=32929876|t=2020. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.|pdf=|usr=019}}
+{{tp|p=32929876|t=2020. The Longitudinal Immune Response to Coronavirus Disease 2019: Ch<iframe src="http://www.kidney.de/amapp.php?a=g the Cytokine Storm.|pdf=|usr=019}}
 {{tp|p=32964796|t=2020. Coronavirus interactions with the cellular autophagy machinery.|pdf=|usr=019}}
 {{tp|p=32975439|t=2020. Cardiac Findings in Pediatric Patients With Multisystem Inflammatory Syndrome in Children Associated With COVID-19.|pdf=|usr=019}}
@@ Zeile 2.509: / Zeile 2.902: @@
 {{tp|p=32619819|t=2020. S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study.|pdf=|usr=012}}
 {{tp|p=32615987|t=2020. Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis.|pdf=|usr=012}}
+{{tp|p=C7568207|t=?. Síndrome inflamatorio multisistémico en niños con COVID-19: una visión desde la reumatología.|pdf=|usr=024}}
+{{tp|p=C7561343|t=?. Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes?.|pdf=|usr=024}}
+{{tp|p=C7544460|t=2020. Caractériser la réponse immunitaire au cours de la pneumopathie grave.|pdf=|usr=024}}
+{{tp|p=C7577707|t=?. Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.|pdf=|usr=024}}
+{{tp|p=C7548726|t=2020. PROTECTIVE FACTORS AGAINST THE COVID-19 STORM.|pdf=|usr=024}}
+{{tp|p=C7548724|t=2020. COVID-19 AND A HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME IN THE ABSENCE OF ARDS.|pdf=|usr=024}}
+{{tp|p=C7548599|t=2020. CALM BEFORE THE STORM: COVID-19 AND CYTOKINE STORM SYNDROME.|pdf=|usr=024}}
+{{tp|p=C7548549|t=2020. SECONDARY HLH PRESENTING AS ARDS.|pdf=|usr=024}}
+{{tp|p=33330852|t=2021. Unfolded protein response in the COVID-19 context.|pdf=|usr=024}}
+{{tp|p=33123500|t=2020. Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection.|pdf=|usr=024}}
+{{tp|p=33095394|t=2020. Multisystem Inflammatory Syndrome in Children: A Mimicker of Severe Dengue.|pdf=|usr=024}}
+{{tp|p=33228920|t=2020. Herd immunity confusion.|pdf=|usr=024}}
+{{tp|p=33031752|t=2020. MIS-C: post-infectious syndrome or persistent infection?|pdf=|usr=024}}
+{{tp|p=33484168|t=2021. Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19.|pdf=|usr=025}}
+{{tp|p=33399182|t=2021. Herd Immunity to COVID-19.|pdf=|usr=025}}
+{{tp|p=33469560|t=2021. Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS).|pdf=|usr=025}}
+{{tp|p=33521168|t=2020. Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications.|pdf=|usr=025}}
+{{tp|p=33406838|t=2021. N- and O-Glycosylation of the SARS-CoV-2 Spike Protein.|pdf=|usr=025}}
+{{tp|p=33458987|t=2021. Sindrome inflamatorio multisistemico en ninos, relacionado con COVID-19: actualizacion a proposito de la presentacion de 2 pacientes criticos.|pdf=|usr=025}}
+{{tp|p=33458972|t=2021. Tormenta de citoquinas y tormenta de informacion asociadas a COVID-19: consideraciones sobre el sindrome inflamatorio multisistemico en ninos.|pdf=|usr=025}}
+{{tp|p=33398692|t=2021. Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective.|pdf=|usr=025}}
+{{tp|p=33483791|t=2021. A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics.|pdf=|usr=025}}
+{{tp|p=33464421|t=2021. Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: an endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations.|pdf=|usr=025}}
+{{tp|p=33462671|t=2021. The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.|pdf=|usr=025}}
+{{tp|p=33521335|t=2021. The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus - evolved or yet to evolve.|pdf=|usr=025}}
+{{tp|p=33506114|t=2021. Mutational sensitivity of D614G in spike protein of SARS-CoV-2 in Jordan.|pdf=|usr=025}}
+{{tp|p=33515911|t=2021. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33413979|t=2021. A nidovirus perspective on SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33450483|t=2021. The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy.|pdf=|usr=025}}
+{{tp|p=33484784|t=2021. Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33445785|t=2021. The Long-Term Evolutionary History of Gradual Reduction of CpG Dinucleotides in the SARS-CoV-2 Lineage.|pdf=|usr=025}}
+{{tp|p=33486617|t=2021. NMR assignments of the macro domain from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).|pdf=|usr=025}}
+{{tp|p=33484403|t=2021. (1)H, (13)C and (15)N chemical shift assignment of the stem-loop 5a from the 5'-UTR of SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33475934|t=2021. (1)H, (13)C and (15)N backbone chemical shift assignments of SARS-CoV-2 nsp3a.|pdf=|usr=025}}
+{{tp|p=33423172|t=2021. (1)H,(13)C and (15)N chemical shift assignments of the SUD domains of SARS-CoV-2 non-structural protein 3c: "The SUD-M and SUD-C domains".|pdf=|usr=025}}
+{{tp|p=33392924|t=2021. Backbone chemical shift assignments for the SARS-CoV-2 non-structural protein Nsp9: intermediate (ms - mus) dynamics in the C-terminal helix at the dimer interface.|pdf=|usr=025}}
+{{tp|p=33389548|t=2021. (1)H, (15)N and (13)C resonance assignments of the N-terminal domain of the nucleocapsid protein from the endemic human coronavirus HKU1.|pdf=|usr=025}}
+{{tp|p=33504682|t=2021. Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection.|pdf=|usr=025}}
+{{tp|p=33484712|t=2021. Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 S-protein.|pdf=|usr=025}}
+{{tp|p=33460600|t=2021. Improving SARS-CoV-2 structures: Peer review by early coordinate release.|pdf=|usr=025}}
+{{tp|p=33401144|t=2021. Entropy-driven electrochemiluminescence ultra-sensitive detection strategy of NF-kappaB p50 as the regulator of cytokine storm.|pdf=|usr=025}}
+{{tp|p=33407800|t=2021. Identification and characterization of a silent mutation in RNA binding domain of N protein coding gene from SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33419930|t=2021. What are SARS-CoV-2 genomes from the WHO Africa region member states telling us?|pdf=|usr=025}}
+{{tp|p=33479725|t=2021. An integrated approach to determine the abundance, mutation rate and phylogeny of the SARS-CoV-2 genome.|pdf=|usr=025}}
+{{tp|p=33491070|t=2021. Noncoding RNAs: modulators and modulatable players during infection-induced stress response.|pdf=|usr=025}}
+{{tp|p=33405097|t=2021. SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation.|pdf=|usr=025}}
+{{tp|p=33448856|t=2021. Dynamic Network Modeling of Allosteric Interactions and Communication Pathways in the SARS-CoV-2 Spike Trimer Mutants: Differential Modulation of Conformational Landscapes and Signal Transmission via Cascades of Regulatory Switches.|pdf=|usr=025}}
+{{tp|p=33426894|t=2021. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.|pdf=|usr=025}}
+{{tp|p=33426872|t=2021. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.|pdf=|usr=025}}
+{{tp|p=33400372|t=2021. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.|pdf=|usr=025}}
+{{tp|p=33485447|t=2021. Neuropathology associated with SARS-CoV-2 infection - Authors' reply.|pdf=|usr=025}}
+{{tp|p=33485446|t=2021. Neuropathology associated with SARS-CoV-2 infection.|pdf=|usr=025}}
+{{tp|p=33485445|t=2021. Neuropathology associated with SARS-CoV-2 infection.|pdf=|usr=025}}
+{{tp|p=33485444|t=2021. Neuropathology associated with SARS-CoV-2 infection.|pdf=|usr=025}}
+{{tp|p=33453781|t=2021. Using EM data to understand COVID-19 pathophysiology - Authors' reply.|pdf=|usr=025}}
+{{tp|p=33453779|t=2021. Using EM data to understand COVID-19 pathophysiology.|pdf=|usr=025}}
+{{tp|p=33450180|t=2021. First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020.|pdf=|usr=025}}
+{{tp|p=33417829|t=2021. New variant of SARS-CoV-2 in UK causes surge of COVID-19.|pdf=|usr=025}}
+{{tp|p=33392518|t=2021. SARS-CoV-2 serological cross-reactivity with autoantibodies - Authors' reply.|pdf=|usr=025}}
+{{tp|p=33392517|t=2021. SARS-CoV-2 serological cross-reactivity with autoantibodies.|pdf=|usr=025}}
+{{tp|p=33454368|t=2021. Monocytes and macrophages in COVID-19: Friends and foes.|pdf=|usr=025}}
+{{tp|p=33453245|t=2021. The proteomic characteristics of airway mucus from critical ill COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33508291|t=2021. SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis.|pdf=|usr=025}}
+{{tp|p=33468702|t=2021. SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia.|pdf=|usr=025}}
+{{tp|p=33468697|t=2021. Atypical Divergence of SARS-CoV-2 Orf8 from Orf7a within the Coronavirus Lineage Suggests Potential Stealthy Viral Strategies in Immune Evasion.|pdf=|usr=025}}
+{{tp|p=33468695|t=2021. SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike.|pdf=|usr=025}}
+{{tp|p=33436436|t=2021. Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity?|pdf=|usr=025}}
+{{tp|p=33511329|t=2020. Adhesive contact between cylindrical (Ebola) and spherical (SARS-CoV-2) viral particles and a cell membrane.|pdf=|usr=025}}
+{{tp|p=33412501|t=2021. Polycations and polyanions in SARS-CoV-2 infection.|pdf=|usr=025}}
+{{tp|p=33505220|t=2021. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.|pdf=|usr=025}}
+{{tp|p=33414350|t=2021. Genomic Sequences and Analysis of Five SARS-CoV-2 Variants Obtained from Patients in Lambayeque, Peru.|pdf=|usr=025}}
+{{tp|p=33414330|t=2021. Mutation Profile of SARS-CoV-2 Genome Sequences Originating from Eight Israeli Patient Isolates.|pdf=|usr=025}}
+{{tp|p=33414329|t=2021. Genome Sequences of Two GH Clade SARS-CoV-2 Strains Isolated from Patients with COVID-19 in South Korea.|pdf=|usr=025}}
+{{tp|p=33509997|t=2021. Genome Sequence of a SARS-CoV-2 VUI 202012/01 Strain Identified from a Patient Returning from London, England, to the Apulia Region of Italy.|pdf=|usr=025}}
+{{tp|p=33509993|t=2021. Genome Sequences of 10 SARS-CoV-2 Viral Strains Obtained by Nanopore Sequencing of Nasopharyngeal Swabs in Malta.|pdf=|usr=025}}
+{{tp|p=33509990|t=2021. Genome Sequencing of a Novel Coronavirus SARS-CoV-2 Isolate from Iraq.|pdf=|usr=025}}
+{{tp|p=33479004|t=2021. Expression of Concern for Sah et al., "Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal".|pdf=|usr=025}}
+{{tp|p=33401565|t=2021. SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients.|pdf=|usr=025}}
+{{tp|p=33445583|t=2021. Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers.|pdf=|usr=025}}
+{{tp|p=33476315|t=2021. Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.|pdf=|usr=025}}
+{{tp|p=33386849|t=2021. Population dynamics and structural effects at short and long range support the hypothesis of the selective advantage of the G614 SARS-Cov2 spike variant.|pdf=|usr=025}}
+{{tp|p=33417854|t=2021. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33444546|t=2021. Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms.|pdf=|usr=025}}
+{{tp|p=33474931|t=2021. Topography, Spike Dynamics, and Nanomechanics of Individual Native SARS-CoV-2 Virions.|pdf=|usr=025}}
+{{tp|p=33420022|t=2021. Host and viral determinants for efficient SARS-CoV-2 infection of the human lung.|pdf=|usr=025}}
+{{tp|p=33397909|t=2021. Neutralizing antibody titres in SARS-CoV-2 infections.|pdf=|usr=025}}
+{{tp|p=33397903|t=2021. Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray.|pdf=|usr=025}}
+{{tp|p=33504779|t=2021. Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics.|pdf=|usr=025}}
+{{tp|p=33483492|t=2021. SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques.|pdf=|usr=025}}
+{{tp|p=33479198|t=2021. The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein.|pdf=|usr=025}}
+{{tp|p=33431842|t=2021. Stabilizing the closed SARS-CoV-2 spike trimer.|pdf=|usr=025}}
+{{tp|p=33402727|t=2021. Endemic SARS-CoV-2 will maintain post-pandemic immunity.|pdf=|usr=025}}
+{{tp|p=33442033|t=2021. What have we learnt so far from COVID-19?|pdf=|usr=025}}
+{{tp|p=33432128|t=2021. Super(antigen) target for SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33425367|t=2021. A single nucleotide distinguishes the SARS-CoV-2 in the Wuhan outbreak in December 2019 from that in Beijing-Xinfadi in June 2020, China.|pdf=|usr=025}}
+{{tp|p=33398006|t=2021. SARS-CoV-2 structural features may explain limited neutralizing-antibody responses.|pdf=|usr=025}}
+{{tp|p=33381273|t=2020. SARS-CoV-2 and Other Respiratory Viruses: What Does Oxidative Stress Have to Do with It?|pdf=|usr=025}}
+{{tp|p=33391390|t=2021. SARS-CoV-2 paediatric inflammatory syndrome.|pdf=|usr=025}}
+{{tp|p=33479801|t=2021. Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33437273|t=2021. Real-Time Polymerase chain reaction trends in COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33401530|t=2021. SARS-CoV-2-Cholesterol Interaction: A Lot of Food for Thought.|pdf=|usr=025}}
+{{tp|p=33428826|t=2021. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis.|pdf=|usr=025}}
+{{tp|p=33433671|t=2021. Extracardiac imaging findings in COVID-19-associated multisystem inflammatory syndrome in children.|pdf=|usr=025}}
+{{tp|p=33404786|t=2021. Chest radiograph features of multisystem inflammatory syndrome in children (MIS-C) compared to pediatric COVID-19.|pdf=|usr=025}}
+{{tp|p=33505806|t=2021. Identification and molecular characterization of mutations in nucleocapsid phosphoprotein of SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33391880|t=2020. Full-length genome characterization and phylogenetic analysis of SARS-CoV-2 virus strains from Yogyakarta and Central Java, Indonesia.|pdf=|usr=025}}
+{{tp|p=33384909|t=2020. Mutational spectra of SARS-CoV-2 isolated from animals.|pdf=|usr=025}}
+{{tp|p=33382773|t=2020. Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis.|pdf=|usr=025}}
+{{tp|p=33382764|t=2020. Antibody response to SARS-CoV-2 infection in humans: A systematic review.|pdf=|usr=025}}
+{{tp|p=33382687|t=2020. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.|pdf=|usr=025}}
+{{tp|p=33507952|t=2021. Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium.|pdf=|usr=025}}
+{{tp|p=33493182|t=2021. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion.|pdf=|usr=025}}
+{{tp|p=33476327|t=2021. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.|pdf=|usr=025}}
+{{tp|p=33465137|t=2021. The coronavirus proofreading exoribonuclease mediates extensive viral recombination.|pdf=|usr=025}}
+{{tp|p=33411764|t=2021. Novel modulators of p53-signaling encoded by unknown genes of emerging viruses.|pdf=|usr=025}}
+{{tp|p=33395426|t=2021. The role of Neuropilin-1 in COVID-19.|pdf=|usr=025}}
+{{tp|p=33399747|t=2020. Sindrome inflamatorio multisistemico asociado con SARS-CoV-2 en pediatria.|pdf=|usr=025}}
+{{tp|p=33399746|t=2020. Sindrome inflamatorio multisistemico temporal asociado con SARS-CoV-2 pediatrico: inverted question markComo nos enfrentamos a un enemigo impredecible?|pdf=|usr=025}}
+{{tp|p=33411967|t=2021. Association of endopeptidases, involved in SARS-CoV-2 infection, with microbial aggravation in sputum of severe asthma.|pdf=|usr=025}}
+{{tp|p=33414185|t=2021. Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'.|pdf=|usr=025}}
+{{tp|p=33414184|t=2021. Response to: 'Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'' by Tampe et al.|pdf=|usr=025}}
+{{tp|p=33446481|t=2021. Covid-19: Past infection provides 83% protection for five months but may not stop transmission, study finds.|pdf=|usr=025}}
+{{tp|p=33380408|t=2020. Covid-19: Antibodies protect against reinfection for at least six months, study finds.|pdf=|usr=025}}
+{{tp|p=33464010|t=2021. COVID-19-Related Potential Multisystem Inflammatory Syndrome in Childhood in a Neonate Presenting as Persistent Pulmonary Hypertension of the Newborn.|pdf=|usr=025}}
+{{tp|p=33414238|t=2021. Inflammatory Bowel Disease Presenting With Concurrent COVID-19 Multisystem Inflammatory Syndrome.|pdf=|usr=025}}
+{{tp|p=33505752|t=2021. COVID-19-Associated Multisystem Inflammatory Syndrome Complicated with Giant Coronary Artery Aneurysm.|pdf=|usr=025}}
+{{tp|p=33382968|t=2021. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.|pdf=|usr=025}}
+{{tp|p=33412089|t=2021. COVID-19-neutralizing antibodies predict disease severity and survival.|pdf=|usr=025}}
+{{tp|p=33497610|t=2021. Adaptive immunity to SARS-CoV-2 and COVID-19.|pdf=|usr=025}}
+{{tp|p=33516131|t=2021. Lysosomal ion channels involved in cellular entry and uncoating of enveloped viruses: Implications for therapeutic strategies against SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33441142|t=2021. On the role of bacterial metalloproteases in COVID-19 associated cytokine storm.|pdf=|usr=025}}
+{{tp|p=33500559|t=2021. Antibodies, epicenter of SARS-CoV-2 immunology.|pdf=|usr=025}}
+{{tp|p=33510134|t=2021. N(6)-methyladenosine regulates RNA abundance of SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33479219|t=2021. SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation into stress granules through its N-terminal intrinsically disordered region.|pdf=|usr=025}}
+{{tp|p=33388094|t=2021. Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19.|pdf=|usr=025}}
+{{tp|p=33483707|t=2021. Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33473190|t=2021. Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response.|pdf=|usr=025}}
+{{tp|p=33420358|t=2021. Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months.|pdf=|usr=025}}
+{{tp|p=33420356|t=2021. The interplay between dendritic cells and CD8 T lymphocytes is a crucial component of SARS-CoV-2 immunity.|pdf=|usr=025}}
+{{tp|p=33408342|t=2021. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity.|pdf=|usr=025}}
+{{tp|p=33449149|t=2021. Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release.|pdf=|usr=025}}
+{{tp|p=33503420|t=2021. The immunodominant and neutralization linear epitopes for SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33440148|t=2021. MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.|pdf=|usr=025}}
+{{tp|p=33417835|t=2021. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction.|pdf=|usr=025}}
+{{tp|p=33485405|t=2021. Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD.|pdf=|usr=025}}
+{{tp|p=33500101|t=2020. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.|pdf=|usr=025}}
+{{tp|p=33495758|t=2021. Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses.|pdf=|usr=025}}
+{{tp|p=33495757|t=2021. Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19.|pdf=|usr=025}}
+{{tp|p=33495756|t=2021. Use of machine learning to identify a T cell response to SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33420426|t=2021. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.|pdf=|usr=025}}
+{{tp|p=33450186|t=2021. ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response.|pdf=|usr=025}}
+{{tp|p=33518776|t=2020. Computed optical spectra of SARS-CoV-2 proteins.|pdf=|usr=025}}
+{{tp|p=33445833|t=2021. Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019.|pdf=|usr=025}}
+{{tp|p=33417689|t=2021. Lack of SARS-CoV2 neutralization by antibodies to seasonal coronaviruses: making sense of the COVID-19 pandemic.|pdf=|usr=025}}
+{{tp|p=33400782|t=2021. The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers.|pdf=|usr=025}}
+{{tp|p=33395482|t=2021. SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses.|pdf=|usr=025}}
+{{tp|p=33388756|t=2021. Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany.|pdf=|usr=025}}
+{{tp|p=33501951|t=2021. Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.|pdf=|usr=025}}
+{{tp|p=33501950|t=2021. Occurrence and Timing of Subsequent Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-transcription Polymerase Chain Reaction Positivity Among Initially Negative Patients.|pdf=|usr=025}}
+{{tp|p=33386403|t=2021. SARS-CoV-2 immunity and reinfection.|pdf=|usr=025}}
+{{tp|p=33479086|t=2021. Lessons of the month: A misunderstood teenager with paediatric inflammatory multisystem syndrome - temporarily associated with SARS-CoV-2 admitted under adult medicine.|pdf=|usr=025}}
+{{tp|p=33524589|t=2021. A global analysis of replacement of genetic variants of SARS-CoV-2 in association with containment capacity and changes in disease severity.|pdf=|usr=025}}
+{{tp|p=33482352|t=2021. Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study.|pdf=|usr=025}}
+{{tp|p=33465499|t=2021. SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient.|pdf=|usr=025}}
+{{tp|p=33450388|t=2021. Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays.|pdf=|usr=025}}
+{{tp|p=33484220|t=2021. Development of a SARS-CoV-2 rapid antibody detection kit and study on dynamic changes in antibodies in infected patients.|pdf=|usr=025}}
+{{tp|p=33389315|t=2021. Haemophagocytic syndrome and COVID-19.|pdf=|usr=025}}
+{{tp|p=33520118|t=2021. Meta-analysis of transcriptome datasets: An alternative method to study IL-6 regulation in coronavirus disease 2019.|pdf=|usr=025}}
+{{tp|p=33506994|t=2021. Different hair loss patterns in two pediatric patients with COVID-19-associated multisystem inflammatory syndrome in children.|pdf=|usr=025}}
+{{tp|p=33522642|t=2021. Syncytia formation by SARS-CoV-2-infected cells.|pdf=|usr=025}}
+{{tp|p=33522893|t=2021. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.|pdf=|usr=025}}
+{{tp|p=33401657|t=2021. The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection.|pdf=|usr=025}}
+{{tp|p=33497356|t=2021. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.|pdf=|usr=025}}
+{{tp|p=33492309|t=2021. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.|pdf=|usr=025}}
+{{tp|p=33427749|t=2021. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.|pdf=|usr=025}}
+{{tp|p=33467466|t=2021. When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It.|pdf=|usr=025}}
+{{tp|p=33399879|t=2021. Production of ORF8 protein from SARS-CoV-2 using an inducible virus-mediated expression system in suspension-cultured tobacco BY-2 cells.|pdf=|usr=025}}
+{{tp|p=33465066|t=2021. Modeling the structure of the frameshift-stimulatory pseudoknot in SARS-CoV-2 reveals multiple possible conformers.|pdf=|usr=025}}
+{{tp|p=33411735|t=2021. COVID-19, leprosy, and neutrophils.|pdf=|usr=025}}
+{{tp|p=33513195|t=2021. High SARS-CoV-2 load in the nasopharynx of patients with a mild form of COVID-19 is associated with clinical deterioration regardless of the hydroxychloroquine administration.|pdf=|usr=025}}
+{{tp|p=33507994|t=2021. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration.|pdf=|usr=025}}
+{{tp|p=33497392|t=2021. Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains.|pdf=|usr=025}}
+{{tp|p=33493185|t=2021. T cell response to SARS-CoV-2 infection in humans: A systematic review.|pdf=|usr=025}}
+{{tp|p=33479167|t=2021. Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.|pdf=|usr=025}}
+{{tp|p=33446512|t=2021. Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset.|pdf=|usr=025}}
+{{tp|p=33406522|t=2021. Genetic Variation and Evolution of the 2019 Novel Coronavirus.|pdf=|usr=025}}
+{{tp|p=33460776|t=2021. Can efficient stimulation of myogenic microcirculatory oscillations by transient ischemia predict low incidence of COVID-19 infection?|pdf=|usr=025}}
+{{tp|p=33472605|t=2021. Plasma microbial cell-free DNA load is associated with mortality in patients with COVID-19.|pdf=|usr=025}}
+{{tp|p=33495715|t=2021. SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production.|pdf=|usr=025}}
+{{tp|p=33495714|t=2021. Binding of the SARS-CoV-2 Spike Protein to Glycans.|pdf=|usr=025}}
+{{tp|p=33420163|t=2021. Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples.|pdf=|usr=025}}
+{{tp|p=33510359|t=2021. Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors.|pdf=|usr=025}}
+{{tp|p=33510353|t=2021. Network theoretic analysis of JAK/STAT pathway and extrapolation to drugs and viruses including COVID-19.|pdf=|usr=025}}
+{{tp|p=33510275|t=2021. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.|pdf=|usr=025}}
+{{tp|p=33504824|t=2021. Altered high-density lipoprotein composition and functions during severe COVID-19.|pdf=|usr=025}}
+{{tp|p=33500507|t=2021. CD8(+) T cells predicted the conversion of common covid-19 to severe.|pdf=|usr=025}}
+{{tp|p=33479465|t=2021. SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness.|pdf=|usr=025}}
+{{tp|p=33432067|t=2021. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.|pdf=|usr=025}}
+{{tp|p=33514692|t=2021. Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA.|pdf=|usr=025}}
+{{tp|p=33514685|t=2021. Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection.|pdf=|usr=025}}
+{{tp|p=33462185|t=2021. Not only ACE2-the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19.|pdf=|usr=025}}
+{{tp|p=33431822|t=2021. Connections between biomechanics and higher infectivity: a tale of the D614G mutation in the SARS-CoV-2 spike protein.|pdf=|usr=025}}
+{{tp|p=33381288|t=2020. Sleep and COVID-19: considerations about immunity, pathophysiology, and treatment.|pdf=|usr=025}}
+{{tp|p=33437929|t=2021. Childhood Multisystem Inflammatory Syndrome: An Emerging Disease with Prominent Cardiovascular Involvement-A Scoping Review.|pdf=|usr=025}}
+{{tp|p=33432304|t=2021. Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection: a Systematic Review with Meta-analysis.|pdf=|usr=025}}
+{{tp|p=33426471|t=2021. Is Eye Immune-Privileged to COVID-19 Infection?|pdf=|usr=025}}
+{{tp|p=33403490|t=2021. Does the Global Outbreak of COVID-19 or Other Viral Diseases Threaten the Stem Cell Reservoir Inside the Body?|pdf=|usr=025}}
+{{tp|p=33500718|t=2021. Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19.|pdf=|usr=025}}
+{{tp|p=33391477|t=2021. Immunopathogenesis and treatment of cytokine storm in COVID-19.|pdf=|usr=025}}
+{{tp|p=33457321|t=2020. Can we Turn off the "Covid-Biting-Tail" Inflammation?|pdf=|usr=025}}
+{{tp|p=33455862|t=2021. Altered Cholesterol and Lipid Synthesis Mediates Hyperinflammation in COVID-19.|pdf=|usr=025}}
+{{tp|p=33451855|t=2021. Dysregulation of Cell Signaling by SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33467724|t=2021. Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome.|pdf=|usr=025}}
+{{tp|p=33440622|t=2021. SARS-CoV-2 Epitope Mapping on Microarrays Highlights Strong Immune-Response to N Protein Region.|pdf=|usr=025}}
+{{tp|p=33413449|t=2021. Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling.|pdf=|usr=025}}
+{{tp|p=33450669|t=2021. Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan.|pdf=|usr=025}}
+{{tp|p=33387787|t=2021. Programmed -1 Ribosomal Frameshifting in coronaviruses: A therapeutic target.|pdf=|usr=025}}
+{{tp|p=33500788|t=2021. Synonymous mutations and the molecular evolution of SARS-CoV-2 origins.|pdf=|usr=025}}
+{{tp|p=33500787|t=2021. Possible host-adaptation of SARS-CoV-2 due to improved ACE2 receptor binding in mink.|pdf=|usr=025}}
+{{tp|p=33476695|t=2021. The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses.|pdf=|usr=025}}
+{{tp|p=33418027|t=2021. Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=025}}
+{{tp|p=33499234|t=2021. Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy.|pdf=|usr=025}}
+{{tp|p=33498225|t=2021. Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein.|pdf=|usr=025}}
+{{tp|p=33477951|t=2021. Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) Patients.|pdf=|usr=025}}
+{{tp|p=33477885|t=2021. Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia.|pdf=|usr=025}}
+{{tp|p=33467206|t=2021. MicroRNAs for Virus Pathogenicity and Host Responses, Identified in SARS-CoV-2 Genomes, May Play Roles in Viral-Host Co-Evolution in Putative Zoonotic Host Species.|pdf=|usr=025}}
+{{tp|p=33440724|t=2021. The Fatty Acid Lipid Metabolism Nexus in COVID-19.|pdf=|usr=025}}
+{{tp|p=33396605|t=2020. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-beta Production.|pdf=|usr=025}}
+{{tp|p=33419245|t=2020. Can Coronaviruses Steal Genes from the Host as Evidenced in Western European Hedgehogs by EriCoV Genetic Characterization?|pdf=|usr=025}}
+{{tp|p=33392306|t=2020. Virus load and virus shedding of SARS-CoV-2 and their impact on patient outcomes.|pdf=|usr=025}}
+{{tp|p=33410308|t=2021. Pitfalls of barcodes in the study of worldwide SARS-CoV-2 variation and phylodynamics.|pdf=|usr=025}}
+{{tp|p=33389884|t=2020. Immune Computation and COVID-19 Mortality: A Rationale for IVIg.|pdf=|usr=025}}
+{{tp|p=33494667|t=2021. Role of Poly(ADP-ribose) polymerase (PARP1) in viral infection and its implication in SARS-CoV-2 pathogenesis.|pdf=|usr=025}}
+{{tp|p=33394725|t=2021. Editorial: Do not lose focus on myeloid biology in the era of COVID-19.|pdf=|usr=025}}
+{{tp|p=33434935|t=2021. Macrophage Activation and Cytokine Release Syndrome in COVID-19: Current Updates and Analysis of Repurposed and Investigational Anti-Cytokine Drugs.|pdf=|usr=025}}
+{{tp|p=33479166|t=2021. Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.|pdf=|usr=025}}
+{{tp|p=33472860|t=2021. Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit.|pdf=|usr=025}}
+{{tp|p=33432808|t=2021. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.|pdf=|usr=025}}
+{{tp|p=33458462|t=2021. Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis.|pdf=|usr=025}}
+{{tp|p=33489438|t=2020. An unorthodox pathophysiology of severe cases of COVID-19 the weak heme hypothesis.|pdf=|usr=025}}
+{{tp|p=33434105|t=2021. SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport.|pdf=|usr=025}}
+{{tp|p=33434104|t=2021. Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality.|pdf=|usr=025}}
+{{tp|p=33416946|t=2021. Are all cytokine storms the same?|pdf=|usr=025}}
+{{tp|p=33407957|t=2021. Junctional tachycardia due to multisystem inflammatory syndrome in children with SARS-CoV-2 infection in a 12-year-old female.|pdf=|usr=025}}
+{{tp|p=33516277|t=2021. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33521695|t=2021. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.|pdf=|usr=025}}
+{{tp|p=33387094|t=2021. Kawasaki disease and influenza-new lessons from old associations.|pdf=|usr=025}}
+{{tp|p=33428101|t=2021. Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic.|pdf=|usr=025}}
+{{tp|p=33411143|t=2021. COVID-19, rheumatic diseases and immune dysregulation-a perspective.|pdf=|usr=025}}
+{{tp|p=33456620|t=2021. Principal Component Analysis Applications in COVID-19 Genome Sequence Studies.|pdf=|usr=025}}
+{{tp|p=33514825|t=2021. SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus.|pdf=|usr=025}}
+{{tp|p=33383528|t=2021. Identification and computational analysis of mutations in SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33456724|t=2021. Unraveling the molecular basis of host cell receptor usage in SARS-CoV-2 and other human pathogenic beta-CoVs.|pdf=|usr=025}}
+{{tp|p=33425248|t=2021. Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes.|pdf=|usr=025}}
+{{tp|p=33391633|t=2021. Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?|pdf=|usr=025}}
+{{tp|p=33397460|t=2021. Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome.|pdf=|usr=025}}
+{{tp|p=33403180|t=2020. Adult Inflammatory Multi-System Syndrome Mimicking Kawasaki Disease in a Patient With COVID-19.|pdf=|usr=025}}
+{{tp|p=33425537|t=2020. A Case of Multisystem Inflammatory Syndrome Post-COVID-19 Infection in an Adult.|pdf=|usr=025}}
+{{tp|p=33457109|t=2021. Decoding Covid-19 with the SARS-CoV-2 Genome.|pdf=|usr=025}}
+{{tp|p=33508651|t=2021. ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?|pdf=|usr=025}}
+{{tp|p=33487779|t=2020. Genomic Study of COVID-19 Corona Virus Excludes Its Origin from Recombination or Characterized Biological Sources and Suggests a Role for HERVS in Its Wide Range Symptoms.|pdf=|usr=025}}
+{{tp|p=33522107|t=2021. Sustained cellular immunity in adults recovered from mild COVID-19.|pdf=|usr=025}}
+{{tp|p=33496367|t=2021. A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID-19.|pdf=|usr=025}}
+{{tp|p=33422265|t=2021. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation.|pdf=|usr=025}}
+{{tp|p=33436069|t=2021. Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus.|pdf=|usr=025}}
+{{tp|p=33388575|t=2021. Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities.|pdf=|usr=025}}
+{{tp|p=33520333|t=2020. Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity.|pdf=|usr=025}}
+{{tp|p=33427152|t=2021. SARS-CoV-2 viral RNA load dynamics in the nasopharynx of infected children.|pdf=|usr=025}}
+{{tp|p=33517929|t=2021. Diversity of SARS-CoV-2 isolates driven by pressure and health index.|pdf=|usr=025}}
+{{tp|p=33462598|t=2021. COVID 19: in the eye of the cytokine storm.|pdf=|usr=025}}
+{{tp|p=33404891|t=2021. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.|pdf=|usr=025}}
+{{tp|p=33421274|t=2021. Circulating cardiovascular microRNAs in critically ill COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33452570|t=2021. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.|pdf=|usr=025}}
+{{tp|p=33419887|t=2021. Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia.|pdf=|usr=025}}
+{{tp|p=33506945|t=2021. High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19.|pdf=|usr=025}}
+{{tp|p=33478625|t=2021. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020.|pdf=|usr=025}}
+{{tp|p=33495994|t=2021. Is lymphopenia different between SARS and COVID-19 patients?|pdf=|usr=025}}
+{{tp|p=33503469|t=2021. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between alpha7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins.|pdf=|usr=025}}
+{{tp|p=33510633|t=2020. Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases.|pdf=|usr=025}}
+{{tp|p=33520952|t=2020. Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19.|pdf=|usr=025}}
+{{tp|p=33521069|t=2020. Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19.|pdf=|usr=025}}
+{{tp|p=33505977|t=2020. Identifying Transcriptomic Signatures and Rules for SARS-CoV-2 Infection.|pdf=|usr=025}}
+{{tp|p=33392109|t=2020. Is the "Common Cold" Our Greatest Ally in the Battle Against SARS-CoV-2?|pdf=|usr=025}}
+{{tp|p=33511102|t=2020. Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences.|pdf=|usr=025}}
+{{tp|p=33469527|t=2020. Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations.|pdf=|usr=025}}
+{{tp|p=33381492|t=2020. Host DDX Helicases as Possible SARS-CoV-2 Proviral Factors: A Structural Overview of Their Hijacking Through Multiple Viral Proteins.|pdf=|usr=025}}
+{{tp|p=33488517|t=2020. The Adrenal Cortex, an Underestimated Site of SARS-CoV-2 Infection.|pdf=|usr=025}}
+{{tp|p=33519902|t=2020. Detecting the Multiomics Signatures of Factor-Specific Inflammatory Effects on Airway Smooth Muscles.|pdf=|usr=025}}
+{{tp|p=33505425|t=2020. Deciphering the Subtype Differentiation History of SARS-CoV-2 Based on a New Breadth-First Searching Optimized Alignment Method Over a Global Data Set of 24,768 Sequences.|pdf=|usr=025}}
+{{tp|p=33424918|t=2020. A Comprehensive Analysis of cis-Acting RNA Elements in the SARS-CoV-2 Genome by a Bioinformatics Approach.|pdf=|usr=025}}
+{{tp|p=33519814|t=2020. Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury.|pdf=|usr=025}}
+{{tp|p=33519802|t=2020. Does Angiotensin II Peak in Response to SARS-CoV-2?|pdf=|usr=025}}
+{{tp|p=33424856|t=2020. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.|pdf=|usr=025}}
+{{tp|p=33391280|t=2020. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.|pdf=|usr=025}}
+{{tp|p=33384691|t=2020. Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures.|pdf=|usr=025}}
+{{tp|p=33392257|t=2020. Surveying the Side-Chain Network Approach to Protein Structure and Dynamics: The SARS-CoV-2 Spike Protein as an Illustrative Case.|pdf=|usr=025}}
+{{tp|p=33469522|t=2020. Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland.|pdf=|usr=025}}
+{{tp|p=33425823|t=2020. Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment.|pdf=|usr=025}}
+{{tp|p=33381049|t=2020. A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface.|pdf=|usr=025}}
+{{tp|p=33510644|t=2020. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?|pdf=|usr=025}}
+{{tp|p=33414726|t=2020. Physiology of Midkine and Its Potential Pathophysiological Role in COVID-19.|pdf=|usr=025}}
+{{tp|p=33392612|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Codon Usage and Replicative Fitness.|pdf=|usr=025}}
+{{tp|p=33403225|t=2020. SARS-CoV-2: A Trigger for Kawasaki Disease or a New Syndrome?|pdf=|usr=025}}
+{{tp|p=33431578|t=2021. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.|pdf=|usr=025}}
+{{tp|p=33495741|t=2021. Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa.|pdf=|usr=025}}
+{{tp|p=33437888|t=2021. Clinically distinct COVID-19 cases share notably similar immune response progression: A follow-up analysis.|pdf=|usr=025}}
+{{tp|p=33524881|t=2021. What do we know about the antibody responses to SARS-CoV-2?|pdf=|usr=025}}
+{{tp|p=33427136|t=2021. The 501.V2 and B.1.1.7 variants of coronavirus disease 2019 (COVID-19): A new time-bomb in the making?|pdf=|usr=025}}
+{{tp|p=33521603|t=2021. A high-throughput liquid bead array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity.|pdf=|usr=025}}
+{{tp|p=33521593|t=2021. The presentation of SARS-CoV-2 peptides by the common HLA-A( )02:01 molecule.|pdf=|usr=025}}
+{{tp|p=33480287|t=2021. Clocks, Viruses, and Immunity: Lessons for the COVID-19 Pandemic.|pdf=|usr=025}}
+{{tp|p=33506741|t=2021. Structural similarity-based prediction of host factors associated with SARS-CoV-2 infection and pathogenesis.|pdf=|usr=025}}
+{{tp|p=33513242|t=2021. Robust neutralizing antibodies to SARS-CoV-2 develop and persist in subjects with diabetes and COVID-19 pneumonia.|pdf=|usr=025}}
+{{tp|p=33524125|t=2021. Post Convalescent SARS-CoV-2 IgG and Neutralizing Antibodies Are Elevated in Individuals with Poor Metabolic Health.|pdf=|usr=025}}
+{{tp|p=33464307|t=2021. Mapping and role of T cell response in SARS-CoV-2-infected mice.|pdf=|usr=025}}
+{{tp|p=33431260|t=2021. Reply to letter to the editor: Kawasaki disease and COVID-19: A pretext for a hot topic.|pdf=|usr=025}}
+{{tp|p=33464637|t=2021. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.|pdf=|usr=025}}
+{{tp|p=33512021|t=2021. Evolutionary analysis of SARS-CoV-2 spike protein for its different clades.|pdf=|usr=025}}
+{{tp|p=33506970|t=2021. Will the emergent SARS-CoV2 B.1.1.7 lineage affect molecular diagnosis of COVID-19?|pdf=|usr=025}}
+{{tp|p=33506952|t=2021. Role of Toll-like receptors in the pathogenesis of COVID-19.|pdf=|usr=025}}
+{{tp|p=33506951|t=2021. Emergence of SARS-CoV-2 Variant: A wake-up call for Pakistan's overburdened healthcare system.|pdf=|usr=025}}
+{{tp|p=33506950|t=2021. Clinical significance of cellular immunity function and inflammatory factors assays in alveolar lavage fluid for severe COVID-19 pneumonia.|pdf=|usr=025}}
+{{tp|p=33506962|t=2021. A parsimonious approach for recognizing SARS-CoV-2 and host interactions.|pdf=|usr=025}}
+{{tp|p=33433004|t=2021. Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure.|pdf=|usr=025}}
+{{tp|p=33427302|t=2021. Antibody response to SARS-CoV-2 in infected patients with different clinical outcome.|pdf=|usr=025}}
+{{tp|p=33493263|t=2021. Kidney injury molecule-1 is a potential receptor for SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33453103|t=2021. Kidney injury molecule-1: a novel entry factor for SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33518219|t=2020. Compelling evidence of a novel multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection.|pdf=|usr=025}}
+{{tp|p=33458751|t=2021. 16 Weeks Later: Expanding the Risk Period for MIS-C.|pdf=|usr=025}}
+{{tp|p=33500262|t=2021. Covid-19: New UK variant may be linked to increased death rate, early data indicate.|pdf=|usr=025}}
+{{tp|p=33380449|t=2021. Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection.|pdf=|usr=025}}
+{{tp|p=33504377|t=2021. Coronary aneurysms, myocardial dysfunction, and shock in a COVID-19 child, role of ECMO, immunomodulation, and cardiac CT.|pdf=|usr=025}}
+{{tp|p=33382348|t=2021. MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?|pdf=|usr=025}}
+{{tp|p=33510385|t=2021. The m(6)A methylome of SARS-CoV-2 in host cells.|pdf=|usr=025}}
+{{tp|p=33394568|t=2021. Illuminating the immunopathology of SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33504318|t=2021. An Alternative "Trojan Horse" Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology.|pdf=|usr=025}}
+{{tp|p=33499661|t=2021. RNA editors: key regulators of viral response in cancer patients.|pdf=|usr=025}}
+{{tp|p=33467896|t=2021. Inter-proteomic posttranslational modifications of the SARS-CoV-2 and the host proteins A new frontier.|pdf=|usr=025}}
+{{tp|p=33435808|t=2021. Immune memory: an evolutionary perspective.|pdf=|usr=025}}
+{{tp|p=33417561|t=2021. Detection of Phenotype-related Mutations of COVID-19 via the Whole Genomic Data.|pdf=|usr=025}}
+{{tp|p=33444511|t=2021. Immune response to COVID-19 infection: a double-edged sword.|pdf=|usr=025}}
+{{tp|p=33443384|t=2021. What Is a Cytokine Storm and Should It Matter to Me?|pdf=|usr=025}}
+{{tp|p=33412850|t=2021. Computational Insight Into the Mechanism of SARS-CoV-2 Membrane Fusion.|pdf=|usr=025}}
+{{tp|p=33427605|t=2021. A genetic element in the SARS-CoV-2 genome is shared with multiple insect species.|pdf=|usr=025}}
+{{tp|p=33506974|t=2021. Multiplexed analysis of circulating IgA antibodies for SARS-CoV-2 and common respiratory pathogens in COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33458832|t=2021. World-wide tracking of major SARS-CoV-2 genome haplotypes in sequences of June 1 to November 15, 2020 and discovery of rapid expansion of a new haplotype.|pdf=|usr=025}}
+{{tp|p=33386744|t=2021. The dilemma of herd immunity for COVID-19.|pdf=|usr=025}}
+{{tp|p=33404091|t=2021. In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humans.|pdf=|usr=025}}
+{{tp|p=33510530|t=2021. Kawasaki Disease like Multisystem Inflammatory Syndrome in a Toddler during SARS-CoV-2 Pandemic in Nepal.|pdf=|usr=025}}
+{{tp|p=33399535|t=2021. Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection.|pdf=|usr=025}}
+{{tp|p=33393462|t=2021. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site.|pdf=|usr=025}}
+{{tp|p=33443016|t=2021. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33496249|t=2021. Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020.|pdf=|usr=025}}
+{{tp|p=33496647|t=2021. Long-Term Humoral Immune Response in Persons with Asymptomatic or Mild SARS-CoV-2 Infection, Vietnam.|pdf=|usr=025}}
+{{tp|p=33407005|t=2021. Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.|pdf=|usr=025}}
+{{tp|p=33399033|t=2021. Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France.|pdf=|usr=025}}
+{{tp|p=33399028|t=2021. The interplay between emerging human coronavirus infections and autophagy.|pdf=|usr=025}}
+{{tp|p=33422505|t=2021. Exposure to particulate matter upregulates ACE2 and TMPRSS2 expression in the murine lung.|pdf=|usr=025}}
+{{tp|p=33478621|t=2021. Updated rapid risk assessment from ECDC on the risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA - first update.|pdf=|usr=025}}
+{{tp|p=33413740|t=2021. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.|pdf=|usr=025}}
+{{tp|p=33400927|t=2021. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?|pdf=|usr=025}}
+{{tp|p=33504359|t=2021. Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33444084|t=2021. Potential role of glycoprotein 340 in milder SARS-CoV-2 infection in children.|pdf=|usr=025}}
+{{tp|p=33382362|t=2021. Changes of peripheral lymphocyte subset in patients with SARS-CoV-2 infection during the whole course of disease.|pdf=|usr=025}}
+{{tp|p=33500774|t=2020. Reproducibly sampling SARS-CoV-2 genomes across time, geography, and viral diversity.|pdf=|usr=025}}
+{{tp|p=33456761|t=2020. SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets.|pdf=|usr=025}}
+{{tp|p=33391730|t=2020. 'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients.|pdf=|usr=025}}
+{{tp|p=33467912|t=2021. The potential association between PARP14 and SARS-CoV-2 infection (COVID-19).|pdf=|usr=025}}
+{{tp|p=33484691|t=2021. Reply: Dysbiosis in SARS-CoV-2 infected patients.|pdf=|usr=025}}
+{{tp|p=33387514|t=2020. Dysbiosis in SARS-CoV-2 infected patients.|pdf=|usr=025}}
+{{tp|p=33398248|t=2021. Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways.|pdf=|usr=025}}
+{{tp|p=33521382|t=2021. Genome-wide in silico identification and characterization of Simple Sequence Repeats in diverse completed SARS-CoV-2 genomes.|pdf=|usr=025}}
+{{tp|p=33490718|t=2021. Mutational analysis of SARS-CoV-2 ORF8 during six months of COVID-19 pandemic.|pdf=|usr=025}}
+{{tp|p=33521384|t=2020. Genetic variations among SARS-CoV-2 strains isolated in China.|pdf=|usr=025}}
+{{tp|p=33503821|t=2021. Epigenetic Evolution of ACE2 and IL-6 Genes: Non-Canonical Interferon-Stimulated Genes Correlate to COVID-19 Susceptibility in Vertebrates.|pdf=|usr=025}}
+{{tp|p=33396837|t=2020. Strong Correlation between the Case Fatality Rate of COVID-19 and the rs6598045 Single Nucleotide Polymorphism (SNP) of the Interferon-Induced Transmembrane Protein 3 (IFITM3) Gene at the Population-Level.|pdf=|usr=025}}
+{{tp|p=33521209|t=2020. Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies.|pdf=|usr=025}}
+{{tp|p=33395363|t=2021. Epigenetic mechanisms influencing COVID-19.|pdf=|usr=025}}
+{{tp|p=33512495|t=2021. Rapid Spread of Mutant Alleles in Worldwide SARS-CoV-2 Strains Revealed by Genome-Wide Single Nucleotide Polymorphism and Variation Analysis.|pdf=|usr=025}}
+{{tp|p=33383142|t=2021. Comprehensive analysis of TCR repertoire in COVID-19 using single cell sequencing.|pdf=|usr=025}}
+{{tp|p=33412761|t=2020. Updated confidence intervals for the COVID-19 antibody retention rate in the Korean population.|pdf=|usr=025}}
+{{tp|p=33412760|t=2020. Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19.|pdf=|usr=025}}
+{{tp|p=33390179|t=2021. Alu retrotransposons and COVID-19 susceptibility and morbidity.|pdf=|usr=025}}
+{{tp|p=33406391|t=2021. T Cell Memory: Understanding COVID-19.|pdf=|usr=025}}
+{{tp|p=33382973|t=2021. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.|pdf=|usr=025}}
+{{tp|p=33513337|t=2021. B cell memory: understanding COVID-19.|pdf=|usr=025}}
+{{tp|p=33428993|t=2021. Did we forget the diffuse chemosensory system when studying COVID-19?|pdf=|usr=025}}
+{{tp|p=33421440|t=2021. Immune reactivity during COVID-19: Implications for treatment.|pdf=|usr=025}}
+{{tp|p=33400966|t=2021. Are the emerging SARS-COV-2 mutations friend or foe?|pdf=|usr=025}}
+{{tp|p=33384516|t=2020. Multisystem Inflammatory Syndrome in Children: Clinical Features and Management-Intensive Care Experience from a Pediatric Public Hospital in Western India.|pdf=|usr=025}}
+{{tp|p=33384501|t=2020. Multisystem Inflammatory Syndrome of Children Related to SARS-CoV-2: A Novel Experience in Children with a Novel Virus.|pdf=|usr=025}}
+{{tp|p=33446986|t=2020. COVID-19-associated Severe Multisystem Inflammatory Syndrome in Children with Encephalopathy and Neuropathy in an Adolescent Girl with the Successful Outcome: An Unusual Presentation.|pdf=|usr=025}}
+{{tp|p=33403611|t=2021. COVID-19 in a Young Infant - A Fatal Multisystem Inflammatory Disorder.|pdf=|usr=025}}
+{{tp|p=33508515|t=2021. Association of clade-G SARS-CoV-2 viruses and age with increased mortality rates across 57 countries and India.|pdf=|usr=025}}
+{{tp|p=33513449|t=2021. Different SARS-CoV-2 haplotypes associate with geographic origin and case fatality rates of COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33516969|t=2021. Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33476804|t=2021. Clade GR and clade GH isolates of SARS-CoV-2 in Asia show highest amount of SNPs.|pdf=|usr=025}}
+{{tp|p=33387262|t=2021. Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strain.|pdf=|usr=025}}
+{{tp|p=33385239|t=2021. Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge.|pdf=|usr=025}}
+{{tp|p=33521758|t=2020. From Animal to Human: Interspecies Analysis Provides a Novel Way of Ascertaining and Fighting COVID-19.|pdf=|usr=025}}
+{{tp|p=33498051|t=2021. Dynamic Changes of Lymphocyte Subsets in the Course of COVID-19.|pdf=|usr=025}}
+{{tp|p=33486489|t=2021. SARS-CoV-2-Associated T-Cell Responses in the Presence of Humoral Immunodeficiency.|pdf=|usr=025}}
+{{tp|p=33440306|t=2021. An overview of Betacoronaviruses-associated severe respiratory syndromes, focusing on sex-type-specific immune responses.|pdf=|usr=025}}
+{{tp|p=33401205|t=2021. The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33385714|t=2021. Genome-wide analysis of Indian SARS-CoV-2 genomes to identify T-cell and B-cell epitopes from conserved regions based on immunogenicity and antigenicity.|pdf=|usr=025}}
+{{tp|p=33450373|t=2021. Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2.|pdf=|usr=025}}
+{{tp|p=33430309|t=2021. Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.|pdf=|usr=025}}
+{{tp|p=33430234|t=2021. Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions.|pdf=|usr=025}}
+{{tp|p=33498725|t=2021. A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections.|pdf=|usr=025}}
+{{tp|p=33498183|t=2021. Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?|pdf=|usr=025}}
+{{tp|p=33396557|t=2020. Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus.|pdf=|usr=025}}
+{{tp|p=33396899|t=2020. Role of Host-Mediated Post-Translational Modifications (PTMs) in RNA Virus Pathogenesis.|pdf=|usr=025}}
+{{tp|p=33433784|t=2021. A Novel Protein Mapping Method for Predicting the Protein Interactions in COVID-19 Disease by Deep Learning.|pdf=|usr=025}}
+{{tp|p=33386601|t=2021. Two different patterns of lymphocyte alterations in critically ill COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33454715|t=2021. Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets.|pdf=|usr=025}}
+{{tp|p=33463113|t=2020. Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.|pdf=|usr=025}}
+{{tp|p=33463127|t=2020. COVID-19 Associated Multisystem Inflammatory Syndrome: A Systematic Review and Meta-analysis.|pdf=|usr=025}}
+{{tp|p=33437935|t=2021. Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections.|pdf=|usr=025}}
+{{tp|p=33421631|t=2021. Type 2 Asthma Inflammation and COVID-19: A Double Edged Sword.|pdf=|usr=025}}
+{{tp|p=33388272|t=2020. Dynamics of severe acute respiratory syndrome coronavirus 2 genome variants in the feces during convalescence.|pdf=|usr=025}}
+{{tp|p=33493496|t=2021. Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico.|pdf=|usr=025}}
+{{tp|p=33472093|t=2021. Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.|pdf=|usr=025}}
+{{tp|p=33406394|t=2021. Insight into the reason of prolonged viral RNA shedding in patients with COVID-19 infection.|pdf=|usr=025}}
+{{tp|p=33383088|t=2021. Emergence of a new SARS-CoV-2 variant in the UK.|pdf=|usr=025}}
+{{tp|p=33487533|t=2021. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.|pdf=|usr=025}}
+{{tp|p=33411935|t=2021. Early differences in cytokine production distinguish severity of COVID-19.|pdf=|usr=025}}
+{{tp|p=33502532|t=2021. Role of cell adhesion molecules for disease development of patients with and without COVID-19 in the emergency department.|pdf=|usr=025}}
+{{tp|p=33493287|t=2021. Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis.|pdf=|usr=025}}
+{{tp|p=33476387|t=2021. Immune profiling reveals early disease trajectories associated with COVID-19 mortality: a sub-study from the ACTT-1 trial.|pdf=|usr=025}}
+{{tp|p=33433587|t=2021. Nature and dimensions of the systemic hyper-inflammation and its attenuation by convalescent plasma in severe COVID-19.|pdf=|usr=025}}
+{{tp|p=33524124|t=2021. Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19.|pdf=|usr=025}}
+{{tp|p=33524110|t=2021. Increased PD-L1 expression may be associated with the cytokine storm and CD8 + T-cell exhaustion in severe COVID-19.|pdf=|usr=025}}
+{{tp|p=33519225|t=2021. Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms.|pdf=|usr=025}}
+{{tp|p=33432259|t=2021. Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species.|pdf=|usr=025}}
+{{tp|p=33429476|t=2021. The Importance of Early Recognition, Timely Management, and the Role of Healthcare Providers in Multisystem Inflammatory Syndrome in Children.|pdf=|usr=025}}
+{{tp|p=33506254|t=2021. Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis.|pdf=|usr=025}}
+{{tp|p=33513240|t=2021. Unusual Clinical Manifestations and Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C) in a Tertiary Care Hospital of North India.|pdf=|usr=025}}
+{{tp|p=33518372|t=2021. Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient.|pdf=|usr=025}}
+{{tp|p=33521734|t=2021. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.|pdf=|usr=025}}
+{{tp|p=33521726|t=2020. Immunogenomic phases of COVID-19 and appropriate clinical management.|pdf=|usr=025}}
+{{tp|p=33521749|t=2021. Cell-Free DNA Tissues-of-Origin by Methylation Profiling Reveals Significant Cell, Tissue and Organ-Specific injury related to COVID-19 Severity.|pdf=|usr=025}}
+{{tp|p=33521750|t=2020. Vaccination Is the Only Acceptable Path to Herd Immunity.|pdf=|usr=025}}
+{{tp|p=33521315|t=2021. CD64, CD11a and CD18 leukocytes expression in children with SARS-CoV-2 multisystem inflammatory syndrome versus children with Kawasaki disease: Similar but not the same.|pdf=|usr=025}}
+{{tp|p=33427554|t=2021. The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases.|pdf=|usr=025}}
+{{tp|p=33514928|t=2021. Addendum: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.|pdf=|usr=025}}
+{{tp|p=33423311|t=2021. Human SARS CoV-2 spike protein mutations.|pdf=|usr=025}}
+{{tp|p=33415739|t=2021. Unsupervised cluster analysis of SARS-CoV-2 genomes reflects its geographic progression and identifies distinct genetic subgroups of SARS-CoV-2 virus.|pdf=|usr=025}}
+{{tp|p=33380494|t=2021. Coronavirus Receptors as Immune Modulators.|pdf=|usr=025}}
+{{tp|p=33514628|t=2021. SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells.|pdf=|usr=025}}
+{{tp|p=33523115|t=2021. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.|pdf=|usr=025}}
+{{tp|p=33404586|t=2021. Genetic Variants of SARS-CoV-2-What Do They Mean?|pdf=|usr=025}}
+{{tp|p=33393161|t=2021. Recent advancements in glycoproteomic studies: Glycopeptide enrichment and derivatization, characterization of glycosylation in SARS CoV2, and interacting glycoproteins.|pdf=|usr=025}}
+{{tp|p=33432184|t=2021. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection.|pdf=|usr=025}}
+{{tp|p=33442016|t=2021. Immune determinants of COVID-19 disease presentation and severity.|pdf=|usr=025}}
+{{tp|p=33402708|t=2021. Cold sensitivity of the SARS-CoV-2 spike ectodomain.|pdf=|usr=025}}
+{{tp|p=33494095|t=2021. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.|pdf=|usr=025}}
+{{tp|p=33461210|t=2021. Evolution of antibody immunity to SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33479534|t=2021. Fast-spreading COVID variant can elude immune responses.|pdf=|usr=025}}
+{{tp|p=33473223|t=2021. Lessons from the host defences of bats, a unique viral reservoir.|pdf=|usr=025}}
+{{tp|p=33469239|t=2021. The world needs a single naming system for coronavirus variants.|pdf=|usr=025}}
+{{tp|p=33429418|t=2021. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.|pdf=|usr=025}}
+{{tp|p=33515497|t=2021. Durability of SARS-CoV-2 IgG Antibody Among Residents in a Long-Term Care Community.|pdf=|usr=025}}
+{{tp|p=33400131|t=2021. European context of the diversity and phylogenetic position of SARS-CoV-2 sequences from Polish COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33401171|t=2021. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.|pdf=|usr=025}}
+{{tp|p=33476648|t=2021. SARS-CoV-2 infects cells following viral entry via clathrin-mediated endocytosis.|pdf=|usr=025}}
+{{tp|p=33434581|t=2020. The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles.|pdf=|usr=025}}
+{{tp|p=33475020|t=2021. Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study.|pdf=|usr=025}}
+{{tp|p=33459964|t=2021. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.|pdf=|usr=025}}
+{{tp|p=33394320|t=2021. Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France.|pdf=|usr=025}}
+{{tp|p=33387156|t=2021. SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.|pdf=|usr=025}}
+{{tp|p=33402024|t=2021. Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease.|pdf=|usr=025}}
+{{tp|p=33383190|t=2021. Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33508323|t=2021. Latent periodicity-2 in coronavirus SARS-CoV-2 genome: Evolutionary implications.|pdf=|usr=025}}
+{{tp|p=33413461|t=2021. Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33413422|t=2021. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33380328|t=2020. Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants.|pdf=|usr=025}}
+{{tp|p=33513380|t=2021. Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.|pdf=|usr=025}}
+{{tp|p=33448184|t=2021. ADP-ribosylhydrolases: from DNA damage repair to COVID-19.|pdf=|usr=025}}
+{{tp|p=33497357|t=2021. Distinct antibody repertoires against endemic human coronaviruses in children and adults.|pdf=|usr=025}}
+{{tp|p=33476301|t=2021. Effective virus-neutralizing activities in antisera from the first wave of survivors of severe COVID-19.|pdf=|usr=025}}
+{{tp|p=33497425|t=2021. Isolating SARS-CoV-2 Strains From Countries in the Same Meridian: Genome Evolutionary Analysis.|pdf=|usr=025}}
+{{tp|p=33496683|t=2020. The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India.|pdf=|usr=025}}
+{{tp|p=33518995|t=2021. Threats from new variants.|pdf=|usr=025}}
+{{tp|p=33519006|t=2021. The coronavirus could end up mild like a common cold.|pdf=|usr=025}}
+{{tp|p=33519005|t=2021. The global threat of the coronavirus variants.|pdf=|usr=025}}
+{{tp|p=33519003|t=2021. What are the new coronavirus variants?|pdf=|usr=025}}
+{{tp|p=33521378|t=2021. Hypoxia-inducible factor (HIF): The link between obesity and COVID-19.|pdf=|usr=025}}
+{{tp|p=33512464|t=2021. How can we interpret SARS-CoV-2 antibody test results?|pdf=|usr=025}}
+{{tp|p=33469663|t=2021. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.|pdf=|usr=025}}
+{{tp|p=33493353|t=2021. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: A French study and literature review.|pdf=|usr=025}}
+{{tp|p=33519278|t=2021. Genome composition and genetic characterization of SARS-CoV-2.|pdf=|usr=025}}
+{{tp|p=33519271|t=2021. Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19.|pdf=|usr=025}}
+{{tp|p=33482019|t=2021. An increase in CD62L(dim) neutrophils precedes the development of pulmonary embolisms in COVID-19 patients.|pdf=|usr=025}}
+{{tp|p=33523532|t=2021. Early humoral defence: Contributing to confining COVID-19 to conducting airways?|pdf=|usr=025}}
+{{tp|p=33521857|t=2021. Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19.|pdf=|usr=025}}
+{{tp|p=33443036|t=2020. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.|pdf=|usr=025}}
+{{tp|p=33436498|t=2021. Cytoplasmic short linear motifs in ACE2 and integrin beta3 link SARS-CoV-2 host cell receptors to mediators of endocytosis and autophagy.|pdf=|usr=025}}
+{{tp|p=33436497|t=2021. Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications.|pdf=|usr=025}}
+{{tp|p=33408181|t=2021. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.|pdf=|usr=025}}
+{{tp|p=33436525|t=2021. Immunological characteristics govern the transition of COVID-19 to endemicity.|pdf=|usr=025}}
+{{tp|p=33419936|t=2021. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK.|pdf=|usr=025}}
+{{tp|p=33421326|t=2021. First genome sequencing of SARS-CoV-2 recovered from an infected cat and its owner in Latin America.|pdf=|usr=025}}
+{{tp|p=33506644|t=2021. Genotype-phenotype correlation identified a novel SARS-CoV-2 variant possibly linked to severe disease.|pdf=|usr=025}}
+{{tp|p=33501730|t=2021. A deletion in SARS-CoV-2 ORF7 identified in COVID-19 outbreak in Uruguay.|pdf=|usr=025}}
+{{tp|p=33452828|t=2021. Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors.|pdf=|usr=025}}
+{{tp|p=33524849|t=2021. Coronavirus infection induces progressive restructuring of the endoplasmic reticulum involving the formation and degradation of double membrane vesicles.|pdf=|usr=025}}
+{{tp|p=33494661|t=2021. COVID-19 evolution during the pandemic - Implications of new SARS-CoV-2 variants on disease control and public health policies.|pdf=|usr=025}}
+{{tp|p=33469204|t=2021. Rogue antibodies could be driving severe COVID-19.|pdf=|usr=025}}
+{{tp|p=33478949|t=2021. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8(+) T cells.|pdf=|usr=025}}
+{{tp|p=33510015|t=2021. Insights from SARS-CoV-2 sequences.|pdf=|usr=025}}
+{{tp|p=33446556|t=2021. Learning the language of viral evolution and escape.|pdf=|usr=025}}
+{{tp|p=33446540|t=2021. Herd immunity by infection is not an option.|pdf=|usr=025}}
+{{tp|p=33484868|t=2021. Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19.|pdf=|usr=025}}
+{{tp|p=33443366|t=2021. Severe COVID-19: Immunosuppression or Hyperinflammation?|pdf=|usr=025}}
+{{tp|p=33481684|t=2021. Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.|pdf=|usr=025}}
+{{tp|p=33423443|t=2021. [Immunological research of COVID-19 and emerging infectious diseases].|pdf=|usr=025}}
+{{tp|p=33685917|t=2021. The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13.|pdf=|usr=026}}
+{{tp|p=33727331|t=2021. Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.|pdf=|usr=026}}
+{{tp|p=33649194|t=2021. Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.|pdf=|usr=026}}
+{{tp|p=33637603|t=2021. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.|pdf=|usr=026}}
+{{tp|p=33784032|t=2021. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Rapid Living Review|pdf=|usr=026}}
+{{tp|p=33745765|t=2021. Hemophagocytic Lymphohistiocytosis in the Emergency Department: Recognizing and Evaluating a Hidden Threat.|pdf=|usr=026}}
+{{tp|p=33656515|t=2021. Immunodominant antibody germlines in COVID-19.|pdf=|usr=026}}
+{{tp|p=33646265|t=2021. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33739364|t=2021. Lasting memories of SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33533916|t=2021. SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.|pdf=|usr=026}}
+{{tp|p=33533915|t=2021. Persistent cellular immunity to SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33707363|t=2021. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.|pdf=|usr=026}}
+{{tp|p=33721886|t=2021. Adaptive metabolic and inflammatory responses identified using accelerated aging metrics are linked to adverse outcomes in severe SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33528568|t=2021. The Nexus between Telomere Length and Lymphocyte Count in Seniors hospitalized with Covid-19.|pdf=|usr=026}}
+{{tp|p=33766545|t=2021. SARS-CoV-2 mutational variants may represent a new challenge to society, but not to the virucidal armamentarium.|pdf=|usr=026}}
+{{tp|p=33644235|t=2021. Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population.|pdf=|usr=026}}
+{{tp|p=33707314|t=2021. Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic.|pdf=|usr=026}}
+{{tp|p=33581239|t=2021. Single nucleotide polymorphisms in key aging pathways, and phenotypic markers of frailty are associated with increased odds of hospital admission with COVID-19.|pdf=|usr=026}}
+{{tp|p=33548358|t=2021. Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK.|pdf=|usr=026}}
+{{tp|p=33545166|t=2021. Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study.|pdf=|usr=026}}
+{{tp|p=33766552|t=2021. Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan.|pdf=|usr=026}}
+{{tp|p=33531292|t=2021. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19.|pdf=|usr=026}}
+{{tp|p=33718952|t=2021. Durability of Viral Neutralization in Asymptomatic Coronavirus Disease 2019 for at Least 60 Days.|pdf=|usr=026}}
+{{tp|p=33675366|t=2021. The Association Between Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Post-COVID-19 Syndrome in Healthcare Workers.|pdf=|usr=026}}
+{{tp|p=33580264|t=2021. Uncovering Ways That Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Lineages May Increase Transmissibility.|pdf=|usr=026}}
+{{tp|p=33580259|t=2021. S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction.|pdf=|usr=026}}
+{{tp|p=33556959|t=2021. Circulating CD4 T Cells Elicited by Endemic Coronaviruses Display Vast Disparities in Abundance and Functional Potential Linked to Antigen Specificity and Age.|pdf=|usr=026}}
+{{tp|p=33693749|t=2021. Sex differences in the evolution of neutralizing antibodies to SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33686421|t=2021. Longitudinal assessment of anti-SARS-CoV-2 immune responses for six months based on the clinical severity of COVID-19.|pdf=|usr=026}}
+{{tp|p=33649773|t=2021. Persistent SARS-CoV-2 RNA Shedding without Evidence of Infectiousness: A Cohort Study of Individuals with COVID-19.|pdf=|usr=026}}
+{{tp|p=33743370|t=2021. Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health.|pdf=|usr=026}}
+{{tp|p=33732005|t=2021. Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers.|pdf=|usr=026}}
+{{tp|p=33531826|t=2021. Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality.|pdf=|usr=026}}
+{{tp|p=33630386|t=2021. Remembering Metchnikoff in the time of COVID-19.|pdf=|usr=026}}
+{{tp|p=33638484|t=2021. New SARS-CoV-2 variant of concern imported from the United Kingdom to Vietnam, December 2020.|pdf=|usr=026}}
+{{tp|p=33620098|t=2021. Antibody response patterns in COVID-19 patients with different levels of disease severity in Japan.|pdf=|usr=026}}
+{{tp|p=33590900|t=2021. Anti-spike S1 receptor-binding domain antibodies against SARS-CoV-2 persist several months after infection regardless of disease severity.|pdf=|usr=026}}
+{{tp|p=33570181|t=2021. Importation of SARS-CoV-2 Variant B.1.1.7 in Pakistan.|pdf=|usr=026}}
+{{tp|p=33638460|t=2021. Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.|pdf=|usr=026}}
+{{tp|p=33624270|t=2021. A comprehensive review of SARS-CoV-2 genetic mutations and lessons from animal coronavirus recombination in one health perspective.|pdf=|usr=026}}
+{{tp|p=33623737|t=2020. Artificial Intelligence in COVID-19 Ultrastructure.|pdf=|usr=026}}
+{{tp|p=33744314|t=2021. SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca(2).|pdf=|usr=026}}
+{{tp|p=33556408|t=2021. The Mechanism of SARS-CoV-2 Nucleocapsid Protein Recognition by the Human 14-3-3 Proteins.|pdf=|usr=026}}
+{{tp|p=33630074|t=2021. Short sequence motif dynamics in the SARS-CoV-2 genome suggest a role for cytosine deamination in CpG reduction.|pdf=|usr=026}}
+{{tp|p=33740562|t=2021. Which species does the virus like most: Binding modes study between SARS-CoV-2 S protein and ACE2 receptor.|pdf=|usr=026}}
+{{tp|p=33588349|t=2021. Epitope mimicry analysis of SARS-COV-2 surface proteins and human lung proteins.|pdf=|usr=026}}
+{{tp|p=33624189|t=2021. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): Role of (18)F-FDG PET/CT to assess myocardial involvement.|pdf=|usr=026}}
+{{tp|p=33550983|t=2021. COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?|pdf=|usr=026}}
+{{tp|p=33640331|t=2021. Intracranial Hypertension in Multisystem Inflammatory Syndrome in Children.|pdf=|usr=026}}
+{{tp|p=33713130|t=2021. Multisystem Inflammatory Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 in Children: A Case Series From Mayotte Island.|pdf=|usr=026}}
+{{tp|p=33626315|t=2021. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes.|pdf=|usr=026}}
+{{tp|p=33613009|t=2021. Aggregation hot spots in the SARS-CoV-2 proteome may constitute potential therapeutic targets for the suppression of the viral replication and multiplication.|pdf=|usr=026}}
+{{tp|p=33724837|t=2021. Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses.|pdf=|usr=026}}
+{{tp|p=33666082|t=2021. Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis.|pdf=|usr=026}}
+{{tp|p=33555895|t=2021. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.|pdf=|usr=026}}
+{{tp|p=33582489|t=2021. Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery.|pdf=|usr=026}}
+{{tp|p=33662570|t=2021. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.|pdf=|usr=026}}
+{{tp|p=33532723|t=2021. Characteristics of COVID-19 infection and antibody formation in patients known at a tertiary immunology department.|pdf=|usr=026}}
+{{tp|p=33693926|t=2021. SARS-CoV-2 Variant of Concern 202 012/01 (B.1.1.7) in a traveller from the UK to China.|pdf=|usr=026}}
+{{tp|p=33693754|t=2021. First Report of SARS-CoV-2 B.1.1.251 lineage in Brazil.|pdf=|usr=026}}
+{{tp|p=33563656|t=2021. The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.|pdf=|usr=026}}
+{{tp|p=33644276|t=2021. Two adult cases of multisystem inflammatory syndrome associated with SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33681536|t=2021. What Are the Clinical Implications of the SARS-CoV-2 Variants: 5 Things Every Cardiologist Should Know.|pdf=|usr=026}}
+{{tp|p=33782672|t=2021. Regression of Coronary Aneurysms With Intravenous Immunoglobulins and Steroids for COVID-19 Adult Multisystem Inflammatory Syndrome.|pdf=|usr=026}}
+{{tp|p=33649746|t=2021. Reversible Coronary Artery Aneurysm With Delayed Anti-inflammatory Therapy in Multisystem Inflammatory Syndrome in Children.|pdf=|usr=026}}
+{{tp|p=33625463|t=2021. Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection.|pdf=|usr=026}}
+{{tp|p=33749770|t=2021. Association of Age With SARS-CoV-2 Antibody Response.|pdf=|usr=026}}
+{{tp|p=33674591|t=2021. Deciphering the state of immune silence in fatal COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33785765|t=2021. SARS-CoV-2 in severe COVID-19 induces a TGF-beta-dominated chronic immune response that does not target itself.|pdf=|usr=026}}
+{{tp|p=33782395|t=2021. The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA.|pdf=|usr=026}}
+{{tp|p=33771993|t=2021. N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33767183|t=2021. SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition.|pdf=|usr=026}}
+{{tp|p=33753738|t=2021. SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19.|pdf=|usr=026}}
+{{tp|p=33741972|t=2021. Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection.|pdf=|usr=026}}
+{{tp|p=33723254|t=2021. SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication.|pdf=|usr=026}}
+{{tp|p=33712622|t=2021. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.|pdf=|usr=026}}
+{{tp|p=33712587|t=2021. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions.|pdf=|usr=026}}
+{{tp|p=33707453|t=2021. Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution.|pdf=|usr=026}}
+{{tp|p=33563974|t=2021. Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection.|pdf=|usr=026}}
+{{tp|p=33558507|t=2021. Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers.|pdf=|usr=026}}
+{{tp|p=33558493|t=2021. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.|pdf=|usr=026}}
+{{tp|p=33547281|t=2021. Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33619281|t=2021. Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33608522|t=2021. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.|pdf=|usr=026}}
+{{tp|p=33597532|t=2021. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery.|pdf=|usr=026}}
+{{tp|p=33597531|t=2021. Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children.|pdf=|usr=026}}
+{{tp|p=33589636|t=2021. Discrete SARS-CoV-2 antibody titers track with functional humoral stability.|pdf=|usr=026}}
+{{tp|p=33574281|t=2021. A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry.|pdf=|usr=026}}
+{{tp|p=33542501|t=2021. SARS-CoV-2 variant evades antibodies whilst maintaining fitness.|pdf=|usr=026}}
+{{tp|p=33542500|t=2021. Do rogue antibodies make the difference between mild versus severe COVID-19?|pdf=|usr=026}}
+{{tp|p=33726806|t=2021. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.|pdf=|usr=026}}
+{{tp|p=33627147|t=2021. Distinguishing active pediatric COVID-19 pneumonia from MIS-C.|pdf=|usr=026}}
+{{tp|p=33665043|t=2021. Low compositions of human toll-like receptor 7/8-stimulating RNA motifs in the MERS-CoV, SARS-CoV and SARS-CoV-2 genomes imply a substantial ability to evade human innate immunity.|pdf=|usr=026}}
+{{tp|p=33614298|t=2021. Is there a link between pre-existing antibodies acquired due to childhood vaccinations or past infections and COVID-19? A case control study.|pdf=|usr=026}}
+{{tp|p=33721239|t=2021. COVID-19 and the ethnicity link - is there a photochemical link?|pdf=|usr=026}}
+{{tp|p=33687143|t=2021. Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19?|pdf=|usr=026}}
+{{tp|p=33625796|t=2021. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.|pdf=|usr=026}}
+{{tp|p=33780434|t=2021. Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium.|pdf=|usr=026}}
+{{tp|p=33760807|t=2021. SARS-CoV-2 variants reveal features critical for replication in primary human cells.|pdf=|usr=026}}
+{{tp|p=33750978|t=2021. A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33730024|t=2021. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.|pdf=|usr=026}}
+{{tp|p=33711012|t=2021. Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen.|pdf=|usr=026}}
+{{tp|p=33730053|t=2021. SARS-CoV-2 viral dynamics in non-human primates.|pdf=|usr=026}}
+{{tp|p=33534793|t=2021. ViralLink: An integrated workflow to investigate the effect of SARS-CoV-2 on intracellular signalling and regulatory pathways.|pdf=|usr=026}}
+{{tp|p=33793546|t=2021. Computational epitope map of SARS-CoV-2 spike protein.|pdf=|usr=026}}
+{{tp|p=33770098|t=2021. Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel.|pdf=|usr=026}}
+{{tp|p=33755704|t=2021. Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan.|pdf=|usr=026}}
+{{tp|p=33750984|t=2021. Antibody kinetics and clinical course of COVID-19 a prospective observational study.|pdf=|usr=026}}
+{{tp|p=33730017|t=2021. Structural analysis of viral ExoN domains reveals polyphyletic hijacking events.|pdf=|usr=026}}
+{{tp|p=33725024|t=2021. Variability in digestive and respiratory tract Ace2 expression is associated with the microbiome.|pdf=|usr=026}}
+{{tp|p=33662015|t=2021. Genomic characterization and evolution of SARS-CoV-2 of a Canadian population.|pdf=|usr=026}}
+{{tp|p=33661923|t=2021. Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.|pdf=|usr=026}}
+{{tp|p=33685917|t=2021. The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13.|pdf=|usr=026}}
+{{tp|p=33727331|t=2021. Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.|pdf=|usr=026}}
+{{tp|p=33649194|t=2021. Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.|pdf=|usr=026}}
+{{tp|p=33637603|t=2021. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.|pdf=|usr=026}}
+{{tp|p=33619452|t=2021. Rare mutations in the accessory proteins ORF6, ORF7b, and ORF10 of the SARS-CoV-2 genomes.|pdf=|usr=026}}
+{{tp|p=33662365|t=2021. The serum metabolome of COVID-19 patients is distinctive and predictive.|pdf=|usr=026}}
+{{tp|p=33631142|t=2021. Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study.|pdf=|usr=026}}
+{{tp|p=33548252|t=2021. COVID-19 letter to the editor: Epicardial fat inflammation as possible enhancer in COVID-19?|pdf=|usr=026}}
+{{tp|p=33750009|t=2021. COVID-19: emergence and mutational diversification of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33727169|t=2021. Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus.|pdf=|usr=026}}
+{{tp|p=33691172|t=2021. Contribution of STAT3 to the pathogenesis of COVID-19.|pdf=|usr=026}}
+{{tp|p=33609650|t=2021. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?|pdf=|usr=026}}
+{{tp|p=33588026|t=2021. Variant analysis of SARS-CoV-2 genomes in the Middle East.|pdf=|usr=026}}
+{{tp|p=33548481|t=2021. Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients.|pdf=|usr=026}}
+{{tp|p=33664151|t=2021. Identification of a SARS-CoV-2 Lineage B1.1.7 Virus in New York following Return Travel from the United Kingdom.|pdf=|usr=026}}
+{{tp|p=33766902|t=2021. Genome Sequences of Three SARS-CoV-2 P.1 Strains Identified from Patients Returning from Brazil to Italy.|pdf=|usr=026}}
+{{tp|p=33766897|t=2021. Near-Complete Genome Sequence of a SARS-CoV-2 VOC 202012/01 Strain in Peru.|pdf=|usr=026}}
+{{tp|p=33737349|t=2021. First Report of a SARS-CoV-2 Genome Sequence with a Spike His69-Val70 Deletion and an Asn439Lys Mutation in Morocco.|pdf=|usr=026}}
+{{tp|p=33707329|t=2021. Coding-Complete Genome Sequences and Mutation Profiles of Nine SARS-CoV-2 Strains Detected from COVID-19 Patients in Bangladesh.|pdf=|usr=026}}
+{{tp|p=33707325|t=2021. Coding-Complete Genome Sequence and Phylogenetic Relatedness of a SARS-CoV-2 Strain Detected in March 2020 in Cameroon.|pdf=|usr=026}}
+{{tp|p=33632859|t=2021. In-Frame 12-Nucleotide Deletion within Open Reading Frame 3a in a SARS-CoV-2 Strain Isolated from a Patient Hospitalized with COVID-19.|pdf=|usr=026}}
+{{tp|p=33632858|t=2021. Genome Sequence of a SARS-CoV-2 Strain from Bangladesh That Is Nearly Identical to United Kingdom SARS-CoV-2 Variant B.1.1.7.|pdf=|usr=026}}
+{{tp|p=33574104|t=2021. Coding-Complete Genome Sequences of NITMA1086 and NITMA1139, Two SARS-CoV-2 Isolates from Belagavi District, Karnataka State, India, Harboring the D614G Mutation.|pdf=|usr=026}}
+{{tp|p=33562210|t=2021. Silence of the Lambs: The Immunological and Molecular Mechanisms of COVID-19 in Children in Comparison with Adults.|pdf=|usr=026}}
+{{tp|p=33652815|t=2021. SARS-CoV-2 Nonstructural Proteins 1 and 13 Suppress Caspase-1 and the NLRP3 Inflammasome Activation.|pdf=|usr=026}}
+{{tp|p=33671631|t=2021. Genomic Epidemiology of SARS-CoV-2 in Madrid, Spain, during the First Wave of the Pandemic: Fast Spread and Early Dominance by D614G Variants.|pdf=|usr=026}}
+{{tp|p=33540596|t=2021. Dynamics of a Dual SARS-CoV-2 Lineage Co-Infection on a Prolonged Viral Shedding COVID-19 Case: Insights into Clinical Severity and Disease Duration.|pdf=|usr=026}}
+{{tp|p=33609027|t=2021. Whole-genome Sequencing of SARS-CoV-2: Using Phylogeny and Structural Modeling to Contextualize Local Viral Evolution.|pdf=|usr=026}}
+{{tp|p=33709674|t=2021. Can natural immunity partially replace vaccine against SARS-COV2 infection? A small single center study.|pdf=|usr=026}}
+{{tp|p=33705368|t=2021. Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021.|pdf=|usr=026}}
+{{tp|p=33705367|t=2021. First Identified Cases of SARS-CoV-2 Variant P.1 in the United States - Minnesota, January 2021.|pdf=|usr=026}}
+{{tp|p=33630825|t=2021. First Identified Cases of SARS-CoV-2 Variant B.1.1.7 in Minnesota - December 2020-January 2021.|pdf=|usr=026}}
+{{tp|p=33630820|t=2021. Detection of B.1.351 SARS-CoV-2 Variant Strain - Zambia, December 2020.|pdf=|usr=026}}
+{{tp|p=33605421|t=2021. Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33555346|t=2021. The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33674876|t=2021. Identifying primate ACE2 variants that confer resistance to SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33713597|t=2021. The SARS-CoV-2 subgenome landscape and its novel regulatory features.|pdf=|usr=026}}
+{{tp|p=33564990|t=2021. Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis.|pdf=|usr=026}}
+{{tp|p=33745077|t=2021. Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs.|pdf=|usr=026}}
+{{tp|p=33740184|t=2021. Possible role of purinergic signaling in COVID-19.|pdf=|usr=026}}
+{{tp|p=33781838|t=2021. Emerging importance of ACE2 in external stratified epithelial tissues.|pdf=|usr=026}}
+{{tp|p=33743061|t=2021. Host-dependent molecular factors mediating SARS-CoV-2 infection to gain clinical insights for developing effective targeted therapy.|pdf=|usr=026}}
+{{tp|p=33590968|t=2021. SARS-CoV-2 infection remodels the host protein thermal stability landscape.|pdf=|usr=026}}
+{{tp|p=33578036|t=2021. Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.|pdf=|usr=026}}
+{{tp|p=33686311|t=2021. PIMS - eine neue padiatrische Herausforderung: 9-Jahre alter Knabe mit SARS-CoV-2 assoziiertem hyperinflammatorischem Schocksyndrom.|pdf=|usr=026}}
+{{tp|p=33816662|t=2021. Severe Acute Respiratory Syndrome Coronavirus 2, Olfactory Mucosa, and the Entrance in the Central Nervous System: Expanding the Evidence?|pdf=|usr=026}}
+{{tp|p=33619443|t=2021. Supervised machine learning approach to molecular dynamics forecast of SARS-CoV-2 spike glycoproteins at varying temperatures.|pdf=|usr=026}}
+{{tp|p=33789940|t=2021. Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.|pdf=|usr=026}}
+{{tp|p=33692194|t=2021. Original Antigenic Sin: the Downside of Immunological Memory and Implications for COVID-19.|pdf=|usr=026}}
+{{tp|p=33627511|t=2021. Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33597174|t=2021. Why Are Viruses Spiked?|pdf=|usr=026}}
+{{tp|p=33568452|t=2021. Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup.|pdf=|usr=026}}
+{{tp|p=33622851|t=2021. Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33608656|t=2021. COVID-19-from mucosal immunology to IBD patients.|pdf=|usr=026}}
+{{tp|p=33526920|t=2021. Myeloid-derived suppressor cells in the era of incre<iframe src="http://www.kidney.de/amapp.php?a=g myeloid cell diversity.|pdf=|usr=026}}
+{{tp|p=33723416|t=2021. The first 12 months of COVID-19: a timeline of immunological insights.|pdf=|usr=026}}
+{{tp|p=33753932|t=2021. Transmissibility and transmission of respiratory viruses.|pdf=|usr=026}}
+{{tp|p=33758362|t=2021. Soluble ACE2 in SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33762726|t=2021. Neuroimmune interactions and COVID-19 in lung transplant recipients.|pdf=|usr=026}}
+{{tp|p=33762725|t=2021. Reply to: Neuroimmune interactions and COVID-19 in lung transplant recipients.|pdf=|usr=026}}
+{{tp|p=33547426|t=2021. Immune cartography of macrophage activation syndrome in the COVID-19 era.|pdf=|usr=026}}
+{{tp|p=33609131|t=2021. The humoral immune response to SARS-CoV-2 mounts and is durable in symptomatic haemodialysis patients.|pdf=|usr=026}}
+{{tp|p=33720379|t=2021. Persistence of antibody response to SARS-CoV-2 in a cohort of haemodialysis patients with COVID-19.|pdf=|usr=026}}
+{{tp|p=33680474|t=2021. Severe acute respiratory syndrome coronavirus 2 may exploit human transcription factors involved in retinoic acid and interferon-mediated response: a hypothesis supported by an in silico analysis.|pdf=|usr=026}}
+{{tp|p=33540664|t=2021. miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells.|pdf=|usr=026}}
+{{tp|p=33670580|t=2021. MicroRNAs and Long Non-Coding RNAs as Potential Candidates to Target Specific Motifs of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33545540|t=2021. SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link?|pdf=|usr=026}}
+{{tp|p=33569904|t=2021. Amino acid sensing pathway: A major check point in the pathogenesis of obesity and COVID-19.|pdf=|usr=026}}
+{{tp|p=33543899|t=2021. Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)-Related Morbidity.|pdf=|usr=026}}
+{{tp|p=33542096|t=2021. Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy.|pdf=|usr=026}}
+{{tp|p=33768966|t=2021. Implications of the Emerging SARS-CoV-2 Variant: Caution is the Key.|pdf=|usr=026}}
+{{tp|p=33778091|t=2021. Cutaneous Findings in SARS-CoV-2-Associated Multisystem Inflammatory Disease in Children.|pdf=|usr=026}}
+{{tp|p=33778090|t=2021. Dysregulated Host Response in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Critical Illness.|pdf=|usr=026}}
+{{tp|p=33614814|t=2021. SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response.|pdf=|usr=026}}
+{{tp|p=33604403|t=2021. Prevalence and Longevity of SARS-CoV-2 Antibodies Among Health Care Workers.|pdf=|usr=026}}
+{{tp|p=33527081|t=2020. Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding Profile From Different Body Sites, and Antibody Response Kinetics.|pdf=|usr=026}}
+{{tp|p=33659153|t=2021. Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020.|pdf=|usr=026}}
+{{tp|p=33738456|t=2021. The role of pseudotype neutralization assays in understanding SARS CoV-2.|pdf=|usr=026}}
+{{tp|p=33585820|t=2021. Mucosal immune responses in COVID19 - a living review.|pdf=|usr=026}}
+{{tp|p=33575657|t=2021. T cell phenotypes in COVID-19 - a living review.|pdf=|usr=026}}
+{{tp|p=33815663|t=2021. HIF-1, the Warburg Effect, and Macrophage/Microglia Polarization Potential Role in COVID-19 Pathogenesis.|pdf=|usr=026}}
+{{tp|p=33691013|t=2021. Protein sequence models for prediction and comparative analysis of the SARS-CoV-2 -human interactome.|pdf=|usr=026}}
+{{tp|p=33631039|t=2021. Postoperative inflammation to "hyper"-inflammation: cryptic COVID-19 connections!|pdf=|usr=026}}
+{{tp|p=33654512|t=2020. In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data.|pdf=|usr=026}}
+{{tp|p=33706759|t=2021. Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19.|pdf=|usr=026}}
+{{tp|p=33572190|t=2021. Molecular Epidemiology Surveillance of SARS-CoV-2: Mutations and Genetic Diversity One Year after Emerging.|pdf=|usr=026}}
+{{tp|p=33561763|t=2021. Fibroblast function in COVID-19.|pdf=|usr=026}}
+{{tp|p=33676105|t=2021. Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: Case report and review of the literature.|pdf=|usr=026}}
+{{tp|p=33817672|t=2021. Network-based virus-host interaction prediction with application to SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33661546|t=2021. SARS-CoV-2-related multisystem inflammatory syndrome in an immunocompromised child with leukemia.|pdf=|usr=026}}
+{{tp|p=33547936|t=2021. Coronary Artery Dilation in an Asymptomatic Pediatric Patient with COVID19 Antibodies.|pdf=|usr=026}}
+{{tp|p=33551363|t=2021. Critical illness-associated brain microhemorrhages in a child with multisystem inflammatory syndrome secondary to coronavirus disease 2019.|pdf=|usr=026}}
+{{tp|p=33595703|t=2021. Imaging in support of the clinical diagnoses of COVID-19 and multisystem inflammatory syndrome in children.|pdf=|usr=026}}
+{{tp|p=33534852|t=2021. Uncovering potential host proteins and pathways that may interact with eukaryotic short linear motifs in viral proteins of MERS, SARS and SARS2 coronaviruses that infect humans.|pdf=|usr=026}}
+{{tp|p=33529260|t=2021. Clinical and whole genome characterization of SARS-CoV-2 in India.|pdf=|usr=026}}
+{{tp|p=33428634|t=2021. Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.|pdf=|usr=026}}
+{{tp|p=33780519|t=2021. Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19.|pdf=|usr=026}}
+{{tp|p=33760889|t=2021. Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry.|pdf=|usr=026}}
+{{tp|p=33635931|t=2021. Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication.|pdf=|usr=026}}
+{{tp|p=33635919|t=2021. Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.|pdf=|usr=026}}
+{{tp|p=33600486|t=2021. Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes.|pdf=|usr=026}}
+{{tp|p=33596266|t=2021. SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development.|pdf=|usr=026}}
+{{tp|p=33556147|t=2021. Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins.|pdf=|usr=026}}
+{{tp|p=33579792|t=2021. The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33571544|t=2021. Dissecting lipid metabolism alterations in SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33584087|t=2021. Cardiac Manifestations, Treatment Characteristics, and Outcomes of Paediatric Inflammatory Multisystem Syndrome Temporally Associated with Severe Acute Respiratory Syndrome Coronavirus-2: systematic review of case reports and case series.|pdf=|usr=026}}
+{{tp|p=33592322|t=2021. Role of arachidonic cascade in COVID-19 infection: A review.|pdf=|usr=026}}
+{{tp|p=33629236|t=2021. A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2.|pdf=|usr=026}}
+{{tp|p=33625752|t=2021. Crystallographic molecular replacement using an in silico-generated search model of SARS-CoV-2 ORF8.|pdf=|usr=026}}
+{{tp|p=33594727|t=2021. Nonstructural protein 7 and 8 complexes of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33778663|t=2021. A Novel Large-Vessel Arteritis in SARS-CoV-2-Related Multisystem Inflammatory Syndrome in Children (MIS-C).|pdf=|usr=026}}
+{{tp|p=33778614|t=2020. Thoracic Imaging Findings of Multisystem Inflammatory Syndrome in Children Associated with COVID-19: What Radiologists Need to Know Now.|pdf=|usr=026}}
+{{tp|p=33785227|t=2021. Revision de los hallazgos clinicos y radiologicos del nuevo sindrome inflamatorio multisistemico pediatrico vinculado a la COVID-19.|pdf=|usr=026}}
+{{tp|p=33662873|t=2021. The age-dependent decline of the extracellular thiol-disulfide balance and its role in SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33719897|t=2021. Post COVID 19 multisystem inflammatory syndrome in an older adult.|pdf=|usr=026}}
+{{tp|p=33749660|t=2021. Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore-Washington metropolitan area.|pdf=|usr=026}}
+{{tp|p=33621211|t=2021. Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33651717|t=2021. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury.|pdf=|usr=026}}
+{{tp|p=33720905|t=2021. A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33575504|t=2021. Valuable Insights into the Immune Responses against Coronavirus Disease 2019.|pdf=|usr=026}}
+{{tp|p=33575497|t=2021. The Neutralizing Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 and the Cytokine/Chemokine Release in Patients with Different Levels of Coronavirus Diseases 2019 Severity: Cytokine Storm Still Persists Despite Viral Disappearance in Critical Patients.|pdf=|usr=026}}
+{{tp|p=33711083|t=2020. A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study.|pdf=|usr=026}}
+{{tp|p=33790073|t=2021. Assessment of Galectin-1, Galectin-3, and PGE2 Levels in Patients with COVID-19.|pdf=|usr=026}}
+{{tp|p=33642431|t=2021. Early anti-SARS-CoV-2 immunoglobulin G response may be associated with disease severity in patients with COVID-19.|pdf=|usr=026}}
+{{tp|p=33774082|t=2021. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection.|pdf=|usr=026}}
+{{tp|p=33743869|t=2021. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.|pdf=|usr=026}}
+{{tp|p=33743854|t=2021. Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33705696|t=2021. (18)F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine.|pdf=|usr=026}}
+{{tp|p=33581803|t=2021. SARS-CoV-2 variants and ending the COVID-19 pandemic.|pdf=|usr=026}}
+{{tp|p=33549181|t=2021. Understanding variants of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33765408|t=2021. Rapid identification and tracking of SARS-CoV-2 variants of concern.|pdf=|usr=026}}
+{{tp|p=33711293|t=2021. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study.|pdf=|usr=026}}
+{{tp|p=33675696|t=2021. Multisystem inflammatory syndrome in a neonate, temporally associated with prenatal exposure to SARS-CoV-2: a case report.|pdf=|usr=026}}
+{{tp|p=33581054|t=2021. Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people.|pdf=|usr=026}}
+{{tp|p=33571446|t=2021. CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants.|pdf=|usr=026}}
+{{tp|p=33723535|t=2021. Surveillance of SARS-CoV-2 in Zimbabwe shows dominance of variants of concern.|pdf=|usr=026}}
+{{tp|p=33778792|t=2021. Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study.|pdf=|usr=026}}
+{{tp|p=33655232|t=2021. Neutrophils as a pallbearer for SARS-CoV-2 disease burden - Authors' reply.|pdf=|usr=026}}
+{{tp|p=33655231|t=2021. Neutrophils as a pallbearer for SARS-CoV-2 disease burden.|pdf=|usr=026}}
+{{tp|p=33655230|t=2021. COVID-19 cytokine storm syndrome: a threshold concept.|pdf=|usr=026}}
+{{tp|p=33754142|t=2021. Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?|pdf=|usr=026}}
+{{tp|p=33562321|t=2021. Population Genomics Insights into the First Wave of COVID-19.|pdf=|usr=026}}
+{{tp|p=33609539|t=2021. A double edged-sword - The Complement System during SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33727249|t=2021. Phylo-geo-network and haplogroup analysis of 611 novel coronavirus (SARS-CoV-2) genomes from India.|pdf=|usr=026}}
+{{tp|p=33574037|t=2021. SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters.|pdf=|usr=026}}
+{{tp|p=33679227|t=2021. Post-COVID-19 Outbreak of Severe Kawasaki-like Multisystem Inflammatory Syndrome in Children.|pdf=|usr=026}}
+{{tp|p=33680867|t=2021. COVID-19 Outbreak in Malaysia: Decoding D614G Mutation of SARS-CoV-2 Virus Isolated from an Asymptomatic Case in Pahang.|pdf=|usr=026}}
+{{tp|p=33715846|t=2021. The Yin and Yang of SARS-CoV-2 Mutation and Evolution.|pdf=|usr=026}}
+{{tp|p=33727353|t=2021. Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication.|pdf=|usr=026}}
+{{tp|p=33727347|t=2021. Mechanism of Viral Glycoprotein Targeting by Membrane-Associated RING-CH Proteins.|pdf=|usr=026}}
+{{tp|p=33589885|t=2021. Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.|pdf=|usr=026}}
+{{tp|p=33554155|t=2021. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes.|pdf=|usr=026}}
+{{tp|p=33649749|t=2021. Deadly COVID-19 among the elderly: Innate immune memory helping those most in need.|pdf=|usr=026}}
+{{tp|p=33681755|t=2021. The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant.|pdf=|usr=026}}
+{{tp|p=33657459|t=2021. COVID-19: A methyl-group assault?|pdf=|usr=026}}
+{{tp|p=33761694|t=2021. Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach.|pdf=|usr=026}}
+{{tp|p=33607766|t=2021. Novel signaling pathways regulate SARS-CoV and SARS-CoV-2 infectious disease.|pdf=|usr=026}}
+{{tp|p=33747404|t=2021. First Tunisian Cluster Admissions of Critically Ill Patients with Multisystem Inflammatory Syndrome in Children (MIS-C).|pdf=|usr=026}}
+{{tp|p=33747397|t=2021. Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options.|pdf=|usr=026}}
+{{tp|p=33630927|t=2021. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.|pdf=|usr=026}}
+{{tp|p=33606828|t=2021. SARS-CoV-2 genetic diversity in Venezuela: Predominance of D614G variants and analysis of one outbreak.|pdf=|usr=026}}
+{{tp|p=33606823|t=2021. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.|pdf=|usr=026}}
+{{tp|p=33596252|t=2021. The analysis on the human protein domain targets and host-like interacting motifs for the MERS-CoV and SARS-CoV/CoV-2 infers the molecular mimicry of coronavirus.|pdf=|usr=026}}
+{{tp|p=33592054|t=2021. Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation.|pdf=|usr=026}}
+{{tp|p=33571241|t=2021. In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses.|pdf=|usr=026}}
+{{tp|p=33544733|t=2021. Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan.|pdf=|usr=026}}
+{{tp|p=33680800|t=2021. Cytokine profiles in severe SARS-CoV-2 infection requiring extracorporeal membrane oxygenation support.|pdf=|usr=026}}
+{{tp|p=33728718|t=2021. Gateway to the lungs: Viral entry receptors and susceptibility to COVID-19.|pdf=|usr=026}}
+{{tp|p=33707796|t=2021. A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children - literature review based on two case reports.|pdf=|usr=026}}
+{{tp|p=33759933|t=2021. Children's Multisystem inflammatory syndrome with myopathy.|pdf=|usr=026}}
+{{tp|p=33742229|t=2021. Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent.|pdf=|usr=026}}
+{{tp|p=33790049|t=2021. COVID-19-induced hyperinflammation, immunosuppression, recovery and survival: how causal inference may help draw robust conclusions.|pdf=|usr=026}}
+{{tp|p=33552515|t=2021. Reviewing immunopathology characteristics of SARS-CoV-2 for cancer entwisted with SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33613046|t=2021. Durability of the humoral immune response in recovered COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33679194|t=2021. Molecular adaptive evolution of SARS-COV-2 spike protein in Saudi Arabia.|pdf=|usr=026}}
+{{tp|p=33674317|t=2021. Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution.|pdf=|usr=026}}
+{{tp|p=33658206|t=2021. Hallmarks of Alpha- and Betacoronavirus non-structural protein 7+8 complexes.|pdf=|usr=026}}
+{{tp|p=33579701|t=2021. Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile.|pdf=|usr=026}}
+{{tp|p=33547084|t=2021. Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression.|pdf=|usr=026}}
+{{tp|p=33536218|t=2021. A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood.|pdf=|usr=026}}
+{{tp|p=33585048|t=2021. Evolutionary analysis and lineage designation of SARS-CoV-2 genomes.|pdf=|usr=026}}
+{{tp|p=33587268|t=2021. Making sense of spike D614G in SARS-CoV-2 transmission.|pdf=|usr=026}}
+{{tp|p=33564978|t=2021. Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19.|pdf=|usr=026}}
+{{tp|p=33637768|t=2021. A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection.|pdf=|usr=026}}
+{{tp|p=33782449|t=2021. DNA methylation architecture of the ACE2 gene in nasal cells of children.|pdf=|usr=026}}
+{{tp|p=33767306|t=2021. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2.|pdf=|usr=026}}
+{{tp|p=33762651|t=2021. Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33758205|t=2021. Emergence of novel SARS-CoV-2 variants in the Netherlands.|pdf=|usr=026}}
+{{tp|p=33737694|t=2021. Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33737684|t=2021. Proteomic blood profiling in mild, severe and critical COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33727674|t=2021. Genomic investigation of the coronavirus disease-2019 outbreak in the Republic of Korea.|pdf=|usr=026}}
+{{tp|p=33723294|t=2021. SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals.|pdf=|usr=026}}
+{{tp|p=33692390|t=2021. Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities.|pdf=|usr=026}}
+{{tp|p=33649400|t=2021. Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient.|pdf=|usr=026}}
+{{tp|p=33542420|t=2021. Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans.|pdf=|usr=026}}
+{{tp|p=33536486|t=2021. Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19.|pdf=|usr=026}}
+{{tp|p=33637823|t=2021. Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses.|pdf=|usr=026}}
+{{tp|p=33637820|t=2021. Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19.|pdf=|usr=026}}
+{{tp|p=33633229|t=2021. Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population.|pdf=|usr=026}}
+{{tp|p=33633155|t=2021. Immunoinformatic based identification of cytotoxic T lymphocyte epitopes from the Indian isolate of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33633121|t=2021. Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients.|pdf=|usr=026}}
+{{tp|p=33623101|t=2021. Clinical correlates of anti-SARS-CoV-2 antibody profiles in Spanish COVID-19 patients from a high incidence region.|pdf=|usr=026}}
+{{tp|p=33619331|t=2021. Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2.|pdf=|usr=026}}
+{{tp|p=33531605|t=2021. Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan.|pdf=|usr=026}}
+{{tp|p=33608566|t=2021. Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community.|pdf=|usr=026}}
+{{tp|p=33608565|t=2021. Flexibility and mobility of SARS-CoV-2-related protein structures.|pdf=|usr=026}}
+{{tp|p=33602998|t=2021. Molecular features similarities between SARS-CoV-2, SARS, MERS and key human genes could favour the viral infections and trigger collateral effects.|pdf=|usr=026}}
+{{tp|p=33568776|t=2021. Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes.|pdf=|usr=026}}
+{{tp|p=33568759|t=2021. Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus).|pdf=|usr=026}}
+{{tp|p=33568715|t=2021. Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature.|pdf=|usr=026}}
+{{tp|p=33568700|t=2021. Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures.|pdf=|usr=026}}
+{{tp|p=33536258|t=2021. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.|pdf=|usr=026}}
+{{tp|p=33593674|t=2021. Mutaciones, variantes y cepas de SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33686064|t=2021. The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity.|pdf=|usr=026}}
+{{tp|p=33677468|t=2021. Dynamic blood single-cell immune responses in patients with COVID-19.|pdf=|usr=026}}
+{{tp|p=33790222|t=2021. Longitudinal dynamics of antibody responses in recovered COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33774649|t=2021. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development.|pdf=|usr=026}}
+{{tp|p=33758169|t=2021. The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33654054|t=2021. 'nAb' the self-reactive activity in the COVID-19 combat.|pdf=|usr=026}}
+{{tp|p=33723219|t=2021. Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins.|pdf=|usr=026}}
+{{tp|p=33707416|t=2021. SARS-CoV-2 non-structural protein 13 (nsp13) hijacks host deubiquitinase USP13 and counteracts host antiviral immune response.|pdf=|usr=026}}
+{{tp|p=33649313|t=2021. TMPRSS2 activity may mediate sex differences in COVID-19 severity.|pdf=|usr=026}}
+{{tp|p=33649300|t=2021. COVID-19: cross-immunity of viral epitopes may influence severity of infection and immune response.|pdf=|usr=026}}
+{{tp|p=33649299|t=2021. Mutation D614G increases SARS-CoV-2 transmission.|pdf=|usr=026}}
+{{tp|p=33649290|t=2021. D614G and SARS-CoV-2 replication fitness.|pdf=|usr=026}}
+{{tp|p=33637679|t=2021. SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies.|pdf=|usr=026}}
+{{tp|p=33786417|t=2021. Potential New Treatments for Kawasaki Disease, Its Variations, and Multisystem Inflammatory Syndrome.|pdf=|usr=026}}
+{{tp|p=33791293|t=2021. Coronavirus-Induced Host Cubic Membranes and Lipid-Related Antiviral Therapies: A Focus on Bioactive Plasmalogens.|pdf=|usr=026}}
+{{tp|p=33644077|t=2021. Mechanistic and Therapeutic Implications of Extracellular Vesicles as a Potential Link Between Covid-19 and Cardiovascular Disease Manifestations.|pdf=|usr=026}}
+{{tp|p=33816325|t=2021. Severe Acute Respiratory Syndrome Coronavirus 2 Viral RNA Load Status and Antibody Distribution Among Patients and Asymptomatic Carriers in Central China.|pdf=|usr=026}}
+{{tp|p=33791232|t=2021. Perspectives and Challenges in the Fight Against COVID-19: The Role of Genetic Variability.|pdf=|usr=026}}
+{{tp|p=33791231|t=2021. SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?|pdf=|usr=026}}
+{{tp|p=33777844|t=2021. Next-Generation Sequencing Reveals the Progression of COVID-19.|pdf=|usr=026}}
+{{tp|p=33732659|t=2021. Exogenous Coronavirus Interacts With Endogenous Retrotransposon in Human Cells.|pdf=|usr=026}}
+{{tp|p=33718270|t=2021. T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression.|pdf=|usr=026}}
+{{tp|p=33659220|t=2021. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?|pdf=|usr=026}}
+{{tp|p=33585285|t=2020. Unraveling the Interconnection Patterns Across Lung Microbiome, Respiratory Diseases, and COVID-19.|pdf=|usr=026}}
+{{tp|p=33815467|t=2021. Initial Insights Into the Genetic Epidemiology of SARS-CoV-2 Isolates From Kerala Suggest Local Spread From Limited Introductions.|pdf=|usr=026}}
+{{tp|p=33815459|t=2021. Genomic Variations in SARS-CoV-2 Genomes From Gujarat: Underlying Role of Variants in Disease Epidemiology.|pdf=|usr=026}}
+{{tp|p=33796130|t=2021. Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection.|pdf=|usr=026}}
+{{tp|p=33767730|t=2021. Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients.|pdf=|usr=026}}
+{{tp|p=33719350|t=2021. A Negative Feedback Model to Explain Regulation of SARS-CoV-2 Replication and Transcription.|pdf=|usr=026}}
+{{tp|p=33679887|t=2021. SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene.|pdf=|usr=026}}
+{{tp|p=33659022|t=2021. SARS CoV-2 Spike Protein in silico Interaction With ACE2 Receptors From Wild and Domestic Species.|pdf=|usr=026}}
+{{tp|p=33613621|t=2020. SARS-CoV-2 Genomes From Oklahoma, United States.|pdf=|usr=026}}
+{{tp|p=33815415|t=2021. Immunity to SARS-CoV-2: Lessons Learned.|pdf=|usr=026}}
+{{tp|p=33796097|t=2021. Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.|pdf=|usr=026}}
+{{tp|p=33790892|t=2021. Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China.|pdf=|usr=026}}
+{{tp|p=33777054|t=2021. T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19.|pdf=|usr=026}}
+{{tp|p=33777047|t=2021. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody.|pdf=|usr=026}}
+{{tp|p=33777028|t=2021. Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.|pdf=|usr=026}}
+{{tp|p=33777012|t=2021. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.|pdf=|usr=026}}
+{{tp|p=33763088|t=2021. Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.|pdf=|usr=026}}
+{{tp|p=33763085|t=2021. Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C).|pdf=|usr=026}}
+{{tp|p=33763078|t=2021. The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33746948|t=2021. Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19.|pdf=|usr=026}}
+{{tp|p=33732254|t=2021. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.|pdf=|usr=026}}
+{{tp|p=33732251|t=2021. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.|pdf=|usr=026}}
+{{tp|p=33717195|t=2021. COVID-19 Impairs Immune Response to Candida albicans.|pdf=|usr=026}}
+{{tp|p=33717193|t=2021. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies.|pdf=|usr=026}}
+{{tp|p=33717168|t=2021. Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19.|pdf=|usr=026}}
+{{tp|p=33717140|t=2021. Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33717074|t=2021. In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection.|pdf=|usr=026}}
+{{tp|p=33692788|t=2021. Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33692785|t=2021. Glycocalyx as Possible Limiting Factor in COVID-19.|pdf=|usr=026}}
+{{tp|p=33679778|t=2021. Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19.|pdf=|usr=026}}
+{{tp|p=33603759|t=2021. Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33597956|t=2021. Cytokine Storm as a Cellular Response to dsDNA Breaks: A New Proposal.|pdf=|usr=026}}
+{{tp|p=33613518|t=2020. Virus Infections and Host Metabolism-Can We Manage the Interactions?|pdf=|usr=026}}
+{{tp|p=33603755|t=2020. Legend of the Sentinels: Development of Lung Resident Memory T Cells and Their Roles in Diseases.|pdf=|usr=026}}
+{{tp|p=33584731|t=2020. Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses.|pdf=|usr=026}}
+{{tp|p=33584719|t=2020. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.|pdf=|usr=026}}
+{{tp|p=33584709|t=2020. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.|pdf=|usr=026}}
+{{tp|p=33584679|t=2020. COVID-19: Imbalanced Immune Responses and Potential Immunotherapies.|pdf=|usr=026}}
+{{tp|p=33584675|t=2020. Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?|pdf=|usr=026}}
+{{tp|p=33552069|t=2020. Delving Into the Origin of Destructive Inflammation in COVID-19: A Betrayal of Natural Host Defense Peptides?|pdf=|usr=026}}
+{{tp|p=33552062|t=2020. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.|pdf=|usr=026}}
+{{tp|p=33542724|t=2020. SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties.|pdf=|usr=026}}
+{{tp|p=33816516|t=2021. Detecting SARS-CoV-2 in the Breath of COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33777970|t=2021. Insights on the Structural Variations of the Furin-Like Cleavage Site Found Among the December 2019-July 2020 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection.|pdf=|usr=026}}
+{{tp|p=33768104|t=2021. Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India.|pdf=|usr=026}}
+{{tp|p=33585509|t=2020. Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study.|pdf=|usr=026}}
+{{tp|p=33585507|t=2020. Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33585502|t=2020. Structural Comparison of the SARS CoV 2 Spike Protein Relative to Other Human-Infecting Coronaviruses.|pdf=|usr=026}}
+{{tp|p=33807556|t=2021. Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level.|pdf=|usr=026}}
+{{tp|p=33809954|t=2021. Why Does SARS-CoV-2 Infection Induce Autoantibody Production?|pdf=|usr=026}}
+{{tp|p=33767074|t=2021. Association Between Treatments and Short-Term Biochemical Improvements and Clinical Outcomes in Post-Severe Acute Respiratory Syndrome Coronavirus-2 Inflammatory Syndrome.|pdf=|usr=026}}
+{{tp|p=33822809|t=2021. Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33811184|t=2021. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes.|pdf=|usr=026}}
+{{tp|p=33804408|t=2021. C1q Complement/Tumor Necrosis Factor-Associated Proteins in Cardiovascular Disease and COVID-19.|pdf=|usr=026}}
+{{tp|p=33633944|t=2021. Multisystem inflammatory syndrome in children during the coronavirus disease 2019 (COVID-19) pandemic: a systematic review of published case studies.|pdf=|usr=026}}
+{{tp|p=33684592|t=2021. COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?|pdf=|usr=026}}
+{{tp|p=33582244|t=2021. Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies.|pdf=|usr=026}}
+{{tp|p=33727176|t=2021. Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India.|pdf=|usr=026}}
+{{tp|p=33548551|t=2021. Evolution of SARS-CoV-2: A prediction on the lineages and vaccine effectiveness.|pdf=|usr=026}}
+{{tp|p=33622601|t=2021. Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation.|pdf=|usr=026}}
+{{tp|p=33597826|t=2021. Current mutatome of SARS-CoV-2 in Turkey reveals mutations of interest.|pdf=|usr=026}}
+{{tp|p=33640145|t=2021. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.|pdf=|usr=026}}
+{{tp|p=33744048|t=2021. Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers.|pdf=|usr=026}}
+{{tp|p=33572702|t=2021. Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review.|pdf=|usr=026}}
+{{tp|p=33661489|t=2021. Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months.|pdf=|usr=026}}
+{{tp|p=33560482|t=2021. Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study.|pdf=|usr=026}}
+{{tp|p=33582454|t=2021. Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33774551|t=2021. The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein.|pdf=|usr=026}}
+{{tp|p=33774510|t=2021. Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution.|pdf=|usr=026}}
+{{tp|p=33711560|t=2021. SARS_CoV2 RBD gene transcription cannot be driven by CMV promoter.|pdf=|usr=026}}
+{{tp|p=33706207|t=2021. Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India.|pdf=|usr=026}}
+{{tp|p=33545556|t=2021. Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution.|pdf=|usr=026}}
+{{tp|p=33757410|t=2021. Immune dysregulation and system pathology in COVID-19.|pdf=|usr=026}}
+{{tp|p=33738124|t=2021. SARS-CoV-2 genomic analyses in cancer patients reveal elevated intrahost genetic diversity.|pdf=|usr=026}}
+{{tp|p=33692906|t=2021. Unification and extensive diversification of M/Orf3-related ion channel proteins in coronaviruses and other nidoviruses.|pdf=|usr=026}}
+{{tp|p=33753180|t=2021. Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay.|pdf=|usr=026}}
+{{tp|p=33737154|t=2021. Global and local mutations in Bangladeshi SARS-CoV-2 genomes.|pdf=|usr=026}}
+{{tp|p=33781798|t=2021. Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism.|pdf=|usr=026}}
+{{tp|p=33631222|t=2021. Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil.|pdf=|usr=026}}
+{{tp|p=33626380|t=2021. The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta.|pdf=|usr=026}}
+{{tp|p=33723515|t=2021. Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus.|pdf=|usr=026}}
+{{tp|p=33530371|t=2021. Viral Evasion of RIG-I-Like Receptor-Mediated Immunity through Dysregulation of Ubiquitination and ISGylation.|pdf=|usr=026}}
+{{tp|p=33557213|t=2021. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.|pdf=|usr=026}}
+{{tp|p=33546489|t=2021. Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33671076|t=2021. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.|pdf=|usr=026}}
+{{tp|p=33652634|t=2021. The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses.|pdf=|usr=026}}
+{{tp|p=33669141|t=2021. Liquid Biomolecular Condensates and Viral Lifecycles: Review and Perspectives.|pdf=|usr=026}}
+{{tp|p=33673067|t=2021. Titers of Neutralizing Antibodies against SARS-CoV-2 Are Independent of Symptoms of Non-Severe COVID-19 in Young Adults.|pdf=|usr=026}}
+{{tp|p=33670182|t=2021. VOC 202012/01 Variant Is Effectively Neutralized by Antibodies Produced by Patients Infected before Its Diffusion in Italy.|pdf=|usr=026}}
+{{tp|p=33728295|t=2021. Regulation of the expression of proinflammatory cytokines induced by SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33728294|t=2021. Review of the risk factors for SARS-CoV-2 transmission.|pdf=|usr=026}}
+{{tp|p=33608839|t=2021. Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis.|pdf=|usr=026}}
+{{tp|p=33738989|t=2021. Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33537743|t=2021. SARS-CoV-2 RT-PCR profile in 298 Indian COVID-19 patients: a retrospective observational study.|pdf=|usr=026}}
+{{tp|p=33724541|t=2021. SARS-CoV-2-specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi-System Syndrome.|pdf=|usr=026}}
+{{tp|p=33651762|t=2021. Distinguishing Features of Patients Evaluated for Multisystem Inflammatory Syndrome in Children.|pdf=|usr=026}}
+{{tp|p=33635161|t=2021. Familial hemophagocytic lymphohistiocytosis induced by SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33591080|t=2021. Severe Foodborne Bacterial Infections Mimicking Multisystem Inflammatory Syndrome in Children Associated With COVID-19.|pdf=|usr=026}}
+{{tp|p=33565816|t=2021. Abnormal Nailfold Capillaroscopy in a Patient With Multisystem Inflammatory Syndrome in Children.|pdf=|usr=026}}
+{{tp|p=33710982|t=2021. Mistaken MIS-C: A Case Series of Bacterial Enteritis Mimicking MIS-C.|pdf=|usr=026}}
+{{tp|p=33813796|t=2021. Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors.|pdf=|usr=026}}
+{{tp|p=33786919|t=2021. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V.|pdf=|usr=026}}
+{{tp|p=33811468|t=2021. Resourcing, annotating, and analysing synthetic peptides of SARS-CoV-2 for immunopeptidomics and other immunological studies.|pdf=|usr=026}}
+{{tp|p=33582906|t=2021. Differences in Immune Responses between Children and Adults with COVID-19.|pdf=|usr=026}}
+{{tp|p=33582904|t=2021. Characteristics of Viral Shedding in Respiratory Samples and Specific Antibodies Production in 564 COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33582903|t=2021. Infection-associated Hemophagocytic Syndrome in Critically Ill Patients with COVID-19.|pdf=|usr=026}}
+{{tp|p=33688459|t=2021. Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients.|pdf=|usr=026}}
+{{tp|p=33608189|t=2021. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors.|pdf=|usr=026}}
+{{tp|p=33573850|t=2021. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved.|pdf=|usr=026}}
+{{tp|p=33563543|t=2021. Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity.|pdf=|usr=026}}
+{{tp|p=33547747|t=2021. Monocyte CD169 expression in COVID-19 patients upon intensive care unit admission.|pdf=|usr=026}}
+{{tp|p=33621488|t=2021. Autophagosome maturation stymied by SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33595856|t=2021. Genetic variation analyses indicate conserved SARS-CoV-2-host interaction and varied genetic adaptation in immune response factors in modern human evolution.|pdf=|usr=026}}
+{{tp|p=33668325|t=2021. Involvement of Oxidative Stress and the Innate Immune System in SARS-CoV-2 Infection.|pdf=|usr=026}}
+{{tp|p=33689070|t=2021. Novel Negative Sense Genes in the RNA Genome of Coronaviruses.|pdf=|usr=026}}
+{{tp|p=33706390|t=2021. Erste Falle des Multisystem Inflammatory Syndrome nach SARS-CoV-2-Infektion bei jungen Erwachsenen in Deutschland.|pdf=|usr=026}}
+{{tp|p=33765855|t=2021. Post-COVID-19 Kawasaki-Like Syndrome.|pdf=|usr=026}}
+{{tp|p=33530741|t=2021. Local Nasal Response Against COVID-19: Debate Regarding the Absence of Nasal Inflammatory Symptoms.|pdf=|usr=026}}
+{{tp|p=33571742|t=2021. COVID-19 and developmental origins of health and disease.|pdf=|usr=026}}
+{{tp|p=33691247|t=2021. Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution.|pdf=|usr=026}}
+{{tp|p=33662833|t=2021. Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARSCoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33530000|t=2021. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses.|pdf=|usr=026}}
+{{tp|p=33754139|t=2021. COVID-19 and the new variant strain in England - What are the implications for those from ethnic minority groups?|pdf=|usr=026}}
+{{tp|p=33589882|t=2021. Antibody titers against SARS-CoV-2 decline, but do not disappear for several months.|pdf=|usr=026}}
+{{tp|p=33533060|t=2021. Isoelectric point determination by imaged CIEF of commercially available SARS-CoV-2 proteins and the hACE2 receptor.|pdf=|usr=026}}
+{{tp|p=33752797|t=2021. Rare variants increase the risk of severe COVID-19.|pdf=|usr=026}}
+{{tp|p=33650490|t=2021. Genomic epidemiology of COVID-19 in care homes in the east of England.|pdf=|usr=026}}
+{{tp|p=33724185|t=2021. Seroconversion stages COVID19 into distinct pathophysiological states.|pdf=|usr=026}}
+{{tp|p=33554856|t=2021. SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.|pdf=|usr=026}}
+{{tp|p=33570490|t=2021. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.|pdf=|usr=026}}
+{{tp|p=33544398|t=2021. Epithelial response to IFN-gamma promotes SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33769253|t=2021. Detecting Rapid Spread of SARS-CoV-2 Variants, France, January 26-February 16, 2021.|pdf=|usr=026}}
+{{tp|p=33760727|t=2021. Risk for International Importations of Variant SARS-CoV-2 Originating in the United Kingdom.|pdf=|usr=026}}
+{{tp|p=33760725|t=2021. Multisystem Inflammatory Syndrome in Children, Chile, May-August 2020.|pdf=|usr=026}}
+{{tp|p=33647228|t=2021. Novel Mutation of SARS-CoV-2, Vietnam, July 2020.|pdf=|usr=026}}
+{{tp|p=33784237|t=2021. Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada.|pdf=|usr=026}}
+{{tp|p=33734962|t=2021. Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK.|pdf=|usr=026}}
+{{tp|p=33600302|t=2021. Difficulties in Differentiating Coronaviruses from Subcellular Structures in Human Tissues by Electron Microscopy.|pdf=|usr=026}}
+{{tp|p=33567247|t=2021. Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan.|pdf=|usr=026}}
+{{tp|p=33567246|t=2021. Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy.|pdf=|usr=026}}
+{{tp|p=33539720|t=2021. Surveillance of COVID-19-Associated Multisystem Inflammatory Syndrome in Children, South Korea.|pdf=|usr=026}}
+{{tp|p=33739917|t=2021. Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy.|pdf=|usr=026}}
+{{tp|p=33734013|t=2021. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.|pdf=|usr=026}}
+{{tp|p=33525998|t=2021. Isolation of SARS-CoV-2 strains carrying a nucleotide mutation, leading to a stop codon in the ORF 6 protein.|pdf=|usr=026}}
+{{tp|p=33554871|t=2021. The Impact of COVID-19 Viral Infection on the Hypothalamic-Pituitary-Adrenal Axis.|pdf=|usr=026}}
+{{tp|p=33685741|t=2021. First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant.|pdf=|usr=026}}
+{{tp|p=33566596|t=2021. Optical Tracking of the Interfacial Dynamics of Single SARS-CoV-2 Pseudoviruses.|pdf=|usr=026}}
+{{tp|p=33685230|t=2021. An immune epigenetic insight to COVID-19 infection.|pdf=|usr=026}}
+{{tp|p=33663644|t=2021. Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.|pdf=|usr=026}}
+{{tp|p=33795929|t=2021. The Functional Classification of ORF8 in SARS-CoV-2 Replication, Immune Evasion, and Viral Pathogenesis Inferred through Phylogenetic Profiling.|pdf=|usr=026}}
+{{tp|p=33738101|t=2021. Let fever do its job: The meaning of fever in the pandemic era.|pdf=|usr=026}}
+{{tp|p=33732461|t=2021. Between a hygiene rock and a hygienic hard place: Avoiding SARS-CoV-2 while needing environmental exposures for immunity.|pdf=|usr=026}}
+{{tp|p=33564281|t=2021. Unraveled roles of hyaluronan in severe COVID-19.|pdf=|usr=026}}
+{{tp|p=33790994|t=2021. Severe acute respiratory syndrome coronavirus 2 ORF3a induces the expression of ACE2 in oral and pulmonary epithelial cells and the food supplement Vita Deyun((R)) diminishes this effect.|pdf=|usr=026}}
+{{tp|p=33718934|t=2021. Membrane remodeling by SARS-CoV-2 - double-enveloped viral replication.|pdf=|usr=026}}
+{{tp|p=33815307|t=2021. Genomic Feature Analysis of Betacoronavirus Provides Insights Into SARS and COVID-19 Pandemics.|pdf=|usr=026}}
+{{tp|p=33746914|t=2021. Global Geographic and Temporal Analysis of SARS-CoV-2 Haplotypes Normalized by COVID-19 Cases During the Pandemic.|pdf=|usr=026}}
+{{tp|p=33643275|t=2021. Low Levels of Natural Anti-alpha-N-Acetylgalactosamine (Tn) Antibodies Are Associated With COVID-19.|pdf=|usr=026}}
+{{tp|p=33679622|t=2020. Evolutionary Dynamics and Dissemination Pattern of the SARS-CoV-2 Lineage B.1.1.33 During the Early Pandemic Phase in Brazil.|pdf=|usr=026}}
+{{tp|p=33816549|t=2021. Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression.|pdf=|usr=026}}
+{{tp|p=33693030|t=2021. Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection.|pdf=|usr=026}}
+{{tp|p=33585567|t=2020. SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells.|pdf=|usr=026}}
+{{tp|p=33585558|t=2020. Characteristics of COVID-19 Patients Based on the Results of Nucleic Acid and Specific Antibodies and the Clinical Relevance of Antibody Levels.|pdf=|usr=026}}
+{{tp|p=33585554|t=2020. SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.|pdf=|usr=026}}
+{{tp|p=33537341|t=2020. Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line.|pdf=|usr=026}}
+{{tp|p=33551947|t=2020. The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains.|pdf=|usr=026}}
+{{tp|p=33816399|t=2021. Kawasaki Disease Shock Syndrome in Japan and Comparison With Multisystem Inflammatory Syndrome in Children in European countries.|pdf=|usr=026}}
+{{tp|p=33816398|t=2021. Characteristics of Children With Kawasaki Disease-Like Signs in COVID-19 Pandemic: A Systematic Review.|pdf=|usr=026}}
+{{tp|p=33537269|t=2020. Prevalence and Clinical Characteristics of SARS-CoV-2 Confirmed and Negative Kawasaki Disease Patients During the Pandemic in Spain.|pdf=|usr=026}}
+{{tp|p=33537261|t=2020. Cross-Immunization Against Respiratory Coronaviruses May Protect Children From SARS-CoV2: More Than a Simple Hypothesis?|pdf=|usr=026}}
+{{tp|p=33716737|t=2021. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19.|pdf=|usr=026}}
+{{tp|p=33633566|t=2020. Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches.|pdf=|usr=026}}
+{{tp|p=33613280|t=2020. Chemokine Regulation During Epidemic Coronavirus Infection.|pdf=|usr=026}}
+{{tp|p=33584267|t=2020. Nasal Delivery of Hesperidin/Chitosan Nanoparticles Suppresses Cytokine Storm Syndrome in a Mouse Model of Acute Lung Injury.|pdf=|usr=026}}
+{{tp|p=33755725|t=2021. Longitudinal Analysis of Human Memory T-Cell Response according to the Severity of Illness up to 8 Months after SARS-CoV-2 Infection.|pdf=|usr=026}}
+{{tp|p=33754149|t=2021. Human rhinovirus infection blocks SARS-CoV-2 replication within the respiratory epithelium: implications for COVID-19 epidemiology.|pdf=|usr=026}}
+{{tp|p=33822106|t=2021. Inflammatory profiles and clinical features of COVID-19 survivors three months after discharge in Wuhan, China.|pdf=|usr=026}}
+{{tp|p=33822097|t=2021. Differential T cell reactivity to endemic coronaviruses and SARS-CoV-2 in community and health care workers.|pdf=|usr=026}}
+{{tp|p=33822045|t=2021. IgG immune complexes may contribute to neutrophil activation in the course of severe COVID-19.|pdf=|usr=026}}
+{{tp|p=33813307|t=2021. A SARS-CoV-2 -human metalloproteome interaction map.|pdf=|usr=026}}
+{{tp|p=33725751|t=2021. Circular RNA-MicroRNA-MRNA interaction predictions in SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33721918|t=2021. Novel perspectives for SARS-CoV-2 genome browsing.|pdf=|usr=026}}
+{{tp|p=33726544|t=2021. COVID-19 hospitalization rates rise exponentially with age, inversely proportional to thymic T-cell production.|pdf=|usr=026}}
+{{tp|p=33593209|t=2021. Infection, inflammation and intervention: mechanistic modelling of epithelial cells in COVID-19.|pdf=|usr=026}}
+{{tp|p=33794925|t=2021. Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.|pdf=|usr=026}}
+{{tp|p=33763697|t=2021. Epidemiological, clinical and genomic snapshot of the first 100 B.1.1.7 SARS-CoV-2 cases in Madrid.|pdf=|usr=026}}
+{{tp|p=33787904|t=2021. Multisystem Inflammatory Syndrome in a Child with Scrub Typhus and Macrophage Activation Syndrome.|pdf=|usr=026}}
+{{tp|p=33608407|t=2021. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.|pdf=|usr=026}}
+{{tp|p=33822073|t=2021. COVID-19 Pandemic Sets New Clues on the Transmission Pathways in Kawasaki Disease.|pdf=|usr=026}}
+{{tp|p=33822065|t=2021. Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan.|pdf=|usr=026}}
+{{tp|p=33822777|t=2021. Natural mucosal barriers and COVID-19 in children.|pdf=|usr=026}}
+{{tp|p=33812491|t=2021. Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33799853|t=2021. Role of Mitochondria in Viral Infections.|pdf=|usr=026}}
+{{tp|p=33821250|t=2021. Alterations in T and B cell function persist in convalescent COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33558375|t=2021. T Cell Phenotyping in Individuals Hospitalized with COVID-19.|pdf=|usr=026}}
+{{tp|p=33535236|t=2021. Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.|pdf=|usr=026}}
+{{tp|p=33759207|t=2021. Monoclonal antibodies capable of binding SARS-CoV-2 spike protein receptor-binding motif specifically prevent GM-CSF induction.|pdf=|usr=026}}
+{{tp|p=33617048|t=2021. B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19.|pdf=|usr=026}}
+{{tp|p=33617030|t=2021. Flow cytometric evaluation of the neutrophil compartment in COVID-19 at hospital presentation: A normal response to an abnormal situation.|pdf=|usr=026}}
+{{tp|p=33725410|t=2021. Similarities and perspectives on the two C's-Cancer and COVID-19.|pdf=|usr=026}}
+{{tp|p=33789998|t=2021. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.|pdf=|usr=026}}
+{{tp|p=33627397|t=2021. Potential differences in cleavage of the S protein and type-1 interferon together control human coronavirus infection, propagation, and neuropathology within the central nervous system.|pdf=|usr=026}}
+{{tp|p=33625505|t=2021. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.|pdf=|usr=026}}
+{{tp|p=33595644|t=2021. SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.|pdf=|usr=026}}
+{{tp|p=33571363|t=2021. SARS-CoV-2 Viral Variants-Tackling a Moving Target.|pdf=|usr=026}}
+{{tp|p=33571356|t=2021. Emergence of a Novel SARS-CoV-2 Variant in Southern California.|pdf=|usr=026}}
+{{tp|p=33630068|t=2021. Otolaryngologic Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With COVID-19.|pdf=|usr=026}}
+{{tp|p=33821923|t=2021. Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic.|pdf=|usr=026}}
+{{tp|p=33753011|t=2021. Extracellular vesicles: Their emerging roles in the pathogenesis of respiratory diseases.|pdf=|usr=026}}
+{{tp|p=33689249|t=2021. Covid-19 et memoire immunologique : des donnees suggerent une protection durable et efficace.|pdf=|usr=026}}
+{{tp|p=33538145|t=2021. Covid 19 : caracteristiques et duree des reponses anticorps et leurs liens a la gravite de la maladie.|pdf=|usr=026}}
+{{tp|p=33724631|t=2021. Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.|pdf=|usr=026}}
+{{tp|p=33724604|t=2021. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.|pdf=|usr=026}}
+{{tp|p=33793006|t=2021. Features of HLA class I expression and its clinical relevance in SARS-CoV-2: What do we know so far?|pdf=|usr=026}}
+{{tp|p=33530819|t=2021. Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points.|pdf=|usr=026}}
+{{tp|p=33712145|t=2021. Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus.|pdf=|usr=026}}
+{{tp|p=33705542|t=2021. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.|pdf=|usr=026}}
+{{tp|p=33817452|t=2021. Echocardiographic clues in diagnosis of Takayasu arteritis in a child with SARS-CoV-2 related Multisystem Inflammatory Syndrome.|pdf=|usr=026}}
+{{tp|p=33532103|t=2021. COVID-19-Related Giant Coronary Aneurysms in an Infant with Multisystem Inflammatory Disorder in Children: The First Case Report from the United Arab Emirates and the Arab Region.|pdf=|usr=026}}
+{{tp|p=33815857|t=2021. A 6-Year-Old Boy with COVID-19-Positive Pleural Effusion and Kawasaki-Like Features.|pdf=|usr=026}}
+{{tp|p=33621484|t=2021. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.|pdf=|usr=026}}
+{{tp|p=33571429|t=2021. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.|pdf=|usr=026}}
+{{tp|p=33794143|t=2021. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.|pdf=|usr=026}}
+{{tp|p=33743211|t=2021. Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions.|pdf=|usr=026}}
+{{tp|p=33735608|t=2021. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.|pdf=|usr=026}}
+{{tp|p=33730597|t=2021. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.|pdf=|usr=026}}
+{{tp|p=33713620|t=2021. Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system.|pdf=|usr=026}}
+{{tp|p=33743212|t=2021. COVID-19 and the human innate immune system.|pdf=|usr=026}}
+{{tp|p=33713619|t=2021. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.|pdf=|usr=026}}
+{{tp|p=33657410|t=2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.|pdf=|usr=026}}
+{{tp|p=33636127|t=2021. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.|pdf=|usr=026}}
+{{tp|p=33631096|t=2021. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.|pdf=|usr=026}}
+{{tp|p=33664221|t=2021. Actively or passively deacidified lysosomes push beta-coronavirus egress.|pdf=|usr=026}}
+{{tp|p=33712574|t=2021. Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis.|pdf=|usr=026}}
+{{tp|p=33649297|t=2021. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes.|pdf=|usr=026}}
+{{tp|p=33758165|t=2021. SARS-CoV-2 cell tropism and multiorgan infection.|pdf=|usr=026}}
+{{tp|p=33705702|t=2021. The great escape? SARS-CoV-2 variants evading neutralizing responses.|pdf=|usr=026}}
+{{tp|p=33548198|t=2021. Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response.|pdf=|usr=026}}
+{{tp|p=33789086|t=2021. The variant gambit: COVID-19's next move.|pdf=|usr=026}}
+{{tp|p=33742186|t=2021. Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm.|pdf=|usr=026}}
+{{tp|p=33637960|t=2021. Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33637958|t=2021. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.|pdf=|usr=026}}
+{{tp|p=33580167|t=2021. Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques.|pdf=|usr=026}}
+{{tp|p=33715015|t=2021. High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients.|pdf=|usr=026}}
+{{tp|p=33789116|t=2021. Cell-type-specific immune dysregulation in severely ill COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33735881|t=2021. SARS-CoV-2 Lineages and Sub-Lineages Circulating Worldwide: A Dynamic Overview.|pdf=|usr=026}}
+{{tp|p=33609517|t=2021. Immunological Subpopulations Within Critically Ill COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33405941|t=2021. Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells.|pdf=|usr=026}}
+{{tp|p=33649742|t=2021. Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children Using Strain Analysis.|pdf=|usr=026}}
+{{tp|p=33720347|t=2021. Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results.|pdf=|usr=026}}
+{{tp|p=33639119|t=2021. Lipid metabolism changes in patients with severe COVID-19.|pdf=|usr=026}}
+{{tp|p=33741357|t=2021. Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.|pdf=|usr=026}}
+{{tp|p=33534923|t=2021. Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.|pdf=|usr=026}}
+{{tp|p=33677852|t=2021. Is multisystem inflammatory syndrome related with coronavirus disease 2019, Kawasaki disease, and angiotensin-converting enzyme 2 in children?|pdf=|usr=026}}
+{{tp|p=33565127|t=2021. Role of the SphK-S1P-S1PRs pathway in invasion of the nervous system by SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33774179|t=2021. Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19.|pdf=|usr=026}}
+{{tp|p=33662591|t=2021. Can we define CD3(+)CD56(+) cells as NKT cells with impunity?|pdf=|usr=026}}
+{{tp|p=33639276|t=2021. The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33610741|t=2021. Coronavirus-induced autoimmunity.|pdf=|usr=026}}
+{{tp|p=33601017|t=2021. Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort.|pdf=|usr=026}}
+{{tp|p=33693643|t=2021. Estimated half-life of SARS-CoV-2 anti-spike antibodies more than double the half-life of anti-nucleocapsid antibodies in healthcare workers.|pdf=|usr=026}}
+{{tp|p=33675655|t=2021. Emergence of a Severe Acute Respiratory Syndrome Coronavirus 2 virus variant with novel genomic architecture in Hong Kong.|pdf=|usr=026}}
+{{tp|p=33730754|t=2021. Antibody Dynamics, Seroreversion, and Persistence After SARS-CoV-2: Another Answer.|pdf=|usr=026}}
+{{tp|p=33624751|t=2021. Persistence of antibodies to SARS-CoV-2 in relation to symptoms in a nationwide prospective study.|pdf=|usr=026}}
+{{tp|p=33596592|t=2021. Plasma metabolomic profiling of patients recovered from COVID-19 with pulmonary sequelae 3 months after discharge.|pdf=|usr=026}}
+{{tp|p=33794345|t=2021. Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations.|pdf=|usr=026}}
+{{tp|p=33631334|t=2021. Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19.|pdf=|usr=026}}
+{{tp|p=33716189|t=2021. Acute liver and cardiac failure in multisystem inflammatory syndrome in adults after COVID-19.|pdf=|usr=026}}
+{{tp|p=33576926|t=2021. Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean.|pdf=|usr=026}}
+{{tp|p=33747512|t=2021. Adaptive immunity to human coronaviruses is widespread but low in magnitude.|pdf=|usr=026}}
+{{tp|p=33747511|t=2021. Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand.|pdf=|usr=026}}
+{{tp|p=33747508|t=2021. RGD-binding integrins and TGF-beta in SARS-CoV-2 infections - novel targets to treat COVID-19 patients?|pdf=|usr=026}}
+{{tp|p=33728049|t=2021. Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity - a cohort study.|pdf=|usr=026}}
+{{tp|p=33628442|t=2021. Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant.|pdf=|usr=026}}
+{{tp|p=33614032|t=2021. High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responses.|pdf=|usr=026}}
+{{tp|p=33552508|t=2021. Pattern of circulating SARS-CoV-2-specific antibody-secreting and memory B-cell generation in patients with acute COVID-19.|pdf=|usr=026}}
+{{tp|p=33784011|t=2021. Distinct kinetics of immunoglobulin isotypes reveal early diagnosis and disease severity of COVID-19: A 6-month follow-up.|pdf=|usr=026}}
+{{tp|p=33634992|t=2021. SARS-CoV-2-related IFITM3 in immune dysfunction and tumor microenvironment: An integrative analysis in pan-cancers.|pdf=|usr=026}}
+{{tp|p=33667185|t=2021. What's important to know about the new COVID-19 variants?|pdf=|usr=026}}
+{{tp|p=33593727|t=2021. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?|pdf=|usr=026}}
+{{tp|p=33674719|t=2021. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33589648|t=2021. Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants.|pdf=|usr=026}}
+{{tp|p=33580175|t=2021. Immunoreactive peptide maps of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33647832|t=2021. UMAP-assisted K-means clustering of large-scale SARS-CoV-2 mutation datasets.|pdf=|usr=026}}
+{{tp|p=33815686|t=2021. Neuropilins: C-end rule peptides and their association with nociception and COVID-19.|pdf=|usr=026}}
+{{tp|p=33777333|t=2021. Specific epitopes form extensive hydrogen-bonding networks to ensure efficient antibody binding of SARS-CoV-2: Implications for advanced antibody design.|pdf=|usr=026}}
+{{tp|p=33758649|t=2021. Structural determinants driving the binding process between PDZ domain of wild type human PALS1 protein and SLiM sequences of SARS-CoV E proteins.|pdf=|usr=026}}
+{{tp|p=33623641|t=2021. Ultra-large-scale ab initio quantum chemical computation of bio-molecular systems: The case of spike protein of SARS-CoV-2 virus.|pdf=|usr=026}}
+{{tp|p=33558827|t=2021. Chemokines and chemokine receptors during COVID-19 infection.|pdf=|usr=026}}
+{{tp|p=33761985|t=2021. Lung compartmentalization of inflammatory biomarkers in COVID-19-related ARDS.|pdf=|usr=026}}
+{{tp|p=33557911|t=2021. Carboxypeptidase B blocks ex vivo activation of the anaphylatoxin-neutrophil extracellular trap axis in neutrophils from COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33557908|t=2021. SARS-CoV-2 pneumonia-receptor binding and lung immunopathology: a narrative review.|pdf=|usr=026}}
+{{tp|p=33786445|t=2021. Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients.|pdf=|usr=026}}
+{{tp|p=33728228|t=2021. Stay-At-Home Orders Are Associated With Emergence of Novel SARS-CoV-2 Variants.|pdf=|usr=026}}
+{{tp|p=33552760|t=2021. Do COVID-19 Antibodies Provide Long-Term Protection?|pdf=|usr=026}}
+{{tp|p=33659125|t=2021. Severe SARS-CoV-2 Infection: A Multisystem Inflammatory Syndrome in Moroccan Children.|pdf=|usr=026}}
+{{tp|p=33744623|t=2021. Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays.|pdf=|usr=026}}
+{{tp|p=33818474|t=2021. Phylogenetic classification of the whole-genome sequences of SARS-CoV-2 from India & evolutionary trends.|pdf=|usr=026}}
+{{tp|p=33819603|t=2021. Comment to the manuscript by William P. Hausdorff and Jorge Flores: Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19, IJID 103 (2021) 37-41.|pdf=|usr=026}}
+{{tp|p=33800954|t=2021. Interactions of SARS-CoV-2 with the Blood-Brain Barrier.|pdf=|usr=026}}
+{{tp|p=33807854|t=2021. Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries.|pdf=|usr=026}}
+{{tp|p=33807682|t=2021. CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands.|pdf=|usr=026}}
+{{tp|p=33806254|t=2021. Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection.|pdf=|usr=026}}
+{{tp|p=33804769|t=2021. Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-beta in Triggering Inflammatory Signals in Cells of Distant Organ.|pdf=|usr=026}}
+{{tp|p=33803997|t=2021. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis.|pdf=|usr=026}}
+{{tp|p=33783202|t=2021. 3D Heteronuclear Magnetization Transfers for the Establishment of Secondary Structures in SARS-CoV-2-Derived RNAs.|pdf=|usr=026}}
+{{tp|p=33794092|t=2021. Protein Footprinting, Conformational Dynamics, and Core Interface-Adjacent Neutralization "Hotspots" in the SARS-CoV-2 Spike Protein Receptor Binding Domain/Human ACE2 Interaction.|pdf=|usr=026}}
+{{tp|p=33822964|t=2021. Longitudinal Assessment of SARS-CoV-2 Anti-Nucleocapsid and anti-Spike-1-RBD Antibody Testing Following PCR-Detected SARS-CoV-2 Infection.|pdf=|usr=026}}
+{{tp|p=33822063|t=2021. Serology testing demonstrates that antibodies to SARS-CoV-2 S1-RBD correlate with neutralization of virus infection of Vero E6 cells.|pdf=|usr=026}}
+{{tp|p=33774672|t=2021. SARS-CoV-2 spike protein binding selectively accelerates substrate-specific catalytic activity of ACE2.|pdf=|usr=026}}
+{{tp|p=33797336|t=2021. In silico characterization of mutations circulating in SARS-CoV-2 structural proteins.|pdf=|usr=026}}
+{{tp|p=33689337|t=2021. Structure, Dynamics, Receptor Binding, and Antibody Binding of the Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein in a Viral Membrane.|pdf=|usr=026}}
+{{tp|p=33602698|t=2021. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.|pdf=|usr=026}}
+{{tp|p=33797663|t=2021. Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics.|pdf=|usr=026}}
+{{tp|p=33820739|t=2021. Genomic surveillance of Nevada patients revealed prevalence of unique SARS-CoV-2 variants bearing mutations in the RdRp gene.|pdf=|usr=026}}
+{{tp|p=33560990|t=2021. In silico prediction of new mutations that can improve the binding abilities between 2019-nCoV coronavirus and human ACE2.|pdf=|usr=026}}
+{{tp|p=33533266|t=2021. Age-associated Ligand-receptor Interactions Imputed from Nasopharyngeal Transcriptomes of COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33742451|t=2021. Emerging roles of extracellular vesicles in COVID-19, a double-edged sword?|pdf=|usr=026}}
+{{tp|p=33550678|t=2021. Comparison of baseline laboratory findings of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis and multisystem inflammatory syndrome in children.|pdf=|usr=026}}
+{{tp|p=33657316|t=2021. Heterogeneity of Glycan Processing on Trimeric SARS-CoV-2 Spike Protein Revealed by Charge Detection Mass Spectrometry.|pdf=|usr=026}}
+{{tp|p=33543668|t=2021. Chronobiology in response to COVID-19.|pdf=|usr=026}}
+{{tp|p=33755190|t=2021. Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data.|pdf=|usr=026}}
+{{tp|p=33751699|t=2021. Variable routes to genomic and host adaptation among coronaviruses.|pdf=|usr=026}}
+{{tp|p=33587028|t=2021. A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India.|pdf=|usr=026}}
+{{tp|p=33782089|t=2021. Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.|pdf=|usr=026}}
+{{tp|p=33689357|t=2021. Theoretical Analysis Reveals the Cost and Benefit of Proofreading in Coronavirus Genome Replication.|pdf=|usr=026}}
+{{tp|p=33709461|t=2021. The envelope protein of SARS-CoV-2 increases intra-Golgi pH and forms a cation channel that is regulated by pH.|pdf=|usr=026}}
+{{tp|p=33582450|t=2021. Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity.|pdf=|usr=026}}
+{{tp|p=33786172|t=2021. Low type I interferon response in COVID-19 patients: Interferon response may be a potential treatment for COVID-19.|pdf=|usr=026}}
+{{tp|p=33542929|t=2021. Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33770349|t=2021. (1)H, (13)C, and (15)N backbone chemical-shift assignments of SARS-CoV-2 non-structural protein 1 (leader protein).|pdf=|usr=026}}
+{{tp|p=33755914|t=2021. Backbone chemical shift spectral assignments of SARS coronavirus-2 non-structural protein nsp9.|pdf=|usr=026}}
+{{tp|p=33730325|t=2021. (1)H, (13)C and (15)N Backbone chemical shift assignments of the n-terminal and central intrinsically disordered domains of SARS-CoV-2 nucleoprotein.|pdf=|usr=026}}
+{{tp|p=33730680|t=2021. A theoretical study on the effects of interdomain flexibility on drug encounter rate for coronavirus nucleocapsid-type proteins.|pdf=|usr=026}}
+{{tp|p=33705760|t=2021. Exploring dynamics and network analysis of spike glycoprotein of SARS-COV-2.|pdf=|usr=026}}
+{{tp|p=33675757|t=2021. Binding mode of SARS-CoV-2 fusion peptide to human cellular membrane.|pdf=|usr=026}}
+{{tp|p=33794152|t=2021. Multivalent binding of the partially disordered SARS-CoV-2 nucleocapsid phosphoprotein dimer to RNA.|pdf=|usr=026}}
+{{tp|p=33794150|t=2021. SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential.|pdf=|usr=026}}
+{{tp|p=33631204|t=2021. Ca(2+)-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide.|pdf=|usr=026}}
+{{tp|p=33609494|t=2021. A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors.|pdf=|usr=026}}
+{{tp|p=33607086|t=2021. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.|pdf=|usr=026}}
+{{tp|p=33581060|t=2021. Graph, pseudoknot, and SARS-CoV-2 genomic RNA: A biophysical synthesis.|pdf=|usr=026}}
+{{tp|p=33577762|t=2021. New and notable: A multiscale coarse-grained model of the SARS-CoV-2 virion.|pdf=|usr=026}}
+{{tp|p=33577761|t=2021. Bow to the enemy: How flexibility of host protein receptors can favor SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33558859|t=2021. Genetic diversity and genomic epidemiology of SARS-CoV-2 in Morocco.|pdf=|usr=026}}
+{{tp|p=33635316|t=2021. Lipidomic alteration of plasma in cured COVID-19 patients using ultra high-performance liquid chromatography with high-resolution mass spectrometry.|pdf=|usr=026}}
+{{tp|p=33625490|t=2021. The SARS-CoV-2 induced targeted amino acid profiling in patients at hospitalized and convalescent stage.|pdf=|usr=026}}
+{{tp|p=33613787|t=2021. On the Verge of Life: Distribution of Nucleotide Sequences in Viral RNAs.|pdf=|usr=026}}
+{{tp|p=33612988|t=2021. Den molekularen Wirtszellveranderungen durch SARS-CoV-2 auf der Spur.|pdf=|usr=026}}
+{{tp|p=33656534|t=2021. The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A.|pdf=|usr=026}}
+{{tp|p=33602138|t=2021. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets.|pdf=|usr=026}}
+{{tp|p=33596826|t=2021. The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19.|pdf=|usr=026}}
+{{tp|p=33557779|t=2021. Differences of blood cells, lymphocyte subsets and cytokines in COVID-19 patients with different clinical stages: a network meta-analysis.|pdf=|usr=026}}
+{{tp|p=33757449|t=2021. Human cell-dependent, directional, time-dependent changes in the mono- and oligonucleotide compositions of SARS-CoV-2 genomes.|pdf=|usr=026}}
+{{tp|p=33618668|t=2021. Identification and functional analysis of the SARS-COV-2 nucleocapsid protein.|pdf=|usr=026}}
+{{tp|p=33627333|t=2021. Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells.|pdf=|usr=026}}
+{{tp|p=33768168|t=2021. Early recognition of PIMS-TS: a single centre retrospective review.|pdf=|usr=026}}
+{{tp|p=33714258|t=2021. Insight into the emerging role of SARS-CoV-2 nonstructural and accessory proteins in modulation of multiple mechanisms of host innate defense.|pdf=|usr=026}}
+{{tp|p=33577445|t=2021. Phylogenetic pattern of SARS-CoV-2 from COVID-19 patients from Bosnia and Herzegovina: lessons learned to optimize future molecular and epidemiological approaches.|pdf=|usr=026}}
+{{tp|p=33598939|t=2021. Unusual morphological abnormality of neutrophils in a patient with SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33817671|t=2021. Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer's disease.|pdf=|usr=026}}
+{{tp|p=33729297|t=2021. Potential link between SARS-CoV-2 and Kawasaki disease: importance of dentists for the diagnosis.|pdf=|usr=026}}
+{{tp|p=33757279|t=2021. Identification and characterization of circRNAs encoded by MERS-CoV, SARS-CoV-1 and SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33725111|t=2021. Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.|pdf=|usr=026}}
+{{tp|p=33675361|t=2021. The miRNA: a small but powerful RNA for COVID-19.|pdf=|usr=026}}
+{{tp|p=33634309|t=2021. A model for pH coupling of the SARS-CoV-2 spike protein open/closed equilibrium.|pdf=|usr=026}}
+{{tp|p=33620066|t=2021. Lysosome activation in peripheral blood mononuclear cells and prognostic significance of circulating LC3B in COVID-19.|pdf=|usr=026}}
+{{tp|p=33611368|t=2021. Comparison of the binding characteristics of SARS-CoV and SARS-CoV-2 RBDs to ACE2 at different temperatures by MD simulations.|pdf=|usr=026}}
+{{tp|p=33611340|t=2021. Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients.|pdf=|usr=026}}
+{{tp|p=33587745|t=2021. Roles of host small RNAs in the evolution and host tropism of coronaviruses.|pdf=|usr=026}}
+{{tp|p=33580783|t=2021. Functional alterations caused by mutations reflect evolutionary trends of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33569598|t=2021. Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment.|pdf=|usr=026}}
+{{tp|p=33539530|t=2021. Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases.|pdf=|usr=026}}
+{{tp|p=33822878|t=2021. Choice of assemblers has a critical impact on de novo assembly of SARS-CoV-2 genome and characterizing variants.|pdf=|usr=026}}
+{{tp|p=33753947|t=2021. COVID-19 chez l'enfant : syndrome inflammatoire multi-systemique lie a SARS-CoV-2 mimant un syndrome de Kawasaki.|pdf=|usr=026}}
+{{tp|p=33476581|t=2021. Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients.|pdf=|usr=026}}
+{{tp|p=33636047|t=2021. An integrated genetic-epigenetic analysis shed light on the mechanisms linking coronavirus disease 2019 (COVID-19) and cancer.|pdf=|usr=026}}
+{{tp|p=33809063|t=2021. Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients.|pdf=|usr=026}}
+{{tp|p=33761319|t=2021. Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33713594|t=2021. The effect of spike mutations on SARS-CoV-2 neutralization.|pdf=|usr=026}}
+{{tp|p=33596407|t=2021. Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33730580|t=2021. Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies.|pdf=|usr=026}}
+{{tp|p=33691089|t=2021. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33567255|t=2021. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.|pdf=|usr=026}}
+{{tp|p=33794145|t=2021. Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class.|pdf=|usr=026}}
+{{tp|p=33649748|t=2021. Total predicted MHC-I epitope load is inversely associated with population mortality from SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33564749|t=2021. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.|pdf=|usr=026}}
+{{tp|p=33748788|t=2021. Long-term persistence of RBD(+) memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33742149|t=2021. SARS-CoV-2 spike protein interacts with and activates TLR41.|pdf=|usr=026}}
+{{tp|p=33737693|t=2021. Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2.|pdf=|usr=026}}
+{{tp|p=33557205|t=2021. A Transcription Regulatory Sequence in the 5' Untranslated Region of SARS-CoV-2 Is Vital for Virus Replication with an Altered Evolutionary Pattern against Human Inhibitory MicroRNAs.|pdf=|usr=026}}
+{{tp|p=33652973|t=2021. Assembly and Cellular Exit of Coronaviruses: Hijacking an Unconventional Secretory Pathway from the Pre-Golgi Intermediate Compartment via the Golgi Ribbon to the Extracellular Space.|pdf=|usr=026}}
+{{tp|p=33540583|t=2021. Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression.|pdf=|usr=026}}
+{{tp|p=33784827|t=2021. SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2.|pdf=|usr=026}}
+{{tp|p=33772260|t=2021. Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands.|pdf=|usr=026}}
+{{tp|p=33819577|t=2021. Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33772259|t=2021. Phylogenetic analyses of SARS-CoV-2 B.1.1.7 lineage suggest a single origin followed by multiple exportation events versus convergent evolution.|pdf=|usr=026}}
+{{tp|p=33813122|t=2021. SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.|pdf=|usr=026}}
+{{tp|p=33813138|t=2021. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.|pdf=|usr=026}}
+{{tp|p=33821784|t=2021. Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan.|pdf=|usr=026}}
+{{tp|p=33755980|t=2021. Gene expression analysis identifies genes associated with SARS-COV-2 receptors, ACE2 and TMPRSS2, in normal human lung tissues.|pdf=|usr=026}}
+{{tp|p=33769912|t=2021. Analysis of the SARS-CoV-2-host protein interaction network reveals new biology and drug candidates: focus on the spike surface glycoprotein and RNA polymerase.|pdf=|usr=026}}
+{{tp|p=33779460|t=2021. SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics.|pdf=|usr=026}}
+{{tp|p=33809949|t=2021. A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection.|pdf=|usr=026}}
+{{tp|p=33789966|t=2021. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19.|pdf=|usr=026}}
+{{tp|p=33798758|t=2021. Molecular epidemiology analysis of early variants of SARS-CoV-2 reveals the potential impact of mutations P504L and Y541C (NSP13) in the clinical COVID-19 outcomes.|pdf=|usr=026}}
+{{tp|p=33545393|t=2021. Probing SARS-CoV-2 sequence diversity of Pakistani isolates.|pdf=|usr=026}}
+{{tp|p=33812037|t=2021. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.|pdf=|usr=026}}
+{{tp|p=33805139|t=2021. Diagnostic Value of IgM and IgG Detection in COVID-19 Diagnosis by the Mobile Laboratory B-LiFE: A Massive Testing Strategy in the Piedmont Region.|pdf=|usr=026}}
+{{tp|p=33750071|t=2021. Cytokine Release Syndrome Biology and Management.|pdf=|usr=026}}
+{{tp|p=33683950|t=2021. Letter by Loomba et al Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".|pdf=|usr=026}}
+{{tp|p=33683948|t=2021. Letter by Navarro Castellanos and Dahdah Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".|pdf=|usr=026}}
+{{tp|p=33683946|t=2021. Letter by Cardenas Suri and Jimomila Bening Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".|pdf=|usr=026}}
+{{tp|p=33683944|t=2021. Letter by Ren et al Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".|pdf=|usr=026}}
+{{tp|p=33554562|t=2021. Laboratory findings in a child with SARS-CoV-2 (COVID-19) multisystem inflammatory syndrome.|pdf=|usr=026}}
+{{tp|p=33675194|t=2021. Protease-antiprotease imbalance in patients with severe COVID-19.|pdf=|usr=026}}
+{{tp|p=33578505|t=2021. Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination.|pdf=|usr=026}}
+{{tp|p=33641271|t=2021. Prospective serological evaluation of anti SARS-CoV-2 IgG and anti S1-RBD antibodies in a community outbreak.|pdf=|usr=026}}
+{{tp|p=33554588|t=2021. Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33554502|t=2020. Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study.|pdf=|usr=026}}
+{{tp|p=33554554|t=2020. Cytokine "storm", cytokine "breeze", or both in COVID-19?|pdf=|usr=026}}
+{{tp|p=33682482|t=2021. Cytokine Storm Unmasks Immunodeficiency in a Child With Severe COVID-19.|pdf=|usr=026}}
+{{tp|p=33533405|t=2021. ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders.|pdf=|usr=026}}
+{{tp|p=33762895|t=2020. Revealing the mechanism of SARS-CoV-2 spike protein binding with ACE2.|pdf=|usr=026}}
+{{tp|p=33769770|t=2021. Potential Endotype Transition for Coronavirus Disease 2019-Related Sepsis With Longitudinal Transcriptome Profiling.|pdf=|usr=026}}
+{{tp|p=33530913|t=2021. Cluster analysis of coronavirus sequences using computational sequence descriptors: With applications to SARS, MERS and SARS-CoV-2 (CoVID-19).|pdf=|usr=026}}
+{{tp|p=33645482|t=2021. Predicted SARS-CoV-2 miRNAs associated with epigenetic viral pathogenesis and the detection of new possible drugs for Covid-19.|pdf=|usr=026}}
+{{tp|p=33687893|t=2021. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability utilizing Natural Agents.|pdf=|usr=026}}
+{{tp|p=33820514|t=2021. The Main Receptors Involved with COVID-19: a Systematic Review and Meta-analysis.|pdf=|usr=026}}
+{{tp|p=33749559|t=2021. RNA sensors as a mechanism of innate immune evasion among SARS-CoV2, HIV and Nipah viruses.|pdf=|usr=026}}
+{{tp|p=33687087|t=2021. Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio-renal damage in COVID-19 infection.|pdf=|usr=026}}
+{{tp|p=33788271|t=2021. Antigen-dependent multistep differentiation of T follicular helper cells and its role in SARS-CoV-2 infection and vaccination.|pdf=|usr=026}}
+{{tp|p=33788264|t=2021. Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33784417|t=2021. Upregulation of CCR4 in activated CD8(+) T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33768543|t=2021. Enrichment of CCR6(+) CD8(+) T cells and CCL20 in the lungs of mechanically ventilated patients with COVID-19.|pdf=|usr=026}}
+{{tp|p=33749902|t=2021. Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages.|pdf=|usr=026}}
+{{tp|p=33756061|t=2021. Non-optimal codon usage preferences of coronaviruses determine their promiscuity for infecting multiple hosts.|pdf=|usr=026}}
+{{tp|p=33705595|t=2021. New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33728680|t=2021. Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations.|pdf=|usr=026}}
+{{tp|p=33552834|t=2021. Structural analysis of COVID-19 spike protein in recognizing the ACE2 receptor of different mammalian species and its susceptibility to viral infection.|pdf=|usr=026}}
+{{tp|p=33547873|t=2021. Rapid Implementation of a Multidisciplinary COVID-19 Cytokine Storm Syndrome Task Force.|pdf=|usr=026}}
+{{tp|p=33733740|t=2021. Computational Mutagenesis at the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Binding Interface: Comparison with Experimental Evidence.|pdf=|usr=026}}
+{{tp|p=33778306|t=2021. Proteomics Analysis of Serum from COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33748632|t=2021. Neutrophil Elastase and Proteinase 3 Cleavage Sites Are Adjacent to the Polybasic Sequence within the Proteolytic Sensitive Activation Loop of the SARS-CoV-2 Spike Protein.|pdf=|usr=026}}
+{{tp|p=33748571|t=2021. SARS-CoV-2 Genome from the Khyber Pakhtunkhwa Province of Pakistan.|pdf=|usr=026}}
+{{tp|p=33615190|t=2021. SARS-CoV-2, Hypoxia, and Calcium Signaling: The Consequences and Therapeutic Options.|pdf=|usr=026}}
+{{tp|p=33615177|t=2021. Innate Immunity Plays a Key Role in Controlling Viral Load in COVID-19: Mechanistic Insights from a Whole-Body Infection Dynamics Model.|pdf=|usr=026}}
+{{tp|p=33525242|t=2020. COVID-19 and NF-kB: The Hepcidin paradox and the Iron Storm - Reply.|pdf=|usr=026}}
+{{tp|p=33525240|t=2020. Hepcidin is a friend rather than a foe in COVID19-induced complications.|pdf=|usr=026}}
+{{tp|p=33525252|t=2020. The role of angiotensin-converting enzyme 2 in COVID-19 induced lung injury.|pdf=|usr=026}}
+{{tp|p=33610693|t=2021. Adaptive immune responses to SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33795524|t=2021. Aging and monocyte immunometabolism in COVID-19.|pdf=|usr=026}}
+{{tp|p=33780352|t=2021. Differentially expressed immune response genes in COVID-19 patients based on disease severity.|pdf=|usr=026}}
+{{tp|p=33744846|t=2021. TMBIM6, a potential virus target protein identified by integrated multiomics data analysis in SARS-CoV-2-infected host cells.|pdf=|usr=026}}
+{{tp|p=33714947|t=2021. Age cohorts stratified according to age-distributions of COVID-19 morbidity statistics identify uniquely age-dependent CD3(+)CD8(+) T-cell lymphocytopenia in COVID-19 patients without comorbidities on admission.|pdf=|usr=026}}
+{{tp|p=33647885|t=2021. The networks of m(6)A-SARS-CoV-2 related genes and immune infiltration patterns in idiopathic pulmonary fibrosis.|pdf=|usr=026}}
+{{tp|p=33640878|t=2021. Elevated frequencies of CD14(+)HLA-DR(lo/neg) MDSCs in COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33532126|t=2021. Prediction of SARS-CoV Interaction with Host Proteins during Lung Aging Reveals a Potential Role for TRIB3 in COVID-19.|pdf=|usr=026}}
+{{tp|p=33532121|t=2021. Coronavirus Disease (COVID-19): A Perspective from Immunosenescence.|pdf=|usr=026}}
+{{tp|p=33815889|t=2021. An Account of Immune Senescence in the Clinical Pathophysiology of COVID-19 Infection in Aging.|pdf=|usr=026}}
+{{tp|p=33722434|t=2021. COVID-19 disease and the hyper-inflammatory response: Are we accusing the wrong suspect?|pdf=|usr=026}}
+{{tp|p=33600784|t=2021. DNA and RNA Oxidative Damage and Mortality of Patients With COVID-19.|pdf=|usr=026}}
+{{tp|p=33781387|t=2021. Fever: Could A Cardinal Sign of COVID-19 Infection Reduce Mortality?|pdf=|usr=026}}
+{{tp|p=33741335|t=2021. Sequence Analysis of 20,453 Severe Acute Respiratory Syndrome Coronavirus 2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern.|pdf=|usr=026}}
+{{tp|p=33689516|t=2021. Molecular mechanisms of Na,K-ATPase dysregulation driving alveolar epithelial barrier failure in severe COVID-19.|pdf=|usr=026}}
+{{tp|p=33645217|t=2021. Detection of SARS-CoV-2 DNA Targets Using Femtoliter Optofluidic Waveguides.|pdf=|usr=026}}
+{{tp|p=33648648|t=2021. The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes.|pdf=|usr=026}}
+{{tp|p=33532706|t=2020. Sensitivity of SARS-CoV-2 to different temperatures.|pdf=|usr=026}}
+{{tp|p=33721518|t=2021. What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1).|pdf=|usr=026}}
+{{tp|p=33721517|t=2021. Antibody Response After SARS-CoV-2 Infection and Implications for Immunity : A Rapid Living Review.|pdf=|usr=026}}
+{{tp|p=33721515|t=2021. Summary for Patients: What is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1).|pdf=|usr=026}}
+{{tp|p=33781803|t=2021. Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33727312|t=2021. Post-COVID-19 paediatric inflammatory multisystem syndrome: association of ethnicity, key worker and socioeconomic status with risk and severity.|pdf=|usr=026}}
+{{tp|p=33677719|t=2021. The Potential of Developing Pan-Coronaviral Antibodies to Spike Peptides in Convalescent COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33526352|t=2021. Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01.|pdf=|usr=026}}
+{{tp|p=33778918|t=2021. Research progress on coronavirus S proteins and their receptors.|pdf=|usr=026}}
+{{tp|p=33761008|t=2021. Diverse SARS-CoV-2 variants preceded the initial COVID-19 outbreak in Croatia.|pdf=|usr=026}}
+{{tp|p=33610750|t=2021. Molecular mimicry between SARS-CoV-2 and human proteins.|pdf=|usr=026}}
+{{tp|p=33550350|t=2020. [Homologous modeling and binding ability analysis of Spike protein after point mutation of severe acute respiratory syndrome coronavirus 2 to receptor proteins and potential antiviral drugs].|pdf=|usr=026}}
+{{tp|p=33614383|t=2021. Imaging of SARS-CoV-2 infected Vero E6 cells by helium ion microscopy.|pdf=|usr=026}}
+{{tp|p=33564691|t=2021. Mutational hotspots and conserved domains of SARS-CoV-2 genome in African population.|pdf=|usr=026}}
+{{tp|p=33527091|t=2021. Variations in Orf3a protein of SARS-CoV-2 alter its structure and function.|pdf=|usr=026}}
+{{tp|p=33813274|t=2021. Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation.|pdf=|usr=026}}
+{{tp|p=33789211|t=2021. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration.|pdf=|usr=026}}
+{{tp|p=33578295|t=2021. Age-dependent effects of the recombinant spike protein/SARS-CoV-2 on the M-CSF- and IL-34-differentiated macrophages in vitro.|pdf=|usr=026}}
+{{tp|p=33545635|t=2021. RNA sequence and ligand binding alter conformational profile of SARS-CoV-2 stem loop II motif.|pdf=|usr=026}}
+{{tp|p=33685621|t=2021. Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33602511|t=2021. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.|pdf=|usr=026}}
+{{tp|p=33581843|t=2021. Pathogenesis of COVID-19 and the quality control of nucleic acid detection.|pdf=|usr=026}}
+{{tp|p=33676232|t=2021. SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.|pdf=|usr=026}}
+{{tp|p=33569952|t=2021. Enhanced Cholesterol-Dependent Hemifusion by Internal Fusion Peptide 1 of SARS Coronavirus-2 Compared to Its N-Terminal Counterpart.|pdf=|usr=026}}
+{{tp|p=33705292|t=2020. COVID-19 and Oxidative Stress.|pdf=|usr=026}}
+{{tp|p=33621516|t=2021. Transport mechanisms of SARS-CoV-E viroporin in calcium solutions: Lipid-dependent Anomalous Mole Fraction Effect and regulation of pore conductance.|pdf=|usr=026}}
+{{tp|p=33771486|t=2021. The SARS-CoV-2 envelope (E) protein has evolved towards membrane topology robustness.|pdf=|usr=026}}
+{{tp|p=33639198|t=2021. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators.|pdf=|usr=026}}
+{{tp|p=33743803|t=2021. Indels in SARS-CoV-2 occur at template-switching hotspots.|pdf=|usr=026}}
+{{tp|p=33786001|t=2021. Metagenomics Approaches to Investigate the Gut Microbiome of COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33560365|t=2021. Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviour.|pdf=|usr=026}}
+{{tp|p=33618659|t=2021. Effects of Cell Proteostasis Network on the Survival of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33808658|t=2021. Exaptation of Retroviral Syncytin for Development of Syncytialized Placenta, Its Limited Homology to the SARS-CoV-2 Spike Protein and Arguments against Disturbing Narrative in the Context of COVID-19 Vaccination.|pdf=|usr=026}}
+{{tp|p=33572760|t=2021. Mucociliary Respiratory Epithelium Integrity in Molecular Defense and Susceptibility to Pulmonary Viral Infections.|pdf=|usr=026}}
+{{tp|p=33771243|t=2020. Predictive Analysis of Susceptibility of Different Species to SARS-CoV-2 based on ACE2 Receptors.|pdf=|usr=026}}
+{{tp|p=33799060|t=2021. Presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during CoViD-19 infection.|pdf=|usr=026}}
+{{tp|p=33762287|t=2021. SARS-CoV-2 infection triggering recurrence of Kawasaki disease in a 10-year-old child.|pdf=|usr=026}}
+{{tp|p=33798491|t=2021. Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant.|pdf=|usr=026}}
+{{tp|p=33795851|t=2021. ACE2 expression is regulated by AhR in SARS-CoV-2-infected macaques.|pdf=|usr=026}}
+{{tp|p=33801464|t=2021. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.|pdf=|usr=026}}
+{{tp|p=33808998|t=2021. Thymic Aging May Be Associated with COVID-19 Pathophysiology in the Elderly.|pdf=|usr=026}}
+{{tp|p=33735872|t=2021. Analysis of Three Mutations in Italian Strains of SARS-CoV-2: Implications for Pathogenesis.|pdf=|usr=026}}
+{{tp|p=33785044|t=2021. Hypothetical COVID-19 protection mechanism: hints from centenarians.|pdf=|usr=026}}
+{{tp|p=33566457|t=2021. Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19.|pdf=|usr=026}}
+{{tp|p=33728103|t=2021. Single Cell Transcriptomic Re-analysis of Immune Cells in Bronchoalveolar Lavage Fluids Reveals the Correlation of B Cell Characteristics and Disease Severity of Patients with SARS-CoV-2 Infection.|pdf=|usr=026}}
+{{tp|p=33728102|t=2021. Transmission Characteristics of SARS-CoV-2 That Hinder Effective Control.|pdf=|usr=026}}
+{{tp|p=33728101|t=2021. Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target.|pdf=|usr=026}}
+{{tp|p=33728096|t=2021. SARS-CoV-2 Infection of Airway Epithelial Cells.|pdf=|usr=026}}
+{{tp|p=33728095|t=2021. SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals.|pdf=|usr=026}}
+{{tp|p=33728094|t=2021. Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis.|pdf=|usr=026}}
+{{tp|p=33577760|t=2021. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.|pdf=|usr=026}}
+{{tp|p=33567252|t=2021. COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses.|pdf=|usr=026}}
+{{tp|p=33765436|t=2021. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19.|pdf=|usr=026}}
+{{tp|p=33765435|t=2021. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses.|pdf=|usr=026}}
+{{tp|p=33706067|t=2021. Why blood group A individuals are at risk whereas blood group O individuals are protected from SARS-CoV-2 (COVID-19) infection: A hypothesis regarding how the virus invades the human body via ABO(H) blood group-determining carbohydrates.|pdf=|usr=026}}
+{{tp|p=33533428|t=2020. Prediction of Single Point Mutations in Human Coronavirus and Their Effects on Binding to 9-O-Acetylated Sialic Acid and Hidroxychloroquine.|pdf=|usr=026}}
+{{tp|p=33757413|t=2021. Moderate forms of COVID-19 among healthcare workers in a Belgian hospital and their immune response.|pdf=|usr=026}}
+{{tp|p=33656719|t=2021. The Novel Coronavirus and Inflammation.|pdf=|usr=026}}
+{{tp|p=33656718|t=2021. The Immune Response and Effectiveness of COVID-19 Therapies.|pdf=|usr=026}}
+{{tp|p=33656713|t=2021. Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.|pdf=|usr=026}}
+{{tp|p=33544010|t=2021. Short Communication:Evidence of Novel SARS-CoV-2 Variants Circulation in Romania.|pdf=|usr=026}}
+{{tp|p=33764510|t=2021. Detection of SARS-CoV-2-specific memory B cells to delineate long-term COVID-19 immunity.|pdf=|usr=026}}
+{{tp|p=33757142|t=2021. Presumptive Neonatal Multisystem Inflammatory Syndrome in Children Associated with Coronavirus Disease 2019.|pdf=|usr=026}}
+{{tp|p=33740387|t=2021. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.|pdf=|usr=026}}
+{{tp|p=33797351|t=2021. The Role of Obesity in the Immunopathogenesis of COVID-19 Respiratory Disease and Critical Illness.|pdf=|usr=026}}
+{{tp|p=33725469|t=2021. Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and Hemoadsorption.|pdf=|usr=026}}
+{{tp|p=33798018|t=2021. Within-city Variation in Reactive Oxygen Species from Fine Particle Air Pollution and COVID-19.|pdf=|usr=026}}
+{{tp|p=33756051|t=2021. SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients.|pdf=|usr=026}}
+{{tp|p=33754452|t=2021. Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in a solid organ transplant recipient.|pdf=|usr=026}}
+{{tp|p=33792109|t=2021. Reduced frequency of T helper 17 and T helper 1 cells and their association with critical coronavirus disease 2019.|pdf=|usr=026}}
+{{tp|p=33651785|t=2021. [Guia para referencia cardiologica de pacientes con sindrome inflamatorio multisistemico pediatrico y enfermedad por Kawasaki asociados al SARS-CoV-2].|pdf=|usr=026}}
+{{tp|p=33785527|t=2021. Implications of a highly transmissible variant of SARS-CoV-2 for children.|pdf=|usr=026}}
+{{tp|p=33586369|t=2021. Prophylactic anticoagulation therapy: comment on the article by Henderson et al.|pdf=|usr=026}}
+{{tp|p=33586355|t=2021. Reply.|pdf=|usr=026}}
+{{tp|p=33648933|t=2021. Acute covid-19 and multisystem inflammatory syndrome in children.|pdf=|usr=026}}
+{{tp|p=33547053|t=2021. Covid-19: The E484K mutation and the risks it poses.|pdf=|usr=026}}
+{{tp|p=33619064|t=2021. What makes new variants of SARS-CoV-2 concerning is not where they come from, but the mutations they contain.|pdf=|usr=026}}
+{{tp|p=33579721|t=2021. Covid-19: Is Manaus the final nail in the coffin for natural herd immunity?|pdf=|usr=026}}
+{{tp|p=33719038|t=2021. Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).|pdf=|usr=026}}
+{{tp|p=33745461|t=2021. COVID-19-associated multisystem inflammatory syndrome in children presenting uniquely with sinus node dysfunction in the setting of shock.|pdf=|usr=026}}
+{{tp|p=33818861|t=2021. The role of autophagy in controlling SARS-CoV-2 infection: An overview on virophagy-mediated molecular drug targets.|pdf=|usr=026}}
+{{tp|p=33592540|t=2021. Myeloid-derived suppressor cells (MDSC): When good intentions go awry.|pdf=|usr=026}}
+{{tp|p=33740320|t=2021. Annulate lamellae and intracellular pathogens.|pdf=|usr=026}}
+{{tp|p=33792447|t=2021. The circadian clock gene Bmal1: Role in COVID-19 and periodontitis.|pdf=|usr=026}}
+{{tp|p=33649539|t=2021. Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants.|pdf=|usr=026}}
+{{tp|p=33634060|t=2020. Immunopathological Changes in SARS-CoV-2 Critical and Non-critical Pneumonia Patients: A Systematic Review to Determine the Cause of Co-infection.|pdf=|usr=026}}
+{{tp|p=33762432|t=2021. COVID-19 transmission following outpatient endoscopy during pandemic acceleration phase involving SARS-CoV-2 VOC 202012/01 variant in UK.|pdf=|usr=026}}
+{{tp|p=33718878|t=2021. Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawai'i Reveals the Worldwide Emerging P681H Mutation.|pdf=|usr=026}}
+{{tp|p=33778179|t=2021. Mutational analysis of structural proteins of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33758785|t=2021. Pan-India novel coronavirus SARS-CoV-2 genomics and global diversity analysis in spike protein.|pdf=|usr=026}}
+{{tp|p=33688586|t=2021. In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors.|pdf=|usr=026}}
+{{tp|p=33644468|t=2021. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages.|pdf=|usr=026}}
+{{tp|p=33553784|t=2021. The molecular assessment of SARS-CoV-2 Nucleocapsid Phosphoprotein variants among Indian isolates.|pdf=|usr=026}}
+{{tp|p=33726831|t=2021. Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids.|pdf=|usr=026}}
+{{tp|p=33752217|t=2020. Variants in ACE2 and TMPRSS2 Genes Are Not Major Determinants of COVID-19 Severity in UK Biobank Subjects.|pdf=|usr=026}}
+{{tp|p=33531264|t=2021. Dynamic changes in monocytes subsets in COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33581170|t=2021. Influence of aging on T cell response and renin-angiotensin system imbalance during SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33559128|t=2021. Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID-19.|pdf=|usr=026}}
+{{tp|p=33728277|t=2021. Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches.|pdf=|usr=026}}
+{{tp|p=33716413|t=2021. Clinical Characteristics of Paediatric Hyperinflammatory Syndrome in the Era of Corona Virus Disease 2019 (COVID-19).|pdf=|usr=026}}
+{{tp|p=33647334|t=2021. Persistence of SARS-CoV-2 antibodies beyond 6 months in health care workers in Mumbai.|pdf=|usr=026}}
+{{tp|p=33625669|t=2021. Multisystem Inflammatory Syndrome in Children Temporarily Associated with SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33745112|t=2021. Fresh Per Rectal Bleeding in Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS).|pdf=|usr=026}}
+{{tp|p=33632963|t=2021. Inclusion of Multisystem Inflammatory Syndrome in Children and Adolescents Temporally Related to COVID -19 in the Differential Diagnosis of Kawasaki Disease: Authors' Reply.|pdf=|usr=026}}
+{{tp|p=33632962|t=2021. Inclusion of Multisystem Inflammatory Syndrome in Children and Adolescents Temporally Related to COVID -19 in the Differential Diagnosis of Kawasaki Disease.|pdf=|usr=026}}
+{{tp|p=33684020|t=2021. Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies.|pdf=|usr=026}}
+{{tp|p=33421654|t=2021. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.|pdf=|usr=026}}
+{{tp|p=33607284|t=2021. Variants in ACE2; potential influences on virus infection and COVID-19 severity.|pdf=|usr=026}}
+{{tp|p=33556558|t=2021. SARS-CoV-2 mutation 614G creates an elastase cleavage site enhancing its spread in high AAT-deficient regions.|pdf=|usr=026}}
+{{tp|p=33677109|t=2021. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.|pdf=|usr=026}}
+{{tp|p=33667722|t=2021. Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations.|pdf=|usr=026}}
+{{tp|p=33689159|t=2021. SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19.|pdf=|usr=026}}
+{{tp|p=33620427|t=2021. Humoral immunological kinetics of severe acute respiratory syndrome coronavirus 2 infection and diagnostic performance of serological assays for coronavirus disease 2019: an analysis of global reports.|pdf=|usr=026}}
+{{tp|p=33618296|t=2021. Immune response of frontline medical workers providing medical support for Wuhan COVID-19 patients, China.|pdf=|usr=026}}
+{{tp|p=33765612|t=2021. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19.|pdf=|usr=026}}
+{{tp|p=33765611|t=2021. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19.|pdf=|usr=026}}
+{{tp|p=33756225|t=2021. Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues.|pdf=|usr=026}}
+{{tp|p=33667553|t=2021. The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play.|pdf=|usr=026}}
+{{tp|p=33390836|t=2021. SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations.|pdf=|usr=026}}
+{{tp|p=33390833|t=2021. A Multiple-Hit Hypothesis Involving Reactive Oxygen Species and Myeloperoxidase Explains Clinical Deterioration and Fatality in COVID-19.|pdf=|usr=026}}
+{{tp|p=33390830|t=2021. ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19.|pdf=|usr=026}}
+{{tp|p=33778151|t=2021. Cardiac abnormalities due to multisystem inflammatory syndrome temporally associated with Covid-19 among children: A systematic review and meta-analysis.|pdf=|usr=026}}
+{{tp|p=33672177|t=2021. Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing.|pdf=|usr=026}}
+{{tp|p=33535692|t=2021. IgM and IgG Profiles Reveal Peculiar Features of Humoral Immunity Response to SARS-CoV-2 Infection.|pdf=|usr=026}}
+{{tp|p=33785459|t=2021. Emergence and outcomes of the SARS-CoV-2 'Marseille-4' variant.|pdf=|usr=026}}
+{{tp|p=33781906|t=2021. Circulating activated neutrophils in COVID-19: An independent predictor for mechanical ventilation and death.|pdf=|usr=026}}
+{{tp|p=33737135|t=2021. COVID-19: Is herd immunity the only option for fragile Yemen?|pdf=|usr=026}}
+{{tp|p=33713819|t=2021. The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33737129|t=2021. Genomic surveillance of SARS-CoV-2 in the Republic of Congo.|pdf=|usr=026}}
+{{tp|p=33684558|t=2021. Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs.|pdf=|usr=026}}
+{{tp|p=33618008|t=2021. Characterizing SARS-CoV-2 genome diversity circulating in South American countries: Signatures of potentially emergent lineages?|pdf=|usr=026}}
+{{tp|p=33582372|t=2021. Multisystem inflammatory syndrome (MIS-C) in an adolescent Nigerian girl with COVID-19: A call for vigilance in Africa.|pdf=|usr=026}}
+{{tp|p=33582369|t=2021. Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay.|pdf=|usr=026}}
+{{tp|p=33578018|t=2021. The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33526974|t=2021. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection induces dysregulation of immunity: in silico gene expression analysis.|pdf=|usr=026}}
+{{tp|p=33649798|t=2021. COVID19 and SARSCoV2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease.|pdf=|usr=026}}
+{{tp|p=33572938|t=2021. Expression of the SARS-CoV-2 Receptor ACE2 and Proinflammatory Cytokines Induced by the Periodontopathic Bacterium Fusobacterium nucleatum in Human Respiratory Epithelial Cells.|pdf=|usr=026}}
+{{tp|p=33567739|t=2021. ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?|pdf=|usr=026}}
+{{tp|p=33567580|t=2021. In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface.|pdf=|usr=026}}
+{{tp|p=33567524|t=2021. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease.|pdf=|usr=026}}
+{{tp|p=33562472|t=2021. Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology.|pdf=|usr=026}}
+{{tp|p=33668756|t=2021. Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.|pdf=|usr=026}}
+{{tp|p=33671651|t=2021. sFasL-The Key to a Riddle: Immune Responses in Aging Lung and Disease.|pdf=|usr=026}}
+{{tp|p=33672738|t=2021. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.|pdf=|usr=026}}
+{{tp|p=33727631|t=2021. Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics.|pdf=|usr=026}}
+{{tp|p=33752089|t=2021. Multisystem inflammatory syndrome in children (MIS-C) and retropharyngeal edema: A case series.|pdf=|usr=026}}
+{{tp|p=33539677|t=2021. Autoantibodies in severe COVID-19-related acute respiratory distress syndrome: Just innocent bystanders?|pdf=|usr=026}}
+{{tp|p=33616462|t=2021. Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality.|pdf=|usr=026}}
+{{tp|p=33759006|t=2021. Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?|pdf=|usr=026}}
+{{tp|p=33534080|t=2021. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience: reply.|pdf=|usr=026}}
+{{tp|p=33787518|t=2021. Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19.|pdf=|usr=026}}
+{{tp|p=33787515|t=2021. The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19.|pdf=|usr=026}}
+{{tp|p=33787510|t=2021. The role and delicate balance of Host Immunity in Coronavirus Disease-19.|pdf=|usr=026}}
+{{tp|p=33615195|t=2021. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14(+) monocytes.|pdf=|usr=026}}
+{{tp|p=33585805|t=2021. Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without.|pdf=|usr=026}}
+{{tp|p=33558857|t=2021. Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19.|pdf=|usr=026}}
+{{tp|p=33532709|t=2021. Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity.|pdf=|usr=026}}
+{{tp|p=33748697|t=2021. Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19.|pdf=|usr=026}}
+{{tp|p=33723527|t=2021. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway.|pdf=|usr=026}}
+{{tp|p=33718825|t=2021. SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway.|pdf=|usr=026}}
+{{tp|p=33557873|t=2021. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics.|pdf=|usr=026}}
+{{tp|p=33708401|t=2021. Crystallographic models of SARS-CoV-2 3CL(pro): in-depth assessment of structure quality and validation.|pdf=|usr=026}}
+{{tp|p=33551030|t=2021. Mortality-related immune features and COVID-19.|pdf=|usr=026}}
+{{tp|p=33551029|t=2021. Reply to "Mortality-related immune features and COVID-19".|pdf=|usr=026}}
+{{tp|p=33677002|t=2021. A response to "Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children''.|pdf=|usr=026}}
+{{tp|p=33632409|t=2021. Oral manifestations of COVID-2019-related multisystem inflammatory syndrome in children: a review of 47 pediatric patients.|pdf=|usr=026}}
+{{tp|p=33540371|t=2021. Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status.|pdf=|usr=026}}
+{{tp|p=33716040|t=2021. The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization.|pdf=|usr=026}}
+{{tp|p=33564646|t=2021. How Our Neanderthal Genes Affect the COVID-19 Mortality: Iran and Mongolia, Two Countries with the Same SARS-CoV-2 Mutation Cluster but Different Mortality Rates.|pdf=|usr=026}}
+{{tp|p=33583326|t=2021. Structural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex.|pdf=|usr=026}}
+{{tp|p=33737495|t=2021. SARS-CoV-2 genomics: An Indian perspective on sequencing viral variants.|pdf=|usr=026}}
+{{tp|p=33709963|t=2021. Pattern of genomic variation in SARS-CoV-2 (COVID-19) suggests restricted nonrandom changes: Analysis using Shewhart control charts.|pdf=|usr=026}}
+{{tp|p=33759345|t=2021. Risk stratification by long non-coding RNAs profiling in COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33734600|t=2021. Back to basics in COVID-19: Antigens and antibodies-Completing the puzzle.|pdf=|usr=026}}
+{{tp|p=33660945|t=2021. Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease.|pdf=|usr=026}}
+{{tp|p=33609069|t=2021. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33624300|t=2021. Akt-independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS-CoV2 infection.|pdf=|usr=026}}
+{{tp|p=33713408|t=2021. The association of TSH and thyroid hormones with lymphopenia in bacterial sepsis and COVID-19.|pdf=|usr=026}}
+{{tp|p=33725211|t=2021. Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses.|pdf=|usr=026}}
+{{tp|p=33705359|t=2021. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children.|pdf=|usr=026}}
+{{tp|p=33529167|t=2021. The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.|pdf=|usr=026}}
+{{tp|p=33635833|t=2021. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.|pdf=|usr=026}}
+{{tp|p=33571162|t=2021. Durable SARS-CoV-2 B cell immunity after mild or severe disease.|pdf=|usr=026}}
+{{tp|p=33561010|t=2021. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33669527|t=2021. Immunological Characteristics of Non-Intensive Care Hospitalized COVID-19 Patients: A Preliminary Report.|pdf=|usr=026}}
+{{tp|p=33671159|t=2021. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.|pdf=|usr=026}}
+{{tp|p=33722841|t=2021. Secondary haemophagocytic lymphohistiocytosis in COVID-19: correlation of the autopsy findings of bone marrow haemophagocytosis with HScore.|pdf=|usr=026}}
+{{tp|p=33636554|t=2021. Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection.|pdf=|usr=026}}
+{{tp|p=33803400|t=2021. Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications.|pdf=|usr=026}}
+{{tp|p=33802569|t=2021. mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection.|pdf=|usr=026}}
+{{tp|p=33805458|t=2021. Transcriptional and Non-Transcriptional Activation, Posttranslational Modifications, and Antiviral Functions of Interferon Regulatory Factor 3 and Viral Antagonism by the SARS-Coronavirus.|pdf=|usr=026}}
+{{tp|p=33739895|t=2021. Serological Evaluation of Human Antibodies of the Immunoglobulin Class A and G Against SARS-CoV-2 in Serum Collected in Newfoundland and Labrador.|pdf=|usr=026}}
+{{tp|p=33656935|t=2021. Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients.|pdf=|usr=026}}
+{{tp|p=33625297|t=2021. T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications.|pdf=|usr=026}}
+{{tp|p=33605822|t=2021. The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses.|pdf=|usr=026}}
+{{tp|p=33648924|t=2020. Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome|pdf=|usr=026}}
+{{tp|p=33734352|t=2021. Major left ventricular thrombi in an adolescent with COVID-19-associated inflammatory syndrome.|pdf=|usr=026}}
+{{tp|p=33609352|t=2021. Inflammatory syndrome in children associated with COVID-19 complicated by acute myocardial infarction.|pdf=|usr=026}}
+{{tp|p=33599835|t=2021. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review.|pdf=|usr=026}}
+{{tp|p=33791862|t=2021. Pediatric multisystem SARS COV2 with versus without cardiac involvement: a multicenter study from Latin America.|pdf=|usr=026}}
+{{tp|p=33540040|t=2021. Importance of glutamine 189 flexibility in SARS-CoV-2 main protease: Lesson learned from in silico virtual screening of ChEMBL database and molecular dynamics.|pdf=|usr=026}}
+{{tp|p=33602859|t=2021. Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33577008|t=2021. COVID-19 pandemic and vaccination build herd immunity.|pdf=|usr=026}}
+{{tp|p=33629341|t=2021. Differential expression and immune correlation analysis of COVID-19 receptor ACE2 and TMPRSS2 genes in all normal and tumor tissues.|pdf=|usr=026}}
+{{tp|p=33629340|t=2021. Evaluation of molecular interaction, physicochemical parameters and conserved pattern of SARS-CoV-2 Spike RBD and hACE2: in silico and molecular dynamics approach.|pdf=|usr=026}}
+{{tp|p=33716535|t=2021. Does NF-kappaB Signaling Pathway Play a Crucial Role in Pneumonia Induced by SARS-COV-2 Virus Causing COVID-19?|pdf=|usr=026}}
+{{tp|p=33769251|t=2021. Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially incre<iframe src="http://www.kidney.de/amapp.php?a=g hospitalisation rate, February 2021, Rio Grande do Sul, Southern Brazil.|pdf=|usr=026}}
+{{tp|p=33739254|t=2021. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February.|pdf=|usr=026}}
+{{tp|p=33706862|t=2021. Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021.|pdf=|usr=026}}
+{{tp|p=33643982|t=2020. Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?|pdf=|usr=026}}
+{{tp|p=33766711|t=2021. SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin.|pdf=|usr=026}}
+{{tp|p=33549714|t=2021. Mutational analysis and assessment of its impact on proteins of SARS-CoV-2 genomes from India.|pdf=|usr=026}}
+{{tp|p=33778182|t=2021. Comparative analysis of mutational hotspots in the spike protein of SARS-CoV-2 isolates from different geographic origins.|pdf=|usr=026}}
+{{tp|p=33723522|t=2021. ACE2: At the crossroad of COVID-19 and lung cancer.|pdf=|usr=026}}
+{{tp|p=33681535|t=2021. Analysis and comparison of genetic variants and mutations of the novel coronavirus SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33615042|t=2021. A comparative genomics-based study of positive strand RNA viruses emphasizing on SARS-CoV-2 utilizing dinucleotide signature, codon usage and codon context analyses.|pdf=|usr=026}}
+{{tp|p=33615041|t=2021. SARS-CoV-2 spillover transmission due to recombination event.|pdf=|usr=026}}
+{{tp|p=33623833|t=2021. Characterizing genomic variants and mutations in SARS-CoV-2 proteins from Indian isolates.|pdf=|usr=026}}
+{{tp|p=33572725|t=2021. Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis.|pdf=|usr=026}}
+{{tp|p=33729332|t=2021. MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19.|pdf=|usr=026}}
+{{tp|p=33570080|t=2021. Challenges in estimating virus divergence times in short epidemic timescales with special reference to the evolution of SARS-CoV-2 pandemic.|pdf=|usr=026}}
+{{tp|p=33788636|t=2021. A study on non-synonymous mutational patterns in structural proteins of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33563320|t=2021. CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes.|pdf=|usr=026}}
+{{tp|p=33618765|t=2021. Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33722935|t=2021. Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data.|pdf=|usr=026}}
+{{tp|p=33602693|t=2021. SARS-CoV-2 genomic diversity and the implications for qRT-PCR diagnostics and transmission.|pdf=|usr=026}}
+{{tp|p=33581339|t=2021. Compositional Variability and Mutation Spectra of Monophyletic SARS-CoV-2 Clades.|pdf=|usr=026}}
+{{tp|p=33704069|t=2020. The Global Landscape of SARS-CoV-2 Genomes, Variants, and Haplotypes in 2019nCoVR.|pdf=|usr=026}}
+{{tp|p=33786200|t=2021. Global Evidence of Temperature Acclimation of COVID-19 D614G Linage.|pdf=|usr=026}}
+{{tp|p=33748343|t=2021. Diversity of Cardiac and Gastrointestinal Presentations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series.|pdf=|usr=026}}
+{{tp|p=33614843|t=2021. The "Golden Hours" Algorithm For the Management of the Multisystem Inflammatory Syndrome in Children (MIS-C).|pdf=|usr=026}}
+{{tp|p=33811541|t=2021. An update: the emerging evidence of complement involvement in COVID-19.|pdf=|usr=026}}
+{{tp|p=33795347|t=2021. Coding-Complete Genome Sequence of a SARS-CoV-2 Strain Isolated in Gilgit, Pakistan.|pdf=|usr=026}}
+{{tp|p=33795344|t=2021. Genome Sequence of a SARS-CoV-2 Strain from a COVID-19 Clinical Sample from the Khagrachari District of Bangladesh.|pdf=|usr=026}}
+{{tp|p=33800807|t=2021. Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 Infection.|pdf=|usr=026}}
+{{tp|p=33792241|t=2021. Diabetes and susceptibility to COVID-19: may miR-146a make the difference between life and death?|pdf=|usr=026}}
+{{tp|p=33761203|t=2021. New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.|pdf=|usr=026}}
+{{tp|p=33822491|t=2021. Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.|pdf=|usr=026}}
+{{tp|p=33795692|t=2021. Systems serology detects functionally distinct coronavirus antibody features in children and elderly.|pdf=|usr=026}}
+{{tp|p=33545711|t=2021. SARS-CoV-2 evolution during treatment of chronic infection.|pdf=|usr=026}}
+{{tp|p=33801496|t=2021. miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery.|pdf=|usr=026}}
+{{tp|p=33693814|t=2021. De novo 3D models of SARS-CoV-2 RNA elements from consensus experimental secondary structures.|pdf=|usr=026}}
+{{tp|p=33653907|t=2021. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19.|pdf=|usr=026}}
+{{tp|p=33692097|t=2021. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.|pdf=|usr=026}}
+{{tp|p=33622975|t=2021. Prolonged evolution of the human B cell response to SARS-CoV-2 infection.|pdf=|usr=026}}
+{{tp|p=33622974|t=2021. Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients.|pdf=|usr=026}}
+{{tp|p=33795722|t=2021. Analysis of SARS-CoV-2 genomic epidemiology reveals disease transmission coupled to variant emergence and allelic variation.|pdf=|usr=026}}
+{{tp|p=33723016|t=2021. T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals.|pdf=|usr=026}}
+{{tp|p=33658326|t=2021. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.|pdf=|usr=026}}
+{{tp|p=33727252|t=2021. Structural impact on SARS-CoV-2 spike protein by D614G substitution.|pdf=|usr=026}}
+{{tp|p=33688063|t=2021. SARS-CoV-2 within-host diversity and transmission.|pdf=|usr=026}}
+{{tp|p=33810465|t=2021. Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope.|pdf=|usr=026}}
+{{tp|p=33810456|t=2021. B-Cell Memory Responses to Variant Viral Antigens.|pdf=|usr=026}}
+{{tp|p=33810401|t=2021. Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure.|pdf=|usr=026}}
+{{tp|p=33810391|t=2021. An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity.|pdf=|usr=026}}
+{{tp|p=33806155|t=2021. Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells.|pdf=|usr=026}}
+{{tp|p=33804667|t=2021. Endogenously Produced SARS-CoV-2 Specific IgG Antibodies May Have a Limited Impact on Clearing Nasal Shedding of Virus during Primary Infection in Humans.|pdf=|usr=026}}
+{{tp|p=33801257|t=2021. The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense.|pdf=|usr=026}}
+{{tp|p=33808906|t=2021. Profiles of Peripheral Immune Cells of Uncomplicated COVID-19 Cases with Distinct Viral RNA Shedding Periods.|pdf=|usr=026}}
+{{tp|p=33804556|t=2021. SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations.|pdf=|usr=026}}
+{{tp|p=33704945|t=2021. Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33596363|t=2021. Audio Interview: Viral Variants and Covid-19.|pdf=|usr=026}}
+{{tp|p=33686287|t=2021. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33674800|t=2021. Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.|pdf=|usr=026}}
+{{tp|p=33531712|t=2021. Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.|pdf=|usr=026}}
+{{tp|p=33723418|t=2021. Lessons learned: new insights on the role of cytokines in COVID-19.|pdf=|usr=026}}
+{{tp|p=33723453|t=2021. Tracking the emergence of new SARS-CoV-2 variants in South Africa.|pdf=|usr=026}}
+{{tp|p=33654293|t=2021. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.|pdf=|usr=026}}
+{{tp|p=33589825|t=2021. Humoral signatures of protective and pathological SARS-CoV-2 infection in children.|pdf=|usr=026}}
+{{tp|p=33531709|t=2021. Sixteen novel lineages of SARS-CoV-2 in South Africa.|pdf=|usr=026}}
+{{tp|p=33649495|t=2021. Assessing the human immune response to SARS-CoV-2 variants.|pdf=|usr=026}}
+{{tp|p=33633408|t=2021. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity.|pdf=|usr=026}}
+{{tp|p=33727702|t=2021. ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity.|pdf=|usr=026}}
+{{tp|p=33767447|t=2021. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.|pdf=|usr=026}}
+{{tp|p=33723411|t=2021. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.|pdf=|usr=026}}
+{{tp|p=33684923|t=2021. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.|pdf=|usr=026}}
+{{tp|p=33737753|t=2021. Five reasons why COVID herd immunity is probably impossible.|pdf=|usr=026}}
+{{tp|p=33452513|t=2021. 'A bloody mess': Confusion reigns over naming of new COVID variants.|pdf=|usr=026}}
+{{tp|p=33452508|t=2021. Alarming COVID variants show vital role of genomic surveillance.|pdf=|usr=026}}
+{{tp|p=33547435|t=2021. Coronapod: Variants - what you need to know.|pdf=|usr=026}}
+{{tp|p=33547438|t=2021. Daily briefing: Call for fully open sharing of coronavirus genome.|pdf=|usr=026}}
+{{tp|p=33580217|t=2021. How 'killer' T cells could boost COVID immunity in face of new variants.|pdf=|usr=026}}
+{{tp|p=33558748|t=2021. Signs of self-sustained inflammatory circuits in severe COVID pneumonia.|pdf=|usr=026}}
+{{tp|p=33690265|t=2021. Detection of a SARS-CoV-2 variant of concern in South Africa.|pdf=|usr=026}}
+{{tp|p=33636719|t=2021. SARS-CoV-2 spike D614G change enhances replication and transmission.|pdf=|usr=026}}
+{{tp|p=33686269|t=2020. Daily briefing: A protein on the surface of the coronavirus might explain why it is so contagious.|pdf=|usr=026}}
+{{tp|p=33684269|t=2020. The Present State of Understanding of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection - A Comprehensive Review of the Current Literature.|pdf=|usr=026}}
+{{tp|p=33783027|t=2021. Coronavirus infection: An immunologists' perspective.|pdf=|usr=026}}
+{{tp|p=33664060|t=2021. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8(+) T cell responses.|pdf=|usr=026}}
+{{tp|p=33766871|t=2021. The emerging plasticity of SARS-CoV-2.|pdf=|usr=026}}
+{{tp|p=33737481|t=2021. Appropriate names for COVID-19 variants.|pdf=|usr=026}}
+{{tp|p=33737468|t=2021. Studies chase clues to immune syndrome in kids.|pdf=|usr=026}}
+{{tp|p=33707254|t=2021. Immunity to SARS-CoV-2 variants of concern.|pdf=|usr=026}}
+{{tp|p=33446545|t=2021. Bioactive lipids in antiviral immunity.|pdf=|usr=026}}
+{{tp|p=33542114|t=2021. Two new vaccines deliver good and bad news for the pandemic.|pdf=|usr=026}}
+{{tp|p=33632832|t=2021. SARS-CoV-2 dependence on host pathways.|pdf=|usr=026}}
+{{tp|p=33534399|t=2021. Immunopathological Roles of Neutrophils in Virus Infection and COVID-19.|pdf=|usr=026}}
+{{tp|p=34094684|t=2021. Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail.|pdf=|usr=027}}
+{{tp|p=33877321|t=2021. A Cytokine/Bradykinin Storm Comparison: What Is the Relationship Between Hypertension and COVID-19?|pdf=|usr=027}}
+{{tp|p=34052147|t=2021. Severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children mimicking Kawasaki disease.|pdf=|usr=027}}
+{{tp|p=34033995|t=2021. Sindrome inflamatorio multisistemico vinculado a SARS-CoV-2 en adolescente.|pdf=|usr=027}}
+{{tp|p=34016042|t=2021. Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil.|pdf=|usr=027}}
+{{tp|p=34074255|t=2021. Molecular epidemiology of SARS-CoV-2 isolated from COVID-19 family clusters.|pdf=|usr=027}}
+{{tp|p=33892639|t=2021. Online biophysical predictions for SARS-CoV-2 proteins.|pdf=|usr=027}}
+{{tp|p=34074244|t=2021. The Great Gut Mimicker: A case report of MIS-C and appendicitis clinical presentation overlap in a teenage patient.|pdf=|usr=027}}
+{{tp|p=34001211|t=2021. Shortcomings of SARS-CoV-2 genomic metadata.|pdf=|usr=027}}
+{{tp|p=33846193|t=2021. COVID-19-associated inflammatory syndrome in an adult woman with unexplained multiple organ failure: staying vigilant for COVID-19 complications as the pandemic surges.|pdf=|usr=027}}
+{{tp|p=33952579|t=2021. COVID-19 rise in Bangladesh correlates with incre<iframe src="http://www.kidney.de/amapp.php?a=g detection of B.1.351 variant.|pdf=|usr=027}}
+{{tp|p=33892096|t=2021. Electron microscopy identification of SARS-COV-2: what is the evidence?|pdf=|usr=027}}
+{{tp|p=33865959|t=2021. Electron microscopic identification of SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33965336|t=2021. Role of striated muscles in the pathogenesis of COVID-19.|pdf=|usr=027}}
+{{tp|p=34075603|t=2021. Genetic and epigenetic control of ACE2 expression and its possible role in COVID-19.|pdf=|usr=027}}
+{{tp|p=34096226|t=2021. Is There any Alternative Receptor for SARS-CoV-2?|pdf=|usr=027}}
+{{tp|p=33980782|t=2021. Multisystem Inflammatory Syndrome in Children- A New Syndrome Complicated With Acute Heart Failure Following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.|pdf=|usr=027}}
+{{tp|p=33980688|t=2021. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.|pdf=|usr=027}}
+{{tp|p=33969287|t=2021. Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=33845428|t=2021. Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or "just" a marker of bacterial coinfection?|pdf=|usr=027}}
+{{tp|p=33900174|t=2021. Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.|pdf=|usr=027}}
+{{tp|p=33928885|t=2021. SARS-CoV-2 mutations: the biological trackway towards viral fitness.|pdf=|usr=027}}
+{{tp|p=34084779|t=2021. ERS International Congress 2020: highlights from the Clinical Techniques, Imaging and Endoscopy assembly.|pdf=|usr=027}}
+{{tp|p=33332751|t=2021. Myocarditis and coronary aneurysms in a child with acute respiratory syndrome coronavirus 2.|pdf=|usr=027}}
+{{tp|p=34055690|t=2021. Case Report: Neonatal Multi-System Inflammatory Syndrome Associated With SARS-CoV-2 Exposure in Two Cases From Saudi Arabia.|pdf=|usr=027}}
+{{tp|p=33919536|t=2021. Successful Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 (PIMS-TS) with Split Doses of Immunoglobulin G and Estimation of PIMS-TS Incidence in a County District in Southern Germany.|pdf=|usr=027}}
+{{tp|p=33898797|t=2021. Identification of PBMC-based molecular signature associational with COVID-19 disease severity.|pdf=|usr=027}}
+{{tp|p=33898857|t=2021. Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing.|pdf=|usr=027}}
+{{tp|p=34075889|t=2021. Mechanism of inflammasome activation by SARS coronavirus 3a protein: abridged secondary publication.|pdf=|usr=027}}
+{{tp|p=33962680|t=2021. An application of slow feature analysis to the genetic sequences of coronaviruses and influenza viruses.|pdf=|usr=027}}
+{{tp|p=33576949|t=2021. The Multisystem Inflammatory Syndrome of Childhood (MIS-C).|pdf=|usr=027}}
+{{tp|p=33864452|t=2021. Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2: A Retrospective Cohort Study From Argentina.|pdf=|usr=027}}
+{{tp|p=33876782|t=2021. Clinical Profile and Short-Term Outcome of Children With SARS-CoV-2 Related Multisystem Inflammatory Syndrome (MIS-C) Treated With Pulse Methylprednisolone.|pdf=|usr=027}}
+{{tp|p=34086418|t=2021. Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.|pdf=|usr=027}}
+{{tp|p=34104087|t=2021. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons in vitro and in vivo.|pdf=|usr=027}}
+{{tp|p=34066920|t=2021. IgM and IgG Immunoreactivity of SARS-CoV-2 Recombinant M Protein.|pdf=|usr=027}}
+{{tp|p=34039006|t=2021. Conformational Ensembles of Noncoding Elements in the SARS-CoV-2 Genome from Molecular Dynamics Simulations.|pdf=|usr=027}}
+{{tp|p=34086443|t=2021. A Trimeric Hydrophobic Zipper Mediates the Intramembrane Assembly of SARS-CoV-2 Spike.|pdf=|usr=027}}
+{{tp|p=33367709|t=2021. SARS-CoV-2 Serologic Immune Response in Exogenously Immunosuppressed Patients.|pdf=|usr=027}}
+{{tp|p=33913101|t=2021. Expression map of entry receptors and infectivity factors for pan-coronaviruses in preimplantation and implantation stage human embryos.|pdf=|usr=027}}
+{{tp|p=33965698|t=2021. Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19.|pdf=|usr=027}}
+{{tp|p=33880178|t=2021. What could be the potential reasons for relatively low coronavirus disease 2019 (COVID-19) fatality rates in Africa? The case for Ethiopia.|pdf=|usr=027}}
+{{tp|p=34080738|t=2021. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.|pdf=|usr=027}}
+{{tp|p=34048113|t=2021. What drives transmission of severe acute respiratory syndrome coronavirus 2?|pdf=|usr=027}}
+{{tp|p=34057753|t=2021. Severe COVID-19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin.|pdf=|usr=027}}
+{{tp|p=34057760|t=2021. Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats.|pdf=|usr=027}}
+{{tp|p=33866607|t=2021. The good, the bad and the ugly: G-CSF, ageing and neutrophils-Implications for severe COVID-19.|pdf=|usr=027}}
+{{tp|p=33847393|t=2021. As a matter of fat: Leptin, monocyte hyperactivation, and COVID-19: A commentary to "Leptin correlates with monocytes activation and severe condition in COVID-19 patients".|pdf=|usr=027}}
+{{tp|p=33909917|t=2021. Emergence of immunosuppressive LOX-1+ PMN-MDSC in septic shock and severe COVID-19 patients with acute respiratory distress syndrome.|pdf=|usr=027}}
+{{tp|p=33847407|t=2021. TRB sequences targeting ORF1a/b are associated with disease severity in hospitalized COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33908113|t=2021. Cardiac injury and vasoplegia in critically ill children due to multisystem inflammatory syndrome in children associated with COVID-19.|pdf=|usr=027}}
+{{tp|p=33358846|t=2021. Electrocardiographic Changes in Children with Multisystem Inflammation Associated with COVID-19: Associated with Coronavirus Disease 2019.|pdf=|usr=027}}
+{{tp|p=33979162|t=2021. Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor.|pdf=|usr=027}}
+{{tp|p=33900080|t=2021. Tuning Proton Transfer Thermodynamics in SARS-CoV-2 Main Protease: Implications for Catalysis and Inhibitor Design.|pdf=|usr=027}}
+{{tp|p=33999630|t=2021. Mechanism of Ligand Recognition by Human ACE2 Receptor.|pdf=|usr=027}}
+{{tp|p=33306377|t=2021. Candidate Binding Sites for Allosteric Inhibition of the SARS-CoV-2 Main Protease from the Analysis of Large-Scale Molecular Dynamics Simulations.|pdf=|usr=027}}
+{{tp|p=33881894|t=2021. Intermolecular Interaction Analyses on SARS-CoV-2 Spike Protein Receptor Binding Domain and Human Angiotensin-Converting Enzyme 2 Receptor-Blocking Antibody/Peptide Using Fragment Molecular Orbital Calculation.|pdf=|usr=027}}
+{{tp|p=33856796|t=2021. Identification and Characterization of Species-Specific Severe Acute Respiratory Syndrome Coronavirus 2 Physicochemical Properties.|pdf=|usr=027}}
+{{tp|p=34080435|t=2021. Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage.|pdf=|usr=027}}
+{{tp|p=33949663|t=2021. Gut microbiome and resistome changes during the first wave of the COVID-19 pandemic in comparison with pre-pandemic travel-related changes.|pdf=|usr=027}}
+{{tp|p=33949647|t=2021. SARS-CoV-2 Genomic Surveillance in Northeast Brazil: Timing of Emergence of the Brazilian Variant of Concern P1.|pdf=|usr=027}}
+{{tp|p=33980601|t=2021. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.|pdf=|usr=027}}
+{{tp|p=33853975|t=2021. Identification of B.1.346 Lineage of SARS-CoV-2 in Japan: Genomic Evidence of Re-entry of Clade 20C.|pdf=|usr=027}}
+{{tp|p=33361386|t=2021. Biological Significance of Anti-SARS-CoV-2 Antibodies: Lessons Learned From Progressive Multifocal Leukoencephalopathy.|pdf=|usr=027}}
+{{tp|p=34021058|t=2021. Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33850037|t=2021. Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33854695|t=2021. Predicting Severity and Intrahospital Mortality in COVID-19: The Place and Role of Oxidative Stress.|pdf=|usr=027}}
+{{tp|p=33995781|t=2021. A case of multisystem inflammatory syndrome in an African adolescent male: case report.|pdf=|usr=027}}
+{{tp|p=33917609|t=2021. Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.|pdf=|usr=027}}
+{{tp|p=33946190|t=2021. Seasonal Stability of SARS-CoV-2 in Biological Fluids.|pdf=|usr=027}}
+{{tp|p=33923138|t=2021. Microscopic Observation of SARS-Like Particles in RT-qPCR SARS-CoV-2 Positive Sewage Samples.|pdf=|usr=027}}
+{{tp|p=33922476|t=2021. Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection.|pdf=|usr=027}}
+{{tp|p=33920011|t=2021. Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children?|pdf=|usr=027}}
+{{tp|p=33955167|t=2021. How we approach thrombosis risk in children with COVID-19 infection and MIS-C.|pdf=|usr=027}}
+{{tp|p=32706422|t=2021. Peripheral blood smears of children with multisystem inflammatory syndrome demonstrate prominence of early myeloid forms with morphologic evidence of toxic change.|pdf=|usr=027}}
+{{tp|p=34076713|t=2021. Multisystem Inflammatory Syndrome Associated with COVID-19 Anti-thrombosis Guideline of Care for Children by Action.|pdf=|usr=027}}
+{{tp|p=33333460|t=2021. Increased Intracranial Pressure in the Setting of Multisystem Inflammatory Syndrome in Children, Associated With COVID-19.|pdf=|usr=027}}
+{{tp|p=33904952|t=2021. Imaging findings of multisystem inflammatory syndrome in children associated with COVID-19.|pdf=|usr=027}}
+{{tp|p=33855870|t=2021. Can cilia provide an entry gateway for SARS-CoV-2 to human ciliated cells?|pdf=|usr=027}}
+{{tp|p=34038453|t=2021. Increased elastase sensitivity and decreased intramolecular interactions in the more transmissible 501Y.V1 and 501Y.V2 SARS-CoV-2 variants' spike protein-an in silico analysis.|pdf=|usr=027}}
+{{tp|p=34038423|t=2021. SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans.|pdf=|usr=027}}
+{{tp|p=34033650|t=2021. SARS-CoV-2: Possible recombination and emergence of potentially more virulent strains.|pdf=|usr=027}}
+{{tp|p=33914789|t=2021. Analysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq.|pdf=|usr=027}}
+{{tp|p=33909660|t=2021. Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein.|pdf=|usr=027}}
+{{tp|p=33857216|t=2021. I-FABP is decreased in COVID-19 patients, independently of the prognosis.|pdf=|usr=027}}
+{{tp|p=33826681|t=2021. Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts.|pdf=|usr=027}}
+{{tp|p=33972411|t=2021. COVID-19 induces lower levels of IL-8, IL-10, and MCP-1 than other acute CRS-inducing diseases.|pdf=|usr=027}}
+{{tp|p=33972410|t=2021. 2'-O methylation of RNA cap in SARS-CoV-2 captured by serial crystallography.|pdf=|usr=027}}
+{{tp|p=33958444|t=2021. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.|pdf=|usr=027}}
+{{tp|p=34108245|t=2021. HIF-1alpha is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes.|pdf=|usr=027}}
+{{tp|p=34001664|t=2021. Detection of differentially abundant cell subpopulations in scRNA-seq data.|pdf=|usr=027}}
+{{tp|p=33874647|t=2021. Children with Kawasaki disease or Kawasaki-like syndrome (MIS-C/PIMS) at the time of COVID-19: are they all the same? Case series and literature review.|pdf=|usr=027}}
+{{tp|p=33350025|t=2021. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.|pdf=|usr=027}}
+{{tp|p=34111408|t=2021. Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies.|pdf=|usr=027}}
+{{tp|p=34096649|t=2021. Virus-triggered secondary hemophagocytic lymphohistiocytosis.|pdf=|usr=027}}
+{{tp|p=33915561|t=2021. INSTRUCTIONS: A Case of Multisystem Inflammatory Syndrome in Children Following SARS-CoV-2 Infection in a Rural Emergency Department.|pdf=|usr=027}}
+{{tp|p=34031864|t=2021. Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond.|pdf=|usr=027}}
+{{tp|p=33973178|t=2021. COVID-19 and Cell Stress.|pdf=|usr=027}}
+{{tp|p=33973177|t=2021. Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV.|pdf=|usr=027}}
+{{tp|p=33892139|t=2021. Double stranded RNA drives anti-viral innate immune responses, sickness behavior and cognitive dysfunction dependent on dsRNA length, IFNAR1 expression and age.|pdf=|usr=027}}
+{{tp|p=33838447|t=2021. Comments on the ambiguity of selected surface markers, signaling pathways and omics profiles hampering the identification of myeloid-derived suppressor cells.|pdf=|usr=027}}
+{{tp|p=33853355|t=2021. An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts.|pdf=|usr=027}}
+{{tp|p=33797464|t=2021. Addressing long-acting reversible contraception access, bias, and coercion: supporting adolescent and young adult reproductive autonomy.|pdf=|usr=027}}
+{{tp|p=34024159|t=2021. SARS-CoV-2 variants: A double-edged sword?|pdf=|usr=027}}
+{{tp|p=33960608|t=2021. Glucose-regulated protein (GRP78) is an important cell surface receptor for viral invasion, cancers, and neurological disorders.|pdf=|usr=027}}
+{{tp|p=34049971|t=2021. Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19.|pdf=|usr=027}}
+{{tp|p=33885337|t=2021. Linkage of Lambda Interferons in Protection Against Severe COVID-19.|pdf=|usr=027}}
+{{tp|p=33704847|t=2021. ACUTE EPIDIDYMITIS ASSOCIATED WITH MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN.|pdf=|usr=027}}
+{{tp|p=34011547|t=2021. Unique Mutations in the Murine Hepatitis Virus Macrodomain Differentially Attenuate Virus Replication, Indicating Multiple Roles for the Macrodomain in Coronavirus Replication.|pdf=|usr=027}}
+{{tp|p=34044706|t=2021. Immune Responses in Patients with COVID-19: An Overview.|pdf=|usr=027}}
+{{tp|p=33892833|t=2021. A comparative study of immunoglobulin only and immunoglobulin with methylprednisolone for treating children with Multisystem Inflammatory Syndrome.|pdf=|usr=027}}
+{{tp|p=34034587|t=2021. Extracorporeal membrane oxygenation for multisystem inflammatory syndrome in children.|pdf=|usr=027}}
+{{tp|p=33936927|t=2021. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2.|pdf=|usr=027}}
+{{tp|p=33190340|t=2021. Multisystem inflammatory syndrome in children rose and fell with the first wave of the COVID-19 pandemic in France.|pdf=|usr=027}}
+{{tp|p=33915560|t=2021. A Case of Multisystem Inflammatory Syndrome in Children Following SARS-CoV-2 Infection in a Rural Emergency Department.|pdf=|usr=027}}
+{{tp|p=34028045|t=2021. Long-term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=33884644|t=2021. Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19.|pdf=|usr=027}}
+{{tp|p=34082189|t=2021. Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: A meta-analysis.|pdf=|usr=027}}
+{{tp|p=34092033|t=2021. T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19.|pdf=|usr=027}}
+{{tp|p=33835707|t=2021. Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients.|pdf=|usr=027}}
+{{tp|p=33830438|t=2021. Intramuscular deposit of calcium is a potential reason for hypocalcaemia in COVID-19.|pdf=|usr=027}}
+{{tp|p=33987131|t=2021. COVID-19-related Multisystem Inflammatory Syndrome in a Young Adult.|pdf=|usr=027}}
+{{tp|p=34084077|t=2021. SARS-Cov2 S Protein Features Potential Estrogen Binding Site.|pdf=|usr=027}}
+{{tp|p=33842877|t=2021. Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data.|pdf=|usr=027}}
+{{tp|p=34055851|t=2021. Gut Microbiota May Not Be Fully Restored in Recovered COVID-19 Patients After 3-Month Recovery.|pdf=|usr=027}}
+{{tp|p=33937152|t=2021. Case Report: MIS-C Temporarily Associated With COVID-19 Complicated by Reye's Syndrome.|pdf=|usr=027}}
+{{tp|p=33937149|t=2021. Effects of Coronavirus Disease 2019 (COVID-19) on Peripheral Blood Lymphocytes and Their Subsets in Children: Imbalanced CD4(+)/CD8(+) T Cell Ratio and Disease Severity.|pdf=|usr=027}}
+{{tp|p=33898353|t=2021. Case Report: Inflammation and Endothelial Injury Profiling of COVID-19 Pediatric Multisystem Inflammatory Syndrome (MIS-C).|pdf=|usr=027}}
+{{tp|p=33995033|t=2021. SARS-CoV-2 Switches 'on' MAPK and NFkappaB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression.|pdf=|usr=027}}
+{{tp|p=33960807|t=2021. Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes.|pdf=|usr=027}}
+{{tp|p=33847161|t=2021. Herd immunity: could it bring the COVID-19 pandemic to an end?|pdf=|usr=027}}
+{{tp|p=34035830|t=2021. SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses.|pdf=|usr=027}}
+{{tp|p=34095559|t=2021. Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19.|pdf=|usr=027}}
+{{tp|p=34075347|t=2021. SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of the immune cells.|pdf=|usr=027}}
+{{tp|p=33883951|t=2021. Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis.|pdf=|usr=027}}
+{{tp|p=33307805|t=2021. Immunity to glycan alpha-Gal and possibilities for the control of COVID-19.|pdf=|usr=027}}
+{{tp|p=34045815|t=2021. Multiple Peaked Cytokine Storm: Is Multiple Exposures to the COVID-19 Virus a Possible Cause?|pdf=|usr=027}}
+{{tp|p=33937889|t=2021. ROS-Driven selection pressure on COVID-19 patients with cardiovascular comorbidities.|pdf=|usr=027}}
+{{tp|p=33310028|t=2021. Dynamic anti-spike protein antibody profiles in COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=34069441|t=2021. Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33946935|t=2021. Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils.|pdf=|usr=027}}
+{{tp|p=33925779|t=2021. PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection-"Rheumatic Fever" of the 21st Century?|pdf=|usr=027}}
+{{tp|p=33835207|t=2021. Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33928414|t=2021. COVID-19-associated autoimmunity as a feature of acute respiratory failure.|pdf=|usr=027}}
+{{tp|p=33937724|t=2021. Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses.|pdf=|usr=027}}
+{{tp|p=33898942|t=2021. Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=34095780|t=2021. Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain.|pdf=|usr=027}}
+{{tp|p=33997662|t=2021. Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids.|pdf=|usr=027}}
+{{tp|p=33969281|t=2021. Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patients.|pdf=|usr=027}}
+{{tp|p=33319167|t=2021. Structural characterization of nonstructural protein 1 from SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33319166|t=2021. Transcriptional response modules characterize IL-1beta and IL-6 activity in COVID-19.|pdf=|usr=027}}
+{{tp|p=33957250|t=2021. Echocardiographic Indicators Associated with Adverse Clinical Course and Cardiac Sequelae in Multisystem Inflammatory Syndrome in Children with Coronavirus Disease 2019.|pdf=|usr=027}}
+{{tp|p=34052944|t=2021. Multisystem inflammatory syndrome in children during the coronavirus disease pandemic of 2019: a review of clinical features and acute phase management.|pdf=|usr=027}}
+{{tp|p=33893156|t=2021. Kinetics of SARS-CoV-2 antibody responses pre-COVID-19 and post-COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study.|pdf=|usr=027}}
+{{tp|p=34007808|t=2021. Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease.|pdf=|usr=027}}
+{{tp|p=33838966|t=2021. Multisystem Inflammatory Syndrome in an Adult.|pdf=|usr=027}}
+{{tp|p=34041138|t=2021. Critical interpretative synthesis of herd immunity for COVID-19 pandemic.|pdf=|usr=027}}
+{{tp|p=34041049|t=2021. Association of coronavirus pathogencity with the level of antioxidants and immune system.|pdf=|usr=027}}
+{{tp|p=33930487|t=2021. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.|pdf=|usr=027}}
+{{tp|p=33956645|t=2021. Whole Genome Sequencing and Phylogenetic Analysis of SARSCoV2 strains in Turkey.|pdf=|usr=027}}
+{{tp|p=33870434|t=2021. SARS-CoV-2 Total and Subgenomic RNA Viral Load in Hospitalized Patients.|pdf=|usr=027}}
+{{tp|p=34023234|t=2021. Immunological map in COVID-19.|pdf=|usr=027}}
+{{tp|p=33880442|t=2021. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms.|pdf=|usr=027}}
+{{tp|p=34059065|t=2021. Exosomes contribution in COVID-19 patients' treatment.|pdf=|usr=027}}
+{{tp|p=34090468|t=2021. SARS-CoV-2 complete genome sequencing from the Italian Campania region using a highly automated next generation sequencing system.|pdf=|usr=027}}
+{{tp|p=34032853|t=2021. Association of Circulating Sex Hormones With Inflammation and Disease Severity in Patients With COVID-19.|pdf=|usr=027}}
+{{tp|p=34009354|t=2021. The Multisystem Inflammatory Syndrome in Adults With SARS-CoV-2 Infection-Another Piece of an Expanding Puzzle.|pdf=|usr=027}}
+{{tp|p=34009351|t=2021. Characteristics Associated With Multisystem Inflammatory Syndrome Among Adults With SARS-CoV-2 Infection.|pdf=|usr=027}}
+{{tp|p=33907361|t=2021. Differences in Interactions Within Viral Replication Complexes of SARS-CoV-2 (COVID-19) and SARS-CoV Coronaviruses Control RNA Replication Ability.|pdf=|usr=027}}
+{{tp|p=33844997|t=2021. COVID-19 severity and obesity: are MAIT cells a factor?|pdf=|usr=027}}
+{{tp|p=33882487|t=2021. Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations.|pdf=|usr=027}}
+{{tp|p=34069835|t=2021. Evaluation of SARS-CoV-2 Spike S1 Protein Response on PI3K-Mediated IL-8 Release.|pdf=|usr=027}}
+{{tp|p=33974614|t=2021. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology.|pdf=|usr=027}}
+{{tp|p=34070998|t=2021. Presence of SARS-CoV-2 and Its Entry Factors in Oral Tissues and Cells: A Systematic Review.|pdf=|usr=027}}
+{{tp|p=34075268|t=2021. Papel del sistema inmune en la infeccion por el SARS-CoV-2: inmunopatologia de la COVID-19.|pdf=|usr=027}}
+{{tp|p=33364597|t=2021. Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis.|pdf=|usr=027}}
+{{tp|p=33305919|t=2021. Insights on Kawasaki disease and multisystem inflammatory syndrome: relationship with COVID-19 infection.|pdf=|usr=027}}
+{{tp|p=33890746|t=2021. SARS-CoV-2 associated multisystem inflammatory syndrome in children (MIS-C). A single center's experience.|pdf=|usr=027}}
+{{tp|p=33939073|t=2021. miR-200c-3p upregulation and ACE2 downregulation via bacterial LPS and LTA as interesting aspects for COVID-19 treatment and immunity.|pdf=|usr=027}}
+{{tp|p=34001144|t=2021. The intersection of COVID-19 and cancer: signaling pathways and treatment implications.|pdf=|usr=027}}
+{{tp|p=33930332|t=2021. Functional landscape of SARS-CoV-2 cellular restriction.|pdf=|usr=027}}
+{{tp|p=33989516|t=2021. The SARS-CoV-2 RNA interactome.|pdf=|usr=027}}
+{{tp|p=34089862|t=2021. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research.|pdf=|usr=027}}
+{{tp|p=34098591|t=2021. An Impaired Inflammatory and Innate Immune Response in COVID-19.|pdf=|usr=027}}
+{{tp|p=34059562|t=2021. Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis.|pdf=|usr=027}}
+{{tp|p=34031419|t=2021. Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=34095334|t=2021. High Prevalence of SARS-CoV-2 Genetic Variation and D614G Mutation in Pediatric Patients With COVID-19.|pdf=|usr=027}}
+{{tp|p=34006982|t=2021. Systemic inflammatory syndrome in COVID-19-SISCoV study: systematic review and meta-analysis.|pdf=|usr=027}}
+{{tp|p=33903171|t=2021. Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike.|pdf=|usr=027}}
+{{tp|p=33883267|t=2021. Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex.|pdf=|usr=027}}
+{{tp|p=33864498|t=2021. The importance of heart and brain imaging in children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C).|pdf=|usr=027}}
+{{tp|p=33910269|t=2021. Evaluation of oxidative stress markers in hospitalized patients with moderate and severe COVID-19.|pdf=|usr=027}}
+{{tp|p=33853928|t=2021. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8(+) T cell activation in COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33963249|t=2021. Angiotensin converting enzyme 2 is a novel target of the gamma-secretase complex.|pdf=|usr=027}}
+{{tp|p=33958627|t=2021. Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress.|pdf=|usr=027}}
+{{tp|p=34031464|t=2021. Estimates of gene ensemble noise highlight critical pathways and predict disease severity in H1N1, COVID-19 and mortality in sepsis patients.|pdf=|usr=027}}
+{{tp|p=34021237|t=2021. SARS-CoV-2 and other human coronavirus show genome patterns previously associated to reduced viral recognition and altered immune response.|pdf=|usr=027}}
+{{tp|p=34021205|t=2021. Flow cytometry detection of sustained humoral immune response (IgG + IgA) against native spike glycoprotein in asymptomatic/mild SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=34017039|t=2021. Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection.|pdf=|usr=027}}
+{{tp|p=34108608|t=2021. A single transcript for the prognosis of disease severity in COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=34108510|t=2021. Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors.|pdf=|usr=027}}
+{{tp|p=33911163|t=2021. Unraveling the stability landscape of mutations in the SARS-CoV-2 receptor-binding domain.|pdf=|usr=027}}
+{{tp|p=33911109|t=2021. Coiled-coil heterodimers with increased stability for cellular regulation and sensing SARS-CoV-2 spike protein-mediated cell fusion.|pdf=|usr=027}}
+{{tp|p=33903660|t=2021. Analysis of IgM, IgA, and IgG isotype antibodies Directed against SARS-CoV-2 spike glycoprotein and ORF8 in the course of COVID-19.|pdf=|usr=027}}
+{{tp|p=34002169|t=2021. Sample processing and single cell RNA-sequencing of peripheral blood immune cells from COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33979601|t=2021. Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33979600|t=2021. SARS-CoV-2 targets glial cells in human cortical organoids.|pdf=|usr=027}}
+{{tp|p=33932324|t=2021. Conformational flexibility and structural variability of SARS-CoV2 S protein.|pdf=|usr=027}}
+{{tp|p=33896688|t=2021. Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses.|pdf=|usr=027}}
+{{tp|p=33843171|t=2021. Impact of COVID-19 on serum melatonin levels and sleep parameters in children|pdf=|usr=027}}
+{{tp|p=33358968|t=2021. A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications.|pdf=|usr=027}}
+{{tp|p=34064525|t=2021. Identification of the SHREK Family of Proteins as Broad-Spectrum Host Antiviral Factors.|pdf=|usr=027}}
+{{tp|p=34072720|t=2021. Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections.|pdf=|usr=027}}
+{{tp|p=34072569|t=2021. Characterization of a Novel SARS-CoV-2 Genetic Variant with Distinct Spike Protein Mutations.|pdf=|usr=027}}
+{{tp|p=33973189|t=2021. Autoimmune Processes Involved in Organ System Failure Following Infection with SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33827042|t=2021. The first SARS-CoV-2 genetic variants of concern (VOC) in Poland: The concept of a comprehensive approach to monitoring and surveillance of emerging variants.|pdf=|usr=027}}
+{{tp|p=33980331|t=2021. Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: Possible favorable mechanisms of interaction.|pdf=|usr=027}}
+{{tp|p=33872261|t=2021. CE: Multisystem Inflammatory Syndrome in Children: A Review.|pdf=|usr=027}}
+{{tp|p=33970826|t=2021. Genetic Variants of SARS-CoV-2: What Do We Know So Far?|pdf=|usr=027}}
+{{tp|p=33950792|t=2021. Molecular Interactions of SARS-CoV-2 in Lung Tissue of Patients with Chronic Obstructive Pulmonary Disease.|pdf=|usr=027}}
+{{tp|p=33349108|t=2021. Search for SARS-CoV-2 RNA in platelets from COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=34035118|t=2021. SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.|pdf=|usr=027}}
+{{tp|p=34035116|t=2021. Polyclonal expansion of TCR Vbeta 21.3(+) CD4(+) and CD8(+) T cells is a hallmark of Multisystem Inflammatory Syndrome in Children.|pdf=|usr=027}}
+{{tp|p=34088747|t=2021. Anti-body antibodies in COVID-19.|pdf=|usr=027}}
+{{tp|p=33887214|t=2021. Coronavirus Activates an Altruistic Stem Cell-Mediated Defense Mechanism that Reactivates Dormant Tuberculosis: Implications in Coronavirus Disease 2019 Pandemic.|pdf=|usr=027}}
+{{tp|p=33844596|t=2021. Unraveling the thread of uncontrolled immune response in COVID-19 and STEMI: an emerging need for knowledge sharing.|pdf=|usr=027}}
+{{tp|p=33978488|t=2021. The oxygen dissociation curve of blood in COVID-19.|pdf=|usr=027}}
+{{tp|p=33895472|t=2021. SARS-CoV-2 variants of concern: the knowns and unknowns.|pdf=|usr=027}}
+{{tp|p=34033926|t=2021. Preliminary data on severe SARS-CoV-2 infection caused by the 501Y.V2 variant.|pdf=|usr=027}}
+{{tp|p=33871970|t=2021. Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells.|pdf=|usr=027}}
+{{tp|p=33991784|t=2021. Diffuse interstitial pneumonia-like/macrophage activation syndrome-like changes in patients with COVID-19 correlate with length of illness.|pdf=|usr=027}}
+{{tp|p=33987283|t=2021. How will emerging SARS-CoV-2 variants impact herd immunity?|pdf=|usr=027}}
+{{tp|p=34066389|t=2021. Comparison of Immunological Profiles of SARS-CoV-2 Variants in the COVID-19 Pandemic Trends: An Immunoinformatics Approach.|pdf=|usr=027}}
+{{tp|p=33950288|t=2021. The interplay between the immune system and SARS-CoV-2 in COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33880885|t=2021. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.|pdf=|usr=027}}
+{{tp|p=34043002|t=2021. Identification of evolutionarily stable functional and immunogenic sites across the SARS-CoV-2 proteome and greater coronavirus family.|pdf=|usr=027}}
+{{tp|p=33895804|t=2021. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C.|pdf=|usr=027}}
+{{tp|p=33986186|t=2021. Leukoerythroblastosis with dyserythropoiesis in an adolescent with SARS-CoV-2-associated macrophage activation syndrome.|pdf=|usr=027}}
+{{tp|p=33832550|t=2021. MUC1-C influences cell survival in lung adenocarcinoma Calu-3 cells after SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=33941085|t=2021. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.|pdf=|usr=027}}
+{{tp|p=33985433|t=2021. IPD 2.0: To derive insights from an evolving SARS-CoV-2 genome.|pdf=|usr=027}}
+{{tp|p=34044758|t=2021. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.|pdf=|usr=027}}
+{{tp|p=33858331|t=2021. Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy.|pdf=|usr=027}}
+{{tp|p=34011641|t=2021. Complicated case of COVID-19 disease with overlapping features of thrombotic thrombocytopenic purpura and haemophagocytic lymphohistiocytosis.|pdf=|usr=027}}
+{{tp|p=33980565|t=2021. Rare presentation of multisystem inflammatory syndrome in an adult associated with SARS-CoV-2 infection: unilateral neck swelling.|pdf=|usr=027}}
+{{tp|p=33975844|t=2021. Sinus bradycardia in a toddler with multisystem inflammatory syndrome in children (MIS-C) related to COVID-19.|pdf=|usr=027}}
+{{tp|p=33888480|t=2021. Pneumatosis intestinalis and intestinal perforation in a case of multisystem inflammatory syndrome in children.|pdf=|usr=027}}
+{{tp|p=33883119|t=2021. Adult multisystem inflammatory syndrome in a patient who recovered from COVID-19 postvaccination.|pdf=|usr=027}}
+{{tp|p=33858888|t=2021. Post-infectious inflammatory syndrome associated with SARS-CoV-2 in a paediatric patient with Down syndrome.|pdf=|usr=027}}
+{{tp|p=33849879|t=2021. COVID-19 multisystemic inflammatory syndrome in adults: a not to be missed diagnosis.|pdf=|usr=027}}
+{{tp|p=33884312|t=2021. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan.|pdf=|usr=027}}
+{{tp|p=34031875|t=2021. COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations.|pdf=|usr=027}}
+{{tp|p=33993471|t=2021. Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19: response.|pdf=|usr=027}}
+{{tp|p=33956332|t=2021. Functional and tissue enrichment analyses suggest that SARS-CoV-2 infection affects host metabolism and catabolism mediated by interference on host proteins.|pdf=|usr=027}}
+{{tp|p=33907801|t=2021. Analyzing master regulators and scRNA-seq of COVID-19 patients reveals an underlying anti-SARS-CoV-2 mechanism of ZNF proteins.|pdf=|usr=027}}
+{{tp|p=33885735|t=2021. New framework for recombination and adaptive evolution analysis with application to the novel coronavirus SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33885726|t=2021. Comparative phylogenetic analysis of SARS-CoV-2 spike protein-possibility effect on virus spillover.|pdf=|usr=027}}
+{{tp|p=33837760|t=2021. Letter to the Editor: Significant mutation enrichment in inverted repeat sites of new SARS-CoV-2 strains.|pdf=|usr=027}}
+{{tp|p=33956950|t=2021. The peripheral and core regions of virus-host network of COVID-19.|pdf=|usr=027}}
+{{tp|p=34015809|t=2021. Global characterization of B cell receptor repertoire in COVID-19 patients by single-cell V(D)J sequencing.|pdf=|usr=027}}
+{{tp|p=34013346|t=2021. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.|pdf=|usr=027}}
+{{tp|p=33993223|t=2021. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders.|pdf=|usr=027}}
+{{tp|p=33377145|t=2021. Evolutionary and codon usage preference insights into spike glycoprotein of SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33341900|t=2021. SARS-CoV-2 hot-spot mutations are significantly enriched within inverted repeats and CpG island loci.|pdf=|usr=027}}
+{{tp|p=33341869|t=2021. Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19.|pdf=|usr=027}}
+{{tp|p=33333559|t=2021. Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 disease.|pdf=|usr=027}}
+{{tp|p=34097003|t=2021. Detecting SARS-CoV-2 and its variant strains with a full genome tiling array.|pdf=|usr=027}}
+{{tp|p=34076249|t=2021. Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions.|pdf=|usr=027}}
+{{tp|p=34037874|t=2021. Compartmental Model Suggests Importance of Innate Immune Response to COVID-19 Infection in Rhesus Macaques.|pdf=|usr=027}}
+{{tp|p=33907373|t=2021. Identification of selected genes associated with the SARS-CoV-2: a therapeutic approach and disease severity.|pdf=|usr=027}}
+{{tp|p=34090979|t=2021. Kawasaki Disease Shock Syndrome versus classical Kawasaki Disease, a Meta-analysis and comparison with SARS-CoV-2 Multisystem Inflammatory Syndrome.|pdf=|usr=027}}
+{{tp|p=34082849|t=2021. Left ventricular thrombus in multisystem inflammatory syndrome in children associated with COVID-19.|pdf=|usr=027}}
+{{tp|p=33962629|t=2021. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.|pdf=|usr=027}}
+{{tp|p=34010620|t=2021. High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies.|pdf=|usr=027}}
+{{tp|p=33852911|t=2021. Antibody evasion by the P.1 strain of SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33891875|t=2021. Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.|pdf=|usr=027}}
+{{tp|p=33861950|t=2021. Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.|pdf=|usr=027}}
+{{tp|p=33831372|t=2021. SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms.|pdf=|usr=027}}
+{{tp|p=33991511|t=2021. Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs.|pdf=|usr=027}}
+{{tp|p=33991510|t=2021. Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19.|pdf=|usr=027}}
+{{tp|p=33974846|t=2021. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities.|pdf=|usr=027}}
+{{tp|p=33961823|t=2021. METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=33961822|t=2021. Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection.|pdf=|usr=027}}
+{{tp|p=33932326|t=2021. Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33897278|t=2021. The dual role of the immune system in the course of COVID-19. The fatal impact of the aging immune system.|pdf=|usr=027}}
+{{tp|p=33967407|t=2021. A fractional-order differential equation model of COVID-19 infection of epithelial cells.|pdf=|usr=027}}
+{{tp|p=33965937|t=2021. Viral Replication and Antibody Kinetics in the Recognition of Asymptomatic COVID-19 Patients.|pdf=|usr=027}}
+{{tp|p=33316234|t=2021. Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients.|pdf=|usr=027}}
+{{tp|p=34082475|t=2021. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.|pdf=|usr=027}}
+{{tp|p=34086878|t=2021. Emergence of the E484K Mutation in SARS-CoV-2 Lineage B.1.1.345 in Upstate New York.|pdf=|usr=027}}
+{{tp|p=33991677|t=2021. Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage.|pdf=|usr=027}}
+{{tp|p=34015530|t=2021. Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19.|pdf=|usr=027}}
+{{tp|p=33984489|t=2021. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.|pdf=|usr=027}}
+{{tp|p=34035555|t=2021. Severe Acute Respiratory Syndrome Coronavirus 2: The Emergence of Important Genetic Variants and Testing Options for Clinical Laboratories.|pdf=|usr=027}}
+{{tp|p=34087062|t=2021. Insights into the potential role of alpha1-antitrypsin in COVID-19 patients: Mechanisms, current update, and future perspectives.|pdf=|usr=027}}
+{{tp|p=34092778|t=2021. Is the Intestine a Portal of Entry for the Serious COVID-19 Complications of Endotoxemia and Thrombosis?|pdf=|usr=027}}
+{{tp|p=33934534|t=2021. Autoantibodies in moderate and critical cases of COVID-19.|pdf=|usr=027}}
+{{tp|p=33932091|t=2021. Antinuclear antibodies in COVID 19.|pdf=|usr=027}}
+{{tp|p=34002013|t=2021. Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis.|pdf=|usr=027}}
+{{tp|p=34083759|t=2021. SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus.|pdf=|usr=027}}
+{{tp|p=34090748|t=2021. kinetics of anti-SARS-CoV-2 antibodies over time. Results of 10 month follow up in over 300 seropositive Health Care Workers.|pdf=|usr=027}}
+{{tp|p=34058787|t=2021. The role of lactate in sepsis and COVID-19: Perspective from contracting skeletal muscle metabolism.|pdf=|usr=027}}
+{{tp|p=33997890|t=2021. Variable post-translational modifications of SARS-CoV-2 nucleocapsid protein.|pdf=|usr=027}}
+{{tp|p=34091116|t=2021. Different T cell related immunological profiles in COVID-19 patients compared to healthy controls.|pdf=|usr=027}}
+{{tp|p=34043356|t=2021. Insight into the LFA-1/SARS-CoV-2 Orf7a Complex by Protein-Protein Docking, Molecular Dynamics, and MM-GBSA Calculations.|pdf=|usr=027}}
+{{tp|p=33855951|t=2021. SARS-CoV-2 one year on: evidence for ongoing viral adaptation.|pdf=|usr=027}}
+{{tp|p=33932299|t=2021. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.|pdf=|usr=027}}
+{{tp|p=33958327|t=2021. Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation.|pdf=|usr=027}}
+{{tp|p=33074884|t=2021. Multisystem Inflammatory Syndrome in Children Mimicking Surgical Pathologies: What Surgeons Need to Know about MIS-C.|pdf=|usr=027}}
+{{tp|p=33985343|t=2021. COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment.|pdf=|usr=027}}
+{{tp|p=33326597|t=2021. Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID-19.|pdf=|usr=027}}
+{{tp|p=33993500|t=2021. Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19.|pdf=|usr=027}}
+{{tp|p=34011563|t=2021. Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer.|pdf=|usr=027}}
+{{tp|p=34013681|t=2021. Is COVID-19 a hyperferritinemic syndrome in children?|pdf=|usr=027}}
+{{tp|p=33853368|t=2021. Multiple Emergency Department Presentations of COVID-19-Related Multisystem Inflammatory Syndrome in Children.|pdf=|usr=027}}
+{{tp|p=33980050|t=2021. Massive Pulmonary Embolism in an Adolescent With Multisystem Inflammatory Syndrome Due to COVID-19.|pdf=|usr=027}}
+{{tp|p=34001691|t=2021. Comparison of Circulating Immune Cells Profiles and Kinetics Between Coronavirus Disease 2019 and Bacterial Sepsis.|pdf=|usr=027}}
+{{tp|p=34049308|t=2021. Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock.|pdf=|usr=027}}
+{{tp|p=34052825|t=2021. The multisystem inflammatory syndrome in children and its association to SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33899752|t=2021. Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection.|pdf=|usr=027}}
+{{tp|p=33909065|t=2021. The Role of Cell Surface Sialic Acids for SARS-CoV-2 Infection.|pdf=|usr=027}}
+{{tp|p=33833065|t=2021. Six-month follow-up of gut microbiota richness in patients with COVID-19.|pdf=|usr=027}}
+{{tp|p=33843609|t=2021. Paediatric multisystem inflammatory syndrome and COVID-19: another novel syndrome?|pdf=|usr=027}}
+{{tp|p=33971803|t=2021. Impacts of reference selection on the assembly of suspicious coronavirus genome.|pdf=|usr=027}}
+{{tp|p=34060425|t=2021. Computational analysis of protein stability and allosteric interaction networks in distinct conformational forms of the SARS-CoV-2 spike D614G mutant: reconciling functional mechanisms through allosteric model of spike regulation.|pdf=|usr=027}}
+{{tp|p=33883466|t=2021. Pandemic analysis of infection and death correlated with genomic open reading frame 10 mutation in severe acute respiratory syndrome coronavirus 2 victims.|pdf=|usr=027}}
+{{tp|p=33952596|t=2021. A SARS-CoV-2 Variant with L452R and E484Q Neutralization Resistance Mutations.|pdf=|usr=027}}
+{{tp|p=33952598|t=2021. Genomic Elucidation of a COVID-19 Resurgence and Local Transmission of SARS-CoV-2 in Guangzhou, China.|pdf=|usr=027}}
+{{tp|p=33843774|t=2021. Role of Biological Agents in the Treatment of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children.|pdf=|usr=027}}
+{{tp|p=33956593|t=2021. Differential role of sphingomyelin in influenza virus, rhinovirus and SARS-CoV-2 infection of Calu-3 cells.|pdf=|usr=027}}
+{{tp|p=33331657|t=2021. Apoptosis-induced T-cell lymphopenia is related to COVID-19 severity.|pdf=|usr=027}}
+{{tp|p=33331649|t=2021. Dysregulation of the mevalonate pathway during SARS-CoV-2 infection: An in silico study.|pdf=|usr=027}}
+{{tp|p=33300133|t=2021. Understanding the pathophysiological changes via untargeted metabolomics in COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33934126|t=2021. Neurological Manifestations of COVID-19 Associated Multi-system Inflammatory Syndrome in Children: A Systematic Review and Meta-analysis.|pdf=|usr=027}}
+{{tp|p=34001792|t=2021. Multisystem Inflammatory Syndrome in a Pediatric Patient With Sickle Cell Disease and COVID-19: A Case Report.|pdf=|usr=027}}
+{{tp|p=33971704|t=2021. Hyperinflammatory syndrome in children during the coronavirus disease 2019 pandemic in sub-Himalayan region.|pdf=|usr=027}}
+{{tp|p=33338007|t=2021. Could the incre<iframe src="http://www.kidney.de/amapp.php?a=g concerns regarding the post-COVID-19 symptoms cause Kawasaki disease to be under-diagnosed?|pdf=|usr=027}}
+{{tp|p=34083758|t=2021. Single-nucleotide conservation state annotation of the SARS-CoV-2 genome.|pdf=|usr=027}}
+{{tp|p=33879833|t=2021. Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals.|pdf=|usr=027}}
+{{tp|p=34004573|t=2021. Image processing unravels the evolutionary pattern of SARS-CoV-2 against SARS and MERS through position-based pattern recognition.|pdf=|usr=027}}
+{{tp|p=33841749|t=2021. Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process.|pdf=|usr=027}}
+{{tp|p=33343834|t=2021. Temperature dependence of the SARS-CoV-2 affinity to human ACE2 determines COVID-19 progression and clinical outcome.|pdf=|usr=027}}
+{{tp|p=33847825|t=2021. The Involvement of MicroRNAs in SARS-CoV-2 Infection Comorbid with HIV-Associated Preeclampsia.|pdf=|usr=027}}
+{{tp|p=33840589|t=2021. Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity.|pdf=|usr=027}}
+{{tp|p=33360025|t=2021. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.|pdf=|usr=027}}
+{{tp|p=33348065|t=2021. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.|pdf=|usr=027}}
+{{tp|p=34074585|t=2021. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?|pdf=|usr=027}}
+{{tp|p=33342718|t=2021. Macrophage-derived cytokines in pneumonia: Linking cellular immunology and genetics.|pdf=|usr=027}}
+{{tp|p=34062530|t=2021. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.|pdf=|usr=027}}
+{{tp|p=34058541|t=2021. Assay dependence of long-term kinetics of SARS-CoV-2 antibodies.|pdf=|usr=027}}
+{{tp|p=33993054|t=2021. An epigenetic signature to fight COVID-19.|pdf=|usr=027}}
+{{tp|p=33993052|t=2021. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.|pdf=|usr=027}}
+{{tp|p=33979758|t=2021. Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers.|pdf=|usr=027}}
+{{tp|p=33915337|t=2021. Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series.|pdf=|usr=027}}
+{{tp|p=34098342|t=2021. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.|pdf=|usr=027}}
+{{tp|p=33876849|t=2021. The SARS-unique domain (SUD) of SARS-CoV and SARS-CoV-2 interacts with human Paip1 to enhance viral RNA translation.|pdf=|usr=027}}
+{{tp|p=33961735|t=2021. Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33931941|t=2021. SARS-CoV-2 worldwide replication drives rapid rise and selection of mutations across the viral genome: a time-course study - potential challenge for vaccines and therapies.|pdf=|usr=027}}
+{{tp|p=33326687|t=2021. The riddle of the Sphinx: why sphingosine-1-phosphate may help define molecular mechanisms underlying risk stratification for serious COVID-19 infections.|pdf=|usr=027}}
+{{tp|p=33900195|t=2021. Novel SARS-CoV-2 Variant Derived from Clade 19B, France.|pdf=|usr=027}}
+{{tp|p=33900193|t=2021. Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China.|pdf=|usr=027}}
+{{tp|p=33350923|t=2021. Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection.|pdf=|usr=027}}
+{{tp|p=33883059|t=2021. Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June-October 2020.|pdf=|usr=027}}
+{{tp|p=34016252|t=2021. Persistence of SARS-CoV-2-Specific IgG in Children 6 Months After Infection, Australia.|pdf=|usr=027}}
+{{tp|p=34099945|t=2021. Primeras importaciones de las variantes SARS-CoV-2 P.1 y P.2 de Brasil a Madrid y transmision comunitaria.|pdf=|usr=027}}
+{{tp|p=34026297|t=2021. Temporal Profiles of Antibody Responses, Cytokines, and Survival of COVID-19 Patients: A Retrospective Cohort in Wuhan, China.|pdf=|usr=027}}
+{{tp|p=33876664|t=2021. Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=33341878|t=2021. Delayed diffuse inflammatory myocardial damage in a child with a history of systemic inflammatory syndrome related to COVID-19.|pdf=|usr=027}}
+{{tp|p=34103090|t=2021. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.|pdf=|usr=027}}
+{{tp|p=34023936|t=2021. Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adults.|pdf=|usr=027}}
+{{tp|p=34047274|t=2021. SARS-CoV-2 variant B.1.1.7 susceptibility and infectiousness of children and adults deduced from investigations of childcare centre outbreaks, Germany, 2021.|pdf=|usr=027}}
+{{tp|p=33960291|t=2021. Case series of four re-infections with a SARS-CoV-2 B.1.351 variant, Luxembourg, February 2021.|pdf=|usr=027}}
+{{tp|p=33890568|t=2021. Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021.|pdf=|usr=027}}
+{{tp|p=33890566|t=2021. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021.|pdf=|usr=027}}
+{{tp|p=33860748|t=2021. Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France.|pdf=|usr=027}}
+{{tp|p=33903146|t=2021. Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19.|pdf=|usr=027}}
+{{tp|p=33960272|t=2021. COVID-19 and the neonatal microbiome: will the pandemic cost infants their microbes?|pdf=|usr=027}}
+{{tp|p=33320447|t=2021. Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33996172|t=2021. Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation.|pdf=|usr=027}}
+{{tp|p=33867206|t=2021. Fatalities of COVID-19 are rather attributable to multisystem inflammatory syndrome than infectious meningitis or sepsis.|pdf=|usr=027}}
+{{tp|p=33913889|t=2021. COVID-19 related multi-inflammatory syndrome presenting with uveitis - A case report.|pdf=|usr=027}}
+{{tp|p=33915216|t=2021. One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages.|pdf=|usr=027}}
+{{tp|p=33905892|t=2021. SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation.|pdf=|usr=027}}
+{{tp|p=33905891|t=2021. Spike protein mutational landscape in India during the complete lockdown phase: Could Muller's ratchet be a future game-changer for COVID-19?|pdf=|usr=027}}
+{{tp|p=33848683|t=2021. Systematizing the genomic order and relatedness in the open reading frames (ORFs) of the coronaviruses.|pdf=|usr=027}}
+{{tp|p=34044140|t=2021. Multisystem inflammatory syndrome in adults: A rare sequela of SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=33989776|t=2021. Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil.|pdf=|usr=027}}
+{{tp|p=33939840|t=2021. Geriatric antibody response to COVID-19.|pdf=|usr=027}}
+{{tp|p=34031932|t=2021. Autoantibodies in Covid-19 - a model for viral induced autoimmunity.|pdf=|usr=027}}
+{{tp|p=33926500|t=2021. SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism.|pdf=|usr=027}}
+{{tp|p=34089757|t=2021. Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks.|pdf=|usr=027}}
+{{tp|p=34036353|t=2021. Type I, II, and III interferon signatures correspond to COVID-19 disease severity.|pdf=|usr=027}}
+{{tp|p=34031695|t=2021. Virological and serological characterization of critically ill patients with COVID-19 in the UK: Interactions of viral load, antibody status and B.1.1.7 variant infection.|pdf=|usr=027}}
+{{tp|p=34086960|t=2021. Marked increase in avidity of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) antibodies 7-8 months after infection is not diminished in old age.|pdf=|usr=027}}
+{{tp|p=34050501|t=2021. The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections.|pdf=|usr=027}}
+{{tp|p=34028559|t=2021. Macrophage Activation Syndrome in a Child with Juvenile Idiopathic Arthritis Secondary to SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=34028528|t=2021. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series Experience in a Tertiary Care Hospital of Southern Turkey.|pdf=|usr=027}}
+{{tp|p=34027897|t=2021. The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age.|pdf=|usr=027}}
+{{tp|p=33986193|t=2021. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=34081630|t=2021. Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern.|pdf=|usr=027}}
+{{tp|p=33830084|t=2021. A mechanism for matrikine regulation in acute inflammatory lung injury.|pdf=|usr=027}}
+{{tp|p=34090610|t=2021. COVID-19 reinfections in The Gambia by phylogenetically distinct SARS-CoV-2 variants-first two confirmed events in west Africa.|pdf=|usr=027}}
+{{tp|p=33857407|t=2021. Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes.|pdf=|usr=027}}
+{{tp|p=33857406|t=2021. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.|pdf=|usr=027}}
+{{tp|p=33341124|t=2021. Persistence of IgG response to SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=34022142|t=2021. SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity.|pdf=|usr=027}}
+{{tp|p=33846703|t=2021. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation.|pdf=|usr=027}}
+{{tp|p=33857454|t=2021. Monitoring differences between the SARS-CoV-2 B.1.1.7 variant and other lineages.|pdf=|usr=027}}
+{{tp|p=33857453|t=2021. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.|pdf=|usr=027}}
+{{tp|p=34027512|t=2021. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland, 2020.|pdf=|usr=027}}
+{{tp|p=33870259|t=2021. Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the United Kingdom and Ireland: What is new?|pdf=|usr=027}}
+{{tp|p=33892550|t=2021. Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=34060079|t=2021. Surveillance for SARS-CoV-2 variants of concern in the Australian context.|pdf=|usr=027}}
+{{tp|p=34031561|t=2021. SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome.|pdf=|usr=027}}
+{{tp|p=34028990|t=2021. Epicardial fat inflammation response to COVID-19 therapies.|pdf=|usr=027}}
+{{tp|p=33945220|t=2021. The association between obesity and peak antibody titer response in COVID-19 infection.|pdf=|usr=027}}
+{{tp|p=34103408|t=2021. Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro.|pdf=|usr=027}}
+{{tp|p=33846272|t=2021. Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues.|pdf=|usr=027}}
+{{tp|p=34029205|t=2021. Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome.|pdf=|usr=027}}
+{{tp|p=34006597|t=2021. Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33361116|t=2021. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.|pdf=|usr=027}}
+{{tp|p=34016740|t=2021. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants.|pdf=|usr=027}}
+{{tp|p=34012360|t=2021. Forecasting the Effects of the New SARS-CoV-2 Variant in Europe.|pdf=|usr=027}}
+{{tp|p=33846275|t=2021. Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19.|pdf=|usr=027}}
+{{tp|p=33912658|t=2021. Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection.|pdf=|usr=027}}
+{{tp|p=33912411|t=2021. Reactivity of human antisera to codon optimized SARS-CoV2 viral proteins expressed in Escherichia coli.|pdf=|usr=027}}
+{{tp|p=34075354|t=2021. A matter of perspective-Cutting-edge technology-driven urine proteome in COVID-19.|pdf=|usr=027}}
+{{tp|p=33845201|t=2021. COVID-19 and hypertension: Is there a role for dsRNA and activation of Toll-like receptor 3?|pdf=|usr=027}}
+{{tp|p=33788823|t=2021. Sixth nerve palsy in pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=33872443|t=2021. Multisystem inflammatory syndrome in children (MIS-C) and the prothrombotic state: Coagulation profiles and rotational thromboelastometry in a MIS-C cohort.|pdf=|usr=027}}
+{{tp|p=33711292|t=2021. Addressing fundamental questions on MIS-C.|pdf=|usr=027}}
+{{tp|p=34043958|t=2021. 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study.|pdf=|usr=027}}
+{{tp|p=33905406|t=2021. Sindrome inflamatorio multisistemico por COVID-19 en ninos: reporte de diez casos en un hospital peruano.|pdf=|usr=027}}
+{{tp|p=33904379|t=2021. A case of multisystem inflammatory syndrome in children in a Japanese boy: with discussion of cytokine profile.|pdf=|usr=027}}
+{{tp|p=33972732|t=2021. Monocyte and dendritic cell defects in COVID-19.|pdf=|usr=027}}
+{{tp|p=33972731|t=2021. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity.|pdf=|usr=027}}
+{{tp|p=33875881|t=2021. Immunity after SARS-CoV-2 infections.|pdf=|usr=027}}
+{{tp|p=34040225|t=2021. Cellular disturbances in COVID-19.|pdf=|usr=027}}
+{{tp|p=33976430|t=2021. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.|pdf=|usr=027}}
+{{tp|p=33963333|t=2021. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.|pdf=|usr=027}}
+{{tp|p=33986507|t=2021. India's neighbours race to sequence genomes as COVID surges.|pdf=|usr=027}}
+{{tp|p=33976409|t=2021. Coronavirus variants are spreading in India - what scientists know so far.|pdf=|usr=027}}
+{{tp|p=33856952|t=2021. Bilateral Acute Anterior Uveitis and Corneal Punctate Epitheliopathy in Children Diagnosed with Multisystem Inflammatory Syndrome Secondary to COVID-19.|pdf=|usr=027}}
+{{tp|p=33926942|t=2021. How SARS-CoV-2 first adapted in humans.|pdf=|usr=027}}
+{{tp|p=33937731|t=2021. An autopsy study of the spectrum of severe COVID-19 in children: From SARS to different phenotypes of MIS-C.|pdf=|usr=027}}
+{{tp|p=33886935|t=2021. Infection of red blood cells by SARS-CoV-2: new evidence.|pdf=|usr=027}}
+{{tp|p=33904403|t=2021. Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses.|pdf=|usr=027}}
+{{tp|p=33835028|t=2021. Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation.|pdf=|usr=027}}
+{{tp|p=33890572|t=2021. SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation.|pdf=|usr=027}}
+{{tp|p=34049471|t=2021. Intra-species sialic acid polymorphism in humans: a common niche for influenza and coronavirus pandemics?|pdf=|usr=027}}
+{{tp|p=34019466|t=2021. Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR.|pdf=|usr=027}}
+{{tp|p=34013835|t=2021. Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate.|pdf=|usr=027}}
+{{tp|p=33944697|t=2021. Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33896413|t=2021. Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications.|pdf=|usr=027}}
+{{tp|p=33870851|t=2021. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.|pdf=|usr=027}}
+{{tp|p=33830901|t=2021. Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort.|pdf=|usr=027}}
+{{tp|p=33372854|t=2021. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.|pdf=|usr=027}}
+{{tp|p=33327866|t=2021. Structure of the multiple functional domains from coronavirus nonstructural protein 3.|pdf=|usr=027}}
+{{tp|p=33848711|t=2021. High levels of TNFalpha in patients with COVID-19 refractory to tocilizumab.|pdf=|usr=027}}
+{{tp|p=33882374|t=2021. Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients.|pdf=|usr=027}}
+{{tp|p=34053848|t=2021. SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors.|pdf=|usr=027}}
+{{tp|p=33878423|t=2021. Aging correlates with lower threshold cycle values for RdRP/RdRP+S genes during molecular detection of SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33953325|t=2021. Innate immune sensing of coronavirus and viral evasion strategies.|pdf=|usr=027}}
+{{tp|p=33828231|t=2021. From bedside to bench: regulation of host factors in SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=33368679|t=2021. Spatial and temporal roles of SARS-CoV PL(pro) -A snapshot.|pdf=|usr=027}}
+{{tp|p=34023458|t=2021. SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis.|pdf=|usr=027}}
+{{tp|p=34026780|t=2021. Implications of the Novel Mutations in the SARS-CoV-2 Genome for Transmission, Disease Severity, and the Vaccine Development.|pdf=|usr=027}}
+{{tp|p=33928117|t=2021. Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production.|pdf=|usr=027}}
+{{tp|p=33912590|t=2021. Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19.|pdf=|usr=027}}
+{{tp|p=33898518|t=2021. An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome-Coronavirus.|pdf=|usr=027}}
+{{tp|p=33900399|t=2021. Genomic Epidemiology of SARS-CoV-2 Infection During the Initial Pandemic Wave and Association With Disease Severity.|pdf=|usr=027}}
+{{tp|p=33835177|t=2021. Genome Analysis for Sequence Variants in SARS-CoV-2 Among Asymptomatic Individuals in a Long-term Care Facility.|pdf=|usr=027}}
+{{tp|p=33887319|t=2021. SARS-CoV-2-reactive cellular and humoral immunity in hemodialysis population.|pdf=|usr=027}}
+{{tp|p=33964249|t=2021. Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19-recovered patients who received a kidney transplant.|pdf=|usr=027}}
+{{tp|p=33972935|t=2021. Waning antibodies to SARS-CoV-2 - Don't panic.|pdf=|usr=027}}
+{{tp|p=34007047|t=2021. Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients.|pdf=|usr=027}}
+{{tp|p=33358483|t=2021. Evaluation of variant frequency in SARS-CoV-2 infection-related genes utilizing lung cancer genomic database.|pdf=|usr=027}}
+{{tp|p=33947753|t=2021. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.|pdf=|usr=027}}
+{{tp|p=33975939|t=2021. The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia.|pdf=|usr=027}}
+{{tp|p=33906918|t=2021. Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment.|pdf=|usr=027}}
+{{tp|p=33879594|t=2021. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.|pdf=|usr=027}}
+{{tp|p=34075014|t=2021. Editorial: COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C).|pdf=|usr=027}}
+{{tp|p=34007243|t=2021. Correlation of Low Levels of alpha-1 Antitrypsin and Elevation of Neutrophil to Lymphocyte Ratio with Higher Mortality in Severe COVID-19 Patients.|pdf=|usr=027}}
+{{tp|p=33953641|t=2021. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.|pdf=|usr=027}}
+{{tp|p=33833618|t=2021. Whole-Transcriptome RNA Sequencing Reveals Significant Differentially Expressed mRNAs, miRNAs, and lncRNAs and Related Regulating Biological Pathways in the Peripheral Blood of COVID-19 Patients.|pdf=|usr=027}}
+{{tp|p=33993637|t=2021. SARS-CoV-2 RNA screening in routine pathology specimens.|pdf=|usr=027}}
+{{tp|p=33373693|t=2021. Spike glycoproteins: Their significance for corona viruses and receptor binding activities for pathogenesis and viral survival.|pdf=|usr=027}}
+{{tp|p=34058304|t=2021. Identification of E484K and other novel SARS-COV-2 variants from the Kingdom of Bahrain.|pdf=|usr=027}}
+{{tp|p=33958417|t=2021. Detection and Genome Sequencing of SARS-CoV-2 Variants Belonging to the B.1.1.7 Lineage in the Philippines.|pdf=|usr=027}}
+{{tp|p=34042476|t=2021. Genome Sequences of SARS-CoV-2 P.1 (Variant of Concern) and P.2 (Variant of Interest) Identified in Uruguay.|pdf=|usr=027}}
+{{tp|p=34065789|t=2021. Molecular Analysis of SARS-CoV-2 Circulating in Bangladesh during 2020 Revealed Lineage Diversity and Potential Mutations.|pdf=|usr=027}}
+{{tp|p=33925854|t=2021. Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern.|pdf=|usr=027}}
+{{tp|p=33881152|t=2021. Post-COVID Multisystem Inflammatory Syndrome in the Deployed Environment.|pdf=|usr=027}}
+{{tp|p=33871249|t=2021. Increased risk for severe outcome in teenagers with multisystem inflammatory syndrome temporally associated with Covid-19 mimicking Kawasaki disease: is there an age-related Achilles heel?|pdf=|usr=027}}
+{{tp|p=33988184|t=2021. Identification of and Surveillance for the SARS-CoV-2 Variants B.1.427 and B.1.429 - Colorado, January-March 2021.|pdf=|usr=027}}
+{{tp|p=33983915|t=2021. Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021.|pdf=|usr=027}}
+{{tp|p=33940513|t=2021. Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=33358567|t=2021. Biological functions of MAIT cells in tissues.|pdf=|usr=027}}
+{{tp|p=34075562|t=2021. The Effect of COVID-19 on NF-kappaB and Neurological Manifestations of Disease.|pdf=|usr=027}}
+{{tp|p=33946306|t=2021. D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency, Geographical Distribution, and Structural Effect.|pdf=|usr=027}}
+{{tp|p=34035552|t=2021. Kawasaki-Syndrom bei einem 9-jahrigen Jungen infolge von COVID-19.|pdf=|usr=027}}
+{{tp|p=34047654|t=2021. Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients.|pdf=|usr=027}}
+{{tp|p=33958704|t=2021. Adipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution.|pdf=|usr=027}}
+{{tp|p=33725430|t=2021. Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England.|pdf=|usr=027}}
+{{tp|p=33883721|t=2021. Blast from the past for coronavirus immunity.|pdf=|usr=027}}
+{{tp|p=33859371|t=2021. Uncovering SARS-CoV-2 kidney tropism.|pdf=|usr=027}}
+{{tp|p=33349661|t=2021. MIS-C: early lessons from immune profiling.|pdf=|usr=027}}
+{{tp|p=33840875|t=2021. How much worse can variants get?|pdf=|usr=027}}
+{{tp|p=33831567|t=2021. Implications of SARS-Cov-2 infection on eNOS and iNOS activity: Consequences for the respiratory and vascular systems.|pdf=|usr=027}}
+{{tp|p=33956156|t=2021. Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity.|pdf=|usr=027}}
+{{tp|p=33842903|t=2021. Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19.|pdf=|usr=027}}
+{{tp|p=34043740|t=2021. TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=34015061|t=2021. DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist.|pdf=|usr=027}}
+{{tp|p=34097716|t=2021. Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan.|pdf=|usr=027}}
+{{tp|p=34097709|t=2021. Signal-regulatory protein alpha is an anti-viral entry factor targeting viruses using endocytic pathways.|pdf=|usr=027}}
+{{tp|p=34061905|t=2021. Extensive C->U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA.|pdf=|usr=027}}
+{{tp|p=33901246|t=2021. Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread.|pdf=|usr=027}}
+{{tp|p=33886690|t=2021. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.|pdf=|usr=027}}
+{{tp|p=33861802|t=2021. Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity.|pdf=|usr=027}}
+{{tp|p=33831133|t=2021. High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19.|pdf=|usr=027}}
+{{tp|p=33831132|t=2021. A human coronavirus evolves antigenically to escape antibody immunity.|pdf=|usr=027}}
+{{tp|p=33827988|t=2021. ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=33850412|t=2021. Management of COVID-19-associated multisystem inflammatory syndrome in children: A comprehensive literature review.|pdf=|usr=027}}
+{{tp|p=33929695|t=2021. Convergent evolution of SARS-CoV-2 in human and animals.|pdf=|usr=027}}
+{{tp|p=33933612|t=2021. Reconstitution and functional characterization of SARS-CoV-2 proofreading complex.|pdf=|usr=027}}
+{{tp|p=34018094|t=2021. Update and Supplementary Articles Proteins of SARS CoV-2, Which Causes COVID-19, and the Interacting Proteins.|pdf=|usr=027}}
+{{tp|p=33890205|t=2021. In Silico Study of Mutational Stability of SARS-CoV-2 Proteins.|pdf=|usr=027}}
+{{tp|p=33867315|t=2021. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.|pdf=|usr=027}}
+{{tp|p=34021763|t=2021. A scientific basis for anxiety about the emergence of resistant strains of covid-19.|pdf=|usr=027}}
+{{tp|p=33907354|t=2021. Fallbericht: Tod eines 2-jahrigen Madchens bei postmortaler Diagnose einer seltenen, Kawasaki-Syndrom-typischen Koronararterienvaskulitis.|pdf=|usr=027}}
+{{tp|p=34020311|t=2021. Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19.|pdf=|usr=027}}
+{{tp|p=34051791|t=2021. Dysregulation of COVID-19 related gene expression in the COPD lung.|pdf=|usr=027}}
+{{tp|p=33935561|t=2021. Humoral immune responses in hospitalized COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33867805|t=2021. Prolonged humoral and cellular immunity in COVID-19-recovered patients.|pdf=|usr=027}}
+{{tp|p=33850424|t=2021. Virus-receptor interactions of SARS-CoV-2 spikereceptor-binding domain and human neuropilin-1 b1 domain.|pdf=|usr=027}}
+{{tp|p=33967583|t=2021. Antibody profile in symptomatic/asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected Saudi persons.|pdf=|usr=027}}
+{{tp|p=33966045|t=2021. SARS-CoV-2 promote autophagy to suppress type I interferon response.|pdf=|usr=027}}
+{{tp|p=34006847|t=2021. Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study.|pdf=|usr=027}}
+{{tp|p=34001855|t=2021. Cellular tropism and antigenicity of mink-derived SARS-CoV-2 variants.|pdf=|usr=027}}
+{{tp|p=33870746|t=2021. Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry.|pdf=|usr=027}}
+{{tp|p=33994605|t=2021. Mass spectrometry analytical responses to the SARS-CoV2 coronavirus in review.|pdf=|usr=027}}
+{{tp|p=34013222|t=2021. A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C).|pdf=|usr=027}}
+{{tp|p=33937741|t=2021. Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein.|pdf=|usr=027}}
+{{tp|p=33918599|t=2021. The Spike Glycoprotein of SARS-CoV-2 Binds to beta1 Integrins Expressed on the Surface of Lung Epithelial Cells.|pdf=|usr=027}}
+{{tp|p=33918060|t=2021. Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33917138|t=2021. The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus.|pdf=|usr=027}}
+{{tp|p=33946311|t=2021. Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
+{{tp|p=33946747|t=2021. Emergence and Spread of SARS-CoV-2 Lineages B.1.1.7 and P.1 in Italy.|pdf=|usr=027}}
+{{tp|p=34079122|t=2021. Daily briefing: Coronavirus variants given Greek names.|pdf=|usr=027}}
+{{tp|p=34075234|t=2021. Coronavirus variants get Greek names - but will scientists use them?|pdf=|usr=027}}
+{{tp|p=34031583|t=2021. What scientists know about new, fast-spreading coronavirus variants.|pdf=|usr=027}}
+{{tp|p=34098568|t=2021. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.|pdf=|usr=027}}
+{{tp|p=33871226|t=2021. Point-of-Care Ultrasound Findings in Multisystem Inflammatory Syndrome in Children: A Cross-Sectional Study.|pdf=|usr=027}}
+{{tp|p=33949910|t=2021. Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) - a case series.|pdf=|usr=027}}
+{{tp|p=33941741|t=2021. Acral Gangrene: Ugly Cousin of "COVID Toes" in Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2?|pdf=|usr=027}}
+{{tp|p=33234669|t=2021. Multisystem Inflammatory Syndrome in Children: An International Survey.|pdf=|usr=027}}
+{{tp|p=34090218|t=2021. COVID-19 patients' sera induce epithelial mesenchymal transition in cancer cells.|pdf=|usr=027}}
+{{tp|p=34023769|t=2021. The emerging role of cellular senescence in complications of COVID-19.|pdf=|usr=027}}
+{{tp|p=34071688|t=2021. SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer.|pdf=|usr=027}}
+{{tp|p=33893398|t=2021. The basis of a more contagious 501Y.V1 variant of SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33977496|t=2021. SARS-CoV-2 in patients with cancer: possible role of mimicry of human molecules by viral proteins and the resulting anti-cancer immunity.|pdf=|usr=027}}
+{{tp|p=33949207|t=2021. Role of the Immune Microenvironment in SARS-CoV-2 Infection.|pdf=|usr=027}}
+{{tp|p=33840257|t=2021. Surviving the Rookie Virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): The Immunopathology of a SARS-CoV2 Infection.|pdf=|usr=027}}
+{{tp|p=34062964|t=2021. The Systemic Immune Response in COVID-19 Is Associated with a Shift to Formyl-Peptide Unresponsive Eosinophils.|pdf=|usr=027}}
+{{tp|p=34071149|t=2021. Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.|pdf=|usr=027}}
+{{tp|p=33972046|t=2021. A dermatologic perspective on multisystem inflammatory syndrome in children.|pdf=|usr=027}}
+{{tp|p=33865990|t=2021. A novel application of delayed-type hipersensitivity reaction to measure cellular immune response in SARS-CoV-2 exposed individuals.|pdf=|usr=027}}
+{{tp|p=33895357|t=2021. SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts.|pdf=|usr=027}}
+{{tp|p=33887436|t=2021. Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application.|pdf=|usr=027}}
+{{tp|p=33301883|t=2021. Kawasaki or Kawasaki-like disease? A debate on COVID-19 infection in children.|pdf=|usr=027}}
+{{tp|p=33333256|t=2021. Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned.|pdf=|usr=027}}
+{{tp|p=34044153|t=2021. SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay.|pdf=|usr=027}}
+{{tp|p=33975009|t=2021. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.|pdf=|usr=027}}
+{{tp|p=34044152|t=2021. Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France.|pdf=|usr=027}}
+{{tp|p=34015535|t=2021. Novel SARS-CoV-2 variants: the pandemics within the pandemic.|pdf=|usr=027}}
+{{tp|p=33956250|t=2021. Clinical features and outcome of MIS-C patients: an experience from Central Anatolia.|pdf=|usr=027}}
+{{tp|p=33439384|t=2021. Pediatric inflammatory multisystem syndrome (PIMS) presenting with retropharyngeal phlegmon mimicking Kawasaki disease.|pdf=|usr=027}}
+{{tp|p=34089099|t=2021. Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children.|pdf=|usr=027}}
+{{tp|p=33763799|t=2021. Clinical and laboratory findings of multisystem inflammatory syndrome in children (MIS-C) below age 1.|pdf=|usr=027}}
+{{tp|p=33981434|t=2021. The up-to-date pathophysiology of Kawasaki disease.|pdf=|usr=027}}
+{{tp|p=33976879|t=2021. Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals.|pdf=|usr=027}}
+{{tp|p=33968405|t=2021. Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019.|pdf=|usr=027}}
+{{tp|p=34047474|t=2021. Preliminary analyses of scRNA sequencing and immunohistochemistry of children's lung tissues indicate the expression of SARS-CoV-2 entry-related genes may not be the key reason for the milder syndromes of COVID-19 in children.|pdf=|usr=027}}
+{{tp|p=33936565|t=2021. Targeting protein-protein interaction interfaces in COVID-19 drug discovery.|pdf=|usr=027}}
+{{tp|p=33907612|t=2021. Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis.|pdf=|usr=027}}
+{{tp|p=33850607|t=2021. Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification.|pdf=|usr=027}}
+{{tp|p=33841750|t=2021. Temperature effect on the SARS-CoV-2: A molecular dynamics study of the spike homotrimeric glycoprotein.|pdf=|usr=027}}
+{{tp|p=33845874|t=2021. Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome.|pdf=|usr=027}}
+{{tp|p=33824793|t=2021. Carotid Artery Dissection and Hemorrhagic Stroke in the Setting of Multisystem Inflammatory Syndrome in Children.|pdf=|usr=027}}
+{{tp|p=33877539|t=2021. Genomic Evolution and Variation of SARS-CoV-2 in the Early Phase of COVID-19 Pandemic in Guangdong Province, China.|pdf=|usr=027}}
+{{tp|p=33945951|t=2021. Structure and function of SARS-CoV-2 polymerase.|pdf=|usr=027}}
+{{tp|p=33898662|t=2021. Statistics and Patterns of Occurrence of Simple Tandem Repeats in SARS-CoV-1 and SARS-CoV-2 Genomic Data.|pdf=|usr=027}}
+{{tp|p=33838172|t=2021. Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via alpha7-nicotinic acetylcholine receptors?|pdf=|usr=027}}
+{{tp|p=34023458|t=2021. SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis.|pdf=|usr=027}}
+{{tp|p=33991578|t=2021. Gut Microbiome Composition Is Associated with COVID-19 Disease Severity.|pdf=|usr=027}}
+{{tp|p=33969236|t=2021. Analysis of single nucleotide polymorphisms between 2019-nCoV genomes and its impact on codon usage.|pdf=|usr=027}}
+{{tp|p=33875973|t=2021. Whole genome comparison of Pakistani Corona virus with Chinese and US Strains along with its predictive severity of COVID-19.|pdf=|usr=027}}
+{{tp|p=34072181|t=2021. Mutational Asymmetries in the SARS-CoV-2 Genome May Lead to Increased Hydrophobicity of Virus Proteins.|pdf=|usr=027}}
+{{tp|p=33916492|t=2021. Genotyping of the Major SARS-CoV-2 Clade by Short-Amplicon High-Resolution Melting (SA-HRM) Analysis.|pdf=|usr=027}}
+{{tp|p=33923155|t=2021. Investigating Cellular Trajectories in the Severity of COVID-19 and Their Transcriptional Programs Using Machine Learning Approaches.|pdf=|usr=027}}
+{{tp|p=33983397|t=2021. Rapid detection of inter-clade recombination in SARS-CoV-2 with Bolotie.|pdf=|usr=027}}
+{{tp|p=33836368|t=2021. Identification of COVID-19 subtypes based on immunogenomic profiling.|pdf=|usr=027}}
+{{tp|p=33310664|t=2021. Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33932694|t=2021. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.|pdf=|usr=027}}
+{{tp|p=33895478|t=2021. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC.|pdf=|usr=027}}
+{{tp|p=33907518|t=2021. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.|pdf=|usr=027}}
+{{tp|p=33907514|t=2021. The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment.|pdf=|usr=027}}
+{{tp|p=33907511|t=2021. The Genetic Variant of SARS-CoV-2: would It Matter for Controlling the Devastating Pandemic?|pdf=|usr=027}}
+{{tp|p=33867845|t=2021. SARS-CoV-2-induced Overexpression of miR-4485 Suppresses Osteogenic Differentiation and Impairs Fracture Healing.|pdf=|usr=027}}
+{{tp|p=34089348|t=2021. Dying of VOC-202012/01 - multimodal investigations in a death case of the SARS-CoV-2 variant.|pdf=|usr=027}}
+{{tp|p=33970428|t=2021. Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital.|pdf=|usr=027}}
+{{tp|p=34050887|t=2021. The role of unconventional T cells in COVID-19.|pdf=|usr=027}}
+{{tp|p=33904682|t=2021. Production of SARS-CoV-2 Antibodies and Emergence of the Clinical Symptoms of COVID-19.|pdf=|usr=027}}
+{{tp|p=33899351|t=2021. The First Fatal Post-COVID-19 Adult Patient with Multi-System Inflammatory Syndrome in Israel.|pdf=|usr=027}}
+{{tp|p=33894209|t=2021. Distinct cytokine profiles associated with COVID-19 severity and mortality.|pdf=|usr=027}}
+{{tp|p=33309039|t=2021. Marked changes in innate immunity associated with a mild course of COVID-19 in identical twins with athymia and absent circulating T cells.|pdf=|usr=027}}
+{{tp|p=33971585|t=2021. An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.|pdf=|usr=027}}
+{{tp|p=33937119|t=2021. How Antivirals Might be Linked to the Emergence of New Variants of SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33963094|t=2021. SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response.|pdf=|usr=027}}
+{{tp|p=33969357|t=2021. Structural Consequences of Variation in SARS-CoV-2 B.1.1.7.|pdf=|usr=027}}
+{{tp|p=33969601|t=2021. Interplay between SARS-CoV-2 and human long non-coding RNAs.|pdf=|usr=027}}
+{{tp|p=33939913|t=2021. Elucidation of Cryptic and Allosteric Pockets within the SARS-CoV-2 Main Protease.|pdf=|usr=027}}
+{{tp|p=33851338|t=2021. Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain.|pdf=|usr=027}}
+{{tp|p=33983545|t=2021. Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency.|pdf=|usr=027}}
+{{tp|p=33950324|t=2021. Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia.|pdf=|usr=027}}
+{{tp|p=33864183|t=2021. Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection-Implications for Therapeutic Monitoring and Therapeutic Targets.|pdf=|usr=027}}
+{{tp|p=34032635|t=2021. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier.|pdf=|usr=027}}
+{{tp|p=34058261|t=2021. Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020-21.|pdf=|usr=027}}
+{{tp|p=33992685|t=2021. Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK.|pdf=|usr=027}}
+{{tp|p=33932451|t=2021. The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33932450|t=2021. Duration of culturable SARS-CoV-2 within different specimens among mild and severe COVID-19 patients: A longitudinal study.|pdf=|usr=027}}
+{{tp|p=34052240|t=2021. One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG.|pdf=|usr=027}}
+{{tp|p=34060263|t=2021. Antibody Responses One Year after Mild SARS-CoV-2 Infection.|pdf=|usr=027}}
+{{tp|p=34035676|t=2021. The Trilogy of SARS-CoV-2 in Pediatrics (Part 2): Multisystem Inflammatory Syndrome in Children.|pdf=|usr=027}}
+{{tp|p=33846690|t=2021. Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era.|pdf=|usr=027}}
+{{tp|p=34026490|t=2021. COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) presenting as appendicitis with shock.|pdf=|usr=027}}
+{{tp|p=33336251|t=2021. Multisystem Inflammatory Syndrome in Children in February 2020 and Implications of Genomic Sequencing for SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33211859|t=2021. Short-Term Outcomes After Multisystem Inflammatory Syndrome in Children Treatment.|pdf=|usr=027}}
+{{tp|p=34086459|t=2021. Machine Learning Reveals the Critical Interactions for SARS-CoV-2 Spike Protein Binding to ACE2.|pdf=|usr=027}}
+{{tp|p=33873242|t=2021. SARS-CoV-2: pushing the E(nvelope).|pdf=|usr=027}}
+{{tp|p=34089533|t=2021. The role of the SARS-CoV-2 envelope protein as a pH-dependent cation channel.|pdf=|usr=027}}
+{{tp|p=33889450|t=2021. Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).|pdf=|usr=027}}
+{{tp|p=33965601|t=2021. SARS-CoV-2, hemoglobin and protoporphyrin IX: Interactions and perspectives.|pdf=|usr=027}}
+{{tp|p=33904656|t=2021. Reduced adiponectin levels in patients with COVID-19 acute respiratory failure: A case-control study.|pdf=|usr=027}}
+{{tp|p=33992044|t=2021. Pediatric Inflammatory Multisystem Syndrome (PIMS) - Potential role for cytokines such Is IL-6.|pdf=|usr=027}}
+{{tp|p=33999778|t=2021. Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19.|pdf=|usr=027}}
+{{tp|p=33961632|t=2021. Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33914735|t=2021. Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.|pdf=|usr=027}}
+{{tp|p=33901166|t=2021. The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.|pdf=|usr=027}}
+{{tp|p=34081747|t=2021. Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform.|pdf=|usr=027}}
+{{tp|p=33984048|t=2021. SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS.|pdf=|usr=027}}
+{{tp|p=33979391|t=2021. Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein.|pdf=|usr=027}}
+{{tp|p=33930996|t=2021. Distance matrices for nitrogenous bases and amino acids of SARS-CoV-2 via structural metric.|pdf=|usr=027}}
+{{tp|p=33934592|t=2021. SARS-CoV-2 infection versus the body immune defenses: the role of immune responses and mechanism of action of dexamethasone.|pdf=|usr=027}}
+{{tp|p=34034620|t=2021. A 'deep dive' into the SARS-Cov-2 polymerase assembly: identifying novel allosteric sites and analyzing the hydrogen bond networks and correlated dynamics.|pdf=|usr=027}}
+{{tp|p=34029506|t=2021. Binding mode characterization of 13b in the monomeric and dimeric states of SARS-CoV-2 main protease using molecular dynamics simulations.|pdf=|usr=027}}
+{{tp|p=33834772|t=2021. Insights into SARS-CoV-2's Mutations for Evading Human Antibodies: Sacrifice and Survival.|pdf=|usr=027}}
+{{tp|p=33830171|t=2021. S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021.|pdf=|usr=027}}
+{{tp|p=33835019|t=2021. Implication de la cascade du complement dans les formes severes de COVID-19.|pdf=|usr=027}}
+{{tp|p=33856143|t=2021. A clinical variant of coronavirus disease 2019 with diarrhoea as the initial symptom compared with other variants.|pdf=|usr=027}}
+{{tp|p=33951359|t=2021. Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control.|pdf=|usr=027}}
+{{tp|p=34040250|t=2021. Had COVID? You'll probably make antibodies for a lifetime.|pdf=|usr=027}}
+{{tp|p=34050346|t=2021. Daily briefing: What we know about fast-spreading coronavirus variants.|pdf=|usr=027}}
+{{tp|p=33990783|t=2021. Coronapod: The variant blamed for India's catastrophic second wave.|pdf=|usr=027}}
+{{tp|p=33986504|t=2021. How a worrisome coronavirus variant spread unnoticed.|pdf=|usr=027}}
+{{tp|p=33979833|t=2021. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis.|pdf=|usr=027}}
+{{tp|p=34030176|t=2021. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.|pdf=|usr=027}}
+{{tp|p=34010947|t=2021. Diverse functional autoantibodies in patients with COVID-19.|pdf=|usr=027}}
+{{tp|p=33348007|t=2021. The role of renin-angiotensin system activated phagocytes in the SARS-CoV-2 coronavirus infection.|pdf=|usr=027}}
+{{tp|p=33999400|t=2021. Hyperinflammation hos vuxna med covid-19 - ovanligt men allvarligt.|pdf=|usr=027}}
+{{tp|p=33969329|t=2021. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics.|pdf=|usr=027}}
+{{tp|p=33880456|t=2021. Mounting evidence of impaired viral control in severe COVID-19.|pdf=|usr=027}}
+{{tp|p=34000237|t=2021. A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19.|pdf=|usr=027}}
+{{tp|p=33965003|t=2021. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity.|pdf=|usr=027}}
+{{tp|p=34095856|t=2021. Defining COVID-19-associated hyperinflammatory syndrome in specific populations.|pdf=|usr=027}}
+{{tp|p=33299142|t=2021. SARS-CoV-2 antibody responses in patients with acute leukaemia.|pdf=|usr=027}}
+{{tp|p=33921938|t=2021. Temporal Dominance of B.1.1.7 over B.1.354 SARS-CoV-2 Variant: A Hypothesis Based on Areas of Variant Co-Circulation.|pdf=|usr=027}}
+{{tp|p=34087834|t=2021. Multi-system inflammatory syndrome in children during the coronavirus disease 2019 in Saudi Arabia: Clinical perspective from a case series.|pdf=|usr=027}}
+{{tp|p=34099172|t=2021. SARS-CoV-2 3a expression, purification, and reconstitution into lipid nanodiscs.|pdf=|usr=027}}
+{{tp|p=34042471|t=2021. Genome Sequencing Identified a SARS-CoV-2 Lineage B.1.1.7 Strain with a High Number of Mutations from Dhaka, Bangladesh.|pdf=|usr=027}}
+{{tp|p=34016683|t=2021. Complete Genome Sequence of a SARS-CoV-2 Strain Sampled in Morocco in May 2020, Obtained Using Sanger Sequencing.|pdf=|usr=027}}
+{{tp|p=33888505|t=2021. Report of SARS-CoV-2 B1.1.7 Lineage in Morocco.|pdf=|usr=027}}
+{{tp|p=33858933|t=2021. Genome Sequences of Three SARS-CoV-2 ORF7a Deletion Variants Obtained from Patients in Hong Kong.|pdf=|usr=027}}
+{{tp|p=33858931|t=2021. Genome Sequences of Five SARS-CoV-2 Variants from Mumbai, India, Obtained by Nanopore Sequencing.|pdf=|usr=027}}
+{{tp|p=34103074|t=2021. SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment.|pdf=|usr=027}}
+{{tp|p=33853691|t=2021. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity.|pdf=|usr=027}}
+{{tp|p=33904651|t=2021. Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut.|pdf=|usr=027}}
+{{tp|p=33852796|t=2021. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.|pdf=|usr=027}}
+{{tp|p=33897804|t=2021. Inherited and acquired corona of coronavirus in the host: Inspiration from the biomolecular corona of nanoparticles.|pdf=|usr=027}}
+{{tp|p=34046592|t=2021. A map of the SARS-CoV-2 RNA structurome.|pdf=|usr=027}}
+{{tp|p=34098792|t=2021. Multisystem Inflammatory Syndrome in Children and COVID-19 Infections.|pdf=|usr=027}}
+{{tp|p=34035301|t=2021. Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.|pdf=|usr=027}}
+{{tp|p=34021148|t=2021. Peripheral and lung resident memory T cell responses against SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=34021143|t=2021. Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes.|pdf=|usr=027}}
+{{tp|p=34011939|t=2021. Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection.|pdf=|usr=027}}
+{{tp|p=33990585|t=2021. Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions.|pdf=|usr=027}}
+{{tp|p=33986286|t=2021. Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein.|pdf=|usr=027}}
+{{tp|p=33976165|t=2021. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.|pdf=|usr=027}}
+{{tp|p=33976134|t=2021. SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes.|pdf=|usr=027}}
+{{tp|p=33972535|t=2021. Identification and characterization of a SARS-CoV-2 specific CD8(+) T cell response with immunodominant features.|pdf=|usr=027}}
+{{tp|p=34103506|t=2021. Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1.|pdf=|usr=027}}
+{{tp|p=34103499|t=2021. A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses.|pdf=|usr=027}}
+{{tp|p=34078893|t=2021. A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2'-O methylation of its first nucleotide.|pdf=|usr=027}}
+{{tp|p=33824342|t=2021. T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.|pdf=|usr=027}}
+{{tp|p=33879890|t=2021. Single-cell multi-omics analysis of the immune response in COVID-19.|pdf=|usr=027}}
+{{tp|p=33349665|t=2021. The SARS-CoV-2 RNA-protein interactome in infected human cells.|pdf=|usr=027}}
+{{tp|p=33854230|t=2021. Seeing SARS-CoV-2 variants through the eyes of T cells.|pdf=|usr=027}}
+{{tp|p=33990788|t=2021. Single-cell atlases dissect tissue destruction by SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33927374|t=2021. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.|pdf=|usr=027}}
+{{tp|p=33910211|t=2021. Evolution of SARS-CoV-2: Review of Mutations, Role of the Host Immune System.|pdf=|usr=027}}
+{{tp|p=33936746|t=2021. Extensive genetic diversity with novel mutations in spike glycoprotein of severe acute respiratory syndrome coronavirus 2, Bangladesh in late 2020.|pdf=|usr=027}}
+{{tp|p=33846689|t=2021. First detection of SARS-CoV-2 variant B.1.1.7 in Senegal.|pdf=|usr=027}}
+{{tp|p=34026228|t=2021. Evaluation of oxidative stress level: total antioxidant capacity, total oxidant status and glutathione activity in patients with COVID-19.|pdf=|usr=027}}
+{{tp|p=33969248|t=2021. The Intersection of COVID-19 and Autoimmunity: What is Our Current Understanding?|pdf=|usr=027}}
+{{tp|p=34072434|t=2021. S-Acylation of Proteins of Coronavirus and Influenza Virus: Conservation of Acylation Sites in Animal Viruses and DHHC Acyltransferases in Their Animal Reservoirs.|pdf=|usr=027}}
+{{tp|p=34064143|t=2021. The Emerging Concern and Interest SARS-CoV-2 Variants.|pdf=|usr=027}}
+{{tp|p=34067881|t=2021. Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old Man.|pdf=|usr=027}}
+{{tp|p=33868814|t=2021. Multi-schema computational prediction of the comprehensive SARS-CoV-2 vs. human interactome.|pdf=|usr=027}}
+{{tp|p=34021074|t=2021. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Iota.|pdf=|usr=027}}
+{{tp|p=34088793|t=2021. Altered amino acid profile in patients with SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=34083352|t=2021. The total number and mass of SARS-CoV-2 virions.|pdf=|usr=027}}
+{{tp|p=34045361|t=2021. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein.|pdf=|usr=027}}
+{{tp|p=34031243|t=2021. Transfer transcriptomic signatures for infectious diseases.|pdf=|usr=027}}
+{{tp|p=33361333|t=2021. Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein.|pdf=|usr=027}}
+{{tp|p=33361332|t=2021. DeepTracer for fast de novo cryo-EM protein structure modeling and special studies on CoV-related complexes.|pdf=|usr=027}}
+{{tp|p=34055582|t=2021. SARS-CoV-2 infection with lytic and non-lytic immune responses: A fractional order optimal control theoretical study.|pdf=|usr=027}}
+{{tp|p=34076402|t=2021. New variants of SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33888467|t=2021. SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity.|pdf=|usr=027}}
+{{tp|p=33863729|t=2021. The SARS-CoV-2 Spike variant D614G favors an open conformational state.|pdf=|usr=027}}
+{{tp|p=33853786|t=2021. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking.|pdf=|usr=027}}
+{{tp|p=34095639|t=2021. Serologic response to SARS-CoV-2 in an African population.|pdf=|usr=027}}
+{{tp|p=34047913|t=2021. NPC1-regulated dynamic of clathrin-coated pits is essential for viral entry.|pdf=|usr=027}}
+{{tp|p=34086155|t=2021. Distinct durability of IgM/IgG antibody responses in COVID-19 patients with differing severity.|pdf=|usr=027}}
+{{tp|p=33945070|t=2021. Longitudinal virological changes and underlying pathogenesis in hospitalized COVID-19 patients in Guangzhou, China.|pdf=|usr=027}}
+{{tp|p=33827897|t=2021. SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation.|pdf=|usr=027}}
+{{tp|p=34045585|t=2021. Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis.|pdf=|usr=027}}
+{{tp|p=34045524|t=2021. Dynamic changes in gene-to-gene regulatory networks in response to SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=34099808|t=2021. SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions.|pdf=|usr=027}}
+{{tp|p=34088957|t=2021. Atomic force microscopy analysis of native infectious and inactivated SARS-CoV-2 virions.|pdf=|usr=027}}
+{{tp|p=33875719|t=2021. Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology.|pdf=|usr=027}}
+{{tp|p=33850271|t=2021. Pattern of inflammatory immune response determines the clinical course and outcome of COVID-19: unbiased clustering analysis.|pdf=|usr=027}}
+{{tp|p=33846375|t=2021. A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood.|pdf=|usr=027}}
+{{tp|p=33979301|t=2021. High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages.|pdf=|usr=027}}
+{{tp|p=33853970|t=2021. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.|pdf=|usr=027}}
+{{tp|p=34001847|t=2021. Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq.|pdf=|usr=027}}
+{{tp|p=33980808|t=2021. The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry.|pdf=|usr=027}}
+{{tp|p=33972497|t=2021. Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=34083512|t=2021. Sera proteomic features of active and recovered COVID-19 patients: potential diagnostic and prognostic biomarkers.|pdf=|usr=027}}
+{{tp|p=33837186|t=2021. Landscapes of SARS-CoV-2-reactive CD8(+) T cells: heterogeneity of host immune responses against SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33895775|t=2021. Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain.|pdf=|usr=027}}
+{{tp|p=33895773|t=2021. RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-kappaB hyper-activation and inflammation.|pdf=|usr=027}}
+{{tp|p=33863870|t=2021. COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas.|pdf=|usr=027}}
+{{tp|p=33309104|t=2021. Using Genetics To Dissect SARS-CoV-2 Infection.|pdf=|usr=027}}
+{{tp|p=34088317|t=2021. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.|pdf=|usr=027}}
+{{tp|p=33931090|t=2021. The basic reproductive number and particle-to-plaque ratio: comparison of these two parameters of viral infectivity.|pdf=|usr=027}}
+{{tp|p=33910569|t=2021. Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes.|pdf=|usr=027}}
+{{tp|p=33900543|t=2021. Genetic Mutation of SARS-CoV-2 during Consecutive Passages in Permissive Cells.|pdf=|usr=027}}
+{{tp|p=33851337|t=2021. Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing.|pdf=|usr=027}}
+{{tp|p=34034617|t=2021. Time-dependent viral interference between influenza virus and coronavirus in the infection of differentiated porcine airway epithelial cells.|pdf=|usr=027}}
+{{tp|p=34030593|t=2021. Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis.|pdf=|usr=027}}
+{{tp|p=33961897|t=2021. Epitope mapping of severe acute respiratory syndrome-related coronavirus nucleocapsid protein with a rabbit monoclonal antibody.|pdf=|usr=027}}
+{{tp|p=33940003|t=2021. Pathogenic perspective of missense mutations of ORF3a protein of SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=34071984|t=2021. The Spike of Concern-The Novel Variants of SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=34073577|t=2021. Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays.|pdf=|usr=027}}
+{{tp|p=34073177|t=2021. Epidemic Spread of SARS-CoV-2 Lineage B.1.1.7 in Brazil.|pdf=|usr=027}}
+{{tp|p=34067349|t=2021. Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19.|pdf=|usr=027}}
+{{tp|p=34070055|t=2021. Prediction and Evolution of the Molecular Fitness of SARS-CoV-2 Variants: Introducing SpikePro.|pdf=|usr=027}}
+{{tp|p=34067890|t=2021. Structural Analysis of the Novel Variants of SARS-CoV-2 and Forecasting in North America.|pdf=|usr=027}}
+{{tp|p=34067878|t=2021. Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2.|pdf=|usr=027}}
+{{tp|p=34067745|t=2021. An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India.|pdf=|usr=027}}
+{{tp|p=34066091|t=2021. Cascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein Interactions.|pdf=|usr=027}}
+{{tp|p=34064904|t=2021. Mutation in a SARS-CoV-2 Haplotype from Sub-Antarctic Chile Reveals New Insights into the Spike's Dynamics.|pdf=|usr=027}}
+{{tp|p=34068703|t=2021. Virological Correlates of IgM-IgG Patterns of Response to SARS-CoV-2 Infection According to Targeted Antigens.|pdf=|usr=027}}
+{{tp|p=33925492|t=2021. The Significance of Phenotyping and Quantification of Plasma Extracellular Vesicles Levels Using High-Sensitivity Flow Cytometry during COVID-19 Treatment.|pdf=|usr=027}}
+{{tp|p=33922936|t=2021. Within-Host and Between-Host Evolution in SARS-CoV-2-New Variant's Source.|pdf=|usr=027}}
+{{tp|p=33923338|t=2021. From Multiplex Serology to Serolomics-A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome.|pdf=|usr=027}}
+{{tp|p=33919314|t=2021. A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.|pdf=|usr=027}}
+{{tp|p=33918371|t=2021. FIB-SEM as a Volume Electron Microscopy Approach to Study Cellular Architectures in SARS-CoV-2 and Other Viral Infections: A Practical Primer for a Virologist.|pdf=|usr=027}}
+{{tp|p=33921873|t=2021. Arthropod Ectoparasites Have Potential to Bind SARS-CoV-2 via ACE.|pdf=|usr=027}}
+{{tp|p=33923828|t=2021. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.|pdf=|usr=027}}
+{{tp|p=33867312|t=2021. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33857905|t=2021. High dimensional cytokine panels reveal common SARS-CoV-2-related inflammation patterns across different latitudes.|pdf=|usr=027}}
+{{tp|p=33840632|t=2021. Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study.|pdf=|usr=027}}
+{{tp|p=34056568|t=2021. A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States.|pdf=|usr=027}}
+{{tp|p=33922613|t=2021. Semicovariance Coefficient Analysis of Spike Proteins from SARS-CoV-2 and Other Coronaviruses for Viral Evolution and Characteristics Associated with Fatality.|pdf=|usr=027}}
+{{tp|p=33824882|t=2021. Viral reverse engineering using Artificial Intelligence and big data COVID-19 infection with Long Short-term Memory (LSTM).|pdf=|usr=027}}
+{{tp|p=34013161|t=2021. Coronary artery ectasia in a child after arterial switch operation for transposition of the great arteries and suspected multisystem inflammatory syndrome in children associated with COVID-19: a case report.|pdf=|usr=027}}
+{{tp|p=34017166|t=2021. Analysis of Emerging Variants in Structured Regions of the SARS-CoV-2 Genome.|pdf=|usr=027}}
+{{tp|p=34040499|t=2021. Potential role of Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in SARS-CoV-2 infection: First insights.|pdf=|usr=027}}
+{{tp|p=33883984|t=2021. Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis.|pdf=|usr=027}}
+{{tp|p=33325750|t=2021. Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana.|pdf=|usr=027}}
+{{tp|p=33849359|t=2021. The importance of genomic analysis in cracking the coronavirus pandemic.|pdf=|usr=027}}
+{{tp|p=33929923|t=2021. Can proteomics-based approaches further help COVID-19 prevention and therapy?|pdf=|usr=027}}
+{{tp|p=34026045|t=2021. Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold coronaviruses.|pdf=|usr=027}}
+{{tp|p=33996638|t=2021. The Unfolded Protein Response and Autophagy on the Crossroads of Coronaviruses Infections.|pdf=|usr=027}}
+{{tp|p=33889552|t=2021. IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection.|pdf=|usr=027}}
+{{tp|p=33968142|t=2021. Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study.|pdf=|usr=027}}
+{{tp|p=33828579|t=2021. Epigenetic Lens to Visualize the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in COVID-19 Pandemic.|pdf=|usr=027}}
+{{tp|p=34093595|t=2021. Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay.|pdf=|usr=027}}
+{{tp|p=34084167|t=2021. SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1.|pdf=|usr=027}}
+{{tp|p=34079547|t=2021. Quantification of Cytokine Storms During Virus Infections.|pdf=|usr=027}}
+{{tp|p=34054876|t=2021. Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course.|pdf=|usr=027}}
+{{tp|p=34054828|t=2021. The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?|pdf=|usr=027}}
+{{tp|p=34054820|t=2021. Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
+{{tp|p=34054808|t=2021. Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.|pdf=|usr=027}}
+{{tp|p=34054793|t=2021. Identify. Quantify. Predict. Why Immunologists Should Widely Use Molecular Imaging for Coronavirus Disease 2019.|pdf=|usr=027}}
+{{tp|p=34046036|t=2021. Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
+{{tp|p=34040616|t=2021. The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome.|pdf=|usr=027}}
+{{tp|p=34025675|t=2021. Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health.|pdf=|usr=027}}
+{{tp|p=33995382|t=2021. SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs.|pdf=|usr=027}}
+{{tp|p=33995366|t=2021. A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain.|pdf=|usr=027}}
+{{tp|p=33995364|t=2021. Cellular Immune Response to COVID-19 and Potential Immune Modulators.|pdf=|usr=027}}
+{{tp|p=33995351|t=2021. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.|pdf=|usr=027}}
+{{tp|p=33995341|t=2021. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.|pdf=|usr=027}}
+{{tp|p=33981314|t=2021. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!|pdf=|usr=027}}
+{{tp|p=33968063|t=2021. Enhancing the Prefusion Conformational Stability of SARS-CoV-2 Spike Protein Through Structure-Guided Design.|pdf=|usr=027}}
+{{tp|p=33959123|t=2021. Circulating Adaptive Immune Cells Expressing the Gut Homing Marker alpha4beta7 Integrin Are Decreased in COVID-19.|pdf=|usr=027}}
+{{tp|p=33936086|t=2021. SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia.|pdf=|usr=027}}
+{{tp|p=33936072|t=2021. Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019.|pdf=|usr=027}}
+{{tp|p=33936053|t=2021. Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19.|pdf=|usr=027}}
+{{tp|p=33936045|t=2021. Antibody Responses in COVID-19: A Review.|pdf=|usr=027}}
+{{tp|p=33936026|t=2021. Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus.|pdf=|usr=027}}
+{{tp|p=33927728|t=2021. Interplay of Opposing Effects of the WNT/beta-Catenin Pathway and PPARgamma and Implications for SARS-CoV2 Treatment.|pdf=|usr=027}}
+{{tp|p=33912161|t=2021. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19.|pdf=|usr=027}}
+{{tp|p=33868301|t=2021. Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19.|pdf=|usr=027}}
+{{tp|p=33868293|t=2021. MicroLet-7b Regulates Neutrophil Function and Dampens Neutrophilic Inflammation by Suppressing the Canonical TLR4/NF-kappaB Pathway.|pdf=|usr=027}}
+{{tp|p=33854501|t=2021. Integrin Activation Enables Sensitive Detection of Functional CD4(+) and CD8(+) T Cells: Application to Characterize SARS-CoV-2 Immunity.|pdf=|usr=027}}
+{{tp|p=33841442|t=2021. Understanding of COVID-19 Pathology: Much More Attention to Plasma Proteins.|pdf=|usr=027}}
+{{tp|p=33841438|t=2021. Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-gamma Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome.|pdf=|usr=027}}
+{{tp|p=33841435|t=2021. Neutrophils in COVID-19.|pdf=|usr=027}}
+{{tp|p=33833755|t=2021. SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients.|pdf=|usr=027}}
+{{tp|p=33889583|t=2021. First Report on the Latvian SARS-CoV-2 Isolate Genetic Diversity.|pdf=|usr=027}}
+{{tp|p=34093495|t=2021. Genomic Epidemiology of SARS-CoV-2 From Mainland China With Newly Obtained Genomes From Henan Province.|pdf=|usr=027}}
+{{tp|p=34093454|t=2021. Antigenic Evolution on a Global Scale Reveals the Potential Natural Selection of Severe Acute Respiratory Syndrome-Coronavirus 2 by Pre-existing Cross-Reactive T-Cell Immunity.|pdf=|usr=027}}
+{{tp|p=34025615|t=2021. Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors.|pdf=|usr=027}}
+{{tp|p=33935986|t=2021. Interrogating the Impact of Intestinal Parasite-Microbiome on Pathogenesis of COVID-19 in Sub-Saharan Africa.|pdf=|usr=027}}
+{{tp|p=33889134|t=2021. Base Composition and Host Adaptation of the SARS-CoV-2: Insight From the Codon Usage Perspective.|pdf=|usr=027}}
+{{tp|p=33996911|t=2021. Computational Identification of a Putative Allosteric Binding Pocket in TMPRSS2.|pdf=|usr=027}}
+{{tp|p=34045976|t=2021. Alteration in the Lipid Profile and the Desaturases Activity in Patients With Severe Pneumonia by SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33912067|t=2021. The Affinity of Hemoglobin for Oxygen Is Not Altered During COVID-19.|pdf=|usr=027}}
+{{tp|p=33825125|t=2021. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity.|pdf=|usr=027}}
+{{tp|p=33840038|t=2021. The first familial cluster of the B.1.1.7 variant of SARS-CoV-2 in the northeast of Italy.|pdf=|usr=027}}
+{{tp|p=33346851|t=2021. Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia.|pdf=|usr=027}}
+{{tp|p=34086061|t=2021. The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications.|pdf=|usr=027}}
+{{tp|p=33864915|t=2021. Is it all MIS-C? Unusual findings in a series of nine German patients with multi-system inflammatory syndrome in children after SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=34058196|t=2021. Role of host factors in SARS-CoV-2 entry.|pdf=|usr=027}}
+{{tp|p=34029587|t=2021. Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication.|pdf=|usr=027}}
+{{tp|p=33965375|t=2021. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection.|pdf=|usr=027}}
+{{tp|p=33844652|t=2021. SARS-CoV-2 as a superantigen in multisystem inflammatory syndrome in children.|pdf=|usr=027}}
+{{tp|p=33830946|t=2021. Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses.|pdf=|usr=027}}
+{{tp|p=34003804|t=2021. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19.|pdf=|usr=027}}
+{{tp|p=33626241|t=2021. COVID-19 and human papillomavirus: Paradoxical immunity.|pdf=|usr=027}}
+{{tp|p=34023553|t=2021. Viral load dynamics in intubated patients with COVID-19 admitted to the intensive care unit.|pdf=|usr=027}}
+{{tp|p=33861846|t=2021. Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection.|pdf=|usr=027}}
+{{tp|p=33904890|t=2021. SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?|pdf=|usr=027}}
+{{tp|p=33890986|t=2021. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.|pdf=|usr=027}}
+{{tp|p=33963016|t=2021. Immune profiling of COVID-19: preliminary findings and implications for the pandemic.|pdf=|usr=027}}
+{{tp|p=33889008|t=2021. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications.|pdf=|usr=027}}
+{{tp|p=33859488|t=2021. Decreased T Cell Levels in Critically Ill Coronavirus Patients: Single-Center, Prospective and Observational Study.|pdf=|usr=027}}
+{{tp|p=33833547|t=2021. Interferon-lambda3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 Pathogenesis.|pdf=|usr=027}}
+{{tp|p=33833543|t=2021. Association of Early Inflammation with Age and Asymptomatic Disease in COVID-19.|pdf=|usr=027}}
+{{tp|p=33915711|t=2021. Previous Humoral Immunity to the Endemic Seasonal Alphacoronaviruses NL63 and 229E Is Associated with Worse Clinical Outcome in COVID-19 and Suggests Original Antigenic Sin.|pdf=|usr=027}}
+{{tp|p=33984360|t=2021. Beclin-1, an autophagy-related protein, is associated with the disease severity of COVID-19.|pdf=|usr=027}}
+{{tp|p=34007097|t=2021. Discrete and continuum models of COVID-19 virus, formal solutions, stability and comparison with real data.|pdf=|usr=027}}
+{{tp|p=33849978|t=2021. Interferon-Independent Restriction of RNA Virus Entry and Replication by a Class of Damage-Associated Molecular Patterns.|pdf=|usr=027}}
+{{tp|p=33849972|t=2021. SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98.|pdf=|usr=027}}
+{{tp|p=33870241|t=2021. Mucosal-associated invariant T cell responses differ by sex in COVID-19.|pdf=|usr=027}}
+{{tp|p=33873150|t=2021. The role of carbohydrate antigen 125 in COVID-19.|pdf=|usr=027}}
+{{tp|p=33308936|t=2021. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory.|pdf=|usr=027}}
+{{tp|p=34059225|t=2021. Living evidence for SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=34111831|t=2021. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19).|pdf=|usr=027}}
+{{tp|p=34109258|t=2021. Use of Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry Analysis of Serum Peptidome to Classify and Predict Coronavirus Disease 2019 Severity.|pdf=|usr=027}}
+{{tp|p=33872279|t=2021. Multisystem Inflammatory Syndrome in Infants <12 months of Age, United States, May 2020-January 2021.|pdf=|usr=027}}
+{{tp|p=34009707|t=2021. Multisystem inflammatory syndrome associated with SARS-CoV-2 in a Japanese girl.|pdf=|usr=027}}
+{{tp|p=33934422|t=2021. Predictable fold switching by the SARS-CoV-2 protein ORF9b.|pdf=|usr=027}}
+{{tp|p=33983654|t=2021. Comparative protein structure network analysis on 3CL(pro) from SARS-CoV-1 and SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33864655|t=2021. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor.|pdf=|usr=027}}
+{{tp|p=33860983|t=2021. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.|pdf=|usr=027}}
+{{tp|p=33945677|t=2021. Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression.|pdf=|usr=027}}
+{{tp|p=33987944|t=2021. Proteomic and metabolomic investigation of serum lactate dehydrogenase elevation in COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33947773|t=2021. Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes.|pdf=|usr=027}}
+{{tp|p=34028939|t=2021. Development and longevity of antibodies against SARS-CoV-2 in kidney transplant recipients after symptomatic COVID-19.|pdf=|usr=027}}
+{{tp|p=33845483|t=2021. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.|pdf=|usr=027}}
+{{tp|p=33915569|t=2021. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.|pdf=|usr=027}}
+{{tp|p=33915568|t=2021. A molecular single-cell lung atlas of lethal COVID-19.|pdf=|usr=027}}
+{{tp|p=33864048|t=2021. Daily briefing: Video guide to the science of coronavirus variants.|pdf=|usr=027}}
+{{tp|p=33854226|t=2021. Coronavirus variants: what viral mutants mean for the pandemic.|pdf=|usr=027}}
+{{tp|p=34097663|t=2021. Rationale of Therapeutic Plasma Exchange as Rescue Immunomodulatory Treatment for MIS-C With Multiorgan Failure.|pdf=|usr=027}}
+{{tp|p=34016834|t=2021. Coronavirus Disease 2019-associated Cytotoxic Lesions of the Corpus Callosum Diagnosis As a Result of Hallucination in a Child With Multisystem Inflammatory Syndrome in Children.|pdf=|usr=027}}
+{{tp|p=33298763|t=2021. Abdominal Imaging Findings in Critically Ill Children With Multisystem Inflammatory Syndrome Associated With COVID-19.|pdf=|usr=027}}
+{{tp|p=34032527|t=2021. The understanding of the immunopathology in COVID-19 infection.|pdf=|usr=027}}
+{{tp|p=33986163|t=2021. Do coronavirus genes slip into human chromosomes?|pdf=|usr=027}}
+{{tp|p=34009775|t=2020. Scientific Brief: SARS-CoV-2 Transmission|pdf=|usr=027}}
+{{tp|p=34009774|t=2020. Science Brief: Emerging SARS-CoV-2 Variants|pdf=|usr=027}}
+{{tp|p=34056088|t=2021. Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike.|pdf=|usr=027}}
+{{tp|p=33988161|t=2021. Pediatric inflammatory multisystem disease in children with COVID-19.|pdf=|usr=027}}
+{{tp|p=33988157|t=2021. Pediatric inflammatory multisystem disease in children with COVID-19 - Reply.|pdf=|usr=027}}
+{{tp|p=33971111|t=2021. SARS-CoV-2 Infection Is Associated with Reduced Kruppel-like Factor 2 in Human Lung Autopsy.|pdf=|usr=027}}
+{{tp|p=33841649|t=2021. Correlation of the ratio of IgM/IgG concentration to days after symptom onset (IgM/T or IgG/T) with disease severity and outcome in non-critical COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33345622|t=2021. Increased expression of hypoxia-induced factor 1alpha mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33327744|t=2021. Journey to a Receptor for Advanced Glycation End Products Connection in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: With Stops Along the Way in the Lung, Heart, Blood Vessels, and Adipose Tissue.|pdf=|usr=027}}
+{{tp|p=33872769|t=2021. Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent.|pdf=|usr=027}}
+{{tp|p=33864942|t=2021. Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?|pdf=|usr=027}}
+{{tp|p=33899609|t=2021. COVID-19: captures iron and generates reactive oxygen species to damage the human immune system.|pdf=|usr=027}}
+{{tp|p=33894532|t=2021. Relevance of carotid bodies in COVID-19: A hypothetical viewpoint.|pdf=|usr=027}}
+{{tp|p=34013072|t=2021. Sequence and structural analysis of COVID-19 E and M proteins with MERS virus E and M proteins-A comparative study.|pdf=|usr=027}}
+{{tp|p=33894414|t=2021. In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5.|pdf=|usr=027}}
+{{tp|p=34000512|t=2021. SARS-Cov-2 spike protein fragment 674-685 protects mitochondria from rele<iframe src="http://www.kidney.de/amapp.php?a=g cytochrome c in response to apoptogenic influence.|pdf=|usr=027}}
+{{tp|p=34062392|t=2021. Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant.|pdf=|usr=027}}
+{{tp|p=34049205|t=2021. Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective.|pdf=|usr=027}}
+{{tp|p=33360543|t=2021. Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex.|pdf=|usr=027}}
+{{tp|p=33367597|t=2021. Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies.|pdf=|usr=027}}
+{{tp|p=33900725|t=2021. Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations.|pdf=|usr=027}}
+{{tp|p=33838638|t=2021. Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection.|pdf=|usr=027}}
+{{tp|p=33838626|t=2021. Recombinant SARS-CoV-2 S Protein Binds to Glycans of the Lactosamine Family in vitro.|pdf=|usr=027}}
+{{tp|p=33338598|t=2021. Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study.|pdf=|usr=027}}
+{{tp|p=33932525|t=2021. Genome sequencing of SARS-CoV-2 in a cohort of Egyptian patients revealed mutation hotspots that are related to clinical outcomes.|pdf=|usr=027}}
+{{tp|p=33984400|t=2021. Molecular simulation studies of the interactions between the human/pangolin/cat/bat ACE2 and the receptor binding domain of the SARS-CoV-2 spike protein.|pdf=|usr=027}}
+{{tp|p=34092964|t=2021. D614G substitution at the hinge region enhances the stability of trimeric SARS-CoV-2 spike protein.|pdf=|usr=027}}
+{{tp|p=33600624|t=2021. Intracellular host cell membrane remodelling induced by SARS-CoV-2 infection in vitro.|pdf=|usr=027}}
+{{tp|p=33986591|t=2021. Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target.|pdf=|usr=027}}
+{{tp|p=34072585|t=2021. Immune Responses to SARS-CoV2 Mirror Societal Responses to COVID-19: Identifying Factors Underlying a Successful Viral Response.|pdf=|usr=027}}
+{{tp|p=34064163|t=2021. Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility.|pdf=|usr=027}}
+{{tp|p=34046413|t=2021. Potential Role of the Galectin-9/TIM-3 Axis in the Disparate Progression of SARS-CoV-2 in a Married Couple: A Case Report.|pdf=|usr=027}}
+{{tp|p=33915502|t=2021. Novel and emerging mutations of SARS-CoV-2: Biomedical implications.|pdf=|usr=027}}
+{{tp|p=34066729|t=2021. Mutations in the B.1.1.7 SARS-CoV-2 Spike Protein Reduce Receptor-Binding Affinity and Induce a Flexible Link to the Fusion Peptide.|pdf=|usr=027}}
+{{tp|p=33920487|t=2021. Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective.|pdf=|usr=027}}
+{{tp|p=33928512|t=2021. (1)H, (13)C, (15)N and (31)P chemical shift assignment for stem-loop 4 from the 5'-UTR of SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33914244|t=2021. The (1)H, (15)N, and (13)C resonance assignments of the N-terminal domain of the nucleocapsid protein from the Middle East respiratory syndrome coronavirus.|pdf=|usr=027}}
+{{tp|p=33660218|t=2021. The highly flexible disordered regions of the SARS-CoV-2 nucleocapsid N protein within the 1-248 residue construct: sequence-specific resonance assignments through NMR.|pdf=|usr=027}}
+{{tp|p=33875625|t=2021. Multifactorial Traits of SARS-CoV-2 Cell Entry Related to Diverse Host Proteases and Proteins.|pdf=|usr=027}}
+{{tp|p=33925394|t=2021. Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach.|pdf=|usr=027}}
+{{tp|p=33340543|t=2021. Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase.|pdf=|usr=027}}
+{{tp|p=34087218|t=2021. Neuropilin-1 assists SARS-CoV-2 infection by stimulating the separation of Spike protein S1 and S2.|pdf=|usr=027}}
+{{tp|p=34087216|t=2021. Physical phenotype of blood cells is altered in COVID-19.|pdf=|usr=027}}
+{{tp|p=34087207|t=2021. Enhanced sampling protocol to elucidate fusion peptide opening of SARS-CoV-2 spike protein.|pdf=|usr=027}}
+{{tp|p=33984310|t=2021. Computational optimization of the SARS-CoV-2 receptor-binding-motif affinity for human ACE2.|pdf=|usr=027}}
+{{tp|p=33359834|t=2021. The Molecular Mechanism of Domain Swapping of the C-Terminal Domain of the SARS-Coronavirus Main Protease.|pdf=|usr=027}}
+{{tp|p=34095806|t=2021. Virology features of a family cluster of SARS-CoV-2 infections in Shanghai, China.|pdf=|usr=027}}
+{{tp|p=33350432|t=2021. Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19.|pdf=|usr=027}}
+{{tp|p=33305306|t=2021. Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potential.|pdf=|usr=027}}
+{{tp|p=34047452|t=2021. SARS-CoV-2 first contact: Spike-ACE2 interactions in COVID-19.|pdf=|usr=027}}
+{{tp|p=33895815|t=2021. Mutation Rates and Selection on Synonymous Mutations in SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=34001247|t=2021. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.|pdf=|usr=027}}
+{{tp|p=33883027|t=2021. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.|pdf=|usr=027}}
+{{tp|p=33879239|t=2021. IFN-gamma and TNF-alpha drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation.|pdf=|usr=027}}
+{{tp|p=33875001|t=2021. Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispecies.|pdf=|usr=027}}
+{{tp|p=34019999|t=2021. Comparative analysis of human coronaviruses focusing on nucleotide variability and synonymous codon usage patterns.|pdf=|usr=027}}
+{{tp|p=33839270|t=2021. ACoRE: Accurate SARS-CoV-2 genome reconstruction for the characterization of intra-host and inter-host viral diversity in clinical samples and for the evaluation of re-infections.|pdf=|usr=027}}
+{{tp|p=33951417|t=2021. CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.|pdf=|usr=027}}
+{{tp|p=33945786|t=2021. CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses.|pdf=|usr=027}}
+{{tp|p=33891889|t=2021. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children.|pdf=|usr=027}}
+{{tp|p=34051148|t=2021. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.|pdf=|usr=027}}
+{{tp|p=34048708|t=2021. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2.|pdf=|usr=027}}
+{{tp|p=34022127|t=2021. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.|pdf=|usr=027}}
+{{tp|p=33915108|t=2021. Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections.|pdf=|usr=027}}
+{{tp|p=33338412|t=2021. PD-1-Expressing SARS-CoV-2-Specific CD8(+) T Cells Are Not Exhausted, but Functional in Patients with COVID-19.|pdf=|usr=027}}
+{{tp|p=33357409|t=2021. The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells.|pdf=|usr=027}}
+{{tp|p=34022670|t=2021. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33928531|t=2021. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).|pdf=|usr=027}}
+{{tp|p=33921604|t=2021. Absence of "Cytokine Storm" in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.|pdf=|usr=027}}
+{{tp|p=34050885|t=2021. Dynamic Antibody Responses in Patients with Different Severity of COVID-19: A Retrospective Study.|pdf=|usr=027}}
+{{tp|p=34044192|t=2021. E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil.|pdf=|usr=027}}
+{{tp|p=34004362|t=2021. Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis.|pdf=|usr=027}}
+{{tp|p=34004360|t=2021. Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33951560|t=2021. Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33932696|t=2021. A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19).|pdf=|usr=027}}
+{{tp|p=33347989|t=2021. Different mutations in SARS-CoV-2 associate with severe and mild outcome.|pdf=|usr=027}}
+{{tp|p=33359807|t=2021. SARS-Cov-2 ORF3a: Mutability and function.|pdf=|usr=027}}
+{{tp|p=33932604|t=2021. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection.|pdf=|usr=027}}
+{{tp|p=33901653|t=2021. Antibody and viral RNA kinetics in SARS-CoV2 infected patients admitted to a Romanian University Hospital of Infectious Diseases.|pdf=|usr=027}}
+{{tp|p=33932603|t=2021. Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors.|pdf=|usr=027}}
+{{tp|p=34073283|t=2021. Induction of the Proinflammatory Chemokine Interleukin-8 Is Regulated by Integrated Stress Response and AP-1 Family Proteins Activated during Coronavirus Infection.|pdf=|usr=027}}
+{{tp|p=34067272|t=2021. Altered Local Interactions and Long-Range Communications in UK Variant (B.1.1.7) Spike Glycoprotein.|pdf=|usr=027}}
+{{tp|p=33989635|t=2021. Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template.|pdf=|usr=027}}
+{{tp|p=33965637|t=2021. A scheme for inferring viral-host associations based on codon usage patterns identifies the most affected signaling pathways during COVID-19.|pdf=|usr=027}}
+{{tp|p=34106885|t=2021. Kawasaki like illness due to COVID-19: a review of the literature.|pdf=|usr=027}}
+{{tp|p=33367897|t=2021. Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=027}}
+{{tp|p=33961690|t=2021. Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection.|pdf=|usr=027}}
+{{tp|p=33895266|t=2021. N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 M(pro) Dimer.|pdf=|usr=027}}
+{{tp|p=34023401|t=2021. Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants.|pdf=|usr=027}}
+{{tp|p=33992693|t=2021. Structural Modeling of the SARS-CoV-2 Spike/Human ACE2 Complex Interface can Identify High-Affinity Variants Associated with Increased Transmissibility.|pdf=|usr=027}}
+{{tp|p=33310017|t=2021. The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition.|pdf=|usr=027}}
+{{tp|p=33340519|t=2021. Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition.|pdf=|usr=027}}
+{{tp|p=33677567|t=2021. Entry, egress and vertical transmission of SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33760045|t=2021. Membraneless organelles restructured and built by pandemic viruses: HIV-1 and SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33377937|t=2020. SARS-CoV-2 infection and the antiviral innate immune response.|pdf=|usr=027}}
+{{tp|p=33377928|t=2020. The development of neutralizing antibodies against SARS-CoV-2 and their common features.|pdf=|usr=027}}
+{{tp|p=33326034|t=2020. A promiscuous interaction of SARS-CoV-2 with bacterial products.|pdf=|usr=027}}
+{{tp|p=33993372|t=2021. The Evolution of Severe Acute Respiratory Syndrome Coronavirus-2 during Pandemic and Adaptation to the Host.|pdf=|usr=027}}
+{{tp|p=34023935|t=2021. Glycosylation is a key in SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=34089819|t=2021. Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19.|pdf=|usr=027}}
+{{tp|p=33921718|t=2021. The Challenging Diagnosis of Pediatric Multisystem Inflammatory Syndrome Associated with Sars-Cov-2 Infection-Two Case Reports and Literature Review.|pdf=|usr=027}}
+{{tp|p=33825700|t=2021. Structural biology of coronavirus ion channels.|pdf=|usr=027}}
+{{tp|p=34086538|t=2021. The Central Role of PAI-1 in COVID-19: Thrombosis and beyond.|pdf=|usr=027}}
+{{tp|p=34003736|t=2021. ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial PAI-1.|pdf=|usr=027}}
+{{tp|p=34033529|t=2021. Importance of Lung Epithelial Injury in COVID-19-associated Acute Respiratory Distress Syndrome: Value of Plasma Soluble Receptor for Advanced Glycation End-Products.|pdf=|usr=027}}
+{{tp|p=33974890|t=2021. Gene selection using hybrid dragonfly black hole algorithm: A case study on RNA-seq COVID-19 data.|pdf=|usr=027}}
+{{tp|p=34088699|t=2021. Covid-19: Delta variant is now UK's most dominant strain and spreading through schools.|pdf=|usr=027}}
+{{tp|p=33942835|t=2021. Influence of charge configuration on substrate binding to SARS-CoV-2 main protease.|pdf=|usr=027}}
+{{tp|p=34037640|t=2021. Immune evasion of SARS-CoV-2 variants of concern is driven by low affinity to neutralizing antibodies.|pdf=|usr=027}}
+{{tp|p=34019602|t=2021. ACE2 glycans preferentially interact with SARS-CoV-2 over SARS-CoV.|pdf=|usr=027}}
+{{tp|p=33902795|t=2021. Experimental Identification of Immuno- dominant B-cell Epitopes from SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=34074849|t=2021. Cytokine levels and pathological characteristics of a patient with severe coronavirus disease 2019: a case report.|pdf=|usr=027}}
+{{tp|p=33992073|t=2021. Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population.|pdf=|usr=027}}
+{{tp|p=33991487|t=2021. Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.|pdf=|usr=027}}
+{{tp|p=34015271|t=2021. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.|pdf=|usr=027}}
+{{tp|p=33974910|t=2021. Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.|pdf=|usr=027}}
+{{tp|p=33333024|t=2021. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.|pdf=|usr=027}}
+{{tp|p=33930298|t=2021. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.|pdf=|usr=027}}
+{{tp|p=33930293|t=2021. SARS-CoV-2 RNA: Exclusive friends and common foes.|pdf=|usr=027}}
+{{tp|p=33831378|t=2021. The origins of viral infection sleuth.|pdf=|usr=027}}
+{{tp|p=33743891|t=2021. Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.|pdf=|usr=027}}
+{{tp|p=33879858|t=2021. SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination.|pdf=|usr=027}}
+{{tp|p=33981020|t=2021. Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes.|pdf=|usr=027}}
+{{tp|p=34035220|t=2021. Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery.|pdf=|usr=027}}
+{{tp|p=34006825|t=2021. Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells.|pdf=|usr=027}}
+{{tp|p=33947832|t=2021. The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes.|pdf=|usr=027}}
+{{tp|p=34035218|t=2021. SARS-CoV-2 nucleocapsid protein impairs stress granule formation to promote viral replication.|pdf=|usr=027}}
+{{tp|p=33850112|t=2021. Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages.|pdf=|usr=027}}
+{{tp|p=33984277|t=2021. An NTD supersite of attack.|pdf=|usr=027}}
+{{tp|p=33887205|t=2021. Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.|pdf=|usr=027}}
+{{tp|p=33984285|t=2021. Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans.|pdf=|usr=027}}
+{{tp|p=34022154|t=2021. Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19.|pdf=|usr=027}}
+{{tp|p=33357464|t=2021. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.|pdf=|usr=027}}
+{{tp|p=33905951|t=2021. Functional responsiveness of memory T cells from COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33359760|t=2021. Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33972738|t=2021. IL-33 in COVID-19: friend or foe?|pdf=|usr=027}}
+{{tp|p=34059791|t=2021. Cross-reactive antibody immunity against SARS-CoV-2 in children and adults.|pdf=|usr=027}}
+{{tp|p=33318627|t=2021. Severe COVID-19 patients exhibit an ILC2 NKG2D(+) population in their impaired ILC compartment.|pdf=|usr=027}}
+{{tp|p=34004174|t=2021. Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells.|pdf=|usr=027}}
+{{tp|p=34043946|t=2021. SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression.|pdf=|usr=027}}
+{{tp|p=33357411|t=2021. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.|pdf=|usr=027}}
+{{tp|p=33857422|t=2021. SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization.|pdf=|usr=027}}
+{{tp|p=34027499|t=2021. SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition.|pdf=|usr=027}}
+{{tp|p=33969320|t=2021. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions.|pdf=|usr=027}}
+{{tp|p=33899033|t=2021. Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.|pdf=|usr=027}}
+{{tp|p=33899032|t=2021. Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome.|pdf=|usr=027}}
+{{tp|p=34075365|t=2021. Broad auto-reactive IgM responses are common in critically ill patients, including those with COVID-19.|pdf=|usr=027}}
+{{tp|p=34056628|t=2021. Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions.|pdf=|usr=027}}
+{{tp|p=34056627|t=2021. Landscape of epitopes targeted by T cells in 852 individuals recovered from COVID-19: Meta-analysis, immunoprevalence, and web platform.|pdf=|usr=027}}
+{{tp|p=33997824|t=2021. Decay of Fc-dependent antibody functions after mild to moderate COVID-19.|pdf=|usr=027}}
+{{tp|p=33977279|t=2021. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=33969322|t=2021. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset.|pdf=|usr=027}}
+{{tp|p=33842902|t=2021. Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.|pdf=|usr=027}}
+{{tp|p=33842901|t=2021. Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19.|pdf=|usr=027}}
+{{tp|p=34067965|t=2021. Impaired Glucose-Insulin Metabolism in Multisystem Inflammatory Syndrome Related to SARS-CoV-2 in Children.|pdf=|usr=027}}
+{{tp|p=33826953|t=2021. Clinical relevance of serum alpha-l-fucosidase activity in the SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=33906227|t=2021. SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection.|pdf=|usr=027}}
+{{tp|p=33905478|t=2021. Disease severity and durability of the SARS-CoV-2 antibody response: A view through the lens of the second year of the pandemic.|pdf=|usr=027}}
+{{tp|p=33851216|t=2021. Sera neutralizing activities against SARS-CoV-2 and multiple variants six month after hospitalization for COVID-19.|pdf=|usr=027}}
+{{tp|p=33872970|t=2021. A unique view of SARS-CoV-2 through the lens of ORF8 protein.|pdf=|usr=027}}
+{{tp|p=34022485|t=2021. Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD.|pdf=|usr=027}}
+{{tp|p=34020131|t=2021. Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach.|pdf=|usr=027}}
+{{tp|p=34020127|t=2021. Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity.|pdf=|usr=027}}
+{{tp|p=33827651|t=2021. Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment.|pdf=|usr=027}}
+{{tp|p=33874973|t=2021. Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study.|pdf=|usr=027}}
+{{tp|p=34089541|t=2021. Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2 in humans and mice.|pdf=|usr=027}}
+{{tp|p=33913206|t=2021. Potential 3-chymotrypsin-like cysteine protease cleavage sites in the coronavirus polyproteins pp1a and pp1ab and their possible relevance to COVID-19 vaccine and drug development.|pdf=|usr=027}}
+{{tp|p=34033145|t=2021. High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33864728|t=2021. Host PDZ-containing proteins targeted by SARS-CoV-2.|pdf=|usr=027}}
+{{tp|p=33991349|t=2021. A weak COPI binding motif in the cytoplasmic tail of SARS-CoV-2 spike glycoprotein is necessary for its cleavage, glycosylation, and localization.|pdf=|usr=027}}
+{{tp|p=33961290|t=2021. Serum levels of the IgA isotype switch factor TGF-beta1 are elevated in patients with COVID-19.|pdf=|usr=027}}
+{{tp|p=34086357|t=2021. SARS-CoV-2-specific CD8(+) T-cell responses and TCR signatures in the context of a prominent HLA-A24:02 allomorph.|pdf=|usr=027}}
+{{tp|p=34053124|t=2021. Monocytes and macrophages in severe COVID-19 - friend, foe or both?|pdf=|usr=027}}
+{{tp|p=34028807|t=2021. COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts.|pdf=|usr=027}}
+{{tp|p=33864388|t=2021. A concomitant diagnosis of COVID-19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report.|pdf=|usr=027}}
+{{tp|p=34078711|t=2021. Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation.|pdf=|usr=027}}
+{{tp|p=34042186|t=2021. Genome-wide analysis of SARS-CoV-2 strains circulating in Vietnam: Understanding the nature of the epidemic and role of the D614G mutation.|pdf=|usr=027}}
+{{tp|p=34009691|t=2021. Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leukocytes sequencing data set of patients with COVID-19.|pdf=|usr=027}}
+{{tp|p=34002405|t=2021. Emergence of the SARS-CoV-2 B.1.1.7 variant observed at the Poitiers University Hospital.|pdf=|usr=027}}
+{{tp|p=33990970|t=2021. Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case report.|pdf=|usr=027}}
+{{tp|p=33990965|t=2021. Multisystemic inflammatory syndrome in a young adult after SARS-CoV-2 infection: Case report.|pdf=|usr=027}}
+{{tp|p=33969513|t=2021. Coronavirus disease 2019 (COVID-19): A systematic review of 133 Children that presented with Kawasaki-like multisystem inflammatory syndrome.|pdf=|usr=027}}
+{{tp|p=33969504|t=2021. SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients.|pdf=|usr=027}}
+{{tp|p=33963559|t=2021. Cytokine storm in severe COVID-19 pneumonia.|pdf=|usr=027}}
+{{tp|p=33951211|t=2021. Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K.|pdf=|usr=027}}
+{{tp|p=33945634|t=2021. Determinants of IgG antibodies kinetics after severe and critical COVID-19.|pdf=|usr=027}}
+{{tp|p=33934387|t=2021. Betacoronaviruses genome analysis reveals evolution toward specific codons usage: Implications for SARS-CoV-2 mitigation strategies.|pdf=|usr=027}}
+{{tp|p=33913550|t=2021. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.|pdf=|usr=027}}
+{{tp|p=33913546|t=2021. Comparable endemic coronavirus nucleoprotein-specific antibodies in mild and severe Covid-19 patients.|pdf=|usr=027}}
+{{tp|p=33913544|t=2021. Characterization of T lymphocytes in severe COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33913542|t=2021. Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach.|pdf=|usr=027}}
+{{tp|p=34061395|t=2021. Relative expression of proinflammatory molecules in COVID-19 patients who manifested disease severities.|pdf=|usr=027}}
+{{tp|p=34061367|t=2021. Longitudinal detection of SARS-CoV-2-specific antibody responses with different serological methods.|pdf=|usr=027}}
+{{tp|p=33837972|t=2021. Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target.|pdf=|usr=027}}
+{{tp|p=33830520|t=2021. SARS-CoV-2 show no infectivity at later stages in a prolonged COVID-19 patient despite positivity in RNA testing.|pdf=|usr=027}}
+{{tp|p=33818797|t=2021. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.|pdf=|usr=027}}
+{{tp|p=33811680|t=2021. Downregulation of type III interferons in patients with severe COVID-19.|pdf=|usr=027}}
+{{tp|p=33782995|t=2021. Transmissibility and viral replication of SARS-COV-2 in immunocompromised patients.|pdf=|usr=027}}
+{{tp|p=33755226|t=2021. Cross-immunity and trained immunity in explaining variable COVID-19 mortality-Guidance for future pandemics.|pdf=|usr=027}}
+{{tp|p=33739452|t=2021. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.|pdf=|usr=027}}
+{{tp|p=33713457|t=2021. Development of neutralizing antibody responses against SARS-CoV-2 in COVID-19 patients.|pdf=|usr=027}}
+{{tp|p=33704818|t=2021. Immunoinformatic analysis of structural and epitope variations in the spike and Orf8 proteins of SARS-CoV-2/B.1.1.7.|pdf=|usr=027}}
+{{tp|p=33893169|t=2021. Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.|pdf=|usr=027}}
+{{tp|p=33848432|t=2021. IL-6 Induction and Signaling: Horizons of COVID-19-Related Pathogenesis.|pdf=|usr=027}}
+{{tp|p=33872068|t=2021. COVID-19: A Mitochondrial Perspective.|pdf=|usr=027}}
+{{tp|p=34081326|t=2021. Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells.|pdf=|usr=027}}
+{{tp|p=33955468|t=2021. Molecular diversity of coronavirus host cell entry receptors.|pdf=|usr=027}}
+{{tp|p=33951416|t=2021. Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection.|pdf=|usr=027}}
+{{tp|p=34035081|t=2021. Navigating in Deep Waters: How Tissue Damage and Inflammation Shape Effector and Memory CD8(+) T Cell Responses.|pdf=|usr=027}}
+{{tp|p=34042182|t=2021. Unknown/enigmatic functions of extracellular ASC.|pdf=|usr=027}}
+{{tp|p=34049969|t=2021. Metabolic Defects of Peripheral T Cells in COVID-19 Patients.|pdf=|usr=027}}
+{{tp|p=33941660|t=2021. Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis.|pdf=|usr=027}}
+{{tp|p=33941657|t=2021. Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients.|pdf=|usr=027}}
+{{tp|p=33846224|t=2021. Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.|pdf=|usr=027}}
+{{tp|p=33980582|t=2021. Identification of T Cell Epitopes in the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2 in Rhesus Macaques.|pdf=|usr=027}}
+{{tp|p=33972373|t=2021. Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination.|pdf=|usr=027}}
+{{tp|p=33952616|t=2021. Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain.|pdf=|usr=027}}
+{{tp|p=33911008|t=2021. Genome-Wide B Cell, CD4(+), and CD8(+) T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines.|pdf=|usr=027}}
+{{tp|p=33298615|t=2021. A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4(+) and CD8(+) T Cells in COVID-19 Patients.|pdf=|usr=027}}
+{{tp|p=33605463|t=2021. Toward an understanding of regulatory T cells in COVID-19: A systematic review.|pdf=|usr=027}}
+{{tp|p=33368386|t=2021. Dynamic tracking of variant frequencies depicts the evolution of mutation sites amongst SARS-CoV-2 genomes from India.|pdf=|usr=027}}
+{{tp|p=33347622|t=2021. Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.|pdf=|usr=027}}
+{{tp|p=33999091|t=2021. Key residues of the receptor binding domain in the spike protein of SARS-CoV-2 mediating the interactions with ACE2: a molecular dynamics study.|pdf=|usr=027}}
+{{tp|p=33953384|t=2021. Delayed production of neutralizing antibodies correlates with fatal COVID-19.|pdf=|usr=027}}
+{{tp|p=34017137|t=2021. CD8(+) T cells contribute to survival in patients with COVID-19 and hematologic cancer.|pdf=|usr=027}}
+{{tp|p=34045737|t=2021. SARS-CoV-2 variants of concern are emerging in India.|pdf=|usr=027}}
+{{tp|p=34035535|t=2021. COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence.|pdf=|usr=027}}
+{{tp|p=34002089|t=2021. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.|pdf=|usr=027}}
+{{tp|p=33907312|t=2021. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.|pdf=|usr=027}}
+{{tp|p=33328624|t=2021. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice.|pdf=|usr=027}}
+{{tp|p=34116467|t=2021. Multisystem inflammatory syndrome in children with COVID-19.|pdf=|usr=028}}
+{{tp|p=34154831|t=2021. The comparison of oxidative markers between Covid-19 patients and healthy subjects.|pdf=|usr=028}}
+{{tp|p=34134920|t=2021. Vasoactive Peptides: Their Role in COVID-19 Pathogenesis and Potential Use as Biomarkers and Therapeutic Targets.|pdf=|usr=028}}
+{{tp|p=34118455|t=2021. Autoimmunity and COVID-19 - The microbiotal connection.|pdf=|usr=028}}
+{{tp|p=34116356|t=2021. Analysis of the molecular mechanism of SARS-CoV-2 antibodies.|pdf=|usr=028}}
+{{tp|p=34121839|t=2021. Bioinformatics Analysis Unveils Certain Mutations Implicated in Spike Structure Damage and Ligand-Binding Site of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=028}}
+{{tp|p=34153851|t=2021. Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options.|pdf=|usr=028}}
+{{tp|p=34144455|t=2021. Identification of oligopeptides from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non structural protein 8 (NSP8) and their similarities with type 1 angiotensin II receptor key sites.|pdf=|usr=028}}
+{{tp|p=34103044|t=2021. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar.|pdf=|usr=028}}
+{{tp|p=34155633|t=2021. Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations'.|pdf=|usr=028}}
+{{tp|p=34160596|t=2021. LSTM-PHV: prediction of human-virus protein-protein interactions by LSTM with word2vec.|pdf=|usr=028}}
+{{tp|p=34134808|t=2021. Cardiac manifestations and short-term outcomes of multisystem inflammatory syndrome in Middle Eastern children during the COVID-19 pandemic: a case series.|pdf=|usr=028}}
+{{tp|p=34166652|t=2021. TRP channels in COVID-19 disease: Potential targets for prevention and treatment.|pdf=|usr=028}}
+{{tp|p=34127868|t=2021. Dynamic properties of SARS-CoV and SARS-CoV-2 RNA-dependent RNA polymerases studied by molecular dynamics simulations.|pdf=|usr=028}}
+{{tp|p=34163622|t=2021. A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design.|pdf=|usr=028}}
+{{tp|p=34168762|t=2021. High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.|pdf=|usr=028}}
+{{tp|p=34123218|t=2020. Unveiling the molecular mechanism of SARS-CoV-2 main protease inhibition from 137 crystal structures using algebraic topology and deep learning.|pdf=|usr=028}}
+{{tp|p=34132013|t=2021. alphaV beta6 Integrin: An Intriguing Target for COVID-19 and Related Diseases.|pdf=|usr=028}}
+{{tp|p=34160124|t=2021. Preliminary Structural Data Revealed That the SARS-CoV-2 B.1.617 Variant's RBD Binds to ACE2 Receptor Stronger Than the Wild Type to Enhance the Infectivity.|pdf=|usr=028}}
+{{tp|p=34155573|t=2021. Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease.|pdf=|usr=028}}
+{{tp|p=34127355|t=2021. Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19.|pdf=|usr=028}}
+{{tp|p=34183243|t=2021. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.|pdf=|usr=028}}
+{{tp|p=34125495|t=2021. Impact of age and gender on lymphocyte subset counts in patients with COVID-19.|pdf=|usr=028}}
+{{tp|p=34183244|t=2021. Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.|pdf=|usr=028}}
+{{tp|p=34164811|t=2021. IFN-gamma(+) cell response and IFN-gamma release concordance after in vitro SARS-CoV-2 stimulation.|pdf=|usr=028}}
+{{tp|p=34114541|t=2021. The SARS-CoV-2 B.1.351 lineage (VOC beta) is outgrowing the B.1.1.7 lineage (VOC alpha) in some French regions in April 2021.|pdf=|usr=028}}
+{{tp|p=34149696|t=2021. SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage.|pdf=|usr=028}}
+{{tp|p=34127926|t=2021. Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity.|pdf=|usr=028}}
+{{tp|p=34122423|t=2021. Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.|pdf=|usr=028}}
+{{tp|p=34122416|t=2021. Potent and Persistent Antibody Response in COVID-19 Recovered Patients.|pdf=|usr=028}}
+{{tp|p=34122407|t=2021. Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection.|pdf=|usr=028}}
+{{tp|p=34113347|t=2021. A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19.|pdf=|usr=028}}
+{{tp|p=34108966|t=2021. Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19.|pdf=|usr=028}}
+{{tp|p=34178896|t=2021. Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?|pdf=|usr=028}}
+{{tp|p=34178893|t=2021. Pediatric Multisystem Inflammatory Syndrome in Children as a Challenging Problem for Pediatric Surgeons in the COVID 19 Pandemic-A Case Report.|pdf=|usr=028}}
+{{tp|p=34178891|t=2021. Efficacy of CytoSorb in a Pediatric Case of Severe Multisystem Infammatory Syndrome (MIS-C): A Clinical Case Report.|pdf=|usr=028}}
+{{tp|p=34178882|t=2021. Multisystem Inflammatory Syndrome in Children (MIS-C)-A Case Series in December 2020 in Vienna, Austria.|pdf=|usr=028}}
+{{tp|p=34150685|t=2021. Multisystemic Inflammatory Syndrome and Thrombotic Microangiopathy as Complications of COVID-19 in a Child: A Case Report.|pdf=|usr=028}}
+{{tp|p=34123977|t=2021. Pediatric Obesity-A Potential Risk Factor for Systemic Inflammatory Syndrome Associated to COVID-19, a Case Report.|pdf=|usr=028}}
+{{tp|p=34123970|t=2021. Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland.|pdf=|usr=028}}
+{{tp|p=34109148|t=2021. Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19.|pdf=|usr=028}}
+{{tp|p=34183466|t=2021. Clinical Spectrum of Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection.|pdf=|usr=028}}
+{{tp|p=34116286|t=2021. Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity.|pdf=|usr=028}}
+{{tp|p=34121407|t=2021. Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics.|pdf=|usr=028}}
+{{tp|p=34182794|t=2021. Mapping the Nonstructural Transmembrane Proteins of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=028}}
+{{tp|p=34128580|t=2021. Case reports of annular erythema: A diagnostic clue of multisystem inflammatory syndrome in children related to coronavirus disease 2019?|pdf=|usr=028}}
+{{tp|p=34161567|t=2021. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.|pdf=|usr=028}}
+{{tp|p=34186336|t=2021. Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis.|pdf=|usr=028}}
+{{tp|p=34118414|t=2021. 7-Ketocholesterol: Effects on viral infections and hypothetical contribution in COVID-19.|pdf=|usr=028}}
+{{tp|p=34185704|t=2021. IL-13 is a driver of COVID-19 severity.|pdf=|usr=028}}
+{{tp|p=34166229|t=2021. Autoantibodies stabilize neutrophil extracellular traps in COVID-19.|pdf=|usr=028}}
+{{tp|p=34143754|t=2021. Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses.|pdf=|usr=028}}
+{{tp|p=34154708|t=2021. COVID-19 and the multisystem inflammatory syndrome in children: how vulnerable are the kidneys?|pdf=|usr=028}}
+{{tp|p=34139198|t=2021. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.|pdf=|usr=028}}
+{{tp|p=34171234|t=2021. SARS-CoV-2 variants and considerations of inferring causality on disease severity.|pdf=|usr=028}}
+{{tp|p=34171232|t=2021. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.|pdf=|usr=028}}
+{{tp|p=34171231|t=2021. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.|pdf=|usr=028}}
+{{tp|p=34139598|t=2021. Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19?|pdf=|usr=028}}
+{{tp|p=34173452|t=2020. Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.|pdf=|usr=028}}
+{{tp|p=34121378|t=2021. A case of B.1.1.7 SARS-CoV-2 UK strain with an atypical radiological presentation.|pdf=|usr=028}}
+{{tp|p=34128696|t=2021. Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021.|pdf=|usr=028}}
+{{tp|p=34119708|t=2021. Is haem the real target of COVID-19?|pdf=|usr=028}}
+{{tp|p=34177077|t=2021. Synchronized attachment and the Darwinian evolution of coronaviruses CoV-1 and CoV-2.|pdf=|usr=028}}
+{{tp|p=34143766|t=2021. The landscape of antibody binding in SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34185681|t=2021. AI-based spectroscopic monitoring of real-time interactions between SARS-CoV-2 and human ACE2.|pdf=|usr=028}}
+{{tp|p=34140350|t=2021. Characterization of a new SARS-CoV-2 variant that emerged in Brazil.|pdf=|usr=028}}
+{{tp|p=34121829|t=2021. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; revisiting the Western New York approach as the pandemic evolves.|pdf=|usr=028}}
+{{tp|p=34184718|t=2021. Linfohistiocitosis hemofagocitica secundaria y sindrome de liberacion de citoquinas en COVID-19, inverted question markentidades iguales o diferentes?|pdf=|usr=028}}
+{{tp|p=34127534|t=2021. Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein.|pdf=|usr=028}}
+{{tp|p=34117209|t=2021. Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity.|pdf=|usr=028}}
+{{tp|p=34179694|t=2021. SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report.|pdf=|usr=028}}
+{{tp|p=34124695|t=2021. Protein purification and crystallization of HLA-A 02:01 in complex with SARS-CoV-2 peptides.|pdf=|usr=028}}
+{{tp|p=34181186|t=2021. Role of Glycoprotein Hemagglutinin-Esterase in COVID-19 Pathophysiology?|pdf=|usr=028}}
+{{tp|p=34155611|t=2021. Stress Decreases Host Viral Resistance and Increases Covid Susceptibility in Embryonic Stem Cells.|pdf=|usr=028}}
+{{tp|p=34151035|t=2021. Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19.|pdf=|usr=028}}
+{{tp|p=34114198|t=2021. Complexities in viral replication strategies as a potential explanation for prevalence of asymptomatic carriers in Covid-19 infections: analytical observation on SARS-Cov2 genome characteristics.|pdf=|usr=028}}
+{{tp|p=34158856|t=2021. TRPV2-spike protein interaction mediates the entry of SARS-CoV-2 into macrophages in febrile conditions.|pdf=|usr=028}}
+{{tp|p=34104908|t=2021. Multisystemic inflammatory syndrome in children associated with COVID-19: a single center experience in Turkey.|pdf=|usr=028}}
+{{tp|p=34160770|t=2021. Clinical characteristics of Kawasaki disease and concurrent pathogens during isolation in COVID-19 pandemic.|pdf=|usr=028}}
+{{tp|p=34164955|t=2021. Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.|pdf=|usr=028}}
+{{tp|p=34115386|t=2021. Kawasaki-like multisystem inflammatory syndrome associated with COVID-19 in an adult: a case report.|pdf=|usr=028}}
+{{tp|p=34143202|t=2021. Understanding structural malleability of the SARS-CoV-2 proteins and relation to the comorbidities.|pdf=|usr=028}}
+{{tp|p=34121111|t=2021. Co-mutation modules capture the evolution and transmission patterns of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34107645|t=2021. Profiling Inflammatory Cytokines in a Cohort Study of Egyptian Patients with COVID-19 Infection.|pdf=|usr=028}}
+{{tp|p=34116534|t=2021. Letter to the Editor: Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.|pdf=|usr=028}}
+{{tp|p=34165401|t=2021. Interfering Reactive Cysteine Proteome in Covid-19 Disease.|pdf=|usr=028}}
+{{tp|p=34161984|t=2021. The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19.|pdf=|usr=028}}
+{{tp|p=34160586|t=2021. The immunopathobiology of SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34085882|t=2021. Potential role of free-radical processes in biomolecules damage during COVID-19 and ways of their regulation.|pdf=|usr=028}}
+{{tp|p=34105843|t=2021. Multisystem inflammatory syndrome in children (MISC): A systematic review.|pdf=|usr=028}}
+{{tp|p=34100279|t=2021. Be aware of SARS-CoV-2 spike protein: There is more than meets the eye.|pdf=|usr=028}}
+{{tp|p=34133162|t=2021. Interactive Interface for Graph-Based Analyses of Dynamic H-Bond Networks: Application to Spike Protein S.|pdf=|usr=028}}
+{{tp|p=34138559|t=2021. Dynamic Profiling of Binding and Allosteric Propensities of the SARS-CoV-2 Spike Protein with Different Classes of Antibodies: Mutational and Perturbation-Based Scanning Reveals the Allosteric Duality of Functionally Adaptable Hotspots.|pdf=|usr=028}}
+{{tp|p=34145203|t=2021. No Increase in Kawasaki Disease-Like Illnesses During the COVID-19 Pandemic Compared With 4 Previous Years: A Retrospective Analysis.|pdf=|usr=028}}
+{{tp|p=34176363|t=2021. The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.|pdf=|usr=028}}
+{{tp|p=34166506|t=2021. Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection.|pdf=|usr=028}}
+{{tp|p=34161170|t=2021. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.|pdf=|usr=028}}
+{{tp|p=34181987|t=2021. Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.|pdf=|usr=028}}
+{{tp|p=34133374|t=2021. Multisystem Inflammatory Syndrome in Children During Induction Chemotherapy in a Newly Diagnosed Pediatric Acute Myeloid Leukemia and Concurrent COVID-19.|pdf=|usr=028}}
+{{tp|p=34173667|t=2021. Retropharyngeal Edema and Neck Pain in Multisystem Inflammatory Syndrome in Children (MIS-c).|pdf=|usr=028}}
+{{tp|p=34110264|t=2021. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.|pdf=|usr=028}}
+{{tp|p=34105996|t=2021. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.|pdf=|usr=028}}
+{{tp|p=34132373|t=2021. SARSCoV2 spike proteininduced host inflammatory response signature in human corneal epithelial cells.|pdf=|usr=028}}
+{{tp|p=34107199|t=2021. Identifying and Tracking SARS-CoV-2 Variants - A Challenge and an Opportunity.|pdf=|usr=028}}
+{{tp|p=34108657|t=2021. Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19.|pdf=|usr=028}}
+{{tp|p=34108656|t=2021. Immune memory in individuals with COVID-19.|pdf=|usr=028}}
+{{tp|p=34183855|t=2021. A STING in the tail for SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34155406|t=2021. SARS-CoV-2-specific hotspots in virus-host interaction networks.|pdf=|usr=028}}
+{{tp|p=34103714|t=2021. SARS-CoV-2 takes its Toll.|pdf=|usr=028}}
+{{tp|p=34183391|t=2021. IgA potentiates NETosis in response to viral infection.|pdf=|usr=028}}
+{{tp|p=34148697|t=2020. Sindrome inflamatorio multisistemico de tipo Kawasaki asociado a COVID-19 en un adulto.|pdf=|usr=028}}
+{{tp|p=34088785|t=2021. Immune responses to SARS-CoV-2 in the lung.|pdf=|usr=028}}
+{{tp|p=34179666|t=2021. Landscape-Based Mutational Sensitivity Cartography and Network Community Analysis of the SARS-CoV-2 Spike Protein Structures: Quantifying Functional Effects of the Circulating D614G Variant.|pdf=|usr=028}}
+{{tp|p=34179644|t=2021. Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein.|pdf=|usr=028}}
+{{tp|p=34115965|t=2021. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals.|pdf=|usr=028}}
+{{tp|p=34125890|t=2021. Possible Pleiotropic Effect Of Sry Gene May Increase Male Susceptibility To Covid-19.|pdf=|usr=028}}
+{{tp|p=34185889|t=2021. An epigenome-wide DNA methylation study of patients with COVID-19.|pdf=|usr=028}}
+{{tp|p=34101005|t=2021. Antibody response in COVID-19 patients with and without re-positive RT-PCR results during the convalescent phase.|pdf=|usr=028}}
+{{tp|p=34116667|t=2021. A blood RNA transcriptome signature for COVID-19.|pdf=|usr=028}}
+{{tp|p=34130987|t=2021. Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis.|pdf=|usr=028}}
+{{tp|p=34102147|t=2021. New Brazilian variant of the SARS-CoV-2 (P1/Gamma) of COVID-19 in Alagoas state.|pdf=|usr=028}}
+{{tp|p=34184738|t=2021. DeepIPs: comprehensive assessment and computational identification of phosphorylation sites of SARS-CoV-2 infection using a deep learning-based approach.|pdf=|usr=028}}
+{{tp|p=34111889|t=2021. Single-cell multi-omics sequencing: application trends, COVID-19, data analysis issues and prospects.|pdf=|usr=028}}
+{{tp|p=34143953|t=2021. Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.|pdf=|usr=028}}
+{{tp|p=34139176|t=2021. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.|pdf=|usr=028}}
+{{tp|p=34171305|t=2021. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.|pdf=|usr=028}}
+{{tp|p=34162440|t=2021. Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion.|pdf=|usr=028}}
+{{tp|p=34103487|t=2021. Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19.|pdf=|usr=028}}
+{{tp|p=34127650|t=2021. Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34174992|t=2021. Antibody and B cell responses to SARS-CoV-2 infection and vaccination.|pdf=|usr=028}}
+{{tp|p=34171266|t=2021. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.|pdf=|usr=028}}
+{{tp|p=34108680|t=2021. Mucins produced by type II pneumocyte: culprits in SARS-CoV-2 pathogenesis.|pdf=|usr=028}}
+{{tp|p=34099890|t=2021. Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection.|pdf=|usr=028}}
+{{tp|p=34117354|t=2021. Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain.|pdf=|usr=028}}
+{{tp|p=34112887|t=2021. I(nsp1)ecting SARS-CoV-2-ribosome interactions.|pdf=|usr=028}}
+{{tp|p=34171504|t=2021. A computational analysis of molecular evolution for virulence genes of zoonotic novel coronavirus (COVID-19).|pdf=|usr=028}}
+{{tp|p=34166886|t=2021. Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak.|pdf=|usr=028}}
+{{tp|p=34157472|t=2021. Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34184973|t=2021. Emergence of the novel SARS-CoV-2 lineage VUI-NP13L and massive spread of P.2 in South Brazil.|pdf=|usr=028}}
+{{tp|p=34125658|t=2021. Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations.|pdf=|usr=028}}
+{{tp|p=34150352|t=2021. Identification of Monocytes Associated with Severe COVID-19 in the PBMCs of Severely Infected patients Through Single-Cell Transcriptome Sequencing.|pdf=|usr=028}}
+{{tp|p=34179146|t=2021. SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity.|pdf=|usr=028}}
+{{tp|p=34124207|t=2021. The Notch Pathway: A Link Between COVID-19 Pathophysiology and Its Cardiovascular Complications.|pdf=|usr=028}}
+{{tp|p=34163530|t=2021. Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation.|pdf=|usr=028}}
+{{tp|p=34122515|t=2021. Transcriptional Start Site Coverage Analysis in Plasma Cell-Free DNA Reveals Disease Severity and Tissue Specificity of COVID-19 Patients.|pdf=|usr=028}}
+{{tp|p=34122498|t=2021. A Computational Framework for Pattern Detection on Unaligned Sequences: An Application on SARS-CoV-2 Data.|pdf=|usr=028}}
+{{tp|p=34177962|t=2021. Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease.|pdf=|usr=028}}
+{{tp|p=34177923|t=2021. SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNgamma-Induced Antiviral Gene Expression in Human Lung Epithelial Cells.|pdf=|usr=028}}
+{{tp|p=34177897|t=2021. Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics.|pdf=|usr=028}}
+{{tp|p=34163491|t=2021. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.|pdf=|usr=028}}
+{{tp|p=34163490|t=2021. PD-L1 Dysregulation in COVID-19 Patients.|pdf=|usr=028}}
+{{tp|p=34149717|t=2021. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets.|pdf=|usr=028}}
+{{tp|p=34146758|t=2021. Analysis of endogenous oxidative damage markers and association with pulmonary involvement severity in patients with SARS-CoV-2 pneumonia.|pdf=|usr=028}}
+{{tp|p=34110618|t=2021. Dynamic Changes in the Immune Response Correlate with Disease Severity and Outcomes During Infection with SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34163183|t=2021. Effect of Genomic and Amino Acid Sequence Mutation on Virulence and Therapeutic Target of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS COV-2).|pdf=|usr=028}}
+{{tp|p=34147651|t=2021. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.|pdf=|usr=028}}
+{{tp|p=34146731|t=2021. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic.|pdf=|usr=028}}
+{{tp|p=34147667|t=2021. Detection of SARS-CoV-2 variants requires urgent global coordination.|pdf=|usr=028}}
+{{tp|p=34067854|t=2021. Viral Interactions with Adaptor-Protein Complexes: A Ubiquitous Trait among Viral Species.|pdf=|usr=028}}
+{{tp|p=34179732|t=2021. Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution.|pdf=|usr=028}}
+{{tp|p=34111453|t=2021. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.|pdf=|usr=028}}
+{{tp|p=34112485|t=2021. Reply to "Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium".|pdf=|usr=028}}
+{{tp|p=34112484|t=2021. Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium.|pdf=|usr=028}}
+{{tp|p=34112483|t=2021. Reply to "Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?"|pdf=|usr=028}}
+{{tp|p=34112482|t=2021. Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?|pdf=|usr=028}}
+{{tp|p=34181169|t=2021. SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19.|pdf=|usr=028}}
+{{tp|p=34137173|t=2021. Single-cell RNA sequencing identify SDCBP in ACE2-positive bronchial epithelial cells negatively correlates with COVID-19 severity.|pdf=|usr=028}}
+{{tp|p=34156227|t=2021. Anchor-Locker Binding Mechanism of the Coronavirus Spike Protein to Human ACE2: Insights from Computational Analysis.|pdf=|usr=028}}
+{{tp|p=34160366|t=2021. Zonulin as a biomarker and potential therapeutic target in multisystem inflammatory syndrome in children.|pdf=|usr=028}}
+{{tp|p=34153860|t=2021. Lack of active SARS-CoV-2 virus in a subset of PCR-positive COVID-19 congregate care patients.|pdf=|usr=028}}
+{{tp|p=34157514|t=2021. SARS-CoV-2 spike protein removes lipids from model membranes and interferes with the capacity of high density lipoprotein to exchange lipids.|pdf=|usr=028}}
+{{tp|p=34107824|t=2021. Of mitochondrion and COVID-19.|pdf=|usr=028}}
+{{tp|p=34146596|t=2021. The incubation period of the SARS-CoV-2 B1.1.7 variant is shorter than that of other strains.|pdf=|usr=028}}
+{{tp|p=34176716|t=2021. Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort.|pdf=|usr=028}}
+{{tp|p=34175236|t=2021. New COVID-19 variant (B.1.1.7): Forecasting the occasion of virus and the related meteorological factors.|pdf=|usr=028}}
+{{tp|p=34168484|t=2021. Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.|pdf=|usr=028}}
+{{tp|p=34163208|t=2021. Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.|pdf=|usr=028}}
+{{tp|p=34184438|t=2021. The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.|pdf=|usr=028}}
+{{tp|p=34138483|t=2021. Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers.|pdf=|usr=028}}
+{{tp|p=34138461|t=2021. Medium-term serostatus in Spanish case series recovered from SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34125455|t=2021. Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge.|pdf=|usr=028}}
+{{tp|p=34101203|t=2021. Prevalence of IgG antibodies induced by the SARS-COV-2 virus in asymptomatic adults in Nuevo Leon, Mexico.|pdf=|usr=028}}
+{{tp|p=34170519|t=2021. Over 1-year duration and age difference of SARS-CoV-2 antibodies in convalescent COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34174328|t=2021. A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.|pdf=|usr=028}}
+{{tp|p=34116123|t=2021. Can We AlphaFold Our Way Out of the Next Pandemic?|pdf=|usr=028}}
+{{tp|p=34161778|t=2021. The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.|pdf=|usr=028}}
+{{tp|p=34153515|t=2021. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Genome Sequencing from Post-Mortem Formalin-Fixed, Paraffin-Embedded Lung Tissues.|pdf=|usr=028}}
+{{tp|p=34121768|t=2021. Comparative analysis of non structural protein 1 of SARS-CoV2 with SARS-CoV1 and MERS-CoV: An in silico study.|pdf=|usr=028}}
+{{tp|p=34163172|t=2021. Structural Zero Data of COVID-19 Discovers Exodus Probabilities.|pdf=|usr=028}}
+{{tp|p=34180678|t=2021. Genetic Variability of the SARS-CoV-2 Pocketome.|pdf=|usr=028}}
+{{tp|p=34124702|t=2021. SARS-CoV-2 emerging variants in Africa: view from Gabon.|pdf=|usr=028}}
+{{tp|p=34118186|t=2021. Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19.|pdf=|usr=028}}
+{{tp|p=34124694|t=2021. Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study.|pdf=|usr=028}}
+{{tp|p=34163002|t=2021. An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner.|pdf=|usr=028}}
+{{tp|p=34168074|t=2021. Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.|pdf=|usr=028}}
+{{tp|p=34182784|t=2021. Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.|pdf=|usr=028}}
+{{tp|p=34182775|t=2021. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.|pdf=|usr=028}}
+{{tp|p=34111060|t=2021. Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020-May 2021.|pdf=|usr=028}}
+{{tp|p=34118193|t=2021. Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection.|pdf=|usr=028}}
+{{tp|p=34146663|t=2021. In-silico analysis of Covid-19 genome sequences of Indian origin: Impact of mutations in identification of SARS-Co-V2.|pdf=|usr=028}}
+{{tp|p=34133855|t=2021. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.|pdf=|usr=028}}
+{{tp|p=34133854|t=2021. Treatment of Multisystem Inflammatory Syndrome in Children.|pdf=|usr=028}}
+{{tp|p=34168138|t=2021. The architecture of the SARS-CoV-2 RNA genome inside virion.|pdf=|usr=028}}
+{{tp|p=34155209|t=2021. Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain.|pdf=|usr=028}}
+{{tp|p=34145263|t=2021. Immunological imprinting of the antibody response in COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34140485|t=2021. Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34162970|t=2021. Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies.|pdf=|usr=028}}
+{{tp|p=34162945|t=2021. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.|pdf=|usr=028}}
+{{tp|p=34131210|t=2021. Attractive and repulsive residue fragments at the interface of SARS-CoV-2 and hACE2.|pdf=|usr=028}}
+{{tp|p=34117310|t=2021. The major genetic risk factor for severe COVID-19 does not show any association among South Asian populations.|pdf=|usr=028}}
+{{tp|p=34131072|t=2021. Mn(2+) coordinates Cap-0-RNA to align substrates for efficient 2'-O-methyl transfer by SARS-CoV-2 nsp16.|pdf=|usr=028}}
+{{tp|p=34106169|t=2021. inverted question markQue sabemos de la enfermedad de Kawasaki y COVID 19?|pdf=|usr=028}}
+{{tp|p=34181887|t=2021. Nuclear factor-kappa B and its role in inflammatory lung disease.|pdf=|usr=028}}
+{{tp|p=34144638|t=2021. Does COVID-19 alter the oxyhemoglobin dissociation curve? - An observational cohort study using a mixed-effect modelling.|pdf=|usr=028}}
+{{tp|p=34116589|t=2021. Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34145459|t=2021. Large-Scale Identification of T-Cell Epitopes Derived From Severe Acute Respiratory Syndrome Coronavirus 2 for the Development of Peptide Vaccines Against Coronavirus Disease 2019.|pdf=|usr=028}}
+{{tp|p=34158670|t=2021. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19.|pdf=|usr=028}}
+{{tp|p=34108654|t=2021. SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse.|pdf=|usr=028}}
+{{tp|p=34158638|t=2021. Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs.|pdf=|usr=028}}
+{{tp|p=34108727|t=2021. How a rampant coronavirus variant blunts our immune defences.|pdf=|usr=028}}
+{{tp|p=34108702|t=2021. Embrace the WHO's new naming system for coronavirus variants.|pdf=|usr=028}}
+{{tp|p=34158664|t=2021. Delta coronavirus variant: scientists brace for impact.|pdf=|usr=028}}
+{{tp|p=34127832|t=2021. A long-term perspective on immunity to COVID.|pdf=|usr=028}}
+{{tp|p=34060442|t=2021. [Prediction of the epitopes of SARS-CoV-2 by immunoinformatics].|pdf=|usr=028}}
+{{tp|p=34146538|t=2021. Peptides of H. sapiens and P. falciparum that are predicted to bind strongly to HLA-A24:02 and homologous to a SARS-CoV-2 peptide.|pdf=|usr=028}}
+{{tp|p=34143752|t=2021. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.|pdf=|usr=028}}
+{{tp|p=34138748|t=2021. Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India.|pdf=|usr=028}}
+{{tp|p=34161644|t=2021. Exploring the Druggability of Conserved RNA Regulatory Elements in the SARS-CoV-2 Genome.|pdf=|usr=028}}
+{{tp|p=34149107|t=2021. Innentitelbild: Synthetic Homogeneous Glycoforms of the SARS-CoV-2 Spike Receptor-Binding Domain Reveals Different Binding Profiles of Monoclonal Antibodies (Angew. Chem. 23/2021).|pdf=|usr=028}}
+{{tp|p=34154787|t=2021. Eosinophils in antiviral immunity and (perhaps) a benefit of having asthma during the SARS-CoV2 pandemic.|pdf=|usr=028}}
+{{tp|p=34113953|t=2022. Antibody persistency and trend post-SARS-CoV-2 infection at eight months.|pdf=|usr=028}}
+{{tp|p=34174806|t=2021. Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.|pdf=|usr=028}}
+{{tp|p=34181320|t=2021. Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study.|pdf=|usr=028}}
+{{tp|p=34127503|t=2021. Can PIMS-TS lead to a facial nerve palsy?|pdf=|usr=028}}
+{{tp|p=34173107|t=2021. Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.|pdf=|usr=028}}
+{{tp|p=34117968|t=2021. Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders.|pdf=|usr=028}}
+{{tp|p=34166618|t=2021. Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.|pdf=|usr=028}}
+{{tp|p=34166617|t=2021. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.|pdf=|usr=028}}
+{{tp|p=34146478|t=2021. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4(+) T cell help.|pdf=|usr=028}}
+{{tp|p=34151306|t=2021. Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity.|pdf=|usr=028}}
+{{tp|p=34124701|t=2021. Young infants exhibit robust functional antibody responses and restrained IFN-gamma production to SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34112954|t=2021. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target.|pdf=|usr=028}}
+{{tp|p=34146659|t=2021. TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2.|pdf=|usr=028}}
+{{tp|p=34139154|t=2021. A time-resolved proteomic and prognostic map of COVID-19.|pdf=|usr=028}}
+{{tp|p=34166080|t=2021. Macrophages: Potential Therapeutic Target of Myocardial Injury in COVID-19.|pdf=|usr=028}}
+{{tp|p=34105720|t=2021. Increased household secondary attacks rates with Variant of Concern SARS-CoV-2 index cases.|pdf=|usr=028}}
+{{tp|p=34155047|t=2021. Multisystem inflammatory syndrome in an adult after SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34122620|t=2021. Correlation Analysis between the Viral Load and the Progression of COVID-19.|pdf=|usr=028}}
+{{tp|p=34109017|t=2021. The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival.|pdf=|usr=028}}
+{{tp|p=34104356|t=2021. Dissecting nucleotide selectivity in viral RNA polymerases.|pdf=|usr=028}}
+{{tp|p=34120861|t=2021. SARS-CoV-2 and Multisystem Inflammatory Syndrome In Children (MIS-C).|pdf=|usr=028}}
+{{tp|p=34186492|t=2021. NK cells on the ViP stage of COVID-19.|pdf=|usr=028}}
+{{tp|p=34158771|t=2021. Functional and Structural Characterization of SARS-Cov-2 Spike Protein: An In Silico Study.|pdf=|usr=028}}
+{{tp|p=34185144|t=2021. Epidemiological analysis in support of hypothesis that D614G virus mutation is a major contributing factor to chemosensory dysfunction in COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34149667|t=2021. SARS-CoV-2-Host Chimeric RNA-Sequencing Reads Do Not Necessarily Arise From Virus Integration Into the Host DNA.|pdf=|usr=028}}
+{{tp|p=34179075|t=2021. Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer.|pdf=|usr=028}}
+{{tp|p=34150848|t=2021. Sex-Related Overactivation of NLRP3 Inflammasome Increases Lethality of the Male COVID-19 Patients.|pdf=|usr=028}}
+{{tp|p=34109214|t=2021. Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study.|pdf=|usr=028}}
+{{tp|p=34136461|t=2021. Proliferation of SARS-CoV-2 B.1.1.7 Variant in Pakistan-A Short Surveillance Account.|pdf=|usr=028}}
+{{tp|p=34123997|t=2021. SARS-CoV-2 B.1.1.7 UK Variant of Concern Lineage-Related Perceptions, COVID-19 Vaccine Acceptance and Travel Worry Among Healthcare Workers.|pdf=|usr=028}}
+{{tp|p=34175388|t=2021. Variants in AGTR2 gene in Maya people with COVID-19.|pdf=|usr=028}}
+{{tp|p=34131597|t=2021. A bioinformatics approach for identifying potential molecular mechanisms and key genes involved in COVID-19 associated cardiac remodeling.|pdf=|usr=028}}
+{{tp|p=34131596|t=2021. SARS-CoV-2 mutations altering regulatory properties: Deciphering host's and virus's perspectives.|pdf=|usr=028}}
+{{tp|p=34152577|t=2021. Comparative study of predicted miRNA between Indonesia and China (Wuhan) SARS-CoV-2: a bioinformatics analysis.|pdf=|usr=028}}
+{{tp|p=34140652|t=2021. Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia.|pdf=|usr=028}}
+{{tp|p=34159627|t=2021. Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain.|pdf=|usr=028}}
+{{tp|p=34183789|t=2021. An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.|pdf=|usr=028}}
+{{tp|p=34179538|t=2021. Computational search of hybrid human/SARS-CoV-2 dsRNA reveals unique viral sequences that diverge from those of other coronavirus strains.|pdf=|usr=028}}
+{{tp|p=34142358|t=2021. The role of estradiol in the immune response against COVID-19.|pdf=|usr=028}}
+{{tp|p=34116863|t=2021. Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms.|pdf=|usr=028}}
+{{tp|p=34166623|t=2021. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.|pdf=|usr=028}}
+{{tp|p=34145089|t=2021. Electron microscopy imaging of SARS-CoV-2 at different temperatures.|pdf=|usr=028}}
+{{tp|p=34137349|t=2021. SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.|pdf=|usr=028}}
+{{tp|p=34163216|t=2021. KDELC1 and TRMT1 Serve as Prognosis-Related SARS-CoV-2 Proteins Binding Human mRNAs and Promising Biomarkers in Clear Cell Renal Cell Carcinoma.|pdf=|usr=028}}
+{{tp|p=34128960|t=2021. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.|pdf=|usr=028}}
+{{tp|p=34128959|t=2021. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.|pdf=|usr=028}}
+{{tp|p=34140221|t=2021. Immune response to COVID-19 in older adults.|pdf=|usr=028}}
+{{tp|p=34150910|t=2021. Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia.|pdf=|usr=028}}
+{{tp|p=34130119|t=2021. The immunological response among COVID-19 patients with acute respiratory distress syndrome.|pdf=|usr=028}}
+{{tp|p=34118739|t=2021. SARS-CoV-2 and Plasmodium falciparum are probably adopting Analogous strategy to invade erythrocytes.|pdf=|usr=028}}
+{{tp|p=34159904|t=2021. B cells and COVID-19: Lessons from agammaglobulinemia patients and the study of functional B cell polymorphisms.|pdf=|usr=028}}
+{{tp|p=34185327|t=2021. Unrecognized introduction of SARS-CoV-2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent.|pdf=|usr=028}}
+{{tp|p=34110159|t=2021. Structural and Dynamical Differences in the Spike Protein RBD in the SARS-CoV-2 Variants B.1.1.7 and B.1.351.|pdf=|usr=028}}
+{{tp|p=34110168|t=2021. Conformational Dynamics in the Interaction of SARS-CoV-2 Papain-like Protease with Human Interferon-Stimulated Gene 15 Protein.|pdf=|usr=028}}
+{{tp|p=34161095|t=2021. Allosteric Cross-Talk among Spike's Receptor-Binding Domain Mutations of the SARS-CoV-2 South African Variant Triggers an Effective Hijacking of Human Cell Receptor.|pdf=|usr=028}}
+{{tp|p=34155521|t=2021. An early assessment of a case fatality risk associated with P.1 SARS-CoV-2 lineage in Brazil: an ecological study.|pdf=|usr=028}}
+{{tp|p=34170328|t=2021. Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.|pdf=|usr=028}}
+{{tp|p=34106002|t=2021. Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells.|pdf=|usr=028}}
+{{tp|p=34160250|t=2021. SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells.|pdf=|usr=028}}
+{{tp|p=34133899|t=2021. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.|pdf=|usr=028}}
+{{tp|p=34133897|t=2021. SARS-CoV-2 NSP12 Protein Is Not an Interferon-beta Antagonist.|pdf=|usr=028}}
+{{tp|p=34166701|t=2021. Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.|pdf=|usr=028}}
+{{tp|p=34110391|t=2021. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34143756|t=2021. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes.|pdf=|usr=028}}
+{{tp|p=34149046|t=2021. Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34149939|t=2021. Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report.|pdf=|usr=028}}
+{{tp|p=34153417|t=2021. Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo.|pdf=|usr=028}}
+{{tp|p=34119626|t=2021. Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions.|pdf=|usr=028}}
+{{tp|p=34132615|t=2021. Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results.|pdf=|usr=028}}
+{{tp|p=34132580|t=2021. Structural Basis and Function of the N Terminus of SARS-CoV-2 Nonstructural Protein 1.|pdf=|usr=028}}
+{{tp|p=34069681|t=2021. Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance.|pdf=|usr=028}}
+{{tp|p=34163035|t=2021. Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.|pdf=|usr=028}}
+{{tp|p=34126625|t=2021. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.|pdf=|usr=028}}
+{{tp|p=34151992|t=2021. Kinetics of Anti-SARS-CoV-2 IgG among healthcare workers in a General Hospital.|pdf=|usr=028}}
+{{tp|p=34185793|t=2021. Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.|pdf=|usr=028}}
+{{tp|p=34166398|t=2021. SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.|pdf=|usr=028}}
+{{tp|p=34161373|t=2021. The human microbiome and COVID-19: A systematic review.|pdf=|usr=028}}
+{{tp|p=34161337|t=2021. SARS-CoV-2 uses major endothelial integrin alphavbeta3 to cause vascular dysregulation in-vitro during COVID-19.|pdf=|usr=028}}
+{{tp|p=34115768|t=2021. Longitudinal changes in IgG levels among COVID-19 recovered patients: A prospective cohort study.|pdf=|usr=028}}
+{{tp|p=34106957|t=2021. SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1.|pdf=|usr=028}}
+{{tp|p=34101725|t=2021. Potential G-quadruplexes and i-Motifs in the SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34181691|t=2021. The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.|pdf=|usr=028}}
+{{tp|p=34146958|t=2021. SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione.|pdf=|usr=028}}
+{{tp|p=34186259|t=2021. Cellular senescence is a potential severity factor for COVID-19: Suitable targets required to eliminate cellular senescence.|pdf=|usr=028}}
+{{tp|p=34159291|t=2021. A Kawasaki-like illness in an adult with recent SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34134991|t=2021. Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity.|pdf=|usr=028}}
+{{tp|p=34170629|t=2021. The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh.|pdf=|usr=028}}
+{{tp|p=34157565|t=2021. Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia.|pdf=|usr=028}}
+{{tp|p=34141447|t=2021. Structural phylogenetic analysis reveals lineage-specific RNA repetitive structural motifs in all coronaviruses and associated variations in SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34118359|t=2021. Positive selection as a key player for SARS-CoV-2 pathogenicity: Insights into ORF1ab, S and E genes.|pdf=|usr=028}}
+{{tp|p=34073934|t=2021. Identification of Novel Candidate CD8(+) T Cell Epitopes of the SARS-CoV2 with Homology to Other Seasonal Coronaviruses.|pdf=|usr=028}}
+{{tp|p=34130462|t=2021. Relational interaction between T-lymphocytes and SARS-CoV-2: A review.|pdf=|usr=028}}
+{{tp|p=34076457|t=2021. Radiologic Manifestations of Multisystem Inflammatory Syndrome in Children.|pdf=|usr=028}}
+{{tp|p=34076453|t=2021. Reply to "Radiologic Manifestations of Multisystem Inflammatory Syndrome in Children".|pdf=|usr=028}}
+{{tp|p=34159794|t=2021. Endothelial metabolism in pulmonary vascular homeostasis and acute respiratory distress syndrome.|pdf=|usr=028}}
+{{tp|p=34183280|t=2021. Apendicitis aguda en ninos con sindrome inflamatorio multisistemico pediatrico asociado a SARS-CoV-2 (SIM-PedS). Una complicacion a considerar.|pdf=|usr=028}}
+{{tp|p=34132382|t=2021. The kidnapping of mitochondrial function associated with the SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34160551|t=2021. Local memory CD4 T cell niches in respiratory viral infection.|pdf=|usr=028}}
+{{tp|p=34117201|t=2021. Ocular Manifestations of Multisystem Inflammatory Syndrome in Children with COVID-19.|pdf=|usr=028}}
+{{tp|p=34117202|t=2021. Intrafamilial Spread and Altered Symptomatology of SARS-CoV-2, During Predominant Circulation of Lineage B.1.1.7 Variant in Israel.|pdf=|usr=028}}
+{{tp|p=34158313|t=2021. Duration of Effective Antibody Levels After COVID-19.|pdf=|usr=028}}
+{{tp|p=34158312|t=2021. Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers.|pdf=|usr=028}}
+{{tp|p=34078749|t=2021. iciHHV-6 in a Patient With Multisystem Inflammatory Syndrome in Children.|pdf=|usr=028}}
+{{tp|p=34137759|t=2021. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2 vs. SARS-CoV and RaTG13.|pdf=|usr=028}}
+{{tp|p=34132301|t=2021. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.|pdf=|usr=028}}
+{{tp|p=34077977|t=2021. Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients.|pdf=|usr=028}}
+{{tp|p=34129731|t=2021. Multisystem inflammatory syndrome in children occurred in one of four thousand children with severe acute respiratory syndrome coronavirus 2.|pdf=|usr=028}}
+{{tp|p=34094637|t=2021. Cellular Tropism of SARS-CoV-2 across Human Tissues and Age-related Expression of ACE2 and TMPRSS2 in Immune-inflammatory Stromal Cells.|pdf=|usr=028}}
+{{tp|p=34303698|t=2021. Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome Sequences.|pdf=|usr=028}}
+{{tp|p=34231390|t=2021. Erythrocytes identify complement activation in patients with COVID-19.|pdf=|usr=028}}
+{{tp|p=34235568|t=2021. Glycosylation of SARS-CoV-2: structural and functional insights.|pdf=|usr=028}}
+{{tp|p=34389878|t=2021. The challenge of structural heterogeneity in the native mass spectrometry studies of the SARS-CoV-2 spike protein interactions with its host cell-surface receptor.|pdf=|usr=028}}
+{{tp|p=34356359|t=2021. Time Course of Redox Biomarkers in COVID-19 Pneumonia: Relation with Inflammatory, Multiorgan Impairment Biomarkers and CT Findings.|pdf=|usr=028}}
+{{tp|p=34450201|t=2021. Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target.|pdf=|usr=028}}
+{{tp|p=34261445|t=2021. Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.|pdf=|usr=028}}
+{{tp|p=34210694|t=2021. Giant coronary artery aneurysm as a feature of coronavirus-related inflammatory syndrome.|pdf=|usr=028}}
+{{tp|p=34192188|t=2021. Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee.|pdf=|usr=028}}
+{{tp|p=34188776|t=2021. Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants.|pdf=|usr=028}}
+{{tp|p=34310359|t=2021. Learning about Kawasaki disease from COVID-19 and the Multisystem Inflammatory Syndrome in Children.|pdf=|usr=028}}
+{{tp|p=34320263|t=2021. Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic.|pdf=|usr=028}}
+{{tp|p=34212320|t=2021. Increased Levels of serum Pentraxin 3 in Critical Coronavirus Disease-2019 Patients.|pdf=|usr=028}}
+{{tp|p=34289974|t=2021. Metabolomic analyses reveals new stage-specific features of the COVID-19.|pdf=|usr=028}}
+{{tp|p=34142653|t=2021. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021.|pdf=|usr=028}}
+{{tp|p=34136131|t=2021. Interactive SARS-CoV-2 mutation timemaps.|pdf=|usr=028}}
+{{tp|p=34186206|t=2021. Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection.|pdf=|usr=028}}
+{{tp|p=34307358|t=2021. Potential Impact of Diabetes and Obesity on Alveolar Type 2 (AT2)-Lipofibroblast (LIF) Interactions After COVID-19 Infection.|pdf=|usr=028}}
+{{tp|p=34268136|t=2021. The Gut Microbiota of Critically Ill Patients With COVID-19.|pdf=|usr=028}}
+{{tp|p=34249864|t=2021. Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.|pdf=|usr=028}}
+{{tp|p=34220703|t=2021. Covid-19 and Growth Hormone/Insulin-Like Growth Factor 1: Study in Critically and Non-Critically Ill Patients.|pdf=|usr=028}}
+{{tp|p=34194420|t=2021. sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.|pdf=|usr=028}}
+{{tp|p=34307408|t=2021. Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.|pdf=|usr=028}}
+{{tp|p=34307393|t=2021. Elevation of Serum Cytokine Profiles and Liver Metabolomic Normalization in Early Convalescence of COVID-19 Patients.|pdf=|usr=028}}
+{{tp|p=34262921|t=2021. Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K.|pdf=|usr=028}}
+{{tp|p=34277453|t=2021. Comparison of COVID-19 and Lung Cancer via Reactive Oxygen Species Signaling.|pdf=|usr=028}}
+{{tp|p=34261300|t=2021. Comparative study: nonsynonymous and synonymous substitution of SARS-CoV-2, SARS-CoV, and MERS-CoV genome.|pdf=|usr=028}}
+{{tp|p=34261299|t=2021. A protein interactions map of multiple organ systems associated with COVID-19 disease.|pdf=|usr=028}}
+{{tp|p=34132630|t=2021. Effect of COVID-19 precautions on the gut microbiota and nosocomial infections.|pdf=|usr=028}}
+{{tp|p=34100340|t=2021. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.|pdf=|usr=028}}
+{{tp|p=34217989|t=2021. COVID-19 variants in India: Potential role in second wave and impact on vaccination.|pdf=|usr=028}}
+{{tp|p=34302327|t=2021. Comparison of Clinical Features and Outcome of Dengue Fever and Multisystem Inflammatory Syndrome in Children Associated With COVID-19 (MIS-C).|pdf=|usr=028}}
+{{tp|p=34293483|t=2021. SARS-CoV-2 as a betacoronavirus comprises five structural proteins?|pdf=|usr=028}}
+{{tp|p=34271187|t=2021. Genetic and evolutionary analysis of SARS-CoV-2 circulating in the region surrounding Islamabad, Pakistan.|pdf=|usr=028}}
+{{tp|p=34252616|t=2021. New infections by SARS-CoV-2 variants of concern after natural infections and post-vaccination in Rio de Janeiro, Brazil.|pdf=|usr=028}}
+{{tp|p=34316588|t=2021. Bangladesh reported delta variant of coronavirus among its citizen: Actionable items to tackle the potential massive third wave.|pdf=|usr=028}}
+{{tp|p=34160788|t=2021. Detection of SARS-CoV-2 variants in India from UK returnees.|pdf=|usr=028}}
+{{tp|p=34174700|t=2021. Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.|pdf=|usr=028}}
+{{tp|p=34286447|t=2021. COVID 19 disease independently predicted endothelial dysfunction measured by flow-mediated dilatation.|pdf=|usr=028}}
+{{tp|p=34107136|t=2021. Algorithm for the diagnosis and management of the multisystem inflammatory syndrome in children associated with COVID-19.|pdf=|usr=028}}
+{{tp|p=34107113|t=2021. Changes of serum IL-10, IL-1beta, IL-6, MCP-1, TNF-alpha, IP-10 and IL-4 in COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34209719|t=2021. New Onset of Hepatic Steatosis Post-Severe Multisystem Inflammatory Syndrome in Children (MIS-C): A Case Report.|pdf=|usr=028}}
+{{tp|p=34299089|t=2021. Role of Extracellular Vimentin in Cancer-Cell Functionality and Its Influence on Cell Monolayer Permeability Changes Induced by SARS-CoV-2 Receptor Binding Domain.|pdf=|usr=028}}
+{{tp|p=34299045|t=2021. Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion.|pdf=|usr=028}}
+{{tp|p=34281186|t=2021. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.|pdf=|usr=028}}
+{{tp|p=34281182|t=2021. Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies.|pdf=|usr=028}}
+{{tp|p=34290504|t=2021. Glycan Nanostructures of Human Coronaviruses.|pdf=|usr=028}}
+{{tp|p=34283611|t=2021. To Knot or Not to Knot: Multiple Conformations of the SARS-CoV-2 Frameshifting RNA Element.|pdf=|usr=028}}
+{{tp|p=34270232|t=2021. Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket.|pdf=|usr=028}}
+{{tp|p=34328324|t=2021. Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Top-Down Mass Spectrometry.|pdf=|usr=028}}
+{{tp|p=34177193|t=2021. Exploring AyuGenomics approach for understanding COVID-19 predisposition and progression.|pdf=|usr=028}}
+{{tp|p=34157282|t=2021. Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion.|pdf=|usr=028}}
+{{tp|p=34116654|t=2021. C-type lectins and extracellular vesicles in virus-induced NETosis.|pdf=|usr=028}}
+{{tp|p=34319802|t=2021. Assessment of SARS-CoV-2 Genome Sequencing: Quality Criteria and Low-Frequency Variants.|pdf=|usr=028}}
+{{tp|p=34232708|t=2021. Indeterminate QuantiFERON Gold Plus Results Reveal Deficient Interferon Gamma Responses in Severely Ill COVID-19 Patients.|pdf=|usr=028}}
+{{tp|p=34315010|t=2021. Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34298379|t=2021. Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34312809|t=2021. Non-thyroidal illness syndrome and SARS-CoV-2-associated multisystem inflammatory syndrome in children.|pdf=|usr=028}}
+{{tp|p=34185312|t=2021. Long-term monitoring of the development and extinction of IgA and IgG responses to SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34273397|t=2021. Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies.|pdf=|usr=028}}
+{{tp|p=34289053|t=2021. The virological impacts of SARS-CoV-2 D614G mutation.|pdf=|usr=028}}
+{{tp|p=34242876|t=2021. Energetic and structural basis for the differences in infectivity between the wild-type and mutant spike proteins of SARS-CoV-2 in the Mexican population.|pdf=|usr=028}}
+{{tp|p=34255304|t=2021. SARS-CoV-2 Infection and Racial Disparities in Children: Protective Mechanisms and Severe Complications Related to MIS-C.|pdf=|usr=028}}
+{{tp|p=34192291|t=2021. Phlegmonous Ileocolitis as a Presentation of Post SARS-CoV-2 (COVID-19) Multisystem Inflammatory Syndrome in Children.|pdf=|usr=028}}
+{{tp|p=34248243|t=2021. Delta to dominate world.|pdf=|usr=028}}
+{{tp|p=34222663|t=2021. T cell epitopes of SARS-CoV-2 spike protein and conserved surface protein of Plasmodium malariae share sequence homology.|pdf=|usr=028}}
+{{tp|p=34265172|t=2021. Oxidant and antioxidant balance in patients with COVID-19.|pdf=|usr=028}}
+{{tp|p=34252080|t=2021. Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.|pdf=|usr=028}}
+{{tp|p=34237054|t=2021. The interplay of SARS-CoV-2 evolution and constraints imposed by the structure and functionality of its proteins.|pdf=|usr=028}}
+{{tp|p=34228725|t=2021. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.|pdf=|usr=028}}
+{{tp|p=34280196|t=2021. Short Report: Early genomic detection of SARS-CoV-2 P.1 variant in Northeast Brazil.|pdf=|usr=028}}
+{{tp|p=34237072|t=2021. Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis.|pdf=|usr=028}}
+{{tp|p=34324605|t=2021. Modeling neutral viral mutations in the spread of SARS-CoV-2 epidemics.|pdf=|usr=028}}
+{{tp|p=34259777|t=2021. Comments on "Kawasaki and COVID-19 disease in children: a systematic review".|pdf=|usr=028}}
+{{tp|p=34140530|t=2021. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.|pdf=|usr=028}}
+{{tp|p=34189404|t=2021. SARS-CoV2 Related Multi System Inflammatory Syndrome in a Child with Chronic Kidney Disease: Case Report.|pdf=|usr=028}}
+{{tp|p=34254052|t=2021. "Authors' Reply: Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection".|pdf=|usr=028}}
+{{tp|p=34250445|t=2021. Comment on: Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection.|pdf=|usr=028}}
+{{tp|p=34308376|t=2021. SARS-CoV-2 spike linear epitope scanning via a peptide microarray through sera profiling.|pdf=|usr=028}}
+{{tp|p=34221480|t=2021. SARS-CoV-2-related Multisystem Inflammatory Syndrome in Children: A case series.|pdf=|usr=028}}
+{{tp|p=34177422|t=2021. Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism.|pdf=|usr=028}}
+{{tp|p=34280534|t=2021. First detection of SARS-CoV-2 A.23.1 sub-lineage in migrants arriving to Italy via the Mediterranean Sea and public health implications.|pdf=|usr=028}}
+{{tp|p=34187722|t=2021. Cell entry by SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34229912|t=2021. Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses: (Trends in Microbiology, 29, 648-662, 2021).|pdf=|usr=028}}
+{{tp|p=34151202|t=2021. Identification of Novel MicroRNAs Targeting SARS-CoV-2 through the Regulation of TMPRSS2/PI3K/AKT/PTEN Alignment in Lung Cancer: An in Silico Analysis.|pdf=|usr=028}}
+{{tp|p=34152944|t=2021. Different long-term avidity maturation for IgG anti-spike and anti-nucleocapsid SARS-CoV-2 in hospitalized COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34279825|t=2021. Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement.|pdf=|usr=028}}
+{{tp|p=34284575|t=2021. Comprehensive O-Glycosylation Analysis of the SARS-CoV-2 Spike Protein with Biomimetic Trp-Arg Materials.|pdf=|usr=028}}
+{{tp|p=34261329|t=2021. Inflammasome Activation in Children With Kawasaki Disease and Multisystem Inflammatory Syndrome.|pdf=|usr=028}}
+{{tp|p=34124300|t=2021. Computational Analysis and Phylogenetic Clustering of SARS-CoV-2 Genomes.|pdf=|usr=028}}
+{{tp|p=34154997|t=2021. Covid-19: Cases of delta variant rise by 79%, but rate of growth slows.|pdf=|usr=028}}
+{{tp|p=34224431|t=2021. Protein S: function, regulation, and clinical perspectives.|pdf=|usr=028}}
+{{tp|p=34227577|t=2021. Cholesterol 25-hydroxylase expression following immune activation in response to SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34261116|t=2021. Clinical features of multisystem inflammatory syndrome in children.|pdf=|usr=028}}
+{{tp|p=34232536|t=2021. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.|pdf=|usr=028}}
+{{tp|p=34328182|t=2021. Roles of steroid receptors in the lung and COVID-19.|pdf=|usr=028}}
+{{tp|p=34136915|t=2021. Regression of coronary arteries aneurysms 6 months after multisystem inflammatory syndrome in children (MIS-C).|pdf=|usr=028}}
+{{tp|p=34237522|t=2021. Dysphonia and dysphagia consequences of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS).|pdf=|usr=028}}
+{{tp|p=34241335|t=2021. The role of the envelope protein in the stability of a coronavirus model membrane against an ethanolic disinfectant.|pdf=|usr=028}}
+{{tp|p=34263708|t=2021. Human microRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2.|pdf=|usr=028}}
+{{tp|p=34250968|t=2021. Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.|pdf=|usr=028}}
+{{tp|p=34227711|t=2021. Multisystem inflammatory syndrome in children: A single-center experience.|pdf=|usr=028}}
+{{tp|p=34219413|t=2021. EVALI versus MIS-C, one more overlapping diagnosis to consider.|pdf=|usr=028}}
+{{tp|p=34293253|t=2021. Cytokine storm syndrome in a young patient with cystic fibrosis.|pdf=|usr=028}}
+{{tp|p=34260328|t=2021. Platelet-leukocyte interactions in the pathogenesis of viral infections.|pdf=|usr=028}}
+{{tp|p=34168071|t=2021. Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.|pdf=|usr=028}}
+{{tp|p=34168070|t=2021. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.|pdf=|usr=028}}
+{{tp|p=34172701|t=2021. Potential severe pediatric SARS-CoV-2-induced multisystem inflammatory syndrome resembles dengue infection.|pdf=|usr=028}}
+{{tp|p=34101517|t=2021. An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay.|pdf=|usr=028}}
+{{tp|p=34304428|t=2021. [Expressions of MPV, P-LCR and NLR in patients with novel coronavirus disease 2019].|pdf=|usr=028}}
+{{tp|p=34452902|t=2021. Letter to the Editor: Morphoproteomics Confirms the Expression of Fatty Acid Synthase (FAS) in Reactive Alveolar Pneumocytes in a COVID-19 Victim: Biological and Therapeutic Implications.|pdf=|usr=028}}
+{{tp|p=34437814|t=2021. COVID-19: Inflammatory Profile.|pdf=|usr=028}}
+{{tp|p=34293954|t=2021. Re: "COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment" by Cumpstey et al.|pdf=|usr=028}}
+{{tp|p=34269622|t=2021. Response to Verd and Verd Re: "COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment".|pdf=|usr=028}}
+{{tp|p=34348482|t=2021. The MAVS Immune Recognition Pathway in Viral Infection and Sepsis.|pdf=|usr=028}}
+{{tp|p=34213801|t=2021. Does chronic inflammation cause acute inflammation to spiral into hyper-inflammation in a manner modulated by diet and the gut microbiome, in severe Covid-19?|pdf=|usr=028}}
+{{tp|p=34406356|t=2021. coronaSPAdes: from biosynthetic gene clusters to RNA viral assemblies.|pdf=|usr=028}}
+{{tp|p=34231935|t=2021. Identification of HLA-A2 restricted CD8(+) T cell epitopes in SARS-CoV-2 structural proteins.|pdf=|usr=028}}
+{{tp|p=34232823|t=2021. The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung.|pdf=|usr=028}}
+{{tp|p=34431626|t=2021. Performance of Cytokine Storm Syndrome Scoring Systems in Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children.|pdf=|usr=028}}
+{{tp|p=34235261|t=2021. Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34341769|t=2021. CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34328734|t=2021. The SARS-CoV-2 Programmed -1 Ribosomal Frameshifting Element Crystal Structure Solved to 2.09 A Using Chaperone-Assisted RNA Crystallography.|pdf=|usr=028}}
+{{tp|p=34437808|t=2021. Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease.|pdf=|usr=028}}
+{{tp|p=34319698|t=2021. Reproducible Breath Metabolite Changes in Children with SARS-CoV-2 Infection.|pdf=|usr=028}}
+{{tp|p=34337269|t=2021. Conformational Variability Correlation Prediction of Transmissibility and Neutralization Escape Ability for Multiple Mutation SARS-CoV-2 Strains using SSSCPreds.|pdf=|usr=028}}
+{{tp|p=34430559|t=2021. Analysis of the dynamic relationship between immune profiles and the clinical features of patients with COVID-19.|pdf=|usr=028}}
+{{tp|p=34410443|t=2021. Identification and characterization of mutations in the SARS-CoV-2 RNA-dependent RNA polymerase as a promising antiviral therapeutic target.|pdf=|usr=028}}
+{{tp|p=34258664|t=2021. Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.|pdf=|usr=028}}
+{{tp|p=34322866|t=2021. First direct human-to-cat transmission of the SARS-CoV-2 B.1.1.7 variant.|pdf=|usr=028}}
+{{tp|p=34281462|t=2021. Manipulation of autophagy by SARS-CoV-2 proteins.|pdf=|usr=028}}
+{{tp|p=34303694|t=2021. Differential mutation profile of SARS-CoV-2 proteins across deceased and asymptomatic patients.|pdf=|usr=028}}
+{{tp|p=34284028|t=2021. Computational analysis of TMPRSS2 expression in normal and SARS-CoV-2-infected human tissues.|pdf=|usr=028}}
+{{tp|p=34276947|t=2021. Determination of intermediate state structures in the opening pathway of SARS-CoV-2 spike using cryo-electron microscopy.|pdf=|usr=028}}
+{{tp|p=34265150|t=2021. Hidden in Plain Sight: Natural Products of Commensal Microbiota as an Environmental Selection Pressure for the Rise of New Variants of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34245743|t=2021. IL-33 Depletion in COVID-19 Lungs.|pdf=|usr=028}}
+{{tp|p=34208141|t=2021. The Role of Therapeutic Plasma Exchange (TPE) in Multisystem Inflammatory Syndrome in Children (MIS-C).|pdf=|usr=028}}
+{{tp|p=34327082|t=2021. Late-Onset COVID-19-Related Multi-System Inflammatory Syndrome in a Middle-Aged Man.|pdf=|usr=028}}
+{{tp|p=34306850|t=2021. The Perfect Cytokine Storm: Utilization of Lung Ultrasound During Urgent Surgery in an Infant With Multisystem Inflammatory Syndrome in Children and Hemophagocytic Lymphohistiocytosis.|pdf=|usr=028}}
+{{tp|p=34311326|t=2021. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34222846|t=2021. Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study.|pdf=|usr=028}}
+{{tp|p=34325753|t=2021. Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany in 2020: insights into the cause of the second wave.|pdf=|usr=028}}
+{{tp|p=34212240|t=2021. Investigation of endothelial dysfunction and arterial stiffness in multisystem inflammatory syndrome in children.|pdf=|usr=028}}
+{{tp|p=34303662|t=2021. SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing DUSP1 expression and activating p38 MAPK pathway.|pdf=|usr=028}}
+{{tp|p=34267671|t=2021. How and to What Extent Immunological Responses to SARS-CoV-2 Shape Pulmonary Function in COVID-19 Patients.|pdf=|usr=028}}
+{{tp|p=34304938|t=2021. Soluble HLA-G is upregulated in serum of patients with severe COVID-19.|pdf=|usr=028}}
+{{tp|p=34209788|t=2021. Does the SARS-CoV-2 Spike Protein Receptor Binding Domain Interact Effectively with the DPP4 (CD26) Receptor? A Molecular Docking Study.|pdf=|usr=028}}
+{{tp|p=34201415|t=2021. Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms.|pdf=|usr=028}}
+{{tp|p=34205487|t=2021. Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives.|pdf=|usr=028}}
+{{tp|p=34215960|t=2021. Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).|pdf=|usr=028}}
+{{tp|p=34225441|t=2021. ORF8 382 Mutation: A Possible Viral Prognostic Biomarker for the Severity of the COVID-19.|pdf=|usr=028}}
+{{tp|p=34308298|t=2021. Multi-omics analysis of respiratory specimen characterizes baseline molecular determinants associated with SARS-CoV-2 outcome.|pdf=|usr=028}}
+{{tp|p=34308276|t=2021. Sensor array and gas chromatographic detection of the blood serum volatolomic signature of COVID-19.|pdf=|usr=028}}
+{{tp|p=34329427|t=2021. SARS-CoV-2 Antibodies and Associated Factors at Different Hospitalization Time Points in 192 COVID-19 Cases.|pdf=|usr=028}}
+{{tp|p=34209269|t=2021. Ocular and Systemic Manifestations in Paediatric Multisystem Inflammatory Syndrome Associated with COVID-19.|pdf=|usr=028}}
+{{tp|p=34196431|t=2021. SARS-CoV-2 virulence evolution: Avirulence theory, immunity and trade-offs.|pdf=|usr=028}}
+{{tp|p=34329486|t=2021. A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine.|pdf=|usr=028}}
+{{tp|p=34314050|t=2021. SARS-CoV-2 R.1 lineage variants that prevailed in Tokyo in March 2021.|pdf=|usr=028}}
+{{tp|p=34314049|t=2021. Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy.|pdf=|usr=028}}
+{{tp|p=34314048|t=2021. Sequencing on an imported case in China of COVID-19 Delta variant emerging from India in a cargo ship in Zhoushan, China.|pdf=|usr=028}}
+{{tp|p=34292617|t=2021. Evolution trace of SARS-CoV-2 from January 19 to March 12, 2020, in the United States.|pdf=|usr=028}}
+{{tp|p=34260088|t=2021. SARS-CoV-2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate?|pdf=|usr=028}}
+{{tp|p=34255352|t=2021. The variants question: What is the problem?|pdf=|usr=028}}
+{{tp|p=34245452|t=2021. Updated SARS-CoV-2 single nucleotide variants and mortality association.|pdf=|usr=028}}
+{{tp|p=34241897|t=2021. Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 (beta) variant (20H/501Y.V2) in Brazil.|pdf=|usr=028}}
+{{tp|p=34193667|t=2021. Less frequent sequence mismatches in variants of concern (VOCs) of SARS-CoV-2 in the real-time RT-PCR assays developed by the National Institute of Infectious Diseases, Japan.|pdf=|usr=028}}
+{{tp|p=34273381|t=2021. Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients.|pdf=|usr=028}}
+{{tp|p=34197767|t=2021. The SARS-CoV-2 B.1.1.7 variant and increased clinical severity-the jury is out.|pdf=|usr=028}}
+{{tp|p=34278372|t=2021. Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.|pdf=|usr=028}}
+{{tp|p=34278371|t=2021. Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany.|pdf=|usr=028}}
+{{tp|p=34292071|t=2021. Genomic Surveillance of SARS-CoV-2 Viruses Collected during the Ending Phase of the First Wave of the COVID-19 Pandemic in Bangladesh.|pdf=|usr=028}}
+{{tp|p=34264104|t=2021. Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines.|pdf=|usr=028}}
+{{tp|p=34264100|t=2021. Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.|pdf=|usr=028}}
+{{tp|p=34197207|t=2021. New SARS-CoV-2 Variant from Jordan.|pdf=|usr=028}}
+{{tp|p=34287058|t=2021. Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks.|pdf=|usr=028}}
+{{tp|p=34200249|t=2021. Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study.|pdf=|usr=028}}
+{{tp|p=34203277|t=2021. Multisystem Inflammatory Syndrome in an Adult (MIS-A) Successfully Treated with Anakinra and Glucocorticoids.|pdf=|usr=028}}
+{{tp|p=34203929|t=2021. Dose-Related Aberrant Inhibition of Intracellular Perforin Expression by S1 Subunit of Spike Glycoprotein That Contains Receptor-Binding Domain from SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34193870|t=2021. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.|pdf=|usr=028}}
+{{tp|p=34234119|t=2021. The molecular basis for SARS-CoV-2 binding to dog ACE2.|pdf=|usr=028}}
+{{tp|p=34230476|t=2021. Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan.|pdf=|usr=028}}
+{{tp|p=34226537|t=2021. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.|pdf=|usr=028}}
+{{tp|p=34326343|t=2021. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.|pdf=|usr=028}}
+{{tp|p=34326336|t=2021. Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34321474|t=2021. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.|pdf=|usr=028}}
+{{tp|p=34315903|t=2021. Integrative genomic analyses identify susceptibility genes underlying COVID-19 hospitalization.|pdf=|usr=028}}
+{{tp|p=34315893|t=2021. Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets.|pdf=|usr=028}}
+{{tp|p=34315889|t=2021. The trans-omics landscape of COVID-19.|pdf=|usr=028}}
+{{tp|p=34199224|t=2021. Is SARS-CoV-2 Neutralized More Effectively by IgM and IgA than IgG Having the Same Fab Region?|pdf=|usr=028}}
+{{tp|p=34297786|t=2021. SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts.|pdf=|usr=028}}
+{{tp|p=34214116|t=2021. Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34320031|t=2021. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34280244|t=2021. Early antibody responses associated with survival in COVID19 patients.|pdf=|usr=028}}
+{{tp|p=34270631|t=2021. SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence.|pdf=|usr=028}}
+{{tp|p=34270613|t=2021. Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection.|pdf=|usr=028}}
+{{tp|p=34260666|t=2021. COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.|pdf=|usr=028}}
+{{tp|p=34259880|t=2021. Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34315815|t=2021. SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block.|pdf=|usr=028}}
+{{tp|p=34248311|t=2021. Genetic Control of Human Infection with SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34188167|t=2021. Activation of NF-kappaB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34238985|t=2021. In vitro Interleukin-7 treatment partially rescues MAIT cell dysfunction caused by SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34234167|t=2021. Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.|pdf=|usr=028}}
+{{tp|p=34226622|t=2021. Understanding protection from SARS-CoV-2 using metabolomics.|pdf=|usr=028}}
+{{tp|p=34312429|t=2021. S494 O-glycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study.|pdf=|usr=028}}
+{{tp|p=34217923|t=2021. Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability.|pdf=|usr=028}}
+{{tp|p=34325286|t=2021. SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung.|pdf=|usr=028}}
+{{tp|p=34265628|t=2021. Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.|pdf=|usr=028}}
+{{tp|p=34320912|t=2021. COVID-19 adaptive evolution during the pandemic - Implications of new SARS-CoV-2 variants on public health policies.|pdf=|usr=028}}
+{{tp|p=34251989|t=2021. The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences.|pdf=|usr=028}}
+{{tp|p=34251592|t=2021. Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.|pdf=|usr=028}}
+{{tp|p=34314772|t=2021. Structural modelling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity.|pdf=|usr=028}}
+{{tp|p=34329696|t=2021. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.|pdf=|usr=028}}
+{{tp|p=34207696|t=2021. HERC5 and the ISGylation Pathway: Critical Modulators of the Antiviral Immune Response.|pdf=|usr=028}}
+{{tp|p=34207490|t=2021. A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic.|pdf=|usr=028}}
+{{tp|p=34200386|t=2021. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.|pdf=|usr=028}}
+{{tp|p=34205098|t=2021. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.|pdf=|usr=028}}
+{{tp|p=34209881|t=2021. Modular Evolution of Coronavirus Genomes.|pdf=|usr=028}}
+{{tp|p=34199077|t=2021. From Recoding to Peptides for MHC Class I Immune Display: Enriching Viral Expression, Virus Vulnerability and Virus Evasion.|pdf=|usr=028}}
+{{tp|p=34206990|t=2021. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.|pdf=|usr=028}}
+{{tp|p=34202160|t=2021. Modulation of Viral Programmed Ribosomal Frameshifting and Stop Codon Readthrough by the Host Restriction Factor Shiftless.|pdf=|usr=028}}
+{{tp|p=34202098|t=2021. How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?|pdf=|usr=028}}
+{{tp|p=34200602|t=2021. The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation.|pdf=|usr=028}}
+{{tp|p=34452902|t=2021. Letter to the Editor: Morphoproteomics Confirms the Expression of Fatty Acid Synthase (FAS) in Reactive Alveolar Pneumocytes in a COVID-19 Victim: Biological and Therapeutic Implications.|pdf=|usr=028}}
+{{tp|p=34437814|t=2021. COVID-19: Inflammatory Profile.|pdf=|usr=028}}
+{{tp|p=34293954|t=2021. Re: "COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment" by Cumpstey et al.|pdf=|usr=028}}
+{{tp|p=34269622|t=2021. Response to Verd and Verd Re: "COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment".|pdf=|usr=028}}
+{{tp|p=34348482|t=2021. The MAVS Immune Recognition Pathway in Viral Infection and Sepsis.|pdf=|usr=028}}
+{{tp|p=34213801|t=2021. Does chronic inflammation cause acute inflammation to spiral into hyper-inflammation in a manner modulated by diet and the gut microbiome, in severe Covid-19?|pdf=|usr=028}}
+{{tp|p=34406356|t=2021. coronaSPAdes: from biosynthetic gene clusters to RNA viral assemblies.|pdf=|usr=028}}
+{{tp|p=34231935|t=2021. Identification of HLA-A2 restricted CD8(+) T cell epitopes in SARS-CoV-2 structural proteins.|pdf=|usr=028}}
+{{tp|p=34232823|t=2021. The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung.|pdf=|usr=028}}
+{{tp|p=34214538|t=2021. Biophysical properties of the isolated spike protein binding helix of human ACE2.|pdf=|usr=028}}
+{{tp|p=34214535|t=2021. Role of spatial patterning of N-protein interactions in SARS-CoV-2 genome packaging.|pdf=|usr=028}}
+{{tp|p=34197807|t=2021. Regulation of epithelial sodium channel activity by SARS-CoV-1 and SARS-CoV-2 proteins.|pdf=|usr=028}}
+{{tp|p=34197802|t=2021. Dynamics of the SARS-CoV-2 nucleoprotein N-terminal domain triggers RNA duplex destabilization.|pdf=|usr=028}}
+{{tp|p=34197805|t=2021. Transient and stabilized complexes of Nsp7, Nsp8, and Nsp12 in SARS-CoV-2 replication.|pdf=|usr=028}}
+{{tp|p=34313294|t=2021. A lipidomic view of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34225645|t=2021. Immune cell profiling and antibody responses in patients with COVID-19.|pdf=|usr=028}}
+{{tp|p=34225644|t=2021. Sex-based clinical and immunological differences in COVID-19.|pdf=|usr=028}}
+{{tp|p=34260684|t=2021. Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.|pdf=|usr=028}}
+{{tp|p=34257504|t=2021. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system.|pdf=|usr=028}}
+{{tp|p=34306789|t=2021. COVID-19 Infection in Spinal Muscular Atrophy Associated with Multisystem Inflammatory Syndrome.|pdf=|usr=028}}
+{{tp|p=34242577|t=2021. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.|pdf=|usr=028}}
+{{tp|p=34289344|t=2021. A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation.|pdf=|usr=028}}
+{{tp|p=34294141|t=2021. Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication.|pdf=|usr=028}}
+{{tp|p=34246414|t=2021. SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET.|pdf=|usr=028}}
+{{tp|p=34238338|t=2021. Single-cell analysis reveals cell communication triggered by macrophages associated with the reduction and exhaustion of CD8(+) T cells in COVID-19.|pdf=|usr=028}}
+{{tp|p=34301919|t=2021. RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.|pdf=|usr=028}}
+{{tp|p=34226505|t=2021. H-Ras gene takes part to the host immune response to COVID-19.|pdf=|usr=028}}
+{{tp|p=34315869|t=2021. ScRNA-seq revealed the kinetic of nasopharyngeal immune responses in asymptomatic COVID-19 carriers.|pdf=|usr=028}}
+{{tp|p=34265243|t=2021. An aberrant inflammatory response in severe COVID-19.|pdf=|usr=028}}
+{{tp|p=34265239|t=2021. Virus hunters: Discovering the evolutionary origins of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34242582|t=2021. HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.|pdf=|usr=028}}
+{{tp|p=34237248|t=2021. SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19.|pdf=|usr=028}}
+{{tp|p=34216827|t=2021. Gut ACE2 Expression, Tryptophan Deficiency, and Inflammatory Responses The Potential Connection That Should Not Be Ignored During SARS-CoV-2 Infection.|pdf=|usr=028}}
+{{tp|p=34321622|t=2021. Increase in serum levels of phosphatidylserine-specific phospholipase A1 in COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34290398|t=2021. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34223911|t=2021. Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.|pdf=|usr=028}}
+{{tp|p=34270919|t=2021. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination.|pdf=|usr=028}}
+{{tp|p=34260965|t=2021. Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.|pdf=|usr=028}}
+{{tp|p=34242574|t=2021. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins.|pdf=|usr=028}}
+{{tp|p=34272947|t=2021. An Update on SARS-CoV-2 Diversity in the United States National Capital Region: Evolution of Novel and Variants of Concern.|pdf=|usr=028}}
+{{tp|p=34221376|t=2021. Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders.|pdf=|usr=028}}
+{{tp|p=34221375|t=2021. Genes, COVID-19 and phenotype.|pdf=|usr=028}}
+{{tp|p=34253247|t=2021. Emerging SARS-CoV-2 variants of concern and potential intervention approaches.|pdf=|usr=028}}
+{{tp|p=34328076|t=2021. An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021.|pdf=|usr=028}}
+{{tp|p=34328074|t=2021. Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021.|pdf=|usr=028}}
+{{tp|p=34269174|t=2021. Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021.|pdf=|usr=028}}
+{{tp|p=34240695|t=2021. Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021.|pdf=|usr=028}}
+{{tp|p=34290742|t=2021. Identification of Causal Genes of COVID-19 Using the SMR Method.|pdf=|usr=028}}
+{{tp|p=34211506|t=2021. COVID-19 and SARS-CoV-2 Variants: Current Challenges and Health Concern.|pdf=|usr=028}}
+{{tp|p=34326844|t=2021. Impaired Priming of SARS-CoV-2-Specific Naive CD8(+) T Cells in Older Subjects.|pdf=|usr=028}}
+{{tp|p=34326843|t=2021. The Many Faces of JAKs and STATs Within the COVID-19 Storm.|pdf=|usr=028}}
+{{tp|p=34322127|t=2021. A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.|pdf=|usr=028}}
+{{tp|p=34322120|t=2021. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.|pdf=|usr=028}}
+{{tp|p=34305949|t=2021. SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns.|pdf=|usr=028}}
+{{tp|p=34305903|t=2021. ROS/RNS Balancing, Aerobic Fermentation Regulation and Cell Cycle Control - a Complex Early Trait ('CoV-MAC-TED') for Combating SARS-CoV-2-Induced Cell Reprogramming.|pdf=|usr=028}}
+{{tp|p=34305895|t=2021. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.|pdf=|usr=028}}
+{{tp|p=34305894|t=2021. The Spike of SARS-CoV-2: Uniqueness and Applications.|pdf=|usr=028}}
+{{tp|p=34305888|t=2021. Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1.|pdf=|usr=028}}
+{{tp|p=34290717|t=2021. Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins.|pdf=|usr=028}}
+{{tp|p=34276680|t=2021. AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19.|pdf=|usr=028}}
+{{tp|p=34276672|t=2021. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.|pdf=|usr=028}}
+{{tp|p=34267764|t=2021. Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.|pdf=|usr=028}}
+{{tp|p=34262555|t=2021. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.|pdf=|usr=028}}
+{{tp|p=34249006|t=2021. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.|pdf=|usr=028}}
+{{tp|p=34248984|t=2021. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.|pdf=|usr=028}}
+{{tp|p=34248968|t=2021. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.|pdf=|usr=028}}
+{{tp|p=34248962|t=2021. Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.|pdf=|usr=028}}
+{{tp|p=34248940|t=2021. Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.|pdf=|usr=028}}
+{{tp|p=34234779|t=2021. Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?|pdf=|usr=028}}
+{{tp|p=34220870|t=2021. Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset.|pdf=|usr=028}}
+{{tp|p=34220859|t=2021. Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19.|pdf=|usr=028}}
+{{tp|p=34220846|t=2021. A Comparative Analysis of Coronavirus Nucleocapsid (N) Proteins Reveals the SADS-CoV N Protein Antagonizes IFN-beta Production by Inducing Ubiquitination of RIG-I.|pdf=|usr=028}}
+{{tp|p=34220844|t=2021. The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom.|pdf=|usr=028}}
+{{tp|p=34211469|t=2021. Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses.|pdf=|usr=028}}
+{{tp|p=34194438|t=2021. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.|pdf=|usr=028}}
+{{tp|p=34194429|t=2021. Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.|pdf=|usr=028}}
+{{tp|p=34239886|t=2021. SARS-CoV-2 Viral Shedding and Transmission Dynamics: Implications of WHO COVID-19 Discharge Guidelines.|pdf=|usr=028}}
+{{tp|p=34239884|t=2021. Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease.|pdf=|usr=028}}
+{{tp|p=34222275|t=2021. Persisting Antibody Response to SARS-CoV-2 in a Local Austrian Population.|pdf=|usr=028}}
+{{tp|p=34229864|t=2021. Humoral immune mechanisms involved in protective and pathological immunity during COVID-19.|pdf=|usr=028}}
+{{tp|p=34273395|t=2021. Distinctive pseudopalisaded histiocytic hyperplasia characterizes the transition of exudative to proliferative phase of diffuse alveolar damage in patients dying of COVID-19.|pdf=|usr=028}}
+{{tp|p=34230877|t=2021. Red face may be a specific sign of SARS-CoV-2 alpha variant.|pdf=|usr=028}}
+{{tp|p=34231951|t=2021. A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia.|pdf=|usr=028}}
+{{tp|p=34246326|t=2021. Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants.|pdf=|usr=028}}
+{{tp|p=34228987|t=2021. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.|pdf=|usr=028}}
+{{tp|p=34292476|t=2021. Humoral immune durability of IgG for anti-SARS-CoV-2 in the normal pregnant women in Wuhan, China.|pdf=|usr=028}}
+{{tp|p=34202646|t=2021. Virus-Negative Necrotizing Coronary Vasculitis with Aneurysm Formation in Human SARS-CoV-2 Infection.|pdf=|usr=028}}
+{{tp|p=34267528|t=2021. Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan.|pdf=|usr=028}}
+{{tp|p=34271202|t=2021. Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case.|pdf=|usr=028}}
+{{tp|p=34273512|t=2021. Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19.|pdf=|usr=028}}
+{{tp|p=34260956|t=2021. High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!|pdf=|usr=028}}
+{{tp|p=34209845|t=2021. Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators.|pdf=|usr=028}}
+{{tp|p=34193364|t=2021. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.|pdf=|usr=028}}
+{{tp|p=34285538|t=2021. Prevalence and Characteristics of Rheumatoid-Associated Autoantibodies in Patients with COVID-19.|pdf=|usr=028}}
+{{tp|p=34319496|t=2021. The potential role of neopterin in Covid-19: a new perspective.|pdf=|usr=028}}
+{{tp|p=34242919|t=2021. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.|pdf=|usr=028}}
+{{tp|p=34254040|t=2021. Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 Isolates.|pdf=|usr=028}}
+{{tp|p=34224908|t=2021. SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?|pdf=|usr=028}}
+{{tp|p=34199852|t=2021. Long-Term Persistence of Anti-SARS-CoV-2 Antibodies in a Pediatric Population.|pdf=|usr=028}}
+{{tp|p=34201967|t=2021. Study of the Plasma and Buffy Coat in Patients with SARS-CoV-2 Infection-A Preliminary Report.|pdf=|usr=028}}
+{{tp|p=34288921|t=2021. Molecular epidemiology of SARS-CoV-2 in Cyprus.|pdf=|usr=028}}
+{{tp|p=34211037|t=2021. The RNA sensor MDA5 detects SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34210996|t=2021. Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant.|pdf=|usr=028}}
+{{tp|p=34230210|t=2021. Kynurenic acid may underlie sex-specific immune responses to COVID-19.|pdf=|usr=028}}
+{{tp|p=34201088|t=2021. A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel.|pdf=|usr=028}}
+{{tp|p=34199761|t=2021. The Many Faces of Innate Immunity in SARS-CoV-2 Infection.|pdf=|usr=028}}
+{{tp|p=34202276|t=2021. Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination.|pdf=|usr=028}}
+{{tp|p=34199357|t=2021. Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination.|pdf=|usr=028}}
+{{tp|p=34276267|t=2021. Variantes de SARS-CoV-2, una historia todavia inacabada.|pdf=|usr=028}}
+{{tp|p=34275492|t=2021. SARS-CoV-2: preliminary study of infected human nasopharyngeal tissue by high resolution microscopy.|pdf=|usr=028}}
+{{tp|p=34201767|t=2021. SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies.|pdf=|usr=028}}
+{{tp|p=34206453|t=2021. Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?|pdf=|usr=028}}
+{{tp|p=34205489|t=2021. Broad Impact of Exchange Protein Directly Activated by cAMP 2 (EPAC2) on Respiratory Viral Infections.|pdf=|usr=028}}
+{{tp|p=34198530|t=2021. Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments.|pdf=|usr=028}}
+{{tp|p=34199223|t=2021. Functions of Coronavirus Accessory Proteins: Overview of the State of the Art.|pdf=|usr=028}}
+{{tp|p=34204754|t=2021. Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.|pdf=|usr=028}}
+{{tp|p=34204732|t=2021. Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera.|pdf=|usr=028}}
+{{tp|p=34208191|t=2021. Full-Length Computational Model of the SARS-CoV-2 Spike Protein and Its Implications for a Viral Membrane Fusion Mechanism.|pdf=|usr=028}}
+{{tp|p=34340962|t=2021. Covid-19: Delta infections threaten herd immunity vaccine strategy.|pdf=|usr=028}}
+{{tp|p=34413059|t=2021. Covid-19: How many variants are there, and what do we know about them?|pdf=|usr=028}}
+{{tp|p=34413020|t=2021. Covid-19: Fully vaccinated people can carry as much delta virus as unvaccinated people, data indicate.|pdf=|usr=028}}
+{{tp|p=34246957|t=2021. Syncope and silent hypoxemia in COVID-19: Implications for the autonomic field.|pdf=|usr=028}}
+{{tp|p=34224022|t=2021. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.|pdf=|usr=028}}
+{{tp|p=34246830|t=2021. Analysis of SARS-CoV-2 nucleocapsid phosphoprotein N variations in the binding site to human 14-3-3 proteins.|pdf=|usr=028}}
+{{tp|p=34213308|t=2021. Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation.|pdf=|usr=028}}
+{{tp|p=34274319|t=2021. Membranotropic and biological activities of the membrane fusion peptides from SARS-CoV spike glycoprotein: The importance of the complete internal fusion peptide domain.|pdf=|usr=028}}
+{{tp|p=34237472|t=2021. In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies.|pdf=|usr=028}}
+{{tp|p=34220199|t=2021. Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins.|pdf=|usr=028}}
+{{tp|p=34234394|t=2021. Differential binding of SARS-CoV-2 Spike protein variants to its cognate receptor hACE2 using molecular modeling based binding analysis.|pdf=|usr=028}}
+{{tp|p=34198622|t=2021. SARS-CoV-2 Variants in Lebanon: Evolution and Current Situation.|pdf=|usr=028}}
+{{tp|p=34193390|t=2021. Role of SARS-CoV-2 and ACE2 variations in COVID-19.|pdf=|usr=028}}
+{{tp|p=34271250|t=2021. Emerging mutation in SARS-CoV-2 spike: Widening distribution over time in different geographic areas.|pdf=|usr=028}}
+{{tp|p=34307679|t=2021. Identifying COVID-19-Specific Transcriptomic Biomarkers with Machine Learning Methods.|pdf=|usr=028}}
+{{tp|p=34258267|t=2021. Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.|pdf=|usr=028}}
+{{tp|p=34202515|t=2021. Oxidative Stress and Inflammation in SARS-CoV-2- and Chlamydia pneumoniae-Associated Cardiovascular Diseases.|pdf=|usr=028}}
+{{tp|p=34207362|t=2021. Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19.|pdf=|usr=028}}
+{{tp|p=34204735|t=2021. Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19-The Role of RAGE-RAS Crosstalk.|pdf=|usr=028}}
+{{tp|p=34237251|t=2021. Computational methods to predict the mutational landscape of the spike protein.|pdf=|usr=028}}
+{{tp|p=34219983|t=2021. Atlas der SARS-CoV-2-RNA-Protein-Interaktionen in infizierten Zellen.|pdf=|usr=028}}
+{{tp|p=34210280|t=2021. Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34189273|t=2021. Mass spectrometric based detection of protein nucleotidylation in the RNA polymerase of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34320442|t=2021. Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach.|pdf=|usr=028}}
+{{tp|p=34246161|t=2021. High-throughput analysis of the interactions between viral proteins and host cell RNAs.|pdf=|usr=028}}
+{{tp|p=34234921|t=2021. Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.|pdf=|usr=028}}
+{{tp|p=34306570|t=2021. Exploiting the molecular basis of age and gender differences in outcomes of SARS-CoV-2 infections.|pdf=|usr=028}}
+{{tp|p=34217135|t=2021. Natural killer cells and unconventional T cells in COVID-19.|pdf=|usr=028}}
+{{tp|p=34272088|t=2021. Alterations of Lipid Profile in COVID-19: A Narrative Review.|pdf=|usr=028}}
+{{tp|p=34305860|t=2021. Host- and Species-Dependent Quasispecies Divergence of Severe Acute Respiratory Syndrome Coronavirus-2 in Non-human Primate Models.|pdf=|usr=028}}
+{{tp|p=34267735|t=2021. Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34234758|t=2021. A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3' Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity.|pdf=|usr=028}}
+{{tp|p=34220784|t=2021. The First Molecular Characterization of Serbian SARS-CoV-2 Isolates From a Unique Early Second Wave in Europe.|pdf=|usr=028}}
+{{tp|p=34322518|t=2021. Mathematical Model of SARS-Cov-2 Propagation Versus ACE2 Fits COVID-19 Lethality Across Age and Sex and Predicts That of SARS.|pdf=|usr=028}}
+{{tp|p=34274478|t=2021. No association between the SARS-CoV-2 variants and mortality rates in the Eastern Mediterranean Region.|pdf=|usr=028}}
+{{tp|p=34202172|t=2021. Uncovering Signals from the Coronavirus Genome.|pdf=|usr=028}}
+{{tp|p=34222571|t=2021. Identification of Cross-Reactive CD8(+) T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant Variants.|pdf=|usr=028}}
+{{tp|p=34228320|t=2021. Relative synonymous codon usage of ORF1ab in SARS-CoV-2 and SARS-CoV.|pdf=|usr=028}}
+{{tp|p=34210356|t=2021. CLIMB-COVID: continuous integration supporting decentralised sequencing for SARS-CoV-2 genomic surveillance.|pdf=|usr=028}}
+{{tp|p=34281603|t=2021. Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19.|pdf=|usr=028}}
+{{tp|p=34296023|t=2021. Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis.|pdf=|usr=028}}
+{{tp|p=34207510|t=2021. Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms.|pdf=|usr=028}}
+{{tp|p=34200325|t=2021. Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors.|pdf=|usr=028}}
+{{tp|p=34198800|t=2021. In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3'-UTR.|pdf=|usr=028}}
+{{tp|p=34207476|t=2021. Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34204305|t=2021. The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA.|pdf=|usr=028}}
+{{tp|p=34206057|t=2021. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses.|pdf=|usr=028}}
+{{tp|p=34205975|t=2021. Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications.|pdf=|usr=028}}
+{{tp|p=34299201|t=2021. Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes).|pdf=|usr=028}}
+{{tp|p=34299124|t=2021. Extension of Collagen Deposition in COVID-19 Post Mortem Lung Samples and Computed Tomography Analysis Findings.|pdf=|usr=028}}
+{{tp|p=34299101|t=2021. COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases.|pdf=|usr=028}}
+{{tp|p=34273582|t=2021. SARS-CoV-2 Infection in the Immunodeficient Host: Necessary and Dispensable Immune Pathways.|pdf=|usr=028}}
+{{tp|p=34273581|t=2021. Association of Varying Clinical Manifestations and Positive Anti-SARS-CoV-2 IgG Antibodies: A Cross-Sectional Observational Study.|pdf=|usr=028}}
+{{tp|p=34303083|t=2021. Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study.|pdf=|usr=028}}
+{{tp|p=34223909|t=2021. Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro.|pdf=|usr=028}}
+{{tp|p=34282461|t=2021. Kinetics of the SARS-CoV-2 antibody response and serological estimation of time since infection.|pdf=|usr=028}}
+{{tp|p=34268819|t=2021. Self-infection with speech aerosol may contribute to COVID-19 severity.|pdf=|usr=028}}
+{{tp|p=34255499|t=2021. Binding of SARS-CoV-2 Fusion Peptide to Host Endosome and Plasma Membrane.|pdf=|usr=028}}
+{{tp|p=34328740|t=2021. Role of ATP in the RNA Translocation Mechanism of SARS-CoV-2 NSP13 Helicase.|pdf=|usr=028}}
+{{tp|p=34196568|t=2021. Interfacial Water Many-Body Effects Drive Structural Dynamics and Allosteric Interactions in SARS-CoV-2 Main Protease Dimerization Interface.|pdf=|usr=028}}
+{{tp|p=34196550|t=2021. Regulation Mechanism for the Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II.|pdf=|usr=028}}
+{{tp|p=34236232|t=2021. Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh.|pdf=|usr=028}}
+{{tp|p=34236224|t=2021. Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.|pdf=|usr=028}}
+{{tp|p=34312385|t=2021. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'.|pdf=|usr=028}}
+{{tp|p=34272374|t=2021. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance.|pdf=|usr=028}}
+{{tp|p=34207055|t=2021. microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection-A Commentary.|pdf=|usr=028}}
+{{tp|p=34294722|t=2021. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.|pdf=|usr=028}}
+{{tp|p=34232992|t=2021. SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.|pdf=|usr=028}}
+{{tp|p=34192263|t=2020. A 3.4-A cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles.|pdf=|usr=028}}
+{{tp|p=34290329|t=2021. Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays.|pdf=|usr=028}}
+{{tp|p=34290262|t=2021. Lipid bilayer degradation induced by SARS-CoV-2 spike protein as revealed by neutron reflectometry.|pdf=|usr=028}}
+{{tp|p=34215811|t=2021. Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34267263|t=2021. A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.|pdf=|usr=028}}
+{{tp|p=34253751|t=2021. Deep learning identifies antigenic determinants of severe SARS-CoV-2 infection within T-cell repertoires.|pdf=|usr=028}}
+{{tp|p=34222416|t=2021. Dynamics of host immune responses to SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34370288|t=2021. Emerging Role for Ferroptosis in Infectious Diseases.|pdf=|usr=028}}
+{{tp|p=34453338|t=2021. In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion.|pdf=|usr=028}}
+{{tp|p=34344757|t=2021. Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19?|pdf=|usr=028}}
+{{tp|p=34365984|t=2021. Preoperative monocytosis is predictable at diagnosis for RT-PCR negative COVID-19 paediatric cardiac surgery patients.|pdf=|usr=028}}
+{{tp|p=34348808|t=2021. Cardiac echocardiogram findings of severe acute respiratory syndrome coronavirus-2-associated multi-system inflammatory syndrome in children.|pdf=|usr=028}}
+{{tp|p=34190246|t=2021. Effective ACE2 peptide-nanoparticle conjugation and its binding with the SARS-Cov-2 RBD quantified by dynamic light scattering.|pdf=|usr=028}}
+{{tp|p=34218284|t=2021. Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34309648|t=2021. Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination.|pdf=|usr=028}}
+{{tp|p=34302458|t=2021. Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis.|pdf=|usr=028}}
+{{tp|p=34231319|t=2021. One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19.|pdf=|usr=028}}
+{{tp|p=34213568|t=2021. Development of IgG, IgM, and IgA autoantibodies against angiotensin converting enzyme 2 in patients with COVID-19.|pdf=|usr=028}}
+{{tp|p=34188005|t=2021. The interaction of the severe acute respiratory syndrome coronavirus 2 spike protein with drug-inhibited angiotensin converting enzyme 2 studied by molecular dynamics simulation.|pdf=|usr=028}}
+{{tp|p=34312258|t=2021. The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated.|pdf=|usr=028}}
+{{tp|p=34301847|t=2021. SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.|pdf=|usr=028}}
+{{tp|p=34329672|t=2021. SARS-CoV-2 viral dynamics in infections with Alpha and Beta variants of concern in the French community.|pdf=|usr=028}}
+{{tp|p=34192326|t=2021. Comment on: Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.|pdf=|usr=028}}
+{{tp|p=34192319|t=2021. Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.|pdf=|usr=028}}
+{{tp|p=34280026|t=2021. Quantitative Insight into Immunopathology of SARS-CoV-2 Infection.|pdf=|usr=028}}
+{{tp|p=34251833|t=2021. Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.|pdf=|usr=028}}
+{{tp|p=34289271|t=2021. ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply.|pdf=|usr=028}}
+{{tp|p=34289270|t=2021. ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.|pdf=|usr=028}}
+{{tp|p=34254633|t=2021. Interaction of serum proteins with SARS-CoV-2 RBD.|pdf=|usr=028}}
+{{tp|p=34316026|t=2021. Broadly neutralizing anti-coronavirus antibodies.|pdf=|usr=028}}
+{{tp|p=34261126|t=2021. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.|pdf=|usr=028}}
+{{tp|p=34237774|t=2021. Mapping the human genetic architecture of COVID-19.|pdf=|usr=028}}
+{{tp|p=34321649|t=2021. Daily briefing: How SARS-CoV-2 infects cells.|pdf=|usr=028}}
+{{tp|p=34290423|t=2021. How the Delta variant achieves its ultrafast spread.|pdf=|usr=028}}
+{{tp|p=34272531|t=2021. Daily briefing: 'Super-antibodies' fight many coronavirus variants.|pdf=|usr=028}}
+{{tp|p=34262194|t=2021. This 'super antibody' for COVID fights off multiple coronaviruses.|pdf=|usr=028}}
+{{tp|p=34321669|t=2021. How the coronavirus infects cells - and why Delta is so dangerous.|pdf=|usr=028}}
+{{tp|p=34239118|t=2021. The quest to find genes that drive severe COVID.|pdf=|usr=028}}
+{{tp|p=34237773|t=2021. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.|pdf=|usr=028}}
+{{tp|p=34275790|t=2021. Profiling of inflammatory biomarkers in mild to critically ill severe acute respiratory syndrome corona virus-19 (SARS Covid-19) patients from Karachi, Pakistan.|pdf=|usr=028}}
+{{tp|p=34210785|t=2021. CD8(+) T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34233952|t=2021. Increasing threats from SARS-CoV-2 variants: Time to establish global surveillance.|pdf=|usr=028}}
+{{tp|p=34315827|t=2021. Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme.|pdf=|usr=028}}
+{{tp|p=34210893|t=2021. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.|pdf=|usr=028}}
+{{tp|p=34301854|t=2021. Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence.|pdf=|usr=028}}
+{{tp|p=34210892|t=2021. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.|pdf=|usr=028}}
+{{tp|p=34269109|t=2021. Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment.|pdf=|usr=028}}
+{{tp|p=34284918|t=2021. Imaging of Multisystem Inflammatory Disease in Children (MIS-C) Associated With COVID-19.|pdf=|usr=028}}
+{{tp|p=34431501|t=2021. COVID-19 and ROS Storm: What is the Forecast for Hypertension.|pdf=|usr=028}}
+{{tp|p=34273437|t=2021. Outcomes From Infections With Variant Strains of SARS-CoV-2 Among Patients Receiving Maintenance Hemodialysis.|pdf=|usr=028}}
+{{tp|p=34328495|t=2021. Neutralizing antibody responses against SARS-CoV-2 spike receptor-binding domain 13 months after the recovery from the disease.|pdf=|usr=028}}
+{{tp|p=34342755|t=2021. Novel phenotypes of coronavirus disease: a temperature-based trajectory model.|pdf=|usr=028}}
+{{tp|p=34461036|t=2021. Annals Graphic Medicine - Wanted: All COVID-19 Variants.|pdf=|usr=028}}
+{{tp|p=34374354|t=2022. Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay.|pdf=|usr=028}}
+{{tp|p=34286216|t=2021. Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34199430|t=2021. Immune Response to SARS-CoV-2 in an Asymptomatic Pediatric Allergic Cohort.|pdf=|usr=028}}
+{{tp|p=34309328|t=2021. Consenso sobre el tratamiento del sindrome inflamatorio multisistemico asociado a COVID-19.|pdf=|usr=028}}
+{{tp|p=34419338|t=2021. OBESITY AND SEVERE COVID-19 IN THE YOUNG: IS DOWNREGULATION OF miR-126 A PIECE OF THE SARS-COV2 PATHOGENICITY PUZZLE?|pdf=|usr=028}}
+{{tp|p=34235495|t=2021. Asymmetric dynamics of dimeric SARS-CoV-2 and SARS-CoV main proteases in an apo form: Molecular dynamics study on fluctuations of active site, catalytic dyad, and hydration water.|pdf=|usr=028}}
+{{tp|p=34326117|t=2021. Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V).|pdf=|usr=028}}
+{{tp|p=34301692|t=2021. Kawasaki-like multisystem inflammatory syndrome associated with SARS-CoV-2 infection in an adult.|pdf=|usr=028}}
+{{tp|p=34312842|t=2021. Haemophagocytosis and atypical vacuolated lymphocytes in bone marrow and blood films after SARS-CoV-2 vaccination.|pdf=|usr=028}}
+{{tp|p=34247384|t=2021. Immature platelets in COVID-19 infection.|pdf=|usr=028}}
+{{tp|p=34230917|t=2021. Impact of SARS-CoV-2 variants on the total CD4(+) and CD8(+) T cell reactivity in infected or vaccinated individuals.|pdf=|usr=028}}
+{{tp|p=34201214|t=2021. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.|pdf=|usr=028}}
+{{tp|p=34200500|t=2021. How SARS-CoV-2 and Other Viruses Build an Invasion Route to Hijack the Host Nucleocytoplasmic Trafficking System.|pdf=|usr=028}}
+{{tp|p=34200372|t=2021. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.|pdf=|usr=028}}
+{{tp|p=34201847|t=2021. Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19.|pdf=|usr=028}}
+{{tp|p=34202997|t=2021. From RNA World to SARS-CoV-2: The Edited Story of RNA Viral Evolution.|pdf=|usr=028}}
+{{tp|p=34205262|t=2021. The Role of Th17 Response in COVID-19.|pdf=|usr=028}}
+{{tp|p=34200572|t=2021. Identification of Lung and Blood Microbiota Implicated in COVID-19 Prognosis.|pdf=|usr=028}}
+{{tp|p=34272033|t=2021. A dermatologic perspective on multisystem inflammatory syndrome in children.|pdf=|usr=028}}
+{{tp|p=34272031|t=2021. Dermatologic manifestations of COVID-19-associated multisystem inflammatory syndrome in children.|pdf=|usr=028}}
+{{tp|p=34303849|t=2021. Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach.|pdf=|usr=028}}
+{{tp|p=34245905|t=2021. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance.|pdf=|usr=028}}
+{{tp|p=34256141|t=2021. The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses.|pdf=|usr=028}}
+{{tp|p=34277221|t=2021. A Case of COVID-19 Mimicking Acute Appendicitis in Multi-System Inflammatory Syndrome.|pdf=|usr=028}}
+{{tp|p=34306899|t=2021. Cardiogenic Shock Due to Multisystem Inflammatory Syndrome in a Young Adult Female.|pdf=|usr=028}}
+{{tp|p=34314723|t=2021. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic.|pdf=|usr=028}}
+{{tp|p=34226898|t=2021. Green bodies: Inclusions in a critically ill COVID-19 patient.|pdf=|usr=028}}
+{{tp|p=34323691|t=2021. Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains.|pdf=|usr=028}}
+{{tp|p=34296442|t=2021. SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage.|pdf=|usr=028}}
+{{tp|p=34260159|t=2021. Individual COVID-19 disease trajectories revealed by plasma proteomics.|pdf=|usr=028}}
+{{tp|p=34232570|t=2021. High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.|pdf=|usr=028}}
+{{tp|p=34314668|t=2021. Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19.|pdf=|usr=028}}
+{{tp|p=34296992|t=2021. SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA.|pdf=|usr=028}}
+{{tp|p=34324704|t=2021. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1.|pdf=|usr=028}}
+{{tp|p=34318976|t=2021. COVID-19 severity, miR-21 targets, and common human genetic variation. Letter regarding the article 'Circulating cardiovascular microRNAs in critically ill COVID-19 patients'.|pdf=|usr=028}}
+{{tp|p=34256840|t=2021. The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization.|pdf=|usr=028}}
+{{tp|p=34228902|t=2021. Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34216102|t=2021. The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes.|pdf=|usr=028}}
+{{tp|p=34307198|t=2021. SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro.|pdf=|usr=028}}
+{{tp|p=34282405|t=2021. Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells.|pdf=|usr=028}}
+{{tp|p=34192318|t=2021. Are sialic acids involved in COVID-19 pathogenesis?|pdf=|usr=028}}
+{{tp|p=34259195|t=2021. A focus on the spread of the delta variant of SARS-CoV-2 in India.|pdf=|usr=028}}
+{{tp|p=34220204|t=2021. Multisystem Inflammatory Syndrome in Children and Adolescents (MIS-C) under the Setting of COVID-19: A Review of Clinical Presentation, Workup and Management.|pdf=|usr=028}}
+{{tp|p=34191907|t=2021. Multisystem Inflammatory Syndrome in an Adult With COVID-19.|pdf=|usr=028}}
+{{tp|p=34213733|t=2021. IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34324165|t=2021. Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?|pdf=|usr=028}}
+{{tp|p=34233864|t=2021. MCP-1: Function, regulation, and involvement in disease.|pdf=|usr=028}}
+{{tp|p=34284045|t=2021. SARS-CoV-2-infected primary human airway epithelia illustrate mucus hypersecretion.|pdf=|usr=028}}
+{{tp|p=34224783|t=2021. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C).|pdf=|usr=028}}
+{{tp|p=34309742|t=2021. Neutralizing Anti-interferon-gamma Autoantibodies: an Ameliorating Factor in COVID-19 Infection?|pdf=|usr=028}}
+{{tp|p=34273064|t=2021. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study.|pdf=|usr=028}}
+{{tp|p=34196300|t=2021. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes.|pdf=|usr=028}}
+{{tp|p=34202613|t=2021. The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review.|pdf=|usr=028}}
+{{tp|p=34205655|t=2021. Carboxyhemoglobinemia in Critically Ill Coronavirus Disease 2019 Patients.|pdf=|usr=028}}
+{{tp|p=34203844|t=2021. SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence.|pdf=|usr=028}}
+{{tp|p=34188786|t=2021. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies.|pdf=|usr=028}}
+{{tp|p=34216637|t=2021. A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.|pdf=|usr=028}}
+{{tp|p=34329674|t=2021. Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 - April 2021.|pdf=|usr=028}}
+{{tp|p=34324939|t=2021. Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays.|pdf=|usr=028}}
+{{tp|p=34320390|t=2021. Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected.|pdf=|usr=028}}
+{{tp|p=34237342|t=2021. Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated health care worker in Italy.|pdf=|usr=028}}
+{{tp|p=34274361|t=2021. Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?|pdf=|usr=028}}
+{{tp|p=34241906|t=2021. Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins.|pdf=|usr=028}}
+{{tp|p=34232521|t=2021. N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.|pdf=|usr=028}}
+{{tp|p=34228322|t=2021. Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients.|pdf=|usr=028}}
+{{tp|p=34193239|t=2021. COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively.|pdf=|usr=028}}
+{{tp|p=34274504|t=2021. Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2-Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology.|pdf=|usr=028}}
+{{tp|p=34283810|t=2021. CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2-infected patients.|pdf=|usr=028}}
+{{tp|p=34291736|t=2021. L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus.|pdf=|usr=028}}
+{{tp|p=34251356|t=2021. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.|pdf=|usr=028}}
+{{tp|p=34265359|t=2021. Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2.|pdf=|usr=028}}
+{{tp|p=34197809|t=2021. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.|pdf=|usr=028}}
+{{tp|p=34198454|t=2021. Track the dynamical features for mutant variants of COVID-19 in the UK.|pdf=|usr=028}}
+{{tp|p=34311587|t=2021. B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies.|pdf=|usr=028}}
+{{tp|p=34311586|t=2021. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.|pdf=|usr=028}}
+{{tp|p=34311574|t=2021. Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect In Vivo in a Mouse Model in a Neutralization-Dependent Manner.|pdf=|usr=028}}
+{{tp|p=34281387|t=2021. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.|pdf=|usr=028}}
+{{tp|p=34225491|t=2021. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.|pdf=|usr=028}}
+{{tp|p=34225487|t=2021. Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.|pdf=|usr=028}}
+{{tp|p=34291385|t=2021. Computational predictions for protein sequences of COVID-19 virus via machine learning algorithms.|pdf=|usr=028}}
+{{tp|p=34199617|t=2021. The Emergence of SARS-CoV-2 Variant(s) and Its Impact on the Prevalence of COVID-19 Cases in the Nabatieh Region, Lebanon.|pdf=|usr=028}}
+{{tp|p=34199203|t=2021. Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19.|pdf=|usr=028}}
+{{tp|p=34254825|t=2021. RNA-Protein Interaction Analysis of SARS-CoV-2 5' and 3' Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection.|pdf=|usr=028}}
+{{tp|p=34221400|t=2021. Differential alterations in peripheral lymphocyte subsets in COVID-19 patients: upregulation of double-positive and double-negative T cells.|pdf=|usr=028}}
+{{tp|p=34289274|t=2021. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.|pdf=|usr=028}}
+{{tp|p=34233096|t=2021. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.|pdf=|usr=028}}
+{{tp|p=34218651|t=2021. Review of the early reports of the epidemiological characteristics of the B.1.1.7 variant of SARS-CoV-2 and its spread worldwide.|pdf=|usr=028}}
+{{tp|p=34270608|t=2021. Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.|pdf=|usr=028}}
+{{tp|p=34270576|t=2021. Is increased mortality by multiple exposures to COVID-19 an overseen factor when aiming for herd immunity?|pdf=|usr=028}}
+{{tp|p=34242356|t=2021. Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.|pdf=|usr=028}}
+{{tp|p=34279520|t=2021. SARS-CoV-2 Variants in Rhode Island.|pdf=|usr=028}}
+{{tp|p=34246424|t=2021. Clinical and radiological findings for the new multisystem inflammatory syndrome in children associated with COVID-19.|pdf=|usr=028}}
+{{tp|p=34231777|t=2021. SARS-CoV-2 nucleic acid shedding is variable for every person.|pdf=|usr=028}}
+{{tp|p=34273991|t=2021. Estimating COVID-19 cases infected with the variant alpha (VOC 202012/01): an analysis of screening data in Tokyo, January-March 2021.|pdf=|usr=028}}
+{{tp|p=34211709|t=2021. The emerging SARS-CoV-2 variants of concern.|pdf=|usr=028}}
+{{tp|p=34405795|t=2021. Inpatient Occupational Therapy Management for a Pediatric Patient With COVID-19 and Multisystem Inflammatory Syndrome in Children: A Case Report.|pdf=|usr=028}}
+{{tp|p=34212497|t=2021. Humoral response to SARS-CoV-2 is well preserved and symptom dependent in kidney transplant recipients.|pdf=|usr=028}}
+{{tp|p=34382433|t=2021. Multi-System Inflammatory Syndrome Presenting as Non-Specific Colitis: A Medical Diagnosis with a Surgical Presentation.|pdf=|usr=028}}
+{{tp|p=34193457|t=2021. How long does covid-19 immunity last?|pdf=|usr=028}}
+{{tp|p=34254909|t=2021. COVID-19 candidate genes and pathways potentially share the association with lung cancer.|pdf=|usr=028}}
+{{tp|p=34298578|t=2021. Determination of Factors to Distinguish MIS-C from Acute Appendicitis in Children with Acute Abdominal Pain.|pdf=|usr=028}}
+{{tp|p=34227076|t=2021. Evolving biothreat of variant SARS-CoV-2 - molecular properties, virulence and epidemiology.|pdf=|usr=028}}
+{{tp|p=34286505|t=2021. Immunohistochemical findings in the lungs of COVID-19 subjects: evidence of surfactant dysregulation.|pdf=|usr=028}}
+{{tp|p=34297037|t=2021. Epigenetic and transcriptional control of interferon-beta.|pdf=|usr=028}}
+{{tp|p=34217595|t=2021. The 'cytokine storm': molecular mechanisms and therapeutic prospects.|pdf=|usr=028}}
+{{tp|p=34297627|t=2021. Pathogenesis of Coronaviruses Through Human Monocytes and Tissue Macrophages.|pdf=|usr=028}}
+{{tp|p=34285445|t=2020. COULD COVID-19 BE A HEMOGLOBINOPATHY?|pdf=|usr=028}}
+{{tp|p=34347313|t=2021. Virus antibodies after SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34331326|t=2021. Multi-inflammatory syndrome and Kawasaki disease in children during the COVID-19 pandemic: A nationwide register-based study and time series analysis.|pdf=|usr=028}}
+{{tp|p=34265136|t=2021. SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population.|pdf=|usr=028}}
+{{tp|p=34228876|t=2021. Relation between ORF8a and the mitochondrial protein TOM70 in SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34430865|t=2021. Lymphopenia and IgG2 subclass deficiency in patients with severe COVID-19 pneumonia.|pdf=|usr=028}}
+{{tp|p=34334284|t=2021. Emergency department levels of NT-proBNP and inotropic/vasoactive support in multi-inflammatory syndrome in children (MIS-C).|pdf=|usr=028}}
+{{tp|p=34358389|t=2021. Decline in Sars-CoV-2 antibodies over 6-month follow-up in obstetrical healthcare workers.|pdf=|usr=028}}
+{{tp|p=34407240|t=2021. Molecular mimicry between SARS-CoV-2 and the female reproductive system.|pdf=|usr=028}}
+{{tp|p=34230709|t=2021. Magnetization Transfer to Enhance NOE Cross-Peaks among Labile Protons: Applications to Imino-Imino Sequential Walks in SARS-CoV-2-Derived RNAs.|pdf=|usr=028}}
+{{tp|p=34352377|t=2021. Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies.|pdf=|usr=028}}
+{{tp|p=34244164|t=2021. Differentiating multisystem inflammatory syndrome in children: a single-centre retrospective cohort study.|pdf=|usr=028}}
+{{tp|p=34313714|t=2021. Plasma Levels of Glycohydrolase Activities in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients.|pdf=|usr=028}}
+{{tp|p=34219981|t=2021. SARS-CoV-2 Nsp1: Ein kleines Protein blockiert die Immunantwort.|pdf=|usr=028}}
+{{tp|p=34315173|t=2021. Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets.|pdf=|usr=028}}
+{{tp|p=34258762|t=2021. Analysis of T-cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain-like lesions during the COVID-19 pandemic.|pdf=|usr=028}}
+{{tp|p=34278987|t=2021. Kawasaki disease shock syndrome in the COVID-19 pandemic.|pdf=|usr=028}}
+{{tp|p=34261560|t=2021. Cardiac implications of multisystem inflammatory syndrome associated with COVID-19 in children under the age of 5 years.|pdf=|usr=028}}
+{{tp|p=34237283|t=2021. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects.|pdf=|usr=028}}
+{{tp|p=34297909|t=2021. Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome.|pdf=|usr=028}}
+{{tp|p=34250512|t=2021. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.|pdf=|usr=028}}
+{{tp|p=34293929|t=2021. SARS-CoV-2 Initiates Programmed Cell Death in Platelets.|pdf=|usr=028}}
+{{tp|p=34238021|t=2021. Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19.|pdf=|usr=028}}
+{{tp|p=34208057|t=2021. Case Series of Multisystem Inflammatory Syndrome (MIS-C) in Children during the SARS-CoV-2 Pandemic in Latvia.|pdf=|usr=028}}
+{{tp|p=34257967|t=2021. SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.|pdf=|usr=028}}
+{{tp|p=34281966|t=2021. Achieving and sustaining herd immunity to SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34253551|t=2021. Alpha, Beta, Delta, Gamma: What's important to know about SARS-CoV-2 variants of concern?|pdf=|usr=028}}
+{{tp|p=34250324|t=2021. Silent hypoxia in COVID-19: a gut microbiota connection.|pdf=|usr=028}}
+{{tp|p=34264880|t=2021. Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate.|pdf=|usr=028}}
+{{tp|p=34189489|t=2021. SARS-CoV-2 NSP1 C-terminal (residues 131-180) is an intrinsically disordered region in isolation.|pdf=|usr=028}}
+{{tp|p=34216296|t=2021. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.|pdf=|usr=028}}
+{{tp|p=34242899|t=2021. Between immunomodulation and immunotolerance: The role of IFNgamma in SARS-CoV-2 disease.|pdf=|usr=028}}
+{{tp|p=34441178|t=2021. Entropy and Fractal Dimension Study of the TDP-43 Protein Low Complexity Domain Sequence in ALS Disease Severity and SARS-CoV-2 Gene Sequences in Virulence Variability.|pdf=|usr=028}}
+{{tp|p=34383213|t=2021. Deciphering epigenetic(s) role in modulating susceptibility to and severity of COVID-19 infection and/or outcome: a systematic rapid review.|pdf=|usr=028}}
+{{tp|p=34375814|t=2021. Modeling the population effects of escape mutations in SARS-CoV-2 to guide vaccination strategies.|pdf=|usr=028}}
+{{tp|p=34412446|t=2021. Herd immunity: challenges and the way forward in Korea.|pdf=|usr=028}}
+{{tp|p=34255566|t=2021. Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C).|pdf=|usr=028}}
+{{tp|p=34253862|t=2021. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms.|pdf=|usr=028}}
+{{tp|p=34324734|t=2021. Dimethyl sulfoxide reduces the stability but enhances catalytic activity of the main SARS-CoV-2 protease 3CLpro.|pdf=|usr=028}}
+{{tp|p=34222140|t=2021. Similarities and Differences Between COVID-19-Related Multisystem Inflammatory Syndrome in Children and Kawasaki Disease.|pdf=|usr=028}}
+{{tp|p=34194534|t=2021. V483A: an emerging mutation hotspot of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34219999|t=2021. Notable and Emerging Variants of SARS-CoV-2 Virus: A Quick Glance.|pdf=|usr=028}}
+{{tp|p=34269987|t=2021. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 Infection.|pdf=|usr=028}}
+{{tp|p=34286362|t=2021. SARS-CoV-2 and pathological matrix remodeling mediators.|pdf=|usr=028}}
+{{tp|p=34241783|t=2021. SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism.|pdf=|usr=028}}
+{{tp|p=34264010|t=2021. Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.|pdf=|usr=028}}
+{{tp|p=34307830|t=2021. In-Silico analysis reveals lower transcription efficiency of C241T variant of SARS-CoV-2 with host replication factors MADP1 and hnRNP-1.|pdf=|usr=028}}
+{{tp|p=34289645|t=2021. Letter to editor: Alimentary system is directly attacked by SARS-COV-2 and further prevents immune dysregulation caused by COVID-19.|pdf=|usr=028}}
+{{tp|p=34195921|t=2021. High anti-SARS-CoV-2 antibody seroprevalence in healthcare workers in an Irish university teaching hospital.|pdf=|usr=028}}
+{{tp|p=34237902|t=2021. Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2.|pdf=|usr=028}}
+{{tp|p=34237894|t=2021. Reply to Hayashi and Konishi: Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between virus and ACE2.|pdf=|usr=028}}
+{{tp|p=34237302|t=2021. Recombinant SARS-CoV-2 envelope protein traffics to the trans-Golgi network following amphipol-mediated delivery into human cells.|pdf=|usr=028}}
+{{tp|p=34270181|t=2021. What is Currently Known About the SARS-CoV2 Variants of Concern.|pdf=|usr=028}}
+{{tp|p=34238684|t=2021. Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19.|pdf=|usr=028}}
+{{tp|p=34252180|t=2021. Surviving older patients show preserved cellular and humoral immunological memory several months after SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34273592|t=2021. Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility.|pdf=|usr=028}}
+{{tp|p=34327751|t=2021. Cardiac Magnetic Resonance Follow-Up of Children After Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 With Initial Cardiac Involvement.|pdf=|usr=028}}
+{{tp|p=34288064|t=2021. A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34248441|t=2021. Multisystem Inflammatory Syndrome in Children.|pdf=|usr=028}}
+{{tp|p=34203982|t=2021. Severe COVID-19 in Hospitalized Carriers of Single CFTR Pathogenic Variants.|pdf=|usr=028}}
+{{tp|p=34225749|t=2021. HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease.|pdf=|usr=028}}
+{{tp|p=34260266|t=2021. SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway.|pdf=|usr=028}}
+{{tp|p=34228642|t=2021. Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents.|pdf=|usr=028}}
+{{tp|p=34265238|t=2021. Lifting of COVID-19 restrictions in the UK and the Delta variant.|pdf=|usr=028}}
+{{tp|p=34204549|t=2021. The Role of Coronavirus RNA-Processing Enzymes in Innate Immune Evasion.|pdf=|usr=028}}
+{{tp|p=34239770|t=2021. Multisystem Inflammatory Syndrome in Adults (MIS-A) Associated with SARS-CoV-2 Infection in a Young Adult Case from Turkey.|pdf=|usr=028}}
+{{tp|p=34208136|t=2021. NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases.|pdf=|usr=028}}
+{{tp|p=34264910|t=2021. SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility - Oklahoma, April-May 2021.|pdf=|usr=028}}
+{{tp|p=34280038|t=2021. Traces of SARS-CoV-2 RNA in Peripheral Blood Cells of Patients with COVID-19.|pdf=|usr=028}}
+{{tp|p=34322566|t=2021. Systemic Inflammation and Microbial Translocation Are Characteristic Features of SARS-CoV-2-Related Multisystem Inflammatory Syndrome in Children.|pdf=|usr=028}}
+{{tp|p=34322559|t=2021. CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants.|pdf=|usr=028}}
+{{tp|p=34295945|t=2021. Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection.|pdf=|usr=028}}
+{{tp|p=34295944|t=2021. SARS-CoV-2 Subgenomic RNA Kinetics in Longitudinal Clinical Samples.|pdf=|usr=028}}
+{{tp|p=34306718|t=2021. Orchiepididymitis in the context of multisystem inflammatory syndrome in a child with Covid-19 from Syria: a very rare presentation for SARS-Cov-19 in children.|pdf=|usr=028}}
+{{tp|p=34192268|t=2020. Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.|pdf=|usr=028}}
+{{tp|p=34192267|t=2020. Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.|pdf=|usr=028}}
+{{tp|p=34187503|t=2021. Intravenous administration of anakinra in children with macrophage activation syndrome.|pdf=|usr=028}}
+{{tp|p=34315200|t=2021. Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review.|pdf=|usr=028}}
+{{tp|p=34228753|t=2021. Characterization of low-density granulocytes in COVID-19.|pdf=|usr=028}}
+{{tp|p=34292871|t=2021. Ongoing global and regional adaptive evolution of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34231823|t=2021. Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.|pdf=|usr=028}}
+{{tp|p=34191369|t=2021. Persistence of humoral response upon SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34260780|t=2021. A systematic meta-analysis of immune signatures in patients with COVID-19.|pdf=|usr=028}}
+{{tp|p=34305429|t=2021. Relevance between COVID-19 and host genetics of immune response.|pdf=|usr=028}}
+{{tp|p=34234112|t=2021. The signal pathways and treatment of cytokine storm in COVID-19.|pdf=|usr=028}}
+{{tp|p=34234102|t=2021. SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.|pdf=|usr=028}}
+{{tp|p=34315848|t=2021. Assessment of infectivity and the impact on neutralizing activity of immune sera of the COVID-19 variant, CAL.20C.|pdf=|usr=028}}
+{{tp|p=34315847|t=2021. N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding.|pdf=|usr=028}}
+{{tp|p=34253708|t=2021. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction.|pdf=|usr=028}}
+{{tp|p=34315677|t=2021. Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors.|pdf=|usr=028}}
+{{tp|p=34230895|t=2021. Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing.|pdf=|usr=028}}
+{{tp|p=34274029|t=2021. Reverse Transcription Polymerase Chain Reaction Pattern of SARS-CoV-2 Beta Variant.|pdf=|usr=028}}
+{{tp|p=34383706|t=2021. Alpha variant (B.1.1.7) of SARS-CoV-2 increases fatality-rate for patients under age of 70 years and hospitalization risk overall.|pdf=|usr=028}}
+{{tp|p=34432905|t=2021. Incidence rate of MIS-C in paediatrics: A good reason to vaccinate children against SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34279831|t=2021. Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known?|pdf=|usr=028}}
+{{tp|p=34418362|t=2021. The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives.|pdf=|usr=028}}
+{{tp|p=34413034|t=2021. Sudden cardiac death in a young boy with multisystemic inflammatory syndrome in children (MISC).|pdf=|usr=028}}
+{{tp|p=34213849|t=2021. Structure-function relations of the SARS-CoV-2 spike protein and impact of mutations in the variants of concern.|pdf=|usr=028}}
+{{tp|p=34213846|t=2021. Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.|pdf=|usr=028}}
+{{tp|p=34213845|t=2021. COVID-19: individual and herd immunity.|pdf=|usr=028}}
+{{tp|p=34265244|t=2021. The devil in the details: Herd immunity and pandemic response.|pdf=|usr=028}}
+{{tp|p=34251316|t=2021. SARS-CoV-2 infection may not be a prerequisite for developing multisystem inflammatory syndrome in children.|pdf=|usr=028}}
+{{tp|p=34259663|t=2021. Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis.|pdf=|usr=028}}
+{{tp|p=34269657|t=2021. The role of PCSK9 in infectious diseases.|pdf=|usr=028}}
+{{tp|p=34189878|t=2021. COVID 19 in India: Waves, Variants of Concern, Airborne Transmission.|pdf=|usr=028}}
+{{tp|p=34233453|t=2021. Viral shedding in symptomatic patients with mild COVID-19: an experience with nebulized nasal treatment.|pdf=|usr=028}}
+{{tp|p=34229570|t=2021. Comparative analysis of SARS-CoV-2 envelope viroporin mutations from COVID-19 deceased and surviving patients revealed implications on its ion-channel activities and correlation with patient mortality.|pdf=|usr=028}}
+{{tp|p=34323931|t=2021. Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19.|pdf=|usr=028}}
+{{tp|p=34287999|t=2021. Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG-I-like receptors.|pdf=|usr=028}}
+{{tp|p=34266903|t=2021. Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.|pdf=|usr=028}}
+{{tp|p=34225390|t=2021. Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1.|pdf=|usr=028}}
+{{tp|p=34190914|t=2021. Sindrome inflamatorio multisistemico pediatrico asociado a COVID-19: reporte preliminar de un hospital del Peru.|pdf=|usr=028}}
+{{tp|p=34425281|t=2021. Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion.|pdf=|usr=028}}
+{{tp|p=34336288|t=2021. Coronavirus Disease 2019-Related Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis.|pdf=|usr=028}}
+{{tp|p=34351418|t=2021. Host ADP-ribosylation and the SARS-CoV-2 macrodomain.|pdf=|usr=028}}
+{{tp|p=34461258|t=2021. SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling.|pdf=|usr=028}}
+{{tp|p=34364043|t=2021. Interleukin-17A (IL-17A): A silent amplifier of COVID-19.|pdf=|usr=028}}
+{{tp|p=34356872|t=2021. Different Within-Host Viral Evolution Dynamics in Severely Immunosuppressed Cases with Persistent SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34440241|t=2021. Structural Dissection of Viral Spike-Protein Binding of SARS-CoV-2 and SARS-CoV-1 to the Human Angiotensin-Converting Enzyme 2 (ACE2) as Cellular Receptor.|pdf=|usr=028}}
+{{tp|p=34453696|t=2021. (1)H, (13)C and (15)N assignment of stem-loop SL1 from the 5'-UTR of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34439792|t=2021. Relevance of BET Family Proteins in SARS-CoV-2 Infection.|pdf=|usr=028}}
+{{tp|p=34439910|t=2021. Molecular Dynamics Simulation Study of the Interaction between Human Angiotensin Converting Enzyme 2 and Spike Protein Receptor Binding Domain of the SARS-CoV-2 B.1.617 Variant.|pdf=|usr=028}}
+{{tp|p=34439887|t=2021. HMGB1-TIM3-HO1: A New Pathway of Inflammation in Skin of SARS-CoV-2 Patients? A Retrospective Pilot Study.|pdf=|usr=028}}
+{{tp|p=34439868|t=2021. Cytokine Storms in the Course of COVID-19 and Haemophagocytic Lymphohistiocytosis in Pregnant and Postpartum Women.|pdf=|usr=028}}
+{{tp|p=34349042|t=2021. Green-blue intracytoplasmic inclusions in the bone marrow in severe COVID-19.|pdf=|usr=028}}
+{{tp|p=34388982|t=2021. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.|pdf=|usr=028}}
+{{tp|p=34373240|t=2021. Severe acute inflammatory myositis and rhabdomyolysis in paediatric SARS-CoV-2-associated MIS-C (multisystem inflammatory syndrome in children).|pdf=|usr=028}}
+{{tp|p=34380685|t=2021. Transient acetylcholine receptor-related myasthenia gravis, post multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19 infection.|pdf=|usr=028}}
+{{tp|p=34351888|t=2021. Lactante criticamente enfermo con sindrome inflamatorio multisistemico relacionado con COVID-19.|pdf=|usr=028}}
+{{tp|p=34392826|t=2021. Sustained seroprevalence of SARS-CoV-2 antibodies one year after infection: one of the first COVID-19 cluster cases in Bosnia and Herzegovina.|pdf=|usr=028}}
+{{tp|p=34428473|t=2021. The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines.|pdf=|usr=028}}
+{{tp|p=34382087|t=2021. Data-driven identification of SARS-CoV-2 subpopulations using PhenoGraph and binary-coded genomic data.|pdf=|usr=028}}
+{{tp|p=34421386|t=2021. Epidemiologic and clinical characteristics of multisystem inflammatory syndrome in adults: a rapid review.|pdf=|usr=028}}
+{{tp|p=34385216|t=2021. Le syndrome inflammatoire multisystemique post-COVID-19 chez les enfants.|pdf=|usr=028}}
+{{tp|p=34385205|t=2021. Post-COVID-19 multisystem inflammatory syndrome in children.|pdf=|usr=028}}
+{{tp|p=34367385|t=2021. The Relationship between Pre-Pandemic Interferon Gamma Release Assay Test Results and COVID-19 Infection: Potential Prognostic Value of Indeterminate IFN-gamma Release Assay Results.|pdf=|usr=028}}
+{{tp|p=34386717|t=2021. Salivary markers and coronavirus disease 2019: insights from cross-talk between the oral microbiome and pulmonary and systemic low-grade inflammation and implications for vascular complications.|pdf=|usr=028}}
+{{tp|p=34352228|t=2021. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.|pdf=|usr=028}}
+{{tp|p=34332650|t=2021. Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike.|pdf=|usr=028}}
+{{tp|p=34351662|t=2021. Role of hemagglutinin-esterase protein in SARS-CoV-2 infection?|pdf=|usr=028}}
+{{tp|p=34389814|t=2021. SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse.|pdf=|usr=028}}
+{{tp|p=34385425|t=2021. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.|pdf=|usr=028}}
+{{tp|p=34429403|t=2021. Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells.|pdf=|usr=028}}
+{{tp|p=34400613|t=2021. Molecular determinants for regulation of G3BP1/2 phase separation by the SARS-CoV-2 nucleocapsid protein.|pdf=|usr=028}}
+{{tp|p=34426672|t=2021. Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.|pdf=|usr=028}}
+{{tp|p=34413488|t=2021. Activation or exhaustion of CD8(+) T cells in patients with COVID-19.|pdf=|usr=028}}
+{{tp|p=34433083|t=2021. The nucleotide addition cycle of the SARS-CoV-2 polymerase.|pdf=|usr=028}}
+{{tp|p=34416153|t=2021. One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening.|pdf=|usr=028}}
+{{tp|p=34380018|t=2021. No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing.|pdf=|usr=028}}
+{{tp|p=34358460|t=2021. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.|pdf=|usr=028}}
+{{tp|p=34341488|t=2021. O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an "O-Follow-N" rule.|pdf=|usr=028}}
+{{tp|p=34438017|t=2021. A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder.|pdf=|usr=028}}
+{{tp|p=34359986|t=2021. Role of Multifunctional Cytoskeletal Filaments in Coronaviridae Infections: Therapeutic Opportunities for COVID-19 in a Nutshell.|pdf=|usr=028}}
+{{tp|p=34359983|t=2021. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.|pdf=|usr=028}}
+{{tp|p=34359957|t=2021. MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women.|pdf=|usr=028}}
+{{tp|p=34359932|t=2021. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.|pdf=|usr=028}}
+{{tp|p=34359931|t=2021. Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells.|pdf=|usr=028}}
+{{tp|p=34440791|t=2021. The Molecular Interplay between Human Coronaviruses and Autophagy.|pdf=|usr=028}}
+{{tp|p=34440767|t=2021. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection.|pdf=|usr=028}}
+{{tp|p=34440765|t=2021. Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses.|pdf=|usr=028}}
+{{tp|p=34440903|t=2021. Implications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections.|pdf=|usr=028}}
+{{tp|p=34440879|t=2021. Expansion of Myeloid Derived Suppressor Cells Contributes to Platelet Activation by L-Arginine Deprivation during SARS-CoV-2 Infection.|pdf=|usr=028}}
+{{tp|p=34440816|t=2021. Secretory Vesicles Are the Principal Means of SARS-CoV-2 Egress.|pdf=|usr=028}}
+{{tp|p=34356552|t=2021. Neonatal Multisystem Inflammatory Syndrome (MIS-N) Associated with Prenatal Maternal SARS-CoV-2: A Case Series.|pdf=|usr=028}}
+{{tp|p=34438603|t=2021. MIS-C-Implications for the Pediatric Surgeon: An Algorithm for Differential Diagnostic Considerations.|pdf=|usr=028}}
+{{tp|p=34353002|t=2021. Clinical spectrum and short-term outcomes of multisystem inflammatory syndrome in children in a south Indian hospital.|pdf=|usr=028}}
+{{tp|p=34343708|t=2021. Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34458720|t=2021. Multisystem inflammatory syndrome in adults following COVID-19 infection: A case report presenting with colitis.|pdf=|usr=028}}
+{{tp|p=34391929|t=2021. Mucosal immunity to SARS-CoV-2: a clinically relevant key to deciphering natural and vaccine-induced defences.|pdf=|usr=028}}
+{{tp|p=34455390|t=2021. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.|pdf=|usr=028}}
+{{tp|p=34419923|t=2021. Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19.|pdf=|usr=028}}
+{{tp|p=34392145|t=2021. High throughput diagnostics and dynamic risk assessment of SARS-CoV-2 variants of concern.|pdf=|usr=028}}
+{{tp|p=34401689|t=2021. Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England.|pdf=|usr=028}}
+{{tp|p=34350827|t=2021. Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy.|pdf=|usr=028}}
+{{tp|p=34435953|t=2021. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.|pdf=|usr=028}}
+{{tp|p=34424199|t=2021. Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia.|pdf=|usr=028}}
+{{tp|p=34414888|t=2021. SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19.|pdf=|usr=028}}
+{{tp|p=34414884|t=2021. N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2.|pdf=|usr=028}}
+{{tp|p=34402426|t=2021. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.|pdf=|usr=028}}
+{{tp|p=34387545|t=2021. Patterns of within-host genetic diversity in SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34375000|t=2021. Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites.|pdf=|usr=028}}
+{{tp|p=34352197|t=2021. SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy.|pdf=|usr=028}}
+{{tp|p=34437831|t=2021. Real-Time Genomic Surveillance for SARS-CoV-2 Variants of Concern, Uruguay.|pdf=|usr=028}}
+{{tp|p=34388358|t=2021. Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021.|pdf=|usr=028}}
+{{tp|p=34402744|t=2021. Host-dependent editing of SARS-CoV-2 in COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34396940|t=2021. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.|pdf=|usr=028}}
+{{tp|p=34400021|t=2021. Aparicion de novo de la mutacion E484K en una variante del linaje B.1.1.7 de SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34365657|t=2021. Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice.|pdf=|usr=028}}
+{{tp|p=34339064|t=2021. S100A8 may govern hyper-inflammation in severe COVID-19.|pdf=|usr=028}}
+{{tp|p=34398806|t=2021. Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34355822|t=2021. Walking down the memory lane with SARS-CoV-2 B cells.|pdf=|usr=028}}
+{{tp|p=34382228|t=2021. Sensitive detection of anti-spike antibodies enables improved understanding of SARS-CoV-2 pathogenesis.|pdf=|usr=028}}
+{{tp|p=34446125|t=2021. Early detection of the SARS-CoV-2 P.1 variant in Rio Grande do Sul, Brazil: a case report.|pdf=|usr=028}}
+{{tp|p=34414454|t=2021. MicroRNA283p inhibits angiotensinconverting enzyme 2 ectodomain shedding in 293T cells treated with the spike protein of severe acute respiratory syndrome coronavirus 2 by targeting A disintegrin and metalloproteinase 17.|pdf=|usr=028}}
+{{tp|p=34346720|t=2021. Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients.|pdf=|usr=028}}
+{{tp|p=34379531|t=2021. Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants.|pdf=|usr=028}}
+{{tp|p=34379530|t=2021. The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery.|pdf=|usr=028}}
+{{tp|p=34428777|t=2021. Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York.|pdf=|usr=028}}
+{{tp|p=34332518|t=2021. Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows.|pdf=|usr=028}}
+{{tp|p=34414796|t=2021. Henoch-Schonlein Purpura in a COVID-19-Positive Child With Abdominal Pain and PIMS-TS.|pdf=|usr=028}}
+{{tp|p=34417262|t=2021. LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes.|pdf=|usr=028}}
+{{tp|p=34424997|t=2021. SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector function.|pdf=|usr=028}}
+{{tp|p=34355378|t=2021. Alterations in lymphocyte subsets and monocytes in patients diagnosed with SARS-CoV-2 pneumonia: a mini review of the literature.|pdf=|usr=028}}
+{{tp|p=34341181|t=2021. Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection.|pdf=|usr=028}}
+{{tp|p=34338591|t=2021. Evolving ribonucleocapsid assembly/packaging signals in the genomes of the human and animal coronaviruses: targeting, transmission and evolution.|pdf=|usr=028}}
+{{tp|p=34371513|t=2021. Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection and Escherichia coli Sepsis: The Role of Procalcitonin for Differential Diagnosis.|pdf=|usr=028}}
+{{tp|p=34346865|t=2021. Memoire immunitaire contre le SARS-CoV-2 - Des anticorps contre l'infection initiale et des lymphocytes B a memoire contre les infections futures.|pdf=|usr=028}}
+{{tp|p=34346864|t=2021. Par ici la sortie ! Le SARS-CoV-2 utilise les lysosomes pour sortir de la cellule infectee.|pdf=|usr=028}}
+{{tp|p=34347959|t=2021. SARS-CoV-2 Variants in Patients with Immunosuppression.|pdf=|usr=028}}
+{{tp|p=34407350|t=2021. Audio Interview: Aspects of Covid-19 Immunity.|pdf=|usr=028}}
+{{tp|p=34376850|t=2021. The lag in SARS-CoV-2 genome submissions to GISAID.|pdf=|usr=028}}
+{{tp|p=34408314|t=2021. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children.|pdf=|usr=028}}
+{{tp|p=34413500|t=2021. A glycan gate controls opening of the SARS-CoV-2 spike protein.|pdf=|usr=028}}
+{{tp|p=34363044|t=2021. Coronavirus footprints.|pdf=|usr=028}}
+{{tp|p=34426697|t=2021. Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genome.|pdf=|usr=028}}
+{{tp|p=34385690|t=2021. Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function.|pdf=|usr=028}}
+{{tp|p=34373640|t=2021. Remember Beta? New data reveal variant's deadly powers.|pdf=|usr=028}}
+{{tp|p=34413530|t=2021. Delta's rise is fuelled by rampant spread from people who feel fine.|pdf=|usr=028}}
+{{tp|p=34413527|t=2021. COVID vaccines protect against Delta, but their effectiveness wanes.|pdf=|usr=028}}
+{{tp|p=34417582|t=2021. The mutation that helps Delta spread like wildfire.|pdf=|usr=028}}
+{{tp|p=34385613|t=2021. How do vaccinated people spread Delta? What the science says.|pdf=|usr=028}}
+{{tp|p=34354278|t=2021. Delta threatens rural regions that dodged earlier COVID waves.|pdf=|usr=028}}
+{{tp|p=34363057|t=2020. Daily briefing: The wildly complicated immune response to COVID-19.|pdf=|usr=028}}
+{{tp|p=34346604|t=2021. Covid-19-geassocieerde 'multisystem inflammatory syndrome'.|pdf=|usr=028}}
+{{tp|p=34423834|t=2021. Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta).|pdf=|usr=028}}
+{{tp|p=34389636|t=2021. Secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality.|pdf=|usr=028}}
+{{tp|p=34384361|t=2021. Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants.|pdf=|usr=028}}
+{{tp|p=34391590|t=2021. Conversations With the Editors: The Emergence of Variants Amid Population-Wide SARS-CoV-2 Vaccination Efforts: How Much Should We Worry?|pdf=|usr=028}}
+{{tp|p=34429968|t=2021. Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34336207|t=2021. Decline in neutralising antibody responses, but sustained T-cell immunity, in COVID-19 patients at 7 months post-infection.|pdf=|usr=028}}
+{{tp|p=34345007|t=2021. Identification, mapping and relative quantitation of SARS-CoV-2 Spike glycopeptides by Mass-Retention Time Fingerprinting.|pdf=|usr=028}}
+{{tp|p=34429502|t=2021. The structure of a dimeric form of SARS-CoV-2 polymerase.|pdf=|usr=028}}
+{{tp|p=34346317|t=2021. Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach.|pdf=|usr=028}}
+{{tp|p=34336146|t=2021. Binding affinity and mechanisms of SARS-CoV-2 variants.|pdf=|usr=028}}
+{{tp|p=34336145|t=2021. Immune evasion of SARS-CoV-2 from interferon antiviral system.|pdf=|usr=028}}
+{{tp|p=34395179|t=2021. SARS-CoV spike proteins can compete for electrolytes in physiological fluids according to structure-based quantum-chemical calculations.|pdf=|usr=028}}
+{{tp|p=34336449|t=2021. Roles and Interplay of SARS-CoV-2 Serology With Clinical Stages of Disease in COVID-19.|pdf=|usr=028}}
+{{tp|p=34336414|t=2021. Acute Appendicitis Associated With Multisystem Inflammatory Syndrome in Children.|pdf=|usr=028}}
+{{tp|p=34422477|t=2021. Case Series of Clinical Findings of Multi-System Inflammatory Syndrome in Children in Contrast to Kawasaki Disease.|pdf=|usr=028}}
+{{tp|p=34454352|t=2021. Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?|pdf=|usr=028}}
+{{tp|p=34383898|t=2021. Comparison of cardiac computed tomography findings of Kawasaki disease and post-COVID-19 coronary aneurysms.|pdf=|usr=028}}
+{{tp|p=34333764|t=2021. Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing.|pdf=|usr=028}}
+{{tp|p=34425479|t=2021. Acute encephalitis in pediatric multisystem inflammatory syndrome associated with COVID-19.|pdf=|usr=028}}
+{{tp|p=34447577|t=2021. Variants in SARS-CoV-2 associated with mild or severe outcome.|pdf=|usr=028}}
+{{tp|p=34453107|t=2021. Mutational spectrum of SARS-CoV-2 during the global pandemic.|pdf=|usr=028}}
+{{tp|p=34409597|t=2021. Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination.|pdf=|usr=028}}
+{{tp|p=34409594|t=2021. Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production.|pdf=|usr=028}}
+{{tp|p=34375459|t=2021. A glycosaminoglycan microarray identifies the binding of SARS-CoV-2 spike protein to chondroitin sulfate E.|pdf=|usr=028}}
+{{tp|p=34422917|t=2021. Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19.|pdf=|usr=028}}
+{{tp|p=34386533|t=2021. IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial.|pdf=|usr=028}}
+{{tp|p=34414185|t=2021. N439K Variant in Spike Protein Alter the Infection Efficiency and Antigenicity of SARS-CoV-2 Based on Molecular Dynamics Simulation.|pdf=|usr=028}}
+{{tp|p=34386498|t=2021. ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 Replication.|pdf=|usr=028}}
+{{tp|p=34434902|t=2021. A Computational Approach to Evaluate the Combined Effect of SARS-CoV-2 RBD Mutations and ACE2 Receptor Genetic Variants on Infectivity: The COVID-19 Host-Pathogen Nexus.|pdf=|usr=028}}
+{{tp|p=34368076|t=2021. Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein.|pdf=|usr=028}}
+{{tp|p=34394197|t=2021. poreCov-An Easy to Use, Fast, and Robust Workflow for SARS-CoV-2 Genome Reconstruction via Nanopore Sequencing.|pdf=|usr=028}}
+{{tp|p=34447386|t=2021. Update Advances on C-Reactive Protein in COVID-19 and Other Viral Infections.|pdf=|usr=028}}
+{{tp|p=34447375|t=2021. SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage.|pdf=|usr=028}}
+{{tp|p=34421894|t=2021. Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19.|pdf=|usr=028}}
+{{tp|p=34408749|t=2021. Long Noncoding RNAs as Emerging Regulators of COVID-19.|pdf=|usr=028}}
+{{tp|p=34394120|t=2021. Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients.|pdf=|usr=028}}
+{{tp|p=34394108|t=2021. Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses.|pdf=|usr=028}}
+{{tp|p=34394094|t=2021. Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19.|pdf=|usr=028}}
+{{tp|p=34394090|t=2021. CD169 Defines Activated CD14(+) Monocytes With Enhanced CD8(+) T Cell Activation Capacity.|pdf=|usr=028}}
+{{tp|p=34386006|t=2021. Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography.|pdf=|usr=028}}
+{{tp|p=34367190|t=2021. Monocytes and Macrophages in COVID-19.|pdf=|usr=028}}
+{{tp|p=34367154|t=2021. Gene Expression Meta-Analysis Reveals Interferon-Induced Genes Associated With SARS Infection in Lungs.|pdf=|usr=028}}
+{{tp|p=34354712|t=2021. Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study.|pdf=|usr=028}}
+{{tp|p=34341659|t=2021. Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells.|pdf=|usr=028}}
+{{tp|p=34335624|t=2021. Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19.|pdf=|usr=028}}
+{{tp|p=34335605|t=2021. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals.|pdf=|usr=028}}
+{{tp|p=34335604|t=2021. The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion?|pdf=|usr=028}}
+{{tp|p=34335596|t=2021. Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention.|pdf=|usr=028}}
+{{tp|p=34458281|t=2021. Gut Microbiota Dysbiosis Is a Crucial Player for the Poor Outcomes for COVID-19 in Elderly, Diabetic and Hypertensive Patients.|pdf=|usr=028}}
+{{tp|p=34434945|t=2021. Role of Th22 Cells in Human Viral Diseases.|pdf=|usr=028}}
+{{tp|p=34414199|t=2021. Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide.|pdf=|usr=028}}
+{{tp|p=34336891|t=2021. Antibodies Can Last for More Than 1 Year After SARS-CoV-2 Infection: A Follow-Up Study From Survivors of COVID-19.|pdf=|usr=028}}
+{{tp|p=34394051|t=2021. Genomic Surveillance and Phylodynamic Analyses Reveal the Emergence of Novel Mutations and Co-mutation Patterns Within SARS-CoV-2 Variants Prevalent in India.|pdf=|usr=028}}
+{{tp|p=34394024|t=2021. Profiling of Oral Microbiota and Cytokines in COVID-19 Patients.|pdf=|usr=028}}
+{{tp|p=34367091|t=2021. Hypoxia: The "Invisible Pusher" of Gut Microbiota.|pdf=|usr=028}}
+{{tp|p=34335535|t=2021. Mutations in SARS-CoV-2 ORF8 Altered the Bonding Network With Interferon Regulatory Factor 3 to Evade Host Immune System.|pdf=|usr=028}}
+{{tp|p=34335530|t=2021. Comprehensive Deep Mutational Scanning Reveals the Immune-Escaping Hotspots of SARS-CoV-2 Receptor-Binding Domain Targeting Neutralizing Antibodies.|pdf=|usr=028}}
+{{tp|p=34335504|t=2021. Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes?|pdf=|usr=028}}
+{{tp|p=34386518|t=2021. Non-RBM Mutations Impaired SARS-CoV-2 Spike Protein Regulated to the ACE2 Receptor Based on Molecular Dynamic Simulation.|pdf=|usr=028}}
+{{tp|p=34355020|t=2021. A Validated Mathematical Model of the Cytokine Release Syndrome in Severe COVID-19.|pdf=|usr=028}}
+{{tp|p=34354952|t=2021. Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma.|pdf=|usr=028}}
+{{tp|p=34434905|t=2021. Acute Kidney Injury in Pediatric Acute SARS-CoV-2 Infection and Multisystem Inflammatory Syndrome in Children (MIS-C): Is There a Difference?|pdf=|usr=028}}
+{{tp|p=34422717|t=2021. Case Report: Mitral Valve Involvement and First-Degree Atrial-Ventricular Block in Two Patients With Multisystem Inflammatory Syndrome in Children.|pdf=|usr=028}}
+{{tp|p=34368030|t=2021. Case Report: Changes in Cytokine Kinetics During the Course of Disease in a Japanese Patient With Multisystem Inflammatory Syndrome in Children.|pdf=|usr=028}}
+{{tp|p=34421600|t=2021. NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments.|pdf=|usr=028}}
+{{tp|p=34335279|t=2021. The Role of High-Density Lipoprotein in COVID-19.|pdf=|usr=028}}
+{{tp|p=34413782|t=2021. Rarely Recognized Antibody Diversification in Covid-19 Evolution to Counteract Advanced SARS-CoV-2 Evasion Strategies, and Implications for Prophylactic Treatment.|pdf=|usr=028}}
+{{tp|p=34366882|t=2021. The Role of Innate Immunity and Bioactive Lipid Mediators in COVID-19 and Influenza.|pdf=|usr=028}}
+{{tp|p=34427676|t=2021. Potential Effect of Previous Human Coronavirus NL63 Infection on the Rate of Infection and the Clinical Course of Coronavirus Disease 2019.|pdf=|usr=028}}
+{{tp|p=34427670|t=2021. Critically ill COVID-19 patients exhibit hyperactive cytokine responses associated with effector exhausted senescent T cells in acute infection.|pdf=|usr=028}}
+{{tp|p=34427652|t=2021. SARS-CoV-2 infectivity correlates with high viral loads and detection of viral antigen and is terminated by seroconversion.|pdf=|usr=028}}
+{{tp|p=34423821|t=2021. Joint Estimation Of Generation Time And Incubation Period For Coronavirus Disease (Covid-19).|pdf=|usr=028}}
+{{tp|p=34409999|t=2021. SARS-CoV-2 variant Delta infects all 6 siblings but spares Comirnaty (BNT162b2, BioNTech/Pfizer)-vaccinated parents.|pdf=|usr=028}}
+{{tp|p=34343373|t=2021. Multisystem inflammatory syndrome in children during severe acute respiratory syndrome coronavirus-2 pandemic in Turkey: A single-centre experience.|pdf=|usr=028}}
+{{tp|p=34388280|t=2021. Neonatal Multisystem Inflammatory Syndrome secondary to SARS-CoV-2 infection.|pdf=|usr=028}}
+{{tp|p=34409452|t=2021. Cluster characterization of SARS-CoV-2 in military personnel deployed to Egypt and subsequent introduction of B.1.1.7 and C.36 lineages to Colombia.|pdf=|usr=028}}
+{{tp|p=34452991|t=2021. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1.|pdf=|usr=028}}
+{{tp|p=34433692|t=2021. Profound Treg perturbations correlate with COVID-19 severity.|pdf=|usr=028}}
+{{tp|p=34369011|t=2021. A distinct ssDNA/RNA binding interface in the Nsp9 protein from SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34375467|t=2021. Molecular dynamics analysis of a flexible loop at the binding interface of the SARS-CoV-2 spike protein receptor-binding domain.|pdf=|usr=028}}
+{{tp|p=34376481|t=2021. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.|pdf=|usr=028}}
+{{tp|p=34404118|t=2021. Natural infection of Delta mutant of SARS-CoV-2 in Asiatic lions of India.|pdf=|usr=028}}
+{{tp|p=34348612|t=2021. Role of potential COVID-19 immune system associated genes and the potential pathways linkage with type-2 diabetes.|pdf=|usr=028}}
+{{tp|p=34397331|t=2021. Low pH and temperature of airway surface liquid are key determinants that potentiate SARS-CoV-2 infectivity.|pdf=|usr=028}}
+{{tp|p=34417260|t=2021. SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis.|pdf=|usr=028}}
+{{tp|p=34389625|t=2021. Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8(+) T Cells during Convalescence.|pdf=|usr=028}}
+{{tp|p=34348975|t=2021. Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.|pdf=|usr=028}}
+{{tp|p=34452933|t=2021. Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.|pdf=|usr=028}}
+{{tp|p=34374752|t=2021. Distinct Mitochondria-Mediated T-Cell Apoptosis Responses in Children and Adults With Coronavirus Disease 2019.|pdf=|usr=028}}
+{{tp|p=34340303|t=2021. Why All the Fury over Furin?|pdf=|usr=028}}
+{{tp|p=34375002|t=2021. Viral proteins recognized by different TLRs.|pdf=|usr=028}}
+{{tp|p=34449894|t=2021. SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers.|pdf=|usr=028}}
+{{tp|p=34450642|t=2021. Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera.|pdf=|usr=028}}
+{{tp|p=34459420|t=2021. Multisystem inflammatory syndrome with persistent neutropenia in neonate exposed to SARS-CoV-2 virus: A case report and review of literature.|pdf=|usr=028}}
+{{tp|p=34417772|t=2021. Bilateral Optic Disc Edema in Multisystem Inflammatory Syndrome in Children Associated With COVID-19.|pdf=|usr=028}}
+{{tp|p=34339544|t=2021. Comparison of clinical and laboratory profile of survivors and non-survivors of SARS-CoV-2-related multisystem inflammatory syndrome of childhood in India: An observational study.|pdf=|usr=028}}
+{{tp|p=34414434|t=2021. Updated Management Protocol for Multisystem Inflammatory Syndrome in Children (MIS-C).|pdf=|usr=028}}
+{{tp|p=34392371|t=2021. Mucocutaneous Findings of Multisystem Inflammatory Syndrome in Children: A Single-Center Experience.|pdf=|usr=028}}
+{{tp|p=34406361|t=2021. Confronting the Delta Variant of SARS-CoV-2, Summer 2021.|pdf=|usr=028}}
+{{tp|p=34383043|t=2021. Potential Implications of SARS-CoV-2 Delta Variant Surges for Rural Areas and Hospitals.|pdf=|usr=028}}
+{{tp|p=34387645|t=2021. Variants of SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34459875|t=2021. One-Year Outcomes of Critical Care Patients Post-COVID-19 Multisystem Inflammatory Syndrome in Children.|pdf=|usr=028}}
+{{tp|p=34341310|t=2021. Prevalence of COVID-19 genomic variation in Africa: a living systematic review protocol.|pdf=|usr=028}}
+{{tp|p=34331778|t=2021. Recurrent assessment of lymphocyte subsets in 32 patients with multisystem inflammatory syndrome in children (MIS-C).|pdf=|usr=028}}
+{{tp|p=34385349|t=2021. Deaths in Children and Adolescents Associated With COVID-19 and MIS-C in the United States.|pdf=|usr=028}}
+{{tp|p=34376480|t=2021. Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study.|pdf=|usr=028}}
+{{tp|p=34413221|t=2021. Do chronic infections breed dangerous new variants?|pdf=|usr=028}}
+{{tp|p=34413215|t=2021. Israel's grim warning: Delta can overwhelm shots.|pdf=|usr=028}}
+{{tp|p=34362872|t=2021. Phylogenomic analysis of SARS-CoV-2 from third wave clusters in Malaysia reveals dominant local lineage B.1.524 and persistent spike mutation A701V.|pdf=|usr=028}}
+{{tp|p=34363852|t=2021. Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021.|pdf=|usr=028}}
+{{tp|p=34355546|t=2021. NLRP3 inflammasome activation and oxidative stress status in the mild and moderate SARS-CoV-2 infected patients: impact of melatonin as a medicinal supplement.|pdf=|usr=028}}
+{{tp|p=34428364|t=2021. Cytokine storm syndrome in SARS-CoV-2: a review.|pdf=|usr=028}}
+{{tp|p=34362671|t=2021. ORF8a as a viroporin in SARS-CoV-2 infection?|pdf=|usr=028}}
+{{tp|p=34425451|t=2021. SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: reports in two cities in the United States.|pdf=|usr=028}}
+{{tp|p=34410992|t=2021. Nine Cases of SARS-CoV-2-PCR-positive Samples Showed No Increase of Antibodies Against SARS-CoV-2.|pdf=|usr=028}}
+{{tp|p=34406867|t=2021. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage.|pdf=|usr=028}}